Citrus Sinensis ID: 011763
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 478 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.776 | 0.648 | 0.666 | 1e-156 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.769 | 0.515 | 0.679 | 1e-152 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.725 | 0.676 | 0.489 | 8e-96 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.728 | 0.689 | 0.490 | 2e-94 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.725 | 0.668 | 0.481 | 3e-93 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.728 | 0.678 | 0.485 | 4e-93 | |
| Q14004 | 1512 | Cyclin-dependent kinase 1 | yes | no | 0.694 | 0.219 | 0.440 | 1e-77 | |
| E1BB52 | 1512 | Cyclin-dependent kinase 1 | yes | no | 0.694 | 0.219 | 0.440 | 2e-77 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | yes | no | 0.694 | 0.219 | 0.440 | 2e-77 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | no | no | 0.688 | 0.220 | 0.435 | 4e-76 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 553 bits (1424), Expect = e-156, Method: Compositional matrix adjust.
Identities = 248/372 (66%), Positives = 309/372 (83%), Gaps = 1/372 (0%)
Query: 92 RLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARD 151
RL N K+ GEQVAAGWP+WLS GEA+ GWVP +AD FEK++KIGQGTYS+V++A+D
Sbjct: 78 RLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKD 137
Query: 152 LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211
+ TGKIVALKKVRFDN EPESV+FMAREIL+LRRLDHPN++KLEGL+TSR+SCS+YLVF+
Sbjct: 138 MLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQ 197
Query: 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLK 271
YM+HD+ GL S P +KFSE+++KC M QL+ GLEHCHSRGVLHRDIKGSNLL+++ GVLK
Sbjct: 198 YMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLK 257
Query: 272 LADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
+ADFGLA + H++P+TSRVVTLWYR PELLLGATDYG +DLWS GC+ AELL G+P
Sbjct: 258 IADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRP 317
Query: 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 391
I+ GRTEVEQLHKI+KLCGSP +DYWKK K H ++KP++PY S+RETFKD P +++
Sbjct: 318 IMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLP 377
Query: 392 LIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHR-EDARRKKV 450
LI+ LLS+EP R TASAAL SE+F+++PYAC+ + LP YPPSKEIDAK R E+ RR++
Sbjct: 378 LIDALLSIEPEDRQTASAALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRA 437
Query: 451 GGRVRGAETRKT 462
+ +G RK
Sbjct: 438 ASKAQGDGARKN 449
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 538 bits (1387), Expect = e-152, Method: Compositional matrix adjust.
Identities = 250/368 (67%), Positives = 304/368 (82%)
Query: 102 GEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALK 161
G QV AGWP+WL++VAGEAI GW+P +AD+FEKLEKIGQGTYSSV++ARDL+T ++VALK
Sbjct: 133 GAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALK 192
Query: 162 KVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL 221
KVRF N +P+SVRFMAREI+ILRRLDHPN++KLEGLITSR+S S+YL+FEYMEHD+ GL
Sbjct: 193 KVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLA 252
Query: 222 SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281
S P I FSEAQIKCYM QLLHGLEHCHSRGVLHRDIKGSNLL+++ LK+ DFGLANF
Sbjct: 253 STPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFY 312
Query: 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341
+QPLTSRVVTLWYRPPELLLG+TDYG +VDLWS GC+ AEL GKPI+ GRTEVEQ
Sbjct: 313 QGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQ 372
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 401
LHKIFKLCGSP ++YWK SKLPHAT+FKPQQPY + ETFK LP++A+ L+E LL+VEP
Sbjct: 373 LHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEP 432
Query: 402 YKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRK 461
R T ++AL SE+F+T P A D SSLP Y P KEID K +E+ ++K + ++++
Sbjct: 433 DARGTTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDSKQ 492
Query: 462 TTRKSHGM 469
+R+S +
Sbjct: 493 VSRESKAV 500
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 351 bits (900), Expect = 8e-96, Method: Compositional matrix adjust.
Identities = 181/370 (48%), Positives = 242/370 (65%), Gaps = 23/370 (6%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D FEKLE+IG+GTY V+ A++ +T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 183 LRRLDHPNIIKLEGLITS---------------RLSCSIYLVFEYMEHDITGLLSCPDIK 227
L++L H N+I+L+ ++TS + SIY+VFEYM+HD+TGL P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
F+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA ++ H
Sbjct: 136 FTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNG 195
Query: 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
LT+RV+TLWYRPPELLLG+T YGP+VD+WSVGC+FAELL GKPIL G+ E EQL KIF+
Sbjct: 196 NLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFE 255
Query: 348 LCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
LCG+P + W +K+P FKPQ+P ++E+FK A++L+E +L+++P +R +
Sbjct: 256 LCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRIS 315
Query: 407 ASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKS 466
A AL +EYF T P CD SLP Y S E K + +R+ A R+ +
Sbjct: 316 AKDALDAEYFWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQ-----AEEAAKRQKLQHP 370
Query: 467 HGMSKLAPVE 476
S+L P++
Sbjct: 371 PPHSRLPPIQ 380
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 346 bits (888), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 181/369 (49%), Positives = 237/369 (64%), Gaps = 21/369 (5%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D FEKLE+IG+GTY V+ A+++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 183 LRRLDHPNIIKLEGLITS--------------RLSCSIYLVFEYMEHDITGLLSCPDIKF 228
L++L H N+I+L+ ++TS + IY+VFEYM+HD+TGL P ++F
Sbjct: 77 LKKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 229 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288
+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA + H
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
LT+RV+TLWYRPPELLLGAT YGP++D+WSVGC+FAELL KPIL G+ E EQL+KIF+L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFEL 256
Query: 349 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
CGSP + W SK+P FKP +P +RE F+ A+ L+E +L ++P +R +A
Sbjct: 257 CGSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISA 316
Query: 408 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH 467
AL +EYF T P CD SLP Y S E K + +R+ A+ +K
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQQRQN----EEAAKRQKLQHPPL 372
Query: 468 GMSKLAPVE 476
S+L P++
Sbjct: 373 QHSRLPPLQ 381
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (879), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 178/370 (48%), Positives = 236/370 (63%), Gaps = 23/370 (6%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D FEKLE+IG+GTY V+ AR+ +T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 183 LRRLDHPNIIKLEGLITS---------------RLSCSIYLVFEYMEHDITGLLSCPDIK 227
L++L H N+I+L+ ++TS + SIY+VFEYM+HD+TGL P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
F+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA + H
Sbjct: 136 FTVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNG 195
Query: 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
LT+RV+TLWYRPPELLLG+T YGP+VD+WSVGC+FAELL GKPIL G+ E EQL KIF
Sbjct: 196 NLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFD 255
Query: 348 LCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
+CG+P + W +K+P FKP + ++E FK A++L+E +L+++P +R +
Sbjct: 256 VCGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRIS 315
Query: 407 ASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKS 466
A AL +EYF + P CD SLP Y S E K + R+ A R+ T+
Sbjct: 316 AQDALDAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQ-----ADEAAKRQKTQHP 370
Query: 467 HGMSKLAPVE 476
+L P++
Sbjct: 371 QPHGRLPPIQ 380
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (876), Expect = 4e-93, Method: Compositional matrix adjust.
Identities = 179/369 (48%), Positives = 235/369 (63%), Gaps = 21/369 (5%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D FEKLE+IG+GTY V+ A+++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 183 LRRLDHPNIIKLEGLITS--------------RLSCSIYLVFEYMEHDITGLLSCPDIKF 228
L++L H N+I L+ ++TS + IY+VFEYM+HD+TGL P ++F
Sbjct: 77 LKKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 229 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288
+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA + H
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
LT+RV+TLWYRPPELLLGAT YGP++D+WSVGC+FAELL GKPIL G+TE EQL+KI++L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYEL 256
Query: 349 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
CGSP + W SK+P K +P +RE ++ A+ L+E +L ++P +R A
Sbjct: 257 CGSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICA 316
Query: 408 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH 467
AL +EYF T P CD SLP Y S E K +R+++ A+ +K
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPTYESSHEFQTK----KKRQQMRHNEEAAKKQKLQHPQQ 372
Query: 468 GMSKLAPVE 476
S+L P +
Sbjct: 373 QHSRLPPQQ 381
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14004|CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 290 bits (742), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 153/347 (44%), Positives = 211/347 (60%), Gaps = 15/347 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
D F+ + IG+GTY V++ARD DTG++VALKKVR DN E E A REI ILR+L H
Sbjct: 703 DKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKILRQLTH 761
Query: 189 PNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
+II ++ ++T + + YLVFEYM+HD+ GLL + F+E IK +M QL
Sbjct: 762 QSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQL 821
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++V+TLWYRP
Sbjct: 822 MEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYRP 881
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP W
Sbjct: 882 PELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDV 941
Query: 361 -KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF-ST 418
KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL E+
Sbjct: 942 IKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEFLRDV 1001
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 465
+P LP++ E+ +K R RR+K G T K RK
Sbjct: 1002 EPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDVSTIKAPRK 1045
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|E1BB52|CDK13_BOVIN Cyclin-dependent kinase 13 OS=Bos taurus GN=CDK13 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (741), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 153/347 (44%), Positives = 211/347 (60%), Gaps = 15/347 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
D F+ + IG+GTY V++ARD DTG++VALKKVR DN E E A REI ILR+L H
Sbjct: 704 DKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKILRQLTH 762
Query: 189 PNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
+II ++ ++T + + YLVFEYM+HD+ GLL + F+E IK +M QL
Sbjct: 763 QSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQL 822
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++V+TLWYRP
Sbjct: 823 MEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYRP 882
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP W
Sbjct: 883 PELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDV 942
Query: 361 -KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF-ST 418
KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL E+
Sbjct: 943 IKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEFLRDV 1002
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 465
+P LP++ E+ +K R RR+K G T K RK
Sbjct: 1003 EPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDVSTVKAPRK 1046
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 290 bits (741), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 153/347 (44%), Positives = 211/347 (60%), Gaps = 15/347 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
D F+ + IG+GTY V++ARD DTG++VALKKVR DN E E A REI ILR+L H
Sbjct: 703 DKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKILRQLTH 761
Query: 189 PNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
+II ++ ++T + + YLVFEYM+HD+ GLL + F+E IK +M QL
Sbjct: 762 QSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQL 821
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++V+TLWYRP
Sbjct: 822 MEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYRP 881
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP W
Sbjct: 882 PELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDV 941
Query: 361 -KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF-ST 418
KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL E+
Sbjct: 942 IKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEFLRDV 1001
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 465
+P LP++ E+ +K R RR+K G T K RK
Sbjct: 1002 EPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDLSTIKAPRK 1045
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 285 bits (730), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 153/351 (43%), Positives = 215/351 (61%), Gaps = 22/351 (6%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
D F+ + IG+GTY V++A+D DTG++VALKKVR DN E E A REI ILR+L H
Sbjct: 725 DKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLIH 783
Query: 189 PNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
+++ ++ ++T + + YLVFEYM+HD+ GLL + FSE IK +M QL
Sbjct: 784 RSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 843
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ GLE+CH + LHRDIK SN+L+NN G +KLADFGLA N+ +P T++V+TLWYRP
Sbjct: 844 MEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 903
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PELLLG Y P++D+WS GC+ EL KPI Q E+ QL I +LCGSP W
Sbjct: 904 PELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDV 963
Query: 361 -KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419
KLP+ KP++ Y LRE F +P+ A++L++ +L+++P KR TA L S++
Sbjct: 964 IKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKD- 1022
Query: 420 PYACDLS-----SLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 465
+LS LP + E+ +K R R+++ G V KT+RK
Sbjct: 1023 ---VELSKMAPPDLPHWQDCHELWSKKRR--RQRQSGVVVEEPPPSKTSRK 1068
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 478 | ||||||
| 224119046 | 685 | predicted protein [Populus trichocarpa] | 0.951 | 0.664 | 0.802 | 0.0 | |
| 255547313 | 661 | ATP binding protein, putative [Ricinus c | 0.903 | 0.653 | 0.794 | 0.0 | |
| 356516828 | 677 | PREDICTED: probable serine/threonine-pro | 0.941 | 0.664 | 0.785 | 0.0 | |
| 449439293 | 697 | PREDICTED: probable serine/threonine-pro | 0.976 | 0.670 | 0.792 | 0.0 | |
| 356508521 | 674 | PREDICTED: probable serine/threonine-pro | 0.935 | 0.663 | 0.781 | 0.0 | |
| 359491675 | 663 | PREDICTED: probable serine/threonine-pro | 0.907 | 0.654 | 0.759 | 0.0 | |
| 356565121 | 671 | PREDICTED: probable serine/threonine-pro | 0.922 | 0.657 | 0.757 | 0.0 | |
| 297733936 | 686 | unnamed protein product [Vitis vinifera] | 0.956 | 0.666 | 0.769 | 0.0 | |
| 356511986 | 670 | PREDICTED: probable serine/threonine-pro | 0.920 | 0.656 | 0.751 | 0.0 | |
| 238479065 | 690 | protein kinase domain-containing protein | 0.966 | 0.669 | 0.730 | 0.0 |
| >gi|224119046|ref|XP_002317972.1| predicted protein [Populus trichocarpa] gi|222858645|gb|EEE96192.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2017), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/480 (80%), Positives = 416/480 (86%), Gaps = 25/480 (5%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVG---NGSGSRNGRGSSNR 57
MGCV++KQAVSVTPALD SG F N+GRIRVG + S +NG
Sbjct: 1 MGCVSAKQAVSVTPALDHSGAF-------------NTGRIRVGVDQHPSFKKNG------ 41
Query: 58 KKGSKGEFGVAVSCGGSELGESGRA-SSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAV 116
+ + VSCGGSELGESGRA SSN ESLSFRL NLHKYIEGEQVAAGWPAWLSAV
Sbjct: 42 --DRRHHHEMVVSCGGSELGESGRAPSSNGESLSFRLRNLHKYIEGEQVAAGWPAWLSAV 99
Query: 117 AGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFM 176
AGEAI GWVPL AD FEKL+KIGQGTYSSVFRAR+ +TG+IVALKKVRFDNFEPESVRFM
Sbjct: 100 AGEAIHGWVPLNADGFEKLDKIGQGTYSSVFRARETETGRIVALKKVRFDNFEPESVRFM 159
Query: 177 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY 236
AREILILRRLDHPNI+KL+GLITSRLSCS+YLVFEYMEHDITGLLSCPD++FSE+QIKCY
Sbjct: 160 AREILILRRLDHPNIMKLDGLITSRLSCSLYLVFEYMEHDITGLLSCPDVRFSESQIKCY 219
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
M QLL GL+HCHS+GV+HRDIKGSNLLVNNEG+LK+ DFGLANF +GHRQPLTSRVVTL
Sbjct: 220 MRQLLSGLDHCHSKGVMHRDIKGSNLLVNNEGILKVGDFGLANFCTSGHRQPLTSRVVTL 279
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
WYRPPELLLG+TDYG SVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+Y
Sbjct: 280 WYRPPELLLGSTDYGASVDLWSVGCVFAELLLGKPILQGRTEVEQLHKIFKLCGSPPDEY 339
Query: 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
WKKSKLPHATLFKPQQPYDS LRETFKDLPTTAVNLIETLLSVEPY R TA +ALASEYF
Sbjct: 340 WKKSKLPHATLFKPQQPYDSCLRETFKDLPTTAVNLIETLLSVEPYNRGTAFSALASEYF 399
Query: 417 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
STKPYACD SSLP YPPSKEIDAK E+A RKK+ GR RG ETRK TRK +G+SKLAP E
Sbjct: 400 STKPYACDPSSLPKYPPSKEIDAKKHEEAGRKKISGRGRGTETRKCTRKPYGISKLAPAE 459
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547313|ref|XP_002514714.1| ATP binding protein, putative [Ricinus communis] gi|223546318|gb|EEF47820.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 775 bits (2001), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/476 (79%), Positives = 407/476 (85%), Gaps = 44/476 (9%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA D SGGF NSGRIR G
Sbjct: 1 MGCVSSKQAVSVTPAFDHSGGF-------------NSGRIRAG----------------- 30
Query: 61 SKGEFGVAVSCGGSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEA 120
ELGESGRASSN ES+SFRL NL KYIEGE VAAGWPAWLSAVAGEA
Sbjct: 31 --------------ELGESGRASSNGESVSFRLRNLQKYIEGEHVAAGWPAWLSAVAGEA 76
Query: 121 IQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREI 180
IQGWVPL+ADAFEKLEKIGQGTYSSVFRAR+++TG+IVALKKVRFDNFEPESVRFMAREI
Sbjct: 77 IQGWVPLKADAFEKLEKIGQGTYSSVFRAREIETGRIVALKKVRFDNFEPESVRFMAREI 136
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
LILRRLDHPN++KL+GLITSRLSCSIYLVFEYMEHDITGLLSCPD++FSE+QIKCYM QL
Sbjct: 137 LILRRLDHPNVMKLDGLITSRLSCSIYLVFEYMEHDITGLLSCPDVRFSESQIKCYMRQL 196
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L GLEHCHS+GV+HRDIKGSNLLVNNEG+LK+ DFGLANF +TGHRQPLTSRVVTLWYRP
Sbjct: 197 LFGLEHCHSKGVMHRDIKGSNLLVNNEGMLKVGDFGLANFCHTGHRQPLTSRVVTLWYRP 256
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PELLLG+T+YG SVDLWSVGCVFAELL+GKP+LQGRTEVEQLHKIFKLCGSPPD+YWKKS
Sbjct: 257 PELLLGSTEYGASVDLWSVGCVFAELLLGKPVLQGRTEVEQLHKIFKLCGSPPDEYWKKS 316
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
+LPHATLFKPQQPYDSSLRE FKDLPTTAVNLIETLLSVEPYKR TAS+ALASEYF TKP
Sbjct: 317 RLPHATLFKPQQPYDSSLREIFKDLPTTAVNLIETLLSVEPYKRGTASSALASEYFMTKP 376
Query: 421 YACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
YACD SSLP YPPSKEIDAK+RE+ARRKK GR RGAETRK RK G++KLAP E
Sbjct: 377 YACDPSSLPKYPPSKEIDAKNREEARRKKTSGRSRGAETRKPARKPGGINKLAPAE 432
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516828|ref|XP_003527095.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/476 (78%), Positives = 411/476 (86%), Gaps = 26/476 (5%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA+D SG FR + AGG + ++
Sbjct: 1 MGCVSSKQAVSVTPAIDHSGAFR----SNAGGLAE------------------PEKKRSK 38
Query: 61 SKGEFGVAVSCGGSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEA 120
+ E G A SE+GESGR SSN +SLSFRLGNLHKY++GE VAAGWPAWLSAVAGEA
Sbjct: 39 KRTESGGA---SQSEVGESGRTSSNCDSLSFRLGNLHKYVQGEHVAAGWPAWLSAVAGEA 95
Query: 121 IQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREI 180
I GWVPLRADAFEKLEKIGQGTYSSVFRAR+L+TGKIVALKKVRFDNFEPESVRFMAREI
Sbjct: 96 IHGWVPLRADAFEKLEKIGQGTYSSVFRARELETGKIVALKKVRFDNFEPESVRFMAREI 155
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS PDIKF+E QIKCYM QL
Sbjct: 156 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSSPDIKFTEPQIKCYMKQL 215
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L GLEHCH RGV+HRDIKGSNLLVNNEGVLK+ADFGLANF N GHRQPLTSRVVTLWYRP
Sbjct: 216 LVGLEHCHLRGVMHRDIKGSNLLVNNEGVLKVADFGLANFVNPGHRQPLTSRVVTLWYRP 275
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PELLLG+TDYGP+VDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+YWKKS
Sbjct: 276 PELLLGSTDYGPAVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDEYWKKS 335
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
+LPHATLFKPQQPYDS LR++FKDLP T+V+L++TLLS+EPYKR TA++AL+SEYF TKP
Sbjct: 336 RLPHATLFKPQQPYDSCLRQSFKDLPVTSVHLLQTLLSIEPYKRGTATSALSSEYFKTKP 395
Query: 421 YACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
YACD SSLP+YPPSKEIDAKHRE++ RKK+ GRVRG ETRK +RK G +KLAP E
Sbjct: 396 YACDPSSLPVYPPSKEIDAKHREES-RKKISGRVRGTETRKPSRKPLGFNKLAPAE 450
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439293|ref|XP_004137420.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] gi|449486990|ref|XP_004157463.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1972), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/481 (79%), Positives = 415/481 (86%), Gaps = 14/481 (2%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVG-NGSGSRNGRGSSNRKK 59
MGCV +KQAVSVTPA D SG FR + G NSGR R+G G + + + KK
Sbjct: 1 MGCVNTKQAVSVTPAFDHSGVFRDNESTAVG----NSGRSRLGLVGEIEKVSKPKAKVKK 56
Query: 60 GSKGEF-GVAVSCGGSELGESGRASSN---SESLSFRLGNLHKYIEGEQVAAGWPAWLSA 115
S EF GV GSE GESGRASS +E+LSFRLGNL+KYIEGEQVAAGWPAWLSA
Sbjct: 57 KSSSEFNGV-----GSEFGESGRASSKGGGNETLSFRLGNLNKYIEGEQVAAGWPAWLSA 111
Query: 116 VAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF 175
VAGEAIQGWVPLR+DA+EKLEKIGQGTYSSVFRAR+L+TG+IVALKKVRFDNFEPESVRF
Sbjct: 112 VAGEAIQGWVPLRSDAYEKLEKIGQGTYSSVFRARELETGRIVALKKVRFDNFEPESVRF 171
Query: 176 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 235
MAREI+ILR LDHPNIIKLEGLITSRLSCSIYLVFEYM+HDITGLLSCPDI FSE+QIKC
Sbjct: 172 MAREIMILRGLDHPNIIKLEGLITSRLSCSIYLVFEYMDHDITGLLSCPDITFSESQIKC 231
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 295
YM QLL GLEHCHSRGV+HRDIKGSNLLVNNEGVLK+ADFGLANF NTGHRQPLTSRVVT
Sbjct: 232 YMKQLLSGLEHCHSRGVMHRDIKGSNLLVNNEGVLKVADFGLANFCNTGHRQPLTSRVVT 291
Query: 296 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
LWYRPPELLLG+TDY SVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+
Sbjct: 292 LWYRPPELLLGSTDYNASVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDE 351
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
YWKKSKLPHATLFKPQ PY++ LR+TFKD P+T VNL+ETLLSVEPYKR AS+AL SEY
Sbjct: 352 YWKKSKLPHATLFKPQHPYNNCLRQTFKDHPSTTVNLLETLLSVEPYKRGVASSALISEY 411
Query: 416 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 475
FSTKPYACD SS+PIYPP+KEIDAK RE+ RRKK GR RG + R+ TRK G+SKLAP
Sbjct: 412 FSTKPYACDPSSMPIYPPNKEIDAKQREETRRKKGSGRSRGLDNRRLTRKHLGISKLAPA 471
Query: 476 E 476
E
Sbjct: 472 E 472
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508521|ref|XP_003523004.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1962), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/476 (78%), Positives = 408/476 (85%), Gaps = 29/476 (6%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA+D G FR + AGG + + R +G G
Sbjct: 1 MGCVSSKQAVSVTPAIDHYGAFR----SNAGGPCEPEKK-RTESGGGPSQ---------- 45
Query: 61 SKGEFGVAVSCGGSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEA 120
SE+GESGR SSN ESLSFRLGNL KY++GE VAAGWPAWLSAVAGEA
Sbjct: 46 -------------SEVGESGRTSSNCESLSFRLGNLQKYVQGEHVAAGWPAWLSAVAGEA 92
Query: 121 IQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREI 180
IQGWVPLRADAFEKLEKIGQGTYSSVFRAR+L+T KIVALKKVRFDNFEPESVRFMAREI
Sbjct: 93 IQGWVPLRADAFEKLEKIGQGTYSSVFRARELETRKIVALKKVRFDNFEPESVRFMAREI 152
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS PDIKF+E QIKCYM QL
Sbjct: 153 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSSPDIKFTEPQIKCYMKQL 212
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L GLEHCH RGV+HRDIKGSNLLVNNEGVLK+ADFGLAN+ N+GHRQPLTSRVVTLWYRP
Sbjct: 213 LAGLEHCHLRGVMHRDIKGSNLLVNNEGVLKVADFGLANYVNSGHRQPLTSRVVTLWYRP 272
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PELLLG+TDY PSVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+YWKKS
Sbjct: 273 PELLLGSTDYDPSVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDEYWKKS 332
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
KLPHATLFKP+QPYDS LR++FKDLPTT+V+L++TLLSVEPYKR TA++AL+SEYF TKP
Sbjct: 333 KLPHATLFKPEQPYDSCLRQSFKDLPTTSVHLLQTLLSVEPYKRGTATSALSSEYFKTKP 392
Query: 421 YACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
YACD SSLP+YPPSKEIDAKHR+++ RKK+ GRVRG TRK +RK G +KLAP E
Sbjct: 393 YACDPSSLPVYPPSKEIDAKHRDES-RKKISGRVRGTATRKPSRKPLGFNKLAPAE 447
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491675|ref|XP_003634302.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1908), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/478 (75%), Positives = 407/478 (85%), Gaps = 44/478 (9%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA DVS FR DN+G R SR GR
Sbjct: 1 MGCVSSKQAVSVTPAFDVSVAFR-----------DNAGSGR------SRGGR-------- 35
Query: 61 SKGEFGVAVSCGGSELGESGRASSNS--ESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAG 118
LGESGR SSN +SLSFRLGNLHKY+EGEQVAAGWPAWLSAVAG
Sbjct: 36 ---------------LGESGRVSSNGGGDSLSFRLGNLHKYVEGEQVAAGWPAWLSAVAG 80
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR 178
EAIQGWVPLRAD+++ LEKIGQGTYS+VFRAR+L+TG++VALKKVRFDNFEPESVRFMAR
Sbjct: 81 EAIQGWVPLRADSYQTLEKIGQGTYSTVFRARELETGRVVALKKVRFDNFEPESVRFMAR 140
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
EI ILRRLDHPNI+KL+GLITSRLSCSIYLVFEYMEHD++GL+SCPDIKFSE+Q+KCY
Sbjct: 141 EITILRRLDHPNIVKLDGLITSRLSCSIYLVFEYMEHDLSGLMSCPDIKFSESQVKCYTK 200
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
QLL GLEHCHSRGV+HRDIKG+NLLVNNEG+LK+ADFGLANF ++ +RQPLTSRVVTLWY
Sbjct: 201 QLLSGLEHCHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVTLWY 260
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
RPPELLLG+TDYG SVDLWSVGCVFAELL+G+PIL+GRTEVEQLHKIFKLCGSPPD+YWK
Sbjct: 261 RPPELLLGSTDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDEYWK 320
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
KSKLPHATLFKPQQPY+S LRE+FKDLPT +V+LIETLLSVEPYKR TAS+ALASEYF T
Sbjct: 321 KSKLPHATLFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEYFKT 380
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
KPYACD SSLP Y P+KEIDAK+RE++RRKKVGGRVRG+E K TRK +G++KL P E
Sbjct: 381 KPYACDPSSLPKYSPNKEIDAKNREESRRKKVGGRVRGSE--KPTRKPNGINKLVPAE 436
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565121|ref|XP_003550793.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 735 bits (1897), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/478 (75%), Positives = 401/478 (83%), Gaps = 37/478 (7%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV KQAVSVTPA++ S +N NRKK
Sbjct: 1 MGCVVVKQAVSVTPAIEHSV-------------------------ESEKN-----NRKKK 30
Query: 61 SKGEFGVAVSCGGSELGESGRASSN--SESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAG 118
++ +V SELGESGRASSN SESLSFRLGNL KY+EGEQ AAGWPAWLSAVA
Sbjct: 31 TE-----SVGASRSELGESGRASSNGGSESLSFRLGNLSKYVEGEQAAAGWPAWLSAVAC 85
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR 178
EAI GWVPLRADAFEKL+KIGQGTYSSVFRA++++TGKIVALKKVRFDNFEPESVRFMAR
Sbjct: 86 EAIHGWVPLRADAFEKLDKIGQGTYSSVFRAKEVETGKIVALKKVRFDNFEPESVRFMAR 145
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
EI+ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL+ P+IKFSE+QIKCYM
Sbjct: 146 EIMILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLARPEIKFSESQIKCYMK 205
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
QLL GLEHCHSRGV+HRDIKGSNLLVNNEG+LK+ADFGLANFSN+G++QPLTSRVVTLWY
Sbjct: 206 QLLSGLEHCHSRGVMHRDIKGSNLLVNNEGILKVADFGLANFSNSGNKQPLTSRVVTLWY 265
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
RPPELLLG+T YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP++YWK
Sbjct: 266 RPPELLLGSTAYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPEEYWK 325
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
K++LPHATLFKPQQPYDSSLRETFKD + VNL++TLLSVEP KR TAS+AL+ EYF
Sbjct: 326 KTRLPHATLFKPQQPYDSSLRETFKDFHASTVNLLQTLLSVEPSKRGTASSALSLEYFKI 385
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
KPYAC+ SSLPIYPPSKEIDAKH E++RRKK+GGR E+RK +RK +SKLAP E
Sbjct: 386 KPYACEPSSLPIYPPSKEIDAKHEEESRRKKIGGRACKPESRKPSRKPLALSKLAPAE 443
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297733936|emb|CBI15183.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1894), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/478 (76%), Positives = 414/478 (86%), Gaps = 21/478 (4%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA DVS FR DN+G R SR GR + +
Sbjct: 1 MGCVSSKQAVSVTPAFDVSVAFR-----------DNAGSGR------SRGGRVVAAEFEK 43
Query: 61 SKGEFGVAVSCGGSELGESGRASSNS--ESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAG 118
K G GSELGESGR SSN +SLSFRLGNLHKY+EGEQVAAGWPAWLSAVAG
Sbjct: 44 KKKSGGGESGLSGSELGESGRVSSNGGGDSLSFRLGNLHKYVEGEQVAAGWPAWLSAVAG 103
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR 178
EAIQGWVPLRAD+++ LEKIGQGTYS+VFRAR+L+TG++VALKKVRFDNFEPESVRFMAR
Sbjct: 104 EAIQGWVPLRADSYQTLEKIGQGTYSTVFRARELETGRVVALKKVRFDNFEPESVRFMAR 163
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
EI ILRRLDHPNI+KL+GLITSRLSCSIYLVFEYMEHD++GL+SCPDIKFSE+Q+KCY
Sbjct: 164 EITILRRLDHPNIVKLDGLITSRLSCSIYLVFEYMEHDLSGLMSCPDIKFSESQVKCYTK 223
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
QLL GLEHCHSRGV+HRDIKG+NLLVNNEG+LK+ADFGLANF ++ +RQPLTSRVVTLWY
Sbjct: 224 QLLSGLEHCHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVTLWY 283
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
RPPELLLG+TDYG SVDLWSVGCVFAELL+G+PIL+GRTEVEQLHKIFKLCGSPPD+YWK
Sbjct: 284 RPPELLLGSTDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDEYWK 343
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
KSKLPHATLFKPQQPY+S LRE+FKDLPT +V+LIETLLSVEPYKR TAS+ALASEYF T
Sbjct: 344 KSKLPHATLFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEYFKT 403
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
KPYACD SSLP Y P+KEIDAK+RE++RRKKVGGRVRG+E K TRK +G++KL P E
Sbjct: 404 KPYACDPSSLPKYSPNKEIDAKNREESRRKKVGGRVRGSE--KPTRKPNGINKLVPAE 459
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511986|ref|XP_003524702.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1890), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/478 (75%), Positives = 399/478 (83%), Gaps = 38/478 (7%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV +KQAVSVTPA++ S NRKK
Sbjct: 1 MGCVVAKQAVSVTPAIEHSV-------------------------------ESEKNRKKK 29
Query: 61 SKGEFGVAVSCGGSELGESGRASSN--SESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAG 118
++ +V SELGESGRASSN SESLSFRLGNL KY+EGEQ AAGWPAWLSAVA
Sbjct: 30 TE-----SVGASRSELGESGRASSNGGSESLSFRLGNLSKYVEGEQAAAGWPAWLSAVAC 84
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR 178
EAI GWVPLRADAFEKL+KIGQGTYSSVFRA+++ TGKIVALKKVRFDNFEPESVRFMAR
Sbjct: 85 EAIHGWVPLRADAFEKLDKIGQGTYSSVFRAKEIQTGKIVALKKVRFDNFEPESVRFMAR 144
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
EI+ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL+ P+IKFSE+QIKCYM
Sbjct: 145 EIMILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLARPEIKFSESQIKCYMK 204
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
QLL G+EHCHSRGV+HRDIKGSNLLVNNEG+LK+ADFGLANFSN+G++QPLTSRVVTLWY
Sbjct: 205 QLLSGIEHCHSRGVMHRDIKGSNLLVNNEGILKVADFGLANFSNSGNKQPLTSRVVTLWY 264
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
RPPELLLG+T YG SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP++YWK
Sbjct: 265 RPPELLLGSTAYGASVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPEEYWK 324
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
K++LPHATLFKPQQPYDS LRETFKD ++VNL++TLLSVEP KR TAS+AL+ EYF T
Sbjct: 325 KTRLPHATLFKPQQPYDSCLRETFKDFHASSVNLLQTLLSVEPSKRGTASSALSLEYFKT 384
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
KPYACD SSLPIYPPSKEIDAK+ E++RRKK+GGR AE+RK +R +SKLAP E
Sbjct: 385 KPYACDPSSLPIYPPSKEIDAKNEEESRRKKIGGRACRAESRKPSRNPLALSKLAPAE 442
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|238479065|ref|NP_001154470.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|332197458|gb|AEE35579.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/478 (73%), Positives = 401/478 (83%), Gaps = 16/478 (3%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQ VSVTPA+D SG F+ + +G SGRI V + + S R +
Sbjct: 1 MGCVSSKQTVSVTPAIDHSGVFKDNENECSG-----SGRIVVEDPPRPTLKKLVSWRSRS 55
Query: 61 SKGEFGVAVSCGGSELG-ESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGE 119
K + GSELG ESGRAS +SLSFRLGN+ +Y+E EQVAAGWPAWLS VAGE
Sbjct: 56 GKRRSQKS----GSELGSESGRAS---DSLSFRLGNVSRYLEAEQVAAGWPAWLSNVAGE 108
Query: 120 AIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMARE 179
AI GWVPLR+DAFEKLEKIGQGTYS+VFRA + +TG+IVALKKVRFDNFEPESV+FMARE
Sbjct: 109 AIHGWVPLRSDAFEKLEKIGQGTYSNVFRAVETETGRIVALKKVRFDNFEPESVKFMARE 168
Query: 180 ILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
ILILRRL+HPNIIKLEGLITS+LSC+I LVFEYMEHD+TGLLS PDIKF+ QIKCYM Q
Sbjct: 169 ILILRRLNHPNIIKLEGLITSKLSCNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKCYMKQ 228
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-TGH-RQPLTSRVVTLW 297
LL GL+HCHSRGV+HRDIKGSNLL++NEG+LK+ADFGLANFSN +GH ++PLTSRVVTLW
Sbjct: 229 LLSGLDHCHSRGVMHRDIKGSNLLLSNEGILKVADFGLANFSNSSGHKKKPLTSRVVTLW 288
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357
YRPPELLLGATDYG SVDLWSVGCVFAELL+GKPIL+GRTEVEQLHKIFKLCGSPP+DYW
Sbjct: 289 YRPPELLLGATDYGASVDLWSVGCVFAELLLGKPILRGRTEVEQLHKIFKLCGSPPEDYW 348
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
KKSKLPHA LFKPQQ YDS LRET KDL T +NLIETLLS++P+KR TAS+AL S+YF+
Sbjct: 349 KKSKLPHAMLFKPQQTYDSCLRETLKDLSETEINLIETLLSIDPHKRGTASSALVSQYFT 408
Query: 418 TKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGR-VRGAETRKTTRKSHGMSKLAP 474
TKP+ACD SSLPIYPPSKEID KHR++A RKK+ G RG + RK +RK+H ++LAP
Sbjct: 409 TKPFACDPSSLPIYPPSKEIDTKHRDEAARKKISGNGRRGIDPRKPSRKAHSFNRLAP 466
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 478 | ||||||
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.834 | 0.570 | 0.780 | 1.5e-177 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.841 | 0.566 | 0.776 | 3.1e-177 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.778 | 0.536 | 0.713 | 3.6e-144 | |
| TAIR|locus:2175743 | 644 | cdc2cAt "CDC2C" [Arabidopsis t | 0.767 | 0.569 | 0.705 | 7.5e-144 | |
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.738 | 0.616 | 0.685 | 6.2e-142 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.822 | 0.550 | 0.642 | 4e-138 | |
| TAIR|locus:504955609 | 629 | AT3G01085 [Arabidopsis thalian | 0.755 | 0.573 | 0.657 | 8.8e-134 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.761 | 0.592 | 0.656 | 1.1e-133 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.778 | 0.577 | 0.646 | 1e-130 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.792 | 0.512 | 0.630 | 3.6e-128 |
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1659 (589.1 bits), Expect = 1.5e-177, Sum P(2) = 1.5e-177
Identities = 317/406 (78%), Positives = 359/406 (88%)
Query: 73 GSELG-ESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADA 131
GSELG ESGRAS +SLSFRLGN+ +Y+E EQVAAGWPAWLS VAGEAI GWVPLR+DA
Sbjct: 64 GSELGSESGRAS---DSLSFRLGNVSRYLEAEQVAAGWPAWLSNVAGEAIHGWVPLRSDA 120
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
FEKLEKIGQGTYS+VFRA + +TG+IVALKKVRFDNFEPESV+FMAREILILRRL+HPNI
Sbjct: 121 FEKLEKIGQGTYSNVFRAVETETGRIVALKKVRFDNFEPESVKFMAREILILRRLNHPNI 180
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
IKLEGLITS+LSC+I LVFEYMEHD+TGLLS PDIKF+ QIKCYM QLL GL+HCHSRG
Sbjct: 181 IKLEGLITSKLSCNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKCYMKQLLSGLDHCHSRG 240
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQ-PLTSRVVTLWYRPPELLLGATD 309
V+HRDIKGSNLL++NEG+LK+ADFGLANFSN+ GH++ PLTSRVVTLWYRPPELLLGATD
Sbjct: 241 VMHRDIKGSNLLLSNEGILKVADFGLANFSNSSGHKKKPLTSRVVTLWYRPPELLLGATD 300
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
YG SVDLWSVGCVFAELL+GKPIL+GRTEVEQLHKIFKLCGSPP+DYWKKSKLPHA LFK
Sbjct: 301 YGASVDLWSVGCVFAELLLGKPILRGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFK 360
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP 429
PQQ YDS LRET KDL T +NLIETLLS++P+KR TAS+AL S+YF+TKP+ACD SSLP
Sbjct: 361 PQQTYDSCLRETLKDLSETEINLIETLLSIDPHKRGTASSALVSQYFTTKPFACDPSSLP 420
Query: 430 IYPPSKEIDAKHREDAXXXXXXXXXXXA-ETRKTTRKSHGMSKLAP 474
IYPPSKEID KHR++A + RK +RK+H ++LAP
Sbjct: 421 IYPPSKEIDTKHRDEAARKKISGNGRRGIDPRKPSRKAHSFNRLAP 466
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1654 (587.3 bits), Expect = 3.1e-177, Sum P(2) = 3.1e-177
Identities = 317/408 (77%), Positives = 353/408 (86%)
Query: 75 ELGESGRASSN--SESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAF 132
EL ESGRASSN SES+SFRLGNL KY+E EQVAAGWPAWLS VAGEAI GWVP R+DAF
Sbjct: 72 ELSESGRASSNCRSESVSFRLGNLSKYLEAEQVAAGWPAWLSNVAGEAIHGWVPFRSDAF 131
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
EKLEKIGQGTYSSVFRAR+ +TG+IVALKKVRFDNFEPESVRFMAREILILR+L+HPNII
Sbjct: 132 EKLEKIGQGTYSSVFRARETETGRIVALKKVRFDNFEPESVRFMAREILILRKLNHPNII 191
Query: 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
KLEG++TS+LSCSI+LVFEYMEHD+TGLLS PDI F+ QIKCYM QLL GL+HCH+RGV
Sbjct: 192 KLEGIVTSKLSCSIHLVFEYMEHDLTGLLSSPDIDFTTPQIKCYMKQLLSGLDHCHARGV 251
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSN-TGHRQPLTSRVVTLWYRPPELLLGATDYG 311
+HRDIKGSNLLVNNEG+LK+ADFGLANF N +G++QPLTSRVVTLWYRPPELLLGAT+YG
Sbjct: 252 MHRDIKGSNLLVNNEGILKVADFGLANFCNASGNKQPLTSRVVTLWYRPPELLLGATEYG 311
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
SVDLWSVGCVFAELLIGKP+LQGRTEVEQLHKIFKLCGSPP+DYWKKSKLPHA LFKPQ
Sbjct: 312 ASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQ 371
Query: 372 QPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP 429
Q YD LRET K L +NLIETLLS++P+KR TAS AL S+YF++KP+ACD SSLP
Sbjct: 372 QHYDGCLRETLKLKGLSDADINLIETLLSIQPHKRGTASTALVSQYFTSKPFACDPSSLP 431
Query: 430 IYPPSKEIDAKHREDAXXXXXXXXXXXA-ETRKTTRKSHGMSKLAPVE 476
+Y PSKEIDAKHRED E+RK TRK +KLAP E
Sbjct: 432 VYSPSKEIDAKHREDTTRKKISGNGRRGTESRKPTRKPPAFAKLAPAE 479
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1409 (501.1 bits), Expect = 3.6e-144, P = 3.6e-144
Identities = 266/373 (71%), Positives = 308/373 (82%)
Query: 98 KYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKI 157
K EGE VAAGWP WL++VAGEAI+GWVP RAD+FEKL+KIGQGTYS+V+RARDLD KI
Sbjct: 100 KATEGEYVAAGWPPWLASVAGEAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKI 159
Query: 158 VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDI 217
VALKKVRFDN EPESVRFMAREI ILRRLDHPNIIKLEGL+TSR+SCS+YLVFEYMEHD+
Sbjct: 160 VALKKVRFDNLEPESVRFMAREIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDL 219
Query: 218 TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 277
GL S P IKFSE+Q+KCY+ QLLHGL+HCHSRGVLHRDIKGSNLL++N GVLK+ADFGL
Sbjct: 220 AGLASHPAIKFSESQVKCYLQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGL 279
Query: 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 337
A+F + QPLTSRVVTLWYRPPELLLGAT YG +VDLWS GC+ AEL GKPI+ GRT
Sbjct: 280 ASFFDPRQTQPLTSRVVTLWYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRT 339
Query: 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 397
EVEQLHKIFKLCGSP +DYW KS+LPHAT+FKP QPY + ETFK+ P A+ L+ETLL
Sbjct: 340 EVEQLHKIFKLCGSPTEDYWVKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLL 399
Query: 398 SVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHR-EDAXXXXXXXXXXX 456
SV P R TA+AAL SE+FST+P CD SSLP YPPSKE+DA+ R E++
Sbjct: 400 SVNPDDRGTATAALKSEFFSTRPLPCDPSSLPKYPPSKELDARMRDEESRRQVGGNRDQR 459
Query: 457 AETRKTTRKSHGM 469
+ R+ T++S +
Sbjct: 460 HQERRGTKESRAI 472
|
|
| TAIR|locus:2175743 cdc2cAt "CDC2C" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1406 (500.0 bits), Expect = 7.5e-144, P = 7.5e-144
Identities = 259/367 (70%), Positives = 310/367 (84%)
Query: 78 ESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEK 137
+S R + + LG+ H+ IE EQ AAGWPAWL + A EA+ GWVPL+A+AF+KLEK
Sbjct: 51 KSRRLGGSDLRIGVSLGSSHRNIEAEQAAAGWPAWLCSAAAEAVHGWVPLKAEAFQKLEK 110
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL 197
IGQGTYSSVFRAR+++TGK+VALKKV+FDN +PES+RFMAREILILR+L+HPNI+KLEG+
Sbjct: 111 IGQGTYSSVFRAREVETGKMVALKKVKFDNLQPESIRFMAREILILRKLNHPNIMKLEGI 170
Query: 198 ITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 257
+TSR S SIYLVFEYMEHD+ GL S PDI+F+E QIKCYM QLL GLEHCH RGV+HRDI
Sbjct: 171 VTSRASSSIYLVFEYMEHDLAGLSSNPDIRFTEPQIKCYMKQLLWGLEHCHMRGVIHRDI 230
Query: 258 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 317
K SN+LVNN+GVLKL DFGLAN ++ LTSRVVTLWYR PELL+G+T YG SVDLW
Sbjct: 231 KASNILVNNKGVLKLGDFGLANVVTPSNKNQLTSRVVTLWYRAPELLMGSTSYGVSVDLW 290
Query: 318 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSS 377
SVGCVFAE+L+GKPIL+GRTE+EQLHKI+KLCGSP D +WK++KLPHAT FKPQ Y+++
Sbjct: 291 SVGCVFAEILMGKPILKGRTEIEQLHKIYKLCGSPQDSFWKRTKLPHATSFKPQHTYEAT 350
Query: 378 LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEI 437
LRE KDL T V L+ETLLS+EP KR TAS+AL SEYF T+PYACD SSLP YPP+KE+
Sbjct: 351 LRERCKDLSATGVYLLETLLSMEPDKRGTASSALNSEYFLTRPYACDPSSLPKYPPNKEM 410
Query: 438 DAKHRED 444
DAK+R+D
Sbjct: 411 DAKYRDD 417
|
|
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1370 (487.3 bits), Expect = 6.2e-142, Sum P(2) = 6.2e-142
Identities = 242/353 (68%), Positives = 300/353 (84%)
Query: 92 RLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARD 151
RL N K+ GEQVAAGWP+WLS GEA+ GWVP +AD FEK++KIGQGTYS+V++A+D
Sbjct: 78 RLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKD 137
Query: 152 LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211
+ TGKIVALKKVRFDN EPESV+FMAREIL+LRRLDHPN++KLEGL+TSR+SCS+YLVF+
Sbjct: 138 MLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQ 197
Query: 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLK 271
YM+HD+ GL S P +KFSE+++KC M QL+ GLEHCHSRGVLHRDIKGSNLL+++ GVLK
Sbjct: 198 YMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLK 257
Query: 272 LADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
+ADFGLA + H++P+TSRVVTLWYR PELLLGATDYG +DLWS GC+ AELL G+P
Sbjct: 258 IADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRP 317
Query: 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 391
I+ GRTEVEQLHKI+KLCGSP +DYWKK K H ++KP++PY S+RETFKD P +++
Sbjct: 318 IMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLP 377
Query: 392 LIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRED 444
LI+ LLS+EP R TASAAL SE+F+++PYAC+ + LP YPPSKEIDAK R++
Sbjct: 378 LIDALLSIEPEDRQTASAALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDE 430
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1352 (481.0 bits), Expect = 4.0e-138, P = 4.0e-138
Identities = 253/394 (64%), Positives = 311/394 (78%)
Query: 73 GSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAF 132
G E+G + + ++ R+ ++ G QV AGWP+WL++VAGEAI GW+P +AD+F
Sbjct: 105 GIEVGANNIGTLQQPKMT-RICSVSNGERGAQVMAGWPSWLASVAGEAINGWIPRKADSF 163
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
EKLEKIGQGTYSSV++ARDL+T ++VALKKVRF N +P+SVRFMAREI+ILRRLDHPN++
Sbjct: 164 EKLEKIGQGTYSSVYKARDLETNQLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVM 223
Query: 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
KLEGLITSR+S S+YL+FEYMEHD+ GL S P I FSEAQIKCYM QLLHGLEHCHSRGV
Sbjct: 224 KLEGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGV 283
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
LHRDIKGSNLL+++ LK+ DFGLANF +QPLTSRVVTLWYRPPELLLG+TDYG
Sbjct: 284 LHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGV 343
Query: 313 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372
+VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGSP ++YWK SKLPHAT+FKPQQ
Sbjct: 344 TVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKISKLPHATIFKPQQ 403
Query: 373 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYP 432
PY + ETFK LP++A+ L+E LL+VEP R T ++AL SE+F+T P A D SSLP Y
Sbjct: 404 PYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEFFTTSPLASDPSSLPKYQ 463
Query: 433 PSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKS 466
P KEID K +E+ ++++ +R+S
Sbjct: 464 PRKEIDVKAQEEEAKRKKDTSSKQNDSKQVSRES 497
|
|
| TAIR|locus:504955609 AT3G01085 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1311 (466.6 bits), Expect = 8.8e-134, P = 8.8e-134
Identities = 238/362 (65%), Positives = 299/362 (82%)
Query: 84 SNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTY 143
S + +S R G H +E EQVAAGWP+WLS+ A EA+ GWVPLRA+ FEK EKIGQGTY
Sbjct: 67 SRTTGVSLRSGLPHSNVEAEQVAAGWPSWLSSAAPEAVHGWVPLRAEDFEKREKIGQGTY 126
Query: 144 SSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203
S+VFRA ++ TG+++ALKK+R NFE E++RF+AREI+ILRRLDHPNI+KLEG+I SR S
Sbjct: 127 SNVFRACEVSTGRVMALKKIRIQNFETENIRFIAREIMILRRLDHPNIMKLEGIIASRNS 186
Query: 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263
S+Y VF+YMEHD+ GL S PDIKF+EAQIKCYM QLL G+EHCH RG++HRDIK +N+L
Sbjct: 187 NSMYFVFDYMEHDLEGLCSSPDIKFTEAQIKCYMKQLLWGVEHCHLRGIMHRDIKAANIL 246
Query: 264 VNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 323
VNN+GVLKLADFGLAN ++ LTSRVVTLWYR PELL+G+T Y SVDLWSVGCVF
Sbjct: 247 VNNKGVLKLADFGLANIVTPRNKNQLTSRVVTLWYRAPELLMGSTSYSVSVDLWSVGCVF 306
Query: 324 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETF 382
AE+L G+P+L+GRTE+EQLHKI+KL GSP +++W+K+KL P +F+PQ Y+ LRE F
Sbjct: 307 AEILTGRPLLKGRTEIEQLHKIYKLSGSPDEEFWEKNKLHPQTKMFRPQHQYEGCLRERF 366
Query: 383 KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHR 442
+ P TA+NL+E LLS++P KR TAS+AL SEYF+T+PYACD S+LP YPP+KE+DAK+R
Sbjct: 367 DEFPKTAINLLENLLSIDPEKRGTASSALMSEYFNTQPYACDPSTLPKYPPNKEMDAKYR 426
Query: 443 ED 444
E+
Sbjct: 427 EE 428
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1310 (466.2 bits), Expect = 1.1e-133, P = 1.1e-133
Identities = 239/364 (65%), Positives = 301/364 (82%)
Query: 81 RASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQ 140
R S N + + N+ + E E +AAGWP WL++VAGEAI+GWVP RAD+FEKL+KIGQ
Sbjct: 90 RVSDNGKGGGLIISNVPRSAEAELIAAGWPYWLTSVAGEAIKGWVPRRADSFEKLDKIGQ 149
Query: 141 GTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITS 200
GTYS V++ARDL+TGKIVA+KKVRF N +PESVRFMAREI ILR+LDHPN++KL+ L+TS
Sbjct: 150 GTYSIVYKARDLETGKIVAMKKVRFANMDPESVRFMAREINILRKLDHPNVMKLQCLVTS 209
Query: 201 RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGS 260
+LS S++LVFEYMEHD++GL P +KF+E QIKC+M QLL GLEHCHSRG+LHRDIKGS
Sbjct: 210 KLSGSLHLVFEYMEHDLSGLALRPGVKFTEPQIKCFMKQLLCGLEHCHSRGILHRDIKGS 269
Query: 261 NLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 320
NLLVNN+GVLK+ DFGLA+F QPLTSRVVTLWYR PELLLG+T+YGP++DLWSVG
Sbjct: 270 NLLVNNDGVLKIGDFGLASFYKPDQDQPLTSRVVTLWYRAPELLLGSTEYGPAIDLWSVG 329
Query: 321 CVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRE 380
C+ AEL + KPI+ GRTEVEQ+HKIFKLCGSP +++W +K P AT +KPQ PY L E
Sbjct: 330 CILAELFVCKPIMPGRTEVEQMHKIFKLCGSPSEEFWNTTKFPQATSYKPQHPYKRVLLE 389
Query: 381 TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAK 440
TFK+L +++++L++ LLSVEP KR +AS+ L SE+F+T+P C +SSLP YPPSKE+DAK
Sbjct: 390 TFKNLSSSSLDLLDKLLSVEPEKRCSASSTLLSEFFTTEPLPCHISSLPKYPPSKELDAK 449
Query: 441 HRED 444
R++
Sbjct: 450 VRDE 453
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1282 (456.3 bits), Expect = 1.0e-130, P = 1.0e-130
Identities = 241/373 (64%), Positives = 290/373 (77%)
Query: 104 QVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV 163
++AAGWPAWL +VAGEA+ W P RA FEKLEKIGQGTYSSV++ARDL KIVALK+V
Sbjct: 109 ELAAGWPAWLVSVAGEALVNWTPRRASTFEKLEKIGQGTYSSVYKARDLTNNKIVALKRV 168
Query: 164 RFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC 223
RFD + ESV+FMAREI+++RRLDHPN++KLEGLIT+ +S S+YLVFEYM+HD+ GL S
Sbjct: 169 RFDLSDLESVKFMAREIIVMRRLDHPNVLKLEGLITASVSSSLYLVFEYMDHDLVGLASI 228
Query: 224 PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283
P IKFSE Q+KCYM QLL GL HCHSRGVLHRDIKGSNLL+++ GVLK+ADFGLA F +
Sbjct: 229 PGIKFSEPQVKCYMQQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGVLKIADFGLATFFDP 288
Query: 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 343
+ PLTSRVVTLWYRPPELLLGA YG VDLWS GC+ EL GKPIL G+TEVEQLH
Sbjct: 289 QNCVPLTSRVVTLWYRPPELLLGACHYGVGVDLWSTGCILGELYSGKPILAGKTEVEQLH 348
Query: 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 403
KIFKLCGSP +DYW+K KLP + F+P PY + E FKDLPT ++L+E LLS++P +
Sbjct: 349 KIFKLCGSPTEDYWRKLKLPPSAAFRPALPYGRRVAEMFKDLPTNVLSLLEALLSIDPDR 408
Query: 404 RATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTT 463
R +A+ AL SEYF T+P+ACD SSLP YPPSKEIDAK R+DA + +T
Sbjct: 409 RGSAARALESEYFRTEPFACDPSSLPKYPPSKEIDAKIRDDAKRQRPTQEKHERQDSQT- 467
Query: 464 RKSHGMSKLAPVE 476
R+SH + PV+
Sbjct: 468 RRSHERKLIPPVK 480
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
Identities = 239/379 (63%), Positives = 289/379 (76%)
Query: 98 KYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKI 157
K E +QVAAGWP+WL +VAGE++ W P RA+ FEKLEKIGQGTYSSV+RARDL KI
Sbjct: 179 KDAERKQVAAGWPSWLVSVAGESLVDWAPRRANTFEKLEKIGQGTYSSVYRARDLLHNKI 238
Query: 158 VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDI 217
VALKKVRFD + ESV+FMAREI+++RRLDHPN++KLEGLIT+ +S S+YLVFEYM+HD+
Sbjct: 239 VALKKVRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVFEYMDHDL 298
Query: 218 TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 277
GL S P +KF+E Q+KCYM QLL GLEHCHSRGVLHRDIKGSNLL++++GVLK+ADFGL
Sbjct: 299 LGLSSLPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKIADFGL 358
Query: 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 337
A F + LTS VVTLWYRPPELLLGA+ YG VDLWS GC+ EL GKPIL G+T
Sbjct: 359 ATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPILPGKT 418
Query: 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 397
EVEQLHKIFKLCGSP ++YW+K KLP + FK PY + E FKD P + ++L+ETLL
Sbjct: 419 EVEQLHKIFKLCGSPTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSLLETLL 478
Query: 398 SVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXA 457
S++P R++A AL SEYF TKP+ACD S+LP YPPSKEIDAK R++A
Sbjct: 479 SIDPDHRSSADRALESEYFKTKPFACDPSNLPKYPPSKEIDAKMRDEAKRQQPMRAEKQE 538
Query: 458 ETRKTTRKSHGMSKLAPVE 476
TR SH + PV+
Sbjct: 539 RQDSMTRISHERKFVPPVK 557
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 478 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-162 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-125 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-119 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-113 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-112 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-111 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-110 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-98 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-98 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-93 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-91 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-91 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-90 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-87 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-87 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-85 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-83 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-81 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-81 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-79 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-79 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-78 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-77 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-77 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-77 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-77 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-73 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-70 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-70 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-67 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-67 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-66 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-65 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-64 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-64 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-63 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-62 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-61 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-60 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-60 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-60 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-59 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-58 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-57 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-55 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-54 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-54 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-53 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-53 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-52 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-51 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-50 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-49 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-48 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-48 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-45 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-45 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-44 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-39 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-39 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-38 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-38 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-37 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-37 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-36 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-34 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-34 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-34 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-29 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-29 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-27 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-27 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-26 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-25 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-25 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-23 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-22 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-20 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-20 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-19 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-18 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-17 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-17 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-17 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-16 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-14 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 460 bits (1187), Expect = e-162
Identities = 164/287 (57%), Positives = 218/287 (75%), Gaps = 2/287 (0%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+EK+ +IG+GTY V++AR+ TG++VALKK+R +N + REI +L++L HPNI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
++L+ ++TS+ SIY+VFEYM+HD+TGLL P++KF+E+QIKCYM QLL GL++ HS G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
+LHRDIKGSN+L+NN+GVLKLADFGLA + T+RV+TLWYRPPELLLGAT YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKP 370
P VD+WSVGC+ AEL +GKPI QG TE+EQL KIF+LCGSP D+ W SKLP KP
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 371 QQPYDSSLRETFKDLPT-TAVNLIETLLSVEPYKRATASAALASEYF 416
++PY LRE FK L +A++L++ LL+++P KR +A AL EYF
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 365 bits (940), Expect = e-125
Identities = 131/291 (45%), Positives = 178/291 (61%), Gaps = 15/291 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE----PESVRFMAREILILRRLD 187
+EKLEK+G+GTY V++ARD TG+IVALKK+R DN E ++R EI +L+ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
HPNI+KL +I + +YLVFEY + D+ L S IK M QLL GL +C
Sbjct: 57 HPNIVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLG 306
HS +LHRD+K N+L+N +GVLKLADFGLA F T VVTLWYR PE+LLG
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLG 172
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHA 365
+ Y +VD+WSVGC+FAE++ GKP+ G +E++QL KIF++ G+P ++ W +KLP
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
P+ P L + L ++L+ +L P KR +A AL YF
Sbjct: 233 KPTFPKFPPK-DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 350 bits (900), Expect = e-119
Identities = 135/302 (44%), Positives = 191/302 (63%), Gaps = 9/302 (2%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--PESVRFMA-REILILRRLDH 188
+EK +K+G+GTY+ V++ARD +TG+IVA+KK++ + + + F A REI +L+ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
PNII L + + +I LVFE+ME D+ ++ I + A IK YM L GLE+ H
Sbjct: 62 PNIIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S +LHRD+K +NLL+ ++GVLKLADFGLA + +R +T +VVT WYR PELL GA
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGAR 178
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATL 367
YG VD+WSVGC+FAELL+ P L G ++++QL KIF+ G+P ++ W + LP
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSS 427
FKP P L++ F A++L++ LL++ P KR TA AL YFS P S
Sbjct: 239 FKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296
Query: 428 LP 429
LP
Sbjct: 297 LP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 336 bits (864), Expect = e-113
Identities = 147/308 (47%), Positives = 200/308 (64%), Gaps = 14/308 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
FEKL +IG+GTY V+RARD +G+IVALKKVR DN E + + + REI +L L HPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNLRHPN 67
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHC 247
I++L+ ++ + SI+LV EY E D+ LL P FSE+Q+KC M QLL GL++
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYL 124
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLG 306
H ++HRD+K SNLL+ ++G LK+ADFGLA G +P+T +VVTLWYR PELLLG
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGCLKIADFGLA--RTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHA 365
T Y ++D+W+VGC+ AELL KP+L G++E+EQL I +L G+P + W S LP
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242
Query: 366 TLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424
F P+QPY ++L+ F L + L+ LL +P KRATA AL S YF KP C+
Sbjct: 243 GKFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301
Query: 425 LSSLPIYP 432
+P +P
Sbjct: 302 PEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 332 bits (853), Expect = e-112
Identities = 147/302 (48%), Positives = 197/302 (65%), Gaps = 11/302 (3%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D F+ + +IG+GTY V++ARD DTG++VALKKVR DN E E A REI I
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 59
Query: 183 LRRLDHPNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFSEAQIK 234
LR+L+H NI+ L+ ++T + + YLVFEYM+HD+ GLL + FSE IK
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294
+M QLL GL +CH + LHRDIK SN+L+NN+G +KLADFGLA N+ +P T++V+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
TLWYRPPELLLG YGP++D+WS GC+ EL KPI Q E+ QL I +LCGSP
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 355 DYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
W KLP+ KP++ Y LRE F +PT A++L++ +L+++P KR TA AL S
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 414 EY 415
+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 329 bits (847), Expect = e-111
Identities = 133/300 (44%), Positives = 185/300 (61%), Gaps = 24/300 (8%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN----FEPESVRFMAREILILRR 185
D +EKL +I +GTY V+RARD TG+IVALKK++ + F S+R EI IL +
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINILLK 60
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
L HPNI+ ++ ++ IY+V EY+EHD+ L+ F ++++KC M QLL G+
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ------PLTSRVVTLWYR 299
H H +LHRD+K SNLL+NN G+LK+ DFGLA R+ P T VVTLWYR
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLA-------REYGSPLKPYTQLVVTLWYR 173
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PELLLGA +Y ++D+WSVGC+FAELL KP+ G++E++QL+KIFKL G+P + W
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233
Query: 360 -SKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
S+LP A + + LR+ F L +L+ LL+ +P KR +A AL YF
Sbjct: 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 329 bits (845), Expect = e-110
Identities = 135/303 (44%), Positives = 191/303 (63%), Gaps = 19/303 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
+E L K+G+GT+ V++AR + TG++VALKK+ N E + A REI IL++L HPN
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREIKILKKLKHPN 68
Query: 191 IIKLEGLI------TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
++ L + + R S+Y+V YM+HD++GLL P +K +E+QIKCYM QLL G+
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGI 128
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----------NFSNTGHRQPLTSRVV 294
+ H +LHRDIK +N+L++N+G+LK+ADFGLA G + T+ VV
Sbjct: 129 NYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
T WYRPPELLLG Y +VD+W +GCVFAE+ +PILQG+++++QLH IFKLCG+P +
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248
Query: 355 DYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
+ W LP Y +L E F L ++L+ LLS++PYKR TAS AL
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308
Query: 414 EYF 416
YF
Sbjct: 309 PYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 296 bits (761), Expect = 3e-98
Identities = 134/287 (46%), Positives = 181/287 (63%), Gaps = 6/287 (2%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
++KL KIG+GTY V++ARD TG+IVA+KK++ FE E + A REI +L+ L+HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR-FESEGIPKTALREIKLLKELNHPN 59
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
IIKL + + +YLVFE+M+ D+ L+ E+ IK Y+ QLL GL CHS
Sbjct: 60 IIKLLDVFRHK--GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
G+LHRD+K NLL+N EGVLKLADFGLA + R P T VVT WYR PELLLG Y
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGY 176
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFK 369
VD+WSVGC+FAELL +P+ G++E++QL KIF+ G+P + W K + L F
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ L + F + A++L+ +L +P+KR TA ALA YF
Sbjct: 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 297 bits (763), Expect = 3e-98
Identities = 138/305 (45%), Positives = 181/305 (59%), Gaps = 24/305 (7%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+EKL KIGQGT+ VF+AR T +IVALKKV +N E E A REI IL+ L H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKH 70
Query: 189 PNIIKL------EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH 242
N++ L + +R S YLVFE+ EHD+ GLLS ++KF+ ++IK M LL+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSNTGHRQPLTSRVVTLWYR 299
GL + H +LHRD+K +N+L+ +G+LKLADFGLA + S T+RVVTLWYR
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PPELLLG DYGP +D+W GC+ AE+ PI+QG TE QL I +LCGS + W
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250
Query: 360 -SKLPHATLFK----PQQPYD---SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
KL LFK PQ L+ KD A++LI+ LL ++P KR A AL
Sbjct: 251 VDKLE---LFKKMELPQGQKRKVKERLKPYVKDP--HALDLIDKLLVLDPAKRIDADTAL 305
Query: 412 ASEYF 416
++F
Sbjct: 306 NHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 1e-93
Identities = 128/292 (43%), Positives = 182/292 (62%), Gaps = 16/292 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
++K+EKIG+GTY V++ARD TG+IVALKK+R + E E V A REI +L+ L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 191 IIKLEGLITS--RLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHC 247
I++L ++ S +L YLVFE+++ D+ + S P IK Y+ QLL G+ +C
Sbjct: 60 IVRLLDVVHSENKL----YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS VLHRD+K NLL++ EG LKLADFGLA R T VVTLWYR PE+LLG+
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGS 174
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
Y VD+WS+GC+FAE++ +P+ G +E++QL +IF+ G+P +D W + LP
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD-- 232
Query: 367 LFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+KP P L + +L ++L+ +L +P KR +A AAL YF
Sbjct: 233 -YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 5e-91
Identities = 107/286 (37%), Positives = 158/286 (55%), Gaps = 33/286 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E LEK+G+G++ V+ ARD TGK+VA+K ++ + + R + REI IL++L HPNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL-REIKILKKLKHPNI 59
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
++L + +YLV EY E D+ LL + SE + + Y+ Q+L LE+ HS+
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
G++HRD+K N+L++ +G +KLADFGLA + G + LT+ V T Y PE+LLG Y
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KGY 173
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370
G +VD+WS+G + ELL GKP G +QL ++FK G P +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPP----------- 219
Query: 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
D+ A +LI LL +P KR TA AL +F
Sbjct: 220 -----------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 277 bits (712), Expect = 6e-91
Identities = 122/298 (40%), Positives = 180/298 (60%), Gaps = 24/298 (8%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---PESVRFMAREILILRRLD- 187
+E+L +IG+G Y +V++ARDL+TG+ VALKKVR E P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 188 --HPNIIKL----EGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQL 240
HPNI++L G T R + LVFE+++ D+ LS CP IK M QL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYR 299
L G++ HS ++HRD+K N+LV ++G +K+ADFGLA +S LTS VVTLWYR
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLWYR 173
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW-K 358
PE+LL ++ Y VD+WSVGC+FAEL +P+ +G +E +QL KIF + G P ++ W +
Sbjct: 174 APEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
LP ++ F P S + ++ ++L++ +L+ P+KR +A AL YF
Sbjct: 233 NVSLPRSS-FPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 1e-90
Identities = 115/292 (39%), Positives = 167/292 (57%), Gaps = 15/292 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKV----RFDNFEPESVRFMAREILILRRLD 187
++ L +IG+G + VF+A+D +TG+ VALKKV + REI L+
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ----ALREIKALQACQ 57
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
HP ++KL L LV EYM D++ +L + EAQ+K YM LL G+ +
Sbjct: 58 HPYVVKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H+ G++HRD+K +NLL++ +GVLK+ADFGLA + + + +V T WYR PELL GA
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
Y P VDLW+VGC+FAELL G P+ G ++EQL +F+ G+P ++ W + LP
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 367 --LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
F +P L E F D A++L++ LL +P KR +A+ AL YF
Sbjct: 236 KITFPESKP--IPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 5e-87
Identities = 124/318 (38%), Positives = 184/318 (57%), Gaps = 31/318 (9%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVR---FDNFEPES--------VRFMA-REILILRR 185
+G+GTY V +A D TGKIVA+KKV+ N + + F RE+ I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+ H NI+ L + I LV + M D+ ++ I+ +E+Q+KC + Q+L+GL
Sbjct: 77 IKHENIMGLVDVYVEG--DFINLVMDIMASDLKKVVD-RKIRLTESQVKCILLQILNGLN 133
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFSNTGHRQPLTSR 292
H +HRD+ +N+ +N++G+ K+ADFGLA R+ +TS+
Sbjct: 134 VLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 352
VVTLWYR PELL+GA Y +VD+WSVGC+FAELL GKP+ G E++QL +IF+L G+P
Sbjct: 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTP 253
Query: 353 PDDYW-KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+D W + KLP T F P++P D L+ F + A++L+++LL + P +R +A AL
Sbjct: 254 NEDNWPQAKKLPLYTEFTPRKPKD--LKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 412 ASEYFSTKPYACDLSSLP 429
EYF + P CD S LP
Sbjct: 312 KHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 9e-87
Identities = 109/287 (37%), Positives = 151/287 (52%), Gaps = 29/287 (10%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E L K+G G++ +V++A+ TGKIVA+K ++ + + + + REI ILRRL HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
++L +YLV EY E D+ LS SE + K Q+L GLE+ HS
Sbjct: 61 VRLIDAFED--KDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
G++HRD+K N+L++ GV+K+ADFGLA LT+ V T WY PE+LLG Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLK-SSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK-LCGSPPDDYWKKSKLPHATLFK 369
GP VD+WS+G + ELL GKP G ++QL I + L D K
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW---------- 226
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
SS E KD LI+ L+ +P KR TA L +F
Sbjct: 227 ------SSGSEEAKD-------LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 4e-85
Identities = 115/319 (36%), Positives = 171/319 (53%), Gaps = 23/319 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
+E L+ IG G Y V A D TG+ VA+KK+ FD+ + + REI +LR L H
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD--LIDAKRILREIKLLRHLRHE 59
Query: 190 NIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
NII L ++ +Y+V E ME D+ ++ P ++ I+ ++ Q+L GL++
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKY 118
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVVTLWYRPPELL 304
HS V+HRD+K SN+LVN+ LK+ DFGLA + + LT VVT WYR PELL
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL 178
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
L ++ Y ++D+WSVGC+FAELL KP+ GR ++QL+ I ++ G+P ++ K
Sbjct: 179 LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238
Query: 365 ATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422
A + P L + F A++L+E +L +P KR TA ALA Y +
Sbjct: 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA----- 293
Query: 423 CDLSSLPIYPPSKEIDAKH 441
++ P E AK
Sbjct: 294 ------QLHDPEDEPVAKP 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 258 bits (662), Expect = 1e-83
Identities = 125/290 (43%), Positives = 175/290 (60%), Gaps = 12/290 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
F+K+EKIG+GTY V++AR+ TG++VALKK+R D E E V A REI +L+ L+HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPN 60
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
I+KL +I + +YLVFE++ D+ + + P IK Y+ QLL GL CHS
Sbjct: 61 IVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
VLHRD+K NLL+N EG +KLADFGLA R T VVTLWYR PE+LLG
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKY 177
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLF 368
Y +VD+WS+GC+FAE++ + + G +E++QL +IF+ G+P + W + LP +
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD---Y 234
Query: 369 KPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
KP P + L +L+ +L +P KR +A AALA +F
Sbjct: 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 253 bits (647), Expect = 3e-81
Identities = 128/293 (43%), Positives = 186/293 (63%), Gaps = 17/293 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
+ K+EKIG+GTY V++ R+ TG+IVA+KK+R ++ E E V A REI +L+ L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPN 60
Query: 191 IIKLEGLIT--SRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQ-IKCYMNQLLHGLEH 246
I+ L+ ++ SRL YL+FE++ D+ L S P ++ +A+ +K Y+ Q+L G+
Sbjct: 61 IVCLQDVLMQESRL----YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
CHSR VLHRD+K NLL++N+GV+KLADFGLA R T VVTLWYR PE+LLG
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-YTHEVVTLWYRAPEVLLG 175
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHA 365
+ Y VD+WS+G +FAE+ KP+ G +E++QL +IF++ G+P +D W + LP
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD- 234
Query: 366 TLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+K P SLR K+L ++L+E +L +P KR +A AL YF
Sbjct: 235 --YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 3e-81
Identities = 127/290 (43%), Positives = 176/290 (60%), Gaps = 12/290 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
+EKLEKIG+GTY +VF+A++ +T +IVALK+VR D+ + E V A REI +L+ L H N
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKN 60
Query: 191 IIKLEGLITS--RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
I++L ++ S +L+ LVFEY + D+ + +K +M QLL GL CH
Sbjct: 61 IVRLYDVLHSDKKLT----LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S VLHRD+K NLL+N G LKLADFGLA R ++ VVTLWYRPP++L GA
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAK 175
Query: 309 DYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
Y S+D+WS GC+FAEL G+P+ G +QL +IF+L G+P ++ W SKLP
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ P P +SL L +T +L++ LL P +R +A AL YF
Sbjct: 236 PY-PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 249 bits (637), Expect = 1e-79
Identities = 127/292 (43%), Positives = 181/292 (61%), Gaps = 11/292 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
D +EK+EKIG+GTY V++ARD T + +ALKK+R + E E V A REI +L+ + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHC 247
NI++L+ ++ S +YLVFEY++ D+ + S PD + IK Y+ Q+L G+ +C
Sbjct: 61 GNIVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 248 HSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
HS VLHRD+K NLL++ LKLADFGLA R T VVTLWYR PE+LLG
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-FTHEVVTLWYRAPEILLG 177
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLP-H 364
+ Y VD+WSVGC+FAE++ KP+ G +E+++L KIF++ G+P ++ W + LP +
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ F P D L L V+L+ +L ++P KR TA AAL EYF
Sbjct: 238 KSAFPKWPPKD--LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 248 bits (634), Expect = 3e-79
Identities = 107/292 (36%), Positives = 163/292 (55%), Gaps = 9/292 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+ +E L +G+G Y V + R+ TG+IVA+KK + ++ + E V+ A RE+ +LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFK-ESEDDEDVKKTALREVKVLRQLRH 59
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+ L R +YLVFEY+E + LL ++ Y+ QLL + +CH
Sbjct: 60 ENIVNL--KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S ++HRDIK N+LV+ GVLKL DFG A PLT V T WYR PELL+G T
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP----DDYWKKSKLPH 364
+YG VD+W++GC+ AELL G+P+ G ++++QL+ I K G P + + +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+P QP +S R + + A++ ++ L ++P +R T L YF
Sbjct: 238 VAFPEPSQP-ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 2e-78
Identities = 130/302 (43%), Positives = 179/302 (59%), Gaps = 23/302 (7%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
DA+EKLEKIG+GTY V++ARD +TGK+VALKK R + + E + A REI +L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 189 -PNIIKL---EGLITSRLSCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQL 240
I++L E + S+YLVFEY++ D+ + P IK +M QL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLA-NFSNTGHRQPL---TSRVVT 295
L G+ HCH GV+HRD+K NLLV+ + G+LK+AD GL FS P+ T +VT
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-----IPVKSYTHEIVT 174
Query: 296 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
LWYR PE+LLG+T Y VD+WSVGC+FAE+ +P+ G +E++QL IFKL G+P +
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234
Query: 356 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
W SKL F +P D L DL ++L++ +L +P KR +A AAL
Sbjct: 235 VWPGVSKLRDWHEFPQWKPQD--LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292
Query: 415 YF 416
YF
Sbjct: 293 YF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 2e-77
Identities = 114/299 (38%), Positives = 174/299 (58%), Gaps = 20/299 (6%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRL 186
+ + ++KL+K+G+G+Y++V++ R TG++VALK++R + E F A RE +L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDL 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLE 245
H NI+ L +I ++ + + LVFEY++ D+ + C S ++ ++ QLL GL
Sbjct: 61 KHANIVTLHDIIHTKKTLT--LVFEYLDTDLKQYMDDCGGG-LSMHNVRLFLFQLLRGLA 117
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF----SNTGHRQPLTSRVVTLWYRPP 301
+CH R VLHRD+K NLL++ G LKLADFGLA S T ++ VVTLWYRPP
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-----YSNEVVTLWYRPP 172
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKK- 359
++LLG+T+Y S+D+W VGC+F E+ G+P+ G T+V +QLHKIF++ G+P ++ W
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232
Query: 360 SKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
S P + L D L L EP KR +A+ A+ YF
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 2e-77
Identities = 116/290 (40%), Positives = 177/290 (61%), Gaps = 12/290 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKV--RFDNFEPESVRFMAREILILRRL-DH 188
++ ++++G GT+ SV+ AR+ +TG++VA+KK+ +F ++E E + RE+ LR+L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK-FSEAQIKCYMNQLLHGLEHC 247
PNI+KL+ + R + +Y VFEYME ++ L+ K FSE+ I+ + Q+L GL H
Sbjct: 58 PNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H G HRD+K NLLV+ V+K+ADFGLA R P T V T WYR PE+LL +
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHAT 366
T Y VD+W++GC+ AEL +P+ G +E++QL+KI + G+P W + KL
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
F+ Q +SL + + A++LI+ +L +P KR TAS AL YF
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 242 bits (618), Expect = 5e-77
Identities = 115/301 (38%), Positives = 169/301 (56%), Gaps = 34/301 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--PESVRFMAREILILRRLDHP 189
F++LEK+G+GTY++V++ R+ TG+IVALK++ D E P + REI +++ L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKHE 58
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK-----FSEAQIKCYMNQLLHGL 244
NI++L +I + + LVFEYM+ D+ + D +K + QLL G+
Sbjct: 59 NIVRLHDVIHTE--NKLMLVFEYMDKDLKKYM---DTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--------NFSNTGHRQPLTSRVVTL 296
CH VLHRD+K NLL+N G LKLADFGLA FSN VVTL
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN---------EVVTL 164
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
WYR P++LLG+ Y S+D+WSVGC+ AE++ G+P+ G +QL KIF++ G+P +
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTEST 224
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
W S+LP P+ P L++ F ++L+ LL + P R +A AL +
Sbjct: 225 WPGISQLPEYKPTFPRYPP-QDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
Query: 416 F 416
F
Sbjct: 284 F 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 7e-77
Identities = 121/325 (37%), Positives = 170/325 (52%), Gaps = 36/325 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVR-FMAREILILRRL-D 187
+E L+K+G+G Y V++A D T ++VALKK+ FD F ++ R F REI+ L+ L D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTF--REIMFLQELGD 65
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDIT-----GLLSCPDIKFSEAQIKCYMNQLLH 242
HPNI+KL +I + IYLVFEYME D+ +L + + M QLL
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILE-------DVHKRYIMYQLLK 118
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVVTLWY 298
L++ HS V+HRD+K SN+L+N++ +KLADFGLA LT V T WY
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
R PE+LLG+T Y VD+WSVGC+ E+L+GKP+ G + + QL KI ++ G P + +
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238
Query: 359 --KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
KS L L E A++L++ LL P KR TA AL Y
Sbjct: 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298
Query: 417 STKPYACDLSSLPIYPPSKEIDAKH 441
+ + PS E +
Sbjct: 299 A-----------QFHNPSDEPVLPY 312
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (597), Expect = 2e-73
Identities = 113/320 (35%), Positives = 167/320 (52%), Gaps = 40/320 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+E IG+GTY V++A+ + GK A+KK + D + + A REI +LR L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKF---------SEAQIKCYMNQ 239
N++ L + S+YL+F+Y EHD+ + IKF + +K + Q
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQI-----IKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQPLTSR--V 293
+L+G+ + HS VLHRD+K +N+LV E GV+K+ D GLA N + V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHK 344
VT+WYR PELLLGA Y ++D+W++GC+FAELL +PI +GR +QL +
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236
Query: 345 IFKLCGSPPDDYWKK-SKLPH----ATLFKPQQPYDSSLR---ETFKDLPTTAVNLIETL 396
IF++ G+P + W K+P FK + +SL E K + +L+ L
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296
Query: 397 LSVEPYKRATASAALASEYF 416
L +P KR TA AL YF
Sbjct: 297 LEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 1e-70
Identities = 103/296 (34%), Positives = 159/296 (53%), Gaps = 19/296 (6%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +EKL KIG+G+Y VF+ R+ +TG+IVA+KK +P + REI +L++L HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
N++ L + R ++LVFEY +H + L E IK + Q L + CH
Sbjct: 61 NLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+HRD+K N+L+ +G +KL DFG A T V T WYR PELL+G T
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVGDTQ 177
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS---------PPDDYWKKS 360
YGP VD+W++GCVFAELL G+P+ G+++V+QL+ I K G + ++K
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+P +P L F ++ + A++ ++ L ++P +R + L YF
Sbjct: 238 SIPEPETREP-------LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 8e-70
Identities = 106/285 (37%), Positives = 158/285 (55%), Gaps = 9/285 (3%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALK--KVRFDNFEPESVRFMAREILILRRL-DHPNI 191
L KIG+GT+S V +A+ TGK A+K K F + E + REI LRRL HPNI
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPHPNI 60
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
++L ++ R + + LVFE M+ ++ L+ E ++K YM QLL L+H H G
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
+ HRDIK N+L+ ++ +LKLADFG + + P T + T WYR PE LL YG
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCRGIYS--KPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
P +D+W+VGCVF E+L P+ G E++Q+ KI + G+P + KK + +
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237
Query: 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ LR+ + ++L++ LL+ +P +R TA AL YF
Sbjct: 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 2e-67
Identities = 112/306 (36%), Positives = 170/306 (55%), Gaps = 22/306 (7%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHPNIIKLE 195
IG+G Y V A++ +T + VA+KK+ FDN ++ R + REI +LR LDH N+I ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTL-REIKLLRHLDHENVIAIK 70
Query: 196 GLI--TSRLSCS-IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
++ R + + +Y+V+E M+ D+ ++ S+ + ++ QLL GL++ HS V
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLRGLKYIHSANV 129
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
LHRD+K SNLL+N LK+ DFGLA ++ +T VVT WYR PELLL ++Y
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTT 188
Query: 313 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372
++D+WSVGC+FAELL KP+ G+ V QL I +L GSP ++ + A +
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248
Query: 373 PYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPI 430
PY S F A++L+E +L +P KR T ALA Y + +
Sbjct: 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA-----------SL 297
Query: 431 YPPSKE 436
+ PS E
Sbjct: 298 HDPSDE 303
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 4e-67
Identities = 116/297 (39%), Positives = 177/297 (59%), Gaps = 19/297 (6%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
+ + + KL+K+G+GTY++VF+ R T +VALK++R ++ E + RE+ +L+ L
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLK 61
Query: 188 HPNIIKLEGLI-TSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLE 245
H NI+ L +I T R + LVFEY++ D+ L +C ++ S +K +M QLL GL
Sbjct: 62 HANIVTLHDIIHTER---CLTLVFEYLDSDLKQYLDNCGNL-MSMHNVKIFMFQLLRGLS 117
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+CH R +LHRD+K NLL+N +G LKLADFGLA + + + ++ VVTLWYRPP++LL
Sbjct: 118 YCHKRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLL 176
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
G+T+Y +D+W VGC+ E+ G+P+ G T E+LH IF+L G+P ++ W P
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW-----PGI 231
Query: 366 TLFKPQQPYD------SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
T + + Y L L T ++L+ +LL E R +A AAL YF
Sbjct: 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 9e-66
Identities = 101/300 (33%), Positives = 155/300 (51%), Gaps = 16/300 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV--RFDNFEPESVRFMAREILILRRLD 187
++ +E IG G Y V A D +GK VA+KK+ FD P + RE+ ILR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFK 62
Query: 188 HPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
H NII + ++ +Y+V + ME D+ ++ D +E I+ ++ QLL GL+
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLK 121
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPE 302
+ HS V+HRD+K SNLLVN + L++ DFG+A S T H+ +T V T WYR PE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
LLL +Y ++D+WSVGC+FAE+L + + G+ V QL I + GSP ++ +
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 363 PHA----TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
+QP + F A++L+ +L +P +R T AL + +
Sbjct: 242 DRVRKYIQNLPRKQPVP--WSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 5e-65
Identities = 116/293 (39%), Positives = 166/293 (56%), Gaps = 14/293 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL---DH 188
+E + +IG G Y +V++ARD +G VALK VR E RE+ +L+RL DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 189 PNIIKLEGLI-TSRL--SCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGL 244
PNI++L + TSR + LVFE+++ D+ L P IK M Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
+ H+ ++HRD+K N+LV + G +KLADFGLA + + LT VVTLWYR PE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYRAPEVL 179
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLP 363
L +T Y VD+WSVGC+FAE+ KP+ G +E +QL KIF L G PP+D W + LP
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
F P+ P ++ ++ + L+ +L+ P+KR +A AL +F
Sbjct: 239 RGA-FSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 3e-64
Identities = 112/292 (38%), Positives = 172/292 (58%), Gaps = 9/292 (3%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
+ + + KL+K+G+GTY++V++ R T +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEH 246
H NI+ L +I + S + LVFEY++ D+ L C + + +K ++ QLL GL +
Sbjct: 63 HANIVTLHDIIHTEKSLT--LVFEYLDKDLKQYLDDCGNS-INMHNVKLFLFQLLRGLNY 119
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
CH R VLHRD+K NLL+N G LKLADFGLA + + + ++ VVTLWYRPP++LLG
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK--SKLPH 364
+TDY +D+W VGC+F E+ G+P+ G T EQLH IF++ G+P ++ W S
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ P+ D + L + L+ LL E KR +A A+ YF
Sbjct: 239 KSYNYPKYRADCLHNHAPR-LDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 5e-64
Identities = 116/312 (37%), Positives = 181/312 (58%), Gaps = 25/312 (8%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
+ + + KLEK+G+GTY++VF+ R T +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEH 246
H NI+ L ++ + S+ LVFEY++ D+ + C +I S +K ++ Q+L GL +
Sbjct: 63 HANIVTLHDIVHT--DKSLTLVFEYLDKDLKQYMDDCGNI-MSMHNVKIFLYQILRGLAY 119
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
CH R VLHRD+K NLL+N G LKLADFGLA + + + ++ VVTLWYRPP++LLG
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLG 178
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW--------- 357
+++Y +D+W VGC+F E+ G+P+ G T ++LH IF+L G+P ++ W
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
K P +KPQ + + R L T + L+ L E KR +A A+ YF
Sbjct: 239 KNYNFPK---YKPQPLINHAPR-----LDTEGIELLTKFLQYESKKRISAEEAMKHAYF- 289
Query: 418 TKPYACDLSSLP 429
+ + SLP
Sbjct: 290 -RSLGTRIHSLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 2e-63
Identities = 119/301 (39%), Positives = 180/301 (59%), Gaps = 16/301 (5%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRL 186
+AD++EKLEK+G+G+Y++V++ + GK+VALK +R E E F A RE +L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFTAIREASLLKGL 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
H NI+ L +I ++ + + LVFEY+ D+ + +K ++ QLL GL +
Sbjct: 61 KHANIVLLHDIIHTKETLT--LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
H R +LHRD+K NLL+++ G LKLADFGLA + + ++ VVTLWYRPP++LLG
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLG 177
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKK-SKLPH 364
+T+Y +D+W VGC+F E++ G G +++ QL +IF + G+P +D W LPH
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237
Query: 365 ATLFKPQQ--PYDS-SLRETFKDLPTT--AVNLIETLLSVEPYKRATASAALASEYFSTK 419
FKP++ Y +LR+ + L A +L LL P R +A AAL+ EYFS
Sbjct: 238 ---FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294
Query: 420 P 420
P
Sbjct: 295 P 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 3e-62
Identities = 108/312 (34%), Positives = 167/312 (53%), Gaps = 19/312 (6%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ L +G G Y V A D TG+ VA+KK+ + RE+ +L+ +DH
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T S +YLV M D+ ++ C K S+ I+ + Q+L GL+
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLK 132
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HS G++HRD+K SN+ VN + LK+ DFGLA ++ +T V T WYR PE++L
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIML 188
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD+WSVGC+ AELL GK + G ++QL +I L G+P ++ +K A
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248
Query: 366 TLFKPQQPYDSSLRETFKDLPTT----AVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+ P ++ FK++ + A++L+E +L ++P KR TA+ ALA Y Y
Sbjct: 249 RNYIQSLPQMP--KKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL--AEY 304
Query: 422 ACDLSSLPIYPP 433
D P+ PP
Sbjct: 305 H-DPEDEPVAPP 315
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 6e-62
Identities = 76/191 (39%), Positives = 114/191 (59%), Gaps = 6/191 (3%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL 197
+G+G + +V+ ARD TGK VA+K ++ ++ + REI IL++L+HPNI+KL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 198 ITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 256
+YLV EY E + LL + K SE +I + Q+L GLE+ HS G++HRD
Sbjct: 60 FEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 257 IKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 315
+K N+L+++ G +KLADFGL+ T + L + V T Y PE+LLG Y D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL-TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 316 LWSVGCVFAEL 326
+WS+G + EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 3e-61
Identities = 109/310 (35%), Positives = 156/310 (50%), Gaps = 42/310 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE--SVRFMAREILILRRLDHP 189
++ L IG+G Y V A TG VA+KK+ FE + R + REI ILRR H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTL-REIKILRRFKHE 63
Query: 190 NIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
NII + +I S +Y+V E ME D+ L+ + S I+ ++ Q+L GL++
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHL--SNDHIQYFLYQILRGLKY 121
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPELL 304
HS VLHRD+K SNLL+N LK+ DFGLA H LT V T WYR PE++
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD--------- 355
L + Y ++D+WSVGC+ AE+L +P+ G+ + QL+ I + G+P +
Sbjct: 182 LNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241
Query: 356 ---YWK----KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
Y K K K+P LF P A++L++ +L+ P+KR T
Sbjct: 242 ARNYIKSLPFKPKVPWNKLF----PNADPK----------ALDLLDKMLTFNPHKRITVE 287
Query: 409 AALASEYFST 418
ALA Y
Sbjct: 288 EALAHPYLEQ 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 1e-60
Identities = 115/315 (36%), Positives = 171/315 (54%), Gaps = 36/315 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ L +G G+ VF A D D K VA+KK+ +P+SV+ REI I+RRLDH NI
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNI 64
Query: 192 IKLEGLI---TSRLSC---------SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
+K+ ++ S L+ S+Y+V EYME D+ +L + SE + +M Q
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL--SEEHARLFMYQ 122
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA-----NFSNTGHRQPLTSRV 293
LL GL++ HS VLHRD+K +N+ +N E VLK+ DFGLA ++S+ G+ L+ +
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY---LSEGL 179
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
VT WYR P LLL +Y ++D+W+ GC+FAE+L GKP+ G E+EQ+ I + S P
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE---SVP 236
Query: 354 -----DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
D + +P +P LR+ + A++ +E +L+ P R TA
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPR-RPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295
Query: 409 AALASEYFSTKPYAC 423
AL Y S Y+C
Sbjct: 296 EALMHPYMS--CYSC 308
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 1e-60
Identities = 117/295 (39%), Positives = 171/295 (57%), Gaps = 14/295 (4%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLD 187
A ++ LEK+G+G+Y++V++ G++VALK + E V F A RE +L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLK 61
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
H NI+ L +I ++ + + VFEYM D+ + ++ +M QLL GL +
Sbjct: 62 HANIVLLHDIIHTKETLT--FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H + +LHRD+K NLL++ G LKLADFGLA + + Q +S VVTLWYRPP++LLGA
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKK-SKLPH- 364
TDY ++D+W GC+F E+L G+P G ++V EQL KI+ + G P +D W SKLP+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238
Query: 365 -ATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRATASAALASEYF 416
F P +P LR +K L P A +L +L + P R +A AL YF
Sbjct: 239 KPEWFLPCKP--QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 2e-60
Identities = 101/289 (34%), Positives = 169/289 (58%), Gaps = 9/289 (3%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
+E L +G+G+Y V + + +TG+IVA+KK ++ + + V+ +A REI +L++L H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
++ L + R +YLVFE+++H + L E++++ Y+ Q+L G+E CHS
Sbjct: 62 LVNL--IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
++HRDIK N+LV+ GV+KL DFG A + T V T WYR PELL+G T Y
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKY 178
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY---WKKSKLPHATL 367
G +VD+W+VGC+ E+L G+P+ G ++++QL+ I K G+ + ++K+ L A +
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL-FAGM 237
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
P+ L + F L ++L + L ++P R ++S L E+F
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 2e-59
Identities = 119/295 (40%), Positives = 171/295 (57%), Gaps = 17/295 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMAREILILRRLD--- 187
+E + +IG+G Y VF+ARDL + G+ VALK+VR E RE+ +LR L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 188 HPNIIKLEGLIT-SRL--SCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHG 243
HPN+++L + T SR + LVFE+++ D+T L P+ IK M QLL G
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
L+ HS V+HRD+K N+LV + G +KLADFGLA + + LTS VVTLWYR PE+
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEV 180
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP-PDDYWKKSKL 362
LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P +D+ + L
Sbjct: 181 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239
Query: 363 PHATLF-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
P K QP + + D+ +L+ L+ P KR +A +AL+ YF
Sbjct: 240 PRQAFHSKSAQP----IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 5e-58
Identities = 110/301 (36%), Positives = 159/301 (52%), Gaps = 29/301 (9%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ L+ +G G + V ARD TG+ VA+KK+ P + RE+ +L+ L H NI
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI 71
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQ-IKCYMNQLLHGLEHCHSR 250
I L + S L IY V E + D+ LL+ + E Q I+ ++ Q+L GL++ HS
Sbjct: 72 ISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRPL---EKQFIQYFLYQILRGLKYVHSA 127
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
GV+HRD+K SN+L+N LK+ DFGLA + + +T V T +YR PE++L Y
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQD--PQ--MTGYVSTRYYRAPEIMLTWQKY 183
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK----------S 360
VD+WS GC+FAE+L GKP+ G+ V Q I L G+PPDD
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
LP + P E FK+ +A++L+E +L +P KR +A+ ALA Y P
Sbjct: 244 SLPK----REPVP----FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL--AP 293
Query: 421 Y 421
Y
Sbjct: 294 Y 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 6e-57
Identities = 117/337 (34%), Positives = 181/337 (53%), Gaps = 25/337 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--PESVRFMAREILILRRLDHP 189
++ E IG+G+Y V A D TG+ VA+KK+ D FE ++ R + REI +LR L HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRIL-REIKLLRLLRHP 59
Query: 190 NIIKLEGLI---TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
+I++++ ++ + R IY+VFE ME D+ ++ D + + ++ QLL L++
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKY 118
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTLWYRPPELL 304
H+ V HRD+K N+L N + LK+ DFGLA F++T T V T WYR PEL
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 305 LGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
G+ + Y P++D+WS+GC+FAE+L GKP+ G+ V QL I L G+P + + +
Sbjct: 179 -GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237
Query: 363 PHATLF----KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
A + + +QP + F + A+ L+E LL+ +P R TA ALA YF
Sbjct: 238 EKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK- 294
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVR 455
L+ + P ++ I E RR+ VR
Sbjct: 295 -----GLAKVEREPSAQPITKLEFEFERRRLTKEDVR 326
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 6e-57
Identities = 74/203 (36%), Positives = 117/203 (57%), Gaps = 6/203 (2%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + E +G+G++ SV+ A D DTG+++A+K V E + + REI IL L HPNI
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYM-EHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++ G ++ + EY+ ++ LL K E I+ Y Q+L GL + HS
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
G++HRDIKG+N+LV+++GV+KLADFG A + + S T ++ PE++ G
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-E 178
Query: 309 DYGPSVDLWSVGCVFAELLIGKP 331
+YG + D+WS+GC E+ GKP
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-55
Identities = 102/305 (33%), Positives = 164/305 (53%), Gaps = 29/305 (9%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDT--GKIVALKKVR--FDNFEPESVRFMAREILILRRL- 186
+E ++++GQG Y V AR+ +T + VA+KK+ F + RE+ +LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFR 59
Query: 187 DHPNIIKLEGL--ITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
H NI L + + +YL E ME D+ ++ ++A + ++ Q+L GL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGL 118
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWY 298
++ HS VLHRD+K NLLVN + LK+ DFGLA N G +T V T WY
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF---MTEYVATRWY 175
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
R PE++L Y ++D+WSVGC+ AELL KP+ +G+ V+QL++I ++ G+P ++
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235
Query: 359 KSKLPHA-----TL-FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ P A +L P++P++S F + A++L+E LL+ +P KR + AL
Sbjct: 236 RIGSPKAQNYIRSLPNIPKKPFESI----FPNANPLALDLLEKLLAFDPTKRISVEEALE 291
Query: 413 SEYFS 417
Y +
Sbjct: 292 HPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 2e-54
Identities = 106/295 (35%), Positives = 166/295 (56%), Gaps = 14/295 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
D + L+++G G Y +V A D TG VA+KK+ + F+ E A RE+ +L+ + H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKH 73
Query: 189 PNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
N+I L + T LS YLV +M D+ L+ K SE +I+ + Q+L GL
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGL 131
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
++ H+ G++HRD+K NL VN + LK+ DFGLA +++ +T VVT WYR PE++
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS----EMTGYVVTRWYRAPEVI 187
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
L Y +VD+WSVGC+ AE+L GKP+ +G ++QL +I K+ G+P ++ +K +
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 365 ATLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
A + + P R + AVN++E +L ++ R TA+ ALA YF
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 7e-54
Identities = 108/300 (36%), Positives = 168/300 (56%), Gaps = 20/300 (6%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILIL 183
+P R + L+++G G Y SV A D TG+ VA+KK+ F+ E A RE+ +L
Sbjct: 13 LPER---YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLL 68
Query: 184 RRLDHPNIIKLEGLITSRLSC----SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
+ + H N+I L + TS +S YLV YM+ D+ ++ P SE +++ + Q
Sbjct: 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQ 125
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
+L GL++ HS G++HRD+K NL VN + LK+ DFGLA ++ +T VVT WYR
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYR 181
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE++L Y +VD+WSVGC+ AE+L GK + +G+ ++QL +I K+ G P ++ +K
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241
Query: 360 SKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ A + P+ P F AV+L+E +L ++ KR TA+ AL YF
Sbjct: 242 LEDKAAKSYIKSLPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 182 bits (462), Expect = 3e-53
Identities = 109/318 (34%), Positives = 166/318 (52%), Gaps = 15/318 (4%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILR 184
VP R ++ L +G G Y SV A D + VA+KK+ R RE+ +L+
Sbjct: 13 VPER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69
Query: 185 RLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
+ H N+I L + T S +YLV M D+ ++ C K S+ ++ + QL
Sbjct: 70 HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQL 127
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L GL++ HS G++HRD+K SN+ VN + L++ DFGLA ++ +T V T WYR
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYRA 183
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PE++L Y +VD+WSVGC+ AELL GK + G ++QL +I ++ G+P + KK
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243
Query: 361 KLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
HA + P+ L++ F+ A++L+E +L ++ KR +AS ALA YFS
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
Query: 419 KPYACDLSSLPIYPPSKE 436
D Y S E
Sbjct: 304 YHDPEDEPEAEPYDESPE 321
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 4e-53
Identities = 102/286 (35%), Positives = 153/286 (53%), Gaps = 11/286 (3%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHPNIIK-L 194
IG G + V+ D GK VALKK+ F N S + + RE+ +L H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNVLSAL 65
Query: 195 EGLITSRLSC--SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
+ L + IY+V E M+ D+ ++ P S +K ++ Q+L GL++ HS G+
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGI 124
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
LHRDIK NLLVN+ VLK+ DFGLA + +T VVT +YR PE+L+G+ Y
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS 184
Query: 313 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS---KLPHATLFK 369
+VD+WSVGC+FAELL + + Q ++ ++QL I L G+P + + + H
Sbjct: 185 AVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGP 244
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
+ P L AV+L+ +L +P KR +A+ ALA Y
Sbjct: 245 HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 9e-52
Identities = 93/335 (27%), Positives = 146/335 (43%), Gaps = 40/335 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESVRFMAREILILRRLDHP- 189
+ L K+G+G++ V+ ARD K+VALK + + + V REI IL L+HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEH 246
NI+KL S +YLV EY++ + LL SE++ + Q+L LE+
Sbjct: 59 NIVKLYDFFQDEGS--LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 247 CHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANF-----SNTGHRQPLTSRVVTLWYRP 300
HS+G++HRDIK N+L++ + V+KL DFGLA S + ++ V T Y
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 301 PELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDD 355
PE+LLG + S D+WS+G ELL G P +G Q KI +P
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
P + A +L++ LL+ +P R ++S+ L+ +
Sbjct: 237 SPLSPSNPE-------------------LISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277
Query: 416 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKV 450
+ S + P + +
Sbjct: 278 LAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALI 312
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 9e-52
Identities = 75/202 (37%), Positives = 115/202 (56%), Gaps = 10/202 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
FE LEKIG+G + V++AR TGK VA+K ++ + E + EI IL++ HPNI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNI 59
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+K G + +++V E+ + LL + +E+QI +LL GLE+ HS
Sbjct: 60 VKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
G++HRDIK +N+L+ ++G +KL DFGL+ S+T R + V T ++ PE++ G
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVING-KP 173
Query: 310 YGPSVDLWSVGCVFAELLIGKP 331
Y D+WS+G EL GKP
Sbjct: 174 YDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 8e-51
Identities = 111/315 (35%), Positives = 171/315 (54%), Gaps = 40/315 (12%)
Query: 137 KIGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPNIIK 193
K+G+GTY V++A+ D + ALK++ E + A REI +LR L HPN+I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELKHPNVIS 62
Query: 194 LEGLITSRLSCSIYLVFEYMEHDITGLL--------SCPDIKFSEAQIKCYMNQLLHGLE 245
L+ + S ++L+F+Y EHD+ ++ + ++ +K + Q+L G+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHR--QPLTSRVVTLWYR 299
+ H+ VLHRD+K +N+LV EG +K+AD G A N+ + L VVT WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCG 350
PELLLGA Y ++D+W++GC+FAELL +PI R E +QL +IF + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
Query: 351 SPPDDYWKK-SKLP-HATL---FKPQQPYDSSL---RETFKDLP-TTAVNLIETLLSVEP 401
P D W+ K+P H+TL F+ + SL E K P + A +L++ LL+++P
Sbjct: 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 302
Query: 402 YKRATASAALASEYF 416
KR T+ A+ YF
Sbjct: 303 IKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 2e-50
Identities = 102/299 (34%), Positives = 155/299 (51%), Gaps = 15/299 (5%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILR 184
VP R ++ L +G G Y SV A D TG VA+KK+ + RE+ +L+
Sbjct: 15 VPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71
Query: 185 RLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
+ H N+I L + T S +YLV M D+ ++ C K ++ ++ + Q+
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 129
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L GL++ HS ++HRD+K SNL VN + LK+ DFGLA ++ +T V T WYR
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRA 185
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PE++L Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P + KK
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245
Query: 361 KLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
A + + F AV+L+E +L ++ KR TA+ ALA YF+
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 2e-49
Identities = 113/315 (35%), Positives = 171/315 (54%), Gaps = 40/315 (12%)
Query: 137 KIGQGTYSSVFRARDLDTG--KIVALKKVRFDNFEPESVRFMA-REILILRRLDHPNIIK 193
K+G+GTY V++A+ D K ALK++ E + A REI +LR L HPN+I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-----EGTGISMSACREIALLRELKHPNVIA 62
Query: 194 LEGLITSRLSCSIYLVFEYMEHDITGLL--------SCPDIKFSEAQIKCYMNQLLHGLE 245
L+ + S ++L+F+Y EHD+ ++ + ++ + +K + Q+L G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHR--QPLTSRVVTLWYR 299
+ H+ VLHRD+K +N+LV EG +K+AD G A N+ + L VVT WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCG 350
PELLLGA Y ++D+W++GC+FAELL +PI R E +QL +IF + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
Query: 351 SPPDDYWKK-SKLP-HATL---FKPQQPYDSSL---RETFKDLPTTAVN-LIETLLSVEP 401
P D W+ K+P + TL F+ +SSL E K P + V L++ LL+++P
Sbjct: 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 302
Query: 402 YKRATASAALASEYF 416
KR T+ AL YF
Sbjct: 303 TKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 8e-49
Identities = 76/217 (35%), Positives = 124/217 (57%), Gaps = 18/217 (8%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
+ IG+G + V++ +L+TG VA+K++ + + E+++ + +EI +L+ L HPNI+K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLLHGLEHCHSR 250
G I + S S+Y++ EY E+ G L I F E+ + Y+ Q+L GL + H +
Sbjct: 66 GSIET--SDSLYIILEYAEN---GSLR--QIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
GV+HRDIK +N+L +GV+KLADFG+A N + + V T ++ PE++ +
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMS--- 174
Query: 311 GPSV--DLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
G S D+WS+GC ELL G P + L +I
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-48
Identities = 91/295 (30%), Positives = 135/295 (45%), Gaps = 48/295 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E +++IG+G++ V+ R GK+ LK++ N + E+ IL++L+HPNI
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 192 IKL-EGLITSRLSCSIYLVFEYMEHDITGLLS-------CPDIKFSEAQIKCYMNQLLHG 243
IK E + +V EY + G LS F E QI + QL
Sbjct: 62 IKYYESFEEK---GKLCIVMEYAD---GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV-TLWYRPP 301
L++ HSR +LHRDIK N+ + + G++KL DFG++ S+T L VV T +Y P
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST---VDLAKTVVGTPYYLSP 172
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
EL Y D+WS+GCV EL K +G +E KI K G P
Sbjct: 173 ELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYP-------P 222
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+P Y S LR NL+ +LL +P +R + + L S +
Sbjct: 223 IP--------SQYSSELR-----------NLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 1e-48
Identities = 106/291 (36%), Positives = 154/291 (52%), Gaps = 8/291 (2%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+ FE L +G+G Y V + R +T +IVA+KK + D+ E E V+ RE+ +LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQ 59
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI++L+ R +YLVFEY+E ++ LL +++ Y+ QL+ + CH
Sbjct: 60 ENIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
++HRDIK NLL+++ VLKL DFG A + G T V T WYR PELLLGA
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK--KSKLPHAT 366
YG +VD+WSVGC+ EL G+P+ G +E++QL I K+ G P + K S
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 367 LFKPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAALASEYF 416
L P + SL + L ++L++ LL + P R L F
Sbjct: 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 91/304 (29%), Positives = 140/304 (46%), Gaps = 47/304 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ LEKIG+G V++A D TGK VA+KK+R E + EILI++ HPNI
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNI 77
Query: 192 IKLEGLITSRLSC-----SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+ +++V EYM+ +T +++ ++ +E QI ++L GLE
Sbjct: 78 VDY-------YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE 130
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HS+ V+HRDIK N+L++ +G +KLADFG A S V T ++ PE++
Sbjct: 131 YLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNSVVGTPYWMAPEVIK 189
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
DYGP VD+WS+G + E+ G+P + L I G PP L +
Sbjct: 190 R-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--------LKNP 239
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 425
+ P+ FKD + L +P KR +A L + AC
Sbjct: 240 EKWSPE----------FKD-------FLNKCLVKDPEKRPSAEELLQHPFLKK---ACPK 279
Query: 426 SSLP 429
Sbjct: 280 EEFA 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 3e-45
Identities = 106/296 (35%), Positives = 160/296 (54%), Gaps = 32/296 (10%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL 197
IG G++ V+ A +DT + VA+KKV D P+ + RE+LI++ L+H NII L+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQ---YKNRELLIMKNLNHINIIFLKDY 127
Query: 198 ITS----RLSCSIYL----------VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
+ + +I+L V +YM+H + P +K Y QL
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF-----LVKLYSYQLCRA 182
Query: 244 LEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
L + HS+ + HRD+K NLL++ N LKL DFG A G R S + + +YR PE
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRFYRAPE 240
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
L+LGAT+Y +DLWS+GC+ AE+++G PI G++ V+QL +I ++ G+P +D K+
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300
Query: 363 PHATL-FKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+A + F +P D L++ F K P A+N I L EP KR ALA +F
Sbjct: 301 NYADIKFPDVKPKD--LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 94/312 (30%), Positives = 158/312 (50%), Gaps = 44/312 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
++ L+ IG G V A D TG+ VA+KK+ F N + RE+++++ ++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVLMKLVNHK 75
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIK--FSEAQIKCYMNQLLHG 243
NII L + T + S +YLV E M+ ++ C I+ ++ + Q+L G
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANL-----CQVIQMDLDHERMSYLLYQMLCG 130
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE+
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEV 188
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK---- 359
+LG Y +VD+WSVGC+ E++ G + G ++Q +KI + G+P D++ +
Sbjct: 189 ILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247
Query: 360 ----------------SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 403
+L LF P + L+ + A +L+ +L ++P K
Sbjct: 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLK------ASQARDLLSKMLVIDPEK 301
Query: 404 RATASAALASEY 415
R + AL Y
Sbjct: 302 RISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 85/299 (28%), Positives = 136/299 (45%), Gaps = 57/299 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKV--RFDNFEPESVRFMAREILILRRLD-H 188
F+ + IG+G++S+V A++ +T K A+K + R E + V+++ E +L RL+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLNGH 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
P IIKL T + ++Y V EY + ++ + E + Y ++L LE+
Sbjct: 62 PGIIKLYY--TFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYL 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-------------------RQP 288
HS+G++HRD+K N+L++ + +K+ DFG A + R+
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
S V T Y PELL G S DLW++GC+ ++L GKP +G E KI KL
Sbjct: 179 FASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237
Query: 349 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
S P ++ D A +LIE LL ++P R
Sbjct: 238 EYSFPPNF-------------------------PPD----AKDLIEKLLVLDPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 90/284 (31%), Positives = 144/284 (50%), Gaps = 38/284 (13%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
++ KIG GT+ V+ A +LDTG+++A+K++R + +P++++ +A E+ +L L HPN++
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 193 KLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
K G+ R +Y+ EY + LL I E I+ Y QLL GL + HS G
Sbjct: 63 KYYGVEVHRE--KVYIFMEYCSGGTLEELLEHGRIL-DEHVIRVYTLQLLEGLAYLHSHG 119
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFG----LANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
++HRDIK +N+ +++ GV+KL DFG L N + T + + S T Y PE++ G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE-VQSLAGTPAYMAPEVITGG 178
Query: 308 TD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI-FKLCGSPPDDYWKKSKLPH 364
+G + D+WS+GCV E+ GK +E++ +I F +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGAGH------------ 223
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
KP P L KD ++ L +P KR TAS
Sbjct: 224 ----KPPIPDSLQLSPEGKD-------FLDRCLESDPKKRPTAS 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 86/273 (31%), Positives = 128/273 (46%), Gaps = 44/273 (16%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPNIIKLE- 195
+G+G++ V R DTGK+ A+K ++ + + V E IL R++HP I+KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
T +YLV EY G L + +FSE + + Y +++ LE+ HS G+
Sbjct: 61 AFQTEE---KLYLVLEYAP---GGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
++RD+K N+L++ +G +KL DFGLA S+ G R + T Y PE+LLG YG
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLLGK-GYG 171
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
+VD WS+G + E+L GKP E KI K + P
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------DPLRFP-------- 213
Query: 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ L A +LI LL +P KR
Sbjct: 214 -----------EFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 5e-40
Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 14/204 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
E+++ +GQG+ V++ R TGKI ALKK+ D + E + + RE+ LR + P +
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYV 61
Query: 192 IKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+K G I +V EYM+ D+ K E + Q+L GL++
Sbjct: 62 VKCYGAFYK--EGEISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYL 115
Query: 248 HS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
H+ R ++HRDIK SNLL+N++G +K+ADFG++ + V T+ Y PE + G
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT-LDQCNTFVGTVTYMSPERIQG 174
Query: 307 ATDYGPSVDLWSVGCVFAELLIGK 330
+ Y + D+WS+G E +GK
Sbjct: 175 ES-YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 87/283 (30%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN---FEPESVRFMAREILILRRLDHPN 190
K E +G G++ SV+ +LD G A+K+V + E+V+ + +EI +L +L HPN
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
I++ G T R ++Y+ E + + LL F E I+ Y Q+L GLE+ H
Sbjct: 64 IVQYLG--TEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHD 120
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
R +HRDIKG+N+LV+ GV+KLADFG+A S + ++ PE++
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
YG + D+WS+GC E+ GKP +++E + +FK+ G +
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKI-GRSKE--------------L 220
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
P P L A + I L +P R TA+ L
Sbjct: 221 PPIP---------DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 85/285 (29%), Positives = 135/285 (47%), Gaps = 39/285 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E LE IG+G++ +V + R GKI+ K++ + N + + + E+ ILR L HPNI
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLS-CPDIK--FSEAQIKCYMNQLLHGLEHC 247
++ I R + ++Y+V EY E D+ L+ C + E I + QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 248 HSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
H+R VLHRD+K +N+ ++ +KL DFGLA + V T +Y PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPYYMSPE 180
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
L + Y D+WS+GC+ EL P R +++ KI K ++
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI---------KEGKFRRI 230
Query: 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
P+ Y S L E +I+++L+V+P KR +
Sbjct: 231 PYR--------YSSELNE-----------VIKSMLNVDPDKRPST 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 100/332 (30%), Positives = 169/332 (50%), Gaps = 33/332 (9%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+++L+ IG G V A D G VA+KK+ + RE+++L+ ++H NI
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 192 IKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L + T + S +YLV E M+ ++ ++ ++ ++ + Q+L G++H
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHL 139
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++LG
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYYRAPEVILG- 196
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK--SKLPHA 365
Y +VD+WSVGC+ EL+ G I QG ++Q +K+ + G+P ++ + + +
Sbjct: 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256
Query: 366 TLFKPQQPYDSSLRETFKD--LP----------TTAVNLIETLLSVEPYKRATASAALAS 413
+PQ P S E F D P + A +L+ +L ++P KR + AL
Sbjct: 257 VENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315
Query: 414 EYFST--KPYACDLSSLPIYPPSKEIDAKHRE 443
Y + P + PP + DA+ E
Sbjct: 316 PYITVWYDPAEAEA------PPPQIYDAQLEE 341
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 7e-38
Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 52/282 (18%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR---FMAREILILRRLDHPNIIKL 194
I +G Y VF A+ TG I A+K ++ + ++ R+IL + P ++KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS--QAQSPYVVKL 58
Query: 195 -EGLITSRLSCSIYLVFEYMEH-DITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ ++YLV EY+ D+ LL E + Y+ +++ LE+ HS
Sbjct: 59 YYSFQGKK---NLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLHS 111
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANF------SNTGHRQPLTSRVV-TLWYRPPE 302
G++HRD+K N+L+++ G LKL DFGL+ N + R+V T Y PE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
++LG + +VD WS+GC+ E L+G P G T E I P+D
Sbjct: 172 VILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED------- 223
Query: 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
++ A++LI LL +P KR
Sbjct: 224 --------------------VEVSDEAIDLISKLLVPDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 90/326 (27%), Positives = 166/326 (50%), Gaps = 23/326 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ L+ IG G V A D + VA+KK+ + RE+++++ ++H NI
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 192 IKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L + T + S +Y+V E M+ ++ ++ ++ ++ + Q+L G++H
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHL 142
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++LG
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 199
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P ++ KK + T
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 368 FKPQQPYDS-SLRETFKDL------------PTTAVNLIETLLSVEPYKRATASAALASE 414
+ + Y S + F D+ + A +L+ +L ++ KR + AL
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 415 YFSTKPYACDLSSLPIYPPSKEIDAK 440
Y + + + P P K++D +
Sbjct: 320 YINVWYDPSEAEAPPPKIPDKQLDER 345
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 94/326 (28%), Positives = 169/326 (51%), Gaps = 23/326 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ L+ IG G V A D + VA+KK+ + RE+++++ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 192 IKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L + T + S +YLV E M+ ++ ++ ++ ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHL 135
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 192
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-------- 359
Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P ++ KK
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 360 --SKLPHATLFKPQQPYDSSL---RETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
++ +A L P+ DS E K + A +L+ +L ++P KR + AL
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312
Query: 415 YFSTKPYACDLSSLPIYPPSKEIDAK 440
Y + ++ + P K++D +
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDER 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 8e-37
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F LE IG+G++ V++A D T ++VA+K + + E E + + +EI L + P I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLHGLEHC 247
K G + ++++ EY G SC D+ K E I + ++L GLE+
Sbjct: 62 TKYYG--SFLKGSKLWIIMEYC-----GGGSCLDLLKPGKLDETYIAFILREVLLGLEYL 114
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR----VVTLWYRPPEL 303
H G +HRDIK +N+L++ EG +KLADFG++ G S+ V T ++ PE+
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQG 335
+ + Y D+WS+G EL G+P L
Sbjct: 170 IKQ-SGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 73/230 (31%), Positives = 124/230 (53%), Gaps = 12/230 (5%)
Query: 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKV--------RFDNFEPESVRFMAREILILRR 185
K E IG+GTY V+ A ++ TG+++A+K+V R D+ + + V+ + EI L+
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
LDH NI++ G T+ SI+L EY+ G +F E ++ + Q+L GL
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT--GHRQPLTSRVVTLWYRPPEL 303
+ HS+G+LHRD+K NLLV+ +G+ K++DFG++ S+ + Q ++ + W P +
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
+ Y VD+WS+GCV E+ G+ + + K+ +PP
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 67/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ F+ LEK+G+G+Y SV++A +TG++VA+K V + E ++ + +EI IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
I+K G + +++V EY ++ ++ + +E +I + Q L GLE+ H
Sbjct: 59 YIVKYYGSY--FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGA 307
S +HRDIK N+L+N EG KLADFG++ + V+ T ++ PE++
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQE- 173
Query: 308 TDYGPSVDLWSVGCVFAELLIGKP 331
Y D+WS+G E+ GKP
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 16/209 (7%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +E +++IG GTY V++ARD+ TG++VA+K ++ + + + +EI +L+ HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHP 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
NI+ G + +++V EY DI + P SE QI + L GL
Sbjct: 61 NIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLA 115
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELL 304
+ H G +HRDIKG+N+L+ +G +KLADFG+ A + T ++ S + T ++ PE+
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR--KSFIGTPYWMAPEVA 173
Query: 305 L--GATDYGPSVDLWSVGCVFAELLIGKP 331
Y D+W++G EL +P
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 9e-35
Identities = 75/226 (33%), Positives = 116/226 (51%), Gaps = 19/226 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES---VRFMAREILILRRLDHPNIIKL 194
+GQG + V+ D+DTG+ +A+K+V FD PE+ V + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 195 EGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
G + + SI++ EYM D +E + Y Q+L G+E+ HS
Sbjct: 70 YGCLRDDETLSIFM--EYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHSN 123
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGAT 308
++HRDIKG+N+L ++ G +KL DFG + T + V T ++ PE++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
YG D+WSVGC E+L KP E E + IFK+ P +
Sbjct: 184 -YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 78/265 (29%), Positives = 136/265 (51%), Gaps = 28/265 (10%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-------VRFMAREILILRRLDHPN 190
IG G++ SV+ + +G+++A+K+V + S + +AREI +L+ L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
I++ G +I+L EY+ + LL+ F E ++ ++ Q+L GL + H+
Sbjct: 68 IVQYLGSSLDADHLNIFL--EYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHN 124
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGL-----ANFSNTGHRQPLTSRVVTLWYRPPELL 304
RG++HRDIKG+N+LV+N+G +K++DFG+ AN +T S ++++ PE +
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE-V 183
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG----SPPDDYWKKS 360
+ T Y D+WS+GC+ E+L GK + QL IFK+ P + ++
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGK---HPFPDCTQLQAIFKIGENASPEIPSNISSEA 240
Query: 361 KLPHATLFKPQQPYDSSLRETFKDL 385
F+ D + R T +L
Sbjct: 241 IDFLEKTFEI----DHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 81/294 (27%), Positives = 128/294 (43%), Gaps = 34/294 (11%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D +E +E IG G + V+ A L + VA+K++ + SV + +E+ + + +HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDELRKEVQAMSQCNHP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N++K ++LV Y+ DI S P EA I + ++L GLE
Sbjct: 60 NVVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMKS-SYPRGGLDEAIIATVLKEVLKGLE 116
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVV--TLWYRPPE 302
+ HS G +HRDIK N+L+ +G +K+ADFG+ A+ ++ G R + T + PE
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
++ Y D+WS G EL G ++ L L PP L
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT--LQNDPPS-------L 227
Query: 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+K Y S R+ +I L +P KR TA L ++F
Sbjct: 228 ETGADYK---KYSKSFRK-----------MISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 78/233 (33%), Positives = 125/233 (53%), Gaps = 13/233 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRF----DNFEPESVRFMAREILILRRLD 187
+ K +++G G +SS ++ARD+ TG ++A+K+V + + + E V + +EI ++ RL+
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
HP+II++ G ++++ E+M L F EA I Y QLL GL +
Sbjct: 62 HPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL 119
Query: 248 HSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA---NFSNTGHRQPLTSRVVTLWYRPPEL 303
H ++HRD+KG+NLL+++ G L++ADFG A TG + + T+ + PE+
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS--PPD 354
L G YG S D+WSVGCV E+ KP L IFK+ + P
Sbjct: 180 LRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 52/293 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDH 188
F+ +KIG+G +S V++A L G++VALKKV+ F+ + ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 189 PNIIK-LEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK--------FSEAQIKCYMN 238
PN+IK L I + + +V E + D++ + IK E I Y
Sbjct: 62 PNVIKYLASFIENN---ELNIVLELADAGDLSRM-----IKHFKKQKRLIPERTIWKYFV 113
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTL 296
QL LEH HS+ ++HRDIK +N+ + GV+KL D GL F S T S V T
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTP 170
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 355
+Y PE + Y D+WS+GC+ E+ + P + + L K + C PP
Sbjct: 171 YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP-- 227
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
P Y LR+ L+ ++ +P KR S
Sbjct: 228 -------------LPADHYSEELRD-----------LVSRCINPDPEKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 25/234 (10%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-D 187
FE +E IG+GTY V++AR TG++VA+K + E E ++ E ILR+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRKYSN 61
Query: 188 HPNIIKLEGLITSRLSCS----IYLVFEYMEHD-----ITGLLSCPDIKFSEAQIKCYMN 238
HPNI G + ++LV E + GL + E I +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILR 120
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 297
+ L GL + H V+HRDIKG N+L+ +KL DFG+ A +T R+ + + T +
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR--NTFIGTPY 178
Query: 298 YRPPELLLGATDYGPSV------DLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
+ PE++ A D P D+WS+G EL GKP L + L KI
Sbjct: 179 WMAPEVI--ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK-VRFDNFEPESVRFMAREILILRRLDHPN 190
FE L IG+G + V + DT K+ A+K + E SVR + E IL+ L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++ L + YLV + + D+ LS +KFSE Q+K ++ +++ LE+ HS
Sbjct: 62 LVNLWYSFQDEENM--YLVVDLLLGGDLRYHLS-QKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+G++HRDIK N+L++ +G + + DF +A TS T Y PE+L
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPEVLCRQ-G 175
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
Y +VD WS+G E L GK +G + D + + L+
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAKQETADVLYP 222
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ A++ I LL +P KR
Sbjct: 223 ATWSTE-------------AIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 93/300 (31%), Positives = 130/300 (43%), Gaps = 70/300 (23%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL 197
+G+GTY V+ ARDL T +A+K++ + V+ + EI + L H NI++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLG- 72
Query: 198 ITSRLSCSIYLVFE-YMEHDITGLLSC-------PDIKFSEAQIKCYMNQLLHGLEHCHS 249
S S F+ +ME G LS P +K +E I Y Q+L GL++ H
Sbjct: 73 -----SDSENGFFKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHD 126
Query: 250 RGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHR----QPLTSRVV-TLWYRPPEL 303
++HRDIKG N+LVN GV+K++DFG T R P T TL Y PE+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFG------TSKRLAGINPCTETFTGTLQYMAPEV 180
Query: 304 L-LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
+ G YG D+WS+GC E+ GKP F G
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKP-------------PFIELGE----------- 216
Query: 363 PHATLFK-------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
P A +FK P+ P + L A N I +P KRA+A L +
Sbjct: 217 PQAAMFKVGMFKIHPEIP---------ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 132 FEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
E +K+G+G + V++ T VA+K ++ E E F+ E I+++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC---PDIKFSEAQIKCYMNQLLHG 243
HPNI++L G+ T +Y+V EYM G LL K + + Q+ G
Sbjct: 60 HPNIVRLLGVCTQGEP--LYIVTEYMPG---GDLLDFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+E+ S+ +HRD+ N LV V+K++DFGL+
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 89/310 (28%), Positives = 144/310 (46%), Gaps = 43/310 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +V+ A D+ TG+ VA+K++ +P+ + EIL++R HPNI
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKK-ELIINEILVMRENKHPNI 78
Query: 192 IKLEGLITSRLSC-SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ + S L +++V EY+ +T +++ + E QI + L LE HS
Sbjct: 79 VNY---LDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS 133
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
V+HRDIK N+L+ +G +KL DFG T + ++ V T ++ PE++
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVT-RKA 191
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
YGP VD+WS+G + E++ G+P + L+ I AT
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNGT 232
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS-TKPYACDLSSL 428
P+ L F+D + L ++ KR +A L + KP LSSL
Sbjct: 233 PELQNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHPFLKIAKP----LSSL 281
Query: 429 -PIYPPSKEI 437
P+ +KE
Sbjct: 282 TPLIAAAKEA 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 97/356 (27%), Positives = 144/356 (40%), Gaps = 77/356 (21%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDH 188
D FE ++ IG+G + V+ RD DTG++ A+K +R D + + + E IL D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 189 PNIIKLEGLITSRLSCS------IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLL 241
P I+KL S +YLV EYM D+ LL D+ F E + Y+ +L+
Sbjct: 61 PWIVKLY--------YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELV 111
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----------NFSNTGHRQPLTS 291
L+ H G +HRDIK N+L++ +G +KLADFGL + N H
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 292 RVVTLW------------------YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 333
V+ Y PE+L G T YG D WS+G + E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 334 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 393
T E +KI WK+S L P P + A++LI
Sbjct: 231 YSDTLQETYNKIIN---------WKES------LRFPPDP----------PVSPEAIDLI 265
Query: 394 ETLL--SVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP--SKEIDAKHREDA 445
LL + + +F + + P + P S +D + +D
Sbjct: 266 CRLLCDPEDRLGSFE--EIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSNFDDF 319
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 78/292 (26%), Positives = 128/292 (43%), Gaps = 50/292 (17%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F+ L+K+G+G+Y SV++ + L + ALK+V + + EI IL ++HPNI
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 192 IKL-EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIK---FSEAQIKCYMNQLLHGLEH 246
I E + + +V EY D++ +S K E +I QLL GL+
Sbjct: 62 ISYKEAFL---DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----NFSNTGHRQPLTSRVVTLWYRPP 301
H + +LHRD+K +N+L+ ++K+ D G++ N + T P Y P
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH--------YMAP 170
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
E+ G Y D+WS+GC+ E+ P + R+ ++ L +K+ K
Sbjct: 171 EVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLR--YKVQRG------KYPP 220
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
+P Y L+ N I ++L V+P R LAS
Sbjct: 221 IPPI--------YSQDLQ-----------NFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 76/237 (32%), Positives = 113/237 (47%), Gaps = 33/237 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPN 190
F+ L ++GQG Y VF A+ DTG+IVALK+++ F+ VR + E IL
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++KL L + +YL EY+ D LL+ + SE + YM ++ ++ H
Sbjct: 63 LVKL--LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALHE 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
G +HRD+K N L++ G +KL DFGL+ + S V + Y PE+L G
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN-----SVVGSPDYMAPEVLRG-K 173
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD------YWKK 359
Y +VD WS+GC+ E L G P GS P++ YWK+
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFP---------------PFSGSTPNETWENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 70/206 (33%), Positives = 109/206 (52%), Gaps = 12/206 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPN 190
F L +IG G++ +V+ ARD+ T ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+ +G + +LV EY + +L E +I + L GL + HS
Sbjct: 77 TIEYKGCYLREHTA--WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD- 309
+HRDIK N+L+ G +KLADFG A+ + P S V T ++ PE++L A D
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPYWMAPEVIL-AMDE 188
Query: 310 --YGPSVDLWSVGCVFAELLIGKPIL 333
Y VD+WS+G EL KP L
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 74/226 (32%), Positives = 116/226 (51%), Gaps = 17/226 (7%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES---VRFMAREILILRRLDHPNIIKL 194
+GQG + V+ D+DTG+ +A K+V+FD PE+ V + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
G + R ++ + EYM +E+ + Y Q+L G+ + HS ++H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 255 RDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
RDIKG+N+L ++ G +KL DFG + S TG R S T ++ PE++ G
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR----SVTGTPYWMSPEVISG-E 184
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
YG D+WS+GC E+L KP E E + IFK+ P +
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTN 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 50/304 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ KIG+G+ V A D TG+ VA+KK+ + + F E++I+R HPNI
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF--NEVVIMRDYQHPNI 78
Query: 192 IKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLHGLE 245
+++ L+ L ++V E++E G L+ DI + +E QI +L L
Sbjct: 79 VEMYSSYLVGDEL----WVVMEFLE---GGALT--DIVTHTRMNEEQIATVCLAVLKALS 129
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELL 304
H++GV+HRDIK ++L+ ++G +KL+DFG A S R+ S V T ++ PE +
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPE-V 186
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
+ YG VD+WS+G + E++ G+P ++ + +I PP K K H
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LPP-----KLKNLH 239
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424
LR ++ +L +P +RATA+ L + + A
Sbjct: 240 KV--------SPRLRS-----------FLDRMLVRDPAQRATAAELLNHPFLAK---AGP 277
Query: 425 LSSL 428
SS+
Sbjct: 278 PSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 84/291 (28%), Positives = 129/291 (44%), Gaps = 43/291 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--- 188
+++LE IG+G Y +V+R + + TG++VALK + D + + V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 189 PNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
PNI K G L RL +++ EY E L +E I + ++L L++
Sbjct: 62 PNITKYYGSYLKGPRL----WIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKY 116
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPELL 304
H GV+HRDIK +N+LV N G +KL DFG+A N+ R T ++ PE++
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVG---TPYWMAPEVI 173
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
Y D+WS+G E+ G P + L KSK P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMMLIP--------KSKPPR 221
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
Y LRE + L EP +R +A L S++
Sbjct: 222 L----EDNGYSKLLRE-----------FVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 71/217 (32%), Positives = 114/217 (52%), Gaps = 10/217 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPN 190
F L +IG G++ +V+ ARD+ T ++VA+KK+ + + E + + +E+ L+R+ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+ +G + +LV EY + LL E +I + L GL + HS
Sbjct: 87 SIEYKGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD- 309
++HRDIK N+L+ G +KLADFG A+ ++ P S V T ++ PE++L +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMAPEVILAMDEG 199
Query: 310 -YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y VD+WS+G EL KP L + L+ I
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 74/225 (32%), Positives = 116/225 (51%), Gaps = 19/225 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES---VRFMAREILILRRLDHPNIIKL 194
+GQG + V+ D DTG+ +A+K+V+FD PE+ V + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G + + ++ + E+M I L +E + Y Q+L G+ + HS ++
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIV 128
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HRDIKG+N+L ++ G +KL DFG + S TG + S T ++ PE++ G
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG----MKSVTGTPYWMSPEVISG- 183
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 352
YG D+WSVGC E+L KP E E + IFK+ P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQP 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 133 EKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+K+G+G + V++ VA+K ++ D E + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHG 243
PNI+KL G+ T + +V EYM G L + S + + + Q+ G
Sbjct: 61 PNIVKLLGVCTEEEP--LMIVMEYMPG---GDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-WYRPPE 302
+E+ S+ +HRD+ N LV V+K++DFGL+ + + + W PE
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APE 174
Query: 303 LLLGATDYGPSVDLWSVGCVFAELL 327
L + D+WS G + E+
Sbjct: 175 SLKEGK-FTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 80/274 (29%), Positives = 132/274 (48%), Gaps = 22/274 (8%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPN 190
F L +IG G++ +V+ ARD+ ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+ G + +LV EY + LL E +I + L GL + HS
Sbjct: 77 TIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD- 309
++HRD+K N+L++ G++KL DFG A+ P V T ++ PE++L +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEVILAMDEG 189
Query: 310 -YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYWKKSKLPHAT 366
Y VD+WS+G EL KP L + L+ I + SP +W +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQSGHWSEY------ 242
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 400
F+ DS L++ +D PT+ V L + E
Sbjct: 243 -FR--NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 30/229 (13%)
Query: 133 EKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+K+G+G + V++ + VA+K ++ D E + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
PN++KL G+ T +Y+V EYME D+ L K S + + + Q+ G+E+
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-WYRPPELLLG 306
S+ +HRD+ N LV V+K++DFGL+ + + W PE L
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKE 177
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
+ D+WS G + L +IF L P
Sbjct: 178 GK-FTSKSDVWSFGVL-------------------LWEIFTLGEQPYPG 206
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 71/241 (29%), Positives = 103/241 (42%), Gaps = 36/241 (14%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D E L ++G G V + TGKI+A+K +R + E + + RE+ IL + + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQIL-RELDILHKCNSP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGL---LSCPDIKFSEAQIKCYMNQLLHGLEH 246
I+ G + + I + EYM D L L + E + +L GL +
Sbjct: 60 YIVGFYGAFYN--NGDISICMEYM--DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY 115
Query: 247 CHS-RGVLHRDIKGSNLLVNNEGVLKLADFG--------LANFSNTGHRQPLTSRVVTLW 297
H ++HRD+K SN+LVN+ G +KL DFG LA + G T
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFVG----------TSS 164
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK----PILQGRTEV-EQLHKIFKLCGSP 352
Y PE + G DY D+WS+G EL G+ P + E L I P
Sbjct: 165 YMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN--EPP 221
Query: 353 P 353
P
Sbjct: 222 P 222
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 70/217 (32%), Positives = 112/217 (51%), Gaps = 10/217 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPN 190
F L +IG G++ +V+ A + T ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+ +G + +LV EY + LL E +I + L GL + HS
Sbjct: 83 TIEYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD- 309
++HRDIK N+L+ G +KLADFG A+ S+ P S V T ++ PE++L +
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMAPEVILAMDEG 195
Query: 310 -YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y VD+WS+G EL KP L + L+ I
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 13/203 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +VF A D+ TG+ VA+K++ +P+ + EIL+++ L +PNI
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKK-ELIINEILVMKELKNPNI 78
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCH 248
+ L + + +++V EY+ +T +++ C D EAQI + L LE H
Sbjct: 79 VNF--LDSFLVGDELFVVMEYLAGGSLTDVVTETCMD----EAQIAAVCRECLQALEFLH 132
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+ V+HRDIK N+L+ +G +KL DFG T + ++ V T ++ PE++
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 309 DYGPSVDLWSVGCVFAELLIGKP 331
YGP VD+WS+G + E++ G+P
Sbjct: 192 -YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 79/231 (34%), Positives = 112/231 (48%), Gaps = 16/231 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
F +KIG+G +S V+RA L G VALKKV+ FD + ++ +EI +L++L+HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFS-------EAQIKCYMNQLLHG 243
+IK +I L E G LS F E + Y QL
Sbjct: 64 VIKYYASFIEDNELNIVL-----ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
LEH HSR V+HRDIK +N+ + GV+KL D GL F ++ S V T +Y PE
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE- 176
Query: 304 LLGATDYGPSVDLWSVGCVFAEL-LIGKPILQGRTEVEQLHKIFKLCGSPP 353
+ Y D+WS+GC+ E+ + P + + L K + C PP
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 10/221 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E ++KIG+G++ ++ A+ + +K++ + +E+++L ++ HPNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHS 249
+ + + + +++V EY + D+ ++ + FSE QI + Q+ GL+H H
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 250 RGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
R +LHRDIK N+ ++ G V KL DFG+A N T V T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQNRP 178
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349
Y D+WS+GCV EL K +G + QL + K+C
Sbjct: 179 -YNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKIC 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 73/285 (25%), Positives = 114/285 (40%), Gaps = 38/285 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + +G+G + R + +V K+V + R EI+IL L HPNI
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I + I + EY +D ++ F E + Y+ Q++ + +
Sbjct: 62 IAYYNHFMDDNTLLIEM--EYANGGTLYDK--IVRQKGQLFEEEMVLWYLFQIVSAVSYI 117
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H G+LHRDIK N+ + G++KL DFG++ + + T V T +Y PEL G
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGV 176
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y D+W++GCV ELL K + + KI + +P
Sbjct: 177 -KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS------------ 223
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
Y S L L+ +LL +P KR TA L
Sbjct: 224 -----VYSSELIS-----------LVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 136 EKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+K+G+G + V++ + D VA+K ++ ++ E + +E ++++L HPN++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-DITGLL--------SCPDIKFSEAQIKCYMNQLLHG 243
+L G+ T +YLV EYME D+ L S S + + Q+ G
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA------NFSNTGHRQPLTSRVVTLW 297
+E+ S+ +HRD+ N LV + V+K++DFGL+ ++ L R W
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAEL 326
PE L + D+WS G + E+
Sbjct: 174 M-APESLKDGI-FTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 28/213 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDH 188
D FE ++ +G G++ V R +GK ALK + + + V + E IL+ + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITG------LLSCPDIKFSEAQIKCYMNQLLH 242
P ++ L G + + ++YLV EY + G L +F E + Y Q++
Sbjct: 61 PFLVNLYG--SFQDDSNLYLVMEY----VPGGELFSHLRKSG--RFPEPVARFYAAQVVL 112
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW----Y 298
LE+ HS +++RD+K NLL++++G +K+ DFG A + R TL Y
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VKGRTYTLCGTPEY 164
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
PE++L YG +VD W++G + E+L G P
Sbjct: 165 LAPEIILS-KGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 51/286 (17%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF----EPESVRFMAREILILRRLDHPN 190
L+ I +G + SV+ A+ TG A+K ++ + + +V+ R I++++ + P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK-AERAIMMIQG-ESPY 58
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK----FSEAQIKCYMNQLLHGLEH 246
+ KL S+ +YLV EY+ L IK E K Y+ +++ G+E
Sbjct: 59 VAKLYYSFQSK--DYLYLVMEYLNGGDCASL----IKTLGGLPEDWAKQYIAEVVLGVED 112
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR--VVTLWYRPPELL 304
H RG++HRDIK NLL++ G LKL DFGL+ R L ++ V T Y PE +
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS-------RNGLENKKFVGTPDYLAPETI 165
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
LG D D WS+GCV E L G P T PD + +
Sbjct: 166 LGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAET---------------PDAVFD--NILS 207
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 410
+ P+ E + AV+LI LL ++P KR A+
Sbjct: 208 RRINWPE--------EVKEFCSPEAVDLINRLLCMDPAKRLGANGY 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 77/232 (33%), Positives = 118/232 (50%), Gaps = 18/232 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
F+ +KIG+G +S V+RA L K VALKKV+ F+ + ++ + +EI +L++L+HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 191 IIK-LEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFS-------EAQIKCYMNQLLH 242
+IK L+ I + +V E + G LS F E + Y QL
Sbjct: 64 VIKYLDSFIEDN---ELNIVLELAD---AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
+EH HSR V+HRDIK +N+ + GV+KL D GL F ++ S V T +Y PE
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE 176
Query: 303 LLLGATDYGPSVDLWSVGCVFAEL-LIGKPILQGRTEVEQLHKIFKLCGSPP 353
+ Y D+WS+GC+ E+ + P + + L + + C PP
Sbjct: 177 -RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 86/301 (28%), Positives = 126/301 (41%), Gaps = 73/301 (24%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDH 188
D FE ++ IG+G + V + DTG I A+KK+R + E E V + E IL D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 189 PNIIKLEGLITSRLSCS------IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLL 241
P ++KL S +YL+ EY+ D+ LL D F+E + + Y+ + +
Sbjct: 61 PWVVKL--------YYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-FTEEETRFYIAETI 111
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--------------- 286
++ H G +HRDIK NLL++ +G +KL+DFGL HR
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 287 -----QPLTS-RVVTLW----------------YRPPELLLGATDYGPSVDLWSVGCVFA 324
+P++S R W Y PE+ L T Y D WS+G +
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMY 230
Query: 325 ELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 384
E+L+G P E KI WK+ TL P + L KD
Sbjct: 231 EMLVGYPPFCSDNPQETYRKIIN---------WKE------TLQFPD---EVPLSPEAKD 272
Query: 385 L 385
L
Sbjct: 273 L 273
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 6/201 (2%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ K++KIG+G++ + + GK +K++ P+ +E+ +L + HPNI
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHS 249
++ + + ++Y+V +Y E D+ ++ + F E QI + Q+ L+H H
Sbjct: 62 VQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
R +LHRDIK N+ + +G +KL DFG+A N+ T + T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICENRP- 177
Query: 310 YGPSVDLWSVGCVFAELLIGK 330
Y D+W++GCV E+ K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 77/236 (32%), Positives = 119/236 (50%), Gaps = 18/236 (7%)
Query: 110 PAWLSAVAGEAIQGWVPLRADAFEKLEK---IGQGTYSSVFRARDLDTGKIVALKKVRFD 166
+ S+ + + G P A + +LE+ IG G +V++ TG++ ALK V +
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYG 109
Query: 167 NFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI 226
N E R + REI ILR ++HPN++K + + I ++ E+M+ G L I
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEFMDG---GSLEGTHI 164
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286
E + Q+L G+ + H R ++HRDIK SNLL+N+ +K+ADFG++
Sbjct: 165 A-DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-M 222
Query: 287 QPLTSRVVTLWYRPPE-----LLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGR 336
P S V T+ Y PE L GA D G + D+WS+G E +G+ P GR
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 88/310 (28%), Positives = 146/310 (47%), Gaps = 45/310 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +V+ A D+ TG+ VA++++ +P+ + EIL++R +PNI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKK-ELIINEILVMRENKNPNI 79
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCH 248
+ L + + +++V EY+ +T +++ C D E QI + L LE H
Sbjct: 80 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLH 133
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S V+HRDIK N+L+ +G +KL DFG T + ++ V T ++ PE++
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
YGP VD+WS+G + E++ G+P + L+ I AT
Sbjct: 193 -YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------------ATNG 232
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS-TKPYACDLSS 427
P+ L F+D + L ++ KR +A L ++ KP LSS
Sbjct: 233 TPELQNPEKLSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFLKIAKP----LSS 281
Query: 428 L-PIYPPSKE 436
L P+ +KE
Sbjct: 282 LTPLIAAAKE 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 3e-24
Identities = 66/203 (32%), Positives = 112/203 (55%), Gaps = 13/203 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +V+ A D+ TG+ VA+K++ +P+ + EIL++R +PNI
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKK-ELIINEILVMRENKNPNI 78
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCH 248
+ L + + +++V EY+ +T +++ C D E QI + L L+ H
Sbjct: 79 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALDFLH 132
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S V+HRDIK N+L+ +G +KL DFG T + ++ V T ++ PE++
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 309 DYGPSVDLWSVGCVFAELLIGKP 331
YGP VD+WS+G + E++ G+P
Sbjct: 192 -YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 134 KLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++++G+G + V R +TG+ VA+K + E + REI ILR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHE 66
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+K +G+ S+ L+ EY+ + L + + ++ + +Q+ G+++
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPPEL 303
S+ +HRD+ N+LV +E ++K++DFGLA ++P S + WY PE
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY-APEC 183
Query: 304 LLGATDYGPSVDLWSVGCVFAELL 327
L + S D+WS G EL
Sbjct: 184 LRTSKFSSAS-DVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 80/264 (30%), Positives = 121/264 (45%), Gaps = 29/264 (10%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES---VRFMAREILILRRLDHPNIIKL 194
+G+G + V+ D DTG+ +A+K+V FD E+ V + EI +L+ L H I++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G + + + EYM I L +E + Y Q+L G+ + HS ++
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIV 128
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HRDIKG+N+L ++ G +KL DFG + S TG + S T ++ PE++ G
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG----IKSVTGTPYWMSPEVISG- 183
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
YG D+WSV C E+L KP E E + IFK+ P K LP
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQP-----TKPMLPDGVS 235
Query: 368 -----FKPQQPYDSSLRETFKDLP 386
F Q + R T + L
Sbjct: 236 DACRDFLKQIFVEEKRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 67/204 (32%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPN 190
FE +++IG GTY V++AR+++TG++ A+K ++ EP E + +EI++++ H N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL---EPGEDFAVVQQEIIMMKDCKHSN 67
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLLHGLE 245
I+ G R +++ E+ G S DI SE+QI + L GL
Sbjct: 68 IVAYFGSYLRR--DKLWICMEF-----CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPEL- 303
+ HS+G +HRDIKG+N+L+ + G +KLADFG+ A + T ++ S + T ++ PE+
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVA 178
Query: 304 -LLGATDYGPSVDLWSVGCVFAEL 326
+ Y D+W+VG EL
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 9/201 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +L ++G+G SV + R +TG I ALK + D P+ + + RE+ I + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
I+K G S SI + EY E I + + E + +L GL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HSR ++HRDIK SN+L+ +G +KL DFG++ T T +Y PE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQ 176
Query: 306 GATDYGPSVDLWSVGCVFAEL 326
G Y + D+WS+G E+
Sbjct: 177 GKP-YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRRLDHPNIIK 193
+G G + V + + ALK V+ + + E + E IL +HP I+K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 194 LEGLITSRLSCSIYLVFEYME-HDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRG 251
L T + IY++ EY ++ +L D F E + Y+ ++ E+ H+RG
Sbjct: 58 LYR--TFKDKKYIYMLMEYCLGGELWTILR--DRGLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGATDY 310
+++RD+K NLL+++ G +KL DFG A +G + T T Y PE++L Y
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEIILN-KGY 169
Query: 311 GPSVDLWSVGCVFAELLIGKP 331
SVD WS+G + ELL G+P
Sbjct: 170 DFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 81/265 (30%), Positives = 140/265 (52%), Gaps = 31/265 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F KLE+IG+G++ VF+ D T ++VA+K + + E E + + +EI +L + D P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 192 IKLEGLITSRLSCS-IYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLHGLEH 246
K G S L + ++++ EY+ G S D+ F E QI + ++L GL++
Sbjct: 65 TKYYG---SYLKGTKLWIIMEYL-----GGGSALDLLRAGPFDEFQIATMLKEILKGLDY 116
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLL 305
HS +HRDIK +N+L++ +G +KLADFG+A ++T ++ + V T ++ PE++
Sbjct: 117 LHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQ 174
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP----DDYWKKSK 361
+ Y D+WS+G EL G+P +++ + +F + + P ++ K K
Sbjct: 175 QSA-YDSKADIWSLGITAIELAKGEP---PNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK 230
Query: 362 -LPHATLFKPQQPYDSSLRETFKDL 385
A L K D S R T K+L
Sbjct: 231 EFIDACLNK-----DPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 2e-23
Identities = 75/257 (29%), Positives = 130/257 (50%), Gaps = 11/257 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ F KLEKIG+G++ VF+ D T K+VA+K + + E E + + +EI +L + D P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 62
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ K G + ++++ EY+ L P E QI + ++L GL++ HS
Sbjct: 63 YVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHS 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+HRDIK +N+L++ G +KLADFG+A ++T ++ + V T ++ PE ++ +
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE-VIKQS 176
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
Y D+WS+G EL G+P +E+ + +F + + P P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP---PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 233
Query: 369 KPQQPYDSSLRETFKDL 385
+ + S R T K+L
Sbjct: 234 EACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 73/243 (30%), Positives = 122/243 (50%), Gaps = 31/243 (12%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREIL----ILR 184
D +E +E IG+GTY V++ + G + A+K + + + + EI IL+
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYNILQ 73
Query: 185 RL-DHPNIIKLEGLITSRLSCS---IYLVFEY-----MEHDITGLLSCPDIKFSEAQIKC 235
L +HPN++K G+ ++LV E + + GLL C + EA I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISY 132
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVV 294
+ L GL+H H+ ++HRD+KG+N+L+ EG +KL DFG+ A ++T R+ + V
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVG 190
Query: 295 TLWYRPPELLLGATDYGPS----VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
T ++ PE++ Y S D+WS+G EL G P L ++ + +FK+
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL---FDMHPVKTLFKIPR 247
Query: 351 SPP 353
+PP
Sbjct: 248 NPP 250
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 5e-23
Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 41/291 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E ++++G GTY V++AR+L TG++ A+K ++ + + S+ + +EI +++ H NI
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNI 68
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLLHGLEH 246
+ G SR +++ EY G S DI SE QI + L GL +
Sbjct: 69 VAYFGSYLSREK--LWICMEY-----CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAY 121
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
HS+G +HRDIKG+N+L+ + G +KLADFG+A T S + T ++ PE+
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 307 ATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
+ Y D+W+VG EL +P + + L + K PP K K
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK---LKDKTKW 237
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
++ F N ++ L+ P KR TA L +
Sbjct: 238 SSTFH---------------------NFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 81/314 (25%), Positives = 130/314 (41%), Gaps = 39/314 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDH 188
F+ +G+G + V R+ TG I A+K ++ E+V F E IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
P I +L+ ++YLV EY D+ LL+ + +F E + Y+ +L+ +
Sbjct: 61 PWIPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQPLTSRVVTLWYRPPELLL- 305
H G +HRDIK N+L++ G +KLADFG A + V T Y PE+L
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS-KLPVGTPDYIAPEVLTT 177
Query: 306 ----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
G YG D WS+G + E++ G+ T + + I
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI---------------- 221
Query: 362 LPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
+ K P+ P SS ++LI++LL +R +FS
Sbjct: 222 MNFQRFLKFPEDPKVSS----------DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270
Query: 421 YACDLSSLPIYPPS 434
+ +SLP + P+
Sbjct: 271 WNNIRNSLPPFVPT 284
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 72/243 (29%), Positives = 123/243 (50%), Gaps = 25/243 (10%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILR 184
P +D +E +E IG+GTY VF+ + G A+K + + + E + E IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILK 69
Query: 185 RL-DHPNIIKLEGLITSRLSCS---IYLVFEY-----MEHDITGLLSCPDIKFSEAQIKC 235
L DHPN++K G+ + + ++LV E + + G L + + E I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE-RMEEPIIAY 128
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVV 294
+++ L GL+H H +HRD+KG+N+L+ EG +KL DFG+ A ++T R+ + V
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVG 186
Query: 295 TLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
T ++ PE++ + Y D+WS+G EL G P L ++ + +FK+
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPR 243
Query: 351 SPP 353
+PP
Sbjct: 244 NPP 246
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 28/227 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-----MAREILILR 184
D E+++ +G GT+ V RD + ALK + PE +R + E +L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI----PEVIRLKQEQHVHNEKRVLK 56
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLH 242
+ HP II+L T +Y++ EY+ + L + +FS + Y ++++
Sbjct: 57 EVSHPFIIRLFW--TEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVC 112
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW----Y 298
LE+ HS+ +++RD+K N+L++ EG +KL DFG A + L R TL Y
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCGTPEY 164
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
PE ++ + + +VD W++G + E+L+G P KI
Sbjct: 165 LAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 26/228 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
FE L KIG+G++ VF+ ++ A+K++ E +L +LD I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 192 IK-LEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
I+ E + + +V EY E H + L E Q+ + Q+L GL H
Sbjct: 62 IRYYESFLDKGK---LNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHRQPLTSRVVTLWYR 299
HS+ +LHRDIK NL ++ +K+ D G+A NF+NT V T +Y
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--------IVGTPYYL 168
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
PE L Y D+W++G V E GK + + KI +
Sbjct: 169 SPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 5e-22
Identities = 75/254 (29%), Positives = 121/254 (47%), Gaps = 9/254 (3%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F KLE+IG+G++ V++ D T ++VA+K + + E E + + +EI +L + D P I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
+ G + ++++ EY+ L P E I + ++L GL++ HS
Sbjct: 65 TRYYG--SYLKGTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSER 121
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
+HRDIK +N+L++ +G +KLADFG+A + T W P + A D+
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF- 180
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
D+WS+G EL G+P + L I K SPP + SK P +
Sbjct: 181 -KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK--NSPPTLEGQYSK-PFKEFVEAC 236
Query: 372 QPYDSSLRETFKDL 385
D R T K+L
Sbjct: 237 LNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 79/316 (25%), Positives = 126/316 (39%), Gaps = 62/316 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRRLDH 188
F+K++ +G+G VF R TGK+ ALK + + + + V+ + E IL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEH 246
P + L + + LV +Y ++ LL P SE + Y ++L LE+
Sbjct: 61 PFLPTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------------NFSNTGHRQPLTS 291
H G+++RD+K N+L++ G + L+DF L+ S + S
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 292 RVV-------------TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 338
T Y PE++ G +G +VD W++G + E+L G +G
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237
Query: 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 398
E I + P P SS +A +LI LL
Sbjct: 238 DETFSNIL-----------------KKEVTFPGSPPVSS----------SARDLIRKLLV 270
Query: 399 VEPYKRATASAALASE 414
+P KR S A+E
Sbjct: 271 KDPSKR-LGSKRGAAE 285
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 35/241 (14%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
D +E + ++G G + V++A+ +TG A K ++ ++ E E FM EI IL H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMV-EIDILSECKH 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CP-----------DIKFSEAQIKCY 236
PNI+ L Y + + E+ + L+ C + +E QI+
Sbjct: 62 PNIVGL------------YEAY-FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV 108
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
Q+L L HS V+HRD+K N+L+ +G +KLADFG++ N Q + + T
Sbjct: 109 CRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA-KNKSTLQKRDTFIGTP 167
Query: 297 WYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 352
++ PE++ T Y D+WS+G EL +P E+ + + K+ S
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP---PHHELNPMRVLLKILKSE 224
Query: 353 P 353
P
Sbjct: 225 P 225
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 80/284 (28%), Positives = 139/284 (48%), Gaps = 41/284 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
E KIG+G+ V AR+ +G+ VA+K + + + F E++I+R H N+
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF--NEVVIMRDYQHQNV 80
Query: 192 IKL--EGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
+++ L+ L +++ E+++ +T ++S + +E QI +L L + H
Sbjct: 81 VEMYKSYLVGEEL----WVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLH 134
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
S+GV+HRDIK ++L+ +G +KL+DFG A S ++ S V T ++ PE ++
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPE-VISR 191
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
T YG VD+WS+G + E++ G+P + V+ + +L SPP P
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPP---------PKLKN 239
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
P LR+ +E +L+ EP +RATA L
Sbjct: 240 AHKISPV---LRD-----------FLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 75/231 (32%), Positives = 119/231 (51%), Gaps = 37/231 (16%)
Query: 135 LEKIGQGTYSSVFRARDL---DTGKIVALK-------KVRFDNFEPESVRF-MAREILIL 183
L+ +GQG++ VF R + D G++ A+K KVR + VR M R+IL
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR------DRVRTKMERDILA- 53
Query: 184 RRLDHPNIIKL------EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 236
++HP I+KL EG +YL+ +++ D+ LS ++ F+E +K Y
Sbjct: 54 -EVNHPFIVKLHYAFQTEG--------KLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFY 103
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
+ +L L+H HS G+++RD+K N+L++ EG +KL DFGL+ S H + S T+
Sbjct: 104 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGTV 162
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
Y PE ++ + S D WS G + E+L G QG+ E + I K
Sbjct: 163 EYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-21
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 132 FEKLEKIGQGTYSSV----FRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
+K+ +G+G + V + + TG++VA+K ++ + ++ +EI IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY 64
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEH 246
H NI+K +G + + + L+ EY+ + L P K + AQ+ + Q+ G+ +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPP 301
HS+ +HRD+ N+L++N+ ++K+ DFGLA GH R+ S V WY
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWYAVE 180
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELL 327
L + + D+WS G ELL
Sbjct: 181 --CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 62/197 (31%), Positives = 111/197 (56%), Gaps = 11/197 (5%)
Query: 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEG 196
KIG+G+ V A +GK+VA+KK+ + + F E++I+R H N++++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF--NEVVIMRDYQHENVVEMYN 84
Query: 197 LITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
+ + +++V E++E +T +++ + +E QI +L L H++GV+HR
Sbjct: 85 --SYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 256 DIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 314
DIK ++L+ ++G +KL+DFG A S R+ S V T ++ PE L+ YGP V
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPE-LISRLPYGPEV 197
Query: 315 DLWSVGCVFAELLIGKP 331
D+WS+G + E++ G+P
Sbjct: 198 DIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 66/227 (29%), Positives = 112/227 (49%), Gaps = 22/227 (9%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESV----RFMAREILILRRLD 187
+ K E +G+G Y +V+ + G+++A+K+V D + + E+ +L+ L
Sbjct: 2 WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFS---EAQIKCYMNQLLHGL 244
H NI++ G + SI+ ME G +S +F E Y Q+L G+
Sbjct: 61 HVNIVQYLGTCLDDNTISIF-----MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGV 115
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-----FSNTGHRQPLTSRVVTLWYR 299
+ H+ V+HRDIKG+N+++ G++KL DFG A + H L S T ++
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 346
PE ++ + YG D+WS+GC E+ GKP L +++L +F
Sbjct: 176 APE-VINESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF 218
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 68/247 (27%), Positives = 115/247 (46%), Gaps = 33/247 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +E + ++G G + V++A++ +TG + A K + + E E +M EI IL +HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMV-EIEILATCNHP 69
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----------DIKFSEAQIKCYMN 238
I+KL G I + F CP D +E QI+
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEF------------CPGGAVDAIMLELDRGLTEPQIQVICR 117
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
Q+L L++ HS ++HRD+K N+L+ +G +KLADFG++ N Q S + T ++
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYW 176
Query: 299 RPPELLLGAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
PE+++ T Y D+WS+G E+ +P E+ + + K+ S P
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSEPP 233
Query: 355 DYWKKSK 361
+ SK
Sbjct: 234 TLSQPSK 240
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 83/300 (27%), Positives = 127/300 (42%), Gaps = 54/300 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDH 188
D FE L+ IG+G + V + DTG I A+K +R D E E V + E IL D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
++K+ + + ++YL+ E++ D+ LL D SE + Y+ + + ++
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI 117
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN----------FSNTGH------------ 285
H G +HRDIK NLL++ +G +KL+DFGL + N H
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 286 ------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 333
RQ S V T Y PE+ + T Y D WS+G + E+LIG P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 334 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 393
T E K+ WK++ +F P+ P ++ T + N I
Sbjct: 237 CSETPQETYRKVMN---------WKET-----LVFPPEVPISEKAKDLILRFCTDSENRI 282
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-20
Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+EK+ +G+G + V R K+V +K++ + + E +L+ L HPNI
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 192 IK-LEGLITSRLSCSIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGL 244
I+ E + + ++ +V EY G L+ C + E I + Q+L L
Sbjct: 62 IEYYENFLEDK---ALMIVMEYAP---GGTLAEYIQKRCNSL-LDEDTILHFFVQILLAL 114
Query: 245 EHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
H H++ +LHRD+K N+L++ ++ V+K+ DFG++ + + V T Y PEL
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYTVVGTPCYISPEL 172
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
G Y D+W++GCV EL K + + KI +P D
Sbjct: 173 CEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDR------- 224
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
Y LR+ LI ++L+++P KR S +A
Sbjct: 225 ----------YSPDLRQ-----------LILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 22/218 (10%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREI---LILRRL-----DHP 189
+G+G++ VF A T + A+K ++ D V M ++ ++ +R+ +HP
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKD------VVLMDDDVECTMVEKRVLSLAWEHP 56
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+ L T + +++ V EY+ + + SC KF + Y +++ GL+
Sbjct: 57 FLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFL 112
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS+G+++RD+K N+L++ +G +K+ADFG+ + G + T T Y PE+LLG
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF-CGTPDYIAPEILLG- 170
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y SVD WS G + E+LIG+ G E E I
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-20
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRR 185
++A+ F+ ++ IG+G + V R + ++ A+K + +F+ + F E I+
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99
Query: 186 LDHPNIIKLEGLITSRLSCS------IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMN 238
+ I+ +L + +Y+V EYM D+ L+S DI E + Y
Sbjct: 100 ANSEWIV--------QLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI--PEKWARFYTA 149
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+++ L+ HS G +HRD+K N+L++ G LKLADFG + + V T Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 299 RPPELLL---GATDYGPSVDLWSVGCVFAELLIGKP 331
PE+L G YG D WSVG E+L+G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 60/234 (25%), Positives = 108/234 (46%), Gaps = 32/234 (13%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKV---RFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+G+G + V + TGK+ A KK+ R + E + ++IL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL------------- 47
Query: 195 EGLITSRLSCSIYLVFEYMEH--DITGLLSCPDIK----------FSEAQIKCYMNQLLH 242
++SR S+ FE + + L++ D+K F EA+ Y Q++
Sbjct: 48 -EKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC 106
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
GLEH H R +++RD+K N+L+++ G ++++D GLA + + R T Y PE
Sbjct: 107 GLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPE 164
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
+L G Y SVD +++GC E++ G+ + R E + ++ + +Y
Sbjct: 165 VLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF----EPESVRFMAREILILRRLDHPNIIK 193
+G+G++ V A T ++ A+K ++ D + E + +L L HP
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT-MTEKRVLALAG-KHP---- 56
Query: 194 LEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSEAQIKCYMNQLLH 242
+T SC ++ V EY M H + +F E + + Y +++
Sbjct: 57 ---FLTQLHSCFQTKDRLFFVMEYVNGGDLMFH----IQRSG--RFDEPRARFYAAEIVL 107
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
GL+ H RG+++RD+K N+L+++EG +K+ADFG+ ++ T Y PE
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPE 166
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
+L YGP+VD W++G + E+L G+ +G E E I
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 38/290 (13%)
Query: 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEG 196
KIG+G+ V A + TGK VA+KK+ + + F E++I+R H N++ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF--NEVVIMRDYHHENVVDMYN 86
Query: 197 LITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
+ + +++V E++E +T +++ + +E QI +L L + H++GV+HR
Sbjct: 87 --SYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 256 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGATDYGPSV 314
DIK ++L+ ++G +KL+DFG + P +V T ++ PE ++ YG V
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPE-VISRLPYGTEV 199
Query: 315 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374
D+WS+G + E++ G+P ++ + +I D+ + K H
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------RDNLPPRVKDSHKV-------- 244
Query: 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS-TKPYAC 423
SS+ F DL +L EP +RATA L + P +C
Sbjct: 245 -SSVLRGFLDL----------MLVREPSQRATAQELLQHPFLKLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 135 LEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++++G+G + SV R D +TG++VA+KK++ E +R REI IL+ L H
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHD 65
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+K +G+ S ++ LV EY+ + + L + ++ Y +Q+ G+E+
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPPEL 303
S+ +HRD+ N+LV +E +K+ DFGL R+P S + WY P L
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI--FWYAPESL 183
Query: 304 LLGATDYGPSV--DLWSVGCVFAEL 326
T+ SV D+WS G V EL
Sbjct: 184 ----TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 28/300 (9%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-VRFMAREILILRRLDHPNIIKLEG 196
IG+G++ V + R DT +I ALK +R + S V E +L +++ P I+ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 197 LITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
S +YLV ++ H + + +F ++ + Y +LL LE+ H
Sbjct: 61 SFQSPEK--LYLVLAFINGGELFHHLQ-----REGRFDLSRARFYTAELLCALENLHKFN 113
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLA--NFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
V++RD+K N+L++ +G + L DFGL N + T Y PELLLG
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG---TPEYLAPELLLG-HG 169
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
Y +VD W++G + E+L G P E KI + PD + + +K L
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLS 229
Query: 370 --PQQPYDSSLRETFKDLPTTAVNLIETLLS---VEPYKRATASAA----LASEYFSTKP 420
P + + + K+ P + + LL P+K A +SA E+ KP
Sbjct: 230 RDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKP 289
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-19
Identities = 82/290 (28%), Positives = 127/290 (43%), Gaps = 58/290 (20%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
FE L+ IG+G + V + DTG + A+K +R D E E V + E IL D
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++K+ +L+ +YL+ E++ D+ LL D +E + + Y+ + + ++ H
Sbjct: 63 VVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQ 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN----------FSNTGH-------------- 285
G +HRDIK NLL++++G +KL+DFGL + N H
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 286 ----------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 335
RQ S V T Y PE+ + T Y D WS+G + E+LIG P
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 336 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 385
T E K+ WK++ +F P+ P + E KDL
Sbjct: 239 ETPQETYKKVMN---------WKET-----LIFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 16/232 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES---VRFMAREILILRRLDH 188
+ L +G+G++ + +++ + A+K++R P+S V +E ++L ++ H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKH 57
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK-FSEAQIKCYMNQLLHGLEH 246
PNI+ + + +Y+V EY + D+ + K F E I + Q+ G++H
Sbjct: 58 PNIVAFKESFEA--DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLL 305
H + VLHRDIK N+ + G +KL DFG A ++ G + V T +Y PPE+
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA--CTYVGTPYYVPPEIWE 173
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP-PDDY 356
Y D+WS+GC+ EL K Q + + K+ + P P Y
Sbjct: 174 NMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHY 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-19
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 31/204 (15%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
EKIG+G + V++ L VA+K R +F+ +E IL++ DHPNI+KL
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLI 58
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH-------GLEHCH 248
G+ + IY+V E + LL+ ++ + ++ + +LL G+E+
Sbjct: 59 GVCVQKQP--IYIVMELVPGG--SLLTF--LRKKKNRLT--VKKLLQMSLDAAAGMEYLE 110
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-------FSNTGHRQPLTSRVVTLWYRPP 301
S+ +HRD+ N LV VLK++DFG++ + G +Q + W P
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ-----IPIKWTAPE 165
Query: 302 ELLLGATDYGPSVDLWSVGCVFAE 325
L G Y D+WS G + E
Sbjct: 166 ALNYGR--YTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRRLD 187
F L +G+G + V A TG++ A+K ++ E ES+ R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 188 HPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSEAQIKCY 236
HP ++ L +C + V EY M H T + FSE + Y
Sbjct: 61 HPFLVNL-------FACFQTEDHVCFVMEYAAGGDLMMHIHTDV-------FSEPRAVFY 106
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
++ GL++ H +++RD+K NLL++ EG +K+ADFGL G ++ T
Sbjct: 107 AACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTP 165
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 340
+ PE+L T Y +VD W +G + E+L+G+ G E E
Sbjct: 166 EFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 66/237 (27%), Positives = 118/237 (49%), Gaps = 13/237 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +E + ++G G + V++A++ +TG ++A KV E E +M EI IL DHP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMV-EIDILASCDHP 62
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+KL L +++++ E+ + ++ + +E QI+ Q L L + H
Sbjct: 63 NIVKL--LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
++HRD+K N+L +G +KLADFG++ NT Q S + T ++ PE+++ T
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 309 D----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
Y D+WS+G E+ +P E+ + + K+ S P + S+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSEPPTLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 5e-19
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 132 FEKLEKIGQGTYSSV----FRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
+++ +G+G + V + +TG+ VA+K ++ ++ + + +EI ILR L
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLY 64
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
H NI+K +G+ T I L+ E++ + L K + Q Y Q+ G+++
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPP 301
SR +HRD+ N+LV +E +K+ DFGL T + L S V WY P
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FWY-AP 181
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELL 327
E L+ + Y S D+WS G ELL
Sbjct: 182 ECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 8e-19
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
A FE +E +G GTY V++ R + TG++ A+K + E E ++ +EI +L++ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 61
Query: 189 -PNIIKLEGLITSR----LSCSIYLVFEYM-EHDITGLL-SCPDIKFSEAQIKCYMNQLL 241
NI G + + ++LV E+ +T L+ + E I ++L
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRP 300
GL H H V+HRDIKG N+L+ +KL DFG+ A T R+ + + T ++
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMA 179
Query: 301 PELLLGATDYGPSV------DLWSVGCVFAELLIGKPIL 333
PE++ A D P DLWS+G E+ G P L
Sbjct: 180 PEVI--ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 9e-19
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR-------FMAREILILRRLDH-P 189
IG+GT+ V++ R DT +I A+K + + E V R IL+ LD P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS----KKEIVAKKEVAHTIGERNILVRTLLDESP 56
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
I+ L+ + + +YLV +YM + +FSE + K Y+ +L+ LEH H
Sbjct: 57 FIVGLK--FSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK 114
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+++RD+K N+L++ G + L DFGL+ +N + + T Y PE+LL
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 310 YGPSVDLWSVGCVFAELLIG 329
Y VD WS+G + E+ G
Sbjct: 174 YTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 136 EKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
E IG G + V R R GK VA+K ++ E + F++ E I+ + DHPNII
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQFDHPNII 68
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
LEG++T S + ++ E+ME+ + L D +F+ Q+ + + G+++
Sbjct: 69 HLEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANF-----SNTGHRQPLTSRVVTLWYRPPELLLG 306
+HRD+ N+LVN+ V K++DFGL+ F S+ + L ++ W P +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY- 185
Query: 307 ATDYGPSVDLWSVGCVFAELL 327
+ + D+WS G V E++
Sbjct: 186 -RKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 69/239 (28%), Positives = 114/239 (47%), Gaps = 24/239 (10%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
A FE +E +G GTY V++ R + TG++ A+K + E E ++ EI +L++ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSH 71
Query: 189 -PNIIKLEGLITSRLSC----SIYLVFEYM-EHDITGLL-SCPDIKFSEAQIKCYMNQLL 241
NI G + ++LV E+ +T L+ + E I ++L
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRP 300
GL H H+ V+HRDIKG N+L+ +KL DFG+ A T R+ + + T ++
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMA 189
Query: 301 PELLLGATDYGPSV------DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
PE++ A D P D+WS+G E+ G P L ++ + +F + +PP
Sbjct: 190 PEVI--ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPP 243
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 75/258 (29%), Positives = 109/258 (42%), Gaps = 48/258 (18%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
F K++ IG G + V R +DT + A+K +R D + E IL D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++KL + + ++Y V +Y+ D+ LL I F E + Y+ +L +E H
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHK 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN-F----------SNTGHRQ----------- 287
G +HRDIK N+L++ +G +KL DFGL F HRQ
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 288 -------PLTSR-------------VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
PL R V T Y PE+LL T Y D WSVG + E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238
Query: 328 IGKPILQGRTEVEQLHKI 345
+G+P T E K+
Sbjct: 239 VGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDL---DTGKIVA---LKKVRFDNFEPESVRFMAREILILRR 185
FE L +G G Y VF R + D GK+ A LKK + ++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHG 243
P ++ L + ++L+ +Y+ T L F+E++++ Y+ +++
Sbjct: 62 RRCPFLVTLHYAFQT--DTKLHLILDYVNGGELFTHL--YQREHFTESEVRVYIAEIVLA 117
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
L+H H G+++RDIK N+L+++EG + L DFGL+ + S T+ Y PE+
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 304 LLGATD-YGPSVDLWSVGCVFAELLIG 329
+ G + + +VD WS+G + ELL G
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
E +G G +V++A L T +I+A+K + D E + + E+ IL + D P II
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 195 EG--LITSRLS-CSIYL------VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
G + +R+S C+ ++ V+ + + G ++ +K GL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVK---------------GLT 109
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS----RVVTLWYRPP 301
+ S +LHRD+K SN+LVN G +KL DFG++ Q + S V T Y P
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS-------TQLVNSIAKTYVGTNAYMAP 162
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQ 334
E + G YG D+WS+G F EL +G+ P Q
Sbjct: 163 ERISG-EQYGIHSDVWSLGISFMELALGRFPYPQ 195
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 72/235 (30%), Positives = 118/235 (50%), Gaps = 20/235 (8%)
Query: 132 FEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF-----EPESVRFMAREILIL 183
FE L+ +G G Y VF R + DTGK+ A+K ++ E R R +L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-TERNVLEH 60
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLH 242
R P ++ L + ++L+ +Y+ ++ L D FSE +++ Y +++
Sbjct: 61 VR-QSPFLVTLHYAFQTE--AKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIIL 116
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
LEH H G+++RDIK N+L+++EG + L DFGL+ + ++ S T+ Y PE
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKP--ILQGR--TEVEQLHKIFKLCGSPP 353
++ G +G +VD WS+G + ELL G L+G T+ E +I K PP
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--DPP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 38/220 (17%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
IG+G + V+ R DTGK+ A+K K R + E++ R +L L
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL----------- 50
Query: 195 EGLITSRLSCSIYLVFEYMEHD------ITGLLSCPDIK--------FSEAQIKCYMNQL 240
S C + Y H I L++ D+ FSE +++ Y ++
Sbjct: 51 ----VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEI 106
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYR 299
+ GLEH H+R V++RD+K +N+L++ G ++++D GLA +FS ++P S V T Y
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHAS-VGTHGYM 162
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTE 338
PE+L T Y S D +S+GC+ +LL G P Q +T+
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 34/222 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTG-KIVALKKVRFDNFE--------PESVRFMAREILI 182
+ LE +G G + V++ R + G ++ALK++ N +S+ + E+ I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 183 LR-RLDHPNIIK-----LEGLITSRLSCSIYLVFEYM------EHDITGLLSCPDIKFSE 230
++ +L HPNI++ LE RL Y+V + + EH + L +F+E
Sbjct: 62 IKEQLRHPNIVRYYKTFLEN---DRL----YIVMDLIEGAPLGEHFNS--LKEKKQRFTE 112
Query: 231 AQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289
+I Q++ L + H + ++HRD+ +N+++ + + + DFGLA L
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL 170
Query: 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
TS V T+ Y PE++ YG D+W+ GC+ ++ +P
Sbjct: 171 TSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 38/220 (17%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
IG+G + V+ R DTGK+ A+K K R + E++ R +L L
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL----------- 50
Query: 195 EGLITSRLSCSIYLVFEYMEHD------ITGLLSCPDIK--------FSEAQIKCYMNQL 240
S C + Y H I L++ D+ FSEA+++ Y ++
Sbjct: 51 ----VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEI 106
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYR 299
+ GLEH H+R V++RD+K +N+L++ G ++++D GLA +FS ++P S V T Y
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHAS-VGTHGYM 162
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTE 338
PE+L Y S D +S+GC+ +LL G P Q +T+
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 11/236 (4%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRR 185
++A+ +E ++ IG+G + V R T K+ A+K + +F+ + F E I+
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
+ P +++L + +Y+V EYM D+ L+S D+ E + Y +++ L
Sbjct: 100 ANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV--PEKWARFYTAEVVLAL 155
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
+ HS G +HRD+K N+L++ G LKLADFG N + V T Y PE+L
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 305 L---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF--KLCGSPPDD 355
G YG D WSVG E+L+G + V KI K + PDD
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D E L+++G+G Y SV++ TG +A+K++R + + + E+ IL + P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGL- 244
I+ G + ++Y+ EYM+ + + E ++ ++ GL
Sbjct: 60 YIVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGI-PEDVLRRITYAVVKGLK 116
Query: 245 ----EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-----ANFSNTGHRQPLTSRVVT 295
EH ++HRD+K +N+LVN G +KL DFG+ A+ + T +
Sbjct: 117 FLKEEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--------IGC 164
Query: 296 LWYRPPELL--LGATD---YGPSVDLWSVGCVFAELLIGK 330
Y PE + G Y D+WS+G E+ +G+
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVR--FMAREILILRRLDHPNIIKL 194
+G+G++ V A T + A+K ++ D E + V + R +L L +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 195 EGLITSRLSCSIYLVFEY------MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
T + ++ V EY M H + S +F EA+ + Y +++ GL+ H
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFH----IQSS--GRFDEARARFYAAEIICGLQFLH 113
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+G+++RD+K N+L++ +G +K+ADFG+ + G + ++ T Y PE+L G
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA-STFCGTPDYIAPEILKGQK 172
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y SVD WS G + E+LIG+ G E E I
Sbjct: 173 -YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 70/227 (30%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 135 LEKIGQGTYSSVFRARDL---DTGKIVA---LKKVRFDNFEPESVRFMAREILILRRLDH 188
L+ +G+G Y VF+ R + DTGKI A LKK + ++ A E IL + H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKH 59
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY-------MEHDITGLLSCPDIKFSEAQIKCYMNQLL 241
P I+ L + + +YL+ EY M + G+ F E Y++++
Sbjct: 60 PFIVDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGI-------FMEDTACFYLSEIS 110
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRP 300
LEH H +G+++RD+K N+L++ +G +KL DFGL S H +T T+ Y
Sbjct: 111 LALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI--HEGTVTHTFCGTIEYMA 168
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
PE+L+ + +G +VD WS+G + ++L G P + + KI K
Sbjct: 169 PEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRR 185
++A+ ++ ++ IG+G + V R + K+ A+K + +F+ + F E I+
Sbjct: 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
+ P +++L + +Y+V EYM D+ L+S D+ E K Y +++ L
Sbjct: 100 ANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV--PEKWAKFYTAEVVLAL 155
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPEL 303
+ HS G++HRD+K N+L++ G LKLADFG TG + T+ V T Y PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDYISPEV 214
Query: 304 LL---GATDYGPSVDLWSVGCVFAELLIG 329
L G YG D WSVG E+L+G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 76/264 (28%), Positives = 116/264 (43%), Gaps = 52/264 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRF-DNFEPESVRFMAREILILRRLDHPN 190
F K++ +G G + V AR +DT + A+K +R D V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+++L + + ++Y V +Y+ D+ LL I F E + Y+ +L +E H
Sbjct: 63 VVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHK 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-----------------------NFSN---- 282
G +HRDIK N+L++ +G +KL DFGL +FSN
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 283 -----TGHR-QPLTSR-------------VVTLWYRPPELLLGATDYGPSVDLWSVGCVF 323
G R +PL R V T Y PE+LL T Y D WSVG +
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 238
Query: 324 AELLIGKPILQGRTEVEQLHKIFK 347
E+L+G+P +T +E K+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 136 EKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+ IG G + V R R GK VA+K ++ + + + + F+ E I+ + DHPNII
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNII 68
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
+LEG++T I + EYME+ + L D KF+ Q+ + + G+++
Sbjct: 69 RLEGVVTKSRPVMI--ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGL--------ANFSNTGHRQPLTSRVVTLWYRPPEL 303
+HRD+ N+LVN+ V K++DFGL A ++ G + P+ W P +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI------RWTAPEAI 180
Query: 304 LLGATDYGPSVDLWSVGCVFAELL 327
+ + D+WS G V E++
Sbjct: 181 AYRK--FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 73/262 (27%), Positives = 118/262 (45%), Gaps = 27/262 (10%)
Query: 177 AREILILRRLDHPNIIKLEGLIT-SRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 235
A E ILR ++HP+II+L+G T ++ +C L+ + D+ L+ + I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC---LILPRYKTDLYCYLAAKR-NIAICDILA 186
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 295
+L +++ H ++HRDIK N+ +N+ G + L DFG A F + T
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 296 LWYRPPELLLGATD-YGPSVDLWSVGCVFAEL------LIGKPILQGRTEVE-QLHKIFK 347
+ PELL A D YGP+VD+WS G V E+ L K L G + + Q+ I +
Sbjct: 247 IATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304
Query: 348 LCGSPPDDYWKKSKLPHATLFK---------PQQPYDSSLRETFKDLPTTAVNLIETLLS 398
G+ P+++ A L + ++P L +LP LI +L+
Sbjct: 305 RSGTHPNEFPID---AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLA 361
Query: 399 VEPYKRATASAALASEYFSTKP 420
+ + R +A A L F P
Sbjct: 362 FDAHHRPSAEALLDFAAFQDIP 383
|
Length = 391 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 29/200 (14%)
Query: 145 SVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204
V A+ T +VA+KK+ D+ E ++ + +EI+ R+L HPNI+ TS +
Sbjct: 15 IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV---TSFIVD 71
Query: 205 S-IYLVFEYMEHDITGLLSCPD-IK------FSEAQIKCYMNQLLHGLEHCHSRGVLHRD 256
S +Y+V M + SC D +K E I + +L+ L++ HS+G +HR
Sbjct: 72 SELYVVSPLMAYG-----SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRS 126
Query: 257 IKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQ-----PLTSRVVTLWYRPPELL----LG 306
+K S++L++ +G + L+ + + G RQ S V L + PE+L G
Sbjct: 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG 186
Query: 307 ATDYGPSVDLWSVGCVFAEL 326
Y D++SVG EL
Sbjct: 187 ---YNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILRRL 186
FE L+ +G G Y VF R + D+GK+ A+K ++ + ++ E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 187 DH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
P ++ L + ++L+ +Y+ +F E +++ Y +++ LE
Sbjct: 62 RQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
H H G+++RDIK N+L+++ G + L DFGL+ + + S T+ Y P+++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 306 GA-TDYGPSVDLWSVGCVFAELLIG 329
G + +VD WS+G + ELL G
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 25/208 (12%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
K+EK IG G + V R GK VA+K ++ E + F++ E I+ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NII LEG++T S + +V EYME+ + L D +F+ Q+ + + G+++
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGL---------ANFSNTGHRQPLTSRVVTLWYR 299
G +HRD+ N+LVN+ V K++DFGL A ++ G + P+ W
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR------WTA 177
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELL 327
P + + + D+WS G V E++
Sbjct: 178 PEA--IAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 52/149 (34%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 179 EILILRRLDHPNIIKLEGL-ITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 237
E +LRRL HP ++ L + + L+C LV D+ L AQ+
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC---LVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TL 296
QLL +++ H G++HRDIK N+LVN + L DFG A F+ P + T+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAE 325
PE+L G Y PSVD+WS G V E
Sbjct: 327 DTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 72/230 (31%), Positives = 113/230 (49%), Gaps = 30/230 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF----EPESVRFMAREILILRRLD 187
FE ++ I G Y +V+ R +T + A+KK+ N + + V F+ R+IL +
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDILTFA--E 59
Query: 188 HPNIIKLEGLI-TSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQI-KCYMNQLLHGL 244
+P ++ + T R C +V EY+E D LL +I + + Y + + L
Sbjct: 60 NPFVVSMFCSFETKRHLC---MVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLAL 114
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN---FSNT-----GH-----RQPLTS 291
E+ H+ G++HRD+K NLL+ + G +KL DFGL+ S T GH R+ L
Sbjct: 115 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 292 RVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 340
+V T Y PE++L YG VD W++G + E L+G G T E
Sbjct: 175 QVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 136 EKIGQGTYSSVFRARD---LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+++G+G++ +V+ +D + ++ LK++ P +E +L +LDHP I+
Sbjct: 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 193 KLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
K R + I + EY E L SE Q+ + QLL G+ + H
Sbjct: 66 KFHASFLERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
R +LHRD+K N+ + N +LK+ DFG++ G T+ T +Y PE L
Sbjct: 124 QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPE-ALKHQ 180
Query: 309 DYGPSVDLWSVGCVFAEL 326
Y D+WS+GC+ E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 82/332 (24%), Positives = 138/332 (41%), Gaps = 43/332 (12%)
Query: 137 KIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+IG+G +SV+ AR TG +V ++ +N E ++ + E+++ HPNI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
+ T+ ++++ +M + LL P+ SEA I + L GL + H G
Sbjct: 65 WTVFTT--GSWLWVISPFMAYGSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG 121
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFS---NTGHRQ------PLTSRVVTLWYRPPE 302
+HR+IK S++L++ +G++ L+ GL++ G + P S V W P
Sbjct: 122 YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
L Y D++SVG EL G+ Q + L + K PP +
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK---GPPYSPLDITTF 236
Query: 363 PH--ATLFKPQQPYDSSLRETF-------------------KDLPTTAVNLIETLLSVEP 401
P + + Q DS + E+ K NL+E L +P
Sbjct: 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDP 296
Query: 402 YKRATASAALASEYFSTKPYACDLSSLPIYPP 433
KR +AS+ L+ +F S L + PP
Sbjct: 297 EKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 62/266 (23%), Positives = 106/266 (39%), Gaps = 56/266 (21%)
Query: 179 EILILRRLDHPNIIKL-EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 237
E ++L+ ++HP++I++ + L++ ++C +V + D+ L+ Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC---MVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS-NTGHRQPLTSRVVTL 296
Q+L GL + H++ ++HRD+K N+ +N+ + + D G A F L V T
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET- 222
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
PE+L Y D+WS G V E+L P IF+ S P++Y
Sbjct: 223 --NAPEVLARDK-YNSKADIWSAGIVLFEML-AYP-----------STIFEDPPSTPEEY 267
Query: 357 WKKSKLPHATLFK------------PQQPYDSSLRETF-------------------KDL 385
K H+ L K P+ P S L F +L
Sbjct: 268 VKSC---HSHLLKIISTLKVHPEEFPRDP-GSRLVRGFIEYASLERQPYTRYPCFQRVNL 323
Query: 386 PTTAVNLIETLLSVEPYKRATASAAL 411
P L+ +L+ + R +A L
Sbjct: 324 PIDGEFLVHKMLTFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-16
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 153 DTGKIVALKKVRFDNFEPES--VRFMAREILILRRLDHPNIIKL--EGLITSRLSCSIYL 208
TG VA+K +R D E E RF RE + RL HPNI+ L G L ++
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVALLDSGEAPPGL---LFA 56
Query: 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268
VFEY+ + D + M Q+L L H++G++HRD+K N++V+ G
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 269 V---LKLADFGLANFSNTGH-----RQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSV 319
V K+ DFG+ T+ V+ T Y PE L G P+ DL++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNSDLYAW 175
Query: 320 GCVFAELLIGKPILQGRTEVEQLHK 344
G +F E L G+ ++QG + E L++
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 47/182 (25%), Positives = 86/182 (47%), Gaps = 22/182 (12%)
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYM 237
E ++ +L HPN+++L G+ T + I++V EYM + + L K +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRP--IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLT 290
+ + +E+ S G +HRD+ N LV + V+K++DFGLA + S+ G + P+
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK 166
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTE---VEQLHKIF 346
+ PPE+ + + D+WS G + E+ GK + + VE + +
Sbjct: 167 -------WAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY 218
Query: 347 KL 348
+L
Sbjct: 219 RL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 67/234 (28%), Positives = 106/234 (45%), Gaps = 32/234 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+++IG G + V+ L+ K VA+K +R E E ++ +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI---EEAQVMMKLSHP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
+++L G+ T R I LVFE+MEH ++ L KFS+ + + G+ +
Sbjct: 60 KLVQLYGVCTER--SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVTLWYRPP 301
S V+HRD+ N LV V+K++DFG+ F S+TG + P+ W P
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPE 171
Query: 302 ELLLGATDYGPSVDLWSVGC----VFAELLIGKPILQGRTE---VEQLHKIFKL 348
Y D+WS G VF+E GK + R+ VE ++ F+L
Sbjct: 172 VFSFS--KYSSKSDVWSFGVLMWEVFSE---GKTPYENRSNSEVVETINAGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (198), Expect = 5e-16
Identities = 66/244 (27%), Positives = 107/244 (43%), Gaps = 31/244 (12%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
R + +E ++KIG G + VF + T + K + + + + E+ ++R L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEH-DIT-GLLSCPDI--KFSEAQIKCYMNQLLHG 243
H NI++ ++ + +Y++ E+ + D++ + C + K E I QLLH
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 244 LEHCHS-------RGVLHRDIKGSNLL-----------------VNNEGVLKLADFGLAN 279
L +CH+ VLHRD+K N+ +N + K+ DFGL+
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTE 338
N G S V T +Y PELLL T Y D+W++GC+ EL GK
Sbjct: 191 --NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248
Query: 339 VEQL 342
QL
Sbjct: 249 FSQL 252
|
Length = 1021 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
F +G+G + V + TGK+ A KK+ + MA E IL +++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHD----ITGLLSCPDIKF----------SEAQIKCY 236
++ L + Y D + L++ D+KF E + Y
Sbjct: 62 VVSL--------------AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY 107
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
++ GLE H +++RD+K N+L+++ G ++++D GLA G + + RV T+
Sbjct: 108 AAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTV 165
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 338
Y PE ++ Y S D W +GC+ E++ GK + R E
Sbjct: 166 GYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
E+IG+G + VF R VA+K R + P+ +E IL++ HPNI++L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 196 GLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
G+ T + IY+V E ++ D L + ++ + G+E+ S+ +H
Sbjct: 60 GVCTQKQP--IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 255 RDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
RD+ N LV + VLK++DFG++ +++TG + ++ W P L G
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK----QIPVKWTAPEALNYGR- 172
Query: 309 DYGPSVDLWSVGCVFAE 325
Y D+WS G + E
Sbjct: 173 -YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPN 190
FE E +G G++ V A+ TG+ A+K ++ + + V+ +A+E IL L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 191 IIK-LEGLITSRLSCSIYLVFEYM--EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I+ + +Y + E++ T L +F K Y +L+ E+
Sbjct: 80 IVNMMCSFQDEN---RVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYL 134
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW----YRPPEL 303
HS+ +++RD+K NLL++N+G +K+ DFG A + + R TL Y PE
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KKVPDRTFTLCGTPEYLAPE- 185
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKP 331
++ + +G +VD W++G + E + G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLE 195
IG+G+Y+ V R T +I A+K V+ + + E + ++ E + + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
+ ++ V EY+ K E + Y ++ L + H RG+++R
Sbjct: 63 SCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 256 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGPS 313
D+K N+L+++EG +KL D+G+ G R T+ T Y PE+L G DYG S
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFS 176
Query: 314 VDLWSVGCVFAELLIGK 330
VD W++G + E++ G+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 52/264 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDH 188
+ F ++ IG+G + V + DTGKI A+K + + F+ + + + E +L D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
P ++ L + + + +YL+ E++ D+ +L D FSE + YM + + +E
Sbjct: 61 PWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAV 117
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-----FSNTGHRQPLTSRVVT------- 295
H G +HRDIK N+L++ G +KL+DFGL+ + +++ L +
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 296 ------------------LW----------------YRPPELLLGATDYGPSVDLWSVGC 321
W Y PE+ L YG D WS+G
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGA 236
Query: 322 VFAELLIGKPILQGRTEVEQLHKI 345
+ E LIG P E KI
Sbjct: 237 IMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLE- 195
+G+GT+ V R+ TG+ A+K +R + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
T C V EY + F+E + + Y +++ LE+ HSR V++R
Sbjct: 63 AFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 256 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGPS 313
DIK NL+++ +G +K+ DFGL G T + T Y PE +L DYG +
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRA 175
Query: 314 VDLWSVGCVFAELLIGK 330
VD W +G V E++ G+
Sbjct: 176 VDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 70/244 (28%), Positives = 109/244 (44%), Gaps = 32/244 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPN 190
F L +G+G++ V A T ++ A+K ++ D + + V E +L D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 191 IIKLEGLITSRLSC-----SIYLVFEY------MEH-DITGLLSCPDIKFSEAQIKCYMN 238
+T SC +Y V EY M H G KF E Q Y
Sbjct: 62 ------FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-------KFKEPQAVFYAA 108
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TL 296
++ GL H RG+++RD+K N+++++EG +K+ADFG+ +T+R T
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTP 165
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
Y PE ++ YG SVD W+ G + E+L G+P G E E I + S P
Sbjct: 166 DYIAPE-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL 224
Query: 357 WKKS 360
K++
Sbjct: 225 SKEA 228
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 38/258 (14%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D E +E++G+G Y V + R + TG I+A+K++R E R + + +R +D P
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEH 246
+ G + +++ E M+ + + E + ++ LE+
Sbjct: 61 YTVTFYGALFRE--GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 247 CHSR-GVLHRDIKGSNLLVNNEGVLKLADFG--------LANFSNTGHRQPLTSRVVTLW 297
HS+ V+HRD+K SN+L+N G +KL DFG +A + G +
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP---------- 168
Query: 298 YRPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP 353
Y PE + + Y D+WS+G EL G+ P +T +QL ++ + P
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSP 226
Query: 354 DDYWKKSKLPHATLFKPQ 371
+LP F P+
Sbjct: 227 -------QLPAEK-FSPE 236
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 59/225 (26%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
E IG+G + +V + TG+ VA+K ++ D + + E ++ +L H N+++L
Sbjct: 12 EIIGEGEFGAVLQGEY--TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLL 65
Query: 196 GLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+I L +Y+V E M + L + S Q+ + + G+E+ S+ ++
Sbjct: 66 GVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 313
HRD+ N+LV+ +GV K++DFGLA G S++ W P L +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEALKHK--KFSSK 177
Query: 314 VDLWSVGCVFAELL-IGK---PILQGRTEVEQLHKIFKLCGSPPD 354
D+WS G + E+ G+ P + + E + K +++ PP+
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EPPE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 66/236 (27%), Positives = 110/236 (46%), Gaps = 24/236 (10%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
E +G+G + VF+ L VA+K + D + ++F++ E IL++ DHPNI+KL
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLI 58
Query: 196 GLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
G+ T R IY+V E + D L + Q+ + G+ + S+ +H
Sbjct: 59 GVCTQRQP--IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 255 RDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
RD+ N LV VLK++DFG++ +S++G +Q + W P L G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-----IPIKWTAPEALNYGR- 170
Query: 309 DYGPSVDLWSVGCVFAEL----LIGKPILQGRTEVEQLHKIFKLCGSP--PDDYWK 358
Y D+WS G + E + P + + EQ+ K +++ PDD +K
Sbjct: 171 -YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK 225
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 78/282 (27%), Positives = 115/282 (40%), Gaps = 56/282 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-VRFDNFEPESVRFMAREILILRRLDH 188
+ E L +IG GT V++ R TG ++A+K+ R N E M ++ +L+ D
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDC 73
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYME---------------HDITGLLSCPDIKFSEAQI 233
P I+K G + +++ E M DI G K + A +
Sbjct: 74 PYIVKCYGYFIT--DSDVFICMELMSTCLDKLLKRIQGPIPEDILG-------KMTVAIV 124
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLT 290
K LH L+ H GV+HRD+K SN+L++ G +KL DFG++ S R
Sbjct: 125 KA-----LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 291 SRVVTLWYRPPELLLGAT---DYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIF 346
+ Y PE + Y D+WS+G EL G+ P +TE E L KI
Sbjct: 178 AA-----YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232
Query: 347 KLCGSPPDDYWKKSKLPHATLFKP--QQPYDSSLRETFKDLP 386
+ PP LP F P D L + + P
Sbjct: 233 QE--EPP-------SLPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 42/222 (18%)
Query: 135 LEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
LE++G+G + V++ + + VA+K ++ +N EP+ + +E ++ L HP
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHP 68
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-----------------------DITGLLSCPDI 226
NI+ L G+ T ++FEY+ H + L C D
Sbjct: 69 NIVCLLGVCTKEQPTC--MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTG 284
QI G+E+ S +HRD+ N LV +K++DFGL+ +S
Sbjct: 127 LHIAIQIAA-------GMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326
+R S + W P +L G + D+WS G V E+
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGK--FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILIL 183
W R D K K+G G Y V+ VA+K ++ D E E F+ +E ++
Sbjct: 1 WEMERTDITMK-HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVM 56
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYM-NQLL 241
+ + HPN+++L G+ T Y++ E+M + ++ L + + A + YM Q+
Sbjct: 57 KEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280
+E+ + +HRD+ N LV ++K+ADFGL+
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 66/229 (28%), Positives = 102/229 (44%), Gaps = 32/229 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPN 190
F L +G+G++ V A T ++ A+K ++ D + + V E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 191 IIKLEGLITSRLSC-----SIYLVFEY------MEH-DITGLLSCPDIKFSEAQIKCYMN 238
+T SC +Y V EY M H G KF E Y
Sbjct: 62 ------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-------KFKEPHAVFYAA 108
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TL 296
++ GL HS+G+++RD+K N++++ EG +K+ADFG+ + G T+R T
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---GKTTRTFCGTP 165
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y PE++ YG SVD W+ G + E+L G+P G E E I
Sbjct: 166 DYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE---SVRFMAREILILRRLDHPNIIKL 194
+G+G++ V AR ++G++ A+K ++ D + + IL L R +HP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 195 EGLI--TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
RL + V E++ +F EA+ + Y ++ L H +G+
Sbjct: 62 YCCFQTPDRL----FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI 117
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDY 310
++RD+K N+L+++EG KLADFG+ G T+ T Y PE +L Y
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMC---KEGIFNGKTTSTFCGTPDYIAPE-ILQEMLY 173
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
GPSVD W++G + E+L G + E + I
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREIL 181
++ D ++G+G + VF + ++VA+K ++ + ++ + RE
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAE 60
Query: 182 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKFSEAQ----IK 234
+L H NI+K G+ T +VFEYMEH D+ L PD F ++ +
Sbjct: 61 LLTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 235 CYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGH 285
++QLL G+ + S+ +HRD+ N LV + V+K+ DFG++ ++ +
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 286 RQPLTSRVVTLWYRPPELLLGATDYGP---SVDLWSVGCVFAEL 326
R ++ + + PPE ++ Y D+WS G V E+
Sbjct: 179 RVG-GHTMLPIRWMPPESIM----YRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 64/259 (24%), Positives = 113/259 (43%), Gaps = 51/259 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ + ++K+G G + V+ K VA+K ++ PES E I+++L H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMKKLRHD 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH--------DITG-LLSCPDIKFSEAQIKCYMNQL 240
+++L +++ IY+V EYM D G L P++ AQ+
Sbjct: 62 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA----- 113
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRV 293
G+ + +HRD++ +N+LV + V K+ADFGLA + G + P+
Sbjct: 114 --GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK--- 168
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQLHKIFKL- 348
W P L G + D+WS G + EL+ + P + R +EQ+ + +++
Sbjct: 169 ---WTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP 223
Query: 349 C--GSPPDDY------WKK 359
C P + WKK
Sbjct: 224 CPQDCPISLHELMLQCWKK 242
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLE- 195
+G+GT+ V R+ TGK A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 196 GLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
T C V EY ++ LS + FSE + + Y +++ L + HS V++
Sbjct: 63 SFQTHDRLC---FVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 255 RDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
RD+K NL+++ +G +K+ DFGL + T + + T Y PE +L DY
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-----MKTFCGTPEYLAPE-VLEDNDY 172
Query: 311 GPSVDLWSVGCVFAELLIGK 330
G +VD W +G V E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 138 IGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
IG G + VFR G+ VA+K ++ E + F++ E I+ + H NII+L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 195 EGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
EG++T I + EYME+ + L D +FS Q+ + + G+++ +
Sbjct: 72 EGVVTKFKPAMI--ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 254 HRDIKGSNLLVNNEGVLKLADFGL---------ANFSNTGHRQPLTSRVVTLWYRPPELL 304
HRD+ N+LVN+ K++DFGL ++ +G + P+ W P
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR------WTAPEA-- 181
Query: 305 LGATDYGPSVDLWSVGCVFAELL 327
+ + + D+WS G V E++
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 4/208 (1%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
F + +G+G + V + TGK+ A K++ + MA E IL +++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
++ L ++ + + L + + + F E + Y ++L GLE H
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
++RD+K N+L+++ G ++++D GLA G + + RV T+ Y PE +L Y
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYMAPE-VLNNQRY 178
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTE 338
S D W +GC+ E++ G+ +GR E
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 64/245 (26%), Positives = 114/245 (46%), Gaps = 38/245 (15%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
A+ + L +IG+G + +V + +G I+A+K++R E E R + +++R D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYME----------HDITGLLSCPDI--KFSEAQIKC- 235
P I+K G + C I + E M+ +++ + +I K + A +K
Sbjct: 63 PYIVKFYGALFREGDCWICM--ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 236 -YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294
Y+ + L ++HRD+K SN+L++ G +KL DFG++ G ++
Sbjct: 121 NYLKEELK---------IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTR 166
Query: 295 TLWYRP---PELLLGATDYGPSV--DLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKL 348
RP PE + + G V D+WS+G E+ GK P + + +QL ++ K
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK- 225
Query: 349 CGSPP 353
G PP
Sbjct: 226 -GDPP 229
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+ +G+G+Y V R GK +KK+ N + +E +L +L HPNI+
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-- 62
Query: 195 EGLITSRLS-----CSIYLVFEYMEH-DITGLLSCPDIKF-SEAQIKCYMNQLLHGLEHC 247
R S +Y+V + E D+ L K E Q+ + Q+ L++
Sbjct: 63 ----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H + +LHRD+K N+ + ++K+ D G+A ++ + T +Y PE L
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLIGTPYYMSPE-LFSN 176
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y D+W++GC E+ K + +++I + KL
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII------------EGKL----- 219
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
P P KD LI T+LS P KR + + L Y
Sbjct: 220 --PPMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 5e-14
Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 11/159 (6%)
Query: 175 FMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEA--- 231
+ EIL L RL+H NI+K+E ++ R + Y++ + + D+ + + +
Sbjct: 209 QLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 232 -QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 289
Q + M QLL +E+ H + ++HRDIK N+ +N +G + L DFG A F R+
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK--EREAF 324
Query: 290 T-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
V T+ PE+L G Y D+WS G + ++L
Sbjct: 325 DYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
LR + E + +G G SV + + + TG ++A KKV + + + RE+ I+
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHEC 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC---YMNQLLHG 243
P I+ G + +I + E+M+ G L K ++ ++ G
Sbjct: 61 RSPYIVSFYGAFLNE--NNICMCMEFMD---CGSLDRIYKKGGPIPVEILGKIAVAVVEG 115
Query: 244 LEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLA-----NFSNTGHRQPLTSRVVTLW 297
L + ++ ++HRDIK SN+LVN+ G +KL DFG++ + ++T V T
Sbjct: 116 LTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--------FVGTST 167
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 330
Y PE + G Y D+WS+G EL +GK
Sbjct: 168 YMSPERIQGG-KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 62/243 (25%), Positives = 110/243 (45%), Gaps = 32/243 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
F + +G+G + V + TGK+ A KK+ + MA E IL +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEK----- 56
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHD----ITGLLSCPDIKF----------SEAQIKCY 236
+ SR S L + Y D + L++ D+KF E + Y
Sbjct: 57 -------VNSRFVVS--LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY 107
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
++ GLE H +++RD+K N+L+++ G ++++D GLA G Q + RV T+
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTV 165
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
Y PE++ Y S D W++GC+ E++ G+ Q R + + ++ +L ++Y
Sbjct: 166 GYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY 224
Query: 357 WKK 359
+K
Sbjct: 225 SEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 69/217 (31%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D FEKL ++G G V + +G I+A K + + +P + RE+ +L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--------CPDI---KFSEAQIK--CY 236
I+ G S SI MEH G L P+ K S A ++ Y
Sbjct: 60 YIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
L H ++HRD+K SN+LVN+ G +KL DFG+ S S V T
Sbjct: 115 -------LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTR 162
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PI 332
Y PE L G T Y D+WS+G E+ IG+ PI
Sbjct: 163 SYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 67/216 (31%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
L+ D FEK+ ++G G VF+ +G I+A K + + +P + RE+ +L
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHEC 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--------CPDIKFSEAQIKCYMN 238
+ P I+ G S SI MEH G L P+ + I
Sbjct: 61 NSPYIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKKAGRIPEQILGKVSIA---- 111
Query: 239 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
++ GL + + ++HRD+K SN+LVN+ G +KL DFG+ S S V T
Sbjct: 112 -VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRS 167
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PI 332
Y PE L G T Y D+WS+G E+ IG+ PI
Sbjct: 168 YMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 70/262 (26%), Positives = 110/262 (41%), Gaps = 52/262 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRF-DNFEPESVRFMAREILILRRLDHPN 190
F K++ +G G + V A +DT + A+K +R D V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++KL + + +Y V +Y+ D+ LL ++ F E + Y+ +L +E H
Sbjct: 63 VVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHK 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA------------------------------N 279
G +HRDIK N+L++ +G +KL DFGL +
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 280 FSN---------------TGHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVF 323
SN H++ L +V T Y PE+LL Y D WSVG +
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVIL 238
Query: 324 AELLIGKPILQGRTEVEQLHKI 345
E+L+G+P T E K+
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 138 IGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
IGQG + VF+AR + +VA+K ++ + F RE ++ DHPNI+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDHPNIV 71
Query: 193 KLEGL-ITSRLSCSIYLVFEYME--------------------HDITGLLSC--PDIKFS 229
KL G+ + C L+FEYM H + C + S
Sbjct: 72 KLLGVCAVGKPMC---LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 230 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQP 288
+ C Q+ G+ + R +HRD+ N LV V+K+ADFGL+ N + + +
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326
+ + + + PPE + Y D+W+ G V E+
Sbjct: 189 SENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 10/217 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F K+G G + V+ + + VA+K ++ D+ + +E+ L+RL H ++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLL--KQQDFQKEVQALKRLRHKHL 64
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMN-QLLHGLEHCHS 249
I L + + +Y++ E ME + L P+ + M Q+ G+ +
Sbjct: 65 ISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+ +HRD+ N+LV + V K+ADFGLA ++ W P G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-- 180
Query: 310 YGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345
+ D+WS G + E+ G+ G E +I
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVR--FMAREILILRRLDHPNIIKL 194
+G+G++ V A T ++ A+K ++ D + + V + IL L HP
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHP----- 56
Query: 195 EGLITSRLSC-----SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+T+ C ++ V EY+ KF E + + Y ++ L H
Sbjct: 57 --FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
GV++RD+K N+L++ EG KLADFG+ + T+ T Y PE +L +
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPE-ILQELE 172
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
YGPSVD W++G + E++ G+P + E + I
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLE 195
IG+G+Y+ V T +I A+K ++ + + E + ++ E + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 196 GLI--TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
SRL + V E++ K E + Y ++ L H RG++
Sbjct: 63 SCFQTESRL----FFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYG 311
+RD+K N+L++ EG +KL D+G+ G R T+ T Y PE+L G DYG
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMC---KEGIRPGDTTSTFCGTPNYIAPEILRG-EDYG 174
Query: 312 PSVDLWSVGCVFAELLIGK 330
SVD W++G + E++ G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
K+G G + V+ T K VA+K ++ PE+ +E I+++L H +++L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQIMKKLRHDKLVQL 66
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMN-QLLHGLEHCHSRGV 252
+ + IY+V EYM + L + K M Q+ G+ + SR
Sbjct: 67 YAVCSEEEP--IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY 124
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
+HRD+ N+LV V K+ADFGLA + + PE A +YG
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE----AANYGR 180
Query: 313 ---SVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345
D+WS G + E++ G+ G T E L ++
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 24/155 (15%)
Query: 136 EKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
IG+G + V++ + KI VA+K + +F+ E I+R+ DHP+I+
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIV 70
Query: 193 KLEGLITSRLSCSIYLVFE---------YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
KL G+IT +++V E Y++ + L I + Y QL
Sbjct: 71 KLIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILY------SY--QLSTA 119
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
L + S+ +HRDI N+LV++ +KL DFGL+
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 8/222 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRRLDH 188
D FE ++ IG+G + V + T +I A+K + +++ + E +L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L +YLV +Y + D+ LLS + + E + Y+ +++ +
Sbjct: 61 QWITTLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H +HRDIK N+L++ G ++LADFG N + V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 308 TD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
D YGP D WS+G E+L G+ + VE KI
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 77/257 (29%), Positives = 116/257 (45%), Gaps = 32/257 (12%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
L+ D FE++ ++G G V + + +G I+A K + + +P + RE+ +L
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHEC 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--------CPDIKFSEAQIKCYMN 238
+ P I+ G S SI MEH G L P+ + I
Sbjct: 61 NSPYIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKEAKRIPEEILGKVSIA---- 111
Query: 239 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
+L GL + + ++HRD+K SN+LVN+ G +KL DFG+ S S V T
Sbjct: 112 -VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRS 167
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDY 356
Y PE L G T Y D+WS+G EL IG+ PI + ++L IF G P D
Sbjct: 168 YMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF---GRPVVD- 220
Query: 357 WKKSKLPHATLFKPQQP 373
+ PH+ +P+ P
Sbjct: 221 -GEEGEPHSISPRPRPP 236
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK-----KVRFDNFEPESVRFMAREILILRRLDHPNII 192
IG+G++ V A+ GK A+K + E MA ++L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK---EQKHIMAERNVLLKNVKHPFLV 59
Query: 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
L + + + +Y V +Y+ + F E + + Y ++ L + HS +
Sbjct: 60 GLH--YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
++RD+K N+L++++G + L DFGL H + ++ T Y PE+L Y
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR-KQPYDR 175
Query: 313 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
+VD W +G V E+L G P R E I
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 6/211 (2%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLDHPNIIKLE 195
IG+G++ V AR K A+K ++ + E M+ ++L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
+ + + +Y V +Y+ + F E + + Y ++ L + HS +++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 256 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 315
D+K N+L++++G + L DFGL N H ++ T Y PE +L Y +VD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRTVD 178
Query: 316 LWSVGCVFAELLIGKPILQGRTEVEQLHKIF 346
W +G V E+L G P R E I
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 41/229 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + ++K+G G + V+ K VA+K ++ + PE+ F+A E ++++L HP
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANLMKQLQHP 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLL-------H 242
+++L ++T IY++ EYME+ S D + IK +N+L+
Sbjct: 62 RLVRLYAVVTQE---PIYIITEYMENG-----SLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVT 295
G+ + +HRD++ +N+LV+ K+ADFGLA + G + P+
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK----- 168
Query: 296 LWYRPPELLLGATDYGP---SVDLWSVGCVFAELLI-GKPILQGRTEVE 340
W P A +YG D+WS G + E++ G+ G T E
Sbjct: 169 -WTAPE-----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 5/194 (2%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEG 196
+G+GT+ V R+ +GK A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 256
+ + + V EY+ + FSE + + Y +++ L++ HS +++RD
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 257 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 316
+K NL+++ +G +K+ DFGL T + + T Y PE +L DYG +VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 317 WSVGCVFAELLIGK 330
W +G V E++ G+
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 136 EKIGQGTYSSVF--RARDL------------DTGKIVALKKVRFDNFEPESVRFMAREIL 181
EK+G+G + V A L +VA+K +R D + F+ +EI
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL-KEIK 69
Query: 182 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDI--KFSEAQ-IKC-- 235
I+ RL +PNII+L G+ S + ++ EYME+ D+ LS +I F+ A I
Sbjct: 70 IMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 236 -----YMN-QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289
YM Q+ G+++ S +HRD+ N LV N +K+ADFG++ +G +
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 290 TSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 328
R V W +LLG + + D+W+ G E+
Sbjct: 188 QGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 10/222 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRRLDHPN 190
FE L+ IG+G + V + + K+ A+K + +++ + E +L D+
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
I L ++YLV +Y + D+ LLS + + E + Y+ +++ ++ H
Sbjct: 63 ITTLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+HRDIK N+L++ G ++LADFG G Q + V T Y PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEILQAME 179
Query: 309 D----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 346
D YGP D WS+G E+L G+ + VE KI
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 8/222 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRRLDH 188
D FE L+ IG+G + V + +TG++ A+K + +++ + E +L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L + +YLV +Y + D+ LLS + + E + Y+ +++ ++
Sbjct: 61 RWITNLHYAFQDENN--LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H G +HRDIK N+L++ G ++LADFG V T Y PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 308 TD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
D YGP D WS+G E+L G+ + VE KI
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR-EILILRRLDHPNIIKLEG 196
+G+G + V + +TGK+ A KK+ + +S MA E IL +++ P I+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDIKF----------SEAQIKCYMNQLLHGLEH 246
S+ + + L++ D+K+ ++ Y Q+ G+ H
Sbjct: 61 AFESKTHLCL----------VMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
HS +++RD+K N+L++++G +L+D GLA G + +T R T Y PE+L
Sbjct: 111 LHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAGTNGYMAPEILKE 168
Query: 307 ATDYGPSVDLWSVGCVFAELLIGK 330
Y VD +++GC E++ G+
Sbjct: 169 EP-YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESVRFMAREILILRRLD-HPNIIKLE 195
IG+G+Y+ V R +I A+K V+ + + E + ++ E + + +P ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 196 GLI--TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
TSRL +LV EY+ K E + Y ++ L H RG++
Sbjct: 63 SCFQTTSRL----FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 313
+RD+K N+L++ +G +KL D+G+ G ++ T Y PE+L G +YG S
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFS 176
Query: 314 VDLWSVGCVFAELLIGK 330
VD W++G + E++ G+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 39/187 (20%)
Query: 158 VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDI 217
VA+K + E F+ E ++ +L HP +++L G+ T + +Y+V E+ME+
Sbjct: 31 VAIKAINEGAMSEED--FI-EEAKVMMKLSHPKLVQLYGVCTQQKP--LYIVTEFMENGC 85
Query: 218 --------TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV 269
G LS D+ S Q C G+E+ +HRD+ N LV++ GV
Sbjct: 86 LLNYLRQRQGKLS-KDMLLSMCQDVC------EGMEYLERNSFIHRDLAARNCLVSSTGV 138
Query: 270 LKLADFGLANF-------SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC- 321
+K++DFG+ + S++G + P+ + PPE+ + Y D+WS G
Sbjct: 139 VKVSDFGMTRYVLDDEYTSSSGAKFPVK-------WSPPEVFN-FSKYSSKSDVWSFGVL 190
Query: 322 ---VFAE 325
VF E
Sbjct: 191 MWEVFTE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+ IG+G + V G+ VA+K ++ D+ ++ F+A E ++ L HPN++
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQA--FLA-EASVMTTLRHPNLV 63
Query: 193 KLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+L G++ +Y+V EYM + L S + AQ + + G+E+ +
Sbjct: 64 QLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
+HRD+ N+LV+ + V K++DFGLA ++ G + ++ W P L +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREK--KF 176
Query: 311 GPSVDLWSVGCVFAEL 326
D+WS G + E+
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 38/110 (34%), Positives = 63/110 (57%), Gaps = 2/110 (1%)
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 295
Y +++ GL+ HS+G+++RD+K N++++ +G +K+ADFG+ + G + ++ T
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCGT 159
Query: 296 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y PE+L G Y SVD WS G + E+LIG+ G E E I
Sbjct: 160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 38/228 (16%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
L K+G G + V+ +T VA+K ++ +P+ F+ E I+++L HP +I+L
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD--FL-AEAQIMKKLRHPKLIQL 66
Query: 195 EGLITSRLSCSIYLV---------FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+ T L IY+V EY++ L P + AQ+ M L
Sbjct: 67 YAVCT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL----- 119
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVTLWY 298
++ +HRD+ N+LV + K+ADFGLA + G + P+ W
Sbjct: 120 --EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK------WT 171
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345
P L + D+WS G + E++ G+ G T E L ++
Sbjct: 172 APEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 14/215 (6%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK----KVRFDNFEPESVRFMAREILILRRLDHPNIIK 193
IG+G++ V A+ GK A+K K+ + E + + MA ++L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLVG 60
Query: 194 LEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
L + + + +Y V +++ + F E + + Y ++ L + HS ++
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 313
+RD+K N+L++++G + L DFGL T+ T Y PE++ Y +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIR-KQPYDNT 176
Query: 314 VDLWSVGCVFAELLIGKPILQGRTEVEQ----LHK 344
VD W +G V E+L G P R E LHK
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 12/221 (5%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLDHPNIIKLE 195
IG+G++ V A+ G A+K ++ + E MA ++L+ L HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
+ + + +Y V +Y+ + F E + + Y ++ + + HS +++R
Sbjct: 63 --YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 256 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 315
D+K N+L++++G + L DFGL + ++ T Y PE +L Y +VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRTVD 178
Query: 316 LWSVGCVFAELLIGKPILQGRTEVEQ-----LHKIFKLCGS 351
W +G V E+L G P R +V Q LHK +L G
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGG 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 57/233 (24%), Positives = 105/233 (45%), Gaps = 33/233 (14%)
Query: 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEG 196
K+GQG + V+ T + VA+K ++ PE+ +E ++++L H +++L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYA 68
Query: 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSE----AQIKCYMNQLLHGLEHCHSRGV 252
+++ IY+V EYM LL + + Q+ Q+ G+ +
Sbjct: 69 VVSEE---PIYIVTEYM--SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVTLWYRPPELLL 305
+HRD++ +N+LV V K+ADFGLA + G + P+ W P L
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALY 177
Query: 306 GATDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQLHKIFKLCGSPPD 354
G + D+WS G + EL + P + R ++Q+ + +++ PP+
Sbjct: 178 GR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 31/167 (18%)
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
E ++ +L H +++L G+ T + IY+V EYM + C E + +
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSN------GCLLNYLREHGKRFQPS 100
Query: 239 QLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTG 284
QLL G+ + S+ +HRD+ N LV+++G +K++DFGL+ + S+ G
Sbjct: 101 QLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK 330
+ P+ + PPE+LL + + D+W+ G + E+ +GK
Sbjct: 161 SKFPVR-------WSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLE- 195
+G+GT+ V ++ TG+ A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLH 254
T C V EY + FSE + + Y +++ L++ HS + V++
Sbjct: 63 SFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 255 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGP 312
RD+K NL+++ +G +K+ DFGL G + T + T Y PE +L DYG
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGR 175
Query: 313 SVDLWSVGCVFAELLIGK 330
+VD W +G V E++ G+
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEPESV-RFMAREIL---- 181
+D+ ++ ++ + Y R L TG V L + ++F P ++ RF +I+
Sbjct: 15 SDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ 74
Query: 182 ---------ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQ 232
IL ++HP + L G + + +YLV E++ + +F
Sbjct: 75 VDHVFSERKILNYINHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-D 131
Query: 233 IKC-YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291
+ C Y Q++ E+ S +++RD+K NLL++ +G +K+ DFG A +T
Sbjct: 132 VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-------- 183
Query: 292 RVVTLWYRP----PELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
R TL P PE+LL +G + D W++G E+L+G P
Sbjct: 184 RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 14/222 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPN 190
F L +G+G++ V A T ++ A+K ++ D + + V E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 191 IIKLEGLITSRLSC-----SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+T SC +Y V EY+ +F E Y ++ GL
Sbjct: 62 ------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
HS+G+++RD+K N+++++EG +K+ADFG+ N + T Y PE ++
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPE-II 173
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
YG SVD W+ G + E+L G+ +G E E I +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEG 196
K+GQG + V+ T K VA+K ++ PE+ +E I+++L H ++ L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYA 68
Query: 197 LITSRLSCSIYLVFEYM-EHDITGLLSCPDIKFSE-AQIKCYMNQLLHGLEHCHSRGVLH 254
+++ IY+V E+M + + L D K+ + Q+ Q+ G+ + +H
Sbjct: 69 VVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 255 RDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVTLWYRPPELLLGA 307
RD++ +N+LV + V K+ADFGLA + G + P+ W P L G
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGR 179
Query: 308 TDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQLHKIFKL 348
+ D+WS G + EL+ + P + R +EQ+ + +++
Sbjct: 180 --FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 36/222 (16%)
Query: 136 EKIGQGTYSSV----------FRARDLDTGKI------VALKKVRFDNFEPESVRFMARE 179
EK+G+G + V F +D VA+K +R D + F+ +E
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL-KE 69
Query: 180 ILILRRLDHPNIIKLEGL-ITSRLSCSIYLVFEYME----------HDITGLLSCPDIKF 228
I I+ RL PNII+L + ITS C ++ EYME H+ D+
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLC---MITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 229 SEAQIKCYM-NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
+M Q+ G+++ S +HRD+ N LV +K+ADFG++ +G
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 288 PLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ R V W +LLG + + D+W+ G E+L
Sbjct: 187 RIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 134 KLEKI-GQGTYSSVFRAR---DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
KL KI G+G + SV + D + VA+K ++ D + E ++ DHP
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 190 NIIKLEGL-ITSRLSCSI---YLVFEYMEH-DITGLLSCPDI-----KFSEAQIKCYMNQ 239
N++KL G+ + I ++ +M+H D+ L + K + +M
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTLW 297
+ G+E+ +R +HRD+ N ++ + + +ADFGL+ +S +RQ +++ W
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELL 327
L Y D+W+ G E+
Sbjct: 182 IAIES--LADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 30/192 (15%)
Query: 226 IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTG 284
+ F E ++ Q++ L+ HSR ++HRD+K +N+ + G++KL DFG + +S++
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344
+S T +Y PE L Y D+WS+G + ELL LH+
Sbjct: 224 SLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELL-------------TLHR 269
Query: 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
FK P + ++ L+ P+ + K L++ LLS P R
Sbjct: 270 PFK---GP-----SQREIMQQVLYGKYDPFPCPVSSGMK-------ALLDPLLSKNPALR 314
Query: 405 ATASAALASEYF 416
T L +E+
Sbjct: 315 PTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 138 IGQGTYSSVFRAR---DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+G+G + SV A+ + + + VA+K ++ D F + RE ++ DHPN+IKL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 195 EGL-ITSRLSCSI---YLVFEYMEH-DITGLLSCPDI-----KFSEAQIKCYMNQLLHGL 244
G+ + SR + ++ +M+H D+ L I + +M + G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTLWYRPPE 302
E+ S+ +HRD+ N ++N + +ADFGL+ +S +RQ S++ W
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 303 LLLGATDYGPSVDLWSVGCVFAELL 327
L Y D+W+ G E++
Sbjct: 187 --LADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 56/213 (26%), Positives = 85/213 (39%), Gaps = 45/213 (21%)
Query: 158 VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-D 216
VA+K +R D + F+ +E+ IL RL PNI +L G+ T + + EYME+ D
Sbjct: 49 VAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTVDPPLCM--IMEYMENGD 105
Query: 217 ITGLLS---------CPDIKFSEAQIKCYM-NQLLHGLEHCHSRGVLHRDIKGSNLLVNN 266
+ L + K YM Q+ G+ + S +HRD+ N LV
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 267 EGVLKLADFGL------ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 320
+K+ADFG+ +++ R PL R W +LLG + D+W+ G
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLGK--FTTKSDVWAFG 219
Query: 321 CVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
L +I LC P
Sbjct: 220 VT-------------------LWEILTLCREQP 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 15/150 (10%)
Query: 136 EKIGQGTYSSVFRAR-DLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+K+G G++ V R GK+ VA+K ++ D F+ +E I+ LDH N+I
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSC-----PDIKFSEAQIKCYMNQLLHGLEHC 247
+L G++ L+ + +V E + LL F + + Y Q+ +G+ +
Sbjct: 60 RLYGVV---LTHPLMMVTELAP--LGSLLDRLRKDALGH-FLISTLCDYAVQIANGMRYL 113
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGL 277
S+ +HRD+ N+L+ ++ +K+ DFGL
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGL 143
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 36/111 (32%), Positives = 61/111 (54%), Gaps = 2/111 (1%)
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
F E + Y Q++ GLEH H R +++RD+K N+L++N+G ++++D GLA G +
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK 153
Query: 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 338
T + PELL G +Y SVD +++G E++ + + R E
Sbjct: 154 T-KGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 38/204 (18%)
Query: 136 EKIGQGTYSSV----FRARDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+++G G + SV + + GK VA+K ++ + RE ++ +LDHP
Sbjct: 1 KELGHGNFGSVVKGVYLMKS---GKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHP 56
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
I++L G+ + LV E L +I + +K +Q+ G+
Sbjct: 57 CIVRLIGVC---KGEPLMLVMELAPLGPLLKY--LKKRREIP--VSDLKELAHQVAMGMA 109
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSN------TGHRQPLTSRVVTL 296
+ S+ +HRD+ N+L+ N K++DFG++ + T R PL
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK------ 163
Query: 297 WYRPPELLLGATDYGPSVDLWSVG 320
WY P + G D+WS G
Sbjct: 164 WYAPECINYGKFSS--KSDVWSYG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 63/239 (26%), Positives = 109/239 (45%), Gaps = 37/239 (15%)
Query: 138 IGQGTYSSVFRARDLDTGK-------IVALKKVRFDNFEPESVRFMAREILILRRL-DHP 189
+G+G + V A L K VA+K ++ D+ + + + E+ +++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 190 NIIKLEGLITSRLSCSIYLVFEY-----------------MEH--DITGLLSCPDIKFSE 230
NII L G T +Y++ EY ME+ DI + PD + +
Sbjct: 82 NIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV---PDEQMTF 136
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 289
+ Q+ G+E+ S+ +HRD+ N+LV V+K+ADFGLA + +N + +
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFK 347
T+ + + + PE L Y D+WS G + E+ +G G VE+L K+ K
Sbjct: 197 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 131 AFEKLEKIGQGTYSSVFRAR---DLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRL 186
EK++ +G G + +V++ + + KI VA+K +R + P++ + + E ++ +
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASV 66
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY--MN---QLL 241
DHP++++L G+ LS + L+ + M LL ++ + I +N Q+
Sbjct: 67 DHPHVVRLLGIC---LSSQVQLITQLMPLG--CLLDY--VRNHKDNIGSQYLLNWCVQIA 119
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTLWYR 299
G+ + + ++HRD+ N+LV +K+ DFGLA + ++ +V W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELL 327
+L Y D+WS G EL+
Sbjct: 180 LESILHR--IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 52/177 (29%), Positives = 75/177 (42%), Gaps = 14/177 (7%)
Query: 178 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK--FSEAQIKC 235
REI IL+ + H II L + R ++ +V + D L + D Q
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCD---LFTYVDRSGPLPLEQAIT 189
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVV 294
+LL L + H RG++HRD+K N+ ++ L DFG A + P
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 295 TLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPIL---QGRTEVEQLHKIFK 347
TL PELL A D Y D+WS G V E+ + L Q ++ QL I +
Sbjct: 250 TLETNSPELL--ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 134 KLEKI-GQGTYSSVFRA-------RDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
K+E+I G G + + R R+L VA+ +R + + F+A E L L +
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKREL----PVAIHTLRAGCSDKQRRGFLA-EALTLGQ 62
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
DH NI++LEG+IT ++ +V EYM + + L + + Q+ + L G+
Sbjct: 63 FDHSNIVRLEGVITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGM 120
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQPLTSRVVTLWYRPPEL 303
++ G +H+ + +LVN++ V K++ F L + ++ + LW P +
Sbjct: 121 KYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 304 LLGATDYGPSVDLWSVGCVFAELL 327
+ + D+WS G V E++
Sbjct: 181 QYH--HFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 32/232 (13%)
Query: 138 IGQGTYSSVFRARDLD-----TGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+G G + V+ D +G I VA+K +R + E F+ E ++ +HPNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLL--------SCPDIKFSE-AQIKCYMNQLL 241
+KL G+ L+ Y++ E ME D+ L P + E I + +
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLAN--FSNTGHRQPLTSRVV 294
LE H +HRD+ N LV+ +G V+K+ DFGLA + + +R+ +
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKI 345
W P LL G + D+WS G + E+L +G+ E L +
Sbjct: 177 VRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 80/337 (23%), Positives = 130/337 (38%), Gaps = 55/337 (16%)
Query: 133 EKLEKIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN 190
E L IG+G +V AR TG+ V ++++ + E V F+ E+ + + +HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK--FSEAQIKCYMNQLLHGLEHCH 248
I+ + +++V +M + L C SE I + +L L++ H
Sbjct: 61 IVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQ--------PLTSRVVTLWYR 299
G +HR +K S++L++ +G + L+ GL +N S H Q P S V W
Sbjct: 119 HMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGK------PILQGRTEVEQLHKIFKLCGS-- 351
P L Y D++SVG EL G P Q E KL G+
Sbjct: 177 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--------KLNGTVP 228
Query: 352 --------PPDDYWKK----------SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 393
P ++ K + + +P +SS + + +
Sbjct: 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNG-ESSSHPYNRTFSPHFHHFV 287
Query: 394 ETLLSVEPYKRATASAALASEYF-STKPYACDLSSLP 429
E L P R +AS L +F K A + +LP
Sbjct: 288 EQCLQRNPDARPSASTLLNHSFFKQIKRRASE--ALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 25/159 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRRLD 187
F ++ I +G + V+ R + K+ A+K V+ + V+ R+ L L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQ-AERDALALSK-- 62
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK--------FSEAQIKCYMNQ 239
P I+ L + S + ++YLV EY+ I G D+K F E Y+++
Sbjct: 63 SPFIVHLYYSLQS--ANNVYLVMEYL---IGG-----DVKSLLHIYGYFDEEMAVKYISE 112
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ L++ H G++HRD+K N+L++NEG +KL DFGL+
Sbjct: 113 VALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 53/227 (23%), Positives = 108/227 (47%), Gaps = 32/227 (14%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREI 180
+PL A F +E++G+ + +++ +D ++VA+K ++ D P+ +E
Sbjct: 2 LPLSAVRF--MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEA 58
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCP--DIKFS---EA 231
++ L HPNI+ L G++T + ++FEY+ H+ ++ P D+ S +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQ--PVCMLFEYLNQGDLHEFL-IMRSPHSDVGCSSDEDG 115
Query: 232 QIKCYMN---------QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--F 280
+K ++ Q+ G+E+ S +H+D+ N+L+ + +K++D GL+ +
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
S +R S + W P ++ G + D+WS G V E+
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 137 KIGQGTYSSVFRARDL----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
++G+G + VF A + KI+ K D + F RE +L L H +I+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-REAELLTNLQHEHIV 70
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-DITGLLSC------------PDIKFSEAQIKCYMNQ 239
K G+ + +VFEYM+H D+ L + +++Q+ Q
Sbjct: 71 KFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWY 298
+ G+ + S+ +HRD+ N LV ++K+ DFG++ + +T + + ++ + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELL 327
PPE ++ + D+WS+G V E+
Sbjct: 189 MPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 36/227 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFD--NFEPESVRFMAREILILRRLDHP 189
++ + IG+G V+ A D + VALKK+R D RF+ RE I L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-HDITGLL----SCPDIKFSEAQIKCYMNQLL--- 241
I+ + + + +Y Y+E + + LL + E K + L
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLS-KELAEKTSVGAFLSIF 119
Query: 242 ----HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN--------------- 282
+E+ HS+GVLHRD+K N+L+ G + + D+G A F
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 283 -TGHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ ++V T Y PE LLG S D++++G + ++L
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRA---RDLDTGKIVALKKVRFDNFEPES-VRFMAREILI 182
L+ ++++ +G G + +V++ + +T KI K+ + P++ V FM E LI
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALI 62
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN---Q 239
+ +DHP++++L G+ LS +I LV + M H LL + +N Q
Sbjct: 63 MASMDHPHLVRLLGVC---LSPTIQLVTQLMPHGC--LLDYVHEHKDNIGSQLLLNWCVQ 117
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--------NFSNTGHRQPLTS 291
+ G+ + R ++HRD+ N+LV + +K+ DFGLA ++ G + P+
Sbjct: 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 292 RVVT-LWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKP 331
+ + YR + D+WS G EL+ GKP
Sbjct: 178 MALECIHYR---------KFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
KLEK +G G + V+ A K VA+K ++ + SV E +++ L H ++
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLV 64
Query: 193 KLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
KL ++T IY++ E+M + L S K ++ + Q+ G+ R
Sbjct: 65 KLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
+HRD++ +N+LV+ V K+ADFGLA + + PE A ++
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE----AINF 177
Query: 311 GP---SVDLWSVGCVFAELL 327
G D+WS G + E++
Sbjct: 178 GSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 8/210 (3%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
F +G+G + V + TGK+ A KK+ + MA E IL +++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
++ L ++ LV M D+ + + + F E + Y +L GLE
Sbjct: 62 VVSLA--YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+++RD+K N+L+++ G ++++D GLA G + RV T+ Y PE++
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEK 177
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTE 338
Y S D W +GC+ E++ G+ + R E
Sbjct: 178 -YTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 64/244 (26%), Positives = 100/244 (40%), Gaps = 52/244 (21%)
Query: 135 LEKIGQGTYSSVFRA--RDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
+ +G+G + V +A LD VA+K ++ D E + ++ E+ +++ + H
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKH 75
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHD-----------ITGLLSCPDIKFSEAQIKCY- 236
NII L G+ T +Y+V EY H S D + E +
Sbjct: 76 KNIINLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 237 ----MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLT 290
Q+ G+E S+ +HRD+ N+LV + V+K+ADFGLA +R+
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 291 SRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
R+ W P L D Y D+WS G +L L +IF L
Sbjct: 194 GRLPVKWMAPEALF----DRVYTHQSDVWSFG-----------VL--------LWEIFTL 230
Query: 349 CGSP 352
GSP
Sbjct: 231 GGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 41/228 (17%)
Query: 128 RADAFEKLEKIGQGTYSSVFRAR------DLDTGKIVALKKVRFDNFEPESVRF-MAREI 180
R D K E +G+G + VF A + D +VA+K ++ + ES R RE
Sbjct: 4 RRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDK-MLVAVKALKEAS---ESARQDFQREA 58
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKFSE------- 230
+L L H +I++ G+ T + +VFEYM H D+ L PD K
Sbjct: 59 ELLTVLQHQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116
Query: 231 -----AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA------N 279
Q+ +Q+ G+ + S +HRD+ N LV V+K+ DFG++ +
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ G R L R + PPE +L + D+WS G V E+
Sbjct: 177 YYRVGGRTMLPIR-----WMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 72/288 (25%), Positives = 117/288 (40%), Gaps = 61/288 (21%)
Query: 138 IGQGTYSSVFRARDL-------DTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HP 189
+G+G + V RA D VA+K ++ DN + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISEMELMKLIGKHK 78
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-------------------DIT----GLLSCPDI 226
NII L G+ T +Y++ EY DIT LS D+
Sbjct: 79 NIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN--TG 284
+ C Q+ G+E+ SR +HRD+ N+LV + V+K+ADFGLA +
Sbjct: 137 ------VSC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-------GKPILQGRT 337
+++ R+ W P L Y D+WS G + E+ G P+ +
Sbjct: 190 YKKTSNGRLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247
Query: 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 385
+ + H++ K + Y + HA P Q R TFK L
Sbjct: 248 LLREGHRMDKPSNCTHELYMLMRECWHAV---PTQ------RPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 33/238 (13%)
Query: 128 RADAFEKLEKIGQGTYSSVFRAR--DLDTGK---IVALKKVRFDNFEPESVRFMAREILI 182
R D K E +G+G + VF A +L K +VA+K ++ + RE +
Sbjct: 4 RRDIVLKRE-LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAEL 60
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKF------SEAQI 233
L L H +I+K G+ + +VFEYM+H D+ L PD +A+
Sbjct: 61 LTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 234 KCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTG 284
+ ++Q+LH G+ + S+ +HRD+ N LV ++K+ DFG++ +S
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GK-PILQ-GRTEV 339
+R + + W PPE ++ + D+WS G + E+ GK P Q TEV
Sbjct: 179 YRVGGHTMLPIRWM-PPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 14/219 (6%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL-EG 196
+G G +V A+ + G+ A+K V + E+ L D +I+K E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 197 LITS--RLSCSIYLVFEYMEHDITGLLSCPDIK--------FSEAQIKCYMNQLLHGLEH 246
R ++ ++ +++ G L +IK F E + Q+L + H
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLR-QEIKSRAKTNRTFREHEAGLLFIQVLLAVHH 158
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLL 305
HS+ ++HRDIK +N+L+ + G++KL DFG + ++ T + T +Y PE+
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344
Y D++S+G + ELL K G E +HK
Sbjct: 219 -RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 65/265 (24%), Positives = 112/265 (42%), Gaps = 40/265 (15%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
L+ IG+G + V G VA+K ++ D + F+A E ++ +L H N+++L
Sbjct: 11 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLA-EASVMTQLRHSNLVQL 64
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH-------GLEHC 247
G+I +Y+V EYM S D S + + LL +E+
Sbjct: 65 LGVIVEEKG-GLYIVTEYMAKG-----SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
+ +HRD+ N+LV+ + V K++DFGL +++ T ++ W P L
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALR--E 173
Query: 308 TDYGPSVDLWSVGCVFAELL-IGK------PILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
+ D+WS G + E+ G+ P+ VE+ +K+ G PP Y
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY---- 229
Query: 361 KLPHATLFKPQQPYDSSLRETFKDL 385
+ K D++ R +F L
Sbjct: 230 -----DVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 29/235 (12%)
Query: 138 IGQGTYSSVFRARDLDTGK-------IVALKKVRFDNFEPESVRFMAREILILRRL-DHP 189
+G+G + V A + K VA+K ++ D+ + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-DDATDKDLSDLVSEMEMMKMIGKHK 78
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC---PDIKFS-------EAQIKCY-- 236
NII L G T +Y++ EY ++ L P + +S E Q+
Sbjct: 79 NIINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 237 ---MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSR 292
Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA + N + + T+
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
+ + + PE L Y D+WS G + E+ VE+L K+ K
Sbjct: 197 RLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 54/229 (23%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ + ++K+G G + V+ ++ K VA+K ++ SV+ E +++ L H
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLMKTLQHD 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYM---------EHDITGLLSCPD-IKFSEAQIKCYMNQ 239
+++L ++T IY++ EYM + D G + P I FS Q
Sbjct: 62 KLVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA--------Q 111
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSR 292
+ G+ + + +HRD++ +N+LV+ + K+ADFGLA + G + P+
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-- 169
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340
W P + G+ + D+WS G + E++ GK G + +
Sbjct: 170 ----WTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 47/204 (23%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
+G+G + SV + I VA+K ++ + E + ++ DHPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 196 GLITSRLSCSIY----LVFEYMEH-DITGLL------SCPDIKFSEAQIKCYMNQLLHGL 244
G+ + Y ++ +M+H D+ L CP ++ +K +M + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTLWYRPPE 302
E+ S+ +HRD+ N ++N + +ADFGL+ ++ +RQ +++ W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185
Query: 303 LLLGATDYGPSVDLWSVGCVFAEL 326
L Y D+WS G E+
Sbjct: 186 --LADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKF---SEAQIKCYMNQLLHGLE 245
PN++ L I S S ++LV ++ E G L KF E +K + +++ L+
Sbjct: 45 PNMVCLHKYIVSEDS--VFLVLQHAE---GGKLWSHISKFLNIPEECVKRWAAEMVVALD 99
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
H G++ RD+ +N+L+++ G ++L F +S V Y PE +
Sbjct: 100 ALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEV--EDSCDGEAVENMYCAPE-VG 154
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQ 334
G ++ + D WS+G + ELL GK +++
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 43/221 (19%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 127 LRADAFEKLEKIGQGTYSSVFR--ARDLDTGKI---VALKKVRFDNFEPESVRFMAREIL 181
L + + ++GQG++ V+ A+ + G+ VA+K V + E + F+ E
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN-EAS 61
Query: 182 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM--------------EHDITGLLSCPDIK 227
+++ + ++++L G++ S +V E M E + L P ++
Sbjct: 62 VMKEFNCHHVVRLLGVV-STGQ-PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHR 286
+ ++ G+ + ++ +HRD+ N +V + +K+ DFG+ + T +
Sbjct: 120 ----KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ ++ + + PE L + D+WS G V E+
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 29/235 (12%)
Query: 138 IGQGTYSSVFRARDLDTGK-------IVALKKVRFDNFEPESVRFMAREILILRRLDHPN 190
+G+G + V A + K VA+K ++ D E + ++ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 191 IIKLEGLITSRLSCSIYLVFEYME----------HDITGLLSC------PDIKFSEAQIK 234
II L G T +Y++ EY G+ C P+ + S +
Sbjct: 86 IINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRV 293
Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA + + + + T+
Sbjct: 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFK 347
+ + + PE L Y D+WS G + E+ +G G VE+L K+ K
Sbjct: 204 LPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 136 EKIGQGTYSSVFRARDLDTGKI---VALKKV-RFDNFEPESVRFMAREILILRRLDHPNI 191
IG+G + V+ +D+ A+K + R + E V +E +I++ HPN+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFSHPNV 58
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+ L G I S +V YM+H D+ + + + + Q+ G+E+ S+
Sbjct: 59 LSLLG-ICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+HRD+ N +++ +K+ADFGLA
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLA 145
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 40/223 (17%)
Query: 130 DAFEKLEKIGQGTYSSVF----RARDLDTGKI-VALKKVRFDNFEPESVRFMAREILILR 184
D+ L +G G + V+ R RD D ++ VA+K + E + F+ E LI+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMS 64
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLL----SCPDIKFSEAQIKCYMNQ 239
+ +H NI++L G+ RL +++ E M D+ L P+ S M
Sbjct: 65 KFNHQNIVRLIGVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLT-----MKD 117
Query: 240 LLH-------GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLA------NFSNT 283
LL G ++ +HRDI N L+ +G V K+ADFG+A ++
Sbjct: 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326
G R L + + PPE L + D+WS G + E+
Sbjct: 178 GGRAMLPIK-----WMPPEAFLDGI-FTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 41/204 (20%)
Query: 141 GTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITS 200
G + V + T K+ K ++ NF + M +++ D+PN IKL +T+
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEPMVHQLM----KDNPNFIKLYYSVTT 80
Query: 201 RLSCSIYLVFEYMEHDITGLLSCPDI--------KFSEAQIKCYMNQLLHGLEHCHSRGV 252
L + L+ +Y++ D+ K SEA++K + QL+ L H +
Sbjct: 81 -LKGHV-LIMDYIK--------DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNI 130
Query: 253 LHRDIKGSNLLVN-NEGVLKLADFGLANFSNT-----GHRQPLTSRVVTLWYRPPELLLG 306
+H DIK N+L + + + L D+GL T G TL Y PE + G
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG----------TLDYFSPEKIKG 180
Query: 307 ATDYGPSVDLWSVGCVFAELLIGK 330
+Y S D W+VG + ELL GK
Sbjct: 181 H-NYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 138 IGQGTYSSVFRARDLDTG--KIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKL 194
IG+G + V +AR G A+K+++ + + R A E+ +L +L HPNII L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDI---------------KFSEAQIKCYMN 238
G R +YL EY H ++ L + S Q+ +
Sbjct: 74 LGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+ G+++ + +HRD+ N+LV V K+ADFGL+ ++ + R+ W
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWM 190
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELL 327
L + Y + D+WS G + E++
Sbjct: 191 AIES--LNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 8e-08
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 137 KIGQGTYSSV------FRARDLDTGKIVALKKVRFDNFEPESVR-FMAREILILRRLDHP 189
++G G + V R + +D VA+K ++ +N +SVR M RE I+ +LD+P
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQID----VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNP 55
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
I+++ G+ + ++ LV E + LS + + + + M+Q+ G+++
Sbjct: 56 YIVRMIGVCEAE---ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE 112
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---------SNTGHRQPLTSRVVTLWYR 299
+ +HRD+ N+L+ N+ K++DFGL+ + + + PL WY
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK------WYA 166
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLI--GKP 331
P + + D+WS G E KP
Sbjct: 167 PECINF--RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 25/204 (12%)
Query: 138 IGQGTYSSVFRARDLDTGKI-----VALKKVRFDNFEPESVRFMAREILILRRL-DHPNI 191
+G G + V A K VA+K ++ E M+ E+ I+ L +H NI
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-ELKIMSHLGNHENI 101
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQ-IKCYMNQLLHGLEHCHS 249
+ L G T + I ++ EY + D+ L F + + + Q+ G+ S
Sbjct: 102 VNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHRQPLTSRVVTLWYRPPE 302
+ +HRD+ N+L+ + ++K+ DFGLA N+ G +R+ W P
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG-----NARLPVKWMAPES 214
Query: 303 LLLGATDYGPSVDLWSVGCVFAEL 326
+ Y D+WS G + E+
Sbjct: 215 IFNCV--YTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 26/193 (13%)
Query: 157 IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH- 215
+VA+K +R D + F+ +E+ IL RL PNII+L G+ + ++ EYME+
Sbjct: 48 LVAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENG 104
Query: 216 DITGLLSCPDIKFSEAQIKCYMNQ-----------LLH-------GLEHCHSRGVLHRDI 257
D+ LS + E + LLH G+++ S +HRD+
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 258 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGPSVD 315
N LV +K+ADFG++ G + R V W +L+G + + D
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASD 222
Query: 316 LWSVGCVFAELLI 328
+W+ G E+L+
Sbjct: 223 VWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 33/74 (44%), Positives = 43/74 (58%), Gaps = 2/74 (2%)
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTS 291
IK M Q+L GL H G++HRDIK NLLV +G +K+ DFG A TG + PL
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 292 RVVTLWYRPPELLL 305
++ Y PPE L+
Sbjct: 371 -MLDPRYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 135 LEKIGQGTYSSVFRARDLDTG-----KIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+E++G+ + V++ T + VA+K ++ D E E ++ RL HP
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHP 68
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL----------SCPDIKFSEAQIKC--- 235
NI+ L G++T S ++F Y H D+ L S D K ++ ++
Sbjct: 69 NIVCLLGVVTKEQPLS--MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 236 --YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTS 291
+ Q+ G+E S V+H+D+ N+LV ++ +K++D GL ++ ++ S
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ W P ++ G + D+WS G V E+
Sbjct: 187 LLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 47/208 (22%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG---KI-VALKKVRFDNFEPESVRFMAREILI 182
L+ F+K++ +G G + +V++ + G KI VA+K++R + P++ + + E +
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 62
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLL 241
+ +D+P++ +L G+ L+ ++ L+ + M + + + + Q+
Sbjct: 63 MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 119
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYR 299
G+ + R ++HRD+ N+LV +K+ DFGLA + +V W
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELL 327
+L Y D+WS G EL+
Sbjct: 180 LESIL--HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 46/221 (20%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 138 IGQGTYSSV-----FRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+G+G + V FR + VA+K ++ +N +R + E +L++++HP++I
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-----------------------DITGLLSCPDIK-F 228
KL G + + L+ EY ++ + L PD +
Sbjct: 67 KLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 229 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHR 286
+ + + Q+ G+++ ++HRD+ N+LV +K++DFGL+ + +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ R+ W L Y D+WS G + E++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 52/232 (22%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 137 KIGQGTYSSVFRA--RDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
++G G + +V + + + K VA+K ++ DN +P + RE ++++LD+P I+++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
G+ + S LV E E + +E I ++Q+ G+++ +H
Sbjct: 62 IGICEAE---SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 255 RDIKGSNLLVNNEGVLKLADFGLAN--------FSNTGH-RQPLTSRVVTLWYRPPELLL 305
RD+ N+L+ + K++DFGL+ + H + P+ WY P +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK------WYAPE--CM 170
Query: 306 GATDYGPSVDLWSVGCVFAELLI--GKPILQGR-TEVEQLHKIFKLCGSPPD 354
+ D+WS G + E KP + EV Q+ + + P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSR 292
CY Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + ++R
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ W P + Y D+WS G + E+
Sbjct: 238 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 48/203 (23%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 138 IGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+G+G + VF A+ + +V +K ++ E F RE+ + R+L H N++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEF-RRELDMFRKLSHKNVV 71
Query: 193 KLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIK--------FSEAQIKCYMNQLLHG 243
+L GL R + Y++ EY + D+ L K S Q Q+ G
Sbjct: 72 RLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
++H + +HRD+ N LV+++ +K++ L+ L + ++ L + PE
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 304 LLGATDYGPSVDLWSVGCVFAEL 326
+ D+ D+WS G + E+
Sbjct: 190 VQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 47/209 (22%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGKI---VALKKVRFDNFEPESVRFMAREILILRRLDHP 189
L ++GQG++ V+ ARD+ G+ VA+K V E + F+ E +++
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCH 69
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKFSEAQIKCYMNQLLH---- 242
++++L G+++ +V E M H D+ L P+ + + + + +++
Sbjct: 70 HVVRLLGVVSK--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 243 ---GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTLW 297
G+ + +++ +HRD+ N +V ++ +K+ DFG+ + +R+ + W
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAEL 326
P L G + S D+WS G V E+
Sbjct: 188 MAPESLKDGV--FTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 36/220 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRA--RDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRR 185
D + + +GT+ +F D GK V +K V+ D+ V + +E +L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYG 64
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIK------FSEAQIK 234
L H NI+ + + ++++ YM G L C + S Q+
Sbjct: 65 LSHQNILPI-LHVCIEDGEPPFVLYPYMNW---GNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGH------R 286
Q+ G+ + H RGV+H+DI N +++ E +K+ D L+ F H
Sbjct: 121 HMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326
+P+ W L+ +Y + D+WS G + EL
Sbjct: 181 RPVK------WMALESLV--NKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSR 292
CY Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + +R
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ W P + Y D+WS G + E+
Sbjct: 243 LPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 46/209 (22%), Positives = 90/209 (43%), Gaps = 15/209 (7%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRA---RDLDTGKIVALKKVRFDNFEPESVRFMAREILIL 183
L+ KL+ +G G + +V + + D+ KI K D ++ + + +L +
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN---QL 240
LDH I++L G+ S+ LV + LL + +N Q+
Sbjct: 64 GSLDHAYIVRLLGICPG---ASLQLVTQLSPLG--SLLDHVRQHRDSLDPQRLLNWCVQI 118
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT--LWY 298
G+ + ++HR++ N+L+ ++ ++++ADFG+A+ ++ S T W
Sbjct: 119 AKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELL 327
+L G Y D+WS G E++
Sbjct: 179 ALESILFGR--YTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 132 FEKLEKIGQGTYSSVFRAR-DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHP 189
FE + IG+G + V RA D K+ A K+ + R A E+ +L +L HP
Sbjct: 6 FEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDI---------------KFSEAQI 233
NII L G +R +Y+ EY + ++ L + + Q+
Sbjct: 64 NIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293
+ + + G+++ + +HRD+ N+LV K+ADFGL+ ++ + R+
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM-GRL 180
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
W L + Y D+WS G + E++
Sbjct: 181 PVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 6e-06
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 138 IGQGTYSSVFRARDLDTG-KIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLE 195
IG+G + V +AR G ++ A K + + R A E+ +L +L HPNII L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 196 GLITSRLSCSIYLVFEYMEH-DITGLLSCPDI---------------KFSEAQIKCYMNQ 239
G R +YL EY H ++ L + S Q+ +
Sbjct: 63 GACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
+ G+++ + +HRD+ N+LV V K+ADFGL+ ++ + R+ W
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWMA 179
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELL 327
L + Y + D+WS G + E++
Sbjct: 180 IES--LNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 26/71 (36%), Positives = 38/71 (53%), Gaps = 1/71 (1%)
Query: 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
R T+ V T YR PE++LG + S D+WS+GC+ EL GK + +E LH +
Sbjct: 299 RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357
Query: 346 FKLCGSPPDDY 356
K G P ++
Sbjct: 358 EKTLGRLPSEW 368
|
Length = 467 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 4/94 (4%)
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSR 292
Y Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + +R
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326
+ W P + Y D+WS G + E+
Sbjct: 237 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 61/248 (24%), Positives = 89/248 (35%), Gaps = 62/248 (25%)
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQI------KCY 236
R L HPNI++ G + LVFEY E D+ LS +Q+ C
Sbjct: 50 RILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC- 106
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVV 294
++ G+ H H LH D+ N + ++ +K+ D+G+ S T + V
Sbjct: 107 --EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCV 163
Query: 295 TLWYRPPEL-------LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
L + PEL L+ A PS ++W++G EL F+
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPS-NVWALGVTLWEL-------------------FE 203
Query: 348 LCGSPPDDYWKKSKLPHAT------LFKPQ--QPYDSSLRETFKDLPTTAVNLIETLLSV 399
P + L H LFKPQ PY E + +
Sbjct: 204 NAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQ------------FCWL 251
Query: 400 EPYKRATA 407
P KRATA
Sbjct: 252 SPEKRATA 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 43/207 (20%), Positives = 91/207 (43%), Gaps = 11/207 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFR---ARDLDTGKIVALKKVRFDNFEPESVRFMAREILIL 183
L+ +K++ +G G + +V++ D + KI KV +N P++ + + E ++
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLH 242
+ P + +L G+ L+ ++ LV + M + + + + + + Q+
Sbjct: 64 AGVGSPYVCRLLGIC---LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTLWYRP 300
G+ + ++HRD+ N+LV + +K+ DFGLA + + +V W
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELL 327
+L + D+WS G EL+
Sbjct: 181 ESIL--HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 19/206 (9%)
Query: 136 EKIGQGTYSSVF--RARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIK 193
++IG G + V A + V +K++R E + F+ +E+ R L+HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQ 59
Query: 194 LEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLH----GLEHCH 248
G S LV E+ D+ L ++ K + ++ GL H
Sbjct: 60 CLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTLWYRPPELL-- 304
+H D+ N + + +K+ D+GLA +T V L + PEL+
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 305 ----LGATDYGPSVDLWSVGCVFAEL 326
L D ++WS+G EL
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 22/125 (17%)
Query: 222 SCPDIKFSEAQIKCYMN------QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275
+ D +E+ YM+ Q+ +G+E S+ +HRD+ N+L+ ++K+ DF
Sbjct: 224 TRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDF 283
Query: 276 GLA-------NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL-- 326
GLA N+ + G S + L + PE + Y D+WS G + E+
Sbjct: 284 GLARDIMRDSNYISKG------STFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFT 336
Query: 327 LIGKP 331
L G P
Sbjct: 337 LGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 60/253 (23%), Positives = 98/253 (38%), Gaps = 69/253 (27%)
Query: 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN 266
Y V Y+ + L + + I+ M Q+L L+ HS G++HRD+K N++ +
Sbjct: 233 YNVEPYLLGKVQDLPKGLERE--NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 267 E-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG------------------- 306
G K+ D G A V + Y P E LL
Sbjct: 291 GSGSFKIIDLGAA-----------ADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAP 339
Query: 307 ----ATDYGPSV---------DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
AT P + D++S G +F ++ P L+ + + Q ++ K
Sbjct: 340 SAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAF--PNLRSDSNLIQFNRQLKRN---- 393
Query: 354 DDY----WKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTA-VNLIETLLSVEPYKRAT 406
DY W+K P A+ LR F+ DL A L+++++ + +R +
Sbjct: 394 -DYDLVAWRKLVEPRAS---------PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443
Query: 407 ASAALASEYFSTK 419
A AALA YF +
Sbjct: 444 AKAALAHPYFDRE 456
|
Length = 566 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 56/264 (21%), Positives = 102/264 (38%), Gaps = 54/264 (20%)
Query: 136 EKIGQGTYSSVFRAR---DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
++IG G + V ++V +K++R E ++F+ E R L H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLE-EAQPYRSLQHSNLL 58
Query: 193 KLEGLITSRLSCSIYLVFEYME-HDITGLL-SC-------PDIKFSEAQIKCYMNQLLHG 243
+ G T LV E+ D+ G L SC PD + ++ C ++ G
Sbjct: 59 QCLGQCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMAC---EIALG 112
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV-VTLWYRPPE 302
L H H +H D+ N L+ + +K+ D+GL++ ++ V L + PE
Sbjct: 113 LLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172
Query: 303 LL------LGATDYGPSVDLWSVGCVFAELL--------------------------IGK 330
L+ L D ++WS+G EL + K
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232
Query: 331 PILQGRTEVEQLHKIFKLCGSPPD 354
P L+ ++ +++ + C P+
Sbjct: 233 PRLK-LPLSDRWYEVMQFCWLQPE 255
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 15/100 (15%)
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSN---TGHRQPLTS 291
Q+ G++ S+ +HRD+ N+L+ + V K+ DFGLA N SN G+ +
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN-----A 274
Query: 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK 330
R+ W P + Y D+WS G + E+ +GK
Sbjct: 275 RLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGK 312
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 45/225 (20%), Positives = 84/225 (37%), Gaps = 23/225 (10%)
Query: 136 EKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMA--REILILRRLDH 188
E +GQGT++++++ DLD V + +A ++ +L H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+++KL G+ + +V EY++ + L S QL L +
Sbjct: 61 KHLVKLYGVC---VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 248 HSRGVLHRDIKGSNLLVNNEGV-------LKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ ++H ++ G N+LV G+ +KL+D G+ R+ R+ W P
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREERVERIP--WIAP 173
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHK 344
+ G + D WS G E+ L + E+
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 26/93 (27%), Positives = 42/93 (45%), Gaps = 8/93 (8%)
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-- 296
Q+ G+E S+ +HRD+ N+L+ ++K+ DFGLA + H S+ T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR--DIMHDSNYVSKGSTFLP 302
Query: 297 --WYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
W P + Y D+WS G + E+
Sbjct: 303 VKWMAPESIF--DNLYTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 34/116 (29%), Positives = 44/116 (37%), Gaps = 39/116 (33%)
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357
Y PELLLG +GP+VD W++G E L G P T
Sbjct: 546 YLAPELLLGKP-HGPAVDWWALGVCLFEFLTGIPPFNDET-------------------- 584
Query: 358 KKSKLPHATLFKPQQPYDSSLR------ETFKDLPTTAVNLIETLLSVEPYKRATA 407
PQQ + + L E + L A N IE LL+++P KRA
Sbjct: 585 ------------PQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGL 628
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 478 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.14 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.91 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.61 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.53 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.33 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.32 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.26 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.24 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.18 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.08 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.94 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.78 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.71 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.71 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.66 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.64 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.6 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.6 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.58 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.53 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.32 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.29 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.28 | |
| PLN02236 | 344 | choline kinase | 97.14 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.78 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.76 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.64 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.55 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.48 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.35 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.33 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.2 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.14 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.91 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.83 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.23 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.98 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.44 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-79 Score=596.02 Aligned_cols=378 Identities=68% Similarity=1.133 Sum_probs=355.0
Q ss_pred ccccCCcccccchhhhhcCcchhhhhcccccccCcccccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC
Q 011763 90 SFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE 169 (478)
Q Consensus 90 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~ 169 (478)
..+.+...+..++++.+++||+|+..+.++++.+|.+...+.|+.+++||+|.||.||+|++..+|+.||+|+++.+...
T Consensus 77 ~~~~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~ 156 (560)
T KOG0600|consen 77 GSRPSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK 156 (560)
T ss_pred ccCCCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC
Confidence 33556666677889999999999999999999999999999999999999999999999999999999999999999888
Q ss_pred hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 011763 170 PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249 (478)
Q Consensus 170 ~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~ 249 (478)
......+.+||.||++|+||||++|.++..+...+.+|||+|||+++|..++......|++.+++.|++||+.||+|||.
T Consensus 157 ~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~ 236 (560)
T KOG0600|consen 157 EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS 236 (560)
T ss_pred CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh
Confidence 88888899999999999999999999999987778999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhC
Q 011763 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 329 (478)
Q Consensus 250 ~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG 329 (478)
+||+|||||.+|||||.+|.+||+|||+|+++.......+++.+.|.||+|||+|+|...|+.++|+||+||||.||+.|
T Consensus 237 ~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g 316 (560)
T KOG0600|consen 237 RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG 316 (560)
T ss_pred cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence 99999999999999999999999999999998888778899999999999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHH
Q 011763 330 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409 (478)
Q Consensus 330 ~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e 409 (478)
++.|++.++.++++.|++++|.|.+++|...++|+...+++..++...+++.|..++..+++|+..||..||.+|.||.+
T Consensus 317 kPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~ 396 (560)
T KOG0600|consen 317 KPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS 396 (560)
T ss_pred CCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCcccCCCCCCCCCCCCCCCCCChhhhhhhhHHHHhhhcCCcCCCccccccccCCC
Q 011763 410 ALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH 467 (478)
Q Consensus 410 ~L~hp~f~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (478)
+|+|+||+..|.+|+++.||.+++.+|++.+.+.+.++...+...+.....+..+.++
T Consensus 397 aL~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~~~~~~~~~~~~~~~~r 454 (560)
T KOG0600|consen 397 ALQSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKGGASKRRIRERGDRGSR 454 (560)
T ss_pred HhcCcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhcccccccccccccccccccC
Confidence 9999999999999999999999999999999999998887755444444434333333
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-63 Score=465.67 Aligned_cols=311 Identities=42% Similarity=0.735 Sum_probs=275.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|+.+++|++|+||.||+|+++.+++.||+|.++.+.-....--.-.+||.+|.+++|||||.+-.+.....-+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 56899999999999999999999999999999999866422221223468999999999999999999998777788999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|||||++++...+.....+|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+... ..+
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~ 233 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKP 233 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-ccc
Confidence 9999999998888887789999999999999999999999999999999999999999999999999999988764 356
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC-cc-
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-AT- 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~~- 366 (478)
++..+.|.||+|||++++...|+.++|+||+|||+.||++++|.|.|..+.+++.+|+..+|.|.+.+|....... ..
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 7888899999999999999999999999999999999999999999999999999999999999999999865433 32
Q ss_pred ccCCCCCCCccchhcccCC--chhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCCCCCCCCCCCChhhhhhh
Q 011763 367 LFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKH 441 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~--~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~~~~~p~~~~~~~~~~~~ 441 (478)
...+.+++ ..++..|..+ ++...+|++.+|.+||.+|+||.|+|+|+||.+.|.++++..+|.+|...+.++..
T Consensus 314 ~~f~~~py-n~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~~~~~~ 389 (419)
T KOG0663|consen 314 MTFSEHPY-NNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVK 389 (419)
T ss_pred cccCCCCc-hhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccccccCC
Confidence 23333333 4567777654 59999999999999999999999999999999999999999999999887765543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-61 Score=440.15 Aligned_cols=299 Identities=44% Similarity=0.760 Sum_probs=266.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|..+++||+|.||.||+|++..+|+.||||+++..+..........+||+.|+.++|+||+.|+++|.. ...+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH--KSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC--CCceEEE
Confidence 47999999999999999999999999999999999877655555667899999999999999999999987 6678999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
+|||+.+|...+......|+..+++.|+.+++.||+|||.+.|+||||||.|+||+.+|.+||+|||+|+.+...... .
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-~ 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-Q 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc-c
Confidence 999999999999999999999999999999999999999999999999999999999999999999999988765433 3
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC-CCCCcccc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLF 368 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~-~~~~~~~~ 368 (478)
+..+.|.||+|||.++|.+.|+..+||||+|||+.||+-+.|.|.|.++.+++..|++.+|+|.++.|+.. .+++...+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 34478999999999999999999999999999999999999999999999999999999999999999874 45554433
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCCCCCCCCCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 433 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~~~~~p~~~~ 433 (478)
. +.-...+...|...++++.||+..||.+||.+|+|+.|+|+|+||++.|.++.+..+|....
T Consensus 239 ~--~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 239 Q--QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred h--cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence 3 11123344478889999999999999999999999999999999999999888877766433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-61 Score=440.52 Aligned_cols=286 Identities=34% Similarity=0.605 Sum_probs=254.4
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+.|+.+.++|+|+||+||+|+++.||+.||||++.-...++...+-.++||++|++|+|+|+|.|+++|.. ...++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 57999999999999999999999999999999997665556666667899999999999999999999977 6779999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
+|||+...+..+......++.+.++.|++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.... .....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 99999999999888777899999999999999999999999999999999999999999999999999997764 33566
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC--CCccc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL--PHATL 367 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~--~~~~~ 367 (478)
+.++.|.||+|||.+.+...|+.++|||++||++.||++|.++|.+.++.+++..|...+|...++...-... .....
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 7889999999999999999999999999999999999999999999999999999999999988765432111 11222
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..|...-...++..++.++..+.||+..||+.||++|++.+|+|.||||..
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 334444556788999999999999999999999999999999999999953
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-61 Score=466.10 Aligned_cols=287 Identities=39% Similarity=0.688 Sum_probs=261.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|.++++||.|.||.||+|+.+.++..||||.++.....-+..-. +||++.|++|+ |||||+|.+++.+... .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 67999999999999999999999999999999999876655333333 47999999998 9999999999988533 899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+|||||+.+|.+++..++..|++..++.|+.||++||+|+|.+|++|||||||||||.....+||+|||+|+.... ..
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--kp 164 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS--KP 164 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997765 36
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhcc-CCCCCcc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~-~~~~~~~ 366 (478)
+.+.++.|.||+|||+|+....|+.++|||++|||++|+.+-+++|.|.++.+++.+|.+.+|.|..+.|.. .++....
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 778899999999999999989999999999999999999999999999999999999999999999999877 4555555
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.+...+.....+...++..+.++.+||.+||.|||.+||||.|+|+||||+..
T Consensus 245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 66666666777888888899999999999999999999999999999999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-59 Score=444.13 Aligned_cols=265 Identities=31% Similarity=0.447 Sum_probs=226.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh-----HHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-----ESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.+.|.+.+.||+|+||.|-+|.++.+++.||||++++..... .....+.+|++||++|+|||||+++++|+. .
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~--~ 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV--P 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--C
Confidence 567889999999999999999999999999999998765432 122345689999999999999999999988 6
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC---CcEEEeecccccc
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANF 280 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a~~ 280 (478)
.+.||||||++|+.+....-.++.+.+..-+.+++||+.||.|||++||+||||||+||||..+ -.+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 7789999999998777777777789999999999999999999999999999999999999876 6799999999998
Q ss_pred cCCCCCCCccccccCCcccCcccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHcCCCCchhh
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~~~-~~~~i~~~~g~~~~~~~ 357 (478)
.+.. ..+.+.||||.|.|||++.+. ..+..++|||||||+||-+++|.+||....... ..++|...-....+..
T Consensus 329 ~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~- 405 (475)
T KOG0615|consen 329 SGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ- 405 (475)
T ss_pred cccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh-
Confidence 8743 566789999999999999752 235558999999999999999999999876555 5566654332222223
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
|..+++++++||.+||.+||++|||++|+|+||||+..+..
T Consensus 406 ------------------------w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 406 ------------------------WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL 446 (475)
T ss_pred ------------------------hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence 35789999999999999999999999999999999976643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-57 Score=451.56 Aligned_cols=257 Identities=31% Similarity=0.494 Sum_probs=233.8
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+|+..+.||+|+|++||.+++..+|+.||+|++.+..+ .....+.+.+||+|.+.|+|||||+++++|++ ..++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 469999999999999999999999999999999987554 45667888999999999999999999999998 788999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|+|+|..+.+..+....++++|.+++.+++||+.||.|||+++|||||||..||||+++.+|||+|||+|....... ..
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Er 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ER 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-cc
Confidence 99999998888888888899999999999999999999999999999999999999999999999999998877443 33
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
..+.||||.|+|||++.. ..++..+||||+|||||.||+|+|||...+..+++.+|...-...|
T Consensus 175 k~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P--------------- 238 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP--------------- 238 (592)
T ss_pred cceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc---------------
Confidence 366899999999999986 6789999999999999999999999999999999999976443333
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..++.++++||.+||+.||.+|||++++|.|+||+..
T Consensus 239 --------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 239 --------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred --------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 2688999999999999999999999999999999653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-56 Score=423.60 Aligned_cols=262 Identities=31% Similarity=0.495 Sum_probs=233.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++.||+|+||+||+++.+++++.||+|++++.... ....+.+..|..||..++||+||+++..|++ ...+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeEE
Confidence 67899999999999999999999999999999999877653 3356778899999999999999999888887 78899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||+||+.|+.|..++++...|++..++.|+.+|+.||.|||++|||||||||+||||+.+|+++|+|||+++..-... .
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~ 180 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-D 180 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-C
Confidence 999999999888888888899999999999999999999999999999999999999999999999999998544332 3
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
...+.|||+.|||||++.+ ..|+.++|+||||+++|||++|.+||.+.+.....++|...-...++
T Consensus 181 ~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p------------- 246 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP------------- 246 (357)
T ss_pred ccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-------------
Confidence 4456899999999999997 68999999999999999999999999999999998888653211111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc----CHHHHHhCcccCCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA----TASAALASEYFSTKPYA 422 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~----ta~e~L~hp~f~~~~~~ 422 (478)
..++.++++||+++|..||++|. .+.++-+||||....|.
T Consensus 247 ---------------~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 247 ---------------GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred ---------------ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 23789999999999999999995 78999999999987764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-56 Score=422.05 Aligned_cols=294 Identities=36% Similarity=0.594 Sum_probs=250.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeee---cCCceE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITS---RLSCSI 206 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---~~~~~~ 206 (478)
..|..++.||.|+||.|+.+.++.+|+.||||++..........++..+|+++|+.++|+||+.+.+++.. ..-..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45777899999999999999999999999999998555566777888999999999999999999999865 234568
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC-C
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-H 285 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~ 285 (478)
|+|+|+|+.+|...+. .+..|++..+..++.||+.||.|+|+.+|+||||||.|+|++.+..+||||||+|+..... .
T Consensus 102 YiV~elMetDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHHhhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 9999999776666554 4446999999999999999999999999999999999999999999999999999877532 2
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
....+..+.|.||+|||++.....|+.++||||+||||.||++|++.|.|.+..+++..|.+.+|.|+++.+....-..+
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 24457788899999999998888999999999999999999999999999999999999999999999888776543222
Q ss_pred cccC--CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCC
Q 011763 366 TLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424 (478)
Q Consensus 366 ~~~~--~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~ 424 (478)
..+. ..+.....+...|+..++.++||+.+||..||.+|+|++|+|+||||.....+.+
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 2111 1122233466778999999999999999999999999999999999987554443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-55 Score=414.89 Aligned_cols=293 Identities=42% Similarity=0.735 Sum_probs=251.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-eeeecceeeecC----C
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN-IIKLEGLITSRL----S 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~----~ 203 (478)
...|+.+++||+|+||+||+|+++.+|+.||+|+++.+...+..-....+|+.+|+.|+|+| ||+|++++.... .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 44699999999999999999999999999999999987543233345678999999999999 999999997642 2
Q ss_pred ceEEEEEeeccCCchhhccCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 204 CSIYLVFEYMEHDITGLLSCPD---IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
..++||+||++-++...+.... ..++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 3789999999998877776554 4688899999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... ...+..++|.||+|||++.+...|+..+||||+|||++||+++++.|.+..+.+++..|++.+|.|.+..|+..
T Consensus 170 ~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 65332 34677889999999999999889999999999999999999999999999999999999999999999999874
Q ss_pred -CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 361 -KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 361 -~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
.+++.....+.......+....+...++..+|+.+||++||.+|+|+..+|.||||...+..
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 34544443333333445555666777899999999999999999999999999999876544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=426.90 Aligned_cols=279 Identities=32% Similarity=0.498 Sum_probs=238.8
Q ss_pred ccccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..+..++|++++.||+|+||.||+|+.+.||..||+|++++..+ ...+++.+..|-.+|...++|+||+|+..|++ .
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~ 213 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--K 213 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--C
Confidence 34568899999999999999999999999999999999998765 55667888899999999999999999988888 7
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
.++||||||++||....++.....|+++.++.|+.+++.|++.||+.|+|||||||+|+|||..|++||+|||++.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 89999999999998888888888999999999999999999999999999999999999999999999999999842210
Q ss_pred ----------------------CC-C-----------------------CCccccccCCcccCcccccCCCCCCChhhHH
Q 011763 284 ----------------------GH-R-----------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLW 317 (478)
Q Consensus 284 ----------------------~~-~-----------------------~~~~~~~~t~~y~APE~l~~~~~~~~~~Diw 317 (478)
.. . ....+.+|||.|+|||++.+ ..|+..+|+|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwW 372 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWW 372 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHH
Confidence 00 0 01123688999999999998 6799999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhcc-CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHh
Q 011763 318 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 396 (478)
Q Consensus 318 slG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~m 396 (478)
||||||||||.|.|||.+.+..++..+|+. |+. +.+|. -..++++++|||.+|
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~n---------wr~~l~fP~-----------------~~~~s~eA~DLI~rl 426 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVN---------WRETLKFPE-----------------EVDLSDEAKDLITRL 426 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---------HhhhccCCC-----------------cCcccHHHHHHHHHH
Confidence 999999999999999999999999999976 221 11110 025678999999999
Q ss_pred cCCCCCCccC---HHHHHhCcccCCCCCCCCCCCCCCCCC
Q 011763 397 LSVEPYKRAT---ASAALASEYFSTKPYACDLSSLPIYPP 433 (478)
Q Consensus 397 L~~dP~~R~t---a~e~L~hp~f~~~~~~~~~~~~p~~~~ 433 (478)
|. ||.+|.- +.||-.||||+...|...-...|.+.|
T Consensus 427 l~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP 465 (550)
T KOG0605|consen 427 LC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVP 465 (550)
T ss_pred hc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCC
Confidence 99 9999985 899999999998887665555444443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=411.47 Aligned_cols=258 Identities=29% Similarity=0.435 Sum_probs=226.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++.+.++.||+|..|+||+++++.+++.+|+|++.. ..+....+++.+|+++++.++|||||.+|+.|..... .++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 4578999999999999999999999999999999954 3467888999999999999999999999999998533 6999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||+++.++.+....+.++|..+..++.++++||.|||+ ++||||||||+||||+..|.|||||||.+...-. .
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn---S 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN---S 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---h
Confidence 99999999998888877889999999999999999999995 8999999999999999999999999999976643 2
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-----TEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~-----~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
...+.+||..|||||.+.+ ..|+.++||||||++++||.+|+.||... ...+.+..|+. .+|+..
T Consensus 233 ~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP~l------ 302 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPPRL------ 302 (364)
T ss_pred hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCCCC------
Confidence 5678899999999999998 78999999999999999999999999874 34455555433 232211
Q ss_pred CCccccCCCCCCCccchhccc-CCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 363 PHATLFKPQQPYDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~-~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
.. .+++++++||..||++||.+|+|+.|+|+|||+++..
T Consensus 303 -------------------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 303 -------------------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred -------------------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 01 3789999999999999999999999999999998643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-54 Score=424.48 Aligned_cols=263 Identities=32% Similarity=0.506 Sum_probs=232.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 206 (478)
.++|.+.+.||+|+|++|++|+++.+++.||||++.+..+ .+...+.+..|-.+|.+| .||.|++|+..|++ ...+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~sL 149 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EESL 149 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccce
Confidence 5689999999999999999999999999999999976654 233345567899999999 89999999888887 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|+|+||++++.+..++..-+.|++..++.|+.||+.||+|||++|||||||||+||||+.|+++||+|||.|+.......
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999876666666777999999999999999999999999999999999999999999999999999987653221
Q ss_pred C------------CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCc
Q 011763 287 Q------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354 (478)
Q Consensus 287 ~------------~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~ 354 (478)
. ...+++||-.|.+||+|.. ...++.+|||+||||||.|+.|.|||.+.++.-++++|+.+-...|
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp- 307 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP- 307 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC-
Confidence 1 1255899999999998876 7889999999999999999999999999999999999998654443
Q ss_pred hhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
+.+++.+.|||+++|..||..|+|+.|+-+||||....|..
T Consensus 308 ----------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 308 ----------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred ----------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 36789999999999999999999999999999999876543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-56 Score=397.57 Aligned_cols=289 Identities=30% Similarity=0.450 Sum_probs=250.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+.|++.+.||+|.|+.|+++.+..+|+.+|+|+++...+.....+.+.+|+.|.+.|+|||||+|++.+.+ ..+.||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeEE
Confidence 678999999999999999999999999999999999888888888999999999999999999999998877 778999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC---CcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a~~~~~~~ 285 (478)
|+|+|.|+.+..-+.....+++..+..+++||+++|+|+|.+||||||+||+|+||-.. -.+||+|||+|...+.
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~-- 165 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND-- 165 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC--
Confidence 99999986554444444678999999999999999999999999999999999999644 4699999999988773
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
......++|||.|||||++.. .+|+..+|||+.|||||-|+.|.+||.+.+..+.+++|+..-...+...|
T Consensus 166 g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w-------- 236 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW-------- 236 (355)
T ss_pred ccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc--------
Confidence 345567899999999999986 78999999999999999999999999999999999999876555555444
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCCCCCCCCCCCChhhhhhhhHHH
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDA 445 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 445 (478)
+.+++++++||++||..||.+|+|+.|+|+|||+.+...-. -...-...++...+-++
T Consensus 237 -----------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~A-----s~~H~~dtvd~lrkfNa 294 (355)
T KOG0033|consen 237 -----------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVA-----SAIHRQDTVDCLKKFNA 294 (355)
T ss_pred -----------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHH-----HHhhhHHHHHHHHHhhH
Confidence 68999999999999999999999999999999997632111 12244567888888888
Q ss_pred HhhhcCC
Q 011763 446 RRKKVGG 452 (478)
Q Consensus 446 ~~~~~~~ 452 (478)
+||-.+.
T Consensus 295 rRKLKga 301 (355)
T KOG0033|consen 295 RRKLKGA 301 (355)
T ss_pred HHHHHHH
Confidence 8875443
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=408.36 Aligned_cols=280 Identities=39% Similarity=0.656 Sum_probs=239.3
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc---eEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC---SIY 207 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~---~~~ 207 (478)
.|...+.+|.|+||.||.|....+++.||||++-.+.- .-.+|+++|+.++|||||+|..+|....+. +..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 69999999999999999999999999999999865431 123699999999999999999888654444 567
Q ss_pred EEEeeccCCchhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC-CcEEEeecccccccCC
Q 011763 208 LVFEYMEHDITGLLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNT 283 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~ 283 (478)
||||||+.++...+.. .+..++...++-|+.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999988776653 46678999999999999999999999999999999999999987 9999999999998765
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
+ .+..++..|..|+|||.+++...|+.+.||||.||++.||+-|++.|.|++..+++..|++.+|.|..+.....+..
T Consensus 179 ~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 179 G--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred C--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 5 33467788999999999999999999999999999999999999999999999999999999999998877665433
Q ss_pred CccccCCCCCCCccchh-cccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 364 HATLFKPQQPYDSSLRE-TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~-~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.. .+...+.....+.+ .+...++++.+|+.++|.++|.+|.++.|+|.||||++.
T Consensus 257 y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 257 YT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred cc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 22 22222222233333 447899999999999999999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=392.81 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=235.0
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
...++|++++.||.|+||.|.+++++.+|..||+|++++... ...+.+...+|..+|+.+.||+++++++.|.+ ..+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCe
Confidence 457899999999999999999999999999999999987654 45667778899999999999999999988877 788
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||||++|+.+..+++..++|++..++.|+.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999988888888889999999999999999999999999999999999999999999999999999877642
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
..+.||||.|+|||++.. ++|+.++|+|+|||++|||+.|.+||...+...+.++|.+.--..|
T Consensus 198 ---T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP------------ 261 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP------------ 261 (355)
T ss_pred ---EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC------------
Confidence 456799999999999986 8899999999999999999999999999999999999987432222
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYAC 423 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~~~ 423 (478)
..++.++++||..+|++|-.+|. -..++-.||||+...|..
T Consensus 262 -----------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 262 -----------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred -----------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 35789999999999999999994 467899999999876643
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-52 Score=397.73 Aligned_cols=276 Identities=27% Similarity=0.370 Sum_probs=234.7
Q ss_pred cccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 126 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.+..+.|++++.||.|.-|+||+++...++..+|+|++.++.+. .....++..|.+||+.++||+++.||..|+. .+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~ 150 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DK 150 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cc
Confidence 45578999999999999999999999999999999999877653 4445667789999999999999999999988 78
Q ss_pred eEEEEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 205 SIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
++||+||||+|+.+..+++ +...|++..++.|+.+++.||+|||..|||+|||||+||||.++|+|.|+||.++..+.
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999987776654 55679999999999999999999999999999999999999999999999999974321
Q ss_pred C---------------------------------C-C---------------------CCCccccccCCcccCcccccCC
Q 011763 283 T---------------------------------G-H---------------------RQPLTSRVVTLWYRPPELLLGA 307 (478)
Q Consensus 283 ~---------------------------------~-~---------------------~~~~~~~~~t~~y~APE~l~~~ 307 (478)
. . . .....+.+||..|+|||++.|
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 0 0 0 011234688999999999998
Q ss_pred CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCch
Q 011763 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 387 (478)
Q Consensus 308 ~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 387 (478)
...+.++|||+|||+|||||.|..||++.+..+++.+|+..--..|. .+.++.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~---------------------------~~~vs~ 362 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE---------------------------EPEVSS 362 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC---------------------------CCcchh
Confidence 66799999999999999999999999999999999998653211111 125678
Q ss_pred hHHHHHHHhcCCCCCCccC----HHHHHhCcccCCCCCCCCCCCCCCC
Q 011763 388 TAVNLIETLLSVEPYKRAT----ASAALASEYFSTKPYACDLSSLPIY 431 (478)
Q Consensus 388 ~l~~Li~~mL~~dP~~R~t----a~e~L~hp~f~~~~~~~~~~~~p~~ 431 (478)
.++|||+++|.+||++|+- |.||-+||||+...|+......|.+
T Consensus 363 ~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 363 AAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred HHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 9999999999999999998 9999999999999987655544444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-52 Score=398.45 Aligned_cols=261 Identities=30% Similarity=0.486 Sum_probs=230.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
..+|.+.+.||.|+|++||+|+++.++..||||.+....+.....+.+..|++||+.++|||||.+++++.. .+++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeEEE
Confidence 568999999999999999999999999999999999888888889999999999999999999999999988 779999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC------CcEEEeecccccccC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE------GVLKLADFGLANFSN 282 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~------~~vkl~DFG~a~~~~ 282 (478)
|||||.|+.+..+....+.+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+...
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999998888888878799999999999999999999999999999999999999875 358999999999887
Q ss_pred CCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
.. ....+.+|++.|||||++.. ..|+.|+|+||+|+|||+|++|++||...+..+.+..+.......|
T Consensus 167 ~~--~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~--------- 234 (429)
T KOG0595|consen 167 PG--SMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP--------- 234 (429)
T ss_pred ch--hHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC---------
Confidence 54 44567899999999999975 7899999999999999999999999999999888775543221111
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
.....+++...+|+..+|..+|..|.+..+-+.|+++...+
T Consensus 235 -----------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 235 -----------------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred -----------------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 00124566778999999999999999999999999987654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=417.54 Aligned_cols=281 Identities=28% Similarity=0.524 Sum_probs=233.9
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-C-----CCeeeecceeeecCCc
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-H-----PNIIKLEGLITSRLSC 204 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~ 204 (478)
+|++++.||+|+||.|.+|++..|++.||||+++.. .....+...|+.||..|+ | -|+|+++++|.. .+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cc
Confidence 689999999999999999999999999999999754 355556677999999996 4 489999999998 78
Q ss_pred eEEEEEeeccCCchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC--cEEEeeccccccc
Q 011763 205 SIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFS 281 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~vkl~DFG~a~~~ 281 (478)
++|||+|.+.-+|.+++..++ ..|+...++.++.||+.||.+||+.+|||+|||||||||.+.+ .|||+|||.|+..
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 899999999999988887654 3589999999999999999999999999999999999998654 7999999999876
Q ss_pred CCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
... . .+++.+..|+|||+|+| .+|+.+.||||||||++||++|.|+|.|.++.+++..|++.+|.||....+..+
T Consensus 342 ~q~---v-ytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQR---V-YTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCc---c-eeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 542 2 36788999999999998 889999999999999999999999999999999999999999999987665432
Q ss_pred CCCccccC--------------------------------CCCC-CCccchhccc-CCchhHHHHHHHhcCCCCCCccCH
Q 011763 362 LPHATLFK--------------------------------PQQP-YDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATA 407 (478)
Q Consensus 362 ~~~~~~~~--------------------------------~~~~-~~~~l~~~~~-~~~~~l~~Li~~mL~~dP~~R~ta 407 (478)
..+..+.. -..+ ....+...+. .....+.|||.+||.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 21111100 0001 1112222222 334568999999999999999999
Q ss_pred HHHHhCcccCCCCC
Q 011763 408 SAALASEYFSTKPY 421 (478)
Q Consensus 408 ~e~L~hp~f~~~~~ 421 (478)
.|+|+||||+....
T Consensus 497 ~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 497 AQALNHPFLTGTSL 510 (586)
T ss_pred HHHhcCcccccccc
Confidence 99999999985433
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=398.16 Aligned_cols=264 Identities=31% Similarity=0.470 Sum_probs=226.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh------------HHHHHHHHHHHHHHhcCCCCeeeecc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP------------ESVRFMAREILILRRLDHPNIIKLEG 196 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~nIv~l~~ 196 (478)
+++|++++.||+|.||.|-+|++..+++.||||++.+..+.. ...+...+||.||++|+|||||+|++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 679999999999999999999999999999999997643211 11357889999999999999999999
Q ss_pred eeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecc
Q 011763 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 276 (478)
Q Consensus 197 ~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG 276 (478)
+..++....+|||+|||..+...........|++.+++.|+++++.||+|||.+|||||||||+|+||+++|++||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 99999999999999999987776665554449999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC----CCCCccccccCCcccCcccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 011763 277 LANFSNTG----HRQPLTSRVVTLWYRPPELLLG---ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349 (478)
Q Consensus 277 ~a~~~~~~----~~~~~~~~~~t~~y~APE~l~~---~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~ 349 (478)
.+...... ....+...+|||.|+|||.+.+ ....+.+.|||||||+||.|+.|+.||.++...+...+|+..-
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 99766322 1122344689999999999876 2345778999999999999999999999999999999997632
Q ss_pred CCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 350 g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
-..| ..+.+.+.++|||.+||++||++|+++.++-.|||....
T Consensus 336 L~fP---------------------------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 336 LEFP---------------------------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccCC---------------------------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 2221 123678899999999999999999999999999999754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=396.86 Aligned_cols=283 Identities=39% Similarity=0.713 Sum_probs=235.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|+++++||.|+||+||+|++..+++.||+|+++.... ......+.+|+.+++.++||||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 5689999999999999999999999999999999975432 2223456789999999999999999999876 567999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+++++...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KT 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cc
Confidence 99999987777666555568999999999999999999999999999999999999999999999999997543322 22
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC--cc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH--AT 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~--~~ 366 (478)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...|....... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 2345678999999998776678999999999999999999999999999999999999999999999887643221 11
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
...+.. ....+....+.++.++++||.+||++||.+|||+.|+|+||||
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQY-RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCcc-CCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 111111 1112223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=405.75 Aligned_cols=257 Identities=32% Similarity=0.505 Sum_probs=222.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---PESVRFMAREILILRRLD-HPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 204 (478)
...|.+.+.||+|+||+|++|++..++..||+|+++..... ....+.+.+|+.++++++ ||||+++++++.. ..
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--~~ 93 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--PT 93 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--CC
Confidence 56899999999999999999999999999999988765221 133556778999999998 9999999999988 55
Q ss_pred eEEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC-CcEEEeecccccccC
Q 011763 205 SIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSN 282 (478)
Q Consensus 205 ~~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~~~~ 282 (478)
.+|+||||+.++ +++.+.. .+++.|..++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 699999999985 5555554 7899999999999999999999999999999999999999999 999999999998774
Q ss_pred CCCCCCccccccCCcccCcccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~-~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
.......+.+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||...+......+|...-...|
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p-------- 243 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP-------- 243 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC--------
Confidence 2335667889999999999998855 446899999999999999999999999888888877655322222
Q ss_pred CCCccccCCCCCCCccchhcccCC-chhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDL-PTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~-~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..+ +.++++||.+||..||.+|+|+.++++||||+.
T Consensus 244 ---------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 ---------------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 134 899999999999999999999999999999997
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-51 Score=412.09 Aligned_cols=265 Identities=26% Similarity=0.415 Sum_probs=233.6
Q ss_pred ccccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC
Q 011763 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (478)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 202 (478)
.++..++|.+++.||+|.||+|+++..+.+++.||||+++++.. ..+.++.+..|..|+... +||++++|+..|+.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-- 440 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-- 440 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--
Confidence 35668899999999999999999999999999999999998765 567788888999999888 59999999999988
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
..++|+||||+.|+.+ .+......|++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++..-
T Consensus 441 ~~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred CCeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 7899999999999884 344455689999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
... ....+.+|||.|||||++.+ ..|+.++|+|+|||+|||||.|.+||.++++.+....|+..--..|
T Consensus 520 ~~g-~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP--------- 588 (694)
T KOG0694|consen 520 GQG-DRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP--------- 588 (694)
T ss_pred CCC-CccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC---------
Confidence 222 34577899999999999987 7899999999999999999999999999999999999876321111
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCCCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYAC 423 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~~~ 423 (478)
..++.++.++|++||..+|++|.- +.+|..||||++..|..
T Consensus 589 --------------------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 589 --------------------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred --------------------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence 257899999999999999999985 58899999999887643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=351.75 Aligned_cols=285 Identities=42% Similarity=0.742 Sum_probs=253.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.+|...++||+|.||+||++++..+++.||+|.++.+..+...-....+||-+|+.|.|.|||+++++... +..+-||
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEe
Confidence 36888899999999999999999999999999999887665555667899999999999999999999876 6678999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
+|||...+...+..-++.+..+.++.++.|++.||.|+|++++.||||||.|+||+.+|.+||+|||+++.++... ...
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-rcy 158 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCY 158 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eee
Confidence 9999999888888888899999999999999999999999999999999999999999999999999998776532 234
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCC-CCCccc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATL 367 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~~ 367 (478)
...+.|.||++|.++++.+-|+...|+||.|||+.||.. |+|+|.+.+..+++.+|+..+|.|.++.|+... +++. .
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy-k 237 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY-K 237 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC-c
Confidence 556779999999999999999999999999999999986 999999999999999999999999999998754 4433 3
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..|..+....+....+.+...-+||+.++|.-+|.+|++++++|+||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 334444455667777888889999999999999999999999999999975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=411.32 Aligned_cols=257 Identities=26% Similarity=0.449 Sum_probs=230.3
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
-|++.+.||.|+.|.|-+|++..||+.+|||++.+. .........+.+||-||+.+.||||+++|+++++ ..++|||
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~lylv 90 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLYLV 90 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEEEE
Confidence 588999999999999999999999999999999876 4455556678899999999999999999999988 7789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
+||+++|-+..+....++|++.++.++++||+.|+.|||..+|+||||||+|+||+..+++||+|||+|..-.++ ..+
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--klL 168 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KLL 168 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC--ccc
Confidence 999999877777777789999999999999999999999999999999999999999999999999999765443 556
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
.+.||.|.|.|||++.|..+.+.++||||.|||||.||+|+.||.+++....+.++.......|
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP---------------- 232 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP---------------- 232 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----------------
Confidence 7789999999999999977778999999999999999999999998888777887765433332
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
..++.++++||++||.+||.+|+|..|+++|||+..-.
T Consensus 233 -------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 233 -------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred -------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 36899999999999999999999999999999998643
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-50 Score=390.41 Aligned_cols=284 Identities=35% Similarity=0.593 Sum_probs=233.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++.+.||+|+||+||++++..+++.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 37999999999999999999999999999999998665444556677889999999999999999999977 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||++++++..+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999988877766566799999999999999999999999999999999999999999999999999976644333333
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC---cc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH---AT 366 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~---~~ 366 (478)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+..+...+....... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 44567999999999876 568999999999999999999999999998888888888888887766554321100 00
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
..................++.++.+||.+||++||++|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000001111122234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=391.09 Aligned_cols=288 Identities=38% Similarity=0.672 Sum_probs=231.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEE
Confidence 56899999999999999999999999999999999754322 223456689999999999999999999987 578999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 159 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT 159 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence 99999998888777666679999999999999999999999999999999999999999999999999987543221 22
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHcCCCCchhhccCCC-CCcc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKL-PHAT 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~ 366 (478)
.....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..+...++.+....|..... +...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 3445679999999998765678999999999999999999999998754 4467777888888887777655321 1110
Q ss_pred ccCCCCCCCccchhccc--CCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 367 LFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~--~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
...........+...+. .+++.+.+||.+||++||.+|||+.|+|+||||++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00000011112222222 3567899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=396.32 Aligned_cols=258 Identities=32% Similarity=0.505 Sum_probs=229.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+........+.+.+|++|++.|+|||||.+++.|+. ..++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 57999999999999999999999999999999998877777778889999999999999999999999988 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
.||+.|+ +..++..+..++|+.++.++.|++.||.|||+++|+|||+||.||||...+++|+||||+|+..... ....
T Consensus 80 te~a~g~-L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vl 157 (808)
T KOG0597|consen 80 TEYAVGD-LFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVL 157 (808)
T ss_pred ehhhhhh-HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-ceee
Confidence 9999995 4555566778999999999999999999999999999999999999999999999999999987653 3556
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
+...|||.|||||++.+ .+|+..+|+||||||+|||+.|+|||......+..+.|...--.+|
T Consensus 158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p---------------- 220 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP---------------- 220 (808)
T ss_pred eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----------------
Confidence 77789999999999886 8899999999999999999999999998877777777754221111
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
...+..+++||..+|.+||.+|+|=.++|.|||.+..-.
T Consensus 221 -------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 221 -------------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred -------------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 267889999999999999999999999999999986543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=385.95 Aligned_cols=303 Identities=46% Similarity=0.770 Sum_probs=251.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||.|+||.||+|.+..+++.||+|+++...........+.+|+.++++++|+||+++++++.......+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 56899999999999999999999999999999999765433333334567999999999999999999987654567899
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.+++...+......+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~ 164 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KP 164 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CC
Confidence 99999987776666555679999999999999999999999999999999999999999999999999997665322 12
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC-CCccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATL 367 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~ 367 (478)
......++.|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|+.... +....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 23334578899999987656789999999999999999999999999999999999999999988888765332 21111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCCCCCCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYP 432 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~~~~~p~~~ 432 (478)
+.........+...+..+++++.+||.+||.+||++|||+.++|.||||+..+.++.+..+|.+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 11111111233344556789999999999999999999999999999999999999988888875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=372.98 Aligned_cols=250 Identities=30% Similarity=0.471 Sum_probs=216.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
..+|+++++||.|.||+||++++..+|..||+|.++.+.++......+..|+.+|++|+|||||++++.-..+....++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 45799999999999999999999999999999999998888888889999999999999999999998433333455899
Q ss_pred EEeeccCCchhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 209 VFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHS--RG--VLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 209 v~e~~~~~ll~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~--~g--ivHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
|||||.++.+..+. .....+++..++.++.|++.||.++|. .. |+||||||.||+|+.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999986665443 456679999999999999999999999 34 99999999999999999999999999998
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... .....+.+|||.||+||++.. .+|++++|||||||++|||+.-++||.+++-.+...+|...-.+|-+.
T Consensus 178 l~s~-~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~----- 250 (375)
T KOG0591|consen 178 LSSK-TTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD----- 250 (375)
T ss_pred hcch-hHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH-----
Confidence 7653 345567899999999999987 789999999999999999999999999998888888876542221110
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta 407 (478)
..++.++..||..|+.+||++||+.
T Consensus 251 ----------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 ----------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ----------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2467889999999999999999984
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=366.96 Aligned_cols=263 Identities=31% Similarity=0.441 Sum_probs=229.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeec
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF------EPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~------~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 201 (478)
.+.|+-.+.||.|..++|-+|.++.+++.+|+|++..... ..+..+...+|+.||+++ .||+|+++.++|+.
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes- 94 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES- 94 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-
Confidence 3478889999999999999999999999999999965321 123344556799999998 79999999999987
Q ss_pred CCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
...+++|+|.|+.+.+.+++.....+++...+.|++||+.|+.|||.++||||||||+|||++++.++||+|||+++..
T Consensus 95 -~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 95 -DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred -cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 6789999999998877777777778999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCccccccCCcccCccccc-----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchh
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLL-----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~-----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~ 356 (478)
..+ ..+...||||+|+|||.+. +...|+..+|+|++|||||.|+.|.+||......-.+..|++.-.......
T Consensus 174 ~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 174 EPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred CCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 766 4457789999999999974 345689999999999999999999999998888888888877554444333
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
|.+++.+.+|||.+||++||++|+|++|+|.||||....
T Consensus 252 -------------------------Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 252 -------------------------WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred -------------------------hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 358899999999999999999999999999999997543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=396.34 Aligned_cols=257 Identities=29% Similarity=0.516 Sum_probs=224.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
...|....+||+|+.|.||.++...+++.||||.+.+... ...+.+.+|+.+|+.++|+|||++++.|.. .+.+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLV--GDELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcc--cceeEE
Confidence 3468899999999999999999999999999999987653 334667899999999999999999998877 577999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|||||+|+.+.++.... .++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+..... .
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 99999998777665443 599999999999999999999999999999999999999999999999999987765432 4
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
..+.+|||.|||||++.. ..|++++||||||+|++||+-|+|||-..+....+..|.. .|.|....
T Consensus 426 R~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk~------------ 491 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLKN------------ 491 (550)
T ss_pred cccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcCC------------
Confidence 467899999999999986 8899999999999999999999999998777776666543 44443222
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...+++.+++||.+||+.||.+|++|.|+|+||||+.
T Consensus 492 -------------~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 492 -------------PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -------------ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 2478999999999999999999999999999999943
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=371.43 Aligned_cols=293 Identities=38% Similarity=0.684 Sum_probs=237.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~----~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
...|+.+.+||+|.||.||+|....++ +.+|||+++.+..........-+|+.+++.++||||+.|..+|... ..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cc
Confidence 457999999999999999999654443 3789999976532212222345799999999999999999998765 66
Q ss_pred eEEEEEeeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC----CcEEEeecc
Q 011763 205 SIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFG 276 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~----~~vkl~DFG 276 (478)
.++|++||.+++|+..+.. ....++...++.|+.||+.|+.|||++-|+||||||.||||..+ |.|||+|||
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 7999999999999887643 23469999999999999999999999999999999999999988 899999999
Q ss_pred cccccCCCCCC--CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHH
Q 011763 277 LANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------EVEQLHKI 345 (478)
Q Consensus 277 ~a~~~~~~~~~--~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~---------~~~~~~~i 345 (478)
+++.+...-.. ....++.|.||+|||.++|...|+.++|||++|||+.||++-.|.|.+.. ..+++.+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99987643221 23446779999999999999999999999999999999999999998753 45789999
Q ss_pred HHHcCCCCchhhccCC-CCCc-cccC--CCCCCCcc-chhcc---cCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 346 FKLCGSPPDDYWKKSK-LPHA-TLFK--PQQPYDSS-LRETF---KDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 346 ~~~~g~~~~~~~~~~~-~~~~-~~~~--~~~~~~~~-l~~~~---~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
++.+|.|.+..|+..+ +|+. .... ....++.. |...+ +.-++...+||.+||++||.+|+|++++|+|+||.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 9999999999998753 4543 1111 11123322 33332 44566699999999999999999999999999999
Q ss_pred CCCCC
Q 011763 418 TKPYA 422 (478)
Q Consensus 418 ~~~~~ 422 (478)
+.+.+
T Consensus 342 ~d~lp 346 (438)
T KOG0666|consen 342 EDPLP 346 (438)
T ss_pred cCCCC
Confidence 98665
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=384.10 Aligned_cols=288 Identities=37% Similarity=0.682 Sum_probs=238.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|.+++.||+|+||+||++++..+++.||+|+++..... .....+.+|+.++++++||||+++++++.. ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEE
Confidence 56899999999999999999999999999999999765422 223456689999999999999999999987 667999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 160 (309)
T cd07872 82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KT 160 (309)
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cc
Confidence 99999998877776666678999999999999999999999999999999999999999999999999987543322 12
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc-
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL- 367 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~- 367 (478)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...|..........
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 2334668999999998765678999999999999999999999999999999999999999999988886643221100
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
..........+....+.+++++++||.+||+.||.+|||+.|+|+||||+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00000111122334457899999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=379.46 Aligned_cols=312 Identities=25% Similarity=0.416 Sum_probs=254.0
Q ss_pred CCCCCCCCccccccCCcccccchhhhhcCcchhhhhcccccccCcccccccceeeeeeeeecCceEEEEEEECCCCcEEE
Q 011763 80 GRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVA 159 (478)
Q Consensus 80 ~~~ss~~~s~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vA 159 (478)
+..........|+.|+||++..|+.+..+ +|.+.++||+|.|+|||+|+|..+.+.||
T Consensus 50 ~~~~eqE~~~dY~kGGYHpV~IGD~F~~g----------------------RY~v~rKLGWGHFSTVWLawDtq~~r~VA 107 (590)
T KOG1290|consen 50 SDDEEQEDPEDYRKGGYHPVRIGDVFNGG----------------------RYHVQRKLGWGHFSTVWLAWDTQNKRYVA 107 (590)
T ss_pred CCcccccChhhhhcCCCceeeccccccCc----------------------eEEEEEeccccccceeEEEeeccCCeEEE
Confidence 33344577789999999999999999854 89999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHHHHHHHHHHhcC-----C---CCeeeecceeee--cCCceEEEEEeeccCCchhhccCCC-CCC
Q 011763 160 LKKVRFDNFEPESVRFMAREILILRRLD-----H---PNIIKLEGLITS--RLSCSIYLVFEYMEHDITGLLSCPD-IKF 228 (478)
Q Consensus 160 lK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~~~~~--~~~~~~~lv~e~~~~~ll~~~~~~~-~~l 228 (478)
+|+++-. +...+....||++|++++ | .+||+|++.|.. .++.++|||+|+++.+||.++...+ ..+
T Consensus 108 lKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGl 184 (590)
T KOG1290|consen 108 LKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGL 184 (590)
T ss_pred EEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCC
Confidence 9999743 344566678999999982 2 479999999964 4567999999999999999887644 458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEec-----------------------------------------
Q 011763 229 SEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNN----------------------------------------- 266 (478)
Q Consensus 229 ~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~----------------------------------------- 266 (478)
+...++.|++|||.||+|||.. ||||.||||+||||..
T Consensus 185 pl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~ 264 (590)
T KOG1290|consen 185 PLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEP 264 (590)
T ss_pred cHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccc
Confidence 9999999999999999999965 9999999999999910
Q ss_pred -------------------------------------------------------------------------C------
Q 011763 267 -------------------------------------------------------------------------E------ 267 (478)
Q Consensus 267 -------------------------------------------------------------------------~------ 267 (478)
.
T Consensus 265 ~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~ 344 (590)
T KOG1290|consen 265 MSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRG 344 (590)
T ss_pred cchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCcccccc
Confidence 0
Q ss_pred ----------------------------------------------CcEEEeecccccccCCCCCCCccccccCCcccCc
Q 011763 268 ----------------------------------------------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301 (478)
Q Consensus 268 ----------------------------------------------~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~AP 301 (478)
-++||+|||.|++.. ...+..+.|..|+||
T Consensus 345 ~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~----khFT~DIQTRQYRap 420 (590)
T KOG1290|consen 345 NNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH----KHFTEDIQTRQYRAP 420 (590)
T ss_pred ccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh----hhhchhhhhhhccCc
Confidence 037899999998865 345667889999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHHHcCCCCchhhccCCCC-----------C
Q 011763 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR------TEVEQLHKIFKLCGSPPDDYWKKSKLP-----------H 364 (478)
Q Consensus 302 E~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~------~~~~~~~~i~~~~g~~~~~~~~~~~~~-----------~ 364 (478)
|++.+ ..|++.+||||++||+|||+||..+|... .+.+.++.|++++|..|..+....+.. +
T Consensus 421 EVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~Lrh 499 (590)
T KOG1290|consen 421 EVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRH 499 (590)
T ss_pred ceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceec
Confidence 99998 67999999999999999999999999643 367899999999999997765443321 1
Q ss_pred ccccCCCCCCCccchhccc---CCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFK---DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~---~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
....+ .+++...|.+.+. .-..++.+||.-||+.+|++|+||.++|+|||++..+.+
T Consensus 500 I~~LK-~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 500 IRRLK-PWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred ccccC-CCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 11111 2233344555443 234568899999999999999999999999999987665
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=388.52 Aligned_cols=290 Identities=34% Similarity=0.563 Sum_probs=231.9
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC---CceEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSIY 207 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~~~ 207 (478)
+|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999999999999999998754333344556788999999999999999999885432 23589
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC--
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-- 285 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-- 285 (478)
+||||+++++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999877666554 34468999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
........+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+...++.++...+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 1122345789999999987642 468899999999999999999999999999888888888888888876654432111
Q ss_pred ccc-c-CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 365 ATL-F-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~-~-~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
... . .........+...++.+++.+.+||.+||..||++|||+.++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000 0 00001112233445678899999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=399.65 Aligned_cols=283 Identities=23% Similarity=0.321 Sum_probs=219.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC------CCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH------PNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~~~~~~~~ 202 (478)
.++|+++++||+|+||+||+|++..+++.||||+++... ........|+.+++.+.| .+|++++++|...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 578999999999999999999999999999999996422 223344567777777754 4588898888754
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCC-------------
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEG------------- 268 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~------------- 268 (478)
..++|||||++.+.++..+... ..+++..++.++.||+.||+|||+ .|||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 4578999999988777766543 479999999999999999999997 5999999999999998765
Q ss_pred ---cEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 011763 269 ---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345 (478)
Q Consensus 269 ---~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i 345 (478)
.+||+|||++..... .....++|+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..+
T Consensus 283 ~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCceEEECCCCccccCcc----ccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998864322 2245678999999999987 67899999999999999999999999999999999999
Q ss_pred HHHcCCCCchhhccCCCCCcc-ccCCC----CCCCc-cchhc-----c--cCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 346 FKLCGSPPDDYWKKSKLPHAT-LFKPQ----QPYDS-SLRET-----F--KDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 346 ~~~~g~~~~~~~~~~~~~~~~-~~~~~----~~~~~-~l~~~-----~--~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
...++.+|..++......... .+... ..... .+... + ....+.+.|||.+||++||.+|||+.|+|+
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 999999887765432211110 00000 00000 00000 0 012456889999999999999999999999
Q ss_pred CcccCCCCC
Q 011763 413 SEYFSTKPY 421 (478)
Q Consensus 413 hp~f~~~~~ 421 (478)
||||.....
T Consensus 438 Hp~~~~~~~ 446 (467)
T PTZ00284 438 HPYVLKYYP 446 (467)
T ss_pred CccccccCC
Confidence 999987433
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=377.69 Aligned_cols=280 Identities=41% Similarity=0.697 Sum_probs=225.6
Q ss_pred ceeeeeeeeecCceEEEEEEECC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCeeeecceeee---cCC
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDNFEPESVRFMAREILILRRL---DHPNIIKLEGLITS---RLS 203 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~-~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~---~~~ 203 (478)
+|++++.||+|+||+||+|++.. +++.||+|+++...........+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 79999999999999999999854 468899999876543333334455677777766 69999999998852 224
Q ss_pred ceEEEEEeeccCCchhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
..+++||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 568999999998776666442 3458999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC-
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK- 361 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~- 361 (478)
.. .......+|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+....+.+.+..|....
T Consensus 162 ~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 162 FQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred CC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 32 22344567999999999876 678999999999999999999999999999999999999988888766664421
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
++... +.. .....+....+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 239 ~~~~~-~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 239 LPRQA-FHS--KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccchh-ccC--CCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 11111 111 11122334446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=400.03 Aligned_cols=284 Identities=33% Similarity=0.566 Sum_probs=227.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec------C
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR------L 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 202 (478)
..+|++.+.||+|+||.||+|.+..+++.||||++..+. ....+|+.+|+.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 457999999999999999999999999999999986432 2234699999999999999998877431 1
Q ss_pred CceEEEEEeeccCCchhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-cEEEeecccc
Q 011763 203 SCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA 278 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a 278 (478)
...+++||||+++++...+. .....+++..++.++.||+.||.|||+++|+||||||+||||+.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 23578999999987655442 3456799999999999999999999999999999999999999665 7999999999
Q ss_pred cccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhc
Q 011763 279 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 279 ~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
+...... ......+|+.|+|||++.+...|+.++|||||||+||||++|.+||.+.+..+.+.++...++.|+.+.+.
T Consensus 219 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 8654322 22345779999999998876679999999999999999999999999999999999999999998876654
Q ss_pred cCCCCCccccCCCCCCCccchhccc-CCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
...........+ ......+...++ ..++++++||.+||.+||.+|||+.|+|.||||.....
T Consensus 297 ~~~~~~~~~~~~-~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 297 EMNPNYADIKFP-DVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HhchhhhcccCC-ccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 322111111111 111122333333 57889999999999999999999999999999986543
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=388.65 Aligned_cols=288 Identities=31% Similarity=0.527 Sum_probs=230.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
.++|++++.||+|+||.||++++..+++.||+|++............+.+|+.+++.++||||+++++++.... ..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46899999999999999999999999999999999765545555667788999999999999999999886432 13
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 5799999999887766532 4789999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.++..+++......
T Consensus 177 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 177 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred --ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 22244577999999999976 678999999999999999999999999999888999999988888776554321100
Q ss_pred ccc-----cCCCCCCC--------ccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 365 ATL-----FKPQQPYD--------SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 365 ~~~-----~~~~~~~~--------~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
... ..+...+. ..........++.+++||.+||..||++|||+.|+|+||||..+..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 000 00000000 00011112356789999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=393.70 Aligned_cols=288 Identities=34% Similarity=0.534 Sum_probs=232.4
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC---CceEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSIY 207 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~~~ 207 (478)
+|++++.||+|+||.||++.+..+++.||||++..........+.+.+|+.+|+.++|+||+++++++.... ...+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 488999999999999999999999999999998754434455567889999999999999999999987632 12689
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||+.+++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999999877665543 447999999999999999999999999999999999999999999999999999765443333
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc-c
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-T 366 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~-~ 366 (478)
......+|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+.+.+|.++...+........ .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 334456789999999998766789999999999999999999999999999999999999999888655432110000 0
Q ss_pred cc-CC-CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 367 LF-KP-QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 367 ~~-~~-~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.. .+ ..+....+.......++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00 00 0000111112234568899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=378.59 Aligned_cols=261 Identities=31% Similarity=0.466 Sum_probs=212.4
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.++...+.||+|+||+||++.+..+|..+|||.+..... ...+.+.+|+.+|.+|+|||||++++.........++++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 368889999999999999999999999999999986632 226678899999999999999999997544322468999
Q ss_pred EeeccCCchhhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-CCcEEEeecccccccCC--CC
Q 011763 210 FEYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNT--GH 285 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~--~~ 285 (478)
|||+.++.+..+....+ .|++..++.+.+||++||.|||++||||+||||+||||+. ++.+||+|||+++.... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999877776665544 7999999999999999999999999999999999999999 79999999999976653 12
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
........||+.|||||++........++|||||||++.||+||.+||... ...+.+..+......|
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P------------ 242 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP------------ 242 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC------------
Confidence 223345788999999999985233345999999999999999999999873 3333333332211000
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.....+++++++||.+||..||.+||||.++|+|||.+..
T Consensus 243 ---------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 243 ---------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ---------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1124689999999999999999999999999999999763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=374.80 Aligned_cols=271 Identities=27% Similarity=0.432 Sum_probs=223.5
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..+.|++...||.|..++||+|+...++.+||||+++.+..+.+ .+.+.+|+..|+.++||||++++..|.. +..+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~L 99 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV--DSEL 99 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe--ccee
Confidence 336789999999999999999999999999999999998876544 7889999999999999999999999988 6789
Q ss_pred EEEEeeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC-
Q 011763 207 YLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT- 283 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~- 283 (478)
|+||.||.++.+..+... ...+.|..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+.....
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999998766555432 22489999999999999999999999999999999999999999999999998754432
Q ss_pred CCCC--CccccccCCcccCccccc-CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 284 GHRQ--PLTSRVVTLWYRPPELLL-GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 284 ~~~~--~~~~~~~t~~y~APE~l~-~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
+.+. .....++|++|||||+++ .-..|+.|+||||||++..||.+|..||........+..- +.+.||.-.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~pp~~~---- 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDPPTLL---- 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCCCCcc----
Confidence 2211 124568899999999954 4467999999999999999999999999988877766443 333443111
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
....-.+..+.++..++.+|..||..||++||||+++|+|+||+..
T Consensus 254 -------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 254 -------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred -------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 0000112234567799999999999999999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=392.57 Aligned_cols=284 Identities=26% Similarity=0.390 Sum_probs=221.6
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+...+|++++.||+|+||.||+|++..+++.||+|+... ..+.+|+.+|+.|+||||++++++|.. ....
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 158 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY--NKFT 158 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE--CCee
Confidence 335689999999999999999999999999999997532 235689999999999999999999987 6779
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|+|||++.+++...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 159 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 99999998776665544 34689999999999999999999999999999999999999999999999999975433222
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHcCCCCchhhcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-------TEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~-------~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|..||... ....++..++..+|.+|.++...
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 33345678999999999876 67899999999999999999999776543 23467778888888776544211
Q ss_pred CCCCCcccc------CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 360 SKLPHATLF------KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 360 ~~~~~~~~~------~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
........+ ....+...........++.++.+||.+||++||.+|||+.|+|+||||+..+.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 000000000 000000111111123467789999999999999999999999999999875544
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=386.19 Aligned_cols=288 Identities=29% Similarity=0.505 Sum_probs=231.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
.++|++.+.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999999999999999999765544555667788999999999999999999875421 24
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 5799999999887766532 4789999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++...++.+..++++......
T Consensus 180 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 180 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred --CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 22234577999999999876 678999999999999999999999999999999999999999988877655432110
Q ss_pred ccccCCCC---------CCC----ccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 365 ATLFKPQQ---------PYD----SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 365 ~~~~~~~~---------~~~----~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
........ ... ..........+..+++||.+||..||.+|||+.|+|+||||..+..+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 327 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 327 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence 00000000 000 00011112345678999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=375.21 Aligned_cols=286 Identities=38% Similarity=0.692 Sum_probs=235.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||.|+||.||++.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEE
Confidence 67899999999999999999999999999999999755422 223456689999999999999999999987 677999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.+++...+......+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... ..
T Consensus 82 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 160 (301)
T cd07873 82 VFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 160 (301)
T ss_pred EEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Cc
Confidence 99999988877776666678999999999999999999999999999999999999999999999999987543322 12
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC-ccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATL 367 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~~~ 367 (478)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|+...... ...
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 2334568899999998775678899999999999999999999999999989999999999998888876532111 000
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..........+......+++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 111111122233344578899999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=384.02 Aligned_cols=264 Identities=34% Similarity=0.499 Sum_probs=229.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~ 206 (478)
.+.|++.+.||.|.||.||+|+++.+|+.+|+|++.+.... ....+.+.+|+.||+++. |||||.++++|+. ...+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCeE
Confidence 45799999999999999999999999999999999876543 334577889999999998 9999999999988 5689
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC----CcEEEeecccccccC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSN 282 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~----~~vkl~DFG~a~~~~ 282 (478)
++|||++.|+.+....... .+++..+..++.||+.++.|||+.||+||||||+|+|+... +.+|++|||++....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999986554443333 49999999999999999999999999999999999999654 479999999998877
Q ss_pred CCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
. .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+..+...+|...-...+...
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~------ 261 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEP------ 261 (382)
T ss_pred C--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCC------
Confidence 6 345677899999999999976 7899999999999999999999999999999988888776443333333
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
|+.++..+++||+.||..||.+|+|+.++|+|||++.....+
T Consensus 262 -------------------w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 262 -------------------WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred -------------------ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 468899999999999999999999999999999998754443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=377.59 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=217.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 379999999999999999999999999999999975432 22345667889999999999999999998877 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999998766665555667999999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....-.
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------------- 216 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE----------------- 216 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC-----------------
Confidence 233568999999999876 66899999999999999999999999998877777666542100
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
....++..+++||++||+.||.+|++ +.++++||||+...+
T Consensus 217 ------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 217 ------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred ------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 01245788999999999999999995 999999999987554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=351.61 Aligned_cols=255 Identities=32% Similarity=0.480 Sum_probs=225.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++.+.||+|.||.||+|+.+.++-.||+|++.+..+.. ....++.+|++|-..|+||||+++|++|.+ ...+|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeE
Confidence 789999999999999999999999999999999998765432 334567789999999999999999999998 67899
Q ss_pred EEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 208 LVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
|++||...+.+...+. ...++++.....|++|++.||.|+|.++||||||||+|+|++..+.+||+|||.+...+..
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~- 177 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN- 177 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC-
Confidence 9999998765544444 6667999999999999999999999999999999999999999999999999999766533
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
...+.+||..|.+||+..+ ..++..+|+|++|++.||++.|.+||...+..+++++|.+.--..|
T Consensus 178 --kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p------------ 242 (281)
T KOG0580|consen 178 --KRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP------------ 242 (281)
T ss_pred --CceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC------------
Confidence 3366799999999999887 7789999999999999999999999999999999999876432222
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..++..+.|||.+||.++|.+|.+..|++.|||...
T Consensus 243 -----------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 -----------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred -----------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 368899999999999999999999999999999865
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=384.08 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=218.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEE
Confidence 6789999999999999999999999999999999975432 23345667889999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999998766655555667899999999999999999999999999999999999999999999999999765432
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... ++
T Consensus 172 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~-------------- 233 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LK-------------- 233 (329)
T ss_pred -cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cC--------------
Confidence 123578999999999876 668999999999999999999999999888777666654311 10
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
....++..+.+||.+||+.||.+|++ +.+++.||||....+
T Consensus 234 -------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 234 -------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred -------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 00236788999999999999999997 799999999987544
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=370.55 Aligned_cols=281 Identities=38% Similarity=0.678 Sum_probs=225.2
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCeeeecceeeec---CCc
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL---DHPNIIKLEGLITSR---LSC 204 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~---~~~ 204 (478)
+|++++.||+|+||+||+|++..+++.||+|+++...........+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48999999999999999999999999999999876433222223345677776665 799999999987642 235
Q ss_pred eEEEEEeeccCCchhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
.+++||||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 68999999998776665443 33589999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. .......+|..|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.+.++....+.+....|......
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 Q--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred c--ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 2 22234567899999999876 66899999999999999999999999999999999999998888876666432111
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
....+.+ .....+....+.++..+.+||.+||++||.+|||+.|+|.||||
T Consensus 238 ~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSP--RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCC--CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1111111 11122344456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-50 Score=359.95 Aligned_cols=294 Identities=43% Similarity=0.752 Sum_probs=243.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec------C
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR------L 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 202 (478)
...|+.+.+||+|.||.||+|+...+++.||+|++..++-....-....+|+.+|..|.|+|++.++++|... .
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4579999999999999999999999999999998765443323334456899999999999999999887431 1
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...+||||.+|++++...+......++...+..++.+++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 33589999999999999998888899999999999999999999999999999999999999999999999999997553
Q ss_pred CCC---CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 283 TGH---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 283 ~~~---~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
... ....+.++.|.||++||.+.|...|+++.|||..||||.||+++.+.|.+.++..+++.|..++|....+.|+.
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 221 23356778899999999999999999999999999999999999999999999999999999999999999976
Q ss_pred C-CCCCcccc--CCCC-CCCccchhcccC--CchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 360 S-KLPHATLF--KPQQ-PYDSSLRETFKD--LPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 360 ~-~~~~~~~~--~~~~-~~~~~l~~~~~~--~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
. +++-.... .|.. .-.+.+....+. -++++.+||..||.+||.+|++++++|+|.||...|.+
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 3 23321111 1100 000111122221 25689999999999999999999999999999887765
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=368.88 Aligned_cols=283 Identities=40% Similarity=0.733 Sum_probs=230.9
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++++.||.|+||.||+|++..+++.||+|++............+.+|+.+++.++||||+++++++.. +..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 4899999999999999999999999999999997654444445667789999999999999999999987 67899999
Q ss_pred eeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 211 EYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 211 e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||+++++...+.. ....+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... ..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 9999876665543 22568999999999999999999999999999999999999999999999999987554322 22
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|...........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 23345688999999987656678999999999999999999999999999888888888888887777754321111000
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.........+......+++++.+||.+||..||.+|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000111122333445689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=370.44 Aligned_cols=283 Identities=41% Similarity=0.693 Sum_probs=232.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||.|+||.||++++..+|+.||+|+++...........+.+|+.+++.++||||+++++++.+ ...+|+|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4899999999999999999999999999999997654444444567789999999999999999999987 66799999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 290 (478)
||++++++..+......+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++....... ....
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcC
Confidence 999988877776656679999999999999999999999999999999999999999999999999997654322 2223
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+...++.++...|............
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 446688999999987756689999999999999999998766 6667777888888888888887766543211111111
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
+..+....+.+..+.+++++.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11222222344456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=385.08 Aligned_cols=265 Identities=27% Similarity=0.405 Sum_probs=217.0
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++++.||+|+||+||+|++..+++.||||+++.... .......+.+|+.++..++|+||+++++.+.+ ...+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 479999999999999999999999999999999975432 23344567789999999999999999999887 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC--
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 286 (478)
||||++++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999877666665666899999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 011763 287 --------------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 334 (478)
Q Consensus 287 --------------------------------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~ 334 (478)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 01124578999999999886 678999999999999999999999999
Q ss_pred CCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCC---ccCHHHHH
Q 011763 335 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK---RATASAAL 411 (478)
Q Consensus 335 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~---R~ta~e~L 411 (478)
+.+..+...++........ +. ....+++++++||.+|+. +|.+ ||+++|++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~--------------------~p-----~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 238 SETPQETYKKVMNWKETLI--------------------FP-----PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCHHHHHHHHHcCcCccc--------------------CC-----CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 9888777777654211100 00 002467899999999876 5554 58999999
Q ss_pred hCcccCCCCCCC
Q 011763 412 ASEYFSTKPYAC 423 (478)
Q Consensus 412 ~hp~f~~~~~~~ 423 (478)
+||||+...|..
T Consensus 292 ~hp~f~~~~~~~ 303 (363)
T cd05628 292 TNPFFEGVDWEH 303 (363)
T ss_pred CCCCCCCCCHHH
Confidence 999998765543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=380.95 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=212.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeecc
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~ 214 (478)
+.||+|+||.||++++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 469999999999999999999999999976432 23445567789999999999999999998877 678999999999
Q ss_pred CCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcccccc
Q 011763 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (478)
Q Consensus 215 ~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 294 (478)
++.+.........+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......++
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccceec
Confidence 87776666666689999999999999999999999999999999999999999999999999987532221 22334578
Q ss_pred CCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCC
Q 011763 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (478)
Q Consensus 295 t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 374 (478)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+......
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----------------------- 213 (323)
T cd05571 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR----------------------- 213 (323)
T ss_pred CccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-----------------------
Confidence 999999999876 67899999999999999999999999887766665554321100
Q ss_pred CccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 375 ~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
....+++++.+||.+||+.||++|| ++.++|+||||....+
T Consensus 214 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 214 ------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred ------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 0135788999999999999999999 8999999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=369.55 Aligned_cols=255 Identities=29% Similarity=0.473 Sum_probs=231.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..+|++.+.||+|.||+|-+|.+...|+.||||.++++.+ +.+..-.+.+||+||..|+||||+.+|++|+. .+.+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--CceEE
Confidence 4589999999999999999999999999999999998876 45666778899999999999999999999987 77899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
|||||..++.+..+....+.|++.+++.+++||..|+.|||.++|+|||||.+|||||.++++||+|||++..+... .
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--k 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--K 207 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--c
Confidence 99999999888888888889999999999999999999999999999999999999999999999999999877654 4
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
.++++||+|-|.+||++.+..+-++.+|.||||++||.|+.|..||.+.+....+.+|.......
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--------------- 272 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--------------- 272 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---------------
Confidence 56889999999999999986667899999999999999999999999999988888886532111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
+.-|.++.-||+.||.++|++|.|+.++-.|=|.+
T Consensus 273 ---------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 273 ---------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ---------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 24567789999999999999999999999998875
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=380.91 Aligned_cols=287 Identities=30% Similarity=0.514 Sum_probs=230.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
.++|++++.||+|+||.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 56899999999999999999999999999999999765545555667788999999999999999999886432 23
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
..|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 96 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 5799999999887765532 4789999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++..++.+..+++.......
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred --cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 22244577999999999876 678999999999999999999999999999999999998888888776654432110
Q ss_pred ccccCCC---------CCCCc----cchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 365 ATLFKPQ---------QPYDS----SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~~---------~~~~~----~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
....... ..... .........+..+++||.+||..||++|||+.|+|+||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0000000 00000 001111235678899999999999999999999999999986533
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=379.63 Aligned_cols=285 Identities=35% Similarity=0.589 Sum_probs=230.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
.++|++++.||.|+||+||+|.+..+++.||+|++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46899999999999999999999999999999999765433344556778999999999999999999885421 24
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
..|++++++.+.+...+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 579999999776655443 336999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...+.......
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 2345789999999998775678999999999999999999999999999889999998888888766654432211
Q ss_pred ccccCC--CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 365 ATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 365 ~~~~~~--~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
...+.. .......+...+...++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 111000 0111122334455677889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=385.23 Aligned_cols=264 Identities=31% Similarity=0.465 Sum_probs=217.7
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|..++||||+++++++.+ ...+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 379999999999999999999999999999999975432 23445567789999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC-
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ- 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~- 287 (478)
||||++++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999998776666555667999999999999999999999999999999999999999999999999998654221100
Q ss_pred ------------------------------------CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCC
Q 011763 288 ------------------------------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331 (478)
Q Consensus 288 ------------------------------------~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~ 331 (478)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCC
Confidence 1113468999999999876 678999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC---HH
Q 011763 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---AS 408 (478)
Q Consensus 332 pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t---a~ 408 (478)
||...+..+....+........ .+ ....+++++++||.+||. +|.+|++ +.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~---------------~~----------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQ---------------FP----------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccC---------------CC----------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 9998887776666543110000 00 001468899999999997 9999998 99
Q ss_pred HHHhCcccCCCCCC
Q 011763 409 AALASEYFSTKPYA 422 (478)
Q Consensus 409 e~L~hp~f~~~~~~ 422 (478)
++|.||||+...+.
T Consensus 292 ~ll~h~~~~~~~~~ 305 (364)
T cd05599 292 EIKSHPFFKGVDWE 305 (364)
T ss_pred HHhcCCCcCCCCHH
Confidence 99999999876553
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=370.14 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=213.5
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.|++.+.||+|+||+||++.+..+++.||+|++...... ......+.+|+.+|..++|+||+++++++.+ ....|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEE
Confidence 388999999999999999999999999999998755432 2233456789999999999999999998877 5689999
Q ss_pred EeeccCCchhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 210 FEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 210 ~e~~~~~ll~~~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
|||++++.+.... .....+++..+..++.||+.||.|||+++|+||||||+|||+++++.++|+|||++...... .
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 9999987664333 23346899999999999999999999999999999999999999999999999999765432 2
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...+.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 222 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE------------- 222 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc-------------
Confidence 2234578999999999986 67899999999999999999999999887654443333332211110
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
.....++.++.+||++||+.||.+||+ ++++++||||....+
T Consensus 223 ------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 223 ------------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred ------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 112357889999999999999999997 899999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=379.58 Aligned_cols=263 Identities=29% Similarity=0.422 Sum_probs=220.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|..++||||+++++++.. ...+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv 79 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYLA 79 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEEE
Confidence 699999999999999999999999999999999765322 2344567789999999999999999999877 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence 99999877777766666899999999999999999999999999999999999999999999999999975543 23
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....+|+.|+|||++.+ ..++.++|||||||++|||++|.+||...+..+....+.........
T Consensus 156 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--------------- 219 (333)
T cd05600 156 NSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR--------------- 219 (333)
T ss_pred CCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC---------------
Confidence 44578999999999887 57899999999999999999999999988877766665432110000
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
+. .......+++++.+||.+||..+|.+||++.++++||||...++
T Consensus 220 ~~------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 220 PV------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred CC------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 00 00000357889999999999999999999999999999997655
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=380.65 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=219.0
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCC-cEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTG-KIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~-~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
..++|++.+.||+|+||.||+|.+..++ ..||+|++..... .......+.+|+.++..++||||+++++++.+ ...
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCE
Confidence 4678999999999999999999876554 6899999875432 23445667889999999999999999999987 678
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+|+||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999998776666666668999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 185 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------- 247 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF------------- 247 (340)
T ss_pred ---cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC-------------
Confidence 234578999999999876 668999999999999999999999999888776666664421111
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~~ 422 (478)
...+++.+.+||++||+.||.+|+ +++++++||||....|.
T Consensus 248 ----------------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 248 ----------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred ----------------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 124678899999999999999995 89999999999876553
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=372.83 Aligned_cols=278 Identities=35% Similarity=0.660 Sum_probs=215.9
Q ss_pred eeeeeecCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEee
Q 011763 135 LEKIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~ 212 (478)
.++||+|+||+||+|++. .+++.||+|++..... ...+.+|+.+|++++||||+++++++.......+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999965 4678999999875432 2345689999999999999999999876666789999999
Q ss_pred ccCCchhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----ecCCcEEEeecccccc
Q 011763 213 MEHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANF 280 (478)
Q Consensus 213 ~~~~ll~~~~~--------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~vkl~DFG~a~~ 280 (478)
+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 99876655431 22358999999999999999999999999999999999999 4557899999999976
Q ss_pred cCCCCC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHc
Q 011763 281 SNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLC 349 (478)
Q Consensus 281 ~~~~~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---------~~~~~~i~~~~ 349 (478)
...... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||..... .+++..++..+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 543211 1223457799999999998766789999999999999999999999976442 46778889999
Q ss_pred CCCCchhhccCCC-CCcccc-----C---CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 350 GSPPDDYWKKSKL-PHATLF-----K---PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 350 g~~~~~~~~~~~~-~~~~~~-----~---~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
+.++...|..... +..... . ........+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9988887765321 110000 0 00001111111112345679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=379.37 Aligned_cols=266 Identities=26% Similarity=0.380 Sum_probs=219.3
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++.+.||+|+||+||++++..+++.||+|+++.... ..+....+.+|+.+++.++|+||+++++++.+ ...+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 369999999999999999999999999999999986543 23445667889999999999999999998877 678999
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||++++.+..+. .....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999876555444 33367999999999999999999999999999999999999999999999999999766543322
Q ss_pred CccccccCCcccCcccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 288 PLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~-----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
......+|+.|+|||++.. ...++.++|||||||++|+|++|+.||...+....+.++........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--------- 229 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK--------- 229 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC---------
Confidence 2234567999999999863 35678899999999999999999999998887777766654210000
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
+ .....++.++.+||..||. ||.+|||+.+++.||||....+..
T Consensus 230 -----------~-----~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 230 -----------F-----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred -----------C-----CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence 0 0012578899999999998 999999999999999998765543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=382.51 Aligned_cols=265 Identities=32% Similarity=0.469 Sum_probs=220.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|..++|+||+++++++.+ ..++|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 3799999999999999999999999999999999765332 2445667889999999999999999999877 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC---
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--- 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--- 285 (478)
||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999886666555555689999999999999999999999999999999999999999999999999997654332
Q ss_pred -------------------------CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 011763 286 -------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 340 (478)
Q Consensus 286 -------------------------~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~ 340 (478)
........+|+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112234568999999999887 678999999999999999999999999988777
Q ss_pred HHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-HHHHHhCcccCCC
Q 011763 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAALASEYFSTK 419 (478)
Q Consensus 341 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-a~e~L~hp~f~~~ 419 (478)
...++........ . .....+++++.+||.+||. ||.+|++ +.++|+||||+..
T Consensus 238 ~~~~i~~~~~~~~---------------~----------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESLR---------------F----------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCccc---------------C----------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 6666654111000 0 0012368899999999997 9999999 9999999999876
Q ss_pred CCCC
Q 011763 420 PYAC 423 (478)
Q Consensus 420 ~~~~ 423 (478)
.+..
T Consensus 292 ~~~~ 295 (350)
T cd05573 292 DWEN 295 (350)
T ss_pred CHHH
Confidence 6543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=382.38 Aligned_cols=263 Identities=29% Similarity=0.413 Sum_probs=213.8
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+ ...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 59999999999999999999999999999999976432 33455678889999999999999999999987 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC----
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---- 285 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---- 285 (478)
|||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999987666665556679999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------------CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHH
Q 011763 286 ------------------------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 323 (478)
Q Consensus 286 ------------------------------------------~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il 323 (478)
.......+||+.|+|||++.+ ..++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHH
Confidence 000123578999999999876 6789999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCC--C
Q 011763 324 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE--P 401 (478)
Q Consensus 324 ~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~d--P 401 (478)
|||++|++||...+..+....+........ . .....+++++++||.+||..+ |
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~-----------------~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH--------I-----------------PPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccC--------C-----------------CCCCCCCHHHHHHHHHHccCcccc
Confidence 999999999998877666655543111100 0 001257889999999976554 4
Q ss_pred CCccCHHHHHhCcccCCCCC
Q 011763 402 YKRATASAALASEYFSTKPY 421 (478)
Q Consensus 402 ~~R~ta~e~L~hp~f~~~~~ 421 (478)
..|+++.++|.||||....+
T Consensus 294 ~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 294 LGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred cCCCCHHHHhcCcccCCCCh
Confidence 45999999999999987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=370.70 Aligned_cols=258 Identities=28% Similarity=0.513 Sum_probs=234.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
-|.+.+.||+|.|..|-+|++.-+|..||||++.+..++......+.+|++.|+.++|||||+||++... ...+|||+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyLiL 96 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYLIL 96 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEEEE
Confidence 5889999999999999999999999999999999988888888889999999999999999999999877 56799999
Q ss_pred eeccC-CchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-CCcEEEeecccccccCCCCCCC
Q 011763 211 EYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 211 e~~~~-~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|+-.+ ++.+++......+.+..+++|+.||+.|+.|||+..||||||||+||++-+ -|.|||+|||++..+.++ ..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~k 174 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--KK 174 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--ch
Confidence 99987 566677777778999999999999999999999999999999999988765 489999999999877765 45
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
+++.||...|-|||+++|..+..+++||||||||||.|++|++||+..++.+++.+|+..-...|
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP--------------- 239 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP--------------- 239 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc---------------
Confidence 67889999999999999977778899999999999999999999999999999999988655444
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
..++.+.++||.+||..||.+|.+.+++..|+|++....
T Consensus 240 --------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 240 --------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred --------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 367899999999999999999999999999999986543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=384.84 Aligned_cols=262 Identities=29% Similarity=0.394 Sum_probs=213.9
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+|++++.||+|+||+||++++..+++.||||++..... .......+.+|+.+|+.++|+||+++++.+.+ ...+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence 69999999999999999999999999999999865322 22334567789999999999999999999987 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC-----
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG----- 284 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~----- 284 (478)
|||++++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|......
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 999998776666655667899999999999999999999999999999999999999999999999997432100
Q ss_pred -------------------------------------CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHH
Q 011763 285 -------------------------------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327 (478)
Q Consensus 285 -------------------------------------~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ell 327 (478)
........+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehh
Confidence 0000123478999999999876 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc--
Q 011763 328 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-- 405 (478)
Q Consensus 328 tG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-- 405 (478)
+|+.||.+.+..+....+........ ......++.++.+||.+|+ .+|.+|+
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLH-------------------------IPSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCcccc-------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 99999998887766655432110000 0001357889999999987 4999999
Q ss_pred -CHHHHHhCcccCCCCC
Q 011763 406 -TASAALASEYFSTKPY 421 (478)
Q Consensus 406 -ta~e~L~hp~f~~~~~ 421 (478)
|+.++|+||||+...+
T Consensus 293 ~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 293 NGADEIKAHPFFKGIDF 309 (376)
T ss_pred CCHHHHhCCCCcCCCCH
Confidence 9999999999987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=355.69 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=229.5
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
..++|..++.||+|.||+|.+|+.+.+++.||+|+++++.. ..+.+...+.|-++|+..+||++..|-..|+. .+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceE
Confidence 47899999999999999999999999999999999988764 45556667789999999999999999777876 7889
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|+||||..|+.+...+.....|++...+.+-.+|+.||.|||+++||+||||.+|+|||.+|++||+|||+++..-...
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g- 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG- 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc-
Confidence 9999999999888888888899999999999999999999999999999999999999999999999999997543222
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
....+.||||.|+|||++.. ..|+.++|+|.+||+||||++|+.||...+....++-|.-.--..
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF-------------- 387 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF-------------- 387 (516)
T ss_pred ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC--------------
Confidence 34567899999999999986 889999999999999999999999999888777666654321111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYA 422 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~~ 422 (478)
...++++++.||..+|..||.+|.- +.|+.+|+||....|.
T Consensus 388 ---------------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 388 ---------------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred ---------------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 1368999999999999999999974 8999999999987663
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=383.51 Aligned_cols=262 Identities=30% Similarity=0.419 Sum_probs=214.7
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+|+.++|+||+++++.+.+ ...+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 59999999999999999999999999999999975432 23445677889999999999999999999987 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC----
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---- 285 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---- 285 (478)
|||++++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999987665555555678999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------------CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHH
Q 011763 286 ------------------------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 323 (478)
Q Consensus 286 ------------------------------------------~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il 323 (478)
.......+||+.|+|||++.+ ..++.++|||||||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHH
Confidence 000123468999999999876 6789999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCC
Q 011763 324 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 403 (478)
Q Consensus 324 ~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~ 403 (478)
|||++|++||.+.+..+...++......... .....+++++.+||.+|+ .||.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHI-------------------------PPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCC-------------------------CCcccCCHHHHHHHHHHc-cCHhH
Confidence 9999999999988877766665431111000 001357889999999987 59999
Q ss_pred ccC---HHHHHhCcccCCCCC
Q 011763 404 RAT---ASAALASEYFSTKPY 421 (478)
Q Consensus 404 R~t---a~e~L~hp~f~~~~~ 421 (478)
|++ +.++++||||+...+
T Consensus 293 R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 293 RLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred cCCCCCHHHHhcCCCcCCcCh
Confidence 997 999999999987554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=380.51 Aligned_cols=268 Identities=25% Similarity=0.378 Sum_probs=221.0
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
+..++|++++.||+|+||.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+ ...
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKY 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCE
Confidence 446799999999999999999999999999999999975432 22334557789999999999999999998877 678
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||||++++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999998766655543 368999999999999999999999999999999999999999999999999997654332
Q ss_pred CCCccccccCCcccCcccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~---~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
.......++|+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+....+.++........
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------- 267 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT--------- 267 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC---------
Confidence 2233456789999999998652 2478899999999999999999999999888777777654211100
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCC--ccCHHHHHhCcccCCCCCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPYA 422 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~--R~ta~e~L~hp~f~~~~~~ 422 (478)
+ .....++.++.+||.+||..+|.+ |+|+.++|+||||+...|.
T Consensus 268 -----------~-----~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 268 -----------F-----PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred -----------C-----CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 0 001257889999999999999998 9999999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=373.05 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=212.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeecc
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~ 214 (478)
+.||+|+||.||++++..+++.||+|++..... .......+.+|+.+++.++||||++++++|.. ...+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 468999999999999999999999999976432 23445566789999999999999999999877 678999999999
Q ss_pred CCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcccccc
Q 011763 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (478)
Q Consensus 215 ~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 294 (478)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .......+
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccC
Confidence 87776666666689999999999999999999999999999999999999999999999999987532221 22234568
Q ss_pred CCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCC
Q 011763 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (478)
Q Consensus 295 t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 374 (478)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+......
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~----------------------- 213 (323)
T cd05595 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR----------------------- 213 (323)
T ss_pred CcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------------------
Confidence 999999999876 67899999999999999999999999988777666655431100
Q ss_pred CccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 375 ~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
....+++++.+||.+||..||.+|+ ++.++|+||||....+
T Consensus 214 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 214 ------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred ------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 0125788999999999999999998 8999999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.31 Aligned_cols=285 Identities=39% Similarity=0.700 Sum_probs=235.9
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||.|+||.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++.. ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 4899999999999999999999899999999998765545556678899999999999999999999987 67899999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 290 (478)
||+.+++...+......+++..++.++.||+.+|.|||+++|+|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99955555555555567999999999999999999999999999999999999999999999999999766543322334
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC-CCccccC
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFK 369 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~~ 369 (478)
...++..|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+..+...++.+....|..... .......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 456789999999987656678999999999999999999999999999999999999888887766654321 1111111
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
........+...++..+..+.+||.+||..||.+|||++++|+||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 111111223445567889999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=382.64 Aligned_cols=263 Identities=28% Similarity=0.428 Sum_probs=214.0
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++++.||+|+||+||++++..+++.||||++..... .......+.+|+.+|+.++||||++++++|.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 379999999999999999999999999999999875432 23445667889999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC--
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 286 (478)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999998876666655566799999999999999999999999999999999999999999999999999863211000
Q ss_pred -----------C---------------------------------CccccccCCcccCcccccCCCCCCChhhHHHHHHH
Q 011763 287 -----------Q---------------------------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 322 (478)
Q Consensus 287 -----------~---------------------------------~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~i 322 (478)
. .....+||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchh
Confidence 0 0012468999999999876 678999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCC
Q 011763 323 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 402 (478)
Q Consensus 323 l~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~ 402 (478)
+|||++|.+||.+.+..+.+..+........ ++ ....++.++.+||.+||. +|.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~p-----------------~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLY--------FP-----------------DDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccC--------CC-----------------CCCCCCHHHHHHHHHHhc-CHh
Confidence 9999999999998887777666653110000 00 012467899999999998 777
Q ss_pred Cc---cCHHHHHhCcccCCCCC
Q 011763 403 KR---ATASAALASEYFSTKPY 421 (478)
Q Consensus 403 ~R---~ta~e~L~hp~f~~~~~ 421 (478)
+| +|+.++|.||||+...+
T Consensus 292 ~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hcCCCCCHHHHhcCCCcCCCCH
Confidence 65 59999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=368.66 Aligned_cols=261 Identities=28% Similarity=0.402 Sum_probs=208.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|+++++||+|+||+||++++..+++.||||++.... .......+.+|+.+|+.++|+||+++++++.. ...+|+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEE
Confidence 457999999999999999999999999999999986543 34455678899999999999999999999877 677999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.++.+... ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 9999998765432 245688889999999999999999999999999999999999999999999997654321 22
Q ss_pred ccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 289 LTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.....+|..|+|||++.. ...++.++|||||||++|||++|+.||......+....+.......+
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 293 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP----------- 293 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-----------
Confidence 344578999999998743 13345689999999999999999999974432222221111110000
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
......++.++.+||.+||..||++|||+.|+|+||||......
T Consensus 294 --------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 294 --------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337 (353)
T ss_pred --------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence 00113578899999999999999999999999999999875443
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=373.87 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=211.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeecc
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~ 214 (478)
+.||+|+||.||++++..+++.||+|++..... .......+.+|+.+|+.++||||+++++++.. ...+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 468999999999999999999999999976432 23445667789999999999999999998877 678999999999
Q ss_pred CCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcccccc
Q 011763 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (478)
Q Consensus 215 ~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 294 (478)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......++
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccC
Confidence 87776666666689999999999999999999999999999999999999999999999999987543221 22234578
Q ss_pred CCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCC
Q 011763 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (478)
Q Consensus 295 t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 374 (478)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~------------------------ 212 (328)
T cd05593 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI------------------------ 212 (328)
T ss_pred CcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc------------------------
Confidence 999999999876 6789999999999999999999999988776665554422100
Q ss_pred CccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 375 ~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
.....++.++.+||.+||..||.+|+ ++.++|+||||....+
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 213 -----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred -----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 00135788999999999999999997 8999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=371.24 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=223.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
...|..++.||+|.||.||+|.+..+++.||+|+++.+.. ....+.+.+|+.+|..++++||.++|+.|.. +..+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHH
Confidence 3468999999999999999999999999999999998764 4557888999999999999999999999988 778999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
+||||.|+....+...+..+.+..+..++++++.||.|||.++.+|||||+.||||..+|.+||+|||.+..........
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999998888888888778999999999999999999999999999999999999999999999999997766543333
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.+.+|||.|||||++.+ ..|+.++||||||++.+||++|.||+........+..| |
T Consensus 169 -~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------p--------------- 224 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------P--------------- 224 (467)
T ss_pred -ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------c---------------
Confidence 67899999999999995 78999999999999999999999999876653322221 1
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
....+.|. .++++.+++|+..||++||+.||+|.++|+|+|++.
T Consensus 225 ---k~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 225 ---KSAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ---CCCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 11111121 267889999999999999999999999999999986
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=370.64 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=210.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCC
Q 011763 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (478)
Q Consensus 138 LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (478)
||+|+||+||++++..+++.||+|++..... .......+.+|+.+|.+++||||+++++++.. ...+|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 6999999999999999999999999975432 33445667789999999999999999998877 67899999999987
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCC
Q 011763 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296 (478)
Q Consensus 217 ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~ 296 (478)
.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......++|+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCc
Confidence 776665556689999999999999999999999999999999999999999999999999987543221 2233457899
Q ss_pred cccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCc
Q 011763 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 376 (478)
Q Consensus 297 ~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (478)
.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~-------------------------- 210 (312)
T cd05585 158 EYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL-------------------------- 210 (312)
T ss_pred ccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC--------------------------
Confidence 9999999886 6789999999999999999999999998877666665543110
Q ss_pred cchhcccCCchhHHHHHHHhcCCCCCCcc---CHHHHHhCcccCCCC
Q 011763 377 SLRETFKDLPTTAVNLIETLLSVEPYKRA---TASAALASEYFSTKP 420 (478)
Q Consensus 377 ~l~~~~~~~~~~l~~Li~~mL~~dP~~R~---ta~e~L~hp~f~~~~ 420 (478)
.....+++++.+||.+||..||.+|| ++.++|.||||....
T Consensus 211 ---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 211 ---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 00135788999999999999999997 589999999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=360.58 Aligned_cols=291 Identities=42% Similarity=0.711 Sum_probs=235.8
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ......+..|+.+++.++|+||+++++++.+ ....|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488999999999999999999989999999999865543 3334556789999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||+.+.+...+......+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++....... .
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-R 157 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-c
Confidence 999999555555544433479999999999999999999999999999999999999999999999999997665432 1
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+++.|+|||++.+...++.++|||||||++|+|++|.++|.+.+..+.+.++...++.+....|....... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 236 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP-DY 236 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc-cc
Confidence 22334557889999998765678899999999999999999999999999888888888888887777665422111 11
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 425 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~~ 425 (478)
..........+...+..++..+.+||.+||.+||++|||+.++|.||||.+.+.+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~ 294 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP 294 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence 1111112223344456778999999999999999999999999999999997776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=367.65 Aligned_cols=281 Identities=24% Similarity=0.328 Sum_probs=217.1
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|++++.||+|+||.||++++..++..||+|++..+. .......+.+|+++|+.++||||+++++++.. ...++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 79 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEIS 79 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEE
Confidence 3578999999999999999999999999999999997643 34556678899999999999999999999987 66799
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
+||||++++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999877776666666799999999999999999999986 6999999999999999999999999998755332
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCc----hhhccCC-
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD----DYWKKSK- 361 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~----~~~~~~~- 361 (478)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.... ++.+.. ..+....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEPHSISP 231 (331)
T ss_pred -ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCccccCc
Confidence 2234567999999999886 6789999999999999999999999987665443322 222111 0000000
Q ss_pred CCCc--cc----cCCCCCCCc------------cchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 362 LPHA--TL----FKPQQPYDS------------SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 362 ~~~~--~~----~~~~~~~~~------------~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.+.. .. .....+... ........+++++++||.+||.+||++|||+.++|+||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000 00 000000000 0000012467889999999999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=373.79 Aligned_cols=264 Identities=27% Similarity=0.408 Sum_probs=210.2
Q ss_pred ceeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCc
Q 011763 131 AFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~---~~~~~vAlK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 204 (478)
+|++++.||+|+||+||++++. .+++.||+|++..... .....+.+..|+.+|..+ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4899999999999999999864 4789999999975432 223345677899999999 59999999988876 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 79999999998766655555567999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.........+|+.|+|||++.+...++.++|||||||++|+|++|+.||...........+.........
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------- 228 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP---------- 228 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC----------
Confidence 3233334578999999999886556889999999999999999999999754322111111111000000
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
.....++..+.+||.+||+.||++|| ++.++|+||||+...+
T Consensus 229 ---------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 229 ---------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 00125788899999999999999999 8899999999987544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=368.93 Aligned_cols=252 Identities=31% Similarity=0.440 Sum_probs=212.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcE-EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~-vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.+.+.+.+.||.|+||+||++... |+. ||+|++..........+.+.+|+.+|.+|+|||||++++++..+.. .++
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceE
Confidence 446677777999999999999874 455 9999998776666657889999999999999999999999987422 689
Q ss_pred EEEeeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCcEEEecCC-cEEEeecccccccCC
Q 011763 208 LVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRG-VLHRDIKGSNLLVNNEG-VLKLADFGLANFSNT 283 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g-ivHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~ 283 (478)
|||||++++.+..+... ...++...+..++.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999877776654 678999999999999999999999999 99999999999999998 999999999986654
Q ss_pred CCCCCccccccCCcccCcccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~-~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
.. ...+...||+.|||||++.+ ...|+.++||||||++||||+||+.||......+....+......|+.
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~-------- 267 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI-------- 267 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--------
Confidence 22 33344788999999999985 267999999999999999999999999999986655555443222211
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHH
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L 411 (478)
....++.+..||.+|+..||.+||+..+++
T Consensus 268 -------------------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 268 -------------------PKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred -------------------CccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 123788999999999999999999999886
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=376.54 Aligned_cols=267 Identities=25% Similarity=0.361 Sum_probs=218.4
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
...++|++++.||+|+||.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~ 117 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKY 117 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCE
Confidence 346789999999999999999999999999999999975322 23334567789999999999999999999877 678
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+|+||||++++.+..+.... .+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999986665555433 58999999999999999999999999999999999999999999999999997654332
Q ss_pred CCCccccccCCcccCcccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~---~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
.......++|+.|+|||++.+. ..++.++|||||||+||+|++|++||.+.+....+.++......+..
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 268 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF-------- 268 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC--------
Confidence 2233456789999999998652 23788999999999999999999999998887777776542211100
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCC--ccCHHHHHhCcccCCCCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 421 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~--R~ta~e~L~hp~f~~~~~ 421 (478)
. ....++..+++||..||..+|.+ |+|+.|+|+||||+...+
T Consensus 269 ------------p-----~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 269 ------------P-----EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred ------------C-----CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 0 01246888999999999865544 899999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.19 Aligned_cols=282 Identities=41% Similarity=0.736 Sum_probs=230.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++++.||.|++|.||+|++..+++.||||++..+.........+.+|++++++++||||+++++++.+ ....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 4899999999999999999999999999999997655444445667889999999999999999999876 67799999
Q ss_pred eeccCCchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 211 EYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 211 e~~~~~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
||+.+++...+.. ....+++..++.++.||+.||+|||+++++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccc
Confidence 9998766555433 34568999999999999999999999999999999999999999999999999987554322 222
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC-CCcccc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLF 368 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~ 368 (478)
....+++.|+|||++.+...++.++|||||||++|+|++|+.||...++.+.+.++++..+.++...|..... +.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3345688899999887655678899999999999999999999999999999999999888888776653221 110000
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.+ ......+....+.+++++++||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FP-KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cc-cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00 111122333345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=370.62 Aligned_cols=277 Identities=22% Similarity=0.334 Sum_probs=212.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
..+|++++.||+|+||.||+|++..+++.||+|+..... ...|+.+|++++|+||+++++++.. ....|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVS--GAITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEe--CCeeEE
Confidence 457999999999999999999999999999999854321 2459999999999999999999987 667899
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|||++.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 135 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 212 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PA 212 (357)
T ss_pred EEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--cc
Confidence 9999999888877776778999999999999999999999999999999999999999999999999999754322 12
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCC---------hHHHHHHHHHHcCCCCchhhc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRT---------EVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~-~pf~~~~---------~~~~~~~i~~~~g~~~~~~~~ 358 (478)
.....+|+.|+|||++.+ ..++.++|||||||++|||+++. ++|.... ....+..++..++..+..+..
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 234568999999999886 67899999999999999999854 5554422 123455555656655544321
Q ss_pred cCCCCCc-cc----cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 359 KSKLPHA-TL----FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 359 ~~~~~~~-~~----~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
....... .+ .....++..........++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1000000 00 000001110000011256788999999999999999999999999999975
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=368.17 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=215.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCC-CCeeeecceeeecCCceEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDH-PNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~l 208 (478)
+|++++.||+|+||.||+|++..+++.||||++..... .....+.+..|+.++..+.| ++|+++++++.. ...+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 48999999999999999999999999999999976432 23445667789999999965 568888888876 567999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 99999987766665556678999999999999999999999999999999999999999999999999986432211 22
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~---------------- 220 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY---------------- 220 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 334578999999999986 678999999999999999999999999888777776664321110
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH-----HHHHhCcccCCCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPY 421 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta-----~e~L~hp~f~~~~~ 421 (478)
...++.++.+||.+||..||.+|++. .++++||||....+
T Consensus 221 -------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 221 -------------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred -------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 12578889999999999999999986 89999999987544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=377.10 Aligned_cols=265 Identities=28% Similarity=0.421 Sum_probs=217.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++++.||+|+||+||++++..+++.||||+++.... .......+.+|+.++..++|+||+++++.+.+ ...+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999975432 23445677889999999999999999999877 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC--
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 286 (478)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999877766665666899999999999999999999999999999999999999999999999999864422110
Q ss_pred --------------------------------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 011763 287 --------------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 334 (478)
Q Consensus 287 --------------------------------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~ 334 (478)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCC
Confidence 01123578999999999876 678999999999999999999999999
Q ss_pred CCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc---CHHHHH
Q 011763 335 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA---TASAAL 411 (478)
Q Consensus 335 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~---ta~e~L 411 (478)
+.+..+...++........ +. ....+++++++||.+|+. ||.+|+ ++.+++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~--------------------~p-----~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 238 SETPQETYRKVMNWKETLV--------------------FP-----PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCHHHHHHHHHcCCCcee--------------------cC-----CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 8887777666643110000 00 001468899999999874 999998 489999
Q ss_pred hCcccCCCCCCC
Q 011763 412 ASEYFSTKPYAC 423 (478)
Q Consensus 412 ~hp~f~~~~~~~ 423 (478)
+||||...+|..
T Consensus 292 ~hp~f~~~~~~~ 303 (360)
T cd05627 292 SHPFFEGVDWGH 303 (360)
T ss_pred cCCCCCCCCHHH
Confidence 999999876644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=360.70 Aligned_cols=287 Identities=45% Similarity=0.776 Sum_probs=236.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||.|+||.||+|.+..+++.||+|.++...........+.+|+.++.+++||||+++++++........|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 45799999999999999999999999999999999865544333445678999999999999999999987754478999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.+++...+......+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 99999987666665555579999999999999999999999999999999999999999999999999997655432 22
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC-CCCccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATL 367 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~~ 367 (478)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.+++..++.+....|.... ++....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 2334568889999998765567899999999999999999999999999999999999999998888776532 222111
Q ss_pred cCCCCCCCccchhcccC--CchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 368 FKPQQPYDSSLRETFKD--LPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~--~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
..........+...++. +++.+.+||.+||+.||++|||+.|+|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11111122233444544 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=367.29 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=212.6
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHH---HhcCCCCeeeecceeeecCCceEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILIL---RRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
|++++.||+|+||.||++.+..+++.||||+++.... .....+.+.+|+.++ +.++||||+++++++.. ...+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 7889999999999999999999999999999975432 223345566676665 45689999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||++++.+...... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 99999998766655543 479999999999999999999999999999999999999999999999999986533221 2
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
.....++++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~--------------- 220 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY--------------- 220 (324)
T ss_pred cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence 2244678999999999876 678999999999999999999999999988877776664421110
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
...++..+.+||.+||+.||.+|| ++.++++||||+...+
T Consensus 221 --------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 221 --------------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred --------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 125788899999999999999999 7999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=363.91 Aligned_cols=319 Identities=24% Similarity=0.371 Sum_probs=252.7
Q ss_pred ccccchhhhhc-CcchhhhhcccccccCcccccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHH-HH
Q 011763 97 HKYIEGEQVAA-GWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-VR 174 (478)
Q Consensus 97 ~~~~~~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~-~~ 174 (478)
+.++.++.+.. -...++.......+-.+.++..+.|...+.||+|+||.||-|+.+.||+.||.|.+.+..+.... ..
T Consensus 151 ~~~L~~~pF~~f~~S~yf~rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~ 230 (591)
T KOG0986|consen 151 CAYLRGDPFQEFLESDYFTRFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGET 230 (591)
T ss_pred HHHhccchHhHhHHHHHHHHHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhH
Confidence 44444444432 11223333344455556778899999999999999999999999999999999998766543332 33
Q ss_pred HHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCCchhhccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 011763 175 FMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEHCHSRGV 252 (478)
Q Consensus 175 ~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~gi 252 (478)
..++|-.||.+++.++||.+-..|+. .+.+||||..|+|+.+..++.+.+ .|++..+..|+.+|+.||++||+.+|
T Consensus 231 maLnEk~iL~kV~s~FiVslaYAfeT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~i 308 (591)
T KOG0986|consen 231 MALNEKQILEKVSSPFIVSLAYAFET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRI 308 (591)
T ss_pred HhhHHHHHHHHhccCcEEEEeeeecC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcce
Confidence 45689999999999999999777766 778999999999988877766554 69999999999999999999999999
Q ss_pred eeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCC
Q 011763 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI 332 (478)
Q Consensus 253 vHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~p 332 (478)
|+|||||+|||||+.|+++|+|+|+|..+..+ .+...++||.+|||||++.+ ..|+...|+|+|||+||||+.|+.|
T Consensus 309 VYRDLKPeNILLDd~GhvRISDLGLAvei~~g--~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sP 385 (591)
T KOG0986|consen 309 VYRDLKPENILLDDHGHVRISDLGLAVEIPEG--KPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSP 385 (591)
T ss_pred eeccCChhheeeccCCCeEeeccceEEecCCC--CccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCc
Confidence 99999999999999999999999999887765 44566799999999999987 5599999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----H
Q 011763 333 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----A 407 (478)
Q Consensus 333 f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a 407 (478)
|....+....+.+-+..-..+. +....+++++++|.+.+|+.||.+|.- +
T Consensus 386 Fr~~KeKvk~eEvdrr~~~~~~-------------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga 440 (591)
T KOG0986|consen 386 FRQRKEKVKREEVDRRTLEDPE-------------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGA 440 (591)
T ss_pred hhhhhhhhhHHHHHHHHhcchh-------------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCc
Confidence 9876554444333332222221 112478999999999999999999974 6
Q ss_pred HHHHhCcccCCCCCCCCCC---CCCCCCCChhhhhhhhHHH
Q 011763 408 SAALASEYFSTKPYACDLS---SLPIYPPSKEIDAKHREDA 445 (478)
Q Consensus 408 ~e~L~hp~f~~~~~~~~~~---~~p~~~~~~~~~~~~~~~~ 445 (478)
.++-+||||+..+|..... ..|..|+..++.++.--+.
T Consensus 441 ~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DI 481 (591)
T KOG0986|consen 441 QEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDI 481 (591)
T ss_pred chhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhh
Confidence 7999999999988755333 3466677777766655444
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=368.86 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=211.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||+||+|++..+++.||+|++..... .......+..|+.++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 469999999999999999999999999975432 233455667788888877 79999999999877 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccccc
Confidence 987766665556689999999999999999999999999999999999999999999999999987543221 2233457
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------- 215 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--------------------- 215 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC---------------------
Confidence 8999999999876 678999999999999999999999999988877777664321110
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCH------HHHHhCcccCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 421 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta------~e~L~hp~f~~~~~ 421 (478)
...++.++.+||.+||+.||.+|+++ .+++.||||+...+
T Consensus 216 --------~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 216 --------PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred --------CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 12467889999999999999999998 99999999987554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=371.82 Aligned_cols=281 Identities=23% Similarity=0.307 Sum_probs=218.6
Q ss_pred ccceeeeeeeeecCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
..+|++++.||+|+||.||+|... .++..||+|.+.... ...+|+.+|+.++||||+++++++.. ...+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRW--KSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEee--CCEE
Confidence 447999999999999999999754 356789999886431 24579999999999999999999877 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|+|||++.+++...+ .....+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||++........
T Consensus 162 ~lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 999999998877766 4455799999999999999999999999999999999999999999999999999976543222
Q ss_pred C-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHcCCCCchhhccCCC
Q 011763 287 Q-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 287 ~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~---~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
. ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ....+..+.+.++..+.++......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 1 2234568999999999876 678999999999999999999999997654 4566777777777665443221110
Q ss_pred CC------c-cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 363 PH------A-TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 363 ~~------~-~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
.. . ....+.......+. -..++.++.+||.+||.+||++|||+.++|.||||.+.|+.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIR--KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred hHHHHHHhhcccccCCccccchhh--ccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 00 0 00000000001110 12457789999999999999999999999999999876543
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=360.02 Aligned_cols=288 Identities=45% Similarity=0.834 Sum_probs=235.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL------ 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 202 (478)
.++|++.++||.|+||.||++++..+++.||+|++............+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 56899999999999999999999999999999998765433333345668999999999999999999875432
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...+|+||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||+++++.++|+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 23579999999988877776666689999999999999999999999999999999999999999999999999997543
Q ss_pred CCCC----------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 011763 283 TGHR----------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 352 (478)
Q Consensus 283 ~~~~----------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~ 352 (478)
.... .......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.....+.+....+.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3211 112234568889999988765668999999999999999999999999999999999999988888
Q ss_pred CchhhccCCC-CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 353 PDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 353 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
++..|..+.. +..............+...+..+.+.+.+||.+||..||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 7776654332 111111112223334555566778899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=366.65 Aligned_cols=287 Identities=30% Similarity=0.538 Sum_probs=229.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
.++|++++.||+|+||.||++.+..+++.||+|++............+.+|+.++++++|+||++++++|.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46899999999999999999999999999999998755444555566778999999999999999999886432 23
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
..|+||||+.+++...+... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 57999999998776665432 889999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...++.++.+++.......
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 F--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred C--CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 2 2233467889999999876 678999999999999999999999999999899999999999998877654422110
Q ss_pred ccccC--------------CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 365 ATLFK--------------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~--------------~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
..... +...+...........++.+.+||.+||+.||++|||+.|+|.||||+.+-.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 00000 0000000000111235677899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=371.30 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=210.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeecc
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~ 214 (478)
+.||+|+||.||++++..+++.||+|++..... .......+.+|++++..++||||+++++++.. ...+||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 469999999999999999999999999976432 23344566789999999999999999998877 678999999999
Q ss_pred CCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 215 ~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
++.+.........+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++....... .......
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccccc
Confidence 87776666666689999999999999999999997 799999999999999999999999999987533221 2223456
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~---------------------- 214 (325)
T cd05594 158 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR---------------------- 214 (325)
T ss_pred CCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC----------------------
Confidence 8999999999876 67899999999999999999999999887766655554321100
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
....+++++.+||.+||+.||.+|+ ++.++|+||||....+
T Consensus 215 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 215 -------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 0124688999999999999999997 9999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=366.16 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=215.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~l 208 (478)
+|++++.||+|+||.||+|++..+++.||+|++..... .......+..|..++..+ +|++|+++++++.. ...+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 48999999999999999999999999999999986532 223344566788888877 68999999998877 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 99999987666555555679999999999999999999999999999999999999999999999999987543211 22
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------------- 220 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---------------- 220 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 334578999999999886 678999999999999999999999999988877777765422111
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
...++.++.+||.+||+.||.+|++ ..++++||||....|
T Consensus 221 -------------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 221 -------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred -------------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1257889999999999999999998 489999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=367.35 Aligned_cols=268 Identities=25% Similarity=0.351 Sum_probs=215.7
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++++.||+|+||+||++++..+++.||+|++.... ........+.+|+.++..++|+||+++++++.. ..++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 47999999999999999999999999999999997532 223344567789999999999999999999887 678999
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||+.++.+..+. .....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999876555443 33557999999999999999999999999999999999999999999999999998765433322
Q ss_pred CccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 288 PLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
......+|+.|+|||++.. ...++.++|||||||++|+|++|+.||...+..+....+.......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---------- 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc----------
Confidence 2233468999999999863 24578899999999999999999999998877776666543211000
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCC--ccCHHHHHhCcccCCCCCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPYAC 423 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~--R~ta~e~L~hp~f~~~~~~~ 423 (478)
+......+++.+++||++||..++.+ |+++.++|+||||....+..
T Consensus 229 --------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 229 --------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred --------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 00111347889999999999765554 78999999999998765543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=362.33 Aligned_cols=277 Identities=36% Similarity=0.660 Sum_probs=213.7
Q ss_pred eeeeecCceEEEEEEECC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~--~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
.+||+|+||+||+|++.. ++..||+|.+..... ...+.+|+.+|+.++||||+++++++.......+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 689999999999998653 568899999875432 23466899999999999999999998765567899999999
Q ss_pred cCCchhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----ecCCcEEEeeccccccc
Q 011763 214 EHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFS 281 (478)
Q Consensus 214 ~~~ll~~~~~--------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~vkl~DFG~a~~~ 281 (478)
++++...+.. ....+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9877655431 22358999999999999999999999999999999999999 45678999999999865
Q ss_pred CCCCC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHcC
Q 011763 282 NTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCG 350 (478)
Q Consensus 282 ~~~~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---------~~~~~~i~~~~g 350 (478)
..... .......+|+.|+|||++.+...++.++|||||||++|||++|++||....+ ..++.++...++
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43221 1223456799999999987756789999999999999999999999976432 356778888889
Q ss_pred CCCchhhccCCCCCc----c-ccCCCCCCCcc----chhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 351 SPPDDYWKKSKLPHA----T-LFKPQQPYDSS----LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 351 ~~~~~~~~~~~~~~~----~-~~~~~~~~~~~----l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.+....|........ . .+......... +.......+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888887765321100 0 00000000001 111112345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=357.80 Aligned_cols=288 Identities=49% Similarity=0.876 Sum_probs=235.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL------ 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 202 (478)
.++|++.+.||+|+||.||+|.+..+++.||+|+++...........+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 56899999999999999999999999999999999765433334456678999999999999999999886532
Q ss_pred --CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 203 --SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 203 --~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
...+|+|+||+++++...+......+++..++.++.||+.||.|||++||+|+||||+||++++++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 237899999999987777766556799999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..............+..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+...++.++...|...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence 65433223333455788999998876556789999999999999999999999999999999999998888887766543
Q ss_pred CC-CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 361 KL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 361 ~~-~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.. +..............+...+..++..+.+||.+||..||.+|||+.++|.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 21 111111111112223444556789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.08 Aligned_cols=283 Identities=36% Similarity=0.651 Sum_probs=227.3
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++.+.||+|+||.||++.+..+++.||+|++..........+.+.+|+.+++.++|+||+++++++.. ....++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 47999999999999999999999899999999987554333334567789999999999999999999987 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||++++++..+......+++..++.++.||+.+|.|||+++|+|+||||+||+++.++.++|+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999988887766666799999999999999999999999999999999999999999999999999976544321 12
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchh---hccCCCCCcc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY---WKKSKLPHAT 366 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~---~~~~~~~~~~ 366 (478)
....++..|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++...... +....... .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK-G 236 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc-c
Confidence 2345688899999987656688999999999999999999999999888777777766555443321 11100000 0
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
...+.......+...++.++..+.+||.+||..||++|||+.|+|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 01111111122344456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=355.01 Aligned_cols=284 Identities=37% Similarity=0.685 Sum_probs=227.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||.|+||.||++.+..+++.||||.+...... .....+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 56899999999999999999999989999999998754322 122345679999999999999999999876 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.+++...+......+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 99999987776666555578999999999999999999999999999999999999999999999999986543221 11
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
.....++..|+|||++.+...++.++|||||||++|+|++|++||.... ..+.+..+.+.++.+....|..........
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2223457889999998765668899999999999999999999998766 567778888888888877775533211100
Q ss_pred -cCCCCCCCccchhcccCCc--hhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 368 -FKPQQPYDSSLRETFKDLP--TTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 368 -~~~~~~~~~~l~~~~~~~~--~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
..........+...+..++ .++.+||.+||+.||++|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000011122333334455 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=371.97 Aligned_cols=267 Identities=27% Similarity=0.369 Sum_probs=217.9
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
+..++|++.+.||+|+||.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~ 117 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRY 117 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCE
Confidence 346799999999999999999999999999999999875322 22334557789999999999999999999877 678
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+|+||||++++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 9999999998766655543 358999999999999999999999999999999999999999999999999997664332
Q ss_pred CCCccccccCCcccCcccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~---~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
.......++|+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+......++.......+.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 268 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF-------- 268 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC--------
Confidence 2233456789999999998652 23788999999999999999999999998887777776542211100
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCC--ccCHHHHHhCcccCCCCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 421 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~--R~ta~e~L~hp~f~~~~~ 421 (478)
.....++..+++||..||..++.+ |+++.++++|+||++.++
T Consensus 269 -----------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 269 -----------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred -----------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 001367889999999999844433 789999999999988654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=399.10 Aligned_cols=277 Identities=28% Similarity=0.374 Sum_probs=238.5
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
+..++|++++.||+|+||.|.+++++.+++.||+|++++-.+ .......|+.|-.+|-.-+.+-|++++-.|++ ..+
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~ 149 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD--ERY 149 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccc
Confidence 456899999999999999999999999999999999976433 24445678889999999999999999999988 789
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||||++||.+-.+...-.++++..+++|+..|+.||+-||+.|+|||||||+|||||..|++||+|||.|.......
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 99999999986554444444489999999999999999999999999999999999999999999999999998777666
Q ss_pred CCCccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--cCCCCchhhcc
Q 011763 286 RQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL--CGSPPDDYWKK 359 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~--~g~~~~~~~~~ 359 (478)
.......+|||.|++||+|.. .+.|+..+|+|||||++|||+.|..||..++..+++-+|+.. ....|+.
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~---- 305 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE---- 305 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc----
Confidence 666677899999999999852 257999999999999999999999999999999999999875 2122211
Q ss_pred CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC---HHHHHhCcccCCCCCCCCCCCCCCCCC
Q 011763 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPYACDLSSLPIYPP 433 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t---a~e~L~hp~f~~~~~~~~~~~~p~~~~ 433 (478)
.++|+++++||+++|. +|+.|.. ++++-.||||.+.+|..-....|++-|
T Consensus 306 -----------------------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 306 -----------------------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred -----------------------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence 2589999999999987 7999998 999999999999999666555555544
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=363.65 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=210.5
Q ss_pred eeeeeecCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 135 LEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~---~~~~~vAlK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++.||+|+||.||++++. .+++.||+|++..... .......+.+|+.+|+.++||||++++++|.. ...+|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEE
Confidence 368999999999999863 4788999999975432 12333456789999999999999999999877 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 9999987776666666678999999999999999999999999999999999999999999999999987543221 222
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....+|+.|+|||++.+ ..++.++|||||||++|||++|++||...+....+..+......
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~------------------ 218 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN------------------ 218 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence 34568999999999876 66889999999999999999999999988877766665432110
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
....+++.+.+||.+||+.||++|| ++.+++.||||....+
T Consensus 219 -----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 219 -----------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred -----------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1135678899999999999999999 8999999999986543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=366.99 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=211.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||.||+|++..+++.||+|++..+.. .......+..|+.++..+ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 468999999999999999999999999976432 233445567799999876 89999999999987 67799999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccc
Confidence 987666555555679999999999999999999999999999999999999999999999999987543221 2233456
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+.......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~--------------------- 215 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY--------------------- 215 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence 8999999999876 678999999999999999999999999998888777765421100
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCcc-------CHHHHHhCcccCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-------TASAALASEYFSTKPY 421 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-------ta~e~L~hp~f~~~~~ 421 (478)
...++.++.+||.+||+.||.+|+ ++.++++||||....|
T Consensus 216 --------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 216 --------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred --------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 023678899999999999999999 9999999999987544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=353.01 Aligned_cols=281 Identities=37% Similarity=0.631 Sum_probs=227.5
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEEEEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
|++++.||+|+||.||++.+..+++.||+|+++......... ...+|+.++.++. |+||+++++++.+.....+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 678999999999999999999999999999987543332322 3346899999884 99999999999875447899999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 290 (478)
||++++++..+......+++..++.++.||+.||.|||+++++|+||+|+||+++. +.+||+|||++...... ....
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--~~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--PPYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--CCcC
Confidence 99998888777665567999999999999999999999999999999999999999 99999999999765432 2223
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCC
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 370 (478)
...++..|+|||++.....++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++..++..........+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 34568899999987655667889999999999999999999999999999999998888888776543322111111111
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.......+......++..+.+||.+||..||++|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111222333345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=356.48 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=213.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+|++.+.||+|+||+||++.+..+++.||+|++...... ......+.+|+.+++.++||||+++++.+.. ...+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 489999999999999999999999999999999754332 2223456789999999999999999998877 5689999
Q ss_pred EeeccCCchhhcc-C-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 210 FEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 210 ~e~~~~~ll~~~~-~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
|||+.++.+..+. . ....+++..+..++.||+.||.|||+++|+|+||||+||++++++.++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--E 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--C
Confidence 9999986665433 2 2346899999999999999999999999999999999999999999999999999765432 1
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...+...+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 222 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE------------- 222 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc-------------
Confidence 2234577999999999876 67899999999999999999999999987665444443332211110
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~~ 422 (478)
.....++..+.+||.+||..||.+|| ++.++++||||....+.
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 223 ------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred ------------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 11135788899999999999999999 99999999999875554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=363.67 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=208.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||.||+|++..+++.||+|+++.+.. .....+.+..|..++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 469999999999999999999999999976432 223344455677777654 89999999999877 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+..+......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 987776665556679999999999999999999999999999999999999999999999999997543222 2234457
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------------- 215 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHF--------------------- 215 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence 8999999999876 668999999999999999999999999988777666654311000
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCH-HHHHhCcccCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-SAALASEYFSTKPY 421 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta-~e~L~hp~f~~~~~ 421 (478)
...++.++.+||.+||..||.+||++ .++++||||....+
T Consensus 216 --------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 216 --------PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred --------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 02467889999999999999999986 58889999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=356.06 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=206.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCC
Q 011763 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (478)
Q Consensus 138 LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (478)
||+|+||+||++.+..+++.||+|++...... ....+.+..|+.+|+.++|+||+++++++.. ...+|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 68999999999999999999999999754432 2234566789999999999999999998876 56799999999987
Q ss_pred chhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcccc
Q 011763 217 ITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292 (478)
Q Consensus 217 ll~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 292 (478)
.+.... .....+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++........ .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccccc
Confidence 665332 2345689999999999999999999999999999999999999999999999999976543322 22345
Q ss_pred ccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCC
Q 011763 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372 (478)
Q Consensus 293 ~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 372 (478)
.+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......+.
T Consensus 158 ~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------ 218 (280)
T cd05608 158 AGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV------------------ 218 (280)
T ss_pred CCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC------------------
Confidence 67999999999986 67899999999999999999999999876543222222221111000
Q ss_pred CCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCCC
Q 011763 373 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (478)
Q Consensus 373 ~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~~ 422 (478)
.....++..+.+||.+||+.||++|| |++++++||||+...+.
T Consensus 219 -------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 219 -------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred -------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 01135788999999999999999999 89999999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=353.78 Aligned_cols=287 Identities=41% Similarity=0.734 Sum_probs=232.1
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++.+.||.|++|+||++.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.. ....|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 57999999999999999999999899999999987654444444667789999999999999999999987 6789999
Q ss_pred EeeccCCchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-CCcEEEeecccccccCCCCCC
Q 011763 210 FEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~~~~ 287 (478)
|||+++++...+.... ..+++..++.++.||+.||.|||+++|+|+||+|+||+++. ++.+||+|||++....... .
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 9999887766654332 34688899999999999999999999999999999999985 4579999999997554321 2
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC-CCCcc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHAT 366 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~ 366 (478)
......+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+.+.+++..++.+....|.... ++...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 22334568899999998765668899999999999999999999999998888899999999988888876422 22211
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
...+.. ....+....+.+++.+.++|.+||+.||++||++.++|+||||.+..
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 239 SAFPKW-PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhcccC-CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 111110 11122233456889999999999999999999999999999998643
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=363.02 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=208.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||.||+|++..+++.||+|+++.... .......+..|+.++..+ +||||+++++++.. ..++||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 469999999999999999999999999976432 123344566788888765 89999999999987 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
.++.+.........+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccC
Confidence 987666555556679999999999999999999999999999999999999999999999999986432211 2234567
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--------------------- 215 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHY--------------------- 215 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------------------
Confidence 8999999999886 678999999999999999999999999888766665553211000
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCH-HHHHhCcccCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-SAALASEYFSTKPY 421 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta-~e~L~hp~f~~~~~ 421 (478)
...++.++.+||.+||+.||.+|+++ +++++||||....+
T Consensus 216 --------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 216 --------PRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred --------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 02367889999999999999999997 58889999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=351.62 Aligned_cols=285 Identities=56% Similarity=1.009 Sum_probs=237.4
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEe
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e 211 (478)
|++++.||.|+||.||++.+..+++.||+|++............+.+|+.+++.++|+||+++++++........++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78899999999999999999989999999999866433444556778999999999999999999998743378999999
Q ss_pred eccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccc
Q 011763 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (478)
Q Consensus 212 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 291 (478)
|+++++...+......+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||++.............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99987777766655689999999999999999999999999999999999999999999999999997665443222344
Q ss_pred cccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC-CCccccCC
Q 011763 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKP 370 (478)
Q Consensus 292 ~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~~~ 370 (478)
..++..|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+...++.++...|..... .......+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 56688899999887656688999999999999999999999999999899999999888888777755322 12222223
Q ss_pred CCCCCccchhcccCC-chhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 371 QQPYDSSLRETFKDL-PTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~-~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.......+.+.+... +..+.++|.+||..||.+||++.++|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 333334445555554 8999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=351.45 Aligned_cols=284 Identities=36% Similarity=0.648 Sum_probs=234.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||.|+||.||+|.+..+++.||+|+++...........+.+|+++++.++|+||+++++++.. ....++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEEE
Confidence 6999999999999999999999999999999987655445556778899999999999999999999987 67899999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 290 (478)
||++++++..+......+++..+..++.||+.||.|||+++|+|+||+|+||++++++.+||+|||++............
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 99999888877666667999999999999999999999999999999999999999999999999999776554332444
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc--ccc
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA--TLF 368 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~--~~~ 368 (478)
...++..|+|||++.+...++.++||||||+++|+|++|++||.+.+..+.+..+...++..+...+........ ...
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 566788999999998744789999999999999999999999999888888888888777776654433211100 000
Q ss_pred CCCCCCCccchhccc-CCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 369 KPQQPYDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~-~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.+.......+...++ .++.++.+||++||..||++|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 011111112233333 358999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=363.21 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=211.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||+||++++..+++.||||+++.... .......+.+|+.++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 469999999999999999999999999986432 233445667899999888 79999999999877 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+.........+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence 987776666666689999999999999999999999999999999999999999999999999986532221 2223456
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~---------------------- 214 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR---------------------- 214 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 8999999999876 67899999999999999999999999988776666555331100
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCH-----HHHHhCcccCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPY 421 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta-----~e~L~hp~f~~~~~ 421 (478)
....++..+.+||.+||..||.+||++ .+++.||||+...+
T Consensus 215 -------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 215 -------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred -------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 012468899999999999999999999 99999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=351.70 Aligned_cols=282 Identities=37% Similarity=0.694 Sum_probs=230.4
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++++.||.|++|.||+|++..+++.||||+++.... ......+.+|+.+++.++|+||+++++++.. ....+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEE
Confidence 48999999999999999999999999999999976543 2234556789999999999999999999987 56789999
Q ss_pred eeccCCchhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 211 EYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 211 e~~~~~ll~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||+++++...+.... ..+++..+..++.||+.||.|||++|++|+||||+||++++++.++|+|||++....... ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NT 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cc
Confidence 999987766654432 468999999999999999999999999999999999999999999999999997544321 12
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....++..|++||++.+...++.++|||+|||++|+|++|++||.+.+..+...++.+....+....|+..........
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 23345688999999987656678999999999999999999999999999999999998888888777765442111111
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.........+....+.++..+.++|.+||+.||.+||++.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 111111122233345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.24 Aligned_cols=286 Identities=42% Similarity=0.712 Sum_probs=227.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCC---ce
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS---CS 205 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~---~~ 205 (478)
++|++.+.||.|+||.||++.+..+++.||||++............+.+|+.+++.+ +|+||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999999876543333445677899999999 56999999998865321 23
Q ss_pred EEEEEeeccCCchhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-CCcEEEeecccccc
Q 011763 206 IYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANF 280 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~ 280 (478)
.|+||||+++++...+... ...+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 7999999998776655432 346899999999999999999999999999999999999998 88999999999875
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.++...|...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 43221 11223356888999999876566899999999999999999999999999999999999888888877766432
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
......... .......+....+.+++++.+||.+||..||.+||++.++|.||||+
T Consensus 240 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEF-PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhc-CcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 211000000 00011122333457899999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=363.71 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=208.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhcCCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREIL-ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||+||++++..+++.||+|++..... .......+..|.. +++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 469999999999999999999999999975432 1222334445554 5678899999999998877 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccccc
Confidence 987776666666689999999999999999999999999999999999999999999999999987533221 2233456
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (323)
T cd05575 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL----------------------- 213 (323)
T ss_pred CChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 8999999999876 6789999999999999999999999998877776666543110
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCH----HHHHhCcccCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKPY 421 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta----~e~L~hp~f~~~~~ 421 (478)
...+.++..+.+||.+||+.||.+||++ .++++||||....+
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 214 ------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 0113568899999999999999999997 69999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=363.81 Aligned_cols=253 Identities=23% Similarity=0.409 Sum_probs=205.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||.||++++..+++.||+|+++.... .......+.+|+.++..+ +||||++++++|.. ...+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 468999999999999999999999999986543 233456677899999998 79999999999977 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccccc
Confidence 987666555555689999999999999999999999999999999999999999999999999986432211 2233457
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHH-HHHHcCCCCchhhccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--------VEQLHK-IFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~--------~~~~~~-i~~~~g~~~~~~~~~~~~~~ 364 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+.+.+ +....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 221 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------------- 221 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC---------------
Confidence 8999999999886 6789999999999999999999999963211 111111 11100
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC------HHHHHhCcccCCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t------a~e~L~hp~f~~~~~ 421 (478)
......++.++.+||.+||+.||.+|++ +.++++||||....+
T Consensus 222 --------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 222 --------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred --------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 0001256788999999999999999987 789999999987544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=351.61 Aligned_cols=284 Identities=34% Similarity=0.618 Sum_probs=228.5
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++++.||.|+||.||+|.+..+++.||+|++..........+.+.+|+++++.++||||+++++++.. ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 37999999999999999999998899999999987554333445667789999999999999999999976 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||++++++..+......+++..++.++.||+.||.|||+.+|+|+||+|+||++++++.++|+|||++....... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 9999998887776555568999999999999999999999999999999999999999999999999987654332 223
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC--ccc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH--ATL 367 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~--~~~ 367 (478)
....++..|+|||++.+...++.++|||||||++|+|++|++||......+....+....+......-....... ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345678899999998765667889999999999999999999999888888887777766554332111100000 000
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
..+.......+...++.++..+.+||.+||..||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 1111112223334456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=365.81 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=211.8
Q ss_pred eeeeeecCceEEEEEEE---CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEe
Q 011763 135 LEKIGQGTYSSVFRARD---LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~---~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e 211 (478)
++.||+|+||.||++++ ..+++.||+|++............+.+|+.+|++++||||+++++++.. ...+|+|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEc
Confidence 36799999999999986 3578999999998654433444556789999999999999999999887 678999999
Q ss_pred eccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccc
Q 011763 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (478)
Q Consensus 212 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 291 (478)
|++++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 99986665555555679999999999999999999999999999999999999999999999999987654321 22334
Q ss_pred cccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCC
Q 011763 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371 (478)
Q Consensus 292 ~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 371 (478)
..+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~------------------- 217 (318)
T cd05582 158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM------------------- 217 (318)
T ss_pred ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence 578999999999876 667899999999999999999999999888777776664321110
Q ss_pred CCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 372 ~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
...+++.+.+||++||+.||.+||+ +.+++.||||....+
T Consensus 218 ----------p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 218 ----------PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred ----------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 1246888999999999999999999 788999999987544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=360.40 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=214.7
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~l 208 (478)
+|++.+.||+|+||+||+|++..+++.||+|++..+.. .....+.+..|+.++..+. |++|+++++++.. ...+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 48889999999999999999999999999999976432 2334455677899998885 6778889888877 567999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 99999987776666666679999999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+.......
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~---------------- 220 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY---------------- 220 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 234568999999999876 678999999999999999999999999988777777665421111
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
...++.++.+||.+||+.||.+|++ ..++++||||....+
T Consensus 221 -------------p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 221 -------------PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred -------------CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 1246788999999999999999997 579999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=353.37 Aligned_cols=288 Identities=43% Similarity=0.720 Sum_probs=227.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL------ 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 202 (478)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 56899999999999999999999999999999998755433333345567999999999999999999876532
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
....|+||||+.+++...+......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 24579999999988777776666679999999999999999999999999999999999999999999999999997554
Q ss_pred CCCC---CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 283 TGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 283 ~~~~---~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
.... .......++..|+|||++.+...++.++||||||+++|+|++|++||.+.+....+..+....+..+...|+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3221 1122345688899999887655678899999999999999999999999988888888888888888776654
Q ss_pred CCCCC-ccccCCCCCCCccchhcc--cCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 360 SKLPH-ATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 360 ~~~~~-~~~~~~~~~~~~~l~~~~--~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
..... .................. ...+..+.+||.+||..||.+|||++++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 32111 000000011100111111 1235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=349.00 Aligned_cols=284 Identities=37% Similarity=0.626 Sum_probs=222.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|.+++.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 46899999999999999999999999999999998755322 223345689999999999999999999876 668999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.++++..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++...... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QT 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CC
Confidence 99999988877766555578899999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHcCCCCchhhccCCC-CCcc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKL-PHAT 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~ 366 (478)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.... ..+.+.++...++.|....|..... +...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2334568899999998765567889999999999999999999997654 4466777777788777665543221 1100
Q ss_pred ccCCCCCCCccchhccc--CCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 367 LFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~--~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
...........+...+. ..+..+.+||.+||..||.+|||+.|+|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000001111222222 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=365.27 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=231.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|..++.+|+|+||.+++++++..++.|++|+++.........+...+|+.+++++.|||||.+.+.|... +..+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEE
Confidence 5689999999999999999999999999999999999887777777788999999999999999999999873 455999
Q ss_pred EEeeccCCchhhcc-CC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLS-CP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||+||+|+.+...+ .. +..|+++.+..|+.||+.||.|||++.|+|||||+.||+++.++.|||.|||+|+..+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 99999987665543 33 3579999999999999999999999999999999999999999999999999999887653
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
....+.+||+.||.||++.+ .+|+.++|||||||++|||++-+++|.+.+-...+.+|++.+..|-+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------ 227 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------ 227 (426)
T ss_pred hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------------
Confidence 35567899999999999887 89999999999999999999999999999999999999887644422
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
...+.+++.||+.||..+|..||++.++|.+|.+.
T Consensus 228 ----------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 228 ----------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ----------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 25688999999999999999999999999999876
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=367.99 Aligned_cols=277 Identities=25% Similarity=0.342 Sum_probs=210.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
...|.+.+.||+|+||.||++.+..+++.||||.... ..+.+|+++|++|+|+|||++++++.. ....||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 4579999999999999999999999999999996432 224579999999999999999999877 677899
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC-
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ- 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~- 287 (478)
|||++.+++...+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9999998888777665567999999999999999999999999999999999999999999999999999765432211
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCC------ChHHHHHHHHHHcCCCCchhhcc-
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-QGR------TEVEQLHKIFKLCGSPPDDYWKK- 359 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf-~~~------~~~~~~~~i~~~~g~~~~~~~~~- 359 (478)
......+|+.|+|||++.+ ..++.++|||||||+||||++|..++ ... ....++.+++.........+-..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1223568999999999987 67899999999999999999987554 322 12344555554433322111000
Q ss_pred -------CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 360 -------SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 360 -------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..........+ .+.......+..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRP--AYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCC--ccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00000000000 0000001112356778999999999999999999999999999975
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=349.28 Aligned_cols=281 Identities=42% Similarity=0.765 Sum_probs=228.3
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEe
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e 211 (478)
|++++.||.|++|.||++.+..++..||+|++..+.........+.+|+.+++.++||||+++++++.+ ....|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 678899999999999999999999999999998665444444567789999999999999999999877 678999999
Q ss_pred eccCCchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc
Q 011763 212 YMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (478)
Q Consensus 212 ~~~~~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 290 (478)
|+++.+...+.... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cccC
Confidence 99876655544332 368999999999999999999999999999999999999999999999999997543321 1122
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC-CCccccC
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFK 369 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~~ 369 (478)
...++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+.++++..+.+....|..... +......
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 335588899999887655678999999999999999999999999998888888888888888777654321 1111100
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
+. .....+....+.++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PK-WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cc-ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00 01112233346788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=361.83 Aligned_cols=266 Identities=23% Similarity=0.335 Sum_probs=214.3
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|+++++||+|+||+||++++..+++.||+|++..... .......+.+|+.++..++|+||+++++.+.+ ...+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 379999999999999999999999999999999864321 22334457789999999999999999998877 678999
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||+.++.+..+. .....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 99999876555444 43567899999999999999999999999999999999999999999999999998754333222
Q ss_pred CccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 288 PLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.....++|+.|+|||++.. ...++.++|||||||++|||++|+.||...+..+.+.++.......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---------- 228 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc----------
Confidence 2334578999999999862 34688999999999999999999999998887777766643211000
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCC--ccCHHHHHhCcccCCCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 421 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~--R~ta~e~L~hp~f~~~~~ 421 (478)
+......++.++++||.+||..++.+ |+++.++++||||....|
T Consensus 229 --------------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 229 --------------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred --------------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 00112357899999999999766555 689999999999987544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=361.66 Aligned_cols=253 Identities=24% Similarity=0.428 Sum_probs=204.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||+||++++..+++.||+|++..... .......+.+|+.++.++ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 469999999999999999999999999986532 234455677899988877 89999999999987 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+.........+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++...... .......
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccccc
Confidence 987776665556689999999999999999999999999999999999999999999999999987532211 2223457
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHH-HHHHHHcCCCCchhhccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT--------EVEQL-HKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~--------~~~~~-~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+.+ ..+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------------- 221 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------------- 221 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------------
Confidence 8999999999886 678999999999999999999999995311 11111 1111100
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC------HHHHHhCcccCCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t------a~e~L~hp~f~~~~~ 421 (478)
......++..+.+||.+||+.||.+|++ +.++++||||....|
T Consensus 222 --------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 222 --------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred --------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 0011356788999999999999999998 589999999987544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=342.15 Aligned_cols=266 Identities=26% Similarity=0.372 Sum_probs=222.7
Q ss_pred eeee-eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEE
Q 011763 132 FEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 132 y~~~-~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
|++. +.||+|+|+.|--|....++..||||++.+. ......++.+|++++..+ .|+||++|+++|++ +..+|||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLV 154 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLV 154 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEE
Confidence 4433 6799999999999999999999999999866 345667888999999999 69999999999988 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC---cEEEeecccccccC----
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSN---- 282 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~DFG~a~~~~---- 282 (478)
||-|.|+.+...+.....|++.++..++++|+.||+|||.+||.||||||+|||..+.+ -||||||.+..-..
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999977666666777899999999999999999999999999999999999998775 48999999974322
Q ss_pred --CCCCCCccccccCCcccCccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---------------hHHH
Q 011763 283 --TGHRQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------------EVEQ 341 (478)
Q Consensus 283 --~~~~~~~~~~~~t~~y~APE~l~----~~~~~~~~~DiwslG~il~elltG~~pf~~~~---------------~~~~ 341 (478)
......+.+.+|+..|||||+.. ....|+.++|.||||+|||.||+|.+||.+.. ....
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 12223345567888999999863 23578999999999999999999999998753 2345
Q ss_pred HHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 342 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
++.|.+.....|+..| .+++.+++|||..+|..|+.+|.++.++|+|||++....
T Consensus 315 FesIQEGkYeFPdkdW-------------------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDW-------------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHhccCCcCChhhh-------------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 6666666666666555 589999999999999999999999999999999987554
Q ss_pred CCCCC
Q 011763 422 ACDLS 426 (478)
Q Consensus 422 ~~~~~ 426 (478)
.+..+
T Consensus 370 ekalp 374 (463)
T KOG0607|consen 370 EKALP 374 (463)
T ss_pred hccCC
Confidence 44433
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=347.55 Aligned_cols=260 Identities=30% Similarity=0.474 Sum_probs=212.5
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEe
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e 211 (478)
|++.+.||+|+||+||++++..+++.||+|++..............+|+.++++++||||+++++++.. ....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 789999999999999999999999999999998765444444445569999999999999999999988 678999999
Q ss_pred eccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccc
Q 011763 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (478)
Q Consensus 212 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 291 (478)
|+.++.+..+......+++..+..++.||+.||.+||+++|+|+||||+||+++.++.++|+|||.+.... ........
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~ 157 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNP 157 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 99995555444455678999999999999999999999999999999999999999999999999997542 12233445
Q ss_pred cccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCC
Q 011763 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371 (478)
Q Consensus 292 ~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 371 (478)
..++..|+|||++.....++.++||||||+++|+|++|..||......+....+...........+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 224 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ------------- 224 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-------------
Confidence 6779999999998734778999999999999999999999999885444444444333222111100
Q ss_pred CCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 372 ~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....+..+.+||.+||+.||++|||+.++++||||
T Consensus 225 ---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 001234789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=358.06 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=207.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||+||+|++..+++.||||+++.... ..........|..++..+ +||||+++++++.+ ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 469999999999999999999999999976432 122334556688888764 99999999999987 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 987666665555678999999999999999999999999999999999999999999999999987532211 2223456
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... +.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~-------------------- 214 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PC-------------------- 214 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CC--------------------
Confidence 8999999999876 678999999999999999999999999887766665543211 00
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCHH-HHHhCcccCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASEYFSTKPY 421 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~-e~L~hp~f~~~~~ 421 (478)
....++.++.+||.+||+.||.+|+++. +++.||||....+
T Consensus 215 -------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 215 -------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred -------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 0013677899999999999999999996 8999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=361.53 Aligned_cols=267 Identities=24% Similarity=0.336 Sum_probs=215.5
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++++.||+|+||+||++++..+++.||+|++..... .......+.+|+.++..++|+||+++++++.. ....||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999875321 23334557789999999999999999999877 678999
Q ss_pred EEeeccCCchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999998866555443 3557899999999999999999999999999999999999999999999999999765443222
Q ss_pred CccccccCCcccCcccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 288 PLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~----~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
......+|+.|+|||++.+. ..++.++|||||||+||+|++|+.||...+..+.+.++......++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---------- 228 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc----------
Confidence 22335689999999988642 3578899999999999999999999998887777666643211100
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCC--ccCHHHHHhCcccCCCCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPYA 422 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~--R~ta~e~L~hp~f~~~~~~ 422 (478)
+...+..+++++++||.+||..++.+ |++++++++||||....|.
T Consensus 229 --------------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 229 --------------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred --------------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 01112357889999999999976655 5699999999999875543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=360.25 Aligned_cols=292 Identities=32% Similarity=0.556 Sum_probs=235.1
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec--CCceEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCSIY 207 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~~~ 207 (478)
++|++.+.||.|+||.||++.+..+++.||+|++............+.+|+.+|+.++||||+++++++... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 589999999999999999999999999999999976543344556677899999999999999999988642 245789
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~- 286 (478)
+||||+.+++...+.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 85 lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999998766655543 44699999999999999999999999999999999999999999999999999975533221
Q ss_pred --CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 287 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 287 --~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.......++..|+|||++.+...++.++|||||||++|+|++|++||...+...++..+...+|.++...+.......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 112234678899999998764568899999999999999999999999999889999999999999877654322111
Q ss_pred ccc--cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 365 ATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 365 ~~~--~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
... ..........+...++.++.++.+||.+||+.||++|||+.++|.||||...+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 000 0001111112233446789999999999999999999999999999999875544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=357.50 Aligned_cols=280 Identities=25% Similarity=0.367 Sum_probs=214.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.++||.|+||.||++.+..++..+|+|++.... .......+.+|+++|+.++|+||++++++|.. ...+||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEE
Confidence 568999999999999999999999999999999987653 34455678899999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||+.++.+..+......+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999999877666655556789999999999999999999975 7999999999999999999999999998755322
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC---
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH--- 364 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~--- 364 (478)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+... + ++.+....+.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL-M---FGCPVEGDPAESETSPRPR 232 (333)
T ss_pred ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH-H---hcCcccCCccccccCcccC
Confidence 1233467899999999876 668999999999999999999999998765433322 1 1111111110000000
Q ss_pred --ccc---cCC-CCCCCc-------cchh-----cccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 365 --ATL---FKP-QQPYDS-------SLRE-----TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 365 --~~~---~~~-~~~~~~-------~l~~-----~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
... ..+ ..+... .+.. ....++.++++||.+||++||++|||+.|+|.||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 000 000000 0000 001356789999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=355.51 Aligned_cols=290 Identities=34% Similarity=0.554 Sum_probs=229.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC---Cce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~ 205 (478)
.++|++.+.||+|+||.||++++..+++.||+|++.... .......+.+|+.+++.++|+||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 468999999999999999999999999999999986432 2234456778999999999999999999875421 246
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
.|+|+||+.+.+...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 899999999876655533 368999999999999999999999999999999999999999999999999987654321
Q ss_pred C--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 286 R--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 286 ~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. .......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+...++.++.+.+......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 11223467899999998766567899999999999999999999999998888888888888888776655432211
Q ss_pred CccccCC--CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 364 HATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 364 ~~~~~~~--~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
....+.. .......+....+.+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 1100000 000111122334567889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=355.52 Aligned_cols=296 Identities=40% Similarity=0.728 Sum_probs=236.0
Q ss_pred ccceee-eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHH------------HHHHHHHHHHHHhcCCCCeeeec
Q 011763 129 ADAFEK-LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES------------VRFMAREILILRRLDHPNIIKLE 195 (478)
Q Consensus 129 ~~~y~~-~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~------------~~~~~~E~~~l~~l~h~nIv~l~ 195 (478)
.++|.. .+.||.|+||+||++.+..+++.||||++......... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 346765 47799999999999999999999999998754322100 12466899999999999999999
Q ss_pred ceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeec
Q 011763 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (478)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF 275 (478)
+++.. ....|+||||+.+++...+. ....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+||
T Consensus 87 ~~~~~--~~~~~lv~e~~~~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVE--GDFINLVMDIMASDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEec--CCcEEEEEeccccCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99877 67899999999987666554 4456899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-------------CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 011763 276 GLANFSNTG-------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 342 (478)
Q Consensus 276 G~a~~~~~~-------------~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~ 342 (478)
|++...... .........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998755410 1111223345788999999877566799999999999999999999999999999999
Q ss_pred HHHHHHcCCCCchhhccCC-CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 343 HKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 343 ~~i~~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
..++..++.++...|.... .+....+. ......+...+...+..+.+||.+||..||++|||++++|.||||+..+.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFT--PRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccC--cCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 9999999988877665432 11111111 11112233445567889999999999999999999999999999998887
Q ss_pred CCCCCCCC
Q 011763 422 ACDLSSLP 429 (478)
Q Consensus 422 ~~~~~~~p 429 (478)
++.+...|
T Consensus 322 ~~~~~~~~ 329 (335)
T PTZ00024 322 PCDPSQLP 329 (335)
T ss_pred CCCcccCC
Confidence 76655443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=351.43 Aligned_cols=280 Identities=26% Similarity=0.447 Sum_probs=224.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-C-C----CeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-H-P----NIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----nIv~l~~~~~~~~ 202 (478)
.++|+++..||+|.||.|-.|++..++..||||+++.- ....+...-|+++|+++. + | -+|++.++|.-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-- 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-- 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--
Confidence 56899999999999999999999999999999999732 233344556999999993 2 2 36788888877
Q ss_pred CceEEEEEeeccCCchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec---------------
Q 011763 203 SCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--------------- 266 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~--------------- 266 (478)
.+++|||+|.++-++.+.+.. .-.+++...++.+.+||+.+++|||+.+++|.||||+|||+.+
T Consensus 163 rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 678999999999888777765 3457999999999999999999999999999999999999843
Q ss_pred -----CCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 011763 267 -----EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341 (478)
Q Consensus 267 -----~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~ 341 (478)
+-.|+|+|||.|+.....+ ...+.|..|+|||++++ -.|+.++||||+||||+||.+|..+|++.++.+.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 2258999999998776543 55677999999999998 8899999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCchhhccC-----------CCCCccccCC---CCCCCccchhcccC---CchhHHHHHHHhcCCCCCCc
Q 011763 342 LHKIFKLCGSPPDDYWKKS-----------KLPHATLFKP---QQPYDSSLRETFKD---LPTTAVNLIETLLSVEPYKR 404 (478)
Q Consensus 342 ~~~i~~~~g~~~~~~~~~~-----------~~~~~~~~~~---~~~~~~~l~~~~~~---~~~~l~~Li~~mL~~dP~~R 404 (478)
++.|...+|++|.....+. .|++...... .......+...... ....+.|||++||.+||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 9999999998887765443 1111111000 00001112222211 22358999999999999999
Q ss_pred cCHHHHHhCcccCC
Q 011763 405 ATASAALASEYFST 418 (478)
Q Consensus 405 ~ta~e~L~hp~f~~ 418 (478)
+|+.|+|.||||+.
T Consensus 398 iTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 398 ITLREALSHPFFAR 411 (415)
T ss_pred ccHHHHhcCHHhhc
Confidence 99999999999975
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=363.95 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=205.4
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc---CCCCeeeecceeeecCCceEEEEEeec
Q 011763 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL---DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 138 LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
||+|+||+||+|++..+++.||+|++..... ..........|..++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 6999999999999999999999999975432 122333445677777665 79999999998877 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCcc
Confidence 987666555566689999999999999999999999999999999999999999999999999987543221 2234567
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.......+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------- 217 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-------------------- 217 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC--------------------
Confidence 899999999987655689999999999999999999999998877666555532110000
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCcc----CHHHHHhCcccCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRA----TASAALASEYFSTKP 420 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~----ta~e~L~hp~f~~~~ 420 (478)
...+++++.+||.+||+.||.+|| ++.++++||||....
T Consensus 218 --------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 218 --------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred --------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 013678899999999999999998 799999999998644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=359.10 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=206.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHH-HHHHhcCCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREI-LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||+||+|++..+++.||+|++...... ......+..|. .+++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 4699999999999999999999999999754321 12223334444 45678899999999999877 67799999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccccc
Confidence 987776666666678999999999999999999999999999999999999999999999999987543211 2234457
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (325)
T cd05602 158 GTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----------------------- 213 (325)
T ss_pred CCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-----------------------
Confidence 8999999999886 6789999999999999999999999998887777666643110
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCHH----HHHhCcccCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS----AALASEYFSTKP 420 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~----e~L~hp~f~~~~ 420 (478)
...+.++..+.+||.+||+.||.+|+++. ++++|+||....
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 214 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 01136788999999999999999999875 899999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=341.40 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=211.5
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
++|++.+.||+|++|.||++.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 4699999999999999999999999999999998754332 2234567889999999999999999999987 5689
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|+||||++++.+..+......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999876665555555789999999999999999999999999999999999999999999999999875543211
Q ss_pred CCc--cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 287 QPL--TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 287 ~~~--~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
... ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+...++......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------- 225 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN------------- 225 (263)
T ss_pred ccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-------------
Confidence 111 23456788999999887 56899999999999999999999999876655554443221100
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 226 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 226 --------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 01113578889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.23 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=207.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhcCCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREIL-ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||+||++++..+++.||+|++..... .......+..|.. +++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 468999999999999999999999999975432 2233344455554 5677899999999998877 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccccc
Confidence 987776666666689999999999999999999999999999999999999999999999999987532211 2224457
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+....-
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~----------------------- 213 (325)
T cd05604 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL----------------------- 213 (325)
T ss_pred CChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-----------------------
Confidence 8999999999876 6789999999999999999999999998877766665543100
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCH----HHHHhCcccCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKPY 421 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta----~e~L~hp~f~~~~~ 421 (478)
...+.++..+.++|.+||..||.+||++ .++++||||....+
T Consensus 214 ------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 214 ------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred ------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 0013567889999999999999999976 59999999986443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=386.24 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=215.3
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|++++.||+|+||+||+|++..++..||+|++............+..|+.+|+.|+|||||+++++|.......+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 36789999999999999999999999999999999987766666677888999999999999999999998776567899
Q ss_pred EEEeeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCcEEEecC---------
Q 011763 208 LVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSR-------GVLHRDIKGSNLLVNNE--------- 267 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~-------givHrDlkp~NILl~~~--------- 267 (478)
|||||++++.|..++. ....+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999765544332 235799999999999999999999984 49999999999999642
Q ss_pred --------CcEEEeecccccccCCCCCCCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 011763 268 --------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTE 338 (478)
Q Consensus 268 --------~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~ 338 (478)
+.+||+|||++...... .......+|+.|+|||++.+. ..++.++||||||||||+|++|..||...+.
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 34899999999765432 222345789999999998642 4588999999999999999999999987766
Q ss_pred HHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 339 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...+...+...... .....+.++.+||..||..||.+||++.|+|.||||+.
T Consensus 249 ~~qli~~lk~~p~l----------------------------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 249 FSQLISELKRGPDL----------------------------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHHHHHHHhcCCCC----------------------------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 55544433211000 01246788999999999999999999999999999975
Q ss_pred C
Q 011763 419 K 419 (478)
Q Consensus 419 ~ 419 (478)
.
T Consensus 301 i 301 (1021)
T PTZ00266 301 V 301 (1021)
T ss_pred c
Confidence 4
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=356.11 Aligned_cols=293 Identities=35% Similarity=0.573 Sum_probs=233.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC---Cce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~ 205 (478)
.++|.+++.||+|+||+||++++..+++.||||.+............+.+|+.+++.++|+||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 34799999999999999999999999999999998754333444556778999999999999999999886432 145
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||||+.+++...+. ....+++..+..++.||+.||.|||+++++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMDTDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCCCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 89999999877665554 34579999999999999999999999999999999999999999999999999997654321
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.++...|........
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 2223456788999999887545688999999999999999999999999988888888888888887666532211111
Q ss_pred cccCC--CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 366 TLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 366 ~~~~~--~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
..+.. .......+...++.+++++.+||.+||+.||.+|||+.++|+||||.....+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 00000 00011122334567899999999999999999999999999999998754443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=372.28 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=217.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC-----
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----- 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 203 (478)
.++|++.+.||+|+||+||++++..+++.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 568999999999999999999999999999999998777666667778899999999999999999887753211
Q ss_pred -ceEEEEEeeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccc
Q 011763 204 -CSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (478)
Q Consensus 204 -~~~~lv~e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a 278 (478)
..+++||||++++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 24789999999765544332 2356899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhh
Q 011763 279 NFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 279 ~~~~~~~-~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 357 (478)
+...... .......++|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~------ 263 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD------ 263 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC------
Confidence 7654321 122344578999999999876 67899999999999999999999999988776666655431100
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....+++++.+||.+||+.||.+||++.++|+|||++.
T Consensus 264 ----------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 264 ----------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 011357889999999999999999999999999999864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=339.45 Aligned_cols=256 Identities=25% Similarity=0.334 Sum_probs=212.0
Q ss_pred ccceeee-eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeec--CCc
Q 011763 129 ADAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR--LSC 204 (478)
Q Consensus 129 ~~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~ 204 (478)
+++|.+- ++||-|-.|.|..|.++.+++.+|+|++... ....+|+++.-.. .|||||.++++|... ...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4567766 6799999999999999999999999998522 3456788887666 699999999999643 244
Q ss_pred eEEEEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC---CcEEEeeccccc
Q 011763 205 SIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLAN 279 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a~ 279 (478)
.+.+|||.|+|+.|....+ ....|+|.++..|++||..|+.|||+.+|.||||||+|+|+... ..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 6789999999876655443 33469999999999999999999999999999999999999764 469999999998
Q ss_pred ccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHcCCCCch
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~----~~~~~~i~~~~g~~~~~ 355 (478)
.... ...+.+.+-||.|.|||++-. ..|+..+|+||+||+||.|++|.|||..... ...-.+|.......|.+
T Consensus 213 ~t~~--~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 213 ETQE--PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccCC--CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 7654 244567788999999998764 7799999999999999999999999987653 23445555544455544
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.| ..++++++|+|+.||..+|.+|+|+.++++|||++..
T Consensus 290 EW-------------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 290 EW-------------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hH-------------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 44 5789999999999999999999999999999999864
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=348.07 Aligned_cols=261 Identities=23% Similarity=0.399 Sum_probs=209.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.|++.+.||+|+||+||++.+..+++.||+|.+...... ......+.+|+.+++.++|+||+++++.+.. ...+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 378899999999999999999999999999998755432 2334556789999999999999999998877 5689999
Q ss_pred EeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 210 FEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 210 ~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
|||++++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999865544432 23468999999999999999999999999999999999999999999999999987554322
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...................+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~------------- 222 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE------------- 222 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh-------------
Confidence 2234578999999999876 66899999999999999999999999875432211111111100000
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
.....+++++.+||.+||+.||.+||| +.|+++||||+...+
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 223 ------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred ------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 011357888999999999999999999 999999999986433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=356.41 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=205.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHH-HHHHhcCCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREI-LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||+||+|++..+++.||+|++..... .......+..|+ .+++.++||||+++++++.+ ...+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 469999999999999999999999999975432 122233444454 46788999999999998877 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccccc
Confidence 987766655556678999999999999999999999999999999999999999999999999987532221 2233457
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+... +.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~~-------------------- 213 (321)
T cd05603 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---PL-------------------- 213 (321)
T ss_pred CCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---CC--------------------
Confidence 8999999999876 67899999999999999999999999988766665555321 00
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCH----HHHHhCcccCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKPY 421 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta----~e~L~hp~f~~~~~ 421 (478)
......+..+.++|.+||+.||.+|+++ .++++|+||....+
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 214 ------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 0012467789999999999999999875 59999999986443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=356.31 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=206.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||+||++++..+++.||+|++..... .......+.+|+.++.++ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 469999999999999999999999999986543 234456677899999888 69999999999877 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceeccc
Confidence 987776655555679999999999999999999999999999999999999999999999999987532211 2234467
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
+|+.|+|||++.+ ..++.++|||||||+||+|++|..||.... ..+.+.++... .+.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~-------------- 220 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KPI-------------- 220 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CCC--------------
Confidence 8999999999876 678999999999999999999999996432 12222222110 000
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC------HHHHHhCcccCCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPYA 422 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t------a~e~L~hp~f~~~~~~ 422 (478)
.....++..+.+||.+||+.||.+|++ ..++++||||+...|.
T Consensus 221 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 221 ------------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred ------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 011256788999999999999999998 5799999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.82 Aligned_cols=289 Identities=39% Similarity=0.629 Sum_probs=231.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++++ +||||+++++++........|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4689999999999999999999988999999999865433344455667899999999 999999999998765456789
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~- 286 (478)
+||||+++++...+... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 86 lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99999998665555433 788999999999999999999999999999999999999999999999999976543221
Q ss_pred ---CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 287 ---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 287 ---~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.......+++.|+|||++.+...++.++|||||||++|+|++|++||.+....+....+....+.++...|.....+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 12233467889999998876567889999999999999999999999999888888888888887776554432111
Q ss_pred Cccc-c-CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 364 HATL-F-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 364 ~~~~-~-~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.... . .........+...++.++.++.+||.+||+.||++|||+.++|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000 0 000111112233445688999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=348.80 Aligned_cols=267 Identities=29% Similarity=0.393 Sum_probs=218.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++.+.||+|+||+||+|.+..+++.||+|.+....... .....+.+|+++|+.++|+||+++++.+.. ....|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 37999999999999999999999999999999998665432 355678889999999999999999999877 678999
Q ss_pred EEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||+.++.+..+.. ....+++..++.++.||+.||.|||+.|++|+||||+||+|+.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999998865555443 235799999999999999999999999999999999999999999999999999865432111
Q ss_pred ----------------------------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 011763 287 ----------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 338 (478)
Q Consensus 287 ----------------------------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~ 338 (478)
.......+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 01123467889999999876 6689999999999999999999999998887
Q ss_pred HHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC----HHHHHhCc
Q 011763 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT----ASAALASE 414 (478)
Q Consensus 339 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t----a~e~L~hp 414 (478)
...+..+...-...+ ....++..+.+||.+||..||++||| +.++|.||
T Consensus 238 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 238 DETFSNILKKEVTFP---------------------------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHhcCCccCC---------------------------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 766665542110000 01136889999999999999999999 99999999
Q ss_pred ccCCCCCCCCCC
Q 011763 415 YFSTKPYACDLS 426 (478)
Q Consensus 415 ~f~~~~~~~~~~ 426 (478)
||+...|+....
T Consensus 291 ~~~~~~~~~~~~ 302 (316)
T cd05574 291 FFRGVNWALIRH 302 (316)
T ss_pred hhhcCChhhccc
Confidence 999877655433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=350.38 Aligned_cols=286 Identities=37% Similarity=0.658 Sum_probs=223.6
Q ss_pred ceeeeeeeeecCceEEEEEEECC--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLD--TGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~--~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
+|++.++||+|+||.||+|.+.. +++.||+|++..... .......+.+|+.++..++||||+++++++.+.....+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 899999999986431 122235567899999999999999999999885557899
Q ss_pred EEEeeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec----CCcEEEeeccccc
Q 011763 208 LVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN----EGVLKLADFGLAN 279 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~----~~~vkl~DFG~a~ 279 (478)
+||||+++++...+.. ....+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999999877665432 2236899999999999999999999999999999999999999 8999999999997
Q ss_pred ccCCCCC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHH
Q 011763 280 FSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV---------EQLHKIFKL 348 (478)
Q Consensus 280 ~~~~~~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~---------~~~~~i~~~ 348 (478)
....... .......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.... ..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6543221 11233466889999999877567899999999999999999999999876532 467777888
Q ss_pred cCCCCchhhccCC-CCCccc---cCCCCCCC-ccchhcc---cCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 349 CGSPPDDYWKKSK-LPHATL---FKPQQPYD-SSLRETF---KDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 349 ~g~~~~~~~~~~~-~~~~~~---~~~~~~~~-~~l~~~~---~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
++.+....|.... .+.... ......+. ..+...+ ...+.++.++|.+||..||++|||+.|+++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 8877776664321 111110 00011111 1222222 2678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=352.02 Aligned_cols=287 Identities=36% Similarity=0.606 Sum_probs=229.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC----c
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----C 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~ 204 (478)
.++|++++.||+|+||.||++.+..++..||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 568999999999999999999999999999999986544334445567789999999999999999998865321 2
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+||||+.+.+...+. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 468999999665544443 246899999999999999999999999999999999999999999999999999755432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||...+.......++...+.++..++.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 2234568899999998764568899999999999999999999999988888888888877777766655433221
Q ss_pred ccccCC--CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 365 ATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~--~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
...+.. .......+....+.++..+.++|.+||+.||.+|||+.++|.||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 111100 001111233344678889999999999999999999999999999987533
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=343.75 Aligned_cols=282 Identities=45% Similarity=0.776 Sum_probs=233.8
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEe
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e 211 (478)
|++.+.||.|++|.||++.+..+++.+++|++............+.+|+.+|++++|+||+++++++.. ....++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEe
Confidence 678899999999999999999899999999998665554556677889999999999999999999877 577999999
Q ss_pred eccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccc
Q 011763 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (478)
Q Consensus 212 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 291 (478)
|+++++...+......+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 99998877776666689999999999999999999999999999999999999999999999999997665432 22233
Q ss_pred cccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC-CCccccCC
Q 011763 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKP 370 (478)
Q Consensus 292 ~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~~~ 370 (478)
..++..|+|||.+.+...++.++|||||||++|+|++|+.||...+..+.+..+...++.+....|..... ........
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 45688899999987754789999999999999999999999999999999999988888887776655322 00000111
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.......+....+.++.++.+||.+||..||.+||++.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1111112233445678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=367.65 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=213.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDT-GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~-~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+..+ .......+.+|+.+|..++|||||++++++.. ...+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEE
Confidence 44599999999999999999998777 788999987544 23444567789999999999999999999987 67899
Q ss_pred EEEeeccCCchhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 208 LVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 208 lv~e~~~~~ll~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
|||||++++.+.... ....++++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999986654322 2345789999999999999999999999999999999999999999999999999986543
Q ss_pred CCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 284 GHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 284 ~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
... ......++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---------- 290 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---------- 290 (478)
T ss_pred ccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence 221 12344568999999999876 678999999999999999999999999888777666654321100
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
....++.++.+||.+||..||++||++.++|.|+|++.
T Consensus 291 ------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 291 ------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 01246788999999999999999999999999999863
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=353.00 Aligned_cols=290 Identities=37% Similarity=0.585 Sum_probs=236.4
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC---CceEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSIY 207 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~~~ 207 (478)
+|++.+.||.|+||.||+|++..+++.||||++..........+.+.+|+.+++.++|+||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999999888999999998765433455667888999999999999999999987632 23689
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~- 286 (478)
+||||+++++...+.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999999766555544 34899999999999999999999999999999999999999999999999999986654321
Q ss_pred -CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 -~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...|........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 1233456788999999998744789999999999999999999999999999999999999999888776653222111
Q ss_pred cccC--CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 366 TLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 366 ~~~~--~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
..+. ........+...++.++..+.+||.+||++||.+|||+.++|.||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 1110 0111122334445678999999999999999999999999999999986433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=344.17 Aligned_cols=261 Identities=23% Similarity=0.392 Sum_probs=213.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.|+..+.||+|+||+||++.+..+++.||+|++....... .....+.+|+.+|+.++|+||+++++.+.. +...|+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEE
Confidence 3788899999999999999999999999999997654322 234456789999999999999999988877 6789999
Q ss_pred EeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 210 FEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 210 ~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
|||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 99999865544332 2346999999999999999999999999999999999999999999999999998654332 2
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~------------- 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE------------- 222 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc-------------
Confidence 2234578999999999876 67899999999999999999999999987765554444332211111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
.....++.++.+||..||..||.+||+ +.+++.|+||+..++
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 223 ------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred ------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 011357788999999999999999999 899999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=354.39 Aligned_cols=290 Identities=36% Similarity=0.618 Sum_probs=235.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC----c
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----C 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~ 204 (478)
.++|++.+.||.|+||.||+|++..+++.||+|++............+.+|+.+++.++|+||+++++++..... .
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 568999999999999999999999999999999987554344455667789999999999999999988765321 3
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
..|+|+||+++++...+.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 4899999997766555543 36899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+++.++.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 2344668899999998764567899999999999999999999999999888999999988888887776544322
Q ss_pred ccccCCCC--CCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCC
Q 011763 365 ATLFKPQQ--PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424 (478)
Q Consensus 365 ~~~~~~~~--~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~ 424 (478)
...+.... .....+...+..+++.+.+||.+||+.||.+|||+.++|.||||.....+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence 21111100 1111223334567899999999999999999999999999999987655443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.43 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=201.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCC
Q 011763 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (478)
Q Consensus 138 LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (478)
||+|+||+||++++..+++.||+|++....... .....+..|+++++.++||||+++++++.. ..++|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 689999999999999999999999997543322 223345569999999999999999998876 67899999999986
Q ss_pred chhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcccccc
Q 011763 217 ITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (478)
Q Consensus 217 ll~~~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 294 (478)
.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ......+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCC
Confidence 654433 233458899999999999999999999999999999999999999999999999987654322 2234567
Q ss_pred CCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCC
Q 011763 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (478)
Q Consensus 295 t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 374 (478)
++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....-..
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 213 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED---------------------- 213 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc----------------------
Confidence 899999999876 558999999999999999999999997654322212221110000
Q ss_pred CccchhcccCCchhHHHHHHHhcCCCCCCccCH----HHHHhCcccCCCCCC
Q 011763 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKPYA 422 (478)
Q Consensus 375 ~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta----~e~L~hp~f~~~~~~ 422 (478)
.+......++.++.+||.+||+.||.+||++ .+++.||||+...++
T Consensus 214 --~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 214 --EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred --ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 0000113578899999999999999999999 778899999886553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=351.01 Aligned_cols=286 Identities=35% Similarity=0.590 Sum_probs=228.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
.++|.+.+.||+|+||.||+|++..+++.||+|++............+.+|+.+++.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 35899999999999999999999989999999998764433333456778999999999999999999886432 13
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+|+||+...+.... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred eEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 56999999986544332 236899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+.+.+++......
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 171 ----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred ----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 2334668899999998765568899999999999999999999999998888889998888888776665443221
Q ss_pred ccccCC--CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 365 ATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~--~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
...+.. .......+...++.++..+.+||.+||+.||.+||++.++|.||||.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 111100 001112233344567889999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=334.43 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=211.3
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
.|++++.||.|++|.||++.+..+++.||+|++..+.......+.+.+|++++++++|+||+++++.+... ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 48999999999999999999999999999999987655555666788899999999999999998877542 45689999
Q ss_pred eeccCCchhhcc-C-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 211 EYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 211 e~~~~~ll~~~~-~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||++++.+.... . ....+++.+++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DM 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Cc
Confidence 999876554433 2 23468999999999999999999999999999999999999999999999999997654322 22
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.... .+
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~~--------------- 220 (257)
T cd08223 159 ASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--LP--------------- 220 (257)
T ss_pred cccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--CC---------------
Confidence 234467889999999876 678899999999999999999999998877655554443311 00
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 221 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 221 -----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0012577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=341.06 Aligned_cols=282 Identities=45% Similarity=0.756 Sum_probs=232.1
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEe
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e 211 (478)
|++.+.||.|+||.||+|++..+++.||+|++..........+.+..|+.+++.++|+||+++++++.. ....++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 677889999999999999999999999999998654334445667789999999999999999999887 578999999
Q ss_pred eccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccc
Q 011763 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (478)
Q Consensus 212 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 291 (478)
|+++++...+......+++..+..++.||+.||.|||++||+|+||+|+||++++++.++|+|||++........ ....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 999876666655445799999999999999999999999999999999999999999999999999976543221 2233
Q ss_pred cccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCC
Q 011763 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371 (478)
Q Consensus 292 ~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 371 (478)
...+..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+.++...++.+.+..|.....-........
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 45578899999987655789999999999999999999999999999999999999999988887765322110000011
Q ss_pred CCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 372 ~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
..........++.++..+.++|++||..||++||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 111122234456678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=352.96 Aligned_cols=266 Identities=28% Similarity=0.474 Sum_probs=215.0
Q ss_pred CcccccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeec
Q 011763 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (478)
Q Consensus 123 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 201 (478)
.++.++...|+++++||.||.+.||++.. .+.+.||+|++.....+.....-+.+|+..|.+| .|.+||+|++|-..
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~- 431 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT- 431 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-
Confidence 45556678899999999999999999985 3456788888877777888888899999999999 69999999998877
Q ss_pred CCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
+.++||||||-+.+|...+.+....++.-.++.|..||+.++.++|++||||.||||.|+|+.. |.+||+|||.|...
T Consensus 432 -d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 432 -DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred -CceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 7899999999999988888776666665689999999999999999999999999999999974 89999999999877
Q ss_pred CCCCCCC-ccccccCCcccCcccccCC----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHc
Q 011763 282 NTGHRQP-LTSRVVTLWYRPPELLLGA----------TDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLC 349 (478)
Q Consensus 282 ~~~~~~~-~~~~~~t~~y~APE~l~~~----------~~~~~~~DiwslG~il~elltG~~pf~~~~-~~~~~~~i~~~~ 349 (478)
..+.... ..+.+||+.||+||.+... -..+.++||||||||||+|+.|++||.... ....+..|.+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~-- 587 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD-- 587 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC--
Confidence 6554322 2356899999999998531 125679999999999999999999998543 2222222211
Q ss_pred CCCCchhhccCCCCCccccCCCCCCCccchhcccCCc--hhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP--TTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 350 g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~--~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
|.. .-.|+.++ .+++++++.||.+||.+|||+.++|+|||+.-.+
T Consensus 588 --P~~------------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 588 --PNH------------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred --CCc------------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 111 11123332 2389999999999999999999999999987533
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=352.05 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=199.2
Q ss_pred cccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeec
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 201 (478)
..++|++.+.||.|+||.||+|.+. .++..||||++.... .......+.+|+.+|..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3578999999999999999999752 345789999987432 334456788999999999 899999999988653
Q ss_pred CCceEEEEEeeccCCchhhccCC---------------------------------------------------------
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCP--------------------------------------------------------- 224 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~--------------------------------------------------------- 224 (478)
...+|+||||++++.+..+...
T Consensus 84 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 84 -NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4568999999998655433221
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-CCccccccCCcc
Q 011763 225 -----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWY 298 (478)
Q Consensus 225 -----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y 298 (478)
..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .......+++.|
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12478889999999999999999999999999999999999999999999999975432211 111223446789
Q ss_pred cCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCcc
Q 011763 299 RPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSS 377 (478)
Q Consensus 299 ~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (478)
+|||++.+ ..++.++|||||||+||||++ |..||.+....+.+...+.. +..+
T Consensus 243 ~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~------------------------ 296 (338)
T cd05102 243 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTRM------------------------ 296 (338)
T ss_pred cCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCCC------------------------
Confidence 99999876 678999999999999999997 99999876544433332221 0000
Q ss_pred chhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 378 LRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 378 l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....+++++.+||.+||..||.+|||+.++++
T Consensus 297 --~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 --RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001256788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=348.23 Aligned_cols=281 Identities=23% Similarity=0.334 Sum_probs=207.3
Q ss_pred eeeeeeec--CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEe
Q 011763 134 KLEKIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (478)
Q Consensus 134 ~~~~LG~G--~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e 211 (478)
+++.||+| +|++||++.+..+++.||+|+++.+.......+.+.+|+.+++.++||||+++++++.. ....|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEe
Confidence 56789999 78999999999999999999998765555566778889999999999999999999987 677999999
Q ss_pred eccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC---
Q 011763 212 YMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--- 286 (478)
Q Consensus 212 ~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--- 286 (478)
|++++.+..+... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9998766555432 34589999999999999999999999999999999999999999999999986543211100
Q ss_pred ---CCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCc--------
Q 011763 287 ---QPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD-------- 354 (478)
Q Consensus 287 ---~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~-------- 354 (478)
.......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.............. +..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchh
Confidence 001122456779999998753 3588999999999999999999999987655443333222 11110
Q ss_pred --hhhccC-------CCCCccccCCCC--CCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 355 --DYWKKS-------KLPHATLFKPQQ--PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 355 --~~~~~~-------~~~~~~~~~~~~--~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
+..... ............ ............+++.+.+||.+||++||++|||+.++|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000000 000000000000 0000111122356788999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=341.10 Aligned_cols=257 Identities=28% Similarity=0.430 Sum_probs=216.5
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++.+.||.|+||.||++.+..+++.||+|++..... .....+.+.+|+++|++++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 379999999999999999999999999999999875432 23445678889999999999999999999877 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+..+......+++..+..++.||+.||.|||++||+|+||+|.||||+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999987666555555568999999999999999999999999999999999999999999999999999765433
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+...++... .++
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--------------- 216 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KVR--------------- 216 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Ccc---------------
Confidence 233467889999998876 56788999999999999999999999887765555555421 110
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~~ 422 (478)
....++..+.++|.+||..||.+|+ ++.++++||||....+.
T Consensus 217 ------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 217 ------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred ------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 0124578899999999999999999 99999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=344.71 Aligned_cols=279 Identities=25% Similarity=0.330 Sum_probs=212.5
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++.+.||+|+||.||++.+..++..||+|.+..+. .......+.+|++++++++||||+++++++.. ...+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 36999999999999999999999999999999987543 34455668889999999999999999999987 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|||++++.+..+......+++..+..++.||+.||.|||+ ++++|+||||+|||++.++.+||+|||++...... .
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 9999987776666555679999999999999999999997 59999999999999999999999999998654322 1
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchh-hccCCCCCccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY-WKKSKLPHATL 367 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~-~~~~~~~~~~~ 367 (478)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.... ..++. ..+... +..........
T Consensus 155 ~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 155 ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFG---RPVSEGEAKESHRPVSGH 229 (308)
T ss_pred cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhc---CccccccccCCcccccCC
Confidence 234567889999998876 5688999999999999999999999987654332 22221 111000 00000000000
Q ss_pred cCCCCC---CCcc---------chhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 368 FKPQQP---YDSS---------LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 368 ~~~~~~---~~~~---------l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..+... .... .......++.++.+||.+||..||++|||+.++|+||||...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000000 0000 000011367789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=366.90 Aligned_cols=286 Identities=23% Similarity=0.301 Sum_probs=206.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCC-cEEEEEEe--------------ec-CCCChHHHHHHHHHHHHHHhcCCCCee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTG-KIVALKKV--------------RF-DNFEPESVRFMAREILILRRLDHPNII 192 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~-~~vAlK~~--------------~~-~~~~~~~~~~~~~E~~~l~~l~h~nIv 192 (478)
.++|++++.||+|+||+||+|..+... ..+++|.+ .+ ..........+.+|+.+|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 458999999999999999998754322 22222211 00 011223445677899999999999999
Q ss_pred eecceeeecCCceEEEEEeeccCCchhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC
Q 011763 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (478)
Q Consensus 193 ~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~ 268 (478)
++++++.. ....|+|++++.+.++..+... ........++.++.||+.||.|||++|||||||||+||||+.++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999987 5678999999988777655432 12234667889999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCC--CChHHHHHHH
Q 011763 269 VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQG--RTEVEQLHKI 345 (478)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~p-f~~--~~~~~~~~~i 345 (478)
.+||+|||++...............+|+.|+|||++.+ ..++.++|||||||+||||++|..+ |.. .....++.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999998765433333344678999999999886 6789999999999999999998754 432 2345566666
Q ss_pred HHHcCCCCchhhcc----CCCCCccccCCCCCCCccchhcc--cCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 346 FKLCGSPPDDYWKK----SKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 346 ~~~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
+..++.+..++... .......... .....+...+ ..++.++.++|.+||++||.+|||+.|+|.||||+..
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEID---HAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcc---cCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 66555443322110 0000000000 0001111111 2467889999999999999999999999999999864
Q ss_pred C
Q 011763 420 P 420 (478)
Q Consensus 420 ~ 420 (478)
.
T Consensus 461 ~ 461 (501)
T PHA03210 461 E 461 (501)
T ss_pred C
Confidence 3
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=332.25 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=213.8
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||+|++|.||++.+..+++.|++|.+............+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 4889999999999999999999999999999998766666667788899999999999999999999877 57899999
Q ss_pred eeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 211 EYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 211 e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||++++.+..+... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NF 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-ch
Confidence 99987655544322 4578999999999999999999999999999999999999999999999999987655432 12
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP---------------- 220 (256)
T ss_pred hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 233467889999999876 568899999999999999999999999888666555543311100
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
....++..+.++|.+||+.+|++||++.++|+|||+
T Consensus 221 ------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 221 ------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 012467889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.67 Aligned_cols=286 Identities=36% Similarity=0.592 Sum_probs=220.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC------
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS------ 203 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 203 (478)
.+|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 589999999999999999999999999999999876543 445667889999999999999999987754322
Q ss_pred ------ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-CCcEEEeecc
Q 011763 204 ------CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFG 276 (478)
Q Consensus 204 ------~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG 276 (478)
...|+||||+++++...+. ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 3579999999976555443 236899999999999999999999999999999999999974 5678999999
Q ss_pred cccccCCCCC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCc
Q 011763 277 LANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354 (478)
Q Consensus 277 ~a~~~~~~~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~ 354 (478)
++........ .......++..|+|||++.....++.++|||||||++|+|++|+.||...+..+....+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9976532211 11122356889999998766567889999999999999999999999988888777777665444333
Q ss_pred hhhccCCCC-CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 355 DYWKKSKLP-HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 355 ~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..+...... ..............+....+.++.++.+||.+||..||.+|||+.++|.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 222111000 00000011112222334456788999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=347.88 Aligned_cols=287 Identities=34% Similarity=0.581 Sum_probs=226.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
.++|++.+.||+|+||.||++.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 47899999999999999999999999999999999765433444566778999999999999999999885421 23
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
..|++++++.+.+...+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~- 172 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 172 (345)
T ss_pred cEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence 5789999886665444432 3589999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
......++..|+|||++.+...++.++|||||||++|+|++|++||...+....+..+....+.++...+.......
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 173 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred ---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 22334668899999988765668899999999999999999999999888888888888888877766654432211
Q ss_pred ccccCC--CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 365 ATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~--~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
...+.. .......+...+...+..+.+||.+||+.||.+|||+.++|.||||++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 000000 000011122223356788999999999999999999999999999987433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=337.46 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=207.1
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++++.||+|+||.||++.+..+++.||+|++..+. .......+.+|+.++.+++||||+++++++.. ....++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEE
Confidence 36899999999999999999999999999999997653 34455678889999999999999999999987 5678999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||++++.+.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ..
T Consensus 78 ~e~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 78 TEFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred EecCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 9999998775442 5789999999999999999999999999999999999999999999999999755432 22
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHcCCCCchhhccCCCCCcc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ---LHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~---~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ..............
T Consensus 151 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------- 218 (279)
T cd06619 151 KTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP----------- 218 (279)
T ss_pred cCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC-----------
Confidence 34577899999999886 6689999999999999999999999975322110 01111111000000
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
......+++++.+||.+||+.||.+||++.++|.||||...
T Consensus 219 ------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 219 ------------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ------------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00012467889999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=341.22 Aligned_cols=270 Identities=26% Similarity=0.371 Sum_probs=218.1
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++++.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+.. ..++|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 379999999999999999999999999999999876543 22344567789999999999999999998876 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC--
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 286 (478)
||||++++.+..+......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999877766665556799999999999999999999999999999999999999999999999999864211100
Q ss_pred ------------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCc
Q 011763 287 ------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354 (478)
Q Consensus 287 ------------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~ 354 (478)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 00112346788999999876 66899999999999999999999999987776666555432111110
Q ss_pred hhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC---HHHHHhCcccCCCCCCCCCCCC
Q 011763 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPYACDLSSL 428 (478)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t---a~e~L~hp~f~~~~~~~~~~~~ 428 (478)
....++.++.+||.+||+.||++||+ +.++|+||||...++......+
T Consensus 238 --------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~ 288 (305)
T cd05609 238 --------------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQK 288 (305)
T ss_pred --------------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcC
Confidence 00247888999999999999999998 8999999999876655433333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=359.34 Aligned_cols=260 Identities=25% Similarity=0.395 Sum_probs=221.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+.++|+..||.|+||.||+|.++.++...|.|+|... ..+..+.+.-||.||..++||+||+|++.|.. .+.++|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~--enkLwi 106 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--ENKLWI 106 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cCceEE
Confidence 34688999999999999999999999999999998644 45667888889999999999999999998877 567999
Q ss_pred EEeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+.|||+|+-.+.+ ..-+..|++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+..... ..+
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q 185 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ 185 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence 9999999765543 44566899999999999999999999999999999999999999999999999999854322 233
Q ss_pred CccccccCCcccCccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 288 PLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
...+++|||.|||||+++ ...+|+.++||||||++|.||..+.||-...+....+.+|... .|+...
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePPTLl------ 256 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTLL------ 256 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCCccc------
Confidence 446789999999999975 3478999999999999999999999999998888888777542 111110
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.....+..+.|||.+||..||..||++.++|+||||++.
T Consensus 257 -----------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 257 -----------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred -----------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 012457789999999999999999999999999999863
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=343.60 Aligned_cols=288 Identities=33% Similarity=0.549 Sum_probs=228.2
Q ss_pred ceeeeeeeeecCceEEEEEEECCC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeee--cCCce
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDT--GKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS--RLSCS 205 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~--~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~--~~~~~ 205 (478)
+|++.+.||.|+||.||++++..+ +..||+|++............+.+|+.+++++ +||||+++++.+.. .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999999887 89999999875433334456677899999999 69999999886542 22356
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+|+++||+++++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~e~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 88999999887666554 34578999999999999999999999999999999999999999999999999997554321
Q ss_pred C---CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 286 R---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 286 ~---~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
. .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..++..++.++...+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 1123346789999999887656789999999999999999999999999999999999999999888766554322
Q ss_pred CCcccc-CCC-CCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 363 PHATLF-KPQ-QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 363 ~~~~~~-~~~-~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
+..... ... ......+...++.++..+.+||.+||+.||.+|||+.++|.||||.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 211100 000 000111223345568899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=333.68 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=208.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
+|++.+.||+|+||.||++.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.......++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 69999999999999999999999999999999875432 223456678899999999999999999988765567789
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC--
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-- 285 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-- 285 (478)
++|||++++.+.........+++..++.++.||+.||.|||+++|+|+||+|+||+++.++.+||+|||++.......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999986665555555578999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
........++..|+|||++.+ ..++.++|||||||++|+|++|+.||........+.++.... ..+
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~~~------------ 228 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-TNP------------ 228 (266)
T ss_pred CCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-CCC------------
Confidence 111122456888999999876 668899999999999999999999998765544444332110 000
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
.....+++.+.+|| +||..||++||++.|+|+||||+
T Consensus 229 --------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 --------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00124577788898 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=342.26 Aligned_cols=285 Identities=36% Similarity=0.602 Sum_probs=229.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||.|+||.||++.+..+++.||+|++..........+.+.+|+.+++.++||||++++++|... ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEEE
Confidence 5689999999999999999999999999999999876544444456677899999999999999999988653 346889
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+++.+...+.. ..+++..+..++.||+.||.|||+++|+|+||+|.|||+++++.++|+|||++......
T Consensus 88 v~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---- 161 (328)
T cd07856 88 VTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---- 161 (328)
T ss_pred EeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence 999998765544432 35789999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||...........+.+.++.++++++..........+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 23345688899999886646789999999999999999999999999888888888888899988777654322111100
Q ss_pred CCC--CCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 369 KPQ--QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 369 ~~~--~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
... ........+.++.+++.+.++|.+||+.||++|||+.++|.||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 000 0011112233456789999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=337.35 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=212.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+.|+++++||.|+||.||++++..+++.|++|++... .....+.+.+|+.+++.++|+||+++++.+.. ...+|+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 86 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWI 86 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEE
Confidence 35799999999999999999999999999999998754 34556678889999999999999999999877 567999
Q ss_pred EEeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||++++.+..+ ......+++..+..++.||+.+|.|||+++|+|+||||+||+++.++.++|+|||++....... .
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 9999998766544 3344578999999999999999999999999999999999999999999999999986543221 2
Q ss_pred CccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 288 PLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
......+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+......++.... ++ ..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~-~~------- 235 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP-TL------- 235 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Cc-cC-------
Confidence 2233456889999998852 2457889999999999999999999998776655544442210 00 00
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.....++.++.+||.+||..||++||++.++|+||||...
T Consensus 236 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 236 ----------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred ----------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0012567789999999999999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=350.27 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=210.3
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..+.+++++.||+|-||.||+|.... ...||+|.++...+.. +.+.+|+++|++|+|+|||++++++.. ++.+
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~--~~pi 276 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTK--QEPI 276 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEec--CCce
Confidence 345568889999999999999999753 4479999998654433 456699999999999999999999987 4579
Q ss_pred EEEEeeccCC-chhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 207 YLVFEYMEHD-ITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 207 ~lv~e~~~~~-ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
|||||||..+ |++.+.. ....+...+...++.||++|++||+++++|||||...||||+++..+||+|||+|+....+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 9999999976 5555554 4667999999999999999999999999999999999999999999999999999965554
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
........--+.-|.|||.+.. ..++.++|||||||+||||+| |+.||.+.+..+.++.+.+..--|.
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------- 425 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------- 425 (468)
T ss_pred ceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC----------
Confidence 4433333344778999999986 679999999999999999999 9999999999999998865432221
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHH
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L 411 (478)
...+|+++.+|+..|++.+|++|||.+.+.
T Consensus 426 ------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 ------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 136899999999999999999999998654
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.55 Aligned_cols=260 Identities=23% Similarity=0.397 Sum_probs=211.5
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++++.||+|+||.||++++..+++.||+|.+.... .......+.+|+.++++++|+||+++++.+.. ...+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 47999999999999999999999899999999987542 34455678899999999999999999998877 6789999
Q ss_pred EeeccCCchhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 210 FEYMEHDITGLLSCP---DIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
|||++++.+..+... ...+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 999998766655443 2368999999999999999999996 59999999999999999999999999998654322
Q ss_pred CCCccccccCCcccCcccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGA-----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~-----~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
......+++.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.......+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 229 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT----- 229 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC-----
Confidence 12334568889999988542 235789999999999999999999997765544443333222211111
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
....++.++.+||.+||..||++||++.+++.||||....
T Consensus 230 --------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 230 --------------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred --------------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 1135788999999999999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=334.99 Aligned_cols=256 Identities=29% Similarity=0.486 Sum_probs=212.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++.+.||.|+||.||++.+..+++.||+|++..+. .......+.+|+.+++.++|+||+++++++.+ ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEE
Confidence 36999999999999999999999999999999997654 23445667889999999999999999999887 5789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
+||+.++.+..+.... ++++..++.++.||+.||.|||+++++|+||+|+||++++++.++|+|||++....... ...
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 9999986665555444 78999999999999999999999999999999999999999999999999997665432 122
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.... ++
T Consensus 156 ~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~---------------- 216 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PP---------------- 216 (274)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--CC----------------
Confidence 33466888999999876 558999999999999999999999998776555444333211 00
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.+.. ..++.++.++|.+||..||++|||+.++|+||||.+
T Consensus 217 -------~~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 217 -------SLEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred -------CCcc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 0000 126788999999999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=321.31 Aligned_cols=261 Identities=24% Similarity=0.394 Sum_probs=218.2
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 205 (478)
...++.+++..||.|..|+||+++.+.+|...|||.+.... +.+..++++..+.++... ++|+||+.+++|.. ...
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~d 165 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTD 165 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--Cch
Confidence 34678889999999999999999999999999999998765 556677888888888777 59999999999987 455
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
+++.||.|.--...++..-..+++|..+-++...++.||.||.++ +|||||+||+|||||+.|++||||||.+-..-..
T Consensus 166 V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 166 VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 788899987655555555666899999999999999999999965 8999999999999999999999999998654432
Q ss_pred CCCCccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHcCCCCchhhccCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~-~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
...+...|.+.|||||.+.- ...|+..+||||||+.|+||.||+.||.+ +++.+.+.++.+.. ||
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e--PP-------- 313 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE--PP-------- 313 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC--CC--------
Confidence 22344577899999999853 24689999999999999999999999998 46778888887622 11
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.|.. -..+++.+.+|+..||..|+.+||...++|+|||+..
T Consensus 314 ---------------~L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 314 ---------------LLPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred ---------------CCCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 1111 1238999999999999999999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=316.74 Aligned_cols=280 Identities=32% Similarity=0.605 Sum_probs=227.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++++|+|.|+.||.|.+..+++.++||+++ +-..+.+.+|+.||+.|. ||||++|+++..++......
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 679999999999999999999999999999999986 445677899999999996 99999999999988788889
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC-CcEEEeecccccccCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~~~~ 286 (478)
||+||+++.....+-. .|+.-.++.++.||+.||+|||++||+|||+||.|++|+.. -.++|+|+|+|.+..++
T Consensus 112 LiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-- 186 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-- 186 (338)
T ss_pred hHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC--
Confidence 9999999865544432 57888999999999999999999999999999999999976 57999999999988765
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHcCCCCc-hhhccCCCCC
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPD-DYWKKSKLPH 364 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~-~pf~~~~~~~~~~~i~~~~g~~~~-~~~~~~~~~~ 364 (478)
.....++.+..|--||.+..-..|+...|+|||||+|..|++.+ |.|.|.++.+++.+|...+|.... .+..+..+.-
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 33455677888999999988788999999999999999999977 556889999999999999987642 2233322221
Q ss_pred ccccCC------CCCCCccchhccc-CCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 365 ATLFKP------QQPYDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 365 ~~~~~~------~~~~~~~l~~~~~-~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...+.. ..++...+..... -+++++.|||.++|.+|-++|+||.|++.||||..
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 111111 0111111111112 24689999999999999999999999999999964
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=337.36 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=213.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||.|+||.||++.+..++..||+|++... .....+.+.+|+.++++++|+||+++++++.. ....|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEE
Confidence 45799999999999999999999889999999998754 34455678889999999999999999999887 667999
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||++++.+..+. .....+++..++.++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 99999987665554 334579999999999999999999999999999999999999999999999999986543321 1
Q ss_pred CccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 288 PLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
......+++.|+|||++.. ...++.++|||||||++|+|++|++||...+....+.++... .++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~--------- 227 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPPT--------- 227 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCCC---------
Confidence 2233467889999998752 245778999999999999999999999887666555444321 1000
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
......++.++.+||.+||+.||.+||++.++|+||||.+
T Consensus 228 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 228 ---------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred ---------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 0001246788999999999999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=331.46 Aligned_cols=255 Identities=29% Similarity=0.531 Sum_probs=208.9
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-------hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-------PESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
+|.+...||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 367889999999999999999888999999998654322 1233567789999999999999999999877 6
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
...++||||++++.+..+......+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 68899999999876666665556789999999999999999999999999999999999999999999999999876542
Q ss_pred CCC-----CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhc
Q 011763 284 GHR-----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 284 ~~~-----~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+.++.... .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~----- 230 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--SP----- 230 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC--CC-----
Confidence 111 11112346788999999876 567889999999999999999999998876655544432210 00
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....++..+.+||.+||+.||.+||++.++|+||||
T Consensus 231 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 231 ---------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ---------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0113578889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=335.05 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=212.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
.|++++.||.|+||.||++.+..++..+++|.+... .....+.+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEE
Confidence 478999999999999999999999999999998643 24455677889999999999999999999877 56899999
Q ss_pred eeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 211 EYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 211 e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
||++++.+..+. ....++++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 999987765543 345579999999999999999999999999999999999999999999999999986543221 222
Q ss_pred cccccCCcccCccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 290 TSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
....+++.|+|||++. ....++.++|||||||++|+|++|++||...+..+....+........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL------------ 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC------------
Confidence 3346788999999874 224577899999999999999999999998777666655543211000
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....++.++.+||.+||+.||.+||++.++|+||||+.
T Consensus 229 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 229 --------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred --------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 001246788999999999999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=336.65 Aligned_cols=256 Identities=28% Similarity=0.486 Sum_probs=214.2
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.+|++.+.||.|+||+||++.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEE
Confidence 479999999999999999999999999999999975532 334667889999999999999999999977 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
+||+.++.+..+.... .+++.++..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 9999987776665433 689999999999999999999999999999999999999999999999999876543321 12
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+.+..+... ..++.
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~--------------- 235 (296)
T cd06655 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL--------------- 235 (296)
T ss_pred CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCccc---------------
Confidence 33467889999998876 66889999999999999999999999988776655544321 11100
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....+++.+.+||.+||..||.+|||+.+++.||||+.
T Consensus 236 ----------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 236 ----------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred ----------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 011357888999999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=331.38 Aligned_cols=261 Identities=27% Similarity=0.430 Sum_probs=213.5
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++.+.||.|+||+||++....++..+|+|++....... ....+.+|+.+|+.++|+||+++++.+.. ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 47999999999999999999998899999999997655433 56778899999999999999999998877 6789999
Q ss_pred EeeccCCchhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 210 FEYMEHDITGLLSCP---DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||+++++.+..+... ...+++..++.++.||+.||.|||++||+|+||+|+||++++++.++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999998665555432 24689999999999999999999999999999999999999999999999999876543322
Q ss_pred C---CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 287 Q---PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 287 ~---~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. ......++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.++... .+..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~------- 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSL------- 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCc-------
Confidence 1 1233457889999999876447889999999999999999999999877665555444331 11000
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.. ...+..+++.+.+||.+||..||++|||+.++|.||||
T Consensus 228 -----------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 228 -----------ET--GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----------CC--ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00 00124678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=328.88 Aligned_cols=256 Identities=30% Similarity=0.472 Sum_probs=213.8
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++++.||.|+||.||++.+..+++.||+|++..........+.+.+|+.+++.++|+||+++++++........|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999987666666677888999999999999999999988765567789999
Q ss_pred eeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 211 EYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCH-----SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 211 e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH-----~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
||++++.+..+.. ...++++..++.++.||+.||.||| +.+|+|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9998765543332 2457899999999999999999999 889999999999999999999999999999866
Q ss_pred CCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+.... .+
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-------- 228 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--FR-------- 228 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--CC--------
Confidence 54321 1234567899999999876 568899999999999999999999999877544444332210 00
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....++..+.+||.+||..||.+|||+.++|+|||+
T Consensus 229 ------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 229 ------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0112567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=334.30 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=204.7
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHH-HHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILI-LRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++++.||+|+||.||++.+..+++.||+|+++........ ..+..|+.+ ++.++||||+++++++.. ....|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence 4799999999999999999999999999999999865433333 344456665 566799999999999876 567999
Q ss_pred EEeeccCCchhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 209 VFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 209 v~e~~~~~ll~~~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
+|||+++.+...+. .....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999986544432 3445799999999999999999999997 9999999999999999999999999998765432
Q ss_pred CCCCccccccCCcccCcccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCchhhccC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~---~~~~~~~DiwslG~il~elltG~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.......++..|+|||++.+. ..++.++|+|||||++|+|++|+.||... ...+.+..+... ..+ ..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-~~---- 228 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PSP-QL---- 228 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CCC-CC----
Confidence 112234678889999988642 34688999999999999999999999653 333444333221 000 00
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
....++.++.+||.+||..||.+|||+.++++||||....
T Consensus 229 --------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 229 --------------------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred --------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 0024688999999999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=336.91 Aligned_cols=257 Identities=27% Similarity=0.476 Sum_probs=211.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
..+|++++.||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++.+.. ....|+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEE
Confidence 3589999999999999999999999999999999976543 234667789999999999999999999887 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+..+... ..+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ..
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-cc
Confidence 9999998766655543 368999999999999999999999999999999999999999999999999987554322 11
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+... +.++.
T Consensus 173 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~-------------- 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPEL-------------- 236 (296)
T ss_pred cCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCCC--------------
Confidence 233467889999998876 66789999999999999999999999877665444332211 11100
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....++..+.+||.+||..||++|||+.++|.||||..
T Consensus 237 -----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 237 -----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred -----------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 001356788999999999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=332.98 Aligned_cols=280 Identities=40% Similarity=0.693 Sum_probs=220.9
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCeeeecceeeecCC---ce
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL---DHPNIIKLEGLITSRLS---CS 205 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~---~~ 205 (478)
|++.+.||.|+||.||++++..+++.||+|+++...........+.+|+.+++++ +|+||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999988899999999975543333344556788777766 59999999999876321 23
Q ss_pred EEEEEeeccCCchhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
++++|||+.+.+...+... ...+++..++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 8999999998766555432 235899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+.++......+....|.......
T Consensus 161 ~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 M--ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred c--ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 1 2223356888999999876 568899999999999999999999999999999999998877766554443322111
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
...+. ...........+.+++.+.+||.+||+.||.+||++.++|.||||
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFP--SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcc--cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11111 111112233345678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=353.59 Aligned_cols=254 Identities=31% Similarity=0.502 Sum_probs=220.7
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.|.-++.||.|+||.||.+++..+.+.||||++..... ..+.+..+..|+.+|++|.|||+|.+-++|.. +...|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHH
Confidence 58889999999999999999999999999999987643 45667788899999999999999999998876 5668999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
||||-|+-.+.+....+++.+.++..|+.+.+.||.|||+++.||||||..||||++.|.|||+|||.|....+ .
T Consensus 105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----A 179 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----A 179 (948)
T ss_pred HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----h
Confidence 99999977777766777899999999999999999999999999999999999999999999999999976643 4
Q ss_pred cccccCCcccCccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 290 TSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~--~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
.+++|||.|||||+|+ ..+.|+-++||||||++..||...+||+...+....+-.|... .+|.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPt-------------- 244 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPT-------------- 244 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCC--------------
Confidence 6789999999999985 3467999999999999999999999998887777666665431 1111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
|. -++.+..+.+|+..||.+-|..|||++++|.|+|...
T Consensus 245 ----------Lq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 245 ----------LQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ----------CC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 11 1356788999999999999999999999999999864
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=333.26 Aligned_cols=280 Identities=39% Similarity=0.679 Sum_probs=226.0
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEEEEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
|++.+.||.|+||+||+|++..+++.||||.+...... .......+|+..+.+++ |+||+++++++.. ....|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 67889999999999999999888999999998754322 22233456999999998 9999999999977 67899999
Q ss_pred eeccCCchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 211 EYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 211 e~~~~~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
||+.+.+...+.... ..+++..+..++.||+.+|.|||+++++|+||+|+||++++++.++|+|||++...... ...
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPY 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CCc
Confidence 999777766665543 46899999999999999999999999999999999999999999999999999765432 122
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc-
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF- 368 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~- 368 (478)
....++..|+|||++.....++.++||||||+++|+|++|++||......+.+.++...++.+....|...........
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 3456788999999986656688999999999999999999999999999999999999998888776654321111110
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.........+...++..+..+.+||++||..||++|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000011112233344557889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=333.32 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=208.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||.|+||.||++++..+++.||+|+++... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEE
Confidence 458999999999999999999999999999999987553 2334567789999999999999999999877 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 99999987666665556689999999999999999999999999999999999999999999999999986554321 22
Q ss_pred ccccccCCcccCccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 289 LTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~--~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
.....++..|+|||++. ....++.++|||||||++|+|++|.+||........+..+......++ .
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~---------- 230 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--K---------- 230 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--c----------
Confidence 23456789999999874 224578899999999999999999999876554443333221100000 0
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcc
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~ 415 (478)
+ .....++..+.+||.+||..||++|||+.++|+|||
T Consensus 231 -----------~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 231 -----------L-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----------c-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 001246778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=329.32 Aligned_cols=256 Identities=26% Similarity=0.451 Sum_probs=209.1
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE----PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+|++.+.||.|+||+||++.+ .+++.+|+|++...... ......+.+|+.+|+.++|+||+++++++.+ ....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeE
Confidence 478899999999999999986 47889999998754321 2334567889999999999999999999987 5789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC--
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-- 284 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-- 284 (478)
|+||||++++.+..+......+++..+..++.||+.||.|||+.+|+|+||+|+||++++++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999998777766665567899999999999999999999999999999999999999999999999998754211
Q ss_pred ---CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 285 ---HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 285 ---~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
.........++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 228 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-------- 228 (265)
T ss_pred cccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC--------
Confidence 1111233457889999999876 6688999999999999999999999987665554433332111111
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....++.++.+||.+||..||.+|||+.++|.||||
T Consensus 229 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 229 ------------------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ------------------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0113578889999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=326.15 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=215.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++++.||.|+||.||.+++..+++.+++|.+............+.+|+.++++++|+||+++++++.+ ...++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 5899999999999999999999999999999998766666667778899999999999999999999987 67899999
Q ss_pred eeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 211 EYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 211 e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||++++.+..+... ...+++..+..++.|++.+|.|||+.|++|+||+|+||++++++.+||+|||++....... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-~~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SM 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-cc
Confidence 99997555444332 3568999999999999999999999999999999999999999999999999997664432 12
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+... .++.
T Consensus 158 ~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~-------------- 220 (256)
T cd08221 158 AETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYTP-------------- 220 (256)
T ss_pred ccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCC--------------
Confidence 344567899999999876 55788999999999999999999999987777766665431 1110
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
....++.++.++|.+||..||.+||++.++|+|+|+
T Consensus 221 ------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 ------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 013567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=332.64 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=205.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC----C
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL----S 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~----~ 203 (478)
...|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.++.++ +|+||+++++++.... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 347999999999999999999999999999999997543 2234577899999998 7999999999986532 2
Q ss_pred ceEEEEEeeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 204 CSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
..+|+||||+.++.+..+... ...+++..+..++.||+.||+|||+++|+|+||||+||++++++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 468999999998655544332 346899999999999999999999999999999999999999999999999998755
Q ss_pred CCCCCCCccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhh
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 357 (478)
.... .......+++.|+|||++.+ ...++.++|||||||++|+|++|..||...........+... +..
T Consensus 162 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~--- 234 (272)
T cd06637 162 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PAP--- 234 (272)
T ss_pred cccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CCC---
Confidence 3321 22234567889999999863 235788999999999999999999999765544333322110 000
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
......++.++.+||.+||..||.+|||+.++|.||||
T Consensus 235 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 ---------------------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ---------------------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00012467889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.86 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=230.7
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCce
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 205 (478)
+..+|.++..||+|+||.|.++..+.+.+.||||+++++.. +.+..+-.+.|-++|... +-|++++++..|+. .+.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDR 424 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDR 424 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhh
Confidence 35689999999999999999999999999999999998764 444555566788888877 57899999999987 678
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+|+||||+.|+.+....+.-+.+-+..+..|+.+|+.||-|||++|||+||||.+||||+.+|++||+|||+++..--+
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~- 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD- 503 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-
Confidence 9999999999888888888889999999999999999999999999999999999999999999999999999753322
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.....+.+|||.|+|||++.- .+|+.++|+|++||+||||+.|++||.+.++.+..+.|++..-..|
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP------------ 570 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP------------ 570 (683)
T ss_pred CcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc------------
Confidence 244567899999999999875 7899999999999999999999999999999999999987543332
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH-----HHHHhCcccCCCCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPYAC 423 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta-----~e~L~hp~f~~~~~~~ 423 (478)
+.++.++.++++.+|...|.+|.-+ .++-.||||....|..
T Consensus 571 -----------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 571 -----------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred -----------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 4688999999999999999999764 6899999999877643
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=328.63 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=209.3
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
++|++.+.||+|+||.||++.+..++..||||++..+.. .....+.+.+|+.++++++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999999865432 23445678889999999999999999998876555678
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
+++|||++++.+..+......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999876665554445689999999999999999999999999999999999999999999999999875432111
Q ss_pred --CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 287 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 287 --~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........+.++.. .+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~--------- 228 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTNP--------- 228 (265)
T ss_pred cccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCCC---------
Confidence 11223457889999999876 5688999999999999999999999987655554433321 11000
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
.....++..+.++|.+||. +|.+||+++++|.|||+.
T Consensus 229 ---------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 229 ---------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ---------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0012467788999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=332.46 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=206.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||.||++++..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEE
Confidence 457999999999999999999999999999999997543 2334567789999999999999999999877 577999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+..+......+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 99999987666655555678999999999999999999999999999999999999999999999999997553221 11
Q ss_pred ccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 289 LTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
.....+++.|+|||++.. ...++.++|||||||++|+|++|++||......+....+......++
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 229 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP------------- 229 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC-------------
Confidence 233467889999998742 24577899999999999999999999875543332222111000000
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcc
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~ 415 (478)
. + .....++..+.+||.+||..||++|||++++|+|+|
T Consensus 230 -----~-----~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 230 -----K-----L-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -----C-----C-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0 0 001246789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=351.72 Aligned_cols=258 Identities=27% Similarity=0.460 Sum_probs=228.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
...|.+++.||+|.|++|.++++..++..||||++.+...+......+.+|+++|..|+|||||+++.+... ...+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeEE
Confidence 347999999999999999999999999999999999888887777778999999999999999999999987 677999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.++.+..+......+.+..++.++.|++.|++|||+++|||||||++||||+.+.++||+|||++..+... ..
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~ 210 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LM 210 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--cc
Confidence 9999998888777777778888999999999999999999999999999999999999999999999999887743 45
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
..+.+|++.|.|||++.+..+.++.+|+||+|++||-|+.|..||.+.+..+.-.+.+......
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI---------------- 274 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI---------------- 274 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc----------------
Confidence 6788999999999999987778999999999999999999999999877655443332211111
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.-.++.+..+||++||..+|.+|++++++..|.|.+..
T Consensus 275 -------------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 275 -------------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred -------------cceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 12467889999999999999999999999999999754
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=336.94 Aligned_cols=256 Identities=26% Similarity=0.472 Sum_probs=214.8
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
-|.++.+||+|+||.||++.++++|+.+|||++..+ .....+..||.||++++.|++|++|+.|.. ...+|+||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEeeh
Confidence 599999999999999999999999999999999754 345567789999999999999999997765 45699999
Q ss_pred eeccCCc-hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 211 EYMEHDI-TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 211 e~~~~~l-l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||+.+. .+.++.++++|+++++..+++..+.||+|||...-||||||..||||+.+|..||+|||.|-.... .....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKR 186 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKR 186 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhh
Confidence 9999654 455556778999999999999999999999999999999999999999999999999999865432 12334
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
.+++|||.|||||++.. ..|+.++||||||++..||..|+|||........+..| --.||+.+
T Consensus 187 NTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPTF------------- 249 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPTF------------- 249 (502)
T ss_pred CccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCCC-------------
Confidence 66889999999999986 67999999999999999999999999876654433322 11222211
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
......+.++.|||++||-..|++|.||.++++|||.++.+
T Consensus 250 ----------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 250 ----------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ----------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 11134678899999999999999999999999999998744
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=349.82 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=219.7
Q ss_pred eeee--eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 132 FEKL--EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 132 y~~~--~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
|+|. +.||.|.||+||-|+++.+|+.||||++.+-.+.......+.+|+.||+.++||.||.+.-.|+. .+.+++|
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVV 641 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVV 641 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEE
Confidence 4443 78999999999999999999999999999888877777889999999999999999999877776 6789999
Q ss_pred EeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC---CcEEEeecccccccCCCC
Q 011763 210 FEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGH 285 (478)
Q Consensus 210 ~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a~~~~~~~ 285 (478)
||-+.|+.+..++ ...+.|++...+.++.||+.||.|||.++|+|+||||+||||... -.+||||||+|++.++.
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 9999999887665 456789999999999999999999999999999999999999765 47999999999998764
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
....+.+|||.|+|||++.+ +.|....|+||+|||+|--++|..||..+.+. -.+|.+...-.|..-
T Consensus 721 -sFRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMyPp~P--------- 787 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMYPPNP--------- 787 (888)
T ss_pred -hhhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccch--hHHhhccccccCCCc---------
Confidence 34467899999999999987 78999999999999999999999999865443 223322222222222
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
|.+++.+++|||..+|++.-.+|.+.++.|.|||+++
T Consensus 788 ----------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 788 ----------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred ----------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 2579999999999999999999999999999999986
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=327.22 Aligned_cols=254 Identities=26% Similarity=0.491 Sum_probs=211.3
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||+|+||.||++++..+++.||+|.+..........+.+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 5899999999999999999999999999999998655555556678899999999999999999999876 67899999
Q ss_pred eeccCCchhh-ccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 211 EYMEHDITGL-LSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 211 e~~~~~ll~~-~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||+.++.+.. +.. ....+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-EL 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hh
Confidence 9998754443 332 23358899999999999999999999999999999999999999999999999997554321 11
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+... ..+.
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~-------------- 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYPP-------------- 220 (256)
T ss_pred hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CCCC--------------
Confidence 223456888999999876 56788999999999999999999999887766666555331 1110
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
....++.++.++|.+||+.+|.+||++.++|+||||
T Consensus 221 ------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 221 ------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 012567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=337.08 Aligned_cols=257 Identities=27% Similarity=0.471 Sum_probs=210.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
..+|++++.||.|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEE
Confidence 3589999999999999999999999999999999976543 334567789999999999999999999977 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+..+... ..+++..+..++.||+.+|.|||+.||+|+||||+|||++.++.++|+|||++....... ..
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 171 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cC
Confidence 9999998766665533 368899999999999999999999999999999999999999999999999987654322 12
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+.. .+.++.
T Consensus 172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~-------------- 235 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL-------------- 235 (297)
T ss_pred cCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCCC--------------
Confidence 233467889999998876 6688999999999999999999999987654333222111 111100
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....++..+.+||.+||..||++||++.++|+||||..
T Consensus 236 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 236 -----------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred -----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 011246788999999999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=325.23 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=211.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||+|+||.||++.+..+++.+|+|.+............+.+|+.+|+.++||||+++++.+.. ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 5899999999999999999999999999999998766666667788899999999999999999998876 67899999
Q ss_pred eeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-cEEEeecccccccCCCCCC
Q 011763 211 EYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 211 e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~~~ 287 (478)
||++++.+..+... ...+++..+..++.|++.+|.|||++||+|+||+|+||+++.++ .+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 99998655544432 34589999999999999999999999999999999999998654 58999999997664322
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+......+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 220 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP--------------- 220 (256)
T ss_pred cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---------------
Confidence 2233467889999999876 567899999999999999999999998877666555543311100
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
....++..+.+||.+||..||.+|||+.|+|.||||
T Consensus 221 -------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 221 -------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 012467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.44 Aligned_cols=250 Identities=20% Similarity=0.199 Sum_probs=204.8
Q ss_pred cceeee--eeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeee--cCCc
Q 011763 130 DAFEKL--EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITS--RLSC 204 (478)
Q Consensus 130 ~~y~~~--~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 204 (478)
++++.. ..|++|+++.||+|.. +++.||||+++..... ....+.+.+|+.+|.+++||||+++++++.+ ....
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 344444 6799999999999987 6889999999765432 2334677899999999999999999999876 4445
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
.+++||||+.++.+..+......+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 7899999999987777766666899999999999999999999984 999999999999999999999999999976543
Q ss_pred CCCCCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
. .....++..|+|||++.+. ..++.++|||||||++|||++|+.||...+..+....+......++.
T Consensus 176 ~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 243 (283)
T PHA02988 176 P----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL-------- 243 (283)
T ss_pred c----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--------
Confidence 2 1234678899999998642 46899999999999999999999999988777666655432211110
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++.+.+||.+||+.||++|||+.++|+
T Consensus 244 -------------------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 244 -------------------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------------------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0246788999999999999999999999984
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=330.06 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=204.1
Q ss_pred ccceeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.++|++.+.||+|+||.||++++. ..+..||+|.++... .......+.+|+.++..++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCC
Confidence 457999999999999999999764 456789999987553 33445677889999999999999999999876 667
Q ss_pred EEEEEeeccCCchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.||||||++++++..+.. ....+++..++.++.||+.||+|||+++++||||||+|||++.++.++|+|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 999999999877665543 3457899999999999999999999999999999999999999999999999987644322
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.........++..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+.+..+.+....+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 228 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP----------- 228 (266)
T ss_pred chhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-----------
Confidence 1111112233578999998876 678999999999999999775 999999888777666553321110
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++..+.+++.+||..||.+||++.++++
T Consensus 229 -----------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 -----------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 01357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=326.29 Aligned_cols=258 Identities=29% Similarity=0.469 Sum_probs=211.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||.|+||.||++.+..+++.+++|++.... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEE
Confidence 358999999999999999999998899999999997653 2355778899999999999999999998877 678999
Q ss_pred EEeeccCCchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+|||++++.+..+.... ..+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++....... .
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999987666554433 689999999999999999999999999999999999999999999999999987654321 1
Q ss_pred CccccccCCcccCcccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 288 PLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
......++..|+|||++.+. ..++.++|||||||++|+|++|.+||...+.......+......++ .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~-~---------- 225 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP-K---------- 225 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-c----------
Confidence 12334668889999988652 2678899999999999999999999988776555444322100000 0
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcc
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~ 415 (478)
+ .....++.++.+||++||..||..|||+.++|.|+|
T Consensus 226 ------------~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 ------------L-KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------------c-cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 001245678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=335.54 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=213.4
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+.|.....||.|+||.||++.+..++..||||++.... ....+.+.+|+.+++.++|+||+++++.+.. .+..|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEE
Confidence 45666788999999999999998899999999986432 3445667899999999999999999999877 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||++++++..+... ..+++..+..++.||+.||.|||+++|+||||||+||++++++.++|+|||++....... ...
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 175 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR 175 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence 999998777665543 368999999999999999999999999999999999999999999999999986543322 222
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..+........
T Consensus 176 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 238 (292)
T cd06658 176 KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV---------------- 238 (292)
T ss_pred ceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc----------------
Confidence 34567889999998875 6688999999999999999999999988776655554433211100
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
.....++..+.+||.+||..||.+|||+.++|+||||...+.+
T Consensus 239 ----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 239 ----------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred ----------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 0012467889999999999999999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=329.24 Aligned_cols=260 Identities=32% Similarity=0.519 Sum_probs=208.5
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE----PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+|+..+.||+|+||.||++.+..+++.||+|++...... ....+.+.+|+.+|++++|+||+++++++.+ ....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 478889999999999999999999999999999754321 2245678899999999999999999999977 6779
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-cEEEeecccccccCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGH 285 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~ 285 (478)
++||||+.++.+..+.....++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999877766655556789999999999999999999999999999999999998776 59999999987654321
Q ss_pred C---CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 286 R---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 286 ~---~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 228 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT--------- 228 (268)
T ss_pred ccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC---------
Confidence 1 11123456889999999876 6688999999999999999999999976543333322222110000
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
.......+++++.++|.+||..||.+|||+.++|+||||.
T Consensus 229 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 229 ---------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0001125678899999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=324.62 Aligned_cols=259 Identities=31% Similarity=0.510 Sum_probs=211.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||+|+||.||++.+..+++.||+|+++.........+.+.+|+.+++.++|+||+++++++.. ...+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 5889999999999999999998899999999998776555677888999999999999999999998876 67799999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc-
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL- 289 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~- 289 (478)
||++++.+..+......+++..++.++.||+.||.|||++||+|+||+|+||++++++.+||+|||++...........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999877777666666789999999999999999999999999999999999999999999999999876543322111
Q ss_pred --cccccCCcccCcccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 290 --TSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 290 --~~~~~t~~y~APE~l~~~~--~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
....+++.|+|||++.+.. .++.++|||||||++|+|++|+.||............... +..+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~----------- 226 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP----------- 226 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC-----------
Confidence 1245678999999987632 2788999999999999999999999765433222222111 11110
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
. .....++..+.+||.+||+.||.+|||+.+++.|||+
T Consensus 227 --------~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 227 --------I-----PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred --------C-----CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0012457889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=334.28 Aligned_cols=255 Identities=30% Similarity=0.493 Sum_probs=212.5
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
..|++.+.||+|+||+||++.+..+++.||+|++..... ..+....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence 469999999999999999999988999999999875432 34455678899999999999999999999987 567899
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.+++...+......+++..+..++.||+.||.|||+++|+|+||+|+||++++++.++|+|||++......
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 9999998877776655567999999999999999999999999999999999999999999999999998755432
Q ss_pred ccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 289 LTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
....+++.|+|||++.+ ...++.++||||||+++|+|++|++||...+.......+... .++.
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~------------ 233 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT------------ 233 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCC------------
Confidence 23456788999998752 356888999999999999999999999877665544433211 0000
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
. ....++..+.+||.+||..||++||++.+++.||||..
T Consensus 234 -------~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 234 -------L------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred -------C------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0 00135678999999999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=329.01 Aligned_cols=253 Identities=30% Similarity=0.428 Sum_probs=210.9
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+|++.+.||.|+||.||++.+..+++.||+|++...... ....+.+.+|++++++++||||+++++.+.. ....|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 489999999999999999999999999999999765432 2456778899999999999999999998876 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
+||+.++.+........++++..+..++.||+.||.|||+++++|+||+|+||++++++.++|+|||++....... ..
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 9999987766665555689999999999999999999999999999999999999999999999999987654332 22
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
....++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+. .+.+.+.... ..
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~-------------- 218 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---AD-------------- 218 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---cc--------------
Confidence 34556888999998876 5589999999999999999999999987764 2222222110 00
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH--HHHHhCccc
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA--SAALASEYF 416 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta--~e~L~hp~f 416 (478)
......++..+.++|.+||..||.+||++ .|+++||||
T Consensus 219 -----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 219 -----------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -----------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 00112467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=328.14 Aligned_cols=261 Identities=28% Similarity=0.504 Sum_probs=208.2
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC--------hHHHHHHHHHHHHHHhcCCCCeeeecceeeecC
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--------PESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 202 (478)
+|.+.+.||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 588899999999999999999889999999998643211 1123567789999999999999999998876
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...+++||||+.++.+..+......+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 57799999999987666655555689999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCC-CccccccCCcccCcccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 283 TGHRQ-PLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 283 ~~~~~-~~~~~~~t~~y~APE~l~~~~-~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... ......++..|+|||++.... .++.++|+||||+++|+|++|..||......+.+..+......+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 231 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP-------- 231 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC--------
Confidence 22111 122345688999999987533 47889999999999999999999997655544433322110000
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.........++..+.+||.+||..||++|||+.++|+||||
T Consensus 232 ---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 232 ---------------PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ---------------cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00011224678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=328.02 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=208.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC----C
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL----S 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~----~ 203 (478)
.++|++.+.||.|+||.||+|.+..+++.|++|++.... .....+.+|+.+++++ .|+||+++++++.... .
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 578999999999999999999998889999999987543 2345678999999999 7999999999987633 4
Q ss_pred ceEEEEEeeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 204 CSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
..+|+||||++++.+..+.. .+..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 56899999999865554432 24578999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCch
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 355 (478)
...... .......++..|+|||++.. ...++.++|||||||+||+|++|++||........+.++... ++..
T Consensus 162 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~ 237 (275)
T cd06608 162 QLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PPPT 237 (275)
T ss_pred ecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CCCC
Confidence 543321 22234567889999998753 234678999999999999999999999876655555444321 1100
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
. .....++..+.+||.+||..||++|||+.++++|||+
T Consensus 238 ~-----------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 L-----------------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred C-----------------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0012367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=330.20 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=205.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeec----CC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR----LS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~ 203 (478)
...|++.+.||.|+||.||++.+..+++.||+|++.... .....+..|+.++.++ +|+||+++++++... ..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 357999999999999999999999999999999986542 3345677899999998 799999999988532 24
Q ss_pred ceEEEEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 204 CSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
..+|++|||++++.+..+.. ....+++..++.++.||+.||.|||+++|+|+||+|+||++++++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 57899999999865554433 2345889999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCCCccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhh
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 357 (478)
.... .......+++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+... .+.
T Consensus 172 ~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~--- 244 (282)
T cd06636 172 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PPP--- 244 (282)
T ss_pred hccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CCC---
Confidence 3221 12234567889999998753 245788999999999999999999999766554443332211 000
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
......++.++.+||.+||..||.+|||+.|+|+||||
T Consensus 245 ---------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 ---------------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ---------------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00013578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=328.95 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=207.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC---Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL---SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~---~~ 204 (478)
.++|++.+.||.|+||.||++.+..+++.+|+|++.... .....+.+|+.+++++ +||||+++++++.... ..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 568999999999999999999999999999999986432 2235567899999999 8999999999986532 24
Q ss_pred eEEEEEeeccCCchhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 205 SIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
..|+||||++++.+..+. .....+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 689999999986665443 2345789999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCccccccCCcccCcccccCCC----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchh
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~----~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~ 356 (478)
...... ......++..|+|||++.... .++.++|||||||++|+|++|++||........+..+... ++...
T Consensus 178 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~ 253 (291)
T cd06639 178 LTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPTL 253 (291)
T ss_pred cccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCCCC
Confidence 543221 112345688899999875422 3678999999999999999999999877665555443221 11000
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
.....++..+.+||.+||..||++||++.++|.||||+
T Consensus 254 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 -----------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -----------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00123567899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.85 Aligned_cols=254 Identities=29% Similarity=0.489 Sum_probs=208.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||.|+||.||++.+..+++.|++|.+.... ..+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l 75 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWI 75 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEE
Confidence 358999999999999999999998889999999987432 25678899999999999999999999987 577999
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
++||++++.+..+. .....+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++........
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999986655443 3456789999999999999999999999999999999999999999999999999976543321
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+.. ..+..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~------------ 218 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPT------------ 218 (256)
T ss_pred ccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCCCC------------
Confidence 2223446888999999876 5789999999999999999999999987655443322211 00000
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
......++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 219 -----------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 219 -----------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -----------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00012467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.74 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=211.3
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
+.++|++++.||+|+||+||++.+..+++.||+|++.... .....+.+.+|+++++.++||||+++++++.. ...+|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 79 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNIC 79 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEE
Confidence 3578999999999999999999999999999999987543 34456778899999999999999999999987 57899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|||||++++.+..+......+++..+..++.||+.+|.|||+ ++++|+||+|+||++++++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999987777666556679999999999999999999997 599999999999999999999999999986442211
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHHHcCCCCch
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-----------EQLHKIFKLCGSPPDD 355 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-----------~~~~~i~~~~g~~~~~ 355 (478)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +.+..+.. ..+..
T Consensus 159 --~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 232 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ---EPPPR 232 (284)
T ss_pred --cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh---ccCCC
Confidence 123467889999999876 57889999999999999999999999865542 11111111 00000
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
. ....++.++.+||.+||..||.+|||+.|+++|+||...
T Consensus 233 ------------------~------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 233 ------------------L------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ------------------C------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 001367789999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=325.04 Aligned_cols=252 Identities=28% Similarity=0.396 Sum_probs=207.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCC
Q 011763 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (478)
Q Consensus 138 LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (478)
||.|+||.||++++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ +...|+||||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 6899999999999998999999999976543 23445678899999999999999999998876 67799999999987
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCC
Q 011763 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296 (478)
Q Consensus 217 ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~ 296 (478)
.+..+......+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ......+++
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 776666555678999999999999999999999999999999999999999999999999997665432 122346788
Q ss_pred cccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCC
Q 011763 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT--EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (478)
Q Consensus 297 ~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~--~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 374 (478)
.|++||.+.+ ..++.++|+|||||++|+|++|..||.... ..+....+......+.
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------- 214 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE--------------------- 214 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC---------------------
Confidence 9999999875 668899999999999999999999998776 4444444332111000
Q ss_pred CccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 375 ~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
.....++++.++|.+||..||++|++ +.|+++||||++..|
T Consensus 215 ------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 215 ------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 00234788999999999999999999 999999999986443
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=322.50 Aligned_cols=255 Identities=32% Similarity=0.503 Sum_probs=210.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
+|+..+.||+|+||.||+|.+..+++.|++|.+..... ..+..+.+.+|+.+++.++|+||+++++++.. ...+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 47788999999999999999988899999999875432 24456778899999999999999999998876 57799
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
++|||+++..+..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999987666665555578999999999999999999999999999999999999999999999999987654322
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......++..|+|||.+.....++.++|+|||||++|+|++|+.||......+....+.... ..+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~-------------- 221 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELP-------------- 221 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCC--------------
Confidence 22345678899999998763348899999999999999999999998766544444432211 000
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....+++.+.+||.+||..||.+||++.++|.|||+
T Consensus 222 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 222 ------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0113567889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=324.26 Aligned_cols=289 Identities=35% Similarity=0.554 Sum_probs=236.2
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc---eE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC---SI 206 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~---~~ 206 (478)
.+.+-.+.||.|+||.||.+.|..+|+.||+|++..-...-...+.+.+|+++|..++|.|++..+++.+...-+ .+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 356777899999999999999999999999999864433445567788999999999999999998887653222 36
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|+|.|+|..++...+..+ ..++.+.++-+++||+.||.|||+.+|.||||||.|+|++.+..+||||||+++.-.....
T Consensus 133 YV~TELmQSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHHhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 889999988776665544 4899999999999999999999999999999999999999999999999999998777666
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC---C
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL---P 363 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~---~ 363 (478)
..++..+.|..|+|||+++|...|+.++||||+|||+.||+..+-+|...+..++++.|.+++|.|..+.++.... .
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 7777788899999999999999999999999999999999999999999999999999999999999776543211 0
Q ss_pred CccccCCCCCCCccchhcc--cCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 364 HATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~--~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
+...-.+.++-.+.|-..- .+-..+..+++..||..||++|++..++|.|++..+.
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 1000111111111111111 1334568899999999999999999999999998653
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=328.70 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=208.3
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++.+.||.|+||.||++.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.. ...++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEE
Confidence 368899999999999999999999999999999976543 3555677889999999999999999999877 5789999
Q ss_pred EeeccCCchhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 210 FEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||+++..+..+... ...+++..+..++.||+.||.|||+ .+++|+||||+||++++++.++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999997555555443 3689999999999999999999999 9999999999999999999999999999865532211
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHcCCCCchhhccCCC
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-----EVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~-----~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+.+..+.. ..+..
T Consensus 157 --~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~------- 223 (265)
T cd06605 157 --KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPPR------- 223 (265)
T ss_pred --hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCCC-------
Confidence 12567888999999876 578999999999999999999999997542 2222222221 11000
Q ss_pred CCccccCCCCCCCccchhccc-CCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 363 PHATLFKPQQPYDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~-~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
... .++.++.+||.+||..||.+|||+.+++.||||+.
T Consensus 224 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 224 ------------------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred ------------------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 001 26888999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=331.30 Aligned_cols=258 Identities=21% Similarity=0.268 Sum_probs=199.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECC----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD----------------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~----------------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv 192 (478)
.++|.+.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4589999999999999999997532 34579999987543 344556788999999999999999
Q ss_pred eecceeeecCCceEEEEEeeccCCchhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 011763 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253 (478)
Q Consensus 193 ~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~-------------------~~~l~~~~~~~i~~qil~aL~~LH~~giv 253 (478)
++++++.+ ....||||||+.++.+..+... ...+++..+..++.||+.||.|||++||+
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999987 5678999999987655433221 12467888999999999999999999999
Q ss_pred eccCCCCcEEEecCCcEEEeecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh--CC
Q 011763 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GK 330 (478)
Q Consensus 254 HrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt--G~ 330 (478)
||||||+|||++.++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999755332211 1122344778999999876 678999999999999999987 56
Q ss_pred CCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHH
Q 011763 331 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 410 (478)
Q Consensus 331 ~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~ 410 (478)
.||...+..+.+..+...+....... .....+.++..+.+||.+||..||.+|||+.++
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQV---------------------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccc---------------------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 78887776665555433211100000 000113567889999999999999999999999
Q ss_pred H
Q 011763 411 L 411 (478)
Q Consensus 411 L 411 (478)
.
T Consensus 299 ~ 299 (304)
T cd05096 299 H 299 (304)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=328.71 Aligned_cols=256 Identities=26% Similarity=0.380 Sum_probs=203.4
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCC
Q 011763 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (478)
Q Consensus 138 LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (478)
||+|+||+||+|.+..+++.||+|++...... ......+..|+.+|+.++||||+++++++.. ....|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 68999999999999999999999998754332 2234455689999999999999999999877 56799999999986
Q ss_pred chhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcccccc
Q 011763 217 ITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (478)
Q Consensus 217 ll~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 294 (478)
.+..+.... ..+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++...... .......+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccC
Confidence 665443332 36899999999999999999999999999999999999999999999999998765432 22233456
Q ss_pred CCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCC
Q 011763 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (478)
Q Consensus 295 t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 374 (478)
+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....-..
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 213 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM---------------------- 213 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc----------------------
Confidence 788999999876 558899999999999999999999998765422222221110000
Q ss_pred CccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCCCC
Q 011763 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYAC 423 (478)
Q Consensus 375 ~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~~~ 423 (478)
.......+++.+.+||.+||..||.+|| ++.+++.||||+...+..
T Consensus 214 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~ 264 (277)
T cd05577 214 ---AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264 (277)
T ss_pred ---cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence 0011135688999999999999999999 999999999998766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=327.27 Aligned_cols=258 Identities=29% Similarity=0.445 Sum_probs=204.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeee---cCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS---RLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~---~~~~ 204 (478)
.++|++++.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.. ..+.
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 678999999999999999999999999999999876432 2234567899999999 79999999998743 2346
Q ss_pred eEEEEEeeccCCchhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 205 SIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
..|+||||++++.+..+. .....+++..+..++.||+.||.|||+++|+||||||+||++++++.+||+|||++..
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 789999999986655432 2345689999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchh
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~ 356 (478)
..... .......+++.|+|||++.. ...++.++|||||||++|+|++|+.||........+.++... .+..
T Consensus 174 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~- 248 (286)
T cd06638 174 LTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---PPPT- 248 (286)
T ss_pred cccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---CCCc-
Confidence 54322 12233467899999998753 244788999999999999999999999876554433322110 0000
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
. .....++..+.+||.+||+.||++|||+.++|+|+||
T Consensus 249 ----------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 ----------L------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ----------c------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0 0001356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=358.03 Aligned_cols=254 Identities=23% Similarity=0.393 Sum_probs=203.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecc-eeeec---C-
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEG-LITSR---L- 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~-~~~~~---~- 202 (478)
..++++.+.|.+|||+.||+|++...+..||+|++-.. +....+.+.+||.+|+.|. |+|||.+++ ..... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 56899999999999999999999888899999998755 6778888999999999995 999999999 33221 1
Q ss_pred CceEEEEEeecc-CCchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEecCCcEEEeecccc
Q 011763 203 SCSIYLVFEYME-HDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLA 278 (478)
Q Consensus 203 ~~~~~lv~e~~~-~~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFG~a 278 (478)
...++|.||||. +++++.+.. ....|++.++++|+.|+++|+.+||... |||||||-|||||..+|++||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 245789999999 477777653 2234999999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCCC--------ccccccCCcccCccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 011763 279 NFSNTGHRQP--------LTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348 (478)
Q Consensus 279 ~~~~~~~~~~--------~~~~~~t~~y~APE~l~--~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~ 348 (478)
.-.-...... ......|+.|+|||++. .....+.|+|||+|||+||-|+....||.......++ ..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----ng 269 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----NG 269 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE----ec
Confidence 6432211110 01124499999999974 3467899999999999999999999999865433222 11
Q ss_pred cCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcc
Q 011763 349 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (478)
Q Consensus 349 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~ 415 (478)
-...|+ ++.++..+++||+.||+.||.+||++.|++.+-+
T Consensus 270 ~Y~~P~---------------------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 270 NYSFPP---------------------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred cccCCC---------------------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 111111 2467889999999999999999999999996644
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=328.88 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=198.8
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEeecCCCChHH-HHHHHHHHHHHH---hcCCCCeeeecceeeecCCceEEEEEee
Q 011763 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-VRFMAREILILR---RLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (478)
Q Consensus 137 ~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~-~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~~~lv~e~ 212 (478)
.||+|+||.||++.+..+++.||+|.+......... .....+|..+++ ..+||||+.+++++.. .+..|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 489999999999999999999999999765432222 222334444443 3479999999998877 5679999999
Q ss_pred ccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcccc
Q 011763 213 MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292 (478)
Q Consensus 213 ~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 292 (478)
++++.+..+......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... ....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCc
Confidence 9987776666566679999999999999999999999999999999999999999999999999986543321 1234
Q ss_pred ccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHcCCCCchhhccCCCCCccccCC
Q 011763 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV--EQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (478)
Q Consensus 293 ~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 370 (478)
.+++.|+|||++.+...++.++|||||||++|+|++|..||...... ..+..+.. ..+
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~----------------- 215 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TVN----------------- 215 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cCC-----------------
Confidence 67999999998865456889999999999999999999999764322 11211110 000
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCCC
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~~ 422 (478)
......++.++.+||.+||..||.+|+ |+.++++||||+...+.
T Consensus 216 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 216 --------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred --------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 011235788999999999999999999 69999999999886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=327.25 Aligned_cols=258 Identities=30% Similarity=0.512 Sum_probs=210.3
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCeeeecceeeecCCceEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD---HPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~ 207 (478)
.|++++.||.|+||.||+|.+..+++.||+|.++... .......+.+|+.+++.+. ||||+++++++.. ....|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 5888999999999999999999999999999987543 3344566778999999996 9999999999876 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||++++.+..+.... .+++..+..++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++....... .
T Consensus 79 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-S 156 (277)
T ss_pred EEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-c
Confidence 999999987666555443 78999999999999999999999999999999999999999999999999997665432 2
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......++..|+|||.+.+...++.++|||||||++|+|++|.+||...........+... .++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~-------------- 220 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPP-------------- 220 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCC--------------
Confidence 2234467889999999876566789999999999999999999999876543332211100 000
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
.+. ...++.++.++|.+||+.||++||++.+++.|+||++..
T Consensus 221 ---------~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 221 ---------RLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ---------CCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 000 013678899999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=326.87 Aligned_cols=257 Identities=27% Similarity=0.489 Sum_probs=211.7
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
.|...+.||.|++|.||++.+..+++.|++|++.... ....+.+.+|+.+++.++||||+++++++.. ....|+|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 5777789999999999999998899999999986543 2334567889999999999999999998876 67799999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 290 (478)
||+.++.+..+... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 99988666655544 4689999999999999999999999999999999999999999999999998865443221 123
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCC
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 370 (478)
...+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+... .++.
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~~~~---------------- 234 (285)
T cd06648 174 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LPPK---------------- 234 (285)
T ss_pred cccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--CCCC----------------
Confidence 3467889999999876 56889999999999999999999999887766666554332 1100
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
+ .....++..+.+||.+||..||++|||+.++|+||||++..
T Consensus 235 -------~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 235 -------L-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred -------C-cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 0 00123678899999999999999999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=325.53 Aligned_cols=262 Identities=27% Similarity=0.390 Sum_probs=207.3
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++.+.||.|++|.||++.+..+++.||+|.+..... ......+.+|+++++.++||||++++++|.......+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 479999999999999999999999999999999975532 3445678889999999999999999999876556679999
Q ss_pred EeeccCCchhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 210 FEYMEHDITGLL----SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 210 ~e~~~~~ll~~~----~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
|||++++.+..+ ......+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999987655432 2334568999999999999999999999999999999999999999999999999986543321
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHcCCCCchhhccC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-----VEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~-----~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+... .....
T Consensus 160 ~---~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~---- 228 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNPEL---- 228 (287)
T ss_pred c---ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cchhh----
Confidence 1 23346788999998876 6789999999999999999999999986522 2222222110 00000
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.... ..-...++.+.+||.+||..||.+|||+.|++.||||++
T Consensus 229 --------------~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 229 --------------KDEP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred --------------ccCC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 0000 000134678999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.08 Aligned_cols=262 Identities=21% Similarity=0.328 Sum_probs=206.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|+..+.||+|+||.||++.+..+++.||+|++...... .....+.+|+.++.++. |+||+++++++.. ....+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~ 79 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCW 79 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEE
Confidence 34788899999999999999999999999999998765433 44566788999999995 9999999998876 56788
Q ss_pred EEEeeccCCchhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 208 LVFEYMEHDITGLL----SCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 208 lv~e~~~~~ll~~~----~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
++|||+...+.... ......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99999987543322 12345799999999999999999999975 99999999999999999999999999987543
Q ss_pred CCCCCCccccccCCcccCcccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||..... ....+.+.....+...
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~---- 231 (288)
T cd06616 160 DSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL---- 231 (288)
T ss_pred cCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC----
Confidence 221 12334568889999998764 3689999999999999999999999976542 2222222211111100
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.......++.++.+||.+||..||.+|||+.++++||||..
T Consensus 232 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 232 -----------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred -----------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 00011357889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=331.51 Aligned_cols=259 Identities=26% Similarity=0.457 Sum_probs=212.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
..|.....||.|+||.||++.+..+++.||+|++..... ...+.+.+|+.++..++||||+++++++.. +...|+|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv 96 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVL 96 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEE
Confidence 356667789999999999999988999999999875432 234567789999999999999999999887 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||++++.+..+... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... ...
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 999998776665543 468999999999999999999999999999999999999999999999999986544322 122
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+... ++ ..
T Consensus 175 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-~~------------- 236 (297)
T cd06659 175 KSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP-PK------------- 236 (297)
T ss_pred cceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-CC-------------
Confidence 33567899999999876 56899999999999999999999999887766655544221 10 00
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
......++..+.++|.+||+.||.+||++.++++||||.+...
T Consensus 237 ---------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 237 ---------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred ---------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 0111356788999999999999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=343.09 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=199.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 202 (478)
.++|++.+.||+|+||.||+|++... +..||+|+++... .......+.+|+.+|+.+ +|+|||++++++..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 56899999999999999999986443 3579999997543 334456788999999999 89999999999877
Q ss_pred CceEEEEEeeccCCchhhccC-----------------------------------------------------------
Q 011763 203 SCSIYLVFEYMEHDITGLLSC----------------------------------------------------------- 223 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~----------------------------------------------------------- 223 (478)
...+||||||+.++.+..+..
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 567999999998755443321
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC-ccc
Q 011763 224 -----------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTS 291 (478)
Q Consensus 224 -----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~-~~~ 291 (478)
...++++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++......... ...
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 11247889999999999999999999999999999999999999999999999997654322111 112
Q ss_pred cccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCC
Q 011763 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (478)
Q Consensus 292 ~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 370 (478)
..++..|+|||++.+ ..++.++|||||||++|+|++ |+.||........+..+......++
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~----------------- 335 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS----------------- 335 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc-----------------
Confidence 234567999999876 678999999999999999997 9999987655444444332111100
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++++.+||.+||+.||.+|||+.++++
T Consensus 336 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 336 ----------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00235789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=327.98 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=205.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTG-----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~-----~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++..++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--E 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--C
Confidence 458999999999999999999876554 689999987443 34455678899999999999999999999876 5
Q ss_pred ceEEEEEeeccCCchhhccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC
Q 011763 204 CSIYLVFEYMEHDITGLLSCPD----------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~ 267 (478)
...|++|||++++.+..+.... ..+++..+..++.||+.||.|||+++|+|+||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 6789999999876554433211 458889999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011763 268 GVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345 (478)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i 345 (478)
+.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999975533221 12233455788999998876 668999999999999999998 99999988776665554
Q ss_pred HHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 346 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.... ++ .....++.++.+|+.+||+.||.+||++.+++++
T Consensus 240 ~~~~--~~--------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQ--LL--------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCC--cC--------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3311 00 0113578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=346.23 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=208.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.+.|++...+|.|+|+.|-.+.+..+++.+++|++.... ....+|+.++... +||||+++++++.+ +.+.|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~ 392 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIY 392 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecC--Cceee
Confidence 678999999999999999999999999999999997552 1234577777666 89999999999988 78899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE-ecCCcEEEeecccccccCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-NNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl-~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
+|||++.++.+...+.....+. .++..|++||+.|+.|||++|||||||||+|||+ +..++++|+|||+++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999876655544443344 7888999999999999999999999999999999 58899999999999876643
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
+.+.+.|..|.|||++.. ..|++++||||||++||+||+|+.||........ |...++.++..
T Consensus 470 --~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~i~~~~~s----------- 532 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTRIQMPKFS----------- 532 (612)
T ss_pred --hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHH---HHHhhcCCccc-----------
Confidence 345567899999999985 7899999999999999999999999998776622 22223333211
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
..+++.+++||..||+.||.+|+++.+++.||||..++.
T Consensus 533 ----------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t 571 (612)
T KOG0603|consen 533 ----------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPT 571 (612)
T ss_pred ----------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence 368999999999999999999999999999999954443
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=326.22 Aligned_cols=255 Identities=33% Similarity=0.505 Sum_probs=213.0
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 207 (478)
++|.+.+.||.|+||.||++.+..+++.||+|++..... .......+.+|+.+++++. |+||+++++++.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 379999999999999999999999999999999876433 3344566778999999998 9999999999876 67799
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~- 286 (478)
+||||+.++.+..+......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999997766655555555799999999999999999999999999999999999999999999999999876543221
Q ss_pred ------------------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 011763 287 ------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348 (478)
Q Consensus 287 ------------------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~ 348 (478)
.......++..|+|||++.. ..++.++|||||||++++|++|+.||...+....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 11223456889999998876 56888999999999999999999999988766665555432
Q ss_pred cCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH----HHHHhCccc
Q 011763 349 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYF 416 (478)
Q Consensus 349 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta----~e~L~hp~f 416 (478)
.... ...+++.+.+||.+||+.||.+|||+ .++|+||||
T Consensus 238 ~~~~-----------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EYSF-----------------------------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCC-----------------------------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 1111 12457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=341.42 Aligned_cols=291 Identities=30% Similarity=0.521 Sum_probs=235.3
Q ss_pred hhhhcccccccCcccccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC----
Q 011763 112 WLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD---- 187 (478)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~---- 187 (478)
++....||.+ -.+|.+....|+|-|++|.+|.+...|+.||||+|+.+. -..+.=+.|++||++|+
T Consensus 421 YYrv~igE~L-------D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~ 490 (752)
T KOG0670|consen 421 YYRVRIGELL-------DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADP 490 (752)
T ss_pred eEEEehhhhh-------cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCc
Confidence 3444555555 348999999999999999999999999999999998543 33344567999999994
Q ss_pred --CCCeeeecceeeecCCceEEEEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 011763 188 --HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263 (478)
Q Consensus 188 --h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NIL 263 (478)
--|+++|+..|.. ..++|||+|.+.-+|...+.. .+..|....++.|+.||+.||..|..+||+|.||||.|||
T Consensus 491 Edk~Hclrl~r~F~h--knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 491 EDKFHCLRLFRHFKH--KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNIL 568 (752)
T ss_pred hhhhHHHHHHHHhhh--cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceE
Confidence 3488999888877 788999999998888777654 3445888999999999999999999999999999999999
Q ss_pred EecC-CcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 011763 264 VNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 342 (478)
Q Consensus 264 l~~~-~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~ 342 (478)
|++. ..+||||||.|...... ..+.+..+..|+|||+++| .+|+...|+||+||+||||.||+-+|.|.++.+.+
T Consensus 569 VNE~k~iLKLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASEN---EITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred eccCcceeeeccCccccccccc---cccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 9987 56899999999877653 3456677889999999998 88999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCchhhccCCCCCccccCC----------------------CCC---CCccchhc--c----cCCchhHHH
Q 011763 343 HKIFKLCGSPPDDYWKKSKLPHATLFKP----------------------QQP---YDSSLRET--F----KDLPTTAVN 391 (478)
Q Consensus 343 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~----------------------~~~---~~~~l~~~--~----~~~~~~l~~ 391 (478)
.-++++-|..|.....+..+.+..+..+ ..| +.+.|... + ..+-..+.+
T Consensus 645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence 9999999999988877655433222111 011 00111110 0 112235899
Q ss_pred HHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 392 LIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 392 Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
||..||..||++|+|+.|+|.||||+.
T Consensus 725 LLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHhccChhhcCCHHHHhcCCcccC
Confidence 999999999999999999999999975
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=325.83 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=199.4
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEeecCCCChHH-HHHHHHHH---HHHHhcCCCCeeeecceeeecCCceEEEEEee
Q 011763 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-VRFMAREI---LILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (478)
Q Consensus 137 ~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~-~~~~~~E~---~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~ 212 (478)
.||+|+||.||++.+..+++.||+|++......... ......|. .+++...||||+++++++.. ....|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 379999999999999999999999999765433211 12223343 34455689999999998887 5789999999
Q ss_pred ccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcccc
Q 011763 213 MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292 (478)
Q Consensus 213 ~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 292 (478)
+.++.+..+......+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||++....... ....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCc
Confidence 9987776666666689999999999999999999999999999999999999999999999999987543221 2334
Q ss_pred ccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCC
Q 011763 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372 (478)
Q Consensus 293 ~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 372 (478)
.++..|+|||++.+...++.++|||||||++|+|++|+.||.......... +.......+.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~------------------ 216 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAV------------------ 216 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhccCC------------------
Confidence 678999999998764568899999999999999999999998763221111 1110000000
Q ss_pred CCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 373 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 373 ~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
.....++.++.+||.+||..||.+|+ ++.++++||||+...+
T Consensus 217 -------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 217 -------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred -------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 01124678999999999999999999 9999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=325.51 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=212.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
.|+.++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.+.|+||+++++++.+ ....|+||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIM 81 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEE
Confidence 58899999999999999999998999999999875532 3445678889999999999999999999987 67899999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 290 (478)
||++++.+..+... .++++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccc
Confidence 99998766555443 468999999999999999999999999999999999999999999999999997654322 1223
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCC
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 370 (478)
...++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...........+.. +.++
T Consensus 160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~----------------- 219 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNPP----------------- 219 (277)
T ss_pred cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CCCC-----------------
Confidence 3456888999999876 5688999999999999999999999987665544333211 0000
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
.....++..+.+||.+||..||++||++.++|.||||.....
T Consensus 220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 220 ---------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred ---------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 111246788999999999999999999999999999976443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=322.32 Aligned_cols=253 Identities=30% Similarity=0.439 Sum_probs=203.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHH-hcCCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILR-RLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||.|+||.||+|.+..+++.||+|++...... ......+..|..++. .++|+||+++++++.. ...+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 5789999999999999999999999998754322 222233445555544 4589999999999976 67899999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
+++.+..+......+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 9877776666666799999999999999999999999999999999999999999999999999875432 12345
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+..+....+.......+.
T Consensus 155 ~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------- 214 (260)
T cd05611 155 GTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE------------------- 214 (260)
T ss_pred CCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCC-------------------
Confidence 6788999999886 45889999999999999999999999887776655554332111000
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccC---HHHHHhCcccCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPY 421 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t---a~e~L~hp~f~~~~~ 421 (478)
.....++..+.++|.+||+.||++||+ +.|+|.||||++..|
T Consensus 215 ------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 215 ------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 011257889999999999999999995 579999999987443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=321.10 Aligned_cols=254 Identities=26% Similarity=0.469 Sum_probs=208.8
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||.|+||.||++.+..++..||+|.+..........+.+.+|+.+++.++|+||+++++.+.. ....|+|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 4899999999999999999999999999999997765444455677889999999999999999998877 67899999
Q ss_pred eeccCCchhhcc-C-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc-EEEeecccccccCCCCCC
Q 011763 211 EYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-LKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 211 e~~~~~ll~~~~-~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-vkl~DFG~a~~~~~~~~~ 287 (478)
||+.+..+..+. . ....+++..+..++.||+.||.|||+++|+|+||||+||++++++. +||+|||.+....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 999875554443 2 2235799999999999999999999999999999999999998864 6999999987654322 1
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+.... .
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~--------------- 219 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY--F--------------- 219 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc--C---------------
Confidence 2223457889999998875 568899999999999999999999998776655554433210 0
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
....+.++.++.++|.+||..+|++|||+.++|.||||
T Consensus 220 -----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 220 -----------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00113567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=320.47 Aligned_cols=256 Identities=31% Similarity=0.474 Sum_probs=212.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++.+.||.|++|.||++++..+++.|++|++...... .....+.+|+.++.+++|+||+++++++.. ....++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEE
Confidence 3699999999999999999999999999999999765432 455678899999999999999999999877 5789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|||++++.+..+......+++..+..++.||+.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ .
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-Q 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-c
Confidence 9999977666665555689999999999999999999999 9999999999999999999999999999976643322 1
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~---~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ..+....+.. ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~----------- 221 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPPP----------- 221 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCCC-----------
Confidence 223456889999998876 578899999999999999999999998774 2333333221 1000
Q ss_pred cccCCCCCCCccchhcccC-CchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 366 TLFKPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~-~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..... ++..+.++|.+||..+|++|||+.++|+||||+.
T Consensus 222 --------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 222 --------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred --------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 00123 7889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.04 Aligned_cols=257 Identities=29% Similarity=0.405 Sum_probs=202.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+.+.....||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. +...++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 82 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKI 82 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEE
Confidence 456667789999999999999999899999999987543 3445678899999999999999999999877 678999
Q ss_pred EEeeccCCchhhccC-CCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-CCcEEEeecccccccCCC
Q 011763 209 VFEYMEHDITGLLSC-PDIKF--SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTG 284 (478)
Q Consensus 209 v~e~~~~~ll~~~~~-~~~~l--~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~ 284 (478)
|+||+.++.+..+.. ....+ ++..+..++.||+.||.|||++||+|+||||+||+++. ++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 999999765554433 33445 88899999999999999999999999999999999976 679999999998755332
Q ss_pred CCCCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. .......+++.|+|||++.+. ..++.++||||||+++|+|++|++||...................
T Consensus 163 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 230 (268)
T cd06624 163 N-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH----------- 230 (268)
T ss_pred C-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccC-----------
Confidence 2 122234568899999998652 347889999999999999999999997543322111100000000
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
......+++++.+||.+||..+|.+|||+.+++.||||
T Consensus 231 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 231 ---------------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ---------------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00113567889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=341.19 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=199.0
Q ss_pred ccceeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 202 (478)
.++|++.+.||+|+||+||+|++ ..++..||||+++... .....+.+.+|+.+|..+ +||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 45899999999999999999974 3456789999987543 233456778899999999 89999999999977
Q ss_pred CceEEEEEeeccCCchhhccC-C---------------------------------------------------------
Q 011763 203 SCSIYLVFEYMEHDITGLLSC-P--------------------------------------------------------- 224 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~-~--------------------------------------------------------- 224 (478)
....|+||||++++.+..+.. .
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 667899999998754433221 1
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 225 -----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 225 -----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788899999999999999999999999999999999999999999999999765432211
Q ss_pred C-ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 288 P-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 288 ~-~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
. .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||........+.+++.....+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM------------- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-------------
Confidence 1 112234567999999876 678999999999999999998 899998766554444333211000
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
......+.++.+||.+||+.||++|||+.++++.
T Consensus 337 --------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 337 --------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0012357789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=328.21 Aligned_cols=256 Identities=29% Similarity=0.471 Sum_probs=213.3
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
+.|...+.||+|+||+||+|++..+++.|++|++..... .......+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 98 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWL 98 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 347788899999999999999999999999999975433 33445667889999999999999999999987 677999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.++++..+.....++++..+..++.||+.+|.|||++||+|+||+|+||+++.++.+||+|||++.....
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 999999888777766666799999999999999999999999999999999999999999999999999864322
Q ss_pred ccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 289 LTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
.....++..|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+... ..+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~~------------ 239 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT------------ 239 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCC------------
Confidence 233467888999999742 256788999999999999999999999887766665554321 1100
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.....++..+.+||.+||+.+|.+||++.++|.||||...
T Consensus 240 -------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 240 -------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred -------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0012456789999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=323.10 Aligned_cols=253 Identities=30% Similarity=0.476 Sum_probs=207.1
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCC
Q 011763 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (478)
Q Consensus 138 LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (478)
||.|+||.||++++..+++.|++|++..... .....+.+.+|+.++++++||||+++++.+.. ....|+||||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999998999999999975543 23455677889999999999999999998876 67899999999986
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-------CCc
Q 011763 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-------QPL 289 (478)
Q Consensus 217 ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-------~~~ 289 (478)
.+..+......+++..+..++.||+.||.|||+++++|+||+|+||++++++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 6655554444789999999999999999999999999999999999999999999999999875433211 122
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....++..|+|||++.. ..++.++||||||+++|+|++|..||......+....+......++.
T Consensus 159 ~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 222 (265)
T cd05579 159 KRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--------------- 222 (265)
T ss_pred cCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc---------------
Confidence 33456788999999876 55888999999999999999999999888776666555331100000
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH---HHHHhCcccCCCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA---SAALASEYFSTKP 420 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta---~e~L~hp~f~~~~ 420 (478)
...++..+.+||.+||+.+|.+|||+ .++|+||||++..
T Consensus 223 ------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 223 ------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred ------------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 01257889999999999999999999 9999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=360.46 Aligned_cols=149 Identities=29% Similarity=0.445 Sum_probs=132.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|.++++||+|+||+||+|++..+++.||||+++.... .......+.+|+.++..++|+||+++++++.. ..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 5689999999999999999999999999999999975433 34445678889999999999999999988876 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
|||||+.++.+..+......+++..++.|+.||+.||.|||+++||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999886666555555578999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.40 Aligned_cols=250 Identities=20% Similarity=0.299 Sum_probs=203.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
..+|.+.+.||.|+||.||+|.+..+++.||+|++..+. .....+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 79 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEE
Confidence 457999999999999999999999899999999987442 334567889999999999999999998876 567899
Q ss_pred EEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||++++.+..+.. ....+++..++.++.||+.||.|||+++++|+||||+|||+++++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999998765544432 234589999999999999999999999999999999999999999999999999976543322
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..... +
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~------------ 224 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR--M------------ 224 (263)
T ss_pred eccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC--C------------
Confidence 21122233567999998876 678899999999999999998 9999988776555444432110 0
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++.++.+||.+||..||++|||+.++++
T Consensus 225 --------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 225 --------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=338.44 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=206.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+++.+...||+|.||+||+|++..+ ||||+++.+..+++..+.|.+|+.+|++-+|.||+-+.|++..+ . +.|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p--~-~AI 464 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP--P-LAI 464 (678)
T ss_pred HHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC--c-eee
Confidence 45788999999999999999998653 99999999988899999999999999999999999999999873 3 489
Q ss_pred EEeeccCCchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC-CC
Q 011763 209 VFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HR 286 (478)
Q Consensus 209 v~e~~~~~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~ 286 (478)
|..+|+|..|. .+......|.....+.|++||++|+.|||.++|||||||..||+|.++++|||+|||++..-... ..
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999996554 44455667999999999999999999999999999999999999999999999999999643211 11
Q ss_pred CCccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 287 QPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.......+...|||||++.. ..+|++.+|||||||++|||++|..||...+....+.++-+....|
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p------------ 612 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP------------ 612 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc------------
Confidence 22233445677999999863 3579999999999999999999999999433333332222211111
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.+.....+.+.++++|+..|+.+++++||+..++|.
T Consensus 613 ------------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 613 ------------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ------------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 112223467889999999999999999999999986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=334.80 Aligned_cols=278 Identities=25% Similarity=0.372 Sum_probs=203.8
Q ss_pred eeeeec--CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G--~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
..||.| +|++||++++..+++.||+|++..........+.+.+|+.+++.++||||++++++|.. +...|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 345666 99999999999999999999998766555666788899999999999999999999987 67799999999
Q ss_pred cCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC----
Q 011763 214 EHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---- 287 (478)
Q Consensus 214 ~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~---- 287 (478)
.++.+..+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+||+.+.........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 97655544332 235899999999999999999999999999999999999999999999999865322111000
Q ss_pred --CccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 288 --PLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 288 --~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
......++..|+|||++.+. ..++.++|||||||++|+|++|++||........+..+... ++...|.....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 238 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKG---PPYSPLDITTFPC 238 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcC---CCCCCccccccch
Confidence 00111235679999998753 34789999999999999999999999887665554444332 2211111110000
Q ss_pred cc--c---------------cCCC---CCCCccch-hcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 365 AT--L---------------FKPQ---QPYDSSLR-ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 365 ~~--~---------------~~~~---~~~~~~l~-~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.. . .... ......+. .....+++.+++||++||..||.+|||+.++|+||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 00 0 0000 00000000 111346778999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=322.78 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=196.9
Q ss_pred ccceeeeeee--eecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKI--GQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~L--G~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 205 (478)
.++|++.+.+ |.|+||.||++.+..++..+|+|++....... .|+.....+ +||||+++++.|.. ...
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~--~~~ 83 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT--LKG 83 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec--CCe
Confidence 3467777776 99999999999999999999999987543221 123333323 79999999999987 568
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-cEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~ 284 (478)
.|+||||++++.+..+......+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999998766655555555899999999999999999999999999999999999999998 9999999998755422
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+.... ..+
T Consensus 164 -----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~---------- 226 (267)
T PHA03390 164 -----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK---------- 226 (267)
T ss_pred -----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc----------
Confidence 22356889999999876 6689999999999999999999999986544332 11111111 000
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-HHHHHhCcccCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAALASEYFST 418 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-a~e~L~hp~f~~ 418 (478)
....+.+++.+.+||.+||+.||.+|++ .+++|+||||++
T Consensus 227 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 227 ---------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ---------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0112357899999999999999999996 599999999964
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=318.13 Aligned_cols=254 Identities=30% Similarity=0.471 Sum_probs=213.1
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||.|+||.||++.+..++..||+|++............+.+|+++++.++|+|++++++.+.. ....++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 5899999999999999999999899999999998766555667778899999999999999999999877 57899999
Q ss_pred eeccCCchhhcc-CC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 211 EYMEHDITGLLS-CP---DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 211 e~~~~~ll~~~~-~~---~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||++++.+.... .. ...+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 999985544433 32 3679999999999999999999999999999999999999999999999999997654432
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
.......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 221 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP--------------- 221 (258)
T ss_pred ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC---------------
Confidence 12233467888999998876 66889999999999999999999999877755555444321100
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....++..+.++|.+||..||++|||+.++|+||||
T Consensus 222 -------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 222 -------------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0012567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=328.69 Aligned_cols=255 Identities=30% Similarity=0.480 Sum_probs=213.1
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
..|+..+.||+|+||.||++++..++..||+|++..... ..+....+.+|+.+++.++|+|++++++++.. ....|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEE
Confidence 358999999999999999999998999999999875432 33445678889999999999999999999877 567899
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.+.++..+.....++++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++......
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 9999998877776655667999999999999999999999999999999999999999999999999998654322
Q ss_pred ccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 289 LTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
....+++.|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+......+.
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 244 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL------------- 244 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC-------------
Confidence 23456888999998742 24578899999999999999999999988766665555543211110
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
....+++.+.+||.+||+.||.+||++.++++|+|+..
T Consensus 245 --------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 245 --------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred --------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 01246778999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.16 Aligned_cols=250 Identities=25% Similarity=0.452 Sum_probs=205.7
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||.|+||.||++.+..+++.||+|.++.... ....+.+.+|+.+++.++|+||+++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 48999999999999999999999999999999875442 3445677789999999999999999999977 67899999
Q ss_pred eeccCCch-hhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 211 EYMEHDIT-GLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 211 e~~~~~ll-~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||++++.+ ..+.. ....+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++....... ..
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 99987544 33332 34468999999999999999999999999999999999999999999999999987654322 12
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+......+
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---------------- 219 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC----------------
Confidence 233567889999999876 668999999999999999999999998877655554443211000
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....++..+.+||.+||+.||++|||+.++|.-
T Consensus 220 ------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 012467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=327.16 Aligned_cols=255 Identities=28% Similarity=0.461 Sum_probs=208.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+.|++++.||.|+||.||+|.+..++..||+|++..... ....+.+.+|+.++++++||||+++++.+.. ....|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEE
Confidence 368889999999999999999988999999999875542 3445678899999999999999999999877 6679999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||++++.+..+... ..+++..++.++.||+.||.|||+++++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 999998766555543 468999999999999999999999999999999999999999999999999987554321 112
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... .++
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~---------------- 219 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--SPP---------------- 219 (277)
T ss_pred hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--CCC----------------
Confidence 23456888999999876 56889999999999999999999999765544433222110 000
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....++.++.+||.+||..+|.+|||+.++|.||||..
T Consensus 220 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 220 ----------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred ----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 001246788999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.84 Aligned_cols=258 Identities=28% Similarity=0.482 Sum_probs=210.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEE
Confidence 458999999999999999999998889999999986543 2334667889999999999999999999987 567999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|+||++++.+..+.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 99999987666554433 578999999999999999999999999999999999999999999999999865543221 2
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.. .+.+.
T Consensus 172 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~--------------- 234 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------- 234 (293)
T ss_pred cccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------------
Confidence 233457888999998876 5688999999999999999999999987665444332211 00000
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
......++..+.+||++||..||++||++.++|.|+||+..
T Consensus 235 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 235 ----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 00112467789999999999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=324.40 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=204.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++.... ..+....+.+|+++|+.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTE--G 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEec--C
Confidence 5679999999999999999998743 46789999987543 33355778899999999999999999999987 5
Q ss_pred ceEEEEEeeccCCchhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc
Q 011763 204 CSIYLVFEYMEHDITGLLSCP--------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV 269 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~ 269 (478)
...|+||||++++.+..+... ...+++..+..++.||+.||.|||++|++|+||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 779999999998665544322 235789999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 011763 270 LKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFK 347 (478)
Q Consensus 270 vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~ 347 (478)
+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999875432211 11123345778999999876 678999999999999999998 9999988777666555532
Q ss_pred HcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 348 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 348 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
..... ....++..+.+||.+||..||++|||+.|+++
T Consensus 240 ~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQ----------------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11100 01256788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=317.84 Aligned_cols=249 Identities=21% Similarity=0.338 Sum_probs=201.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||.||++... .+..+|+|.+...... ...+.+|+.+|+.++||||+++++++.. ....|+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~i 76 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYI 76 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEE
Confidence 457999999999999999999875 4567999988654332 3457789999999999999999999877 567999
Q ss_pred EEeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||++++.+..+ ......+++..+..++.||+.||.|||++||+|+||||+||++++++.+||+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999987655444 334456899999999999999999999999999999999999999999999999998755332222
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+.+..+.......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-------------- 221 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY-------------- 221 (256)
T ss_pred ccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC--------------
Confidence 1122234567999999876 678999999999999999999 999999888777766654321000
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....+..+.+||.+||..||++||++.++++
T Consensus 222 --------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 --------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred --------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00134678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=318.09 Aligned_cols=258 Identities=27% Similarity=0.428 Sum_probs=209.8
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN---FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
.+|++.+.||+|+||.||++++..+++.||+|++.... ........+.+|+.++++++|+||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 37999999999999999999999999999999986432 123455678889999999999999999998876556678
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC-
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH- 285 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~- 285 (478)
+++|||++++.+.........+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999986665554444568999999999999999999999999999999999999999999999999997543211
Q ss_pred -CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 -RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 -~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
........++..|+|||++.+ ..++.++|||||||++|+|++|++||......+.+.++.. .+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~--------- 228 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTKP--------- 228 (264)
T ss_pred cCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCCC---------
Confidence 111223457889999999876 5678999999999999999999999987765555444321 11100
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....+++.+.++|.+||. +|.+|||+.++|.|||.
T Consensus 229 ---------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 ---------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0113578889999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=320.94 Aligned_cols=284 Identities=32% Similarity=0.554 Sum_probs=233.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
..+|.-+..+|.|+- .|..+.|.-.++.||+|++..........+...+|..++..+.|+||++++.+|.... ..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 447999999999999 8888999999999999998776555666777889999999999999999999996532 22
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
..|+|||+|..++-.... ..+.-..+..++.|++.|+.|||+.||+||||||+||++..+..+||.|||+|+.....
T Consensus 95 e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 479999999988776665 35678899999999999999999999999999999999999999999999999765543
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
...+..+.|..|+|||++.+ ..|.+.+||||+||++.||++|+-+|.+.+..++..++.+.+|.|.+.+.++..-..
T Consensus 172 --~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred --cccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 35677888999999999998 459999999999999999999999999999999999999999999999877643222
Q ss_pred ccccCCCCCCC-ccchhccc------------CCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 365 ATLFKPQQPYD-SSLRETFK------------DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 365 ~~~~~~~~~~~-~~l~~~~~------------~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
+....+...+. ....+.|+ .-...+.+|+.+||..||++|.++.++|.||||+-|
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence 22211111110 11111111 123458999999999999999999999999999843
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=333.51 Aligned_cols=262 Identities=26% Similarity=0.361 Sum_probs=196.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
+++|...+.||+|+||.||+|.... +..||||++....... ...|.+|+.+|.+++|||||+|+|||.+... ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEE
Confidence 6799999999999999999998644 5899999887554322 4458999999999999999999999988322 5899
Q ss_pred EEeeccCCchhhccC-CCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 209 VFEYMEHDITGLLSC-PDI-KFSEAQIKCYMNQLLHGLEHCHSRG---VLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 209 v~e~~~~~ll~~~~~-~~~-~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
|||||.++.|..++. ... +++|....+|+.+++.||+|||+.. |||||||++|||||++.+.||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999866655444 333 8999999999999999999999853 99999999999999999999999999976654
Q ss_pred CCCCCcccc-ccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHcCCCCchhhcc
Q 011763 284 GHRQPLTSR-VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 284 ~~~~~~~~~-~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~---~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
. ....... .||.+|+|||++.. ...+.++||||||++|+||++|+.+..... ......-....+ ..
T Consensus 230 ~-~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~--------~~ 299 (361)
T KOG1187|consen 230 G-DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL--------EE 299 (361)
T ss_pred c-ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH--------HC
Confidence 1 1222222 78999999999875 678999999999999999999998876432 111111111111 00
Q ss_pred CCCCCccccCCCCCCCccch-hccc--CCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 360 SKLPHATLFKPQQPYDSSLR-ETFK--DLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~-~~~~--~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.+ .....|+.+. ..+. ..-..+..+..+|++.+|..||++.|+++
T Consensus 300 ~~--------~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 300 GK--------LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred cc--------hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00 0011222221 1111 11223678889999999999999999753
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=314.50 Aligned_cols=254 Identities=31% Similarity=0.543 Sum_probs=214.2
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||+|++|.||++.+..+++.|++|.+............+.+|++++.+++|+|++++++++.. ....+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 4889999999999999999999899999999998776555667788899999999999999999999877 57899999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 290 (478)
||+++..+..+......+++..+..++.|++.+|.|||++||+|+||+|+||+++.++.++|+|||++......... ..
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 99998766666555568999999999999999999999999999999999999999999999999999766543321 23
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCC
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 370 (478)
...++..|+|||.+.+ ..++.++|||+||+++|+|++|..||...+......++... ..+
T Consensus 158 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----------------- 217 (254)
T cd06627 158 SVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--DHP----------------- 217 (254)
T ss_pred ccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--CCC-----------------
Confidence 3456889999998876 45889999999999999999999999876655444443210 000
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....++..+.++|.+||..+|++|||+.++|.||||
T Consensus 218 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 218 ---------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0012567889999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=321.02 Aligned_cols=255 Identities=30% Similarity=0.477 Sum_probs=210.5
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+-|++++.||.|+||.||++.+..++..||||++..... ......+.+|+.++.+++||||+++++++.. +...|+|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEE
Confidence 358899999999999999999988999999999865432 3445678889999999999999999999987 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||++++.+..+... ..+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 999998766655443 368999999999999999999999999999999999999999999999999987554321 112
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+... .++
T Consensus 159 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---------------- 219 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NPP---------------- 219 (277)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CCC----------------
Confidence 33456888999998875 56788999999999999999999999876655444443211 000
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....++.++.++|.+||..||.+||++.++|+||||.+
T Consensus 220 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 220 ----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred ----------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 001246788999999999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=318.32 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=203.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++.+.||+|+||.||+|++..+++.||||.+.... ........+.+|+.+++.++||||+++++++.. ....++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 47999999999999999999999999999999886533 344555667889999999999999999999887 567899
Q ss_pred EEeeccCCchhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 209 VFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 209 v~e~~~~~ll~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
||||++++.+..+. .....+++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999986554332 23446899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ...+...+...+.++.
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 228 (267)
T cd08228 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL--------- 228 (267)
T ss_pred h-HHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC---------
Confidence 2 11223456888999999876 5688999999999999999999999865432 2222222222221110
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....++..+.+||.+||..||++||++.++|+.
T Consensus 229 -----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 -----------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -----------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 012467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=322.08 Aligned_cols=260 Identities=18% Similarity=0.265 Sum_probs=203.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--G 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 5689999999999999999997542 34589999986443 23334456789999999999999999999876 5
Q ss_pred ceEEEEEeeccCCchhhccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEe
Q 011763 204 CSIYLVFEYMEHDITGLLSCP----------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 273 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~----------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~ 273 (478)
...|+||||+.++.+..+... ...++...+..++.||+.||.|||+++|+||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 678999999987655544321 1235677889999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 011763 274 DFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (478)
Q Consensus 274 DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 351 (478)
|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+.... .
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~ 239 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-Y 239 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C
Confidence 99998754332111 1122234677999999876 668999999999999999998 789998877666554443210 0
Q ss_pred CCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh------CcccCCCC
Q 011763 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA------SEYFSTKP 420 (478)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~------hp~f~~~~ 420 (478)
+ ......++.+.++|.+||+.||++|||+.++++ ||||....
T Consensus 240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 240 L---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 0 001245788999999999999999999999987 99997643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=318.06 Aligned_cols=250 Identities=20% Similarity=0.326 Sum_probs=202.3
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|+++++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 77 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIY 77 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcE
Confidence 3578999999999999999999864 56779999986433 234677889999999999999999988876 56789
Q ss_pred EEEeeccCCchhhcc-C-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 208 LVFEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 208 lv~e~~~~~ll~~~~-~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
++|||+.++.+..+. . ....+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999875544433 2 34568899999999999999999999999999999999999999999999999997654322
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
........++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM------------- 223 (261)
T ss_pred eeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 222223344678999998876 668899999999999999998 99999987776666555332110
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++.++.+||.+||..||++||+++++++
T Consensus 224 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 ---------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=342.12 Aligned_cols=253 Identities=29% Similarity=0.500 Sum_probs=206.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccC
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH 215 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~ 215 (478)
-.||+|.||+||-|+|..+...+|||.+... +.+...-+.+||.+.+.|+|.|||+++|.+.+ ++++-|.||-++|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPG 656 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCC
Confidence 3699999999999999999999999998643 23445667899999999999999999999876 6788899999999
Q ss_pred CchhhccCC-CCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-CCcEEEeecccccccCCCCCCCccc
Q 011763 216 DITGLLSCP-DIKF--SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTS 291 (478)
Q Consensus 216 ~ll~~~~~~-~~~l--~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~~ 291 (478)
+.+..+++. =+++ .+..+..|.+||++||.|||++.|||||||-+||||+. .|.+||+|||.++....-+ ....+
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTET 735 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccc
Confidence 777666543 3456 78899999999999999999999999999999999974 6899999999997654322 23346
Q ss_pred cccCCcccCccccc-CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCC
Q 011763 292 RVVTLWYRPPELLL-GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (478)
Q Consensus 292 ~~~t~~y~APE~l~-~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 370 (478)
+.||..|||||++. |...|+.++|||||||++.||.||+|||......... |++. .+++-
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-----------------GmyKv 796 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-----------------GMYKV 796 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh-----------------cceec
Confidence 77899999999996 4467999999999999999999999999865543322 2211 11111
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..+. ...++.++++||.+|+.+||..||+|.++|.+||++..
T Consensus 797 HP~i-------Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 797 HPPI-------PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCCC-------cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 1111 12567889999999999999999999999999999865
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.14 Aligned_cols=255 Identities=21% Similarity=0.316 Sum_probs=199.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 202 (478)
.++|++.+.||.|+||.||+|.+.. +++.||+|+++... .....+.+.+|+.++.++ +|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 4589999999999999999997533 45789999987443 334456677899999999 899999999988653
Q ss_pred CceEEEEEeeccCCchhhccCC----------------------------------------------------------
Q 011763 203 SCSIYLVFEYMEHDITGLLSCP---------------------------------------------------------- 224 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~---------------------------------------------------------- 224 (478)
+..++++|||++++.+..+...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4578999999998655433211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC-CccccccCCcccC
Q 011763 225 ---DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRP 300 (478)
Q Consensus 225 ---~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~t~~y~A 300 (478)
...+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++......... ......++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 126789999999999999999999999999999999999999999999999999765332211 1122344678999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccch
Q 011763 301 PELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLR 379 (478)
Q Consensus 301 PE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 379 (478)
||++.+ ..++.++|||||||++|+|++ |..||.+....+.+...+... ..+
T Consensus 244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~-------------------------- 295 (337)
T cd05054 244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-TRM-------------------------- 295 (337)
T ss_pred cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-CCC--------------------------
Confidence 999886 678999999999999999998 999998755444433332210 000
Q ss_pred hcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 380 ETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 380 ~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
......++++.+++.+||+.+|++||++.++++|
T Consensus 296 ~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=340.44 Aligned_cols=241 Identities=25% Similarity=0.368 Sum_probs=203.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+....++-||.|+.|.||+|+. .++.||||+++.- -..+|+-|++|+||||+.+.++|.. ...+||
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtq--sPcyCI 189 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQ--SPCYCI 189 (904)
T ss_pred HHHhhhhhhhccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecC--CceeEE
Confidence 44566778899999999999985 5688999998521 1358999999999999999999987 567999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|||||..+-|..++....+++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..... ..
T Consensus 190 iMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST 267 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST 267 (904)
T ss_pred eeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence 9999999888888888889999999999999999999999999999999999999999999999999999766543 44
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
...++||..|||||+|.+ .+.+.++|||||||+|||||||..||+..+...++ + ..|..
T Consensus 268 kMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---w-GVGsN---------------- 326 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---W-GVGSN---------------- 326 (904)
T ss_pred hhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeE---E-eccCC----------------
Confidence 567899999999999987 88999999999999999999999999865433221 1 11111
Q ss_pred CCCCCCCccchhc-ccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 369 KPQQPYDSSLRET-FKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 369 ~~~~~~~~~l~~~-~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.|.-. ....|+-++=||++||+..|..||+..++|.|
T Consensus 327 --------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 327 --------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred --------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 01110 13578889999999999999999999999988
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=327.43 Aligned_cols=273 Identities=24% Similarity=0.325 Sum_probs=200.3
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCCchhhc
Q 011763 142 TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL 221 (478)
Q Consensus 142 ~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~ 221 (478)
+++.||++++..+++.||||++............+.+|+.+++.++|+||+++++++.. ....|++|||++++.+..+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHHHH
Confidence 44556666667789999999998765566677889999999999999999999999877 6678999999998766555
Q ss_pred cCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC------CCccccc
Q 011763 222 SCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR------QPLTSRV 293 (478)
Q Consensus 222 ~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~------~~~~~~~ 293 (478)
... ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||.+........ .......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 432 34689999999999999999999999999999999999999999999999998864432111 1112334
Q ss_pred cCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC---
Q 011763 294 VTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--- 369 (478)
Q Consensus 294 ~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~--- 369 (478)
++..|+|||++... ..++.++|||||||++|+|++|..||........+..... +..+. .+.....+......
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPC-LLDKSTYPLYEDSMSQS 246 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcc-ccccCchhhhcCCcCcc
Confidence 57789999998653 3578899999999999999999999987765544333222 11111 11111111000000
Q ss_pred -----CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 370 -----PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 370 -----~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
...............++.++.+||.+||.+||++|||+.++|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00000000001112356789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=312.50 Aligned_cols=259 Identities=33% Similarity=0.522 Sum_probs=211.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|.+.+.||+|++|.||+|.+..+++.|++|++..........+.+.+|+.++++++|+||+++++.+.......+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 48889999999999999999998999999999987655556677888999999999999999999988773337899999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC-Cc
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PL 289 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~~ 289 (478)
||+++..+..+......+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99987666655555558999999999999999999999999999999999999999999999999999766543210 12
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||....... ..+.......
T Consensus 161 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~----------------- 220 (260)
T cd06606 161 GSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGSSG----------------- 220 (260)
T ss_pred cCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccccC-----------------
Confidence 33466889999998876 558899999999999999999999998766221 1111111000
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
........++..+.+||.+||..||.+||++.++|.||||
T Consensus 221 -------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 221 -------EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0001113457899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=315.28 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=200.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||.|+||.||++.+. +++.||+|.++..... .+.+.+|+.++++++|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEec--CCCeee
Confidence 467999999999999999999875 4578999998754432 3557789999999999999999998876 567899
Q ss_pred EEeeccCCchhhcc-CC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLS-CP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||+.++.+..+. .. ...+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999765544443 32 24689999999999999999999999999999999999999999999999999976653221
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
........+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 224 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP------------- 224 (261)
T ss_pred cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 11112222457999998876 678999999999999999999 999999887766665553321100
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++..+.+||.+||+.||.+||++.+++.
T Consensus 225 ---------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 225 ---------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 01246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=322.95 Aligned_cols=264 Identities=25% Similarity=0.423 Sum_probs=208.4
Q ss_pred ceeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCc
Q 011763 131 AFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~---~~~~~vAlK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 204 (478)
+|++.+.||.|+||.||++++. .+|..||+|++..... .....+.+.+|+.+|+.+ +|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4889999999999999999874 4789999999875432 123345677899999999 69999999988876 56
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
..|+||||++++.+.........+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 78999999998766655555567899999999999999999999999999999999999999999999999999765443
Q ss_pred CCCCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.........++..|+|||++.+. ..++.++|||||||++|+|++|..||...........+...+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 229 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--------- 229 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC---------
Confidence 22223345678899999998642 34678999999999999999999999754332222222221100000
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
+ ....++..+.+||.+||..||.+|+ ++.+++.||||+...|
T Consensus 230 ---------~-------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 230 ---------P-------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred ---------C-------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 0 0124678899999999999999997 8999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=323.30 Aligned_cols=258 Identities=26% Similarity=0.455 Sum_probs=211.3
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
.|....+||+|+||.||++.+..+++.||+|++.... ......+.+|+.+++.++|+||+++++.+.. .+..|+||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 96 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVM 96 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEE
Confidence 3555578999999999999999999999999986432 3345668889999999999999999999987 67899999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 290 (478)
||++++.+..+... ..+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~ 174 (292)
T cd06657 97 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRK 174 (292)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccc
Confidence 99998777665533 368999999999999999999999999999999999999999999999999986554322 1223
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCC
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 370 (478)
...+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..+.......
T Consensus 175 ~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------------ 235 (292)
T cd06657 175 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK------------------ 235 (292)
T ss_pred ccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc------------------
Confidence 3457889999998865 567899999999999999999999999877665555443211000
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
+ .....++..+.++|.+||..||.+||++.++|.||||.....
T Consensus 236 -------~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 236 -------L-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred -------c-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 0 011346788999999999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=325.96 Aligned_cols=256 Identities=29% Similarity=0.475 Sum_probs=211.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.+.|+..+.||+|+||.||++++..+++.||+|.+..... .......+.+|+.+++.++|+|++++++++.. ....+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeE
Confidence 3468899999999999999999999999999999875432 33445667789999999999999999999877 56789
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||+.+.+...+.....++++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++......
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 99999998777666555567899999999999999999999999999999999999999999999999998755432
Q ss_pred CccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 288 PLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+....+..... +.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~------------ 233 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA------------ 233 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-CC------------
Confidence 23456888999998752 24578899999999999999999999987665544444332110 00
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....++..+.+||.+||..+|.+||++.++++|||+..
T Consensus 234 --------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 234 --------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred --------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 001246778999999999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=327.35 Aligned_cols=253 Identities=19% Similarity=0.342 Sum_probs=200.5
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKI----VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~----vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
...+|++++.||+|+||+||+|++..++.. ||+|+++... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--- 80 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 80 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---
Confidence 356899999999999999999987665554 8999986432 34455678889999999999999999998865
Q ss_pred ceEEEEEeeccCCc-hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHDI-TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~l-l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...++|+||+.++. .+.+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 24679999998754 44444445568899999999999999999999999999999999999999999999999998665
Q ss_pred CCCCCC-ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 283 TGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 283 ~~~~~~-~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
...... ......+..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+. ..+......++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~------ 232 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQ------ 232 (316)
T ss_pred CCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCC------
Confidence 322211 122233678999999876 678999999999999999997 9999987665443 333321111110
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....+.++.++|.+||..||.+||++.+++.+
T Consensus 233 ---------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 233 ---------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ---------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=316.49 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=203.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.++|++.+.||+|+||+||+|.+..+ ...||+|+++... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCc
Confidence 45899999999999999999987643 4589999987543 34445667889999999999999999998876 567
Q ss_pred EEEEEeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.++||||++++.+..+ ......+++..+..++.||+.||.|||+++|+|+||||+|||+++++.++|+|||++......
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 8999999998655544 344457899999999999999999999999999999999999999999999999999876421
Q ss_pred CCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 285 HRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 285 ~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
... .......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+......+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 229 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP--------- 229 (266)
T ss_pred ccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---------
Confidence 111 1112233678999998876 678999999999999999998 9999987776665555433111000
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....+..+.+|+.+||+.||++||++.+++++
T Consensus 230 -------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 230 -------------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=320.40 Aligned_cols=254 Identities=20% Similarity=0.354 Sum_probs=202.2
Q ss_pred cccceeeeeeeeecCceEEEEEEE----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARD----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~----~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..++|++.+.||+|+||+||+|.+ ..++..||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 79 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--E 79 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--C
Confidence 356899999999999999999985 3456789999987543 34455678889999999999999999999876 5
Q ss_pred ceEEEEEeeccCCchhhccC-C----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec
Q 011763 204 CSIYLVFEYMEHDITGLLSC-P----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN 266 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~-~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~ 266 (478)
...|+||||+.++.+..+.. . ...+++..+..++.||+.||.|||+++|+|+||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 67899999999765544331 1 224788999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011763 267 EGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHK 344 (478)
Q Consensus 267 ~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~ 344 (478)
++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999976533221 11122344677999999876 568999999999999999998 9999988776555444
Q ss_pred HHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 345 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
+... ..+ .....+++.+.++|.+||+.||.+||++.+++++
T Consensus 239 ~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKR-QLL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 4221 100 0113567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=319.57 Aligned_cols=253 Identities=16% Similarity=0.253 Sum_probs=200.0
Q ss_pred ccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|++.+.||+|+||.||++.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~ 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 568999999999999999999864 235679999986433 23344567889999999999999999999876 5
Q ss_pred ceEEEEEeeccCCchhhccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEe
Q 011763 204 CSIYLVFEYMEHDITGLLSCP----------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 273 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~----------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~ 273 (478)
...++||||++++.+..+... ...+++..+..++.||+.||.|||+.+++|+||||+|||+++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 679999999998655544321 1235778899999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 011763 274 DFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (478)
Q Consensus 274 DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 351 (478)
|||++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~ 239 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-L 239 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c
Confidence 9999875432211 11122344678999999876 668999999999999999999 789998877666555443211 0
Q ss_pred CCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
+ .....++..+.+||.+||+.||++|||+.+++++
T Consensus 240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 L---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0012467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=316.08 Aligned_cols=250 Identities=21% Similarity=0.319 Sum_probs=200.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||++.+.. +..||+|.+...... ...+.+|+.+++.++||||+++++++.. ....|+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 76 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYI 76 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEE
Confidence 4579999999999999999998654 456999998754332 3457889999999999999999999876 566899
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||+.++.+..+. .....+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||.++........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999876554443 33447899999999999999999999999999999999999999999999999998765432211
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......+.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 222 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR------------- 222 (256)
T ss_pred ecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC-------------
Confidence 1122234567999999876 568899999999999999998 9999988777665555533211100
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....+..+.++|.+||..||.+|||+.++|.+
T Consensus 223 ---------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 223 ---------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 01357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=313.72 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=195.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccC
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH 215 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~ 215 (478)
+.||+|+||.||+|++..+++.||+|.+... ...+....+.+|+++++.++||||+++++++.. ....|+||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 3689999999999999989999999988643 244556678899999999999999999999877 5679999999988
Q ss_pred Cchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC-ccccc
Q 011763 216 DITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRV 293 (478)
Q Consensus 216 ~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~-~~~~~ 293 (478)
+.+..+. .....+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.......... .....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 6555443 344568999999999999999999999999999999999999999999999999987543221111 01112
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 372 (478)
.+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..... +
T Consensus 158 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-~-------------------- 215 (252)
T cd05084 158 IPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-L-------------------- 215 (252)
T ss_pred CceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-C--------------------
Confidence 2456999998876 568999999999999999998 8899987666554443322110 0
Q ss_pred CCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 373 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 373 ~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++..+.+||.+||..||++|||+.++++
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 -------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001245788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.57 Aligned_cols=252 Identities=33% Similarity=0.515 Sum_probs=208.3
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.+.||.|++|.||++.+..+++.|++|++..... .....+.+|+.+++.++|+||+++++++.. ....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence 48889999999999999999988899999999976542 355678899999999999999999999877 56789999
Q ss_pred eeccCCchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 211 EYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 211 e~~~~~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
||+++..+..+.. ....+++..+..++.||+.+|.|||++|++|+||+|+||++++++.++|+|||.+........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 9999755554443 335789999999999999999999999999999999999999999999999999976654321 2
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...+.......+... ..+...
T Consensus 155 ~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~------------- 218 (253)
T cd05122 155 NTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--GPPGLR------------- 218 (253)
T ss_pred cceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--CCCCcC-------------
Confidence 34567889999999876 55889999999999999999999999877655554443321 110000
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcc
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~ 415 (478)
....++..+.++|.+||..||++|||+.++|+|||
T Consensus 219 -----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 219 -----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=313.96 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=210.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+|++.++||.|+||.||++.+..+++.||+|.+............+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 4899999999999999999999999999999998765555556677889999999999999999999877 57899999
Q ss_pred eeccCCchhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 211 EYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 211 e~~~~~ll~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||+++..+..+... ...+++..++.++.||+.||.|||++|++|+||+|+||++++++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99987655444322 356899999999999999999999999999999999999999999999999999766543
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 219 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP--------------- 219 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---------------
Confidence 2223456889999999876 67888999999999999999999999987765554443221100
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....++.+++++|.+||..+|.+|||+.++|+||++
T Consensus 220 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 220 -------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0012467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=322.03 Aligned_cols=262 Identities=24% Similarity=0.386 Sum_probs=207.3
Q ss_pred cccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCc
Q 011763 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 126 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 204 (478)
.+..++|++.+.||+|+||.||++.+..+++.||||+++..... .....+..|+.++..+ .|+||+++++++.. ..
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~ 87 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DS 87 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec--CC
Confidence 34477899999999999999999999888999999999765432 3344556677777776 59999999999987 66
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..|++|||+++.+...+......+++..+..++.||+.||.|||+ .+|+||||+|+||+++.++.+||+|||++.....
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 799999999876665555545579999999999999999999997 5999999999999999999999999999875533
Q ss_pred CCCCCccccccCCcccCcccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCCCchhhcc
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~---~~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~ 359 (478)
.. ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||..... .+.+..+.... .+.
T Consensus 168 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~----- 238 (296)
T cd06618 168 SK--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PPS----- 238 (296)
T ss_pred CC--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CCC-----
Confidence 21 11223467889999998653 2478899999999999999999999976432 33333332210 000
Q ss_pred CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
. .....++.++.+||.+||..||.+||++.+++.||||..
T Consensus 239 --------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 239 --------------L-----PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred --------------C-----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0 000146788999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=316.98 Aligned_cols=253 Identities=19% Similarity=0.259 Sum_probs=199.1
Q ss_pred eeeeeeeeecCceEEEEEEECCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec----CCce
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGK--IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSCS 205 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~--~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----~~~~ 205 (478)
|.+.+.||+|+||.||+|++..++. .||+|.++.........+.+.+|+.+++.++|+||+++++++... ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999877665 699999876655556677788999999999999999999876432 1235
Q ss_pred EEEEEeeccCCchhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 206 IYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
.++||||+.++.+..+. .....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999975544322 123458999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhh
Q 011763 280 FSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 280 ~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 357 (478)
........ .......++.|+|||++.+ ..++.++|||||||++|+|++ |++||.+....+....+... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~~---- 233 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--NRL---- 233 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CCC----
Confidence 65432211 1112234678999998876 678999999999999999999 89999887665554444321 000
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.....++..+.++|.+||+.||++|||+.+++++
T Consensus 234 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 ----------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0012567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=320.74 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=201.9
Q ss_pred ccceeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|.+.+.||+|+||+||++.+ ..++..+|+|.+... .......+.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--G 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 56899999999999999999985 234567999988643 24445678899999999999999999999876 6
Q ss_pred ceEEEEEeeccCCchhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcE
Q 011763 204 CSIYLVFEYMEHDITGLLSCP-------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL 270 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~-------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~v 270 (478)
...|+||||++++.+..+... ...+++..+..++.||+.||+|||++|++||||||+|||+++++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 779999999997655444321 1248999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 011763 271 KLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKL 348 (478)
Q Consensus 271 kl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 348 (478)
||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+...
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999975533211 11122334678999998876 678999999999999999998 99999888776666655431
Q ss_pred cCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 349 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 349 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
. .+ .....++.++.+||.+||+.||.+|||+.+++.
T Consensus 239 ~--~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 R--VL--------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred C--cC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1 00 001246788999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=316.88 Aligned_cols=253 Identities=19% Similarity=0.266 Sum_probs=201.1
Q ss_pred eeeeeeeeecCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC----c
Q 011763 132 FEKLEKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----C 204 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~---~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~ 204 (478)
|++.+.||+|+||.||+|.... ++..||+|++..+.........+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998754 34789999998765555666778899999999999999999988754221 3
Q ss_pred eEEEEEeeccCCchhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccc
Q 011763 205 SIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a 278 (478)
..+++|||+.++.+..+. .....+++..+..++.||+.||.|||+++|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 479999999976554332 12346899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchh
Q 011763 279 NFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 279 ~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~ 356 (478)
+........ .......+..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+.... .+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~--- 234 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--RL--- 234 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CC---
Confidence 765432211 1111234668999998865 678999999999999999999 899998877766555443210 00
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.....++..+.++|.+||+.||.+|||+.+++++
T Consensus 235 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -----------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -----------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=318.96 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=200.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--R 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--C
Confidence 4689999999999999999999876 77889999886443 23344567889999999999999999998876 4
Q ss_pred ceEEEEEeeccCCchhhccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC---cEEEe
Q 011763 204 CSIYLVFEYMEHDITGLLSCPD-------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLA 273 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~-------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~ 273 (478)
...++||||+.++.+..+.... ..+++..+..++.||+.||.|||+++++|+||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 5689999999876555443221 2589999999999999999999999999999999999998765 59999
Q ss_pred ecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 011763 274 DFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (478)
Q Consensus 274 DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 351 (478)
|||+++........ .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence 99999765322111 1112233567999999876 668999999999999999997 99999987766555443221 00
Q ss_pred CCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
+ .....++..+.+||.+||+.||++|||+.++|+|
T Consensus 240 ~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0012567889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=315.54 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=200.0
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.+|++.+.||+|+||.||++.+. ++..+|+|++...... ...+.+|+.+++.++|+||+++++++.. ....|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEE
Confidence 47999999999999999999875 4668999998654332 2356779999999999999999998876 5678999
Q ss_pred EeeccCCchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 210 FEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 210 ~e~~~~~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|||++++.+. .+......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999876544 443434578999999999999999999999999999999999999999999999999987654322111
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---------------- 220 (256)
T ss_pred cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----------------
Confidence 112223457999998876 678999999999999999999 89999887776665554321100
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
......+..+.+|+.+||..+|++|||+.++++.
T Consensus 221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 ------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0012468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=336.61 Aligned_cols=263 Identities=29% Similarity=0.444 Sum_probs=215.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..-|..++.||-|+||.|.++...+|...||+|.+++.. +...++..+..|..||..-+.+-||+||..|++ .+.+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLY 705 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLY 705 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceE
Confidence 345999999999999999999999999999999997643 355666777789999999999999999888887 77899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc------
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS------ 281 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~------ 281 (478)
+||+|++|+.+..++-..+-|+|..++.|+.+|..|+++.|..|+|||||||+|||||.+|++||+|||+|.-+
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999998765555555567999999999999999999999999999999999999999999999999998421
Q ss_pred ---CCCCC--C------------------------------CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHH
Q 011763 282 ---NTGHR--Q------------------------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326 (478)
Q Consensus 282 ---~~~~~--~------------------------------~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~el 326 (478)
..+.. + .....+||+.|+|||+|.. ..|+..+|+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHH
Confidence 11100 0 0123578999999999987 6789999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchh-cccCCchhHHHHHHHhcCCCCCCcc
Q 011763 327 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRE-TFKDLPTTAVNLIETLLSVEPYKRA 405 (478)
Q Consensus 327 ltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~l~~Li~~mL~~dP~~R~ 405 (478)
+.|++||...+..++..+++. |. ..|.- ...+++.++.+||.++.+ +++.|+
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~n---------w~-----------------~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVIN---------WR-----------------NFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred hhCCCCccCCCCCcceeeeee---------hh-----------------hccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999998887776655532 21 11111 124789999999999654 788997
Q ss_pred C---HHHHHhCcccCCCCC
Q 011763 406 T---ASAALASEYFSTKPY 421 (478)
Q Consensus 406 t---a~e~L~hp~f~~~~~ 421 (478)
- ++|+-.||||+...|
T Consensus 918 Gkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 918 GKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred cccchhhhhcCccccccch
Confidence 4 778999999997655
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=339.79 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=217.2
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.+....||+|+|-+||+|.|..+|..||--.++...+ .+...+++..|+.+|+.|+|||||++++++.+.....+.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 3445789999999999999999999999766655444 45566889999999999999999999999988777789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEecC-CcEEEeecccccccCCCCC
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~~~~ 286 (478)
.|++..|.|..++.....+....++.|++||+.||.|||++. |||||||.+||+|+.+ |.|||+|+|+|......
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-- 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-- 199 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc--
Confidence 999999988888888888999999999999999999999984 9999999999999876 89999999999887653
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.....+|||.|||||++. ..|+..+||||||+.|+||+|+..||.......+ ++++.. |..|..+.
T Consensus 200 -~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~sl~-------- 266 (632)
T KOG0584|consen 200 -HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAALS-------- 266 (632)
T ss_pred -ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHHhh--------
Confidence 335589999999999886 5799999999999999999999999987665544 444433 33333221
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
+=-.+++++||.+||.. ...|+|+.|+|.||||...
T Consensus 267 -----------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 -----------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -----------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 11257899999999998 9999999999999999875
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=319.83 Aligned_cols=257 Identities=32% Similarity=0.542 Sum_probs=212.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+.|++.+.||+|+||.||++.+..++..|++|++..... ..+.+.+|+.+++.++|+||+++++.+.. ....|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEE
Confidence 5579999999999999999999988899999999975532 45667789999999999999999999987 578999
Q ss_pred EEeeccCCchhhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
|+||+++..+..+..... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-S 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-h
Confidence 999999765555544443 79999999999999999999999999999999999999999999999999986544321 1
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+... +.++
T Consensus 172 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~-------------- 235 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP-------------- 235 (286)
T ss_pred hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC--------------
Confidence 1223346788999998876 56899999999999999999999999877666555444321 0000
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
......++..+.+||.+||+.+|.+|||+.++|+|+||..
T Consensus 236 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 236 -----------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred -----------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 0001236788999999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=356.86 Aligned_cols=260 Identities=30% Similarity=0.476 Sum_probs=206.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL------ 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 202 (478)
..+|+.+..||+||||.||+++++-+|+.||||+|.... .......+.+|+..|.+|+|||||+++..+.+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 568999999999999999999999999999999998776 6677788999999999999999999865431100
Q ss_pred --------------------------------------------------------------------------------
Q 011763 203 -------------------------------------------------------------------------------- 202 (478)
Q Consensus 203 -------------------------------------------------------------------------------- 202 (478)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------ceEEEEEeeccCCchhhccCCCCCC-CHHHHHHHHHHHHHHHHHHHhC
Q 011763 203 -----------------------S--------CSIYLVFEYMEHDITGLLSCPDIKF-SEAQIKCYMNQLLHGLEHCHSR 250 (478)
Q Consensus 203 -----------------------~--------~~~~lv~e~~~~~ll~~~~~~~~~l-~~~~~~~i~~qil~aL~~LH~~ 250 (478)
+ ..+||=||||+..++..+...+... ....++.+++||+.||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 1468899999999888888777555 5788999999999999999999
Q ss_pred CceeccCCCCcEEEecCCcEEEeecccccccC-----------------CCCCCCccccccCCcccCcccccCCC--CCC
Q 011763 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-----------------TGHRQPLTSRVVTLWYRPPELLLGAT--DYG 311 (478)
Q Consensus 251 givHrDlkp~NILl~~~~~vkl~DFG~a~~~~-----------------~~~~~~~~~~~~t~~y~APE~l~~~~--~~~ 311 (478)
|||||||||.||+|++++.|||+|||+|+... .......+..+||.-|+|||++.+.. .|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999997611 11223567789999999999998755 699
Q ss_pred ChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-cCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHH
Q 011763 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL-CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 390 (478)
Q Consensus 312 ~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~ 390 (478)
.|+|+||||+||+||+. ||... .+.+..+..+ -|..|.+ ...+..--+.-.
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~g~iP~~-----------------------~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLRKGSIPEP-----------------------ADFFDPEHPEEA 848 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcccCCCCCC-----------------------cccccccchHHH
Confidence 99999999999999994 46532 3332222211 1111110 011122234457
Q ss_pred HHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 391 NLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 391 ~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
.+|+.||+.||.+||||.|+|++.||-
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 899999999999999999999999985
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=353.92 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=201.2
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++.++||+|+||.||+|++..+++.||+|+++.+.. .....+.+.+|+.++..++||||+++++++.+ .+..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 479999999999999999999999999999999975433 23445678899999999999999999999877 678999
Q ss_pred EEeeccCCchhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccc
Q 011763 209 VFEYMEHDITGLLSCP-----------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 277 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~-----------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~ 277 (478)
||||++++.+..+... ...++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999998665543321 12356677889999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-----------------CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 011763 278 ANFSNTGH-----------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 340 (478)
Q Consensus 278 a~~~~~~~-----------------~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~ 340 (478)
+....... .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 97652110 011123468999999999876 678999999999999999999999998754433
Q ss_pred HHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 341 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.... .....+. . ...+..+++.+.+++.+||..||++|++..+.|.+
T Consensus 239 i~~~--~~i~~P~-~-----------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYR--DVILSPI-E-----------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhh--hhccChh-h-----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2211 1111110 0 00123678899999999999999999987776654
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=299.21 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=201.2
Q ss_pred cccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec---C
Q 011763 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR---L 202 (478)
Q Consensus 126 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---~ 202 (478)
-+..++|.+.+.||+|||+-||+++...++..||+|++.... .+..+..++|++..++++||||++++++.... .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 344679999999999999999999999999999999997654 56678888999999999999999998876422 3
Q ss_pred CceEEEEEeeccCC-chhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEecCCcEEEeecc
Q 011763 203 SCSIYLVFEYMEHD-ITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFG 276 (478)
Q Consensus 203 ~~~~~lv~e~~~~~-ll~~~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFG 276 (478)
....||+++|...+ +++.+. ..+..+++.++..|+.+|++||.+||+.. ++||||||.|||+.+++.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 45689999999865 554443 24457999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCC--------CCccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 011763 277 LANFSNTGHR--------QPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 346 (478)
Q Consensus 277 ~a~~~~~~~~--------~~~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~ 346 (478)
.++...-.-. +.-.....|..|+|||.+.- ....+.++|||||||+||.|+.|..||... +
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~ 245 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------Y 245 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------h
Confidence 9875432110 00111234888999998743 234688999999999999999999999632 1
Q ss_pred HHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 347 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
+.-|....... .+....|. -..+++.+.+||+.||+.||.+||++.++|.+
T Consensus 246 ~~GgSlaLAv~------n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 246 QQGGSLALAVQ------NAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred hcCCeEEEeee------ccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11111110000 00000000 02478999999999999999999999999864
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=314.06 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=198.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.++||+|+||.||++++..+ ..||+|++...... .+.+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEE
Confidence 45799999999999999999988655 46999998754332 3457789999999999999999887643 45799
Q ss_pred EEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||++++.+..+.. ....+++..+..++.||+.||.|||+++|+|+||||+||++++++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999755544433 234578999999999999999999999999999999999999999999999999976543322
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+..... .+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~------------ 223 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP------------ 223 (262)
T ss_pred ccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-CC------------
Confidence 22223345678999998875 668999999999999999999 8899988776666555432110 00
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++..+.+||.+||+.||++||++.++++
T Consensus 224 ---------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 224 ---------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ---------------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01256788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.60 Aligned_cols=244 Identities=21% Similarity=0.285 Sum_probs=197.6
Q ss_pred eeeecCceEEEEEEE--CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeecc
Q 011763 137 KIGQGTYSSVFRARD--LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (478)
Q Consensus 137 ~LG~G~~g~V~~~~~--~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~ 214 (478)
.||+|+||.||+|.+ ..++..||+|+++.........+.+.+|+.+++.++||||+++++++.. ...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 589999999999964 4567899999997665555666778899999999999999999998753 45789999999
Q ss_pred CCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC--Ccccc
Q 011763 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSR 292 (478)
Q Consensus 215 ~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~--~~~~~ 292 (478)
++.+..+......+++..+..++.||+.||.|||++||+|+||||.|||++.++.+||+|||++......... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 8766655555567999999999999999999999999999999999999999999999999999765432211 11122
Q ss_pred ccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCC
Q 011763 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371 (478)
Q Consensus 293 ~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 371 (478)
.++..|+|||.+.. ..++.++|||||||++|||++ |.+||...+..+....+..... ++
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~------------------ 218 (257)
T cd05116 159 KWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-ME------------------ 218 (257)
T ss_pred CCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CC------------------
Confidence 33578999998865 668889999999999999998 9999988777666555432110 00
Q ss_pred CCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 372 ~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++++.+||.+||+.||++||++.++..
T Consensus 219 ---------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 219 ---------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ---------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 01257889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=320.61 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=202.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..+|++.+.||+|+||.||+|.+.. .++.||||+++... .....+.+.+|+.++..++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~ 80 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--E 80 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C
Confidence 5679999999999999999998754 35789999997543 33445667889999999999999999999877 5
Q ss_pred ceEEEEEeeccCCchhhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC
Q 011763 204 CSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~----------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~ 267 (478)
...++++||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 66899999998765443321 12357889999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011763 268 GVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345 (478)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i 345 (478)
+.+||+|||+++....... .......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875533221 11223344778999999876 568999999999999999998 88999888777666665
Q ss_pred HHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 346 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
......+ ....++..+.+||.+||+.||.+||++.+++..
T Consensus 240 ~~~~~~~----------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLP----------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCC----------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 4321100 013578889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.02 Aligned_cols=256 Identities=20% Similarity=0.266 Sum_probs=199.0
Q ss_pred cccccceeeeeeeeecCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceee
Q 011763 126 PLRADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLIT 199 (478)
Q Consensus 126 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~ 199 (478)
....++|.+.+.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|.++. ||||+++++++.
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 34467899999999999999999986432 3479999997543 3444567889999999996 999999999997
Q ss_pred ecCCceEEEEEeeccCCchhhccCC-------------------------------------------------------
Q 011763 200 SRLSCSIYLVFEYMEHDITGLLSCP------------------------------------------------------- 224 (478)
Q Consensus 200 ~~~~~~~~lv~e~~~~~ll~~~~~~------------------------------------------------------- 224 (478)
. ...+||||||++++.+..+...
T Consensus 112 ~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 K--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred c--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 6 6779999999987654332110
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 011763 225 -----------------------------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263 (478)
Q Consensus 225 -----------------------------------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NIL 263 (478)
...+++..+..++.||+.||.|||+++|+|+||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 124788889999999999999999999999999999999
Q ss_pred EecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 011763 264 VNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQ 341 (478)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~ 341 (478)
++.++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 99999999999999976533211 11223345778999999876 678999999999999999997 9999987554333
Q ss_pred HHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 342 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+...+.....++ ....++.++.+||.+||+.||++|||+.++.+
T Consensus 349 ~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 349 FYNKIKSGYRMA---------------------------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 332222110000 01256788999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=332.96 Aligned_cols=267 Identities=23% Similarity=0.344 Sum_probs=235.0
Q ss_pred CcccccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeec
Q 011763 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (478)
Q Consensus 123 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 201 (478)
.+..+...+++++..||-|+||.|=++........+|+|++++... +..+.+.+..|-+||..++.|+||++|..|.+
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd- 491 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD- 491 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-
Confidence 4445667889999999999999999998766555699999986544 56667888899999999999999999999987
Q ss_pred CCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
..++||+||-|-|+.+..+.+..+.|.+..++.|+..+++|++|||.+|||+|||||+|+||+.+|-+||.|||+|+..
T Consensus 492 -~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 492 -SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred -chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence 7899999999999888888888889999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
..+. ...+++|||.|.|||++++ +..+.++|.|+||+++|||++|.|||.+.+...++..|...+...
T Consensus 571 ~~g~--KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--------- 638 (732)
T KOG0614|consen 571 GSGR--KTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--------- 638 (732)
T ss_pred ccCC--ceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---------
Confidence 7653 3467899999999999997 678999999999999999999999999999999999988754221
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
+....++..+.+||+++...+|.+|.- +.++-+|.||..-.|
T Consensus 639 ------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 639 ------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred ------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 111367888999999999999999986 899999999986554
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=314.96 Aligned_cols=254 Identities=17% Similarity=0.265 Sum_probs=202.2
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 201 (478)
+..++|++.+.||+|+||.||++.+... +..||+|.+.... .......+.+|+.+|..++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST- 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-
Confidence 3467899999999999999999987643 4789999986443 33444567789999999999999999999877
Q ss_pred CCceEEEEEeeccCCchhhccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEE
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCP----------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLK 271 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~----------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vk 271 (478)
....|+||||++++.+..+... ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+|
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 5779999999987555443321 22478889999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHc
Q 011763 272 LADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLC 349 (478)
Q Consensus 272 l~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 349 (478)
|+|||+++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~ 237 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-G 237 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-C
Confidence 999999875543211 12223345778999998875 568999999999999999998 9999988776665554431 1
Q ss_pred CCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 350 g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
..++ ....++..+.+||.+||+.+|.+|||+.++++
T Consensus 238 ~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 238 GHLD---------------------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1100 01235788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=319.24 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=202.9
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeee
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 200 (478)
+..++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.++.++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3467899999999999999999987643 3789999987543 334456678899999999 89999999999876
Q ss_pred cCCceEEEEEeeccCCchhhcc----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 011763 201 RLSCSIYLVFEYMEHDITGLLS----------------CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (478)
Q Consensus 201 ~~~~~~~lv~e~~~~~ll~~~~----------------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl 264 (478)
...+++||||+.++.+..+. .....+++..+..++.||+.||.|||+++|+|+||||+|||+
T Consensus 88 --~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 88 --EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred --CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 56799999999876554443 223568999999999999999999999999999999999999
Q ss_pred ecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011763 265 NNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQL 342 (478)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~ 342 (478)
++++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999999976543211 11122233567999998876 678999999999999999997 99999887766555
Q ss_pred HHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 343 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
..+..... + ......+..+.+||.+||..||.+|||+.++|++
T Consensus 245 ~~~~~~~~--~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 245 KLLKEGYR--M--------------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHcCCc--C--------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 44432110 0 0012457889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=314.91 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=204.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
..+|+++++||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.+++.++|+||+++++++.. ....++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEE
Confidence 4579999999999999999999877 8899999987543 2334567889999999999999999998877 567899
Q ss_pred EEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||++++.+..+.. ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999855544433 334689999999999999999999999999999999999999999999999999976543221
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
. .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+.+..+......+
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 224 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP------------- 224 (261)
T ss_pred c-ccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC-------------
Confidence 1 123344678999998876 678899999999999999998 899999888777666654321110
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++.+.++|.+||+.||.+|||+.++++
T Consensus 225 ---------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 ---------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.86 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=198.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|+++++||+|+||.||++.+. .+..||+|.+...... .+.+.+|+.++++++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEE
Confidence 468999999999999999999865 5667999998765433 2457889999999999999999987743 45789
Q ss_pred EEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
+|||+.++.+..+.. ....+++..++.++.||+.||.|||+++|+|+||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999998765544432 234589999999999999999999999999999999999999999999999999976543221
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.... .++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~------------ 223 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RMP------------ 223 (260)
T ss_pred ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC------------
Confidence 11122234567999998875 668899999999999999999 899998877766665553211 000
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHH
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L 411 (478)
.....+..+.+||.+||..||++|||+.+++
T Consensus 224 ---------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 224 ---------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred ---------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 0135678899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=311.89 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=202.7
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|++.+.||.|+||+||++.+. .++.||||.+...... ...+.+|+.+++.++|+||+++++++.. ....+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceE
Confidence 4678999999999999999999975 4577999998755432 3567789999999999999999998876 56789
Q ss_pred EEEeeccCCchhhcc-CC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 208 LVFEYMEHDITGLLS-CP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 208 lv~e~~~~~ll~~~~-~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||++++.+..+. .. ...+++..+..++.||+.||.|||+++++|+||||+||++++++.++|+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999876554443 32 2468999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.........+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 225 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR----------- 225 (261)
T ss_pred hhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 111122233567999998876 668999999999999999998 9999998877776666543211110
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+.++.++|.+||..||++||++.++++
T Consensus 226 -----------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 226 -----------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -----------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1245788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=322.83 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=198.5
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcE--EEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCC
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~--vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 203 (478)
+..++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~ 80 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 80 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--C
Confidence 3467899999999999999999998777754 577766532 2344556778899999999 89999999999877 5
Q ss_pred ceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC
Q 011763 204 CSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~ 267 (478)
..+|+||||++++.+..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 679999999987554443321 2357899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011763 268 GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 346 (478)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~ 346 (478)
+.+||+|||++....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred CcEEeCccccCcccchhh--hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 999999999986432111 1111223567999998865 568899999999999999998 999998777665544432
Q ss_pred HHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 347 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
... .+ .....+++++.+||.+||+.||++||++.++|.+
T Consensus 238 ~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGY--RL--------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCC--cC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 100 00 0012467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.47 Aligned_cols=252 Identities=18% Similarity=0.302 Sum_probs=199.8
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..++|+++++||.|+||+||+|++..++. .||+|++.... .......+.+|+.++..++|+||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT--- 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---
Confidence 35689999999999999999998776665 48999987543 34455678889999999999999999998865
Q ss_pred ceEEEEEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...++++||++++.+ ..+......+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 346799999987544 4444445578999999999999999999999999999999999999999999999999997664
Q ss_pred CCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 283 TGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 283 ~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||...........+ .....++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~------ 232 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERLPQ------ 232 (279)
T ss_pred cccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCC------
Confidence 32211 1112234677999999876 568999999999999999998 99999876654443322 21111110
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+.++.++|.+||..||++||++.+++.
T Consensus 233 ---------------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 233 ---------------------PPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ---------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1246778999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.05 Aligned_cols=259 Identities=20% Similarity=0.277 Sum_probs=203.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCC----------------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTG----------------KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~----------------~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv 192 (478)
..+|++++.||+|+||.||++.+...+ ..||+|++.... .....+.+.+|+.+++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 458999999999999999999876543 568999987553 345567788999999999999999
Q ss_pred eecceeeecCCceEEEEEeeccCCchhhccCCCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 011763 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----------KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 261 (478)
Q Consensus 193 ~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~-----------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~N 261 (478)
++++++.. ....+++|||+.++.+..+..... .+++..++.++.||+.||.|||+++|+|+||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99999877 567899999998765554433322 68999999999999999999999999999999999
Q ss_pred EEEecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCh
Q 011763 262 LLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKPILQGRTE 338 (478)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt--G~~pf~~~~~ 338 (478)
|+++.++.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ +..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999875433221 11223345778999998876 568999999999999999998 7789987776
Q ss_pred HHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 339 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.+.+..+.......... ........++.++.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQ---------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhcccccccc---------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 66655554321110000 000011246788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=313.89 Aligned_cols=252 Identities=30% Similarity=0.458 Sum_probs=201.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++.+.||.|+||.||++++..++..||||.+..... .......+.+|+.+++.++|+||+++++++.. ....++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 479999999999999999999988999999998865332 33445677889999999999999999999987 668999
Q ss_pred EEeeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 209 VFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 209 v~e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
+|||++++.+..+.. ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999865544322 3456899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHcCCCCchhhccCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV--EQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
. .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.... +....+.. ...++.
T Consensus 160 ~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-------- 228 (267)
T cd08229 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPL-------- 228 (267)
T ss_pred C-cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CCCCCC--------
Confidence 2 12233467889999999876 56889999999999999999999999765432 22222211 110000
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++..+.+||.+||..||++|||+.++++
T Consensus 229 ------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 229 ------------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ------------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 01246788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=310.19 Aligned_cols=252 Identities=31% Similarity=0.458 Sum_probs=202.0
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|+.++++++|+||+++++++.. ....++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 479999999999999999999998999999999875332 34446778899999999999999999999987 567899
Q ss_pred EEeeccCCchhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 209 VFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 209 v~e~~~~~ll~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
||||++++.+..+. .....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999975554332 23456899999999999999999999999999999999999999999999999998755432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHcCCCCchhhccCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+....+......+
T Consensus 160 ~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 227 (267)
T cd08224 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP---------- 227 (267)
T ss_pred C-cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC----------
Confidence 2 12233457888999999876 6688999999999999999999999965432 12222221100000
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.+ ...++..+.++|.+||..+|++|||+.++++
T Consensus 228 ---------~~--------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 228 ---------LP--------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---------CC--------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 1246778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.83 Aligned_cols=250 Identities=23% Similarity=0.295 Sum_probs=197.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGK--IVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~--~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 206 (478)
++|++.+.||+|+||.||+|++..++. .+++|.++... .....+.+.+|+.++.++ +||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence 479999999999999999999877664 46888876322 334456678899999999 79999999998876 5678
Q ss_pred EEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcE
Q 011763 207 YLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL 270 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~v 270 (478)
|+||||++++.+..+... ...+++..++.++.||+.||+|||++||+||||||+|||+++++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 999999987555433321 1258899999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHc
Q 011763 271 KLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLC 349 (478)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 349 (478)
||+|||++....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999986432211 1111122457999998876 668999999999999999997 999998877766555543211
Q ss_pred CCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 350 g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.. .....++..+.+||.+||..||.+|||++++++.
T Consensus 236 ~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RM----------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0012577889999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=318.66 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=201.6
Q ss_pred ccccceeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeee
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 200 (478)
+..++|.+.+.||+|+||.||++.+ ..++..||+|+++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 3356899999999999999999975 2345689999987543 234456788899999999 79999999999877
Q ss_pred cCCceEEEEEeeccCCchhhcc-CC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccc
Q 011763 201 RLSCSIYLVFEYMEHDITGLLS-CP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (478)
Q Consensus 201 ~~~~~~~lv~e~~~~~ll~~~~-~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a 278 (478)
....|+||||+.++.+..+. .. ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++
T Consensus 111 --~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 111 --GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 56799999999976554443 22 234899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchh
Q 011763 279 NFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 279 ~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~ 356 (478)
......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+.........++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--- 264 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--- 264 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC---
Confidence 755432211 1122344678999999876 568999999999999999998 9999988776555444432110000
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++.+.+||.+||..||++|||+.+++.
T Consensus 265 ------------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 265 ------------------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=306.08 Aligned_cols=264 Identities=23% Similarity=0.416 Sum_probs=220.5
Q ss_pred cccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCC
Q 011763 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (478)
Q Consensus 126 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 203 (478)
.+..++|.+++.||+|+|.+|.+++.+.+.+.||+|+++++-. +.+.......|-.+...- +||++|-|+..|+. +
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--e 323 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--E 323 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--c
Confidence 3457899999999999999999999999999999999987655 345566777888888766 89999999999987 6
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..+++|.||++|+.+....+...+|+++.++.|..+|+.||.|||++|||+||||..||||+..|++||+|+|+++..-.
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 78999999999988888778888999999999999999999999999999999999999999999999999999975433
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHH-HHcCCCCch
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-------RTEVEQLHKIF-KLCGSPPDD 355 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~-------~~~~~~~~~i~-~~~g~~~~~ 355 (478)
. .....+.+|||.|+|||++.+ ..|+..+|+|+||++|+||+.|+.||.- .+..+.+.+++ +.--
T Consensus 404 ~-gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----- 476 (593)
T KOG0695|consen 404 P-GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----- 476 (593)
T ss_pred C-CcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-----
Confidence 2 234467899999999999987 7899999999999999999999999952 12233333332 1100
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC------HHHHHhCcccCCCCCC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPYA 422 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t------a~e~L~hp~f~~~~~~ 422 (478)
.....++-.+..+++..|++||.+|.. ..++-.|+||....|.
T Consensus 477 ------------------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 477 ------------------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred ------------------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 011245667888999999999999964 6799999999976653
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=365.48 Aligned_cols=263 Identities=29% Similarity=0.470 Sum_probs=220.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+++...+||.|.||.||-|.+..+|...|+|.++...........+.+|+.+|..++|||+|+.+++-.+ .+.++|.|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rekv~IFM 1313 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REKVYIFM 1313 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec--HHHHHHHH
Confidence 5677889999999999999999999999999998776666666778899999999999999999998877 56689999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC---CC
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQ 287 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---~~ 287 (478)
|||+++.+..+.....-.++...+.+..|++.|+.|||++|||||||||+||+|+.+|.+|++|||.|....... ..
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999998888887778889999999999999999999999999999999999999999999999997665432 12
Q ss_pred CccccccCCcccCcccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 288 PLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~--~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
......||+.|||||++.+.. ....++|||||||++.||+||+-||...+..=++.-.+.....|+
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq------------ 1461 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ------------ 1461 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC------------
Confidence 335568899999999998743 456789999999999999999999986554433322232222221
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
.| ..++.+..+||.+||..||.+|+++.|+|+|.|=+.....
T Consensus 1462 ------~P---------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1462 ------IP---------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred ------Cc---------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence 11 2488899999999999999999999999999997754433
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=316.64 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=200.3
Q ss_pred ccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..+|.+.+.||+|+||.||++.+. .++..+++|.+.... ....+.+.+|+.++++++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGD--G 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--C
Confidence 457999999999999999999853 345678999886432 3444667899999999999999999999876 6
Q ss_pred ceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC
Q 011763 204 CSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~ 267 (478)
...++||||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 679999999987655544321 2348999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011763 268 GVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345 (478)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i 345 (478)
+.++|+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999975543221 11223345788999998876 678899999999999999998 99999887776655443
Q ss_pred HHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 346 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
... ..+ .....++..+.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~--~~~--------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQG--RVL--------------------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCC--CCC--------------------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 221 000 001246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=309.68 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=202.4
Q ss_pred eeeeecCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEee
Q 011763 136 EKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~ 212 (478)
+.||+|+||.||+|.+... +..|++|++....... ..+.+.+|+.+++.++|+||+++++++.. ...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 4689999999999998765 8899999998654332 46778899999999999999999999887 6789999999
Q ss_pred ccCCchhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 213 MEHDITGLLSCP---------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 213 ~~~~ll~~~~~~---------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
++++.+..+... ...+++..++.++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||.+.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 976555544443 36799999999999999999999999999999999999999999999999999976654
Q ss_pred CCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 284 GHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 284 ~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
... .......++..|+|||.+.. ..++.++|||||||++|+|++ |..||......+....+... ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~~~-------- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--YRL-------- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCC--------
Confidence 321 11233456888999998876 578999999999999999999 69999988766665555431 000
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.....++.++.++|.+||..||++|||+.+++++
T Consensus 227 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 227 ------------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0112468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=311.24 Aligned_cols=248 Identities=21% Similarity=0.372 Sum_probs=200.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|+++++||+|+||.||+|... +++.||+|.+...... ...+.+|+.++++++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEE
Confidence 568999999999999999999864 5788999998755433 3467789999999999999999988743 45899
Q ss_pred EEeeccCCchhhc-cC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLL-SC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~-~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
+|||+.++.+..+ .. ....+++..+..++.||+.||.|||++|++|+||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999987544433 22 334689999999999999999999999999999999999999999999999999976543222
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......++..|+|||++.. ..++.++|||||||++|+|++ |++||.+.+..+....+......+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 223 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP------------- 223 (260)
T ss_pred ccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-------------
Confidence 22223344678999998875 668899999999999999998 999999887766655543221110
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....+.++.+||.+||+.||++|||+++++.
T Consensus 224 ---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 ---------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ---------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=313.37 Aligned_cols=254 Identities=20% Similarity=0.354 Sum_probs=202.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|++++.||.|+||.||+|+... +.+.|++|.+.... .......+.+|+.+|++++|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 80 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--A 80 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC--C
Confidence 4589999999999999999999653 35679999886433 23345678889999999999999999998876 5
Q ss_pred ceEEEEEeeccCCchhhccCCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEee
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDI---------KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D 274 (478)
...|+||||++++.+..+..... .+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 67899999999766655443332 689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCC
Q 011763 275 FGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPP 353 (478)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~ 353 (478)
||++...............++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........+..+.... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~--~~ 237 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK--LE 237 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC--cC
Confidence 99986543222222233455778999998876 567889999999999999998 889998766655554432210 00
Q ss_pred chhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
| .....++..+.++|.+||..||.+|||+.++|.+
T Consensus 238 ---~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 238 ---L----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---C----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 0012577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=311.05 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=203.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.++|+..+.||+|+||.||++.+..++. .+|+|.+.... .......+..|+.++..++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCC
Confidence 4589999999999999999999876554 79999986543 33445667889999999999999999999876 567
Q ss_pred EEEEEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.|+||||++++.+..+. .....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 89999999986665554 33457899999999999999999999999999999999999999999999999998755432
Q ss_pred CCCCccc--cccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 285 HRQPLTS--RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 285 ~~~~~~~--~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
....... ...+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~~------- 231 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLPA------- 231 (268)
T ss_pred cccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCCC-------
Confidence 2111111 122457999998876 568899999999999999997 999998877766665554321 1110
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
...++.++.+||.+||..||++||++.++++
T Consensus 232 --------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 --------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred --------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1246788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=308.19 Aligned_cols=246 Identities=33% Similarity=0.494 Sum_probs=204.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCC
Q 011763 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (478)
Q Consensus 138 LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (478)
||.|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++.+.. +..+|+||||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 68999999999999888999999998765432 3355677889999999999999999999876 67899999999776
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCC
Q 011763 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296 (478)
Q Consensus 217 ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~ 296 (478)
.+..+......+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCc
Confidence 555555555578999999999999999999999999999999999999999999999999987654321 1223455688
Q ss_pred cccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCc
Q 011763 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 376 (478)
Q Consensus 297 ~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (478)
.|++||.+.+ ..++.++|+|+||+++|+|++|..||...+..+....+... .++
T Consensus 158 ~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----------------------- 211 (250)
T cd05123 158 EYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PLR----------------------- 211 (250)
T ss_pred cccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CCC-----------------------
Confidence 8999998876 55788999999999999999999999877765544444321 000
Q ss_pred cchhcccCCchhHHHHHHHhcCCCCCCccCH---HHHHhCccc
Q 011763 377 SLRETFKDLPTTAVNLIETLLSVEPYKRATA---SAALASEYF 416 (478)
Q Consensus 377 ~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta---~e~L~hp~f 416 (478)
....++..+.++|.+||..||++|||+ .++++||||
T Consensus 212 ----~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 ----FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ----CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 012357889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=314.14 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=196.7
Q ss_pred eeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 132 FEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~----~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
|++++.||+|+||+||++. ...++..||+|+++... .......+.+|+.+|+.++||||+++++++.......+|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 4999999999999998864 34567899999987553 233456677899999999999999999988765556789
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||+.++.+..+... ..+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.........
T Consensus 85 lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred EEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 99999998766655443 35899999999999999999999999999999999999999999999999999765432211
Q ss_pred --CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-cCCCCchhhccCCCCC
Q 011763 288 --PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL-CGSPPDDYWKKSKLPH 364 (478)
Q Consensus 288 --~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~-~g~~~~~~~~~~~~~~ 364 (478)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +..+... .+......+.. ...
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~ 238 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIE--LLE 238 (283)
T ss_pred hccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhh--hhh
Confidence 1112234667999998876 66889999999999999999999998654321 1111100 00000000000 000
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.. .. ......++..+.+|+.+||+.||++|||+.++++
T Consensus 239 ~~---~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RG---MR-------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cC---CC-------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00 0011356789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=316.04 Aligned_cols=264 Identities=25% Similarity=0.412 Sum_probs=204.4
Q ss_pred ceeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCc
Q 011763 131 AFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~---~~~~~vAlK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 204 (478)
+|++.+.||.|+||.||++++. .+++.||||+++.... .....+.+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4889999999999999999864 4678899999875422 123345677899999999 69999999998876 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+||||+.++.+.........+++..++.++.|++.+|.|||+.+++|+||+|.||+++.++.++|+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 79999999998666555555567899999999999999999999999999999999999999999999999998765433
Q ss_pred CCCCccccccCCcccCcccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~-~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.........++..|+|||.+.+.. .++.++||||||+++|+|++|..||...........+....-..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 227 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS----------- 227 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-----------
Confidence 222222345788999999886532 36789999999999999999999997543221111111110000
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC---HHHHHhCcccCCCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPY 421 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t---a~e~L~hp~f~~~~~ 421 (478)
. ......++..+.+||.+||+.||++||| +.++|+||||+...+
T Consensus 228 -------~-------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 228 -------K-------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred -------C-------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 0 0001246788999999999999999998 567899999987554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=311.08 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=202.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTG---KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~---~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.++|++.+.||+|+||.||+|.+..++ ..+|+|.++... .....+.+.+|+.++..++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCc
Confidence 458999999999999999999876444 379999987543 33455678889999999999999999999876 567
Q ss_pred EEEEEeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.|+||||++++.+..+ ......+++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 8999999987655444 344456899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcc--ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 285 HRQPLT--SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 285 ~~~~~~--~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
...... ....+..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+.+.... +
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~-------- 229 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL-P-------- 229 (267)
T ss_pred cceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC-C--------
Confidence 211111 1222567999999876 668999999999999999886 99999887766655554332110 0
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++..+.+|+.+||+.+|.+||++.++++
T Consensus 230 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 -------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 01246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=324.40 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=196.7
Q ss_pred ccceeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 202 (478)
.++|++.+.||.|+||+||+|++ ..+++.||||+++... .......+.+|+.+|.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 46899999999999999999984 3467899999997543 234456678899999999 789999999988654
Q ss_pred CceEEEEEeeccCCchhhccCC----------------------------------------------------------
Q 011763 203 SCSIYLVFEYMEHDITGLLSCP---------------------------------------------------------- 224 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~---------------------------------------------------------- 224 (478)
+..+++||||++++.+..+...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4568999999998655433211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-CCcccccc
Q 011763 225 ---------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVV 294 (478)
Q Consensus 225 ---------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~ 294 (478)
...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........ .......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12367888899999999999999999999999999999999999999999999876432211 11112234
Q ss_pred CCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 295 t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+..|+|||++.+ ..++.++|||||||++|+|++ |..||........+.........++
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 302 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-------------------- 302 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC--------------------
Confidence 667999999876 678999999999999999997 9999987544333322221100000
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.....++++.+++..||+.||.+|||+.++++|
T Consensus 303 -------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 -------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=308.79 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=198.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|.+.+.||+|+||.||++.+..+ ..+|+|++..... ..+.+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEE
Confidence 35799999999999999999987654 4699998865432 23457789999999999999999887743 45789
Q ss_pred EEeeccCC-chhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHD-ITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~-ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||+.++ +...+.. ....+++..+..++.||+.||.|||+.||+|+||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999975 4444433 233588999999999999999999999999999999999999999999999999976543322
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.... .++
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~------------ 223 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RMP------------ 223 (260)
T ss_pred cccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC------------
Confidence 22222344678999998875 668999999999999999999 999999887766665553311 000
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++..+.+||.+||..||.+||++.++++
T Consensus 224 ---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 224 ---------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ---------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01256788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=316.34 Aligned_cols=259 Identities=22% Similarity=0.282 Sum_probs=200.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCC--------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDT--------------GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~--------------~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 194 (478)
.++|++.+.||+|+||.||+|++..+ ...||+|+++... .......+.+|+++|.+++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45899999999999999999987543 2358999987543 34555678899999999999999999
Q ss_pred cceeeecCCceEEEEEeeccCCchhhccCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 011763 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPD------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (478)
Q Consensus 195 ~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NI 262 (478)
++++.. ....|+||||+.++.+..+.... ..+++..+..++.||+.||.|||+++++|+||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999876 56789999999986554433211 2368889999999999999999999999999999999
Q ss_pred EEecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCChH
Q 011763 263 LVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKPILQGRTEV 339 (478)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt--G~~pf~~~~~~ 339 (478)
|+++++.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ +..||...+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999875433211 11122334678999999876 568999999999999999998 66889887766
Q ss_pred HHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 340 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+.+..+.......... ......+.+++.+.+||.+||..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQ---------------------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhcccc---------------------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 6655543321100000 000011246789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=313.70 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=200.3
Q ss_pred ccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..+|.+.++||+|+||.||++... .++..+|+|.+... .......+.+|+++++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE--G 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--C
Confidence 457999999999999999999742 35678999987643 34555678899999999999999999998877 5
Q ss_pred ceEEEEEeeccCCchhhccCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC
Q 011763 204 CSIYLVFEYMEHDITGLLSCPD---------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~---------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~ 268 (478)
...+++|||+.++.+..+.... ..+++..+..++.||+.||.|||++||+|+||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 6789999999876554443221 3488999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011763 269 VLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 346 (478)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~ 346 (478)
.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 999999999875432211 11122234678999998876 668999999999999999998 999998877766655543
Q ss_pred HHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 347 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
... ++ .....+++.+.+||.+||+.||.+||++.+++.
T Consensus 239 ~~~--~~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGR--EL--------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCc--cC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 211 00 001256788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=306.93 Aligned_cols=244 Identities=23% Similarity=0.353 Sum_probs=199.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||.|+||.||++.. .++.||+|++..... ..+.+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 56899999999999999999986 478999999975532 45678889999999999999999999877 677999
Q ss_pred EEeeccCCchhhccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||++++.+..+..... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||.+.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999999755554433322 68999999999999999999999999999999999999999999999999997664321
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.....+..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+....+.... .+
T Consensus 157 ---~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~------------- 218 (256)
T cd05039 157 ---DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-RM------------- 218 (256)
T ss_pred ---ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC-------------
Confidence 12234567999998875 678899999999999999997 999998776655444332210 00
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....+++.+.+||.+||..+|++|||+.++++
T Consensus 219 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 --------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 001246889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=317.32 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=198.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-------TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 200 (478)
.++|.+.+.||+|+||.||++++.. +...||+|++..+. .......+.+|+.+++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 5789999999999999999998643 23579999997543 334456677899999999 79999999999877
Q ss_pred cCCceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 011763 201 RLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (478)
Q Consensus 201 ~~~~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl 264 (478)
....|+||||+.++.+..+... ...+++..+..++.||+.||+|||++|++||||||+|||+
T Consensus 96 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 96 --DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 5679999999987554433321 1348889999999999999999999999999999999999
Q ss_pred ecCCcEEEeecccccccCCCCCCC-ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011763 265 NNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQL 342 (478)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~-~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~ 342 (478)
+.++.+||+|||++.......... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 999999999999987554221111 111223567999999876 668999999999999999998 88999876655444
Q ss_pred HHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 343 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
..+.... .+ .....++.++.+||.+||..+|.+|||+.+++++
T Consensus 253 ~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKEGH--RM--------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHcCC--CC--------------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4332210 00 0112567899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=308.24 Aligned_cols=244 Identities=20% Similarity=0.281 Sum_probs=194.8
Q ss_pred eeeeecCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEee
Q 011763 136 EKIGQGTYSSVFRARDLDTG---KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~---~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~ 212 (478)
++||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.++|+||+++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEe
Confidence 46999999999999875544 78999999866543 445677889999999999999999987753 457999999
Q ss_pred ccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc--
Q 011763 213 MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-- 290 (478)
Q Consensus 213 ~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~-- 290 (478)
++++.+..+......+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|||+++...........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 987655555555557899999999999999999999999999999999999999999999999999766433221111
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+... ...
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~----------------- 217 (257)
T cd05060 157 AGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ERL----------------- 217 (257)
T ss_pred CccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CcC-----------------
Confidence 1122457999998876 668999999999999999998 99999887765554444221 000
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++..+.+||.+||..||.+||++.++++
T Consensus 218 ----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 218 ----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=312.16 Aligned_cols=251 Identities=17% Similarity=0.273 Sum_probs=196.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.++|++++.||+|+||+||+|.+..+++ .|++|.+.... .......+..|+.++..++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC---C
Confidence 5689999999999999999999877776 47777765322 23344567788889999999999999998743 4
Q ss_pred eEEEEEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..++++||+.++.+ ..+......+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 57889999986544 44444456789999999999999999999999999999999999999999999999999976543
Q ss_pred CCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 284 GHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 284 ~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+......... +.....++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~------- 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-LEKGERLAQ------- 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCcCCC-------
Confidence 2221 1223345678999999876 668999999999999999998 9999988765443322 221111100
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+.++.+++.+||..||.+|||+.++++
T Consensus 233 --------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 233 --------------------PQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred --------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0124567899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=306.41 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=201.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
..+|++.+.||.|+||.||++.+. .+..+|+|++...... ...+.+|+++++.++||||+++++++.. ....|+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 76 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICL 76 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEE
Confidence 357999999999999999999875 4678999998755433 2456789999999999999999998876 567899
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||+.++.+..+. .....+++..++.++.||+.+|.|||+++++|+||||+||+++.++.++|+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999986665444 33456899999999999999999999999999999999999999999999999998755432211
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
.......+..|+|||++.+ ..++.++|||||||++|+|++ |..||......+.+..+.......
T Consensus 157 ~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 221 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY-------------- 221 (256)
T ss_pred ccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC--------------
Confidence 1222334678999998876 668899999999999999998 999998877666655543211000
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
. ....+..+.+|+.+||+.+|++|||+.++|++
T Consensus 222 --------~------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 222 --------K------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred --------C------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0 01357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=308.20 Aligned_cols=245 Identities=19% Similarity=0.335 Sum_probs=196.6
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|++.+.||+|+||.||++.. .+..||+|.+..+. ..+.+.+|+.++++++|+||+++++++... ....|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceE
Confidence 356899999999999999999976 47789999986432 245677899999999999999999876543 45689
Q ss_pred EEEeeccCCchhhc-cCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 208 LVFEYMEHDITGLL-SCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 208 lv~e~~~~~ll~~~-~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||++++.+..+ .... ..+++..+..++.||+.||.|||++||+||||||+||++++++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999987554443 3322 348899999999999999999999999999999999999999999999999987543321
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.....+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.... .+
T Consensus 157 ----~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~----------- 218 (256)
T cd05082 157 ----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KM----------- 218 (256)
T ss_pred ----CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CC-----------
Confidence 22334567999998876 668899999999999999997 999998776655554442210 00
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++..+.+||.+||+.||++|||+.++++
T Consensus 219 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 219 ---------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=313.93 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=196.8
Q ss_pred ceeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
+|++.+.||+|+||.||+|.+.. ....+++|++.... .......+.+|+.+++.++||||+++++.+.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 47889999999999999998643 23578999886543 33445678889999999999999999998876 567
Q ss_pred EEEEEeeccCCchhhccC------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 011763 206 IYLVFEYMEHDITGLLSC------------------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 261 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~------------------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~N 261 (478)
.+++|||+.++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 899999999765554321 12357899999999999999999999999999999999
Q ss_pred EEEecCCcEEEeecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 011763 262 LLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEV 339 (478)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~ 339 (478)
||+++++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999754322111 1122234678999998876 668999999999999999998 99999877655
Q ss_pred HHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 340 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+....+..... + .....++.++.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGYR-M---------------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCCC-C---------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 54433321100 0 001246788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=309.43 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=202.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
...|++.+.||.|+||.||+|.+..+++ .||||++.... .......+..|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCc
Confidence 3469999999999999999999876654 69999986542 44556778899999999999999999998876 667
Q ss_pred EEEEEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.++||||++++.+..+. .....+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 89999999986655443 34456899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCC-ccccc---cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 285 HRQP-LTSRV---VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 285 ~~~~-~~~~~---~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
.... ..... .+..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+....+......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------ 232 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP------ 232 (269)
T ss_pred ccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC------
Confidence 2111 11111 1457999999876 678999999999999999886 9999988777666555532111000
Q ss_pred CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
...++..+.+++.+||..+|.+||++.+++.
T Consensus 233 ----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 233 ----------------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ----------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1256788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=308.92 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=201.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.++|.+.+.||+|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CC
Confidence 45799999999999999999987543 4568999886443 34556678899999999999999999998865 34
Q ss_pred EEEEEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.|+||||++++.+..+. .....+++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 78999999876555444 33446899999999999999999999999999999999999999999999999999765433
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
..........+..|+|||.+.. ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------------ 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------------ 227 (270)
T ss_pred cceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------------
Confidence 2111122233567999998875 668999999999999999986 99999888776665554321100
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.....++..+.+||.+||..+|.+|||+.+++..
T Consensus 228 ----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 228 ----------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113567899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.34 Aligned_cols=269 Identities=23% Similarity=0.337 Sum_probs=197.1
Q ss_pred ccceeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
..+|++++.||+|+||.||++. +..++..||+|++... .....+.+.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 3479999999999999999997 3457889999998644 345556788999999999999999999987655456
Q ss_pred eEEEEEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
.+++||||++++.+..+. .....+++..+..++.||+.||.|||++||+|+||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 789999999876555443 4445689999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCC--ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 284 GHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 284 ~~~~~--~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
..... ......+..|+|||++.+ ..++.++|||||||++|||++|..++..... .....+...... +...+...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQG-QMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhccccccc-ccchHHHHH
Confidence 22111 111123456999999876 6689999999999999999998877643321 111111000000 000000000
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
..... ........++.++.+||.+||..||++|||+.++++
T Consensus 238 -----~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 238 -----LLKNN-----GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred -----HHhcC-----CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000 000011357789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=311.97 Aligned_cols=248 Identities=29% Similarity=0.429 Sum_probs=194.7
Q ss_pred eeeeeeeecCceEEEEEEEC----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 133 EKLEKIGQGTYSSVFRARDL----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 133 ~~~~~LG~G~~g~V~~~~~~----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++.+.||.|.||.||+|... ..+..|+||+++.. ...+..+.+.+|++++++++||||+++++++.. ....++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccc--cccccc
Confidence 46789999999999999887 45678999999543 345557888999999999999999999999985 555999
Q ss_pred EEeeccCCchh-hccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITG-LLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~-~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||+.++.+. .+... ...+++..+..|+.||+.||.|||+++|+|+||++.||||+.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999975554 44443 46799999999999999999999999999999999999999999999999999976632111
Q ss_pred -CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 287 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 287 -~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
...........|+|||.+.. ..++.++||||||+++|||++ |+.||...+..+...++.+..-.+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~------------ 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP------------ 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT------------
T ss_pred ccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccce------------
Confidence 11122345678999999876 558999999999999999999 789999887777776663321100
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++..+.+||..||..||.+|||+.++++
T Consensus 226 ----------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 226 ----------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ----------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ----------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11357889999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=315.11 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=202.4
Q ss_pred ccccceeeeeeeeecCceEEEEEEEC-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeeccee
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDL-------DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLI 198 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 198 (478)
+..++|.+.+.||+|+||.||++++. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 33678999999999999999999752 234579999987442 344556788999999999 899999999998
Q ss_pred eecCCceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 011763 199 TSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (478)
Q Consensus 199 ~~~~~~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NI 262 (478)
.. ....|+||||+.++.+..+... ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 91 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 91 TQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred ec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 77 5678999999997655443321 23578889999999999999999999999999999999
Q ss_pred EEecCCcEEEeecccccccCCCCCCC-ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 011763 263 LVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340 (478)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~-~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~ 340 (478)
|++.++.+||+|||+++......... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999997664322111 122334678999999876 668999999999999999998 889998877666
Q ss_pred HHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 341 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....+.... .. .....++..+.+||.+||..+|.+|||+.++|+.
T Consensus 248 ~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 248 LFKLLKEGH--RM--------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHcCC--cC--------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 555543210 00 0012567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=308.48 Aligned_cols=253 Identities=24% Similarity=0.420 Sum_probs=202.1
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecC---CCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFD---NFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
+|.+.+.||+|+||.||++.+..++..+++|+++.. .........+..|+.+++.++||||+++++++.+ ....+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 589999999999999999998877777777776532 2223333456679999999999999999999876 56689
Q ss_pred EEEeeccCCchhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 208 LVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 208 lv~e~~~~~ll~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
+||||++++.+..+. .....+++..++.++.||+.||.|||++|++|+||+|+||++++ +.++|+|||++.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999986655432 23457899999999999999999999999999999999999975 6799999999876543
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.. .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+... ..+
T Consensus 158 ~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~---------- 223 (260)
T cd08222 158 SC-DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTP---------- 223 (260)
T ss_pred Cc-ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCC----------
Confidence 22 12223456888999998865 66788999999999999999999999877665555544321 111
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....++.++.++|.+||..||++||++.++|+||||
T Consensus 224 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 ----------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0012567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.68 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=201.9
Q ss_pred eeeeeeeeecCceEEEEEEECCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTG----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~----~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
|++.+.||.|+||.||++.+...+ ..||+|++..... ......+..|+.+++.++|+||+++++++.+ ....|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeE
Confidence 467889999999999999988766 8999999975532 2356678899999999999999999999877 46799
Q ss_pred EEEeeccCCchhhccCC-CCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 208 LVFEYMEHDITGLLSCP-DIK-FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~-~~~-l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
++|||++++.+..+... ... +++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999988655544433 323 8999999999999999999999999999999999999999999999999997665432
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL------------- 223 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 111112235788999998865 678999999999999999998 88999887766666554331100
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++.++.++|.+||..||++|||+.++++
T Consensus 224 ---------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 224 ---------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 001236888999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.53 Aligned_cols=244 Identities=24% Similarity=0.335 Sum_probs=195.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccC
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH 215 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~ 215 (478)
+.||+|+||.||++... ++..||+|++.... .......+.+|+.+++.++||||+++++++.. ....++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 36899999999999864 68899999987543 34444567889999999999999999999876 5678999999987
Q ss_pred Cchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcccccc
Q 011763 216 DITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (478)
Q Consensus 216 ~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 294 (478)
+.+..+ ......+++..+..++.||+.+|.|||++|++|+||||+||+++.++.+||+|||++...............+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 655444 3344568999999999999999999999999999999999999999999999999986543322111122233
Q ss_pred CCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 295 t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
+..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.... ..
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--~~-------------------- 213 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--RM-------------------- 213 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--CC--------------------
Confidence 567999998875 668899999999999999998 999998877665554442210 00
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++..+.+|+.+||..+|++||++.++++
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 214 ------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011256789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=312.50 Aligned_cols=269 Identities=23% Similarity=0.339 Sum_probs=198.8
Q ss_pred cceeeeeeeeecCceEEEEEEE----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 130 DAFEKLEKIGQGTYSSVFRARD----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~----~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
..|++++.||+|+||.||+++. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4689999999999999999974 4568899999987543 3444567889999999999999999999887754567
Q ss_pred EEEEEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.++||||++++.+..+. .....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999886665554 33346899999999999999999999999999999999999999999999999999765432
Q ss_pred CC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 285 HR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 285 ~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
.. .......++..|+|||++.+ ..++.++|||||||++|+|+++..|+..... ......+......... ..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~~~~-~~ 235 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQMTVT-RL 235 (284)
T ss_pred ccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccccHH-HH
Confidence 21 11122345677999999876 5688999999999999999998766543211 0111111111000000 00
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
. ....... .......++..+.+||.+||+.||++|||+.++|++
T Consensus 236 ~--~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 V--RVLEEGK-----RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred H--HHHHcCc-----cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 0000000 000123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.28 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=199.5
Q ss_pred ccceeeeeeeeecCceEEEEEEEC-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL-------DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 200 (478)
.++|.+.+.||+|+||.||++++. .....||+|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 568999999999999999999753 234579999987543 344556678899999999 69999999999876
Q ss_pred cCCceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 011763 201 RLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (478)
Q Consensus 201 ~~~~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl 264 (478)
...+|+||||+.++.+..+... ...+++..+..++.||+.||.|||++||+|+||||+|||+
T Consensus 90 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 --EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 5678999999997655443321 2358899999999999999999999999999999999999
Q ss_pred ecCCcEEEeecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011763 265 NNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQL 342 (478)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~ 342 (478)
+.++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999765432111 1111223467999999876 678999999999999999999 89999887766655
Q ss_pred HHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 343 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
..+.... .. .....++.++.+||.+||..||.+|||+.++++
T Consensus 247 ~~~~~~~--~~--------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGH--RM--------------------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCC--CC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5543210 00 001256788999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=339.33 Aligned_cols=280 Identities=22% Similarity=0.310 Sum_probs=186.6
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCC----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceee---
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDT----GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLIT--- 199 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~----~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--- 199 (478)
...++|++.+.||+|+||.||+|++..+ +..||+|++..... .+....| .+....+.+++.++..+.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 3578999999999999999999999888 89999998763221 1111111 122222333333322211
Q ss_pred -ecCCceEEEEEeeccCCchhhccCCC-C-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 011763 200 -SRLSCSIYLVFEYMEHDITGLLSCPD-I-------------------KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (478)
Q Consensus 200 -~~~~~~~~lv~e~~~~~ll~~~~~~~-~-------------------~l~~~~~~~i~~qil~aL~~LH~~givHrDlk 258 (478)
......++|||||++++.+..+.... . ...+..+..++.||+.||.|||+++|+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 12356789999999986554443221 1 11234567899999999999999999999999
Q ss_pred CCcEEEec-CCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCC---------------------CCCChhhH
Q 011763 259 GSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT---------------------DYGPSVDL 316 (478)
Q Consensus 259 p~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~---------------------~~~~~~Di 316 (478)
|+||||+. ++.+||+|||+|+..............+++.|+|||.+.... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999996 579999999999865443333345567899999999764211 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHh
Q 011763 317 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 396 (478)
Q Consensus 317 wslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~m 396 (478)
|||||+||||+++.. ...+....+..++...+..... |.....+. ..+. .....+.+........+||.+|
T Consensus 363 wSlGviL~el~~~~~--~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~---~~~~---~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 363 YSAGLIFLQMAFPNL--RSDSNLIQFNRQLKRNDYDLVA-WRKLVEPR---ASPD---LRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred HHHHHHHHHHHhCcC--CCchHHHHHHHHHHhcCCcHHH-HHHhhccc---cchh---hhhhhhhccccchHHHHHHHHH
Confidence 999999999998654 4445555555555544433222 21110000 0000 0001112233455677999999
Q ss_pred cCCCCCCccCHHHHHhCcccCCCCC
Q 011763 397 LSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 397 L~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
|++||.+|||+.|+|+||||+....
T Consensus 434 L~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 434 MRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCcccCCCHHHHhCCcCcCCCCc
Confidence 9999999999999999999987543
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=312.36 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=199.8
Q ss_pred ccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|++.+.||.|+||.||++.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.. +
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV--G 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--C
Confidence 568999999999999999999874 367889999987543 34445668889999999999999999998876 5
Q ss_pred ceEEEEEeeccCCchhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 011763 204 CSIYLVFEYMEHDITGLLSCP----------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 261 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~----------------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~N 261 (478)
...|+||||++++.+..+... ...+++..++.++.||+.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 678999999997554433321 1247888999999999999999999999999999999
Q ss_pred EEEecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 011763 262 LLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEV 339 (478)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~ 339 (478)
||++.++.++|+|||++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999875432211 11122234667999998876 678999999999999999997 88899877766
Q ss_pred HHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 340 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+....+.... .. .....++.++.+||.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~--~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGN--VL--------------------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCC--CC--------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6555443210 00 001246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.74 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=210.7
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCc---E-EEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGK---I-VALKKVRFD-NFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~-vAlK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 201 (478)
+..++-.+.++||+|+||.||+|.....+. . ||+|..+.+ ....+....+.+|+++|+.++|||||+++|++..
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~- 232 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL- 232 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC-
Confidence 345677778999999999999998764322 3 899999863 3577888899999999999999999999999988
Q ss_pred CCceEEEEEeeccCCchhhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
...+|||||+|.|+.+..++.... .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++.
T Consensus 233 -~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 233 -EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred -CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 567999999999876665555444 699999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
....... ......+..|+|||.+.. ..|+.++|||||||++||+++ |..||.+....+...+|.......+.
T Consensus 312 ~~~~~~~-~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~----- 384 (474)
T KOG0194|consen 312 GSQYVMK-KFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI----- 384 (474)
T ss_pred Ccceeec-cccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC-----
Confidence 5421111 112234778999999986 589999999999999999999 88999999999988888542211110
Q ss_pred CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....|.++..++.+|+..||+.|||+.++.+
T Consensus 385 ----------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 385 ----------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ----------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 0246778899999999999999999998863
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.25 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=195.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccC
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH 215 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~ 215 (478)
++||.|+||.||++.+.. ++.||+|++...... .....+.+|++++++++|+||+++++++.. ....++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 468999999999999877 999999998765433 455678899999999999999999999877 5678999999987
Q ss_pred Cchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc-cccc
Q 011763 216 DITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRV 293 (478)
Q Consensus 216 ~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~-~~~~ 293 (478)
+.+. .+......+++..+..++.|++.+|.|||+++++||||||+|||++.++.++|+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 5444 4434445789999999999999999999999999999999999999999999999999975542211111 1122
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 372 (478)
.+..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+......+
T Consensus 157 ~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~-------------------- 215 (251)
T cd05041 157 IPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP-------------------- 215 (251)
T ss_pred ceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC--------------------
Confidence 3567999998876 678999999999999999999 889998777655444432211000
Q ss_pred CCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 373 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 373 ~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++..+.+||.+||..+|.+|||+.|+|+
T Consensus 216 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 216 --------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 01246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=340.55 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=212.9
Q ss_pred ccccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 201 (478)
+...+.+..+.||+|+||+||+|+.. .....||||.++.+. +.+....|.+|+++|..|+|||||+|+|+|..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~- 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCRE- 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-
Confidence 44667888999999999999999753 345689999998554 45577889999999999999999999999988
Q ss_pred CCceEEEEEeeccCCchhhccC----------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC
Q 011763 202 LSCSIYLVFEYMEHDITGLLSC----------P----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~----------~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~ 267 (478)
++.+|||+|||..+.|..++. . ..+|+..+...|+.||+.|+.||-++.+|||||-..|+||.++
T Consensus 561 -~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 561 -GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred -CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 778999999999765554432 1 2248899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCCCCcc-ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011763 268 GVLKLADFGLANFSNTGHRQPLT-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345 (478)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~~~~~-~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i 345 (478)
..|||+|||+++.....+..... ....+..|||||.|+- ..|+.++|||||||+|||+++ |+.|+.+.++.+.++.|
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 99999999999865543322222 3455889999999986 789999999999999999998 99999999999999888
Q ss_pred HHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHH
Q 011763 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (478)
Q Consensus 346 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L 411 (478)
.+. .+.....+.|.++.+|+..|++.+|.+||+.+||-
T Consensus 719 ~~g----------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAG----------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcC----------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 542 11222357899999999999999999999999873
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.62 Aligned_cols=254 Identities=19% Similarity=0.260 Sum_probs=201.5
Q ss_pred cccceeeeeeeeecCceEEEEEEECC----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLD----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~----~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..++|++.+.||+|+||.||+|.+.. ++..|++|++... ........+.+|+.+|+.++|+||+++++++... .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-G 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-C
Confidence 36789999999999999999999865 3578999988643 3455567788999999999999999999987653 4
Q ss_pred ceEEEEEeeccCCchhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeec
Q 011763 204 CSIYLVFEYMEHDITGLLSCP--------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF 275 (478)
...++++||+.++.+..+... ...+++..+..++.||+.||.|||+++++|+||||+||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 568899999987555444321 145899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCC-ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCC
Q 011763 276 GLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPP 353 (478)
Q Consensus 276 G~a~~~~~~~~~~-~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~ 353 (478)
|+++......... .....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+.... .++
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~ 239 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RLA 239 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CCC
Confidence 9997654322111 122334667999999876 668999999999999999999 999998876655443332210 000
Q ss_pred chhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++++.++|.+||..||++|||+.++++
T Consensus 240 ---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 ---------------------------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ---------------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01246788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.93 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=200.6
Q ss_pred cccceeeeeeeeecCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceee
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLD-------TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLIT 199 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 199 (478)
...+|++.+.||+|+||.||++++.. ....||+|++.... .......+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 35579999999999999999998643 22368999887432 344566788899999999 8999999999987
Q ss_pred ecCCceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 011763 200 SRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263 (478)
Q Consensus 200 ~~~~~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NIL 263 (478)
. ...+|++|||++++.+..+... ...++...+..++.||+.||.|||++||+||||||+|||
T Consensus 89 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 89 Q--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred c--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 7 5679999999988655444321 234788889999999999999999999999999999999
Q ss_pred EecCCcEEEeecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 011763 264 VNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQ 341 (478)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~ 341 (478)
++.++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999765432111 1112233567999999876 678899999999999999998 8899988776665
Q ss_pred HHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 342 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...+..... + ......+.++.+||.+||+.+|.+|||+.++|++
T Consensus 246 ~~~~~~~~~--~--------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 246 FKLLKEGHR--M--------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHcCCC--C--------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 555432110 0 0012467789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.43 Aligned_cols=254 Identities=21% Similarity=0.261 Sum_probs=199.3
Q ss_pred ccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 202 (478)
.++|.+.+.||+|+||.||+|++. .+++.||||+++... .......+.+|+.+|.++. ||||+++++++..
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 568999999999999999999853 345689999997543 2333456788999999997 9999999999877
Q ss_pred CceEEEEEeeccCCchhhccCC----------------------------------------------------------
Q 011763 203 SCSIYLVFEYMEHDITGLLSCP---------------------------------------------------------- 224 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~---------------------------------------------------------- 224 (478)
...+|+||||+.++.+..+...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 5679999999997654433211
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 011763 225 ----------------------------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (478)
Q Consensus 225 ----------------------------------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl 264 (478)
...+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 1236777889999999999999999999999999999999
Q ss_pred ecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011763 265 NNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQL 342 (478)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~ 342 (478)
++++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||......+.+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 9999999999999975432211 11223356788999999876 668999999999999999998 89999876655554
Q ss_pred HHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 343 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...+.....++ ....++.++.+||.+||..||.+||++.++|..
T Consensus 352 ~~~~~~~~~~~---------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRMA---------------------------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44332110000 012467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=306.59 Aligned_cols=239 Identities=18% Similarity=0.238 Sum_probs=186.8
Q ss_pred eeeeecCceEEEEEEECC------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 136 EKIGQGTYSSVFRARDLD------------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~------------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
+.||+|+||.||+|+... ....|++|++.... ......+.+|+.++..++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR--D 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 368999999999997432 23368899876432 3344567789999999999999999999876 5
Q ss_pred ceEEEEEeeccCCchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc-------EEEeec
Q 011763 204 CSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-------LKLADF 275 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-------vkl~DF 275 (478)
...++||||++++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+||||+.++. ++|+||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 56799999999877665554 3456899999999999999999999999999999999999987664 899999
Q ss_pred ccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHcCCCCc
Q 011763 276 GLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPD 354 (478)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ell-tG~~pf~~~~~~~~~~~i~~~~g~~~~ 354 (478)
|++...... ....++..|+|||++.....++.++|||||||++|+|+ .|..||......+.. .+.... .
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~--~-- 226 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ--C-- 226 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC--c--
Confidence 998654321 23456788999998875567899999999999999998 588888765543322 111100 0
Q ss_pred hhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
......+.++.+||.+||+.||.+||++.++|++
T Consensus 227 -------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 -------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0011345678999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=304.48 Aligned_cols=243 Identities=20% Similarity=0.258 Sum_probs=192.4
Q ss_pred eeeecCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeecc
Q 011763 137 KIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (478)
Q Consensus 137 ~LG~G~~g~V~~~~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~ 214 (478)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++|+||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 3899999999999764 445679999987543 34445678899999999999999999998753 46899999998
Q ss_pred CCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC--ccc
Q 011763 215 HDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTS 291 (478)
Q Consensus 215 ~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~--~~~ 291 (478)
++.+..+. .....+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++.......... ...
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 76555443 345578999999999999999999999999999999999999999999999999997544322111 111
Q ss_pred cccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCC
Q 011763 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (478)
Q Consensus 292 ~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 370 (478)
...+..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+... ..+
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~----------------- 217 (257)
T cd05115 158 GKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--KRL----------------- 217 (257)
T ss_pred CCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--CCC-----------------
Confidence 222568999998875 568899999999999999996 99999887766655444221 100
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
......++++.+||.+||..||++||++.++++
T Consensus 218 ---------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 218 ---------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=308.72 Aligned_cols=238 Identities=20% Similarity=0.263 Sum_probs=186.1
Q ss_pred eeeecCceEEEEEEECC------------------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCee
Q 011763 137 KIGQGTYSSVFRARDLD------------------------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192 (478)
Q Consensus 137 ~LG~G~~g~V~~~~~~~------------------------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv 192 (478)
+||+|+||.||++.... ....||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 68999999999997422 22458899886432 23345677899999999999999
Q ss_pred eecceeeecCCceEEEEEeeccCCchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC---
Q 011763 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--- 268 (478)
Q Consensus 193 ~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--- 268 (478)
++++++.. ....||||||++++.+..+.. ....+++..+..++.||+.||+|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999987 567899999999877665553 455789999999999999999999999999999999999998654
Q ss_pred ----cEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHH
Q 011763 269 ----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLH 343 (478)
Q Consensus 269 ----~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ell-tG~~pf~~~~~~~~~~ 343 (478)
.+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||......+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999988543221 22345778999998876567899999999999999995 6999998765544322
Q ss_pred HHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 344 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
+....... ....+..+.+||.+||+.+|++|||+.++|++
T Consensus 233 -~~~~~~~~-----------------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRL-----------------------------PEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCC-----------------------------CCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 21110000 01234678999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=303.58 Aligned_cols=245 Identities=24% Similarity=0.329 Sum_probs=196.8
Q ss_pred eeeeecCceEEEEEEECC-CCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEee
Q 011763 136 EKIGQGTYSSVFRARDLD-TGK--IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~-~~~--~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~ 212 (478)
+.||+|++|.||++.+.. .++ .||||.+..+... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 468999999999998755 333 6999999876544 566778899999999999999999998876 678999999
Q ss_pred ccCCchh-hccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC--C
Q 011763 213 MEHDITG-LLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--P 288 (478)
Q Consensus 213 ~~~~ll~-~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~--~ 288 (478)
++++.+. .+.... ..+++..++.++.||+.||.|||+++++|+||||+||+++.++.+||+|||++......... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9875444 443333 46899999999999999999999999999999999999999999999999999765432111 1
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.......+
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE-------------- 221 (257)
T ss_pred ccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--------------
Confidence 112345778999998875 668999999999999999998 9999988777776665543110000
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++..+.+|+.+||..+|.+|||+.++++
T Consensus 222 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 222 -------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 01246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=303.49 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=197.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.++||+|+||.||++.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 568999999999999999999864 45679999886432 334567889999999999999999988765 45799
Q ss_pred EEeeccCCch-hhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDIT-GLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll-~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
+|||++++.+ ..+.. ....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999987544 44433 234578889999999999999999999999999999999999999999999999976543222
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......++..|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--------------
Confidence 22222334667999999876 668899999999999999998 99999987766555544321100
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++.++.+++.+||+.||++||++.++++
T Consensus 223 --------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 223 --------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred --------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011356788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=310.07 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=197.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECC----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD----------------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~----------------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv 192 (478)
.++|++.+.||+|+||.||++.+.. +...||+|++.... .......+.+|+.+|+.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3579999999999999999986432 34579999987543 344456788999999999999999
Q ss_pred eecceeeecCCceEEEEEeeccCCchhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 011763 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 261 (478)
Q Consensus 193 ~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~-----------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~N 261 (478)
++++++.. ....|+||||+.++.+..+... ...+++..+..++.||+.||+|||++||+|+||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 99999877 5678999999987555443221 1247788999999999999999999999999999999
Q ss_pred EEEecCCcEEEeecccccccCCCCCCC-ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCh
Q 011763 262 LLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKPILQGRTE 338 (478)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~~~-~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt--G~~pf~~~~~ 338 (478)
||++.++.++|+|||++.......... ......+..|+|||++.+ ..++.++|||||||++|||++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999997553322111 122233678999998776 568999999999999999998 7789987766
Q ss_pred HHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 339 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.+.+.......... +. .... .....++..+.+||.+||..||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~----~~-------~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 240 EQVIENTGEFFRDQ----GR-------QVYL----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhhc----cc-------cccC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 55544332211000 00 0000 001246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=307.35 Aligned_cols=239 Identities=20% Similarity=0.240 Sum_probs=187.3
Q ss_pred eeeeecCceEEEEEEECCCCc-------EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 136 EKIGQGTYSSVFRARDLDTGK-------IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~-------~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
+.||.|+||.||+|.+...+. .||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEE
Confidence 368999999999998765443 48888875432 3444567789999999999999999999987 567899
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc--------EEEeeccccc
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--------LKLADFGLAN 279 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--------vkl~DFG~a~ 279 (478)
||||++++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999987665554 44446899999999999999999999999999999999999988765 6999999986
Q ss_pred ccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHcCCCCchhhc
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~-~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
..... ....++..|+|||++.+...++.++|||||||++|+|++|. +||...+....... .......
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~------ 224 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDRHQL------ 224 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHccccC------
Confidence 54321 23456788999999976556889999999999999999984 67665554433221 1110000
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....+.++.+||.+||+.||++|||+.++|+.
T Consensus 225 -----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 225 -----------------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -----------------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 01345678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=303.42 Aligned_cols=251 Identities=24% Similarity=0.429 Sum_probs=202.2
Q ss_pred ceeeeeeeeecCceEEEEEEECC-CCcEEEEEEeecCC--------CChHHHHHHHHHHHHHHh-cCCCCeeeecceeee
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDN--------FEPESVRFMAREILILRR-LDHPNIIKLEGLITS 200 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~-~~~~vAlK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~ 200 (478)
.|++.+.||+|+||.||++.+.. +++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999877 68899999886432 123344556778988875 699999999999877
Q ss_pred cCCceEEEEEeeccCCchhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeec
Q 011763 201 RLSCSIYLVFEYMEHDITGLL----SCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADF 275 (478)
Q Consensus 201 ~~~~~~~lv~e~~~~~ll~~~----~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DF 275 (478)
....|+||||++++.+..+ ......+++..++.++.||+.+|.|||+ .+|+|+||+|+|||++.++.++|+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 6789999999987554433 2344578999999999999999999996 68999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCch
Q 011763 276 GLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 355 (478)
|++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|++||...........+......+..
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 234 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP- 234 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC-
Confidence 9997654432 2344567889999999876 66899999999999999999999999877666555554432211100
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...++..+.+||.+||..||++||++.|+..+
T Consensus 235 --------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 --------------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred --------------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 02467889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=305.03 Aligned_cols=250 Identities=21% Similarity=0.344 Sum_probs=199.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
..+|++.+.||+|+||+||+|.+..++. .||+|.+.... .......+.+|+.++++++||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 4689999999999999999999876654 58999887554 24455677889999999999999999998875 5
Q ss_pred eEEEEEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..++||||++++.+ ..+......+++..+..++.||+.||+|||+++|+|+||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 68999999987544 44444455699999999999999999999999999999999999999999999999999976553
Q ss_pred CCCCC-ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 284 GHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 284 ~~~~~-~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
..... ......+..|+|||.+.. ..++.++|||||||++|||++ |+.||.+....+....+... ...+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~------- 232 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERLPQ------- 232 (279)
T ss_pred cccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCCCC-------
Confidence 22111 111223567999998865 678899999999999999998 99999887765554444321 11100
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHH
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L 411 (478)
....+.++.++|.+||..||.+|||+.+++
T Consensus 233 --------------------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 233 --------------------PPICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred --------------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 023567789999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=305.02 Aligned_cols=243 Identities=26% Similarity=0.347 Sum_probs=189.9
Q ss_pred eeeeecCceEEEEEEECCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEEEee
Q 011763 136 EKIGQGTYSSVFRARDLDTGK--IVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEY 212 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~--~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv~e~ 212 (478)
+.||+|+||.||++++..++. .+++|.+... ........+.+|+.++.++ +||||+++++++.. ...+|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEe
Confidence 358999999999999887775 4688887632 2344556788899999999 89999999999877 5678999999
Q ss_pred ccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecc
Q 011763 213 MEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 276 (478)
Q Consensus 213 ~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG 276 (478)
++++.+..+... ...+++..+..++.||+.||+|||++|++|+||||+|||++.++.+||+|||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence 987555443321 1247899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCch
Q 011763 277 LANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~ 355 (478)
++....... .......+..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+.... ..
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--~~-- 230 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RL-- 230 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC--CC--
Confidence 985332111 0111223567999998865 678999999999999999997 999998776655554432110 00
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+....++.++.+||.+||..||.+|||+.++|.
T Consensus 231 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 ------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 001246778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=303.11 Aligned_cols=229 Identities=23% Similarity=0.315 Sum_probs=183.5
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCCchhh
Q 011763 141 GTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL 220 (478)
Q Consensus 141 G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~ 220 (478)
|.|+.||++++..+++.||+|++.... ...+|...+....||||+++++++.. ....|+||||++++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHH
Confidence 899999999999999999999997542 12235555556679999999999877 678999999999866655
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccC
Q 011763 221 LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300 (478)
Q Consensus 221 ~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~A 300 (478)
+......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+...... .....++..|+|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 5444456999999999999999999999999999999999999999999999999987654432 122345678999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchh
Q 011763 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRE 380 (478)
Q Consensus 301 PE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 380 (478)
||.+.+ ..++.++|||||||++|+|++|+.||........ . .. . ..
T Consensus 151 PE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----~---------~~------------------~-~~ 196 (237)
T cd05576 151 PEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----T---------HT------------------T-LN 196 (237)
T ss_pred CcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----c---------cc------------------c-cC
Confidence 998865 5678999999999999999999988753221000 0 00 0 00
Q ss_pred cccCCchhHHHHHHHhcCCCCCCccCH-----HHHHhCccc
Q 011763 381 TFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYF 416 (478)
Q Consensus 381 ~~~~~~~~l~~Li~~mL~~dP~~R~ta-----~e~L~hp~f 416 (478)
....+++.+.+||.+||+.||++|+++ .++++||||
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 112467889999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=303.00 Aligned_cols=250 Identities=18% Similarity=0.256 Sum_probs=189.0
Q ss_pred eeeeecCceEEEEEEECC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~--~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++|+||+++++.+.. ....|+||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeC
Confidence 368999999999996432 44578888876433 34445667789999999999999999998876 56799999999
Q ss_pred cCCchhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-C
Q 011763 214 EHDITGLLSCPD-----IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-Q 287 (478)
Q Consensus 214 ~~~ll~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 287 (478)
+++.+..+.... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 986665543221 2346788899999999999999999999999999999999999999999999865332211 1
Q ss_pred CccccccCCcccCcccccC------CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 288 PLTSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~------~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
......+++.|+|||++.. ...++.++|||||||++|||++ |..||....+.+.+..+..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----- 232 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK----- 232 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC-----
Confidence 1122344677999998742 2356889999999999999999 789998877766665554322111000
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
......++..+.+++..|+ .||++|||++++++
T Consensus 233 ------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 233 ------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ------------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0011356788899999988 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=300.44 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=189.3
Q ss_pred eeeeecCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEee
Q 011763 136 EKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~---~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~ 212 (478)
+.||+|+||.||+|.+.. ....||+|.+.... .....+.+.+|+.+++.++||||+++++++... +...++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 468999999999998643 34679999875322 344556778899999999999999999977543 4457899999
Q ss_pred ccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC---CC
Q 011763 213 MEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QP 288 (478)
Q Consensus 213 ~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~ 288 (478)
+.++.+..+. .....+++..+..++.||+.||.|||+.+|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9876555443 3344567888899999999999999999999999999999999999999999999875432111 11
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
.....++..|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+... .++.
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~~~------------- 222 (262)
T cd05058 159 HTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RRLL------------- 222 (262)
T ss_pred cccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CCCC-------------
Confidence 112334678999998876 678999999999999999999 56778776655544433211 0000
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....++..+.++|.+||..||++||++.++|..
T Consensus 223 -------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 223 -------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred -------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 002457789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=307.91 Aligned_cols=253 Identities=20% Similarity=0.322 Sum_probs=197.9
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..++|++.+.||+|+||.||++.+..++. .||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--- 80 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLS--- 80 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---
Confidence 35689999999999999999999877765 47888886543 23334467789999999999999999998865
Q ss_pred ceEEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...++++||++++ +...+......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 2367999999975 444444444568999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 283 TGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 283 ~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.. .+......++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~------- 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERLP------- 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCCC-------
Confidence 32211 1122344678999999876 678999999999999999997 89999876544332 2222111110
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.....+..+.++|.+|+..||++||++.++++.
T Consensus 232 --------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 --------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred --------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012356789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=300.02 Aligned_cols=242 Identities=25% Similarity=0.404 Sum_probs=194.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||.||++. .+++.||+|+++.+. ....+.+|+.+++.++||||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~ 75 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYI 75 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEE
Confidence 4679999999999999999986 467889999986432 23567789999999999999999998865 23789
Q ss_pred EEeeccCCchh-hccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITG-LLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~-~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||+.++.+. .+... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999875444 43322 2358899999999999999999999999999999999999999999999999987543221
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.....+..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+......
T Consensus 155 ---~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 216 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM-------------- 216 (254)
T ss_pred ---CCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC--------------
Confidence 12233567999998875 678899999999999999997 99999887766554444221000
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++..+.+||.+||+.+|.+||++.+++.
T Consensus 217 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 217 --------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=302.32 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=193.0
Q ss_pred eeeeecCceEEEEEEECCCC------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 136 EKIGQGTYSSVFRARDLDTG------KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~------~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+.||.|+||.||++++.... +.||+|.+.... .......+.+|+.+++.++||||+++++++.. ....++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEE
Confidence 46899999999999876543 689999886432 23445677889999999999999999999876 5678999
Q ss_pred EeeccCCchhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-----cEEEeeccc
Q 011763 210 FEYMEHDITGLLSC-------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGL 277 (478)
Q Consensus 210 ~e~~~~~ll~~~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-----~vkl~DFG~ 277 (478)
|||++++.+..+.. ....+++..+..++.||+.||.|||+++++|+||||+||+++.++ .++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99998755543322 223478899999999999999999999999999999999999887 899999999
Q ss_pred ccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCch
Q 011763 278 ANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 278 a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~ 355 (478)
+........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~--- 232 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL--- 232 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc---
Confidence 875432211 11122344678999999876 668999999999999999998 999998877666554442210 00
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++..+.+||.+||..+|.+||++.++++
T Consensus 233 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 ------------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 011356788999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=337.57 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=210.9
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG-----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~-----~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 201 (478)
+....-++.+.||+|+||.||.|.-.... ..||||.++... +.+....|.+|..+|+.++|||||+++|++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~- 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD- 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-
Confidence 44667889999999999999999865332 348999987654 56677888999999999999999999999988
Q ss_pred CCceEEEEEeeccCC-chhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEee
Q 011763 202 LSCSIYLVFEYMEHD-ITGLLSCP------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~-ll~~~~~~------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D 274 (478)
....+|++|||+++ |+..+... ...++..++..++.||++|+.||+++++|||||...|+||+....+||+|
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 66789999999975 55555554 45689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCcccc-ccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCC
Q 011763 275 FGLANFSNTGHRQPLTSR-VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSP 352 (478)
Q Consensus 275 FG~a~~~~~~~~~~~~~~-~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~ 352 (478)
||+|+............. .....|||||.+.. ..++.++|||||||+|||+++ |..||...++.+.+....+.- ..
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence 999985433222211222 33568999999986 789999999999999999999 999999999998887665432 11
Q ss_pred CchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+. ...+|+.+.+||..|++.+|+.||+...+++
T Consensus 924 ~~---------------------------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DP---------------------------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CC---------------------------CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11 1368899999999999999999999999986
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=303.20 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=198.7
Q ss_pred ccceeeeeeeeecCceEEEEEEEC----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.+.|++.+.||+|+||.||++... .++..||+|++...... .....+.+|+.+++.+.|+||+++++++......
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 347899999999999999999854 34789999999765433 3567788999999999999999999988775566
Q ss_pred eEEEEEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..++||||++++.+..+. .....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 799999999875554443 3344689999999999999999999999999999999999999999999999999976653
Q ss_pred CCCCC--ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH-----------HHHHHHHcC
Q 011763 284 GHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-----------LHKIFKLCG 350 (478)
Q Consensus 284 ~~~~~--~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~-----------~~~i~~~~g 350 (478)
..... ......+..|+|||.+.+ ..++.++|||||||++|+|++|..||........ ...+...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 22111 112233567999998876 5788999999999999999999998865432110 111111100
Q ss_pred CCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
... .. .....++.++.+|+.+||..||.+|||+.++++
T Consensus 241 ~~~-------------------~~-----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGE-------------------RL-----PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCC-------------------cC-----CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000 00 001245688999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=301.10 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=197.6
Q ss_pred eeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC----c
Q 011763 132 FEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----C 204 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~---~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~ 204 (478)
|.+.+.||+|+||.||+|.+. .+++.||||++..+.......+.+.+|+.+|+.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999854 357899999998766556667778899999999999999999998764321 1
Q ss_pred eEEEEEeeccCCchhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccc
Q 011763 205 SIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a 278 (478)
..++++||+.++.+..+. .....+++..++.++.||+.||+|||+++|+|+||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 347889999876554321 11235789999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchh
Q 011763 279 NFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 279 ~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~ 356 (478)
+........ ......+++.|++||.+.. ..++.++|||||||++|+|++ |++||...+..+....+... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~--- 235 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRLK--- 235 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcCC---
Confidence 765432111 1122234678999998876 667899999999999999999 89999887765544443321 0000
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.....+..+.+|+.+||..+|++||++.+++.+
T Consensus 236 ------------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 236 ------------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 002467889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=299.16 Aligned_cols=250 Identities=20% Similarity=0.250 Sum_probs=187.1
Q ss_pred eeeeecCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+ ....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 36899999999999754 3456799999875542 3334567789999999999999999998876 56689999999
Q ss_pred cCCchhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-C
Q 011763 214 EHDITGLLSC-----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-Q 287 (478)
Q Consensus 214 ~~~ll~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 287 (478)
+++.+..+.. ....+++..+..++.||+.||.|||+++++|+||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9765554432 123456778889999999999999999999999999999999999999999999865432211 1
Q ss_pred CccccccCCcccCcccccCC------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 288 PLTSRVVTLWYRPPELLLGA------TDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~------~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
......++..|+|||++.+. ..++.++|||||||++|||++ |+.||......+...........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL--------- 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC---------
Confidence 11233457889999988542 135789999999999999996 99999876655543332211000
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+.+ .+ ......++.+.++|..|+ .||++|||+.+++.
T Consensus 229 ~~~--------~~------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 KLP--------KP------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCC--------CC------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 00 001235677899999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.89 Aligned_cols=236 Identities=22% Similarity=0.260 Sum_probs=186.0
Q ss_pred eeeeecCceEEEEEEECCCC----------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 136 EKIGQGTYSSVFRARDLDTG----------KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~----------~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
+.||+|+||.||++.+..++ ..|++|++.... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 46899999999999987766 357888776433 115667889999999999999999998866 34
Q ss_pred EEEEEeeccCCchhhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-------cEEEeeccc
Q 011763 206 IYLVFEYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-------VLKLADFGL 277 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-------~vkl~DFG~ 277 (478)
.++||||+.++.+..+..... .+++..+..++.||+.||.|||++||+|+||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 689999999877766654433 789999999999999999999999999999999999999888 799999999
Q ss_pred ccccCCCCCCCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCch
Q 011763 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 278 a~~~~~~~~~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~ 355 (478)
+...... ....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+....... ....
T Consensus 155 a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~--- 225 (259)
T cd05037 155 PITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRL--- 225 (259)
T ss_pred ccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCC---
Confidence 8765431 223456779999998763 368999999999999999999 5788876653332222110 0000
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.......+.+||.+||..||.+|||+.++|+
T Consensus 226 --------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 226 --------------------------PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred --------------------------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0011267899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=308.89 Aligned_cols=266 Identities=24% Similarity=0.401 Sum_probs=213.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCC-C----ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-F----EPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~-~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|-+++.||+|+|+.||++.|....++||+|+-..+. + .....+...+|..|.+.|+||.||++|++|.-. .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-t 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-T 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-c
Confidence 568999999999999999999999999999999865432 1 123345567899999999999999999999754 5
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcEEEecC---CcEEEeecccc
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNE---GVLKLADFGLA 278 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--givHrDlkp~NILl~~~---~~vkl~DFG~a 278 (478)
+.+|.|+|||+|+.+++++.....+++.+++.|+.||+.||.||.+. .|||-||||.||||... |.+||+|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 67899999999999999988888999999999999999999999987 59999999999999654 78999999999
Q ss_pred cccCCCCCC------CccccccCCcccCcccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 011763 279 NFSNTGHRQ------PLTSRVVTLWYRPPELLLG---ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349 (478)
Q Consensus 279 ~~~~~~~~~------~~~~~~~t~~y~APE~l~~---~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~ 349 (478)
+++...... ......||.||++||.+.- ....+.++||||+|||+|..+.|+.||..+.....+.+.-..+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 987643322 1233567999999999753 2457889999999999999999999998654333222111110
Q ss_pred CCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 350 g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.. ..+..|.. +-++.++++||++||++--+.|+...++-.||||.-
T Consensus 701 kA-------------tEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 701 KA-------------TEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred cc-------------eeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 00 00001111 357899999999999999999999999999999965
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=301.45 Aligned_cols=261 Identities=18% Similarity=0.157 Sum_probs=187.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecCCCChHHH---------HHHHHHHHHHHhcCCCCeeeecc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESV---------RFMAREILILRRLDHPNIIKLEG 196 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vAlK~~~~~~~~~~~~---------~~~~~E~~~l~~l~h~nIv~l~~ 196 (478)
.++|++.+.||+|+||+||+|.+..+ +..+|+|+........... .....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 45899999999999999999998777 6778888754433211100 01122334455678999999988
Q ss_pred eeeecCC--ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEee
Q 011763 197 LITSRLS--CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (478)
Q Consensus 197 ~~~~~~~--~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D 274 (478)
....... ...++++|++...+...+.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 6544222 24478888876655444332 23467888999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 011763 275 FGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348 (478)
Q Consensus 275 FG~a~~~~~~~~------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~ 348 (478)
||+|+....... .......+|+.|+|||++.+ ..++.++|||||||+||||++|.+||.+......+......
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999976532111 11223468999999998876 67899999999999999999999999887432222111110
Q ss_pred cCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 349 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 349 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+++..... -....+..+..+.+++..|+..+|++||++.++++
T Consensus 249 ------~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 ------DFIKRLHE---------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------HHHHHhhh---------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00000000 00012356788999999999999999999999874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.77 Aligned_cols=203 Identities=31% Similarity=0.480 Sum_probs=174.7
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----CceE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SCSI 206 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~~ 206 (478)
.+...+.||+|+||.||+++++.+|+.||||.++... .....+...+|+++|++|+|+|||+++++-.... ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3566788999999999999999999999999998654 3455677788999999999999999998876554 4556
Q ss_pred EEEEeeccCCchhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC--C--cEEEeeccccc
Q 011763 207 YLVFEYMEHDITGLLSCP---DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--G--VLKLADFGLAN 279 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~--~--~vkl~DFG~a~ 279 (478)
.+|||||.++.+....+. ...|++.++..++..+..||.|||++|||||||||.||++-.. | ..||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 899999998766655442 2459999999999999999999999999999999999998543 3 36999999999
Q ss_pred ccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 336 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~ 336 (478)
...++ ....+.+||+.|++||++.....|+..+|.|||||++|+.+||..||...
T Consensus 173 el~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 173 ELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 87764 47788999999999999885588999999999999999999999999654
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.82 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=186.8
Q ss_pred eeeeecCceEEEEEEECCC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDT--GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~--~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+.||+|+||+||++..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.. ....|+||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecC
Confidence 3689999999999975432 3356677766443 23445678889999999999999999999877 56789999999
Q ss_pred cCCchhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC-CCC
Q 011763 214 EHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQP 288 (478)
Q Consensus 214 ~~~ll~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 288 (478)
+++.+..+... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 97655443322 2346777888999999999999999999999999999999999999999999985432111 111
Q ss_pred ccccccCCcccCcccccC------CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 289 LTSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~------~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
.....++..|+|||++.. ...++.++|||||||++|||++ |.+||...++.+.+..+....... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~----- 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---L----- 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc---c-----
Confidence 233456888999998753 1235778999999999999997 578898777766666554321100 0
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+.+ . ....+++.+.++|..|+ .+|++||++.++++
T Consensus 230 ------~~~------~---~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 230 ------FKP------Q---LELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ------CCC------c---cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 000 0 01246778899999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=293.02 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=207.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++.+-+..||.|+||+|++..++.+|+..|||.++..+.. ....+++.|.....+- ++||||++++.+.. ++..|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcW 139 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCW 139 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCcee
Confidence 45677788999999999999999999999999999977653 4445666787765554 89999999998876 45589
Q ss_pred EEEeeccCCchhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 208 LVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 208 lv~e~~~~~ll~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
|.||+|.-++-.++. ..+..++|..+-.|....+.||+||... .|||||+||+||||+..|.+||||||.+-...
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999999875543332 2445689999999999999999999965 89999999999999999999999999986543
Q ss_pred CCCCCCccccccCCcccCcccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCCCchhhccC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~-~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.. -..+...|...|||||.+.... .|+.++||||||++|||+.||+.|+.+-+. .+++.+++. |.||.-..
T Consensus 220 ~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~~--- 292 (361)
T KOG1006|consen 220 DS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILLF--- 292 (361)
T ss_pred HH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeecC---
Confidence 22 2224456788899999997544 499999999999999999999999987443 345544432 33331100
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
....-+++..+..+|..||.+|-..||...+++++||+..
T Consensus 293 ------------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 293 ------------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred ------------------cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 0111257889999999999999999999999999999974
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=320.14 Aligned_cols=263 Identities=27% Similarity=0.437 Sum_probs=218.1
Q ss_pred cccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeee---c
Q 011763 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS---R 201 (478)
Q Consensus 126 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~---~ 201 (478)
+...+.|++...||.|.+|.||++++..+++.+|+|++..+. +..+.+..|.+||+.+ +|||++.++++|.. .
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 445788999999999999999999999999999999997654 3335566799999988 79999999998853 3
Q ss_pred CCceEEEEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 202 LSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
.++.+|||||||.++...++.. .+..+.|+.+..|++.++.||.+||.+.++|||||-.|||++.++.|||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 3568999999999877655543 25578999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCccccccCCcccCcccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCch
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~~~----~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 355 (478)
..... .....+.+|||.|||||++... ..|+..+|+||||++..||.-|.||+-.......+..|- -.||+.
T Consensus 172 QldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RNPPPk 247 (953)
T KOG0587|consen 172 QLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPPK 247 (953)
T ss_pred eeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---CCCCcc
Confidence 66532 2344667899999999998642 347789999999999999999999998777665554442 222221
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
. ..+...+.++.+||..||.+|-.+||+..++|+|||+++
T Consensus 248 L-----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 L-----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred c-----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 1 112456788999999999999999999999999999985
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=299.86 Aligned_cols=258 Identities=22% Similarity=0.283 Sum_probs=208.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+...+.++||+|-||.|.+|+. ..+..||+|+++.+. .......|.+||++|.+|+|||||.|+++|.. .+.+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePicm 612 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPLCM 612 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCchHH
Confidence 56788999999999999999985 447899999998664 44556788999999999999999999999987 677999
Q ss_pred EEeeccCCchhhccCCC-CC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLSCPD-IK-FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~-~~-l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|+|||+++.+..+.... .+ +.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++....+..
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999986655544333 22 34455667999999999999999999999999999999999999999999986554433
Q ss_pred CCcc-ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 287 QPLT-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 287 ~~~~-~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt--G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.... ..+.+..|||||.+.. ++++.++|+|+||++|||+++ ...||...++.+..++.-..+...+....
T Consensus 693 y~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~------ 765 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV------ 765 (807)
T ss_pred eeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee------
Confidence 3333 3345889999999986 679999999999999999865 77999988888877776655433322110
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+-++..+.+||.+|+..|-.+||+.+++..
T Consensus 766 ---------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 766 ---------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ---------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 0111357889999999999999999999999853
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=305.69 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=205.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECC--C--CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD--T--GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~--~--~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.+.....++||.|-||.||.|.... . .--||||..+.+. +.+..+.|+.|..+|+.++|||||+|+|+|.+ .
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~ 463 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---Q 463 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec---c
Confidence 3345566789999999999997532 2 3358999998765 55668889999999999999999999999986 4
Q ss_pred eEEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
.+|||||+++.+ |...+..+...|+...+..|+.||..||.|||+..+|||||-..|||+.....|||+|||+++....
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 589999999965 4455556667899999999999999999999999999999999999999999999999999998876
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
......+....+.-|||||.+.- ..++.++|||-|||.|||++. |..||.+-.+.+.+-.|-+.--.|
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP---------- 612 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP---------- 612 (974)
T ss_pred cchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC----------
Confidence 55444444444778999999875 678999999999999999987 999999987777655443211100
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHH
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L 411 (478)
..+.+|+.+..|+.+|+.+||.+||+..++.
T Consensus 613 ------------------~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 613 ------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 1247899999999999999999999987653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=308.47 Aligned_cols=276 Identities=24% Similarity=0.317 Sum_probs=187.9
Q ss_pred ccccceeeeeeeeecCceEEEEEEEC----------------CCCcEEEEEEeecCCCCh------------HHHHHHHH
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDL----------------DTGKIVALKKVRFDNFEP------------ESVRFMAR 178 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~----------------~~~~~vAlK~~~~~~~~~------------~~~~~~~~ 178 (478)
...++|++.++||+|+||+||+|.+. ..++.||||.+....... ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34789999999999999999999742 245679999986543110 00112234
Q ss_pred HHHHHHhcCCCCe-----eeecceeeec------CCceEEEEEeeccCCchhhccCC-----------------------
Q 011763 179 EILILRRLDHPNI-----IKLEGLITSR------LSCSIYLVFEYMEHDITGLLSCP----------------------- 224 (478)
Q Consensus 179 E~~~l~~l~h~nI-----v~l~~~~~~~------~~~~~~lv~e~~~~~ll~~~~~~----------------------- 224 (478)
|+.++.+++|.++ ++++++|... .....+|||||++++.+..+...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7778888876654 6677776532 12457999999998655443321
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccCccc
Q 011763 225 -DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303 (478)
Q Consensus 225 -~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~ 303 (478)
...+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++...............+|+.|+|||+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 1134667889999999999999999999999999999999999999999999997554332222222334789999998
Q ss_pred ccCCCC-------------------C--CChhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 304 LLGATD-------------------Y--GPSVDLWSVGCVFAELLIGKP-ILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 304 l~~~~~-------------------~--~~~~DiwslG~il~elltG~~-pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
+..... | ....||||+|||+|+|++|.. ||..........+. .. .....|...+
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~---~~-~~~~~~r~~~ 457 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ---YD-NDLNRWRMYK 457 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh---cc-chHHHHHhhc
Confidence 754211 1 124799999999999999874 77543221111000 00 0011121111
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCC---CCccCHHHHHhCcccCC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP---YKRATASAALASEYFST 418 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP---~~R~ta~e~L~hp~f~~ 418 (478)
.. .++ ...+..+++..+|||.+||..+| .+|+|+.|+|+||||..
T Consensus 458 ~~---------~~~---~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 GQ---------KYD---FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cc---------CCC---cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 000 11245678999999999999876 68999999999999954
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=279.72 Aligned_cols=244 Identities=38% Similarity=0.591 Sum_probs=197.1
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCCchhhc
Q 011763 142 TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL 221 (478)
Q Consensus 142 ~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~ 221 (478)
+||.||++.+..+++.+|+|++........ .+.+.+|+.++++++|+||+++++.+.. ....++++||++++.+..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 589999999988899999999976543221 5678899999999999999999999877 5678999999998555555
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccCc
Q 011763 222 SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301 (478)
Q Consensus 222 ~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~AP 301 (478)
......+++..+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||.+....... ......++..|++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 4444448999999999999999999999999999999999999999999999999997665432 23345668889999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhc
Q 011763 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRET 381 (478)
Q Consensus 302 E~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 381 (478)
|.+.+ ..++.++|||+||+++|+|++|..||......+.+.+.......... ..
T Consensus 156 E~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~ 209 (244)
T smart00220 156 EVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-------------------------PP 209 (244)
T ss_pred HHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------------cc
Confidence 98875 56788999999999999999999999874443333333221110000 00
Q ss_pred ccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 382 FKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 382 ~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
...++.++.+++.+||..||++||++.++++||||
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 01277889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=312.55 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=222.7
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG---KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~---~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
+......|.+.||.|.||.|++|+.+..+ ..||||.++... ...+...|+.|+.||.+++||||++|.++.+. .
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s 702 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--S 702 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec--C
Confidence 44567889999999999999999987655 469999998554 66777888999999999999999999999987 6
Q ss_pred ceEEEEEeeccCCchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
..+.||.|||+++.|+ +++.+++.|+..++..+++.|+.|+.||-++++|||||...||||+.+...|++|||+++...
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 7799999999986555 555677889999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCcccccc--CCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 283 TGHRQPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 283 ~~~~~~~~~~~~--t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
++.....++.-| +..|.|||.|.- .+++.++||||+|++|||.++ |.-||...++.+.+..|.+...-||+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP----- 856 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP----- 856 (996)
T ss_pred cCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-----
Confidence 655444444433 678999999986 789999999999999999886 99999999999999999887766653
Q ss_pred CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.+.|..+.+|+..|+++|-.+||+..|++.+
T Consensus 857 -----------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 -----------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred -----------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 2689999999999999999999999998743
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=293.23 Aligned_cols=281 Identities=32% Similarity=0.510 Sum_probs=214.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 204 (478)
.+.|..+++||+|.|++||++.+.. ....||+|.+.... ....+.+|+++|..+ .+.||+++.+.+.. ++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd 108 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRN--ND 108 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhcc--CC
Confidence 5689999999999999999999877 78899999987543 335588999999999 69999999998876 78
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC-CcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~ 283 (478)
.+++||||+++.....+.. .++...++.|++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||+|.....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 8999999999865555443 46788999999999999999999999999999999999865 7789999999962100
Q ss_pred C-------------------------------------------CCCCccccccCCcccCcccccCCCCCCChhhHHHHH
Q 011763 284 G-------------------------------------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 320 (478)
Q Consensus 284 ~-------------------------------------------~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG 320 (478)
. .....-.+.||++|+|||+++....-++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 000012356899999999999877778899999999
Q ss_pred HHHHHHHhCCCCC-CCCChHHHHHHHHHHcCCCC--------ch--hhccCCCCCc--------cc-cCCCCCCCc---c
Q 011763 321 CVFAELLIGKPIL-QGRTEVEQLHKIFKLCGSPP--------DD--YWKKSKLPHA--------TL-FKPQQPYDS---S 377 (478)
Q Consensus 321 ~il~elltG~~pf-~~~~~~~~~~~i~~~~g~~~--------~~--~~~~~~~~~~--------~~-~~~~~~~~~---~ 377 (478)
+|+..+++++.|| ...++.+.+..|...+|.-. .. .|.....+.. .. ......-+. .
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999775 55666677777766655433 12 3443221100 00 000011111 1
Q ss_pred chhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 378 LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 378 l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.......++..+.+|+.+||+.||.+|+||+++|+||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 22222445668999999999999999999999999999984
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=300.40 Aligned_cols=254 Identities=22% Similarity=0.304 Sum_probs=209.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-CC--cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-TG--KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-~~--~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.++..+.++||+|.||.||+|.+.. .| ..||||.++.+.... ....|.+|+.+|.+|+|+|+++||++..+ ..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~---qp 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD---QP 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc---ch
Confidence 3466778999999999999998754 33 368999998777654 56788999999999999999999999876 34
Q ss_pred EEEEEeeccC-CchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 206 IYLVFEYMEH-DITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 206 ~~lv~e~~~~-~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
+.||||+++. +|++.+.. ....|....+..|+.||+.||.||..+++|||||-..||||-....|||+|||+.+....
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 7899999996 55666655 455688999999999999999999999999999999999999999999999999987765
Q ss_pred CCCCC--ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 284 GHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 284 ~~~~~--~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
+.... .........|+|||.|.. ..++.++|||+|||+||||++ |+.||.+....+++++|-+.-
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e----------- 332 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE----------- 332 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-----------
Confidence 43322 112233667999999886 789999999999999999998 889999999999988874311
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcc
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~ 415 (478)
....-+.+++++.+++..|+..+|+.|||...+.+.-+
T Consensus 333 -----------------rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 333 -----------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -----------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 11122468999999999999999999999988864433
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=292.53 Aligned_cols=246 Identities=20% Similarity=0.333 Sum_probs=204.3
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
+....++||-|.||.||.+.++.-...||||.++.+. -..+.|+.|+.+|+.++|||+|+|+++|+. +..+|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~--EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhcc--CCCeEEEE
Confidence 5667799999999999999999888999999997554 345678889999999999999999999988 56799999
Q ss_pred eeccC-CchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 211 EYMEH-DITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 211 e~~~~-~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|||.. +|++.+...+ ..++...+.+++.||..|+.||..+++|||||-..|+|+.++..|||+|||+++++..+....
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 99985 6777776544 346777888999999999999999999999999999999999999999999999887654443
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
.....-..-|.|||-|.- ..++.++|||+|||+|||+.| |-.||.+.+....+..+.+.. +
T Consensus 423 HAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-----------R------ 484 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-----------R------ 484 (1157)
T ss_pred ccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-----------c------
Confidence 333334778999999875 678999999999999999998 889999987655543332210 0
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHH
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 410 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~ 410 (478)
- +....+|+.+.+|++.|++|.|..||+..|+
T Consensus 485 --M---------~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 485 --M---------DGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred --c---------cCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 0 0113689999999999999999999998876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.42 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=190.7
Q ss_pred ceeeeeeeeecCceE-EEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEE
Q 011763 131 AFEKLEKIGQGTYSS-VFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~-V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~l 208 (478)
-|.-.+.+|.|+.|+ ||+|.- .++.||||.+- .+......+||..|+.. +|||||+++ |.+....+.||
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyy--c~E~d~qF~YI 580 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYY--CSEQDRQFLYI 580 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee--CCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEE--eeccCCceEEE
Confidence 355567789999987 799975 67899999874 34556778999999998 699999995 45555789999
Q ss_pred EEeeccCCchhhccCC--CCCC-CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec---C--CcEEEeecccccc
Q 011763 209 VFEYMEHDITGLLSCP--DIKF-SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---E--GVLKLADFGLANF 280 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~--~~~l-~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~--~~vkl~DFG~a~~ 280 (478)
..|.|..+|.+.+... .... .....+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+++.
T Consensus 581 alELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 581 ALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred EehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9999999888777653 1111 11456788899999999999999999999999999987 3 4689999999987
Q ss_pred cCCCCCC--CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCCchhh
Q 011763 281 SNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 281 ~~~~~~~--~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 357 (478)
...+... ...+..||-+|+|||++... .-+.++|||||||++|+.++| ..||...- +...+|+... .
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~--~----- 730 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGN--Y----- 730 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCc--c-----
Confidence 7654322 23456789999999999874 346799999999999999985 89997533 2223333211 0
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
.+...-+....++.|||.+||++||..||+|.++|.||||=
T Consensus 731 -------------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 731 -------------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred -------------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 11111111222899999999999999999999999999993
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=251.67 Aligned_cols=216 Identities=25% Similarity=0.442 Sum_probs=179.4
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 205 (478)
+..+...-+..||+|+||.|-+.++..+|+..|+|.+.... +.+..+++++|+.+..+. .+|++|.+++.+.. ...
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egd 119 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGD 119 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--ccc
Confidence 33567778889999999999999999999999999997654 345556677899988776 79999999998766 566
Q ss_pred EEEEEeeccCCchhhc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 206 IYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~---~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
+++.||.|.-++..+. ...+..++|..+-+|+..++.||.|||++ .|||||+||+||||+.+|++||||||.+-..
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999999987654333 45677899999999999999999999987 8999999999999999999999999998655
Q ss_pred CCCCCCCccccccCCcccCcccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLG---ATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFK 347 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~---~~~~~~~~DiwslG~il~elltG~~pf~~-~~~~~~~~~i~~ 347 (478)
... -..+-..|...|||||.+.. ...|+-++||||||+.++||.+++.||.. .++.+++.++++
T Consensus 200 ~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 200 VDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 432 11222456778999999853 34689999999999999999999999965 678888888876
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=320.41 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=184.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
..|...+.||+|+||.||+|++..++..||+|++...... ...|+.++++++|||||++++++.+ ....|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEE
Confidence 3567778999999999999999889999999998643211 1246889999999999999999987 5668999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH---SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|||++++.+..+.. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. |+........
T Consensus 762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999876666553 3789999999999999999999 6699999999999999998888775 6655432211
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcC-CCCchhhccCCCCC
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCG-SPPDDYWKKSKLPH 364 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~g-~~~~~~~~~~~~~~ 364 (478)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+........ ......|
T Consensus 836 ---~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 904 (968)
T PLN00113 836 ---TKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW------- 904 (968)
T ss_pred ---CCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe-------
Confidence 22366899999999876 6789999999999999999999999854221 011111111100 0000000
Q ss_pred ccccCCCCCCCccchhcc---cCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 365 ATLFKPQQPYDSSLRETF---KDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~---~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.+..+.... .....++.+++.+||+.||++|||+.|+++.
T Consensus 905 ---------~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 ---------IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ---------eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000000 1123357889999999999999999999865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=291.94 Aligned_cols=260 Identities=30% Similarity=0.439 Sum_probs=220.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|+.+..+|.|.||.||+++++.+++..|+|+++.+. .....-+.+|+-+++.++|||||.+++.+.. ...+++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr--~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhh--hcCcEE
Confidence 568999999999999999999999999999999998765 3445567789999999999999999998876 566899
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
.||||+++.++.+..-.+++++.++.+.++..++||+|||++|-+|||||-.|||+++.|.+||.|||.+..+..- ...
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh-hhh
Confidence 9999999999888888889999999999999999999999999999999999999999999999999998655431 223
Q ss_pred ccccccCCcccCccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 289 LTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~--~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
...++||+.|||||+.. ....|...+|||++|+...||-.-++|.........+..+-.....||.-
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l----------- 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL----------- 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc-----------
Confidence 45689999999999852 33579999999999999999988888877666666666655544433310
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
++ -...++.+-+|++.+|..+|.+|||++.+|.|||..
T Consensus 238 ------------kD-k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs 275 (829)
T KOG0576|consen 238 ------------KD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVS 275 (829)
T ss_pred ------------cC-CccchHHHHHHHHHHhcCCCccCCChhhheeceeec
Confidence 00 124567899999999999999999999999999985
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=280.76 Aligned_cols=203 Identities=27% Similarity=0.431 Sum_probs=175.9
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHH------HHHHHHHHHHHHhcC---CCCeeeeccee
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES------VRFMAREILILRRLD---HPNIIKLEGLI 198 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~------~~~~~~E~~~l~~l~---h~nIv~l~~~~ 198 (478)
+..+|..++.||.|+||.|++|.++.+...|+||.+.++..-.+. .-.+..||+||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 455799999999999999999999999999999999876432111 122345999999996 99999999999
Q ss_pred eecCCceEEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccc
Q 011763 199 TSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 277 (478)
Q Consensus 199 ~~~~~~~~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~ 277 (478)
++ .+++||+||.-..+ .+..++.....++|.+++.|++|++.|+++||++||||||||-+||+++.+|-+||+|||.
T Consensus 639 Ed--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 ED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 98 78999999987643 3555566667899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 011763 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 335 (478)
Q Consensus 278 a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~ 335 (478)
|..... .+....+||..|.|||++.|..+.+..-|||+||++||.++....||..
T Consensus 717 aa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 987765 4556788999999999999877788899999999999999998888863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-33 Score=269.14 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=186.9
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc--CCCCeeeecceeeecC--C
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL--DHPNIIKLEGLITSRL--S 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~~--~ 203 (478)
..+..++++.||+|.||.||+|+. +++.||||++. .+....+.+|.+|.... .|+||++++++-.... .
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 356788899999999999999985 56999999986 45566677788777754 8999999987653211 3
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCcEEEecCCcEEEee
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR---------GVLHRDIKGSNLLVNNEGVLKLAD 274 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---------givHrDlkp~NILl~~~~~vkl~D 274 (478)
..++||++|.+.+.|..++..+ .+++....+++..|++||+|||+- .|+|||||..||||..|++.-|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 3689999999987766665544 689999999999999999999963 499999999999999999999999
Q ss_pred cccccccCCCCC-CCccccccCCcccCcccccCCCCCC-----ChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 011763 275 FGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYG-----PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348 (478)
Q Consensus 275 FG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~-----~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~ 348 (478)
||+|..+..+.. ......+||..|||||+|.+...+. .+.||||+|.+||||++.-..+......+...-.-..
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999987654322 2334578999999999998755444 3689999999999999865433211100100001111
Q ss_pred cCCCC--chhhccCCCCCccccCCCCCCCccchhccc--CCchhHHHHHHHhcCCCCCCccCHHH
Q 011763 349 CGSPP--DDYWKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASA 409 (478)
Q Consensus 349 ~g~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~l~~Li~~mL~~dP~~R~ta~e 409 (478)
+|.-| ++.|... ..... .+.+...|. .-..-+.+.|+.|+..||+.|+||.=
T Consensus 440 vG~hPt~e~mq~~V------V~kK~---RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 440 VGNHPTLEEMQELV------VRKKQ---RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred hcCCCCHHHHHHHH------Hhhcc---CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 12111 1111000 00000 001111121 22345789999999999999999853
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=285.76 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=198.9
Q ss_pred ccceeeeeeeeecCceEEEEEEEC----C---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL----D---TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~----~---~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 200 (478)
.++.++.+.||+|.||.||++.-. . ....||||.++..... ...+.+..|+++|+.+ .|+||+.+++++..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 445567779999999999999632 1 1457999998765544 6778889999999999 79999999999988
Q ss_pred cCCceEEEEEeeccCC-chhhccCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 011763 201 RLSCSIYLVFEYMEHD-ITGLLSCPD---------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (478)
Q Consensus 201 ~~~~~~~lv~e~~~~~-ll~~~~~~~---------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl 264 (478)
.+.+++|+||+..+ ++..+.... ..++..++..++.||+.|++||++..+|||||-..||||
T Consensus 374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI 451 (609)
T ss_pred --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe
Confidence 67899999999964 555544433 248999999999999999999999999999999999999
Q ss_pred ecCCcEEEeecccccccCCCCCCCccccc--cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC-hHH
Q 011763 265 NNEGVLKLADFGLANFSNTGHRQPLTSRV--VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRT-EVE 340 (478)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~--~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~-~~~ 340 (478)
..+..+||+|||+|+.............. ....|||||.+.. ..|+.++||||||++||||++ |..||.+.. ..+
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 99999999999999865433222111111 3556999999987 889999999999999999999 889999855 444
Q ss_pred HHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHH
Q 011763 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (478)
Q Consensus 341 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L 411 (478)
.++.+... ... +.....++++.++++.|++.+|++||+..++.
T Consensus 531 l~~~l~~G-~r~---------------------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 531 LLEFLKEG-NRM---------------------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HHHHHhcC-CCC---------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 44332221 000 11135688999999999999999999998876
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=279.78 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=200.7
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
...+..++||.|+||+||+|.+...++ +||||++.... .......+++|+.+|.+|+|||+++|++++... .
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~ 771 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLS---T 771 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---h
Confidence 356677899999999999998765454 68999987544 345566788999999999999999999999763 3
Q ss_pred EEEEEeeccC-CchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~-~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
+.||++|++. .|++.+...+..+-.+....|..||++||.|||++.+|||||-..||||.....+||.|||+++.....
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 7799999996 566777777778999999999999999999999999999999999999999999999999999877654
Q ss_pred CCCCcc-ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 285 HRQPLT-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 285 ~~~~~~-~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
...... .-...+-|||-|.+.. ..|+.++|||||||++|||+| |..|+.+....++-.. ++.-...
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-le~geRL---------- 919 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-LEKGERL---------- 919 (1177)
T ss_pred cccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-HhccccC----------
Confidence 332221 2223677999998876 789999999999999999998 9999998876554322 2210000
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHH
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L 411 (478)
...+..+.++.-++.+||..|+..||+++++.
T Consensus 920 -----------------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 920 -----------------SQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred -----------------CCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 00135677889999999999999999998865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=235.78 Aligned_cols=213 Identities=38% Similarity=0.613 Sum_probs=179.1
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCCc
Q 011763 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDI 217 (478)
Q Consensus 138 LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~l 217 (478)
||.|.+|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++.. ....+++||++.+..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 689999999999998889999999998654322 34678899999999999999999999877 477899999999655
Q ss_pred hhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-CCcEEEeecccccccCCCCCCCccccccC
Q 011763 218 TGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVT 295 (478)
Q Consensus 218 l~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~~~~~t 295 (478)
+..+.... ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+........ ........
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 54444332 46899999999999999999999999999999999999999 89999999999976654321 12334567
Q ss_pred CcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCC
Q 011763 296 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 375 (478)
Q Consensus 296 ~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (478)
..|++||.+.....++.+.|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8899999887633778899999999999999
Q ss_pred ccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCc
Q 011763 376 SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414 (478)
Q Consensus 376 ~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp 414 (478)
..+.++|..||..||++||++.++++|+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1357799999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=253.93 Aligned_cols=249 Identities=25% Similarity=0.289 Sum_probs=182.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCCeeeecceeeecCC--c
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR--LDHPNIIKLEGLITSRLS--C 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~~--~ 204 (478)
..+..+.+.||+|.||.||+|.+ .|+.||||++... ....+.+|.+|.+. |+|+||+.+++.-....+ -
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeeccc--cCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 34789999999999999999987 4789999999622 22345567777765 499999999876543222 2
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcEEEecCCcEEEeecc
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFG 276 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------givHrDlkp~NILl~~~~~vkl~DFG 276 (478)
.+|||.+|-+.+.|.+++.. ..++.+....++..++.||+|||.. .|.|||||..||||..++..-|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 58999999998877777766 4789999999999999999999953 39999999999999999999999999
Q ss_pred cccccCCCC---CCCccccccCCcccCcccccCCCCC-----CChhhHHHHHHHHHHHHhC----------CCCCCCC--
Q 011763 277 LANFSNTGH---RQPLTSRVVTLWYRPPELLLGATDY-----GPSVDLWSVGCVFAELLIG----------KPILQGR-- 336 (478)
Q Consensus 277 ~a~~~~~~~---~~~~~~~~~t~~y~APE~l~~~~~~-----~~~~DiwslG~il~elltG----------~~pf~~~-- 336 (478)
+|....... ....+.++||..|||||+|...... -..+||||||.+|||++.. ++||..-
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 996554332 2344668999999999998653221 1258999999999999752 3555432
Q ss_pred --ChHHHHHHHHH--HcCCCCchhhccCCCCCccccCCCCCCCccchhcccCC--chhHHHHHHHhcCCCCCCccCHHHH
Q 011763 337 --TEVEQLHKIFK--LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRATASAA 410 (478)
Q Consensus 337 --~~~~~~~~i~~--~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~l~~Li~~mL~~dP~~R~ta~e~ 410 (478)
...+.+.+++- .+.+..+.. |... =..+-.||+.|+..+|.-|.||-.+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnr-------------------------W~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNR-------------------------WKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcc-------------------------cccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 22222222211 111111111 1111 1246788999999999999998665
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=237.15 Aligned_cols=211 Identities=37% Similarity=0.591 Sum_probs=173.6
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEe
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e 211 (478)
|.+.+.||.|++++||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++.. ....++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEe
Confidence 56789999999999999999888999999999865432 256778889999999999999999998876 567899999
Q ss_pred eccCCchhhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc
Q 011763 212 YMEHDITGLLSCPDIK-FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (478)
Q Consensus 212 ~~~~~ll~~~~~~~~~-l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 290 (478)
|+++..+..+...... +++..+..++.|++.+|.+||+++++|+||+|.||+++.++.++|+|||++............
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9998555444433334 899999999999999999999999999999999999999999999999999776543211223
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC-CChH-HHHHHH
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEV-EQLHKI 345 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~-~~~~-~~~~~i 345 (478)
...++..|++||.+.....++.++|||+||+++++|++|++||.. .... .....+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 446678899999874346678899999999999999999999977 3444 344444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=294.31 Aligned_cols=203 Identities=18% Similarity=0.209 Sum_probs=146.0
Q ss_pred hcCC-CCeeeecceeeec-----CCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 011763 185 RLDH-PNIIKLEGLITSR-----LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (478)
Q Consensus 185 ~l~h-~nIv~l~~~~~~~-----~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlk 258 (478)
.+.| .||++++++|... ....++++||+++++|...+......+++..++.++.||+.||+|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 5777788877221 124578889999888777776656679999999999999999999999999999999
Q ss_pred CCcEEEecCC-------------------cEEEeecccccccCCCC---------------CCCccccccCCcccCcccc
Q 011763 259 GSNLLVNNEG-------------------VLKLADFGLANFSNTGH---------------RQPLTSRVVTLWYRPPELL 304 (478)
Q Consensus 259 p~NILl~~~~-------------------~vkl~DFG~a~~~~~~~---------------~~~~~~~~~t~~y~APE~l 304 (478)
|+||||+..+ .+||+|||+++...... .......++|++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 45555666554321000 0001123578999999998
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccC
Q 011763 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 384 (478)
Q Consensus 305 ~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 384 (478)
.+ ..|+.++|||||||+||||++|.+||.... ..+..+.... .+... ..
T Consensus 188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~~--------------------------~~ 236 (793)
T PLN00181 188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQI--------------------------LL 236 (793)
T ss_pred cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChhh--------------------------hh
Confidence 87 678999999999999999999998876322 1222221111 01000 01
Q ss_pred CchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 385 LPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 385 ~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
......+++.+||+.||.+||++.|+|+||||.+
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 1334678999999999999999999999999976
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=240.37 Aligned_cols=258 Identities=24% Similarity=0.305 Sum_probs=195.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.+.|.|.+.||+|-||.+.+|+++.+++.+++|.+.... ...+.+.+|...--.| .|.||+.-|++..+. .+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEE
Confidence 468999999999999999999999999999999997654 3346677787765555 699999988764333 56788
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC--CcEEEeecccccccCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGH 285 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~--~~vkl~DFG~a~~~~~~~ 285 (478)
+++||++.+.|..-... ..+-|...+.++.|++.||.|+|++++||||||.+||||-+. ..|||||||+.+..+.-
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 99999997655444333 357899999999999999999999999999999999999543 58999999998755421
Q ss_pred CCCccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
.....-+..|.+||++.. .....+.+|||.||+++|.+++|.+||+.....+ ..+|+-.+
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-------------~~Y~~~~~ 240 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-------------KPYWEWEQ 240 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-------------chHHHHHH
Confidence 111223566999998642 2235778999999999999999999998433221 11221111
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCc---cCHHHHHhCccc
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR---ATASAALASEYF 416 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R---~ta~e~L~hp~f 416 (478)
+. +.....+.+.|..+++.+..+.++-|..+|+.| .++......-|.
T Consensus 241 w~--------~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 241 WL--------KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred Hh--------cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 11 111224456678899999999999999999999 677766666665
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=237.04 Aligned_cols=253 Identities=20% Similarity=0.287 Sum_probs=202.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTG-----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~-----~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++++....+-+|.||.||.|.+++.+ +.|.+|.++. ...+-+...++.|.-.|..+.|||+..+.+++.+. .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-Y 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-c
Confidence 567888899999999999999765433 3466777653 33566778888999999999999999999988764 4
Q ss_pred ceEEEEEeeccCCchh-hcc-----C--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeec
Q 011763 204 CSIYLVFEYMEHDITG-LLS-----C--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~-~~~-----~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF 275 (478)
...+.++.+++-+.+. ++. . ....++..++..++.||+.|++|||+++|||.||-..|++|++..++||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 5677888888854433 333 1 1234778889999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcccc-ccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCC
Q 011763 276 GLANFSNTGHRQPLTSR-VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPP 353 (478)
Q Consensus 276 G~a~~~~~~~~~~~~~~-~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~ 353 (478)
.+++..-+.+....... .-+..||+||.+.+ ..|+.++|+||||++||||+| |+.|+...+..+...-+.+..
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy---- 515 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY---- 515 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc----
Confidence 99987655444333322 22567999999987 789999999999999999999 999999998888776664421
Q ss_pred chhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+..+| -+.|+++..++.-|+..+|++||+.+|+..
T Consensus 516 ---------------RlaQP---------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 ---------------RLAQP---------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ---------------eecCC---------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11122 268999999999999999999999999863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=267.27 Aligned_cols=265 Identities=26% Similarity=0.336 Sum_probs=202.1
Q ss_pred eeeeeeeecCceEEEEEEECCCCcEEEEEEeec----CCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRF----DNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 133 ~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~----~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
...+.+|.|++|.|+.+......+.++.|.++. ..........+..|+.+-..|.|+|++..+..+.+. ...+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccchh
Confidence 456789999999899888777666677776542 221222223366788888899999998888777663 33444
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC--
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 286 (478)
+||||++ .+..+......++..++..+++||+.||+|||+.||.|||||++|++++.+|.+||+|||.+.....+..
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 5999999 5555555556799999999999999999999999999999999999999999999999999976654333
Q ss_pred -CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHcCCCCchhhccCCCCC
Q 011763 287 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH-KIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 287 -~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~-~i~~~~g~~~~~~~~~~~~~~ 364 (478)
......+|+..|+|||++.+.......+||||.|++++.|++|+.||+.....+... .+..
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~----------------- 540 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY----------------- 540 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-----------------
Confidence 345667889999999999885555567899999999999999999998654433221 1000
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
.............+..++...+.+|.+||++||.+|+|+++||+.+||+....
T Consensus 541 ----~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 541 ----SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred ----ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 00001111223344578899999999999999999999999999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=217.78 Aligned_cols=164 Identities=21% Similarity=0.291 Sum_probs=125.2
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCC
Q 011763 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296 (478)
Q Consensus 217 ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~ 296 (478)
|.+.+......+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...+|+
T Consensus 3 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g~~ 68 (176)
T smart00750 3 LADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRVDP 68 (176)
T ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCCcc
Confidence 44444444557999999999999999999999998 999999999999999 9999765432 125789
Q ss_pred cccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCC
Q 011763 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 375 (478)
Q Consensus 297 ~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (478)
.|+|||++.+ ..++.++|||||||++|||++|++||...... ..+..+........ . ..
T Consensus 69 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~----------------~~ 128 (176)
T smart00750 69 YFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD---P----------------RD 128 (176)
T ss_pred cccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC---c----------------cc
Confidence 9999999986 67899999999999999999999999765443 22333322111000 0 00
Q ss_pred ccchhcccCCch--hHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 376 SSLRETFKDLPT--TAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 376 ~~l~~~~~~~~~--~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
. .....++. .+.+||.+||..||.+|||+.++++|+|+.
T Consensus 129 ~---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 129 R---SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred c---ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0 00012333 699999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-25 Score=215.34 Aligned_cols=262 Identities=34% Similarity=0.508 Sum_probs=205.4
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChH-HHHHHHHHHHHHHhcCCC-CeeeecceeeecCCceEEEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE-SVRFMAREILILRRLDHP-NIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~~~lv 209 (478)
|.+...||.|+|+.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++++.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 788999999999999999986 7899999976654432 567788999999999888 79999999855 4558999
Q ss_pred EeeccCCchhhccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-cEEEeecccccccCCCC
Q 011763 210 FEYMEHDITGLLSCPDI---KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGH 285 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~ 285 (478)
++++.+..+..+..... .++...+..++.|++.++.|+|+.+++||||||+||+++..+ .++++|||++.......
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999876665544443 789999999999999999999999999999999999999998 79999999997554332
Q ss_pred CC-----CccccccCCcccCcccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCCC-Cc
Q 011763 286 RQ-----PLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSP-PD 354 (478)
Q Consensus 286 ~~-----~~~~~~~t~~y~APE~l~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~~~~g~~-~~ 354 (478)
.. ......+|..|+|||.+.+. ..+....|+|++|++++++++|..||..... .......+.....+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 21 24567889999999998763 4788899999999999999999999887764 33333333332222 00
Q ss_pred hhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.. ...... ......+.+++..++..+|..|.+..+...++|...
T Consensus 237 ~~-----------------~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 237 SP-----------------LSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cc-----------------cCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 00 000000 122357899999999999999999999999977654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-28 Score=243.64 Aligned_cols=242 Identities=27% Similarity=0.454 Sum_probs=200.6
Q ss_pred eeecCceEEEEEEE---CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEEEEEeec
Q 011763 138 IGQGTYSSVFRARD---LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 138 LG~G~~g~V~~~~~---~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
+|.|.||.|++++. .+.+..+|+|++++.............|..++..++ ||++|+++..|+. ....+++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhhc
Confidence 68999999999853 356788999998765543222224456888999886 9999999888877 56789999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 293 (478)
.++.+.........+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.... .+
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~c 154 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----AC 154 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----cc
Confidence 9987777777777889999999999999999999999999999999999999999999999999986654322 28
Q ss_pred cCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 294 ~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
||..|||||++.+ ...++|+||||+++|+|++|..||.+ +...+|....-..|
T Consensus 155 gt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p-------------------- 207 (612)
T KOG0603|consen 155 GTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP-------------------- 207 (612)
T ss_pred cchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc--------------------
Confidence 8999999999873 57799999999999999999999998 66777765332222
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCCC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYA 422 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~~ 422 (478)
..++..+.+++..|+..+|.+|.- +.++++|+||..+.|.
T Consensus 208 ---------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 208 ---------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ---------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 245678899999999999999975 4799999999876654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=224.97 Aligned_cols=164 Identities=21% Similarity=0.234 Sum_probs=128.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-CCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCeee-ecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDNF---EPESVRFMAREILILRRLDHPNIIK-LEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-~~~~vAlK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~ 203 (478)
.++|.+.+.||+|+||+||+|++.. +++.||||++..... .......+.+|+++|+.|+|+||++ +++.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------ 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------ 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence 6689999999999999999998876 678889998753311 2334566889999999999999985 4321
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI-KGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDl-kp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...||||||+++..+.... . .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+...
T Consensus 91 ~~~~LVmE~~~G~~L~~~~-~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR-P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHhC-c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 3479999999987765332 1 11 1467899999999999999999999 9999999999999999999998654
Q ss_pred CCCC-------CCccccccCCcccCccccc
Q 011763 283 TGHR-------QPLTSRVVTLWYRPPELLL 305 (478)
Q Consensus 283 ~~~~-------~~~~~~~~t~~y~APE~l~ 305 (478)
.... .......+++.|+|||.+.
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 3211 1123456688899999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=237.66 Aligned_cols=226 Identities=29% Similarity=0.436 Sum_probs=172.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|..++.|-.|+||.||+++++.+.+.+|+| ++++++ +.+- ||.....|++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee----------------
Confidence 458999999999999999999999999999994 443321 1110 22222333333
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC---
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--- 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--- 285 (478)
++....+ ..-++++.. ++.+++|||+.||+|||+||+|+||+.-|++|+.|||+++......
T Consensus 136 ------gDc~tll-k~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ------GDCATLL-KNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ------chhhhhc-ccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 2222222 222244433 2779999999999999999999999999999999999986432110
Q ss_pred -----------CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCc
Q 011763 286 -----------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354 (478)
Q Consensus 286 -----------~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~ 354 (478)
.......++|+.|+|||++.. ..|+..+|||++|+|+||.+-|..||.+++..+.+.+.+......|+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 011234688999999999987 77999999999999999999999999999999999888876554443
Q ss_pred hhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc---CHHHHHhCcccCCCCCC
Q 011763 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA---TASAALASEYFSTKPYA 422 (478)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~---ta~e~L~hp~f~~~~~~ 422 (478)
.. ..++++++++|.++|..+|..|. .+.++-+|+||+...|.
T Consensus 280 ~d--------------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 280 ED--------------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cC--------------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 32 36789999999999999999995 57788899999876654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=212.17 Aligned_cols=255 Identities=24% Similarity=0.222 Sum_probs=190.2
Q ss_pred ceeeeeeeeecCceEEEEEEECCCC-cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC----CCeeeecceeeecCCce
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTG-KIVALKKVRFDNFEPESVRFMAREILILRRLDH----PNIIKLEGLITSRLSCS 205 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~-~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~~~~~~~~ 205 (478)
+|.+.++||+|+||.||++.+..++ ..+|+|+......... ..+..|+.+|..+.. +++..+++... ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 7999999999999999999987764 6789998765432211 146678888888862 58888877764 22667
Q ss_pred EEEEEeeccCCchhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC-----CcEEEeeccccc
Q 011763 206 IYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-----GVLKLADFGLAN 279 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-----~~vkl~DFG~a~ 279 (478)
-||||+.++.+|.++.... ...|+...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 8999999998888776443 4789999999999999999999999999999999999999865 469999999998
Q ss_pred ccC--CCC----CCC---ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 011763 280 FSN--TGH----RQP---LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350 (478)
Q Consensus 280 ~~~--~~~----~~~---~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g 350 (478)
... ... ... .....||..|+++.+..+ ...+.+.|+||++.++.+|+.|..|+..........++.....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 221 111 111 223458999999998887 6779999999999999999999999977654333333322110
Q ss_pred CCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
... ........+..+..++..+-..+...+|....+...
T Consensus 255 ~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLL------------------------TDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhc------------------------cccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 000 000122355677777777777888889988776544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=202.12 Aligned_cols=209 Identities=24% Similarity=0.298 Sum_probs=173.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.|.+.++||+|+||.+++|.+.-+++.||||.-... ....++..|....+.| ..+.|..++.+-. .+.+-.||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGq--eG~~NiLV 102 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQ--EGKYNILV 102 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeecc--ccchhhhh
Confidence 799999999999999999999999999999975433 2234567789888888 5789988854333 36777899
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-----cEEEeecccccccCCC
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTG 284 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-----~vkl~DFG~a~~~~~~ 284 (478)
+|+++.+|.+++.-.+..|+...+.-++.||+.-++|+|++.+|+|||||+|+||...+ .|-|+|||+|+.+...
T Consensus 103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 99999998888888888999999999999999999999999999999999999997554 5899999999877544
Q ss_pred CCC------CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHH
Q 011763 285 HRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR---TEVEQLHKIF 346 (478)
Q Consensus 285 ~~~------~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~---~~~~~~~~i~ 346 (478)
... ...+..||..||+--..++ ..-+...|+=+||-+++.+|-|..||++. +..+..++|-
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred cccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 322 2244567999999887777 55688899999999999999999999874 5556666653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=193.65 Aligned_cols=247 Identities=21% Similarity=0.248 Sum_probs=191.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH-PNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~ 207 (478)
...|.++++||.|+||.+|++....+|..||||+-..... ...+.-|..+.+.|++ ..|..+..+..+ ..+-.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccc--cccce
Confidence 5689999999999999999999999999999998654322 2346679999998854 677777777766 67788
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC---CcEEEeecccccccCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTG 284 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a~~~~~~ 284 (478)
|||+++..++.+++.-....|+...+.-++-|++.-++|+|.+++|||||||+|+|..-+ ..+.|+|||+|+.+.+.
T Consensus 88 lVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 999999998888887777789999999999999999999999999999999999998644 57899999999866432
Q ss_pred CCC------CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHcCCCCch
Q 011763 285 HRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV---EQLHKIFKLCGSPPDD 355 (478)
Q Consensus 285 ~~~------~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~---~~~~~i~~~~g~~~~~ 355 (478)
... .-....||..|.+--...+ ..-+...|+-|+|.+|..+.-|..||++.... +..++|.+.-
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK------ 240 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK------ 240 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh------
Confidence 211 1234567888988766655 34467889999999999999999999986543 4445554432
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t 406 (478)
....++..++.+|.++.-.|.-|=..-=++-|.
T Consensus 241 ------------------~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 241 ------------------MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred ------------------cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 222345566788888888888775444444454
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=230.59 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=181.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCC--CChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN--FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
+|...+.||.+.|=+|.+|++.+ |. |+||++-+.. ..-...++...|++ ...++|||.+++.-+... ....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 68889999999999999998753 44 8999986543 33444455555666 566699999998776544 456789
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc--CCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS--NTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~--~~~~~ 286 (478)
|-+|+.++|.+.+. .+..+...+.+.|+.||+.||..+|..||+|+|||.+||||+.-+-+.|+||..-+.. .+++.
T Consensus 99 vRqyvkhnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99999988877664 4446788899999999999999999999999999999999999999999999887543 22222
Q ss_pred CCcccccc----CCcccCcccccCC---------CC-CCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 011763 287 QPLTSRVV----TLWYRPPELLLGA---------TD-YGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (478)
Q Consensus 287 ~~~~~~~~----t~~y~APE~l~~~---------~~-~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 351 (478)
...+-+.. -.+|+|||.+... .. .+++.||||+||+++||++ |+|||.- .++-.....- .
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~-~ 252 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGN-A 252 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccC-c
Confidence 22222222 3469999988541 12 6789999999999999998 7999961 1111111100 0
Q ss_pred CCchhhccCCCCCccccCCCCCCCccchhcccC-CchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
. ..+..+.. -+..+++||..|++.||.+|.+|++.|+-
T Consensus 253 ~------------------------~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 D------------------------DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred c------------------------CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 00001111 13368999999999999999999999976
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=192.03 Aligned_cols=142 Identities=20% Similarity=0.226 Sum_probs=109.4
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHH------------------------HHHHHHHHHHHHhcCCCC
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES------------------------VRFMAREILILRRLDHPN 190 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~n 190 (478)
...||+|+||.||+|.+. +|+.||||+++........ ......|+.+|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 8999999999765321111 122345999999998877
Q ss_pred eeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCcEEEecCCc
Q 011763 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC-HSRGVLHRDIKGSNLLVNNEGV 269 (478)
Q Consensus 191 Iv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~givHrDlkp~NILl~~~~~ 269 (478)
+.....+. . .. .+|||||++++.+.........+++..+..++.||+.+|.+| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~-~--~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPIL-L--KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEE-e--cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 64332222 1 12 379999999865543322345789999999999999999999 699999999999999998 578
Q ss_pred EEEeecccccccC
Q 011763 270 LKLADFGLANFSN 282 (478)
Q Consensus 270 vkl~DFG~a~~~~ 282 (478)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-24 Score=201.97 Aligned_cols=237 Identities=22% Similarity=0.314 Sum_probs=151.2
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCC----------CCeeeecceee
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDH----------PNIIKLEGLIT 199 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h----------~nIv~l~~~~~ 199 (478)
.+...+.||.|+++.||.+++..+++.+|||++..... .....+.+.+|......+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 57788999999999999999999999999999876553 23346666666655544322 12222222221
Q ss_pred ---------ecCC-c-----eEEEEEeeccCCchhhcc---C-CC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 011763 200 ---------SRLS-C-----SIYLVFEYMEHDITGLLS---C-PD--IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (478)
Q Consensus 200 ---------~~~~-~-----~~~lv~e~~~~~ll~~~~---~-~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlk 258 (478)
...+ . ..+++|+-+.+++...+. . .. ..+.......+..|+++.+++||..||+|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1100 1 236788888776654432 1 11 122333345566899999999999999999999
Q ss_pred CCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccCcccccCC-------CCCCChhhHHHHHHHHHHHHhCCC
Q 011763 259 GSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-------TDYGPSVDLWSVGCVFAELLIGKP 331 (478)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~-------~~~~~~~DiwslG~il~elltG~~ 331 (478)
|+|++++.+|.++|+||+.....+... .....+..|.+||..... ..++.+.|.|+||+++|.|+++..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999999876554311 112335779999976321 247889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCc
Q 011763 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404 (478)
Q Consensus 332 pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R 404 (478)
||......... + ..+ ..+.++|+.+++||..||+.||.+|
T Consensus 249 Pf~~~~~~~~~-----------~---------------------~~f-~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADP-----------E---------------------WDF-SRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTS-----------G---------------------GGG-TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccc-----------c---------------------ccc-hhcCCcCHHHHHHHHHHccCCcccC
Confidence 99854321100 0 011 2234789999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=192.00 Aligned_cols=174 Identities=14% Similarity=0.162 Sum_probs=132.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChH-HHHH------HHHHHHHHHhcCCCCeeeecceeeec
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE-SVRF------MAREILILRRLDHPNIIKLEGLITSR 201 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~-~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~ 201 (478)
..+|.+++.||.|+||.||++.+ ++..+|||+++......+ .... +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 45899999999999999999765 466899999975543222 2222 56899999999999999998886643
Q ss_pred C------CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeec
Q 011763 202 L------SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (478)
Q Consensus 202 ~------~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF 275 (478)
. ....+|||||++|..+..+. .+++ ....+|+.+|..||+.|++|+||||+||+++++| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 23578999999996665542 2333 2456999999999999999999999999999988 999999
Q ss_pred ccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHH
Q 011763 276 GLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327 (478)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ell 327 (478)
|........... . .+++. ..|+.++|+|+||+++..+.
T Consensus 179 g~~~~~~e~~a~--d-----------~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK--D-----------RIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH--H-----------HHHHH-hHhcccccccceeEeehHHH
Confidence 988654321110 0 02222 45778999999999988765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=184.75 Aligned_cols=143 Identities=20% Similarity=0.250 Sum_probs=111.3
Q ss_pred eeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh------------------------HHHHHHHHHHHHHHhcCCC
Q 011763 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP------------------------ESVRFMAREILILRRLDHP 189 (478)
Q Consensus 134 ~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~------------------------~~~~~~~~E~~~l~~l~h~ 189 (478)
+...||+|+||.||+|.+. +|+.||||+++...... .....+.+|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999998653110 0022345799999999998
Q ss_pred CeeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCC
Q 011763 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEG 268 (478)
Q Consensus 190 nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~ 268 (478)
+|.....+... ..||||||+++..+.........++...+..++.|++.+|.+||+ +||+||||||+|||++ ++
T Consensus 80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 87544333322 248999999986332221233467889999999999999999999 9999999999999999 89
Q ss_pred cEEEeecccccccC
Q 011763 269 VLKLADFGLANFSN 282 (478)
Q Consensus 269 ~vkl~DFG~a~~~~ 282 (478)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=182.36 Aligned_cols=192 Identities=19% Similarity=0.156 Sum_probs=140.5
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~l 208 (478)
+.+...|+.|+||+|+++.. .+..++.+.+..... ..-....+.+|+++|++|. |++|++++++ ...|+
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~l 75 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHL 75 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEE
Confidence 45678899999999998864 677888887765443 1122235678999999994 5889999775 23689
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI-KGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDl-kp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+|||+.|..+..... .. ...++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 76 vmeyI~G~~L~~~~~------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 76 DRSYLAGAAMYQRPP------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred EEeeecCccHHhhhh------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999999876653321 11 2357889999999999999999999 799999999999999999999755432210
Q ss_pred ----C---c-----cccccCCcccCcccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 011763 288 ----P---L-----TSRVVTLWYRPPELLLGATDYG-PSVDLWSVGCVFAELLIGKPILQGRTE 338 (478)
Q Consensus 288 ----~---~-----~~~~~t~~y~APE~l~~~~~~~-~~~DiwslG~il~elltG~~pf~~~~~ 338 (478)
. . .-...++.|+.|+.-.--...+ ...++++.|+.+|.++|+..++.++++
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 0 0012377788887543211222 467999999999999999988876553
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.3e-22 Score=189.04 Aligned_cols=208 Identities=23% Similarity=0.338 Sum_probs=143.0
Q ss_pred CCCCeeeecceeeecC-------------------------CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHH
Q 011763 187 DHPNIIKLEGLITSRL-------------------------SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLL 241 (478)
Q Consensus 187 ~h~nIv~l~~~~~~~~-------------------------~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil 241 (478)
.|||||++..+|.+.- +..+|+||......+...+..+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHH
Confidence 5999999988875421 2367999998888777666544 356677778899999
Q ss_pred HHHHHHHhCCceeccCCCCcEEEe--cCC--cEEEeecccccccCCC-----CCCCccccccCCcccCcccccCCCC---
Q 011763 242 HGLEHCHSRGVLHRDIKGSNLLVN--NEG--VLKLADFGLANFSNTG-----HRQPLTSRVVTLWYRPPELLLGATD--- 309 (478)
Q Consensus 242 ~aL~~LH~~givHrDlkp~NILl~--~~~--~vkl~DFG~a~~~~~~-----~~~~~~~~~~t~~y~APE~l~~~~~--- 309 (478)
+|+.|||++||.|||||.+||||. +|+ .+.|+|||.+...... ........-|.-..||||+...-..
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999985 333 4789999988533221 1111122334667899998753111
Q ss_pred --CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCch
Q 011763 310 --YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 387 (478)
Q Consensus 310 --~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 387 (478)
.-.++|.|+.|.+.||+++...||.+..+.-.-..-++ +. .|......+++
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-----------e~----------------qLPalp~~vpp 484 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-----------ES----------------QLPALPSRVPP 484 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-----------hh----------------hCCCCcccCCh
Confidence 12378999999999999999999987433211111010 00 01111246788
Q ss_pred hHHHHHHHhcCCCCCCccCH---HHHHh------CcccCCCCCCC
Q 011763 388 TAVNLIETLLSVEPYKRATA---SAALA------SEYFSTKPYAC 423 (478)
Q Consensus 388 ~l~~Li~~mL~~dP~~R~ta---~e~L~------hp~f~~~~~~~ 423 (478)
.+++|+..+|+.||.+|+++ .-+|+ |.|++.....|
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~~~ 529 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMMEKC 529 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhcccc
Confidence 99999999999999999985 44553 45555444444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.9e-22 Score=180.21 Aligned_cols=255 Identities=15% Similarity=0.207 Sum_probs=192.4
Q ss_pred cccccCcccccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecce
Q 011763 118 GEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL 197 (478)
Q Consensus 118 ~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 197 (478)
......+..+......++.+|.+...|..|++++.. ..++.|++.....+....+.|.+|.-.|+-+.||||+.+++.
T Consensus 178 datlsr~~gid~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlga 255 (448)
T KOG0195|consen 178 DATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGA 255 (448)
T ss_pred ccccccccCcchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhh
Confidence 334445555556677788899999999999999854 456778887766666666778889999999999999999999
Q ss_pred eeecCCceEEEEEeeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEecCCcEEEe
Q 011763 198 ITSRLSCSIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLA 273 (478)
Q Consensus 198 ~~~~~~~~~~lv~e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkl~ 273 (478)
|.. ..++.+|..||+.+.+..++.. ....+..++..++.+|+.|++|||+.. |..--|....|+||++.+.+|.
T Consensus 256 cns--ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 256 CNS--PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred ccC--CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee
Confidence 987 4668899999998766655433 334677889999999999999999884 4445788899999999877664
Q ss_pred --ecccccccCCCCCCCccccccCCcccCcccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 011763 274 --DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349 (478)
Q Consensus 274 --DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~--~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~ 349 (478)
|--++... ..+...|.||+||.+..... .-.++|+|||+++||||.|...||..-...+.-.+|.- -
T Consensus 334 mad~kfsfqe--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-e 404 (448)
T KOG0195|consen 334 MADTKFSFQE--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-E 404 (448)
T ss_pred cccceeeeec--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-c
Confidence 33332111 22344788999999875221 23478999999999999999999998887776555421 0
Q ss_pred CCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHH
Q 011763 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (478)
Q Consensus 350 g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L 411 (478)
|- -....+.++..+..|+.-|++.||.+||..+.++
T Consensus 405 gl--------------------------rv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 405 GL--------------------------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cc--------------------------cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 10 0111246788899999999999999999987664
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-22 Score=199.64 Aligned_cols=154 Identities=29% Similarity=0.487 Sum_probs=114.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC-----CCCccccccCCcccCcc
Q 011763 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPPE 302 (478)
Q Consensus 228 l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-----~~~~~~~~~t~~y~APE 302 (478)
.+......++.|++.+++| ++.+|+|+||.||++..+..+||.|||+........ ....+..++|.+||+||
T Consensus 356 ~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPE 432 (516)
T KOG1033|consen 356 RSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPE 432 (516)
T ss_pred cchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHH
Confidence 4556678889999999999 999999999999999999999999999987654433 22345678899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhc
Q 011763 303 LLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRET 381 (478)
Q Consensus 303 ~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 381 (478)
.|.+ ..|+.++|||+||+||+||+. =...|.. ...+..+ + -|..|+.+|
T Consensus 433 Qi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~-r-~g~ip~~~~------------------------ 482 (516)
T KOG1033|consen 433 QIRG-QQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDI-R-DGIIPPEFL------------------------ 482 (516)
T ss_pred HHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhh-h-cCCCChHHh------------------------
Confidence 9997 789999999999999999997 1222211 0111111 1 122222222
Q ss_pred ccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 382 FKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 382 ~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.-.+.-.+|+.+||...|.+||++.+.-.|+|.
T Consensus 483 --~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 483 --QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred --hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 112344689999999999999988888777775
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-20 Score=175.82 Aligned_cols=146 Identities=21% Similarity=0.190 Sum_probs=112.5
Q ss_pred ceeeeeeeeecCceEEEEEE-ECCCCcEEEEEEeecCCCCh----------------------HHHHHHHHHHHHHHhcC
Q 011763 131 AFEKLEKIGQGTYSSVFRAR-DLDTGKIVALKKVRFDNFEP----------------------ESVRFMAREILILRRLD 187 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~-~~~~~~~vAlK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 187 (478)
-|.+.+.||+|+||.||+|. +..+|+.||||+++...... .....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 66789999999997543210 01123567999999997
Q ss_pred CCCeeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCcEEEec
Q 011763 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG-VLHRDIKGSNLLVNN 266 (478)
Q Consensus 188 h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-ivHrDlkp~NILl~~ 266 (478)
+.. +.+..++.. . ..+|||||+++..+.........+....+..++.||+.+|.+||++| |+|+||||+||+++
T Consensus 109 ~~~-i~~p~~~~~--~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAG-VPVPKPIAW--R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcC-CCCCeeeEe--c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 532 222222322 1 24799999999665544333445677778899999999999999999 99999999999999
Q ss_pred CCcEEEeeccccccc
Q 011763 267 EGVLKLADFGLANFS 281 (478)
Q Consensus 267 ~~~vkl~DFG~a~~~ 281 (478)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 889999999998643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=170.04 Aligned_cols=139 Identities=14% Similarity=0.185 Sum_probs=104.8
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-----CCCCeeeecceeeecCC-ce
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-----DHPNIIKLEGLITSRLS-CS 205 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~~-~~ 205 (478)
+.-.+.||+|+|+.||. +..++.. +||++..... ...+.+.+|+.+++.+ +||||+++++++....+ ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 34457899999999996 6666665 6999876432 2346688999999999 57999999999987532 33
Q ss_pred EE-EEEeecc--CCchhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCcEEEecC----CcEEEeeccc
Q 011763 206 IY-LVFEYME--HDITGLLSCPDIKFSEAQIKCYMNQLLHGL-EHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGL 277 (478)
Q Consensus 206 ~~-lv~e~~~--~~ll~~~~~~~~~l~~~~~~~i~~qil~aL-~~LH~~givHrDlkp~NILl~~~----~~vkl~DFG~ 277 (478)
++ +|+||.+ ++.+..+.... .+++. ..++.|++.++ +|||+++|+||||||+|||++.. ..++|+||+.
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 33 7899944 55555554433 46665 35678888887 99999999999999999999743 3799999543
Q ss_pred c
Q 011763 278 A 278 (478)
Q Consensus 278 a 278 (478)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4e-20 Score=199.91 Aligned_cols=195 Identities=26% Similarity=0.327 Sum_probs=152.0
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCeeeecceeeecCC
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD---HPNIIKLEGLITSRLS 203 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~ 203 (478)
+..+.|.|.+.||+|+||+||+|.+.. |+.||||+-+..+. ++... -.+++.+|+ -+.|+.+...+.. .
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~----WEfYI-~~q~~~RLk~~~~~~~~~~~~a~~~--~ 766 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP----WEFYI-CLQVMERLKPQMLPSIMHISSAHVF--Q 766 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc----eeeee-hHHHHHhhchhhhcchHHHHHHHcc--C
Confidence 456789999999999999999999766 99999998764431 11000 122333443 2344455444444 3
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-------CCcEEEeecc
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------EGVLKLADFG 276 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-------~~~vkl~DFG 276 (478)
+..+||+||.+.+.+..+.+....+++..+..+..||+..|++||.++|||+||||+|+||.. .--++|+|||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 446899999998777777778888999999999999999999999999999999999999953 2358999999
Q ss_pred cccccCCC-CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCC
Q 011763 277 LANFSNTG-HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 330 (478)
Q Consensus 277 ~a~~~~~~-~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~ 330 (478)
.+.....- .......++.|-.+-.+|+..| ++|++.+|.|.|+.+++.||+|+
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 99654322 1245566778999999998887 89999999999999999999996
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.5e-21 Score=200.97 Aligned_cols=263 Identities=29% Similarity=0.407 Sum_probs=206.7
Q ss_pred cceeeeeeeeecCceEEEEEEEC-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~-~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 207 (478)
..|.+.+.||+|+|+.|-+.... .....+|+|.+..........+.+..|..+-..+. |.|++.+++.... ....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Ccccc
Confidence 36888999999999999998764 34456777777655434455556667888888886 9999999998876 66789
Q ss_pred EEEeeccCCchhhcc-CCCC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEecCC-cEEEeecccccccCC
Q 011763 208 LVFEYMEHDITGLLS-CPDI-KFSEAQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNT 283 (478)
Q Consensus 208 lv~e~~~~~ll~~~~-~~~~-~l~~~~~~~i~~qil~aL~~LH-~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~ 283 (478)
++++|..++.+.... ..+. ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999998887666555 4444 6788889999999999999999 99999999999999999999 999999999987654
Q ss_pred --CCCCCcccccc-CCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 284 --GHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 284 --~~~~~~~~~~~-t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
+........++ ++.|+|||.+.+.....+..|+||.|+++.-+++|..|+......+.. ...|...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----------~~~~~~~ 246 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----------YSSWKSN 246 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----------ceeeccc
Confidence 33444556678 999999999887556788999999999999999999887654433210 0001000
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
+ .......|..++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 247 ~-------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 K-------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred c-------------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 00112234678889999999999999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=161.40 Aligned_cols=139 Identities=21% Similarity=0.266 Sum_probs=109.5
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE------SVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++.||+|++|.||+|.+ .+..|++|+......... ....+.+|+.++..+.|++|+....++.. ....++
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~l 76 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFII 76 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEE
Confidence 35789999999999986 677899998764332211 12456789999999999988766556554 345789
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
||||++|..+..+..... . ....++.+|+.+|.+||+.+++|+|++|.|||++ ++.++|+|||.+....
T Consensus 77 v~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred EEEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 999999866655543321 2 7788999999999999999999999999999999 7899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=159.24 Aligned_cols=139 Identities=21% Similarity=0.213 Sum_probs=107.4
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh--------------------HHHHHHHHHHHHHHhcCCCC
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP--------------------ESVRFMAREILILRRLDHPN 190 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~n 190 (478)
.|.+.+.||.|+||.||++... +++.||||+++...... ........|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888899999999999999864 79999999987543110 01123567899999998774
Q ss_pred --eeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC
Q 011763 191 --IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (478)
Q Consensus 191 --Iv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~ 268 (478)
++.+++ .+..++||||+++..+..+... .....++.+|+.++.++|+.||+|+||||+||+|++++
T Consensus 95 i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID------WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee------cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 333332 2345899999998766544321 34567889999999999999999999999999999999
Q ss_pred cEEEeecccccccC
Q 011763 269 VLKLADFGLANFSN 282 (478)
Q Consensus 269 ~vkl~DFG~a~~~~ 282 (478)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999986444
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.1e-18 Score=155.00 Aligned_cols=133 Identities=19% Similarity=0.227 Sum_probs=101.5
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP------ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 137 ~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
.||+|+||.||++.. ++..|++|+........ .....+.+|++++..+.|+++....-++.. ....+|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 379999999999984 56789999865433211 123556789999999988765443333333 34468999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
||++|..+..+...... .++.||+.+|.+||+.|++|+|++|.||+++ ++.++|+|||++...
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99998766554332211 7889999999999999999999999999999 899999999998654
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.9e-18 Score=170.62 Aligned_cols=205 Identities=29% Similarity=0.424 Sum_probs=150.8
Q ss_pred HHhcCCCCeeeecceeeecCCceEEEEEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCC
Q 011763 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV-LHRDIKGS 260 (478)
Q Consensus 183 l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~gi-vHrDlkp~ 260 (478)
|+.+.|.|+.++++.+.+ +...++|.+||..+.+ +.+......+++.....++++|+.||.|||.-.| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 356789999999999988 4778999999986554 4445557788999999999999999999998865 99999999
Q ss_pred cEEEecCCcEEEeecccccccCCC-CCCCccccccCCcccCcccccCCC------CCCChhhHHHHHHHHHHHHhCCCCC
Q 011763 261 NLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGAT------DYGPSVDLWSVGCVFAELLIGKPIL 333 (478)
Q Consensus 261 NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~~~~t~~y~APE~l~~~~------~~~~~~DiwslG~il~elltG~~pf 333 (478)
|++++....+||+|||+....... ............-|.|||.+.+.. ..+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998765320 001111111244599999987531 1466799999999999999999999
Q ss_pred CCCCh----HHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHH
Q 011763 334 QGRTE----VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409 (478)
Q Consensus 334 ~~~~~----~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e 409 (478)
..... .+.+.++.. .+..+ ++ +.+.. ...+++++..+++.|+..+|..||++++
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~~~--------------~r------P~i~~-~~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGSNP--------------FR------PSIEL-LNELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccccCChHHHHHHHHh-cCCCC--------------cC------cchhh-hhhcchHHHHHHHHhcccChhhCccHHH
Confidence 76332 233333322 11111 00 11111 1145668999999999999999999988
Q ss_pred HH
Q 011763 410 AL 411 (478)
Q Consensus 410 ~L 411 (478)
+-
T Consensus 217 i~ 218 (484)
T KOG1023|consen 217 IR 218 (484)
T ss_pred HH
Confidence 74
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=150.28 Aligned_cols=137 Identities=23% Similarity=0.217 Sum_probs=97.5
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHH----------------------HHHHHHHHHhcCCCC--
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF----------------------MAREILILRRLDHPN-- 190 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~n-- 190 (478)
.+.||+|+||+||+|.+. +++.||||+++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999976 7899999998764322111111 134666666664432
Q ss_pred eeeecceeeecCCceEEEEEeeccCCchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCC
Q 011763 191 IIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEG 268 (478)
Q Consensus 191 Iv~l~~~~~~~~~~~~~lv~e~~~~~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~ 268 (478)
+.++++. ...+|||||++++.+. ...... .. ...+..++.+++.++.++|. ++|+|+||||+||+++ ++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 3333322 2358999999983221 111110 11 16788999999999999999 9999999999999999 89
Q ss_pred cEEEeeccccccc
Q 011763 269 VLKLADFGLANFS 281 (478)
Q Consensus 269 ~vkl~DFG~a~~~ 281 (478)
.++|+|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=173.70 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=106.5
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC------hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE------PESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..|...+.||+|+||+||++..... .+++|+....... ....+.+.+|++++..++|++|+....++.. .
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~ 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--P 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--C
Confidence 3456789999999999999986443 3444433221111 1223557789999999999998877666555 3
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
...++||||+++..+..+.. ....++.||+.+|.+||+.||+||||||+|||+ +++.++|+|||+++..
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 45789999999876655432 457789999999999999999999999999999 6789999999998653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.2e-16 Score=147.87 Aligned_cols=138 Identities=18% Similarity=0.201 Sum_probs=101.8
Q ss_pred eeee-ecCceEEEEEEECCCCcEEEEEEeecCCC-----------ChHHHHHHHHHHHHHHhcCCCCe--eeecceeeec
Q 011763 136 EKIG-QGTYSSVFRARDLDTGKIVALKKVRFDNF-----------EPESVRFMAREILILRRLDHPNI--IKLEGLITSR 201 (478)
Q Consensus 136 ~~LG-~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~ 201 (478)
..|| .|+.|+||.+.. .+..++||.+..... +......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 789999999976 367899998854221 11233567789999999988775 6666654432
Q ss_pred CCc--eEEEEEeeccC-CchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccc
Q 011763 202 LSC--SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (478)
Q Consensus 202 ~~~--~~~lv~e~~~~-~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a 278 (478)
... ..+||||++++ ..+..+... ..+++.. +.||+.+|.+||++||+|+||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 222 23599999997 455444333 2455543 568999999999999999999999999999999999999988
Q ss_pred cc
Q 011763 279 NF 280 (478)
Q Consensus 279 ~~ 280 (478)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 54
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.8e-16 Score=133.73 Aligned_cols=132 Identities=23% Similarity=0.241 Sum_probs=108.9
Q ss_pred eeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCeeeecceeeecCCceEEEEEe
Q 011763 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--PNIIKLEGLITSRLSCSIYLVFE 211 (478)
Q Consensus 134 ~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~~~lv~e 211 (478)
+++.||.|.++.||++.... ..+++|.+..... ...+.+|+.++..+.| .++++++.++.. .+..+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEE
Confidence 46789999999999999743 7899999865432 3567789999999976 588888777765 466899999
Q ss_pred eccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR---GVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 212 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
|+.+..+..+ +......++.+++.+|.+||.. +++|+||+|.||++++.+.++|+|||.+..
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9998655433 5567778899999999999985 699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-16 Score=158.64 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=197.4
Q ss_pred ccceeeeeeeee--cCceEEEEEEE--CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQ--GTYSSVFRARD--LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~--G~~g~V~~~~~--~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 203 (478)
...|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.....+.....-.+|+.....+ .|+|.++.+..+.. .
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~ 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--S 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--C
Confidence 446888999999 99999999988 88899999998443322222223334577777777 59999998777776 7
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCcEEEecC-CcEEEeecccc
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH----GLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLA 278 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~----aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a 278 (478)
+..|+-+|++...+..........++...++.++.++.. ||.++|..+++|-|+||.||++..+ ...+++|||+.
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 789999999998888877777777999999999999999 9999999999999999999999999 88999999998
Q ss_pred cccCCCCCCCc----cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHcCCC
Q 011763 279 NFSNTGHRQPL----TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR--TEVEQLHKIFKLCGSP 352 (478)
Q Consensus 279 ~~~~~~~~~~~----~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~--~~~~~~~~i~~~~g~~ 352 (478)
........... ....+...|++||++.+ -++...|||+||.++.+-.++..++... +...++.+++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------ 342 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------ 342 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc------
Confidence 77665432111 11244667999998764 5789999999999999998887665433 2222221111
Q ss_pred CchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...+.+...+.++...+..|+..||..|+++..+++|++...
T Consensus 343 ------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 343 ------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 011223455666777999999999999999999999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.4e-17 Score=171.79 Aligned_cols=269 Identities=24% Similarity=0.252 Sum_probs=201.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.+.|.+.+-+-.|.++.++.+.-..++...++|+...... .....+.+..+-.++-..++|.++...--+.. ....+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP~~ 880 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSPLP 880 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC--CCCcc
Confidence 5678889999999999999998878887777777654322 22233344445555555566777766444333 55689
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC---
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG--- 284 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~--- 284 (478)
|+++|++++.+..........+.+-++.++..+..++++||...++|+|++|.|+|+..+++.++.||+........
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999988655555555556788888899999999999999999999999999999999999999999844221100
Q ss_pred -----C--------------C--------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 011763 285 -----H--------------R--------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 337 (478)
Q Consensus 285 -----~--------------~--------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~ 337 (478)
. . .......+|+.|.+||.+.+ ......+|+|++|++++|.++|.+||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0 00123466999999999987 566889999999999999999999999988
Q ss_pred hHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHH---HHHhCc
Q 011763 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AALASE 414 (478)
Q Consensus 338 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~---e~L~hp 414 (478)
.......|...--..| .-....+.++++++..+|..+|.+|..+. ++-.|+
T Consensus 1040 pq~~f~ni~~~~~~~p--------------------------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~ 1093 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWP--------------------------EGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHP 1093 (1205)
T ss_pred hhhhhhccccCCCCCC--------------------------CCccccChhhhhhhhhhhccCchhccCcccccccccCC
Confidence 8777766644211111 11135678899999999999999999987 889999
Q ss_pred ccCCCCCCCCCC
Q 011763 415 YFSTKPYACDLS 426 (478)
Q Consensus 415 ~f~~~~~~~~~~ 426 (478)
||+..+|.....
T Consensus 1094 ~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1094 FFQDVDWENLAL 1105 (1205)
T ss_pred ccCCCCcccccc
Confidence 999887765443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.6e-13 Score=124.89 Aligned_cols=141 Identities=18% Similarity=0.193 Sum_probs=100.0
Q ss_pred eeeeeecCceEEEEEEECC------CCcEEEEEEeecCCC--------------------ChHHHHHH----HHHHHHHH
Q 011763 135 LEKIGQGTYSSVFRARDLD------TGKIVALKKVRFDNF--------------------EPESVRFM----AREILILR 184 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~------~~~~vAlK~~~~~~~--------------------~~~~~~~~----~~E~~~l~ 184 (478)
...||.|.-+.||.|.... .+..+|||+.+.... .......+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998643 357899999753210 00111222 37999999
Q ss_pred hcCC--CCeeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCc
Q 011763 185 RLDH--PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC-HSRGVLHRDIKGSN 261 (478)
Q Consensus 185 ~l~h--~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~givHrDlkp~N 261 (478)
++.. -++++++++ ..-+|||||++++.+....-.+..+++..+..+..|++.+|..| |+.||||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 9943 456666543 12479999998743221111222456667788889999999999 89999999999999
Q ss_pred EEEecCCcEEEeecccccccC
Q 011763 262 LLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~ 282 (478)
||+. ++.+.|+|||.+....
T Consensus 156 IL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE-CCcEEEEECCCceeCC
Confidence 9997 5789999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1e-12 Score=135.32 Aligned_cols=171 Identities=22% Similarity=0.331 Sum_probs=127.6
Q ss_pred EE-EEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCCchhhccCC
Q 011763 146 VF-RARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP 224 (478)
Q Consensus 146 V~-~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~ 224 (478)
+| .|..+.++.+|.|.+.+.... .....+.+-++.|+.|+||||+++++.+.. ...+|||+|-+..-. ..+.
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~Pl~-~~lk-- 99 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVRPLE-TVLK-- 99 (690)
T ss_pred cccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccccHH-HHHH--
Confidence 45 355667888999998876543 445566778899999999999999998877 568999999886411 1111
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccCccc
Q 011763 225 DIKFSEAQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303 (478)
Q Consensus 225 ~~~l~~~~~~~i~~qil~aL~~LH-~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~ 303 (478)
.+....+...+.||+.||.||| +.+++|++|.-..|+|+..|.+||++|.++........ +......-..|..|+.
T Consensus 100 --~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 100 --ELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEE 176 (690)
T ss_pred --HhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhh
Confidence 2347778888999999999998 56899999999999999999999999999854432211 1111222334677775
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHhC
Q 011763 304 LLGATDYGPSVDLWSVGCVFAELLIG 329 (478)
Q Consensus 304 l~~~~~~~~~~DiwslG~il~elltG 329 (478)
+... +-..|.|-|||++++++.|
T Consensus 177 ~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc---ccchhhhhHHHHHHHHhCc
Confidence 5431 2457999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.8e-14 Score=144.44 Aligned_cols=258 Identities=21% Similarity=0.228 Sum_probs=187.6
Q ss_pred cCcccccccceeeeeeeeecCceEEEEEEEC-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceee
Q 011763 122 QGWVPLRADAFEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLIT 199 (478)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~-~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 199 (478)
..|......+|..+..||.|.|+.|+.+... .++..|++|.+............-..|+.+...+ .|.+++..+..+.
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence 3344455678999999999999999998755 6788999998865544444444445688888777 5888888777665
Q ss_pred ecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC-CcEEEeecccc
Q 011763 200 SRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLA 278 (478)
Q Consensus 200 ~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a 278 (478)
. ....|+=.|||++....+.......+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||..
T Consensus 337 ~--~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 337 Q--LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred c--cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccc
Confidence 5 44567899999887666555555568888999999999999999999999999999999999886 77899999988
Q ss_pred cccCCCCCCCccccccCCccc-CcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhh
Q 011763 279 NFSNTGHRQPLTSRVVTLWYR-PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 279 ~~~~~~~~~~~~~~~~t~~y~-APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 357 (478)
...... .......-++. ..|++.....+..+.|+++||..+.+.+++.+.-....... .|..
T Consensus 415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~---------- 477 (524)
T KOG0601|consen 415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRS---------- 477 (524)
T ss_pred ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeec----------
Confidence 532111 01112233455 36666666788899999999999999999875432211111 1100
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
..-...+.....+..+.+.|+..|+..|+.+.++..|.=|.
T Consensus 478 -------------------~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 478 -------------------GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -------------------ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00001123346788899999999999999999998887664
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.1e-13 Score=135.71 Aligned_cols=143 Identities=20% Similarity=0.229 Sum_probs=94.5
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChH--------------------------------HHH------HH
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE--------------------------------SVR------FM 176 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~--------------------------------~~~------~~ 176 (478)
.+.||.|++|.||+|+.. +|+.||||+.+......- ... .+
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999864 789999999865321000 000 13
Q ss_pred HHHHHHHHhc----CCCCeeeecceeeecCCceEEEEEeeccCCchhhccCC-CCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 011763 177 AREILILRRL----DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLH-GLEHCHSR 250 (478)
Q Consensus 177 ~~E~~~l~~l----~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~-~~~l~~~~~~~i~~qil~-aL~~LH~~ 250 (478)
.+|+..+.++ .|.+-+.+-.++.+. ....+|||||++|..+..+... ...+ ....++.+++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 3455555555 233333443344322 2336899999998655443221 1112 22345555655 47889999
Q ss_pred CceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 251 givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
|++|+|++|.||++++++.++|+|||++....
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.9e-13 Score=118.17 Aligned_cols=127 Identities=17% Similarity=0.114 Sum_probs=93.1
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCe-eeecceeeecCCceEEEEEeec
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~lv~e~~ 213 (478)
++.|+.|.++.||+++.. +..|++|+...... ....+..|+.+++.+.+.++ ++++.... ...++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEec
Confidence 467889999999999863 77899998754321 12234679999998865444 34443322 2247999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCcEEEecCCcEEEeeccccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV-----LHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~gi-----vHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
++..+.... .....++.+++.+|..||..++ +|+|++|.||+++ ++.++|+||+.+.
T Consensus 74 ~G~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCcccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 986554320 1123456799999999999985 9999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.9e-13 Score=142.49 Aligned_cols=145 Identities=21% Similarity=0.309 Sum_probs=95.3
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC---------------------------Ch-----HHHHHH-
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---------------------------EP-----ESVRFM- 176 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~---------------------------~~-----~~~~~~- 176 (478)
..|+. +.||.|++|.||+|+.+.+|+.||||+++.... +. +..+.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 899999999999999988899999999975421 00 111122
Q ss_pred -----HHHHHHHHhcC----CCCeeeecceeeecCCceEEEEEeeccCCchhhc---cCCCC---CCCHHHHHHHHHHHH
Q 011763 177 -----AREILILRRLD----HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL---SCPDI---KFSEAQIKCYMNQLL 241 (478)
Q Consensus 177 -----~~E~~~l~~l~----h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~---~~~~~---~l~~~~~~~i~~qil 241 (478)
.+|+..+.++. +.+.+.+-.++.+- ....+|||||+.|..+..+ ...+. .+.+..+..++.||+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 23444444442 33334333333321 2346799999998655432 11111 244444555555554
Q ss_pred HHHHHHHhCCceeccCCCCcEEEecCC----cEEEeecccccccCC
Q 011763 242 HGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNT 283 (478)
Q Consensus 242 ~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~DFG~a~~~~~ 283 (478)
..|++|+|+||.||+++.++ .++++|||++.....
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999988 999999999865543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.2e-13 Score=124.92 Aligned_cols=240 Identities=18% Similarity=0.186 Sum_probs=153.1
Q ss_pred EEEEEEECCCCcEEEEEEeecCCC-C-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecC---CceEEEEEeeccCCchh
Q 011763 145 SVFRARDLDTGKIVALKKVRFDNF-E-PESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITG 219 (478)
Q Consensus 145 ~V~~~~~~~~~~~vAlK~~~~~~~-~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~~~lv~e~~~~~ll~ 219 (478)
.||++-+...|..|+.-.++.... + ..+.+....-..-|-.+.|.|||+++.|+.+.. ...+.++.|||..+.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 467777777777665443322110 0 111111112233455567999999999987532 23578999999965443
Q ss_pred hc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcEEEecCCcEEEeecccccccCCCCC---CCcc
Q 011763 220 LL----SCPDIKFSEAQIKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLT 290 (478)
Q Consensus 220 ~~----~~~~~~l~~~~~~~i~~qil~aL~~LH~~--givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~ 290 (478)
.+ ......+....+++|+.||+.||.|||+. -|+|+++...-|++..+|-+||.--........... ....
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence 33 23445688999999999999999999988 499999999999999999888753222111110000 0011
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP-ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~-pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
...+-++|.+||.=.. ...+.++|||+||....+|..+.- +-.+....+.-..|...+..
T Consensus 241 ~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~------------------ 301 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG------------------ 301 (458)
T ss_pred ccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee------------------
Confidence 1233578999996443 456778999999999999987762 23332222222222211100
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
.-...-.++|.+||+-.|..||++.++|.||.+-
T Consensus 302 --------------len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 302 --------------LENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred --------------ccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 0011125689999999999999999999999753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.8e-10 Score=112.46 Aligned_cols=212 Identities=19% Similarity=0.262 Sum_probs=151.9
Q ss_pred eEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec--CCceEEEEEeeccC--Cchh
Q 011763 144 SSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCSIYLVFEYMEH--DITG 219 (478)
Q Consensus 144 g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~~~lv~e~~~~--~ll~ 219 (478)
.+.|+++...+|..|++|.++.+.. ........-+++++++.|.|||++.++|... ....++|||+|.++ .|.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 5789999999999999999954332 1111223467889999999999999988621 24568999999987 3333
Q ss_pred hccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 220 LLSC--------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 220 ~~~~--------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
.+.. .+...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+-+++|..-|.......+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 3321 22347899999999999999999999999999999999999998889988777765544322
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHH-HHHHHHHcCCCCchhhccCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~p-f~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. |-+.. -.+-|.=-||.+++.|.+|..- ...+..... +..|
T Consensus 448 -------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------------ 490 (655)
T KOG3741|consen 448 -------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------------ 490 (655)
T ss_pred -------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------------
Confidence 0 11222 2356999999999999999632 222222222 2222
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...++.++.++|.-+...+++. -++.++|.|
T Consensus 491 ------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 ------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 2357788888998888888875 667777644
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.3e-10 Score=108.61 Aligned_cols=144 Identities=19% Similarity=0.235 Sum_probs=104.4
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCeeeecceeeecC-CceEEEEEe
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--PNIIKLEGLITSRL-SCSIYLVFE 211 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~-~~~~~lv~e 211 (478)
++.|+.|.++.||++... +|+.+++|+....... .....+.+|+.+++.+.+ .++.+++.+..... .+..++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 367889999999999864 3678999997644321 134457789999999965 34566665544321 125689999
Q ss_pred eccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 011763 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS------------------------------------------ 249 (478)
Q Consensus 212 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~------------------------------------------ 249 (478)
|++|..+...... ..+++.....++.+++..|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9998655543321 356777777888888888888874
Q ss_pred --------------CCceeccCCCCcEEEec--CCcEEEeeccccccc
Q 011763 250 --------------RGVLHRDIKGSNLLVNN--EGVLKLADFGLANFS 281 (478)
Q Consensus 250 --------------~givHrDlkp~NILl~~--~~~vkl~DFG~a~~~ 281 (478)
..++|+|++|.|||++. ++.+.|+||+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23699999999999998 667899999988643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.2e-10 Score=100.76 Aligned_cols=144 Identities=18% Similarity=0.257 Sum_probs=99.5
Q ss_pred eeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC------hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE------PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 134 ~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.+..|-+|+-+.|+++.. .|+.+.||.=....+. .-...+..+|+++|.++.--.|.--.=+|.+. ..-+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQ 86 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCe
Confidence 678888999999999975 6777778753322221 22234566899999998543332221144442 2346
Q ss_pred EEEeeccC--CchhhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC---cEEEeeccccccc
Q 011763 208 LVFEYMEH--DITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFS 281 (478)
Q Consensus 208 lv~e~~~~--~ll~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~DFG~a~~~ 281 (478)
|+|||+++ ...+.+..... .........++++|-..+.-||.++|||+||..+||+|.+++ .+.|+|||++...
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 89999998 44444433222 233334478889999999999999999999999999998775 3589999998544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.3e-12 Score=129.54 Aligned_cols=156 Identities=25% Similarity=0.355 Sum_probs=116.1
Q ss_pred HHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccc--------cccCCcccCcccccCCCC
Q 011763 239 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--------RVVTLWYRPPELLLGATD 309 (478)
Q Consensus 239 qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~--------~~~t~~y~APE~l~~~~~ 309 (478)
+.+.||.|+|.. ++||++|.|++|.++..+.+||+.|+++.........+... ......|.|||++.+ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 334899999976 89999999999999999999999999986554422211111 122567999999987 67
Q ss_pred CCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchh
Q 011763 310 YGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 388 (478)
Q Consensus 310 ~~~~~DiwslG~il~ell-tG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 388 (478)
.+.++|+|||||++|.+. .|+..|...........-....+ ......-..+|++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~-------------------------~~~~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN-------------------------AGAFGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc-------------------------cccccccccCcHH
Confidence 789999999999999999 57777766544333322211110 0111111578999
Q ss_pred HHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 389 AVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 389 l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
+++=|.++|..|+..||++.+++..|||.+..
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 99999999999999999999999999998743
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.2e-10 Score=101.15 Aligned_cols=133 Identities=20% Similarity=0.287 Sum_probs=92.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHH-----HHHHHHHHHHHHhcCCC--CeeeecceeeecCCceEE
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPES-----VRFMAREILILRRLDHP--NIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~-----~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~~~ 207 (478)
..+++|+-+.++.+.. -|..+++|.=..... .++. .+...+|+.+|.++.-- +.+.++++ + .....
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D--~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--D--PDNGL 75 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--c--CCCCE
Confidence 3567899999999865 344466664322222 2222 23456799999988543 33444433 3 33456
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
|+|||++|.++....... ...++..+-.-+.-||..||||+||.++||++..++ +.++|||++.+..
T Consensus 76 I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 76 IVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred EEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 999999998877555433 245666777778889999999999999999998765 9999999986543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.1e-10 Score=102.20 Aligned_cols=128 Identities=26% Similarity=0.313 Sum_probs=82.4
Q ss_pred EEEEEEECCCCcEEEEEEeecCC------------------------CChHHHHHHHHHHHHHHhcCCC--Ceeeeccee
Q 011763 145 SVFRARDLDTGKIVALKKVRFDN------------------------FEPESVRFMAREILILRRLDHP--NIIKLEGLI 198 (478)
Q Consensus 145 ~V~~~~~~~~~~~vAlK~~~~~~------------------------~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~ 198 (478)
.||.|.. ..+..+|||+.+... ..........+|.++|.++..- ++++++++-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 457899999975321 0011123456799999999655 566665432
Q ss_pred eecCCceEEEEEeecc--CCchhhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCcEEEecCCcEEEeec
Q 011763 199 TSRLSCSIYLVFEYME--HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH-CHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (478)
Q Consensus 199 ~~~~~~~~~lv~e~~~--~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~-LH~~givHrDlkp~NILl~~~~~vkl~DF 275 (478)
. -+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+||
T Consensus 80 ----~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----R--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----T--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----C--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 1 269999999 65454443322 2244566777788885555 579999999999999999987 9999999
Q ss_pred ccccccC
Q 011763 276 GLANFSN 282 (478)
Q Consensus 276 G~a~~~~ 282 (478)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9986543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.6e-09 Score=99.02 Aligned_cols=138 Identities=26% Similarity=0.263 Sum_probs=101.1
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCC--------------------CChHHHHHHHHHHHHHHhcCCC--
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN--------------------FEPESVRFMAREILILRRLDHP-- 189 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~--------------------~~~~~~~~~~~E~~~l~~l~h~-- 189 (478)
+.+..+||-|.-+.||.|.+. .|.++|||.=+... +-........+|.++|++|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999975 68899999743211 0012233456799999999544
Q ss_pred CeeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc
Q 011763 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV 269 (478)
Q Consensus 190 nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~ 269 (478)
.+++.+++ +...+||||++|-.+.... +.......++..|+.-+.-+-..||||+|+.+-|||++++|.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 66666552 3457999999996655443 134445555666666666666899999999999999999999
Q ss_pred EEEeeccccccc
Q 011763 270 LKLADFGLANFS 281 (478)
Q Consensus 270 vkl~DFG~a~~~ 281 (478)
+.++||-.+...
T Consensus 241 ~~vIDwPQ~v~~ 252 (304)
T COG0478 241 IVVIDWPQAVPI 252 (304)
T ss_pred EEEEeCcccccC
Confidence 999999887543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=9.8e-09 Score=98.72 Aligned_cols=132 Identities=16% Similarity=0.116 Sum_probs=88.9
Q ss_pred EEEEEECCCCcEEEEEEeecCCCCh---------HHHHHHHHHHHHHHhcCCCCe--eeecceeeecC---CceEEEEEe
Q 011763 146 VFRARDLDTGKIVALKKVRFDNFEP---------ESVRFMAREILILRRLDHPNI--IKLEGLITSRL---SCSIYLVFE 211 (478)
Q Consensus 146 V~~~~~~~~~~~vAlK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~~---~~~~~lv~e 211 (478)
|++... .|+.|.||......... .....+.+|...+.+|..-+| +.++.+..... ....+||+|
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 555543 56788999764322110 001136688888888843333 33334443211 234689999
Q ss_pred eccCC-chhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-------CCcEEEeeccccc
Q 011763 212 YMEHD-ITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------EGVLKLADFGLAN 279 (478)
Q Consensus 212 ~~~~~-ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-------~~~vkl~DFG~a~ 279 (478)
++++. .+..+.. .....+......++.+|+..+.-||+.||+|+||++.||||+. +..+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99984 3433322 1234567778899999999999999999999999999999985 4689999999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=4e-08 Score=96.59 Aligned_cols=259 Identities=15% Similarity=0.140 Sum_probs=154.8
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecc----e-eeecCCce
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEG----L-ITSRLSCS 205 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~----~-~~~~~~~~ 205 (478)
....+.||+|+-+.+|-.-.. +. .+.|+.....- .... +-+..|... .||-+-.-+. . +-...+..
T Consensus 13 i~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Ppp--a~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPP--AAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred cCCCccccCCccceeeecchh--hc-hhheeecCCCc--hHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 344578999999999976432 22 34577764432 1111 223334443 5664432111 1 11122334
Q ss_pred EEEEEeeccCC--chhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccc
Q 011763 206 IYLVFEYMEHD--ITGLLS-----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (478)
Q Consensus 206 ~~lv~e~~~~~--ll~~~~-----~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a 278 (478)
+-+.|+.+.+. ....+. +.-....++.+...++.|+.+.+.||+.|.+-+|+.++|+|+.+++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 77889888762 222221 12234678899999999999999999999999999999999999999999986544
Q ss_pred cccCCCCCCCccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCC
Q 011763 279 NFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPP 353 (478)
Q Consensus 279 ~~~~~~~~~~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~~g~~~ 353 (478)
..... .......++...|.+||.-.- .-.-+...|.|.||+++|+|+.| +.||.+.....- -+.|-
T Consensus 165 qi~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~-------ap~p~ 235 (637)
T COG4248 165 QINAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD-------APNPL 235 (637)
T ss_pred eeccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC-------CCCcc
Confidence 33322 233345678899999996431 12346678999999999999986 899987531100 00000
Q ss_pred chhhccCCCCCccccCCCCCCCc-cchhcccCCchhHHHHHHHhcCC--CCCCccCHHH
Q 011763 354 DDYWKKSKLPHATLFKPQQPYDS-SLRETFKDLPTTAVNLIETLLSV--EPYKRATASA 409 (478)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~l~~Li~~mL~~--dP~~R~ta~e 409 (478)
+..+....+..... ....+.. ...--|.-+++++..|..+|+.. ++.-|||++.
T Consensus 236 E~~Ia~g~f~ya~~--~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 236 ETDIAHGRFAYASD--QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhhhhcceeeechh--ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 00000000000000 0000000 11112346789999999999874 3568999763
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.1e-08 Score=89.55 Aligned_cols=139 Identities=19% Similarity=0.238 Sum_probs=96.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCC--------------------ChHHH--HHHHHHHHHHHhcC--CCCe
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--------------------EPESV--RFMAREILILRRLD--HPNI 191 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~--------------------~~~~~--~~~~~E~~~l~~l~--h~nI 191 (478)
-.|..|.-+.||+|.. .++..||+|+++.... +.... .....|+..|.++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3566777788999984 5688999999864321 11111 12235888888883 4445
Q ss_pred eeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcE
Q 011763 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVL 270 (478)
Q Consensus 192 v~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~v 270 (478)
++-+.+.. -.|||||++....-.-.-.+.++...++..+..++++.+.-|-. .++||+||..-|||+. ++.+
T Consensus 133 P~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 133 PEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 55554432 36999999865221111122244555788888899999988887 8999999999999999 8899
Q ss_pred EEeecccccccC
Q 011763 271 KLADFGLANFSN 282 (478)
Q Consensus 271 kl~DFG~a~~~~ 282 (478)
.|+||+.|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999986443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.9e-08 Score=92.09 Aligned_cols=108 Identities=21% Similarity=0.202 Sum_probs=80.0
Q ss_pred HHHHHHHHHHHhcCCC--CeeeecceeeecCC--ceEEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 011763 174 RFMAREILILRRLDHP--NIIKLEGLITSRLS--CSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248 (478)
Q Consensus 174 ~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~--~~~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH 248 (478)
....+|...+..|..- .+++.+.+.....+ ...+||+|++++. .+..+......++......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 3566788888887433 23444444443222 3458999999973 44444443223677788899999999999999
Q ss_pred hCCceeccCCCCcEEEecCC---cEEEeeccccccc
Q 011763 249 SRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFS 281 (478)
Q Consensus 249 ~~givHrDlkp~NILl~~~~---~vkl~DFG~a~~~ 281 (478)
++||+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999987 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.6e-09 Score=106.37 Aligned_cols=246 Identities=16% Similarity=0.133 Sum_probs=166.0
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-eeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN-IIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~~~l 208 (478)
.-|...+.+++++++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+ +.+.+.++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i 311 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWI 311 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC--Ccccccch
Confidence 34667788899999999999876665544 6665422 22334889999999999 44443333 33678899
Q ss_pred EEeeccCC--chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~--ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
+++++..+ ...........+.+-+...+.+.-+++|++||+.--+|+| ||+..+ +..+..||+.........
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-
Confidence 99999865 3333333333455556666777778899999998778998 777665 788999999886655432
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
...+..+|+.++|||+... ..+....|.|+++.--.+|.-|-+|-.... .... ..|..+
T Consensus 386 -~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~----~~g~~p------------- 444 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLP----MIGNGP------------- 444 (829)
T ss_pred -ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCc--cccC----CCCCCC-------------
Confidence 2355678999999998876 668889999999987777777777654310 0000 001100
Q ss_pred ccCCCCCCCccch--hcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 367 LFKPQQPYDSSLR--ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 367 ~~~~~~~~~~~l~--~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
-...|. ..|.... -.++...|+...|..|++...++.|.+|+.-+.
T Consensus 445 -------~s~~L~~~~aw~~~~--~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 445 -------NSPMLTDKSAWSPVF--HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred -------CccccchhhhcCccc--ccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 000010 1111111 115778899999999999999999999987444
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.7e-07 Score=82.39 Aligned_cols=139 Identities=17% Similarity=0.171 Sum_probs=96.8
Q ss_pred eecCceEEEEEEECCCCcEEEEEEeecCC---CC-hHHHHHHHHHHHHHHhcCCC--Ceeeecceee---ecCCceEEEE
Q 011763 139 GQGTYSSVFRARDLDTGKIVALKKVRFDN---FE-PESVRFMAREILILRRLDHP--NIIKLEGLIT---SRLSCSIYLV 209 (478)
Q Consensus 139 G~G~~g~V~~~~~~~~~~~vAlK~~~~~~---~~-~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~---~~~~~~~~lv 209 (478)
|.||-+.|+.... .|+.+-+|.-.... +. +.....+.+|+..|+.|..- .++++. ++. ....-..+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 4588888988764 34468888753111 11 33456788999999999532 244444 332 1112235899
Q ss_pred EeeccC--CchhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc--EEEeecccccc
Q 011763 210 FEYMEH--DITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLANF 280 (478)
Q Consensus 210 ~e~~~~--~ll~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--vkl~DFG~a~~ 280 (478)
+|-+++ ++...+... -.+.++.....++.+|+..|.-||+.|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998885 343333221 235677788899999999999999999999999999999987777 99999997753
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.5e-07 Score=81.92 Aligned_cols=140 Identities=19% Similarity=0.218 Sum_probs=89.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHH-HHH------HHHHHHHHHhcC---CCCeeeeccee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-VRF------MAREILILRRLD---HPNIIKLEGLI 198 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~-~~~------~~~E~~~l~~l~---h~nIv~l~~~~ 198 (478)
..+|.+++.+-......|.+..- +++.+++|..+......+. ... ..+++..+.++. ...+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 35899999998888888888763 6788999987654321111 111 123444444442 22222222222
Q ss_pred ee---cCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeec
Q 011763 199 TS---RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (478)
Q Consensus 199 ~~---~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF 275 (478)
.- ......+|+|||++|-.+..+.. +++ .+...|..++.-||+.|++|+|..|.|++++++ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 11 11234568999999965443321 222 244567778999999999999999999999854 5999999
Q ss_pred cccc
Q 011763 276 GLAN 279 (478)
Q Consensus 276 G~a~ 279 (478)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.8e-06 Score=80.95 Aligned_cols=139 Identities=22% Similarity=0.313 Sum_probs=80.5
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC--Ceeeecceeee-cCCceEEEEEe
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP--NIIKLEGLITS-RLSCSIYLVFE 211 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~-~~~~~~~lv~e 211 (478)
++.|+.|..+.||++.... ..+++|+.... .....+.+|+.+++.|... .+.+++..... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999998654 48999997532 4556777899999888432 34566553322 12345799999
Q ss_pred eccCCchhhc--------------------cC---CCCCCCHHH------HHHH---------------HHHHHH-HHHH
Q 011763 212 YMEHDITGLL--------------------SC---PDIKFSEAQ------IKCY---------------MNQLLH-GLEH 246 (478)
Q Consensus 212 ~~~~~ll~~~--------------------~~---~~~~l~~~~------~~~i---------------~~qil~-aL~~ 246 (478)
++++..+... .. ....+.... .... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 9998654440 00 001111000 0000 011222 2333
Q ss_pred HHh-------CCceeccCCCCcEEEe-cCCcEEEeeccccc
Q 011763 247 CHS-------RGVLHRDIKGSNLLVN-NEGVLKLADFGLAN 279 (478)
Q Consensus 247 LH~-------~givHrDlkp~NILl~-~~~~vkl~DFG~a~ 279 (478)
+++ ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 332 3599999999999999 56667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.5e-06 Score=81.73 Aligned_cols=133 Identities=14% Similarity=0.133 Sum_probs=79.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--eeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN--IIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
..||.|..+.||+.. +..+++|...... ....+.+|.++++.+..-. +.+++++... .....+|||++
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeec
Confidence 578999999999842 4467889876422 2234678999999985433 3555555544 45578899999
Q ss_pred cCCc-hhhcc----------------------C---CCCCCCHHHHHHHHHHH----------HH-HHHHHHh----CCc
Q 011763 214 EHDI-TGLLS----------------------C---PDIKFSEAQIKCYMNQL----------LH-GLEHCHS----RGV 252 (478)
Q Consensus 214 ~~~l-l~~~~----------------------~---~~~~l~~~~~~~i~~qi----------l~-aL~~LH~----~gi 252 (478)
+|.. ..... . ....++. ....+..++ .. ...+|.. ..+
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 9852 11000 0 0001110 001110000 11 1122221 247
Q ss_pred eeccCCCCcEEEecCCcEEEeecccccc
Q 011763 253 LHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 253 vHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
+|+|+.|.||++++++ +.|+||+.+..
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 8999999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.2e-06 Score=88.19 Aligned_cols=144 Identities=19% Similarity=0.235 Sum_probs=86.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCC---------------------------CCh-HH----HHH------HH
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDN---------------------------FEP-ES----VRF------MA 177 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~---------------------------~~~-~~----~~~------~~ 177 (478)
..|+.++-|.||+|+.. +|+.||||+.+.+- ... +. .+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67899999999999975 49999999986431 000 00 111 22
Q ss_pred HHHHHHHhcC----CCCeeeecceeeecCCceEEEEEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 011763 178 REILILRRLD----HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252 (478)
Q Consensus 178 ~E~~~l~~l~----h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~gi 252 (478)
+|...+.++. ...-+.+-.+|.+- ...-.|+|||++|--+.... -....++...+.....++. +..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 3555555541 12222232333221 23357999999994333321 1112344333322222221 223334799
Q ss_pred eeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 253 vHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
+|.|.+|.||+++.+|.+.+.|||+.....+
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999999865543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.8e-06 Score=94.84 Aligned_cols=202 Identities=18% Similarity=0.177 Sum_probs=136.0
Q ss_pred HHHHHHHHHhcCCCCeeeecceeeecCCce--EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 011763 176 MAREILILRRLDHPNIIKLEGLITSRLSCS--IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253 (478)
Q Consensus 176 ~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~--~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~giv 253 (478)
...|+..+.+..|+|++.++.|-....... ..+..+++....+..+...-...+...++.+..+++.||.|+|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 345777888889999999877654432221 223446666655555566666889999999999999999999998655
Q ss_pred eccCCCC---cEEEecCCcEEEe--ecccccccCCCCCCCccccccCCcccCcccccCCCCCCC--hhhHHHHHHHHHHH
Q 011763 254 HRDIKGS---NLLVNNEGVLKLA--DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP--SVDLWSVGCVFAEL 326 (478)
Q Consensus 254 HrDlkp~---NILl~~~~~vkl~--DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~--~~DiwslG~il~el 326 (478)
|.-|... +...+.++.+.+. ||+.......... ......+..+.++|.... ..+.. ..|+|++|..+..+
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhh
Confidence 5555444 3444555667766 8988876554321 223344666888887654 33333 36999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCc-hhHHHHHHHhcCCCCCCcc
Q 011763 327 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP-TTAVNLIETLLSVEPYKRA 405 (478)
Q Consensus 327 ltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~l~~Li~~mL~~dP~~R~ 405 (478)
..|..+-... ..+. ....... ....+++.+|+.-|+++|+
T Consensus 386 ~~~~~i~~~~------~~~~---------------------------------~~l~~~~~~~~~d~~~~~~~~~~~~Rl 426 (1351)
T KOG1035|consen 386 SQGEDISEKS------AVPV---------------------------------SLLDVLSTSELLDALPKCLDEDSEERL 426 (1351)
T ss_pred hhcCcccccc------cchh---------------------------------hhhccccchhhhhhhhhhcchhhhhcc
Confidence 8875432110 0000 0011111 2678899999999999999
Q ss_pred CHHHHHhCcccCCC
Q 011763 406 TASAALASEYFSTK 419 (478)
Q Consensus 406 ta~e~L~hp~f~~~ 419 (478)
.+.++|.|+|.+..
T Consensus 427 ~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 427 SALELLTHPFLRFP 440 (1351)
T ss_pred chhhhhhchhcccc
Confidence 99999999998753
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.2e-05 Score=89.80 Aligned_cols=148 Identities=23% Similarity=0.380 Sum_probs=90.4
Q ss_pred eeeeeeecCceEEEEEEECCCC--cEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCe--eeecceeeecC-CceEE
Q 011763 134 KLEKIGQGTYSSVFRARDLDTG--KIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNI--IKLEGLITSRL-SCSIY 207 (478)
Q Consensus 134 ~~~~LG~G~~g~V~~~~~~~~~--~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~~-~~~~~ 207 (478)
.++.|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.|. |.+| ++++.++.+.. .+..|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3677899999999998764432 46788876543221 12345778999999995 6654 66666665421 23578
Q ss_pred EEEeeccCCchhhc------------------------cCCCC----------C--CCHHHHHHHHHH------------
Q 011763 208 LVFEYMEHDITGLL------------------------SCPDI----------K--FSEAQIKCYMNQ------------ 239 (478)
Q Consensus 208 lv~e~~~~~ll~~~------------------------~~~~~----------~--l~~~~~~~i~~q------------ 239 (478)
+||||++|..+... ..... + +...++..|..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 99999998532110 00000 0 111233222221
Q ss_pred ---HHHHHHHHHh-----------CCceeccCCCCcEEEecC-Cc-EEEeecccccccC
Q 011763 240 ---LLHGLEHCHS-----------RGVLHRDIKGSNLLVNNE-GV-LKLADFGLANFSN 282 (478)
Q Consensus 240 ---il~aL~~LH~-----------~givHrDlkp~NILl~~~-~~-vkl~DFG~a~~~~ 282 (478)
+...+.+|.. ..+||+|+++.|||++.+ +. +-|.||+++....
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2233556632 249999999999999853 33 5799999986543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.24 E-value=9.9e-06 Score=77.11 Aligned_cols=74 Identities=15% Similarity=0.108 Sum_probs=48.6
Q ss_pred eeeecCc-eEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEEEEEeecc
Q 011763 137 KIGQGTY-SSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYME 214 (478)
Q Consensus 137 ~LG~G~~-g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~lv~e~~~ 214 (478)
.|-.|.+ ..||++... +..++||+..... ...+.+|+.+++.+. +--+.+++++... .+..++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeC
Confidence 3445555 679999743 4678889875332 234567999998883 4445566665544 345789999999
Q ss_pred CCchh
Q 011763 215 HDITG 219 (478)
Q Consensus 215 ~~ll~ 219 (478)
|..+.
T Consensus 76 G~~l~ 80 (244)
T cd05150 76 GVPAA 80 (244)
T ss_pred CccHh
Confidence 85443
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.18 E-value=5.2e-05 Score=69.06 Aligned_cols=130 Identities=28% Similarity=0.361 Sum_probs=90.8
Q ss_pred ccceeeeeeeeecCc-eEEEEEEECCCCcEEEEEEeec---CC-------CCh---------HHHHHHHHHHHHHHhcC-
Q 011763 129 ADAFEKLEKIGQGTY-SSVFRARDLDTGKIVALKKVRF---DN-------FEP---------ESVRFMAREILILRRLD- 187 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~-g~V~~~~~~~~~~~vAlK~~~~---~~-------~~~---------~~~~~~~~E~~~l~~l~- 187 (478)
..+++.++.||.|.- |.||+++. .|+.||||++.. .. ... ....-+..|.+...+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 368999999999999 99999985 678999999432 11 000 12234567888888774
Q ss_pred --CCCe--eeecceeeec----------------CCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 011763 188 --HPNI--IKLEGLITSR----------------LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247 (478)
Q Consensus 188 --h~nI--v~l~~~~~~~----------------~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~L 247 (478)
+.++ |++++++.-. .....-||.||+.... .+... -+.+|+.-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHH
Confidence 4455 8999887321 0112357777776533 22233 345677788889
Q ss_pred HhCCceeccCCCCcEEEecCCcEEEeecccc
Q 011763 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (478)
Q Consensus 248 H~~givHrDlkp~NILl~~~~~vkl~DFG~a 278 (478)
|..||+-+|+++.|.. .=||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999985 3478999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=8.1e-06 Score=72.03 Aligned_cols=130 Identities=21% Similarity=0.229 Sum_probs=88.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCee-eecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII-KLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~lv 209 (478)
.....+.|++|.+|.||++.+ .+..+|+|+-+.+ .....+..|+++|..+.-.++- +++.+-. .++.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~ 90 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGE------DFIR 90 (201)
T ss_pred hhhhhhhhhcccccEEEEeec--cCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEech------hhhh
Confidence 345667899999999999986 4568999987654 3345677899999998765553 3433221 3466
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CCcEEEecCCcEEEeeccccc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK-GSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlk-p~NILl~~~~~vkl~DFG~a~ 279 (478)
|||+.|..+....... + ++-+..+++.---|-..||-|..|. |..++|..++.+.|+||..|+
T Consensus 91 me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 91 MEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 9999985444432211 2 2233345555555667799999986 555555556699999999986
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.7e-05 Score=73.75 Aligned_cols=29 Identities=31% Similarity=0.456 Sum_probs=25.1
Q ss_pred CceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 251 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 251 givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
.++|+|+.+.|||+++++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999876656799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=1.4e-05 Score=76.98 Aligned_cols=139 Identities=17% Similarity=0.190 Sum_probs=95.3
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC--------------------hHHHHHHHHHHHHHHhcC-CC
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--------------------PESVRFMAREILILRRLD-HP 189 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~-h~ 189 (478)
-+.+.++||-|.-+.||.+-+ ..|+..++|+-++.... .-+.-...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 477889999999999999986 45888999964332110 111122346888898883 43
Q ss_pred C-eeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC
Q 011763 190 N-IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (478)
Q Consensus 190 n-Iv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~ 268 (478)
+ +++.++ .+..|+|||++.+-.+.....-. .+..+...|+.-+--|-.+|+||+|+.--||+|++++
T Consensus 172 fpVPkpiD------~~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPID------HNRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCccc------ccceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 3 334444 24568999999985444333211 1233444555556677789999999999999999999
Q ss_pred cEEEeecccccccC
Q 011763 269 VLKLADFGLANFSN 282 (478)
Q Consensus 269 ~vkl~DFG~a~~~~ 282 (478)
.++++||-......
T Consensus 240 ~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 240 KIVVIDFPQMVSTS 253 (465)
T ss_pred CEEEeechHhhccC
Confidence 99999998775443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=68.48 Aligned_cols=74 Identities=14% Similarity=0.166 Sum_probs=45.9
Q ss_pred eeeeeecCceEEEEEEECC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CCeeeecceeeecCCceEEEEEee
Q 011763 135 LEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDNFEPESVRFMAREILILRRLDH-PNIIKLEGLITSRLSCSIYLVFEY 212 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~-~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~lv~e~ 212 (478)
++.|..|-...||++.... .+..|++|+...... ..-...+|+.+++.+.. .-.++++..+. . .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ---N---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC---C---cEEEEe
Confidence 4567778888999997532 356788997653221 11122468888888843 33444443322 1 379999
Q ss_pred ccCCc
Q 011763 213 MEHDI 217 (478)
Q Consensus 213 ~~~~l 217 (478)
++|..
T Consensus 74 i~G~~ 78 (235)
T cd05157 74 IPGRT 78 (235)
T ss_pred eCCCc
Confidence 98843
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00023 Score=65.27 Aligned_cols=130 Identities=18% Similarity=0.219 Sum_probs=87.4
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCC--------------CChHHHHHHHHHHHHHHhcC------CCCeeee
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN--------------FEPESVRFMAREILILRRLD------HPNIIKL 194 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------h~nIv~l 194 (478)
...||.|+.-.||.-- .+....||++.... ..........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4578999999998753 34457899987655 11122445566776666665 7899999
Q ss_pred cceeeecCCceEEEEEeeccC---C---chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC
Q 011763 195 EGLITSRLSCSIYLVFEYMEH---D---ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (478)
Q Consensus 195 ~~~~~~~~~~~~~lv~e~~~~---~---ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~ 268 (478)
+|+.+. ....-+|+|.+.. . .+..+... ..+++ .+.. .|-.-..||-+++|+.+||+|.||++....
T Consensus 83 ~G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 83 YGFVET--NLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred eEEEec--CCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 999987 4557888888753 1 23333322 23444 3333 344456788899999999999999997543
Q ss_pred ----cEEEee
Q 011763 269 ----VLKLAD 274 (478)
Q Consensus 269 ----~vkl~D 274 (478)
.+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.83 E-value=8.7e-05 Score=67.64 Aligned_cols=98 Identities=26% Similarity=0.186 Sum_probs=76.5
Q ss_pred HHHHHHHhcCC-CCeeeecceeeecCCceEEEEEeeccCCchh-hc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Q 011763 178 REILILRRLDH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LL--SCPDIKFSEAQIKCYMNQLLHGLEHCHSR--- 250 (478)
Q Consensus 178 ~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~-~~--~~~~~~l~~~~~~~i~~qil~aL~~LH~~--- 250 (478)
.|.-+|+.+.+ +++++++|+|- .++|.||.+.+.+. .. ...-...++..+..|+.+++..+.+|+..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 48888999965 69999999873 25788999864221 10 01112358999999999999999999973
Q ss_pred CceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 251 givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
.+.-.|++++|+-|++++++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 4777899999999999999999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00033 Score=68.77 Aligned_cols=143 Identities=21% Similarity=0.267 Sum_probs=98.3
Q ss_pred eeeeeeeecCceEEEEEEECCCCcEEEEEEeecCC----------------------CChHHHH--HHHHHHHHHHhcCC
Q 011763 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN----------------------FEPESVR--FMAREILILRRLDH 188 (478)
Q Consensus 133 ~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~----------------------~~~~~~~--~~~~E~~~l~~l~h 188 (478)
.+-.+|..|.-+.||.+.. .+|..+|||+++... -++...- ....|++-|.+|+.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3446678888999999984 568889999875321 0111111 22358888888866
Q ss_pred CCeeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecC
Q 011763 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNE 267 (478)
Q Consensus 189 ~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~ 267 (478)
..|.----+. - ....|||+|++..-...-.-.+..++...+..+-.|++.-+.-|-+ +++||.||.--|+|+. +
T Consensus 226 aGIP~PePIl-L---k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 226 AGIPCPEPIL-L---KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D 300 (520)
T ss_pred cCCCCCCcee-e---ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence 5543221111 1 1246999999864333333344568888899999999988887765 5999999999999986 5
Q ss_pred CcEEEeeccccccc
Q 011763 268 GVLKLADFGLANFS 281 (478)
Q Consensus 268 ~~vkl~DFG~a~~~ 281 (478)
|.+.|+|.+.+...
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 79999999987533
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00026 Score=73.93 Aligned_cols=142 Identities=21% Similarity=0.201 Sum_probs=84.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-----------------------------hHHHHHH------HHHH
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-----------------------------PESVRFM------AREI 180 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-----------------------------~~~~~~~------~~E~ 180 (478)
+.||.-+.+.|++|+.+. |+.||||+-+..-.. .+..+.+ .+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 678999999999999765 999999996532100 1111122 2233
Q ss_pred HHHHhc----CCCC---eeeecceeeecCCceEEEEEeeccCC---chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 011763 181 LILRRL----DHPN---IIKLEGLITSRLSCSIYLVFEYMEHD---ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250 (478)
Q Consensus 181 ~~l~~l----~h~n---Iv~l~~~~~~~~~~~~~lv~e~~~~~---ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~ 250 (478)
+...+. .|-+ -|.+-.++.+- ...-.|+||||+|. .++.+... .++...+...+.++.. .-|-..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHH--HHHHhc
Confidence 333222 3444 11222233221 22457999999983 33333333 3455544443333221 222356
Q ss_pred CceeccCCCCcEEEec----CCcEEEeecccccccCC
Q 011763 251 GVLHRDIKGSNLLVNN----EGVLKLADFGLANFSNT 283 (478)
Q Consensus 251 givHrDlkp~NILl~~----~~~vkl~DFG~a~~~~~ 283 (478)
|++|.|=+|.||++.. ++.+.+-|||+......
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999994 56899999999865543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00064 Score=69.05 Aligned_cols=77 Identities=23% Similarity=0.179 Sum_probs=52.4
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCC---C--hHHHHHHHHHHHHHHhcC---CCCeeeecceeeecCCceE
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---E--PESVRFMAREILILRRLD---HPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~---~--~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~ 206 (478)
.+.||.|.+..||++.+...++.|+||.-..... . +...++...|.+.|+.+. -.++++++.+. ....
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----EELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----CCCC
Confidence 5789999999999999864445899998531100 0 123455667888888862 24577776553 2346
Q ss_pred EEEEeeccC
Q 011763 207 YLVFEYMEH 215 (478)
Q Consensus 207 ~lv~e~~~~ 215 (478)
++|||++++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 799999876
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00065 Score=66.70 Aligned_cols=80 Identities=16% Similarity=0.167 Sum_probs=54.8
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC---CCeeeecceeeec-CCceE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH---PNIIKLEGLITSR-LSCSI 206 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~-~~~~~ 206 (478)
...-.+.||.|..+.||...... + .+++|..+. . .....+..|...|+.|.. -.++++++++... ..+..
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQ-G-NPMPLMARS-F---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hhheeeecCCccceeEEEEEcCC-C-CEEEEEecc-c---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 34556789999999999996422 3 467777432 1 122467789999998843 3677777766432 13457
Q ss_pred EEEEeeccCC
Q 011763 207 YLVFEYMEHD 216 (478)
Q Consensus 207 ~lv~e~~~~~ 216 (478)
+||||++++.
T Consensus 89 ~LVmE~i~G~ 98 (297)
T PRK10593 89 VLLLERLRGV 98 (297)
T ss_pred EEEEeccCCE
Confidence 9999999874
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00088 Score=66.43 Aligned_cols=30 Identities=33% Similarity=0.550 Sum_probs=26.0
Q ss_pred CCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 250 ~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999976556899999874
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0002 Score=68.64 Aligned_cols=133 Identities=24% Similarity=0.240 Sum_probs=74.5
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCe-eeecceeeecCCceEEEEEeeccCC
Q 011763 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLITSRLSCSIYLVFEYMEHD 216 (478)
Q Consensus 138 LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~lv~e~~~~~ 216 (478)
+..|-...+|+.. .++..+++|+........ . -...+|..+++.+....+ .+++... . -++||||++|.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~----~--~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVN----E--HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEe----C--CEEEEEeccCc
Confidence 4457778899887 356678888754321110 0 123568899998854333 3333322 1 25899999985
Q ss_pred chhhc------------------cC---CCCCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceeccC
Q 011763 217 ITGLL------------------SC---PDIKFSE-AQIKCYMNQL---------LHGLEHCHS--------RGVLHRDI 257 (478)
Q Consensus 217 ll~~~------------------~~---~~~~l~~-~~~~~i~~qi---------l~aL~~LH~--------~givHrDl 257 (478)
.+... .. ...+++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 43211 00 0111111 1222222122 111222211 24899999
Q ss_pred CCCcEEEecCCcEEEeeccccccc
Q 011763 258 KGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 258 kp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
.|.|||+++++ +.|+||..+...
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCcC
Confidence 99999999877 789999988543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00071 Score=66.79 Aligned_cols=143 Identities=19% Similarity=0.182 Sum_probs=81.5
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--eeeeccee----eecCCc
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN--IIKLEGLI----TSRLSC 204 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~----~~~~~~ 204 (478)
....++.++.|....+|++.. .++ .+++|+..... . ...+..|+.++..|.... +++++... .....+
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred CceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 344567778887789999864 334 57889875421 1 233456777777774222 33433211 111134
Q ss_pred eEEEEEeeccCCchhh---------------ccC--CCC--C----CCHHH-----HH----------HHHHHHHHHHHH
Q 011763 205 SIYLVFEYMEHDITGL---------------LSC--PDI--K----FSEAQ-----IK----------CYMNQLLHGLEH 246 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~---------------~~~--~~~--~----l~~~~-----~~----------~i~~qil~aL~~ 246 (478)
..+++++|++|..... +.. ... . ..... .. .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 5789999998843210 000 000 0 00000 00 001122334555
Q ss_pred HHh-------CCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 247 CHS-------RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 247 LH~-------~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
+.. .++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 542 579999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.60 E-value=1e-05 Score=90.93 Aligned_cols=164 Identities=12% Similarity=-0.013 Sum_probs=115.0
Q ss_pred ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCCchh-hccC---CCCCCCHHHHHHHHHHHHHHH
Q 011763 169 EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC---PDIKFSEAQIKCYMNQLLHGL 244 (478)
Q Consensus 169 ~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~-~~~~---~~~~l~~~~~~~i~~qil~aL 244 (478)
.+...+....|...++...|+++.....-.........|..++|+.++.+. .+.. ...++.+.-+.....+.+.+.
T Consensus 1269 sePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~ 1348 (2724)
T KOG1826|consen 1269 SEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNR 1348 (2724)
T ss_pred hhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhcc
Confidence 334445555676777777899988776655544455568899999865443 3332 222334444444444547777
Q ss_pred HHHHhC-----CceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHH
Q 011763 245 EHCHSR-----GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 319 (478)
Q Consensus 245 ~~LH~~-----givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~Diwsl 319 (478)
.-+|.. -.+|++||+.|.+|..+.++|+.++|+.+.-.+. .......++++.|+.|++... ..++.++|+|..
T Consensus 1349 ~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1349 NVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRR 1426 (2724)
T ss_pred chhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHH
Confidence 777754 2799999999999999999999999999843322 223344566888999996654 677888999999
Q ss_pred HHHHHHHHhCCCCCC
Q 011763 320 GCVFAELLIGKPILQ 334 (478)
Q Consensus 320 G~il~elltG~~pf~ 334 (478)
++.+|++.-|.++|.
T Consensus 1427 s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHhcccHHHH
Confidence 999999999887775
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00053 Score=67.15 Aligned_cols=140 Identities=16% Similarity=0.121 Sum_probs=81.9
Q ss_pred eeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--eeeeccee----eecCCceE
Q 011763 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN--IIKLEGLI----TSRLSCSI 206 (478)
Q Consensus 133 ~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~----~~~~~~~~ 206 (478)
.-++.|..|....+|+... .+..+++|+... .....+..|+.++..|.+.. +++++... .....+..
T Consensus 17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred hheecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 3466777788889999864 334688998753 12244667888888884322 44443311 11113456
Q ss_pred EEEEeeccCCchhhcc---------------C--CC--C------CCCHHHH--H--------HHHHHHHHHHHHHHh--
Q 011763 207 YLVFEYMEHDITGLLS---------------C--PD--I------KFSEAQI--K--------CYMNQLLHGLEHCHS-- 249 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~---------------~--~~--~------~l~~~~~--~--------~i~~qil~aL~~LH~-- 249 (478)
++|+++++|..+.... . .. . ...+... . .....+..++.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 8999999985432210 0 00 0 0000000 0 011112334444443
Q ss_pred -----CCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 250 -----RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 250 -----~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
.++||+|+.|.|||+++++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999988778899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00051 Score=67.52 Aligned_cols=74 Identities=23% Similarity=0.268 Sum_probs=45.3
Q ss_pred eeeeeecCceEEEEEEECC------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-eeeecceeeecCCceEE
Q 011763 135 LEKIGQGTYSSVFRARDLD------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN-IIKLEGLITSRLSCSIY 207 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~~~ 207 (478)
++.|..|-...||++.... .++.|++|+..... .......+|+.++..+.... ..+++.++.. .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN------G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC------C
Confidence 3556667777899987533 25789999965432 12233457888888884322 3445444422 2
Q ss_pred EEEeeccCCc
Q 011763 208 LVFEYMEHDI 217 (478)
Q Consensus 208 lv~e~~~~~l 217 (478)
+|+||++|..
T Consensus 74 ~v~e~i~G~~ 83 (302)
T cd05156 74 RIEEFIPSRT 83 (302)
T ss_pred chhheeCCCc
Confidence 5899988743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0015 Score=64.09 Aligned_cols=150 Identities=18% Similarity=0.220 Sum_probs=86.1
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCeeeecceeeecCCceEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--PNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~~~l 208 (478)
...+++.+-.|..-.+|...+. ++.++|+ ...............+|+.+|+.+.- .-+...++++.+..-...|.
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 4455555544444456666543 7888888 43222234555667789999988843 23344455665532245689
Q ss_pred EEeeccCCchhhccCCC--------------------------------CCCCHHHHHHHHHHH--------------HH
Q 011763 209 VFEYMEHDITGLLSCPD--------------------------------IKFSEAQIKCYMNQL--------------LH 242 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~--------------------------------~~l~~~~~~~i~~qi--------------l~ 242 (478)
||+|++|.......... ..+...++..+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 99999983211110000 000111111111111 12
Q ss_pred HHHHHHhC--------CceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 243 GLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 243 aL~~LH~~--------givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
-..||+.+ .++|+|+.+.||+|++++.+-|+||+++....+
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 23344432 489999999999999999999999999976543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0037 Score=60.66 Aligned_cols=31 Identities=19% Similarity=0.394 Sum_probs=25.8
Q ss_pred CceeccCCCCcEEEecCCc-EEEeeccccccc
Q 011763 251 GVLHRDIKGSNLLVNNEGV-LKLADFGLANFS 281 (478)
Q Consensus 251 givHrDlkp~NILl~~~~~-vkl~DFG~a~~~ 281 (478)
.++|+|++|.|||+++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 469999988543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00049 Score=70.30 Aligned_cols=172 Identities=22% Similarity=0.357 Sum_probs=110.3
Q ss_pred HHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 011763 175 FMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254 (478)
Q Consensus 175 ~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH 254 (478)
.+.-...+++.+.|+|+...+++-... .....+|||+++-++.+...... +-.. +++ .+++.|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~~~Sled~~~~~~--l~~~-------s~~-------~~~~~~ 90 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHYTMSLEDILKTGN--LKDE-------SLL-------AHGVLH 90 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhhccchHHHHHhcc--cchh-------hhc-------ccccce
Confidence 345578889999999999988876543 34588999999877666544332 1100 111 122222
Q ss_pred ccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 011763 255 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 334 (478)
Q Consensus 255 rDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~ 334 (478)
- || ++++| -++ |. | | ....+++|||++|.++.++.-|...+.
T Consensus 91 ~-----~~-------~~~td-~~~----------------t~-~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 91 L-----NI-------IYITD-HFL----------------TK-Y--P------SPIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred e-----hh-------hhccc-ccc----------------cc-C--C------CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 2 22 22233 000 00 1 1 112259999999999999999999999
Q ss_pred CCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccch-hcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 335 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLR-ETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 335 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...+.+++..+......+.... ....+ ...-..+..+.+++..|+...|..||...++.++
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~------------------~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~ 194 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELL------------------STAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKR 194 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHH------------------HHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcC
Confidence 8888888877766433222110 00000 1113567778999999999999999999999999
Q ss_pred cccCCC
Q 011763 414 EYFSTK 419 (478)
Q Consensus 414 p~f~~~ 419 (478)
+-|.+.
T Consensus 195 ~i~~ev 200 (725)
T KOG1093|consen 195 CSFTEV 200 (725)
T ss_pred ccHHHH
Confidence 999753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.003 Score=63.03 Aligned_cols=147 Identities=18% Similarity=0.250 Sum_probs=81.1
Q ss_pred CcccccccceeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCe-eeeccee
Q 011763 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLI 198 (478)
Q Consensus 123 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~ 198 (478)
+|..+..+.+++....| |-.-.+|++..... +..|++|+..... . ..-.-.+|..+++.+..-++ +++++++
T Consensus 8 ~w~~~~~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~IdR~~E~~il~~l~~~gl~P~~l~~~ 83 (330)
T PLN02421 8 GWSDLDDSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YVIDRERELQAIKYLSAAGFGAKLLGVF 83 (330)
T ss_pred ccccCCcCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc--C-eEechHHHHHHHHHHHhcCCCCceeEEe
Confidence 34333344555555544 77778999875432 3378999875322 1 11112468888888854444 4555544
Q ss_pred eecCCceEEEEEeeccCCchhhc------------------cCCCC-----CCCHHHHHHHHHHH---------------
Q 011763 199 TSRLSCSIYLVFEYMEHDITGLL------------------SCPDI-----KFSEAQIKCYMNQL--------------- 240 (478)
Q Consensus 199 ~~~~~~~~~lv~e~~~~~ll~~~------------------~~~~~-----~l~~~~~~~i~~qi--------------- 240 (478)
.. + +|.+|+++..+... ..... +-....+..+..++
T Consensus 84 ~~--G----~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~ 157 (330)
T PLN02421 84 GN--G----MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYE 157 (330)
T ss_pred CC--c----EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhc
Confidence 22 2 58889877433210 01110 11123333333222
Q ss_pred -------HHHHHH----HHhCC----ceeccCCCCcEEEec-CCcEEEeeccccc
Q 011763 241 -------LHGLEH----CHSRG----VLHRDIKGSNLLVNN-EGVLKLADFGLAN 279 (478)
Q Consensus 241 -------l~aL~~----LH~~g----ivHrDlkp~NILl~~-~~~vkl~DFG~a~ 279 (478)
..-+.. +...+ ++|+|+.+.|||+++ ++.++|+||..|.
T Consensus 158 ~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 158 TISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred ccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 111111 11112 799999999999985 4789999999874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0055 Score=61.47 Aligned_cols=140 Identities=13% Similarity=0.189 Sum_probs=79.7
Q ss_pred ceeeeeeeeecCceEEEEEEECC----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCe-eeecceeeecCCce
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLD----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLITSRLSCS 205 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~----~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~ 205 (478)
... +..|-.|-.-.+|++.... .++.|++|+..... ..... ..+|+.+++.+..-++ .++++.+.. +
T Consensus 38 ~~~-i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~--g-- 109 (344)
T PLN02236 38 ALQ-VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN--G-- 109 (344)
T ss_pred cEE-EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC--c--
Confidence 344 4455558888899987432 34689999875432 11111 2568999888853333 345554422 2
Q ss_pred EEEEEeeccCCchhhc------------------cCCC---C--CCCHHHHHHHHHHHH-----------------HHHH
Q 011763 206 IYLVFEYMEHDITGLL------------------SCPD---I--KFSEAQIKCYMNQLL-----------------HGLE 245 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~------------------~~~~---~--~l~~~~~~~i~~qil-----------------~aL~ 245 (478)
.|.+|+++..+... .... . ......+..++.++. ..+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 58899887433211 0000 0 111233334332221 1111
Q ss_pred HH----H----hCCceeccCCCCcEEEec-CCcEEEeecccccc
Q 011763 246 HC----H----SRGVLHRDIKGSNLLVNN-EGVLKLADFGLANF 280 (478)
Q Consensus 246 ~L----H----~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~ 280 (478)
.| . ...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12 1 225899999999999986 46899999998853
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0068 Score=60.44 Aligned_cols=74 Identities=19% Similarity=0.252 Sum_probs=46.8
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEeec------CCCChHHHHHHHHHHHHHHhcC--CC-CeeeecceeeecCCceEE
Q 011763 137 KIGQGTYSSVFRARDLDTGKIVALKKVRF------DNFEPESVRFMAREILILRRLD--HP-NIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 137 ~LG~G~~g~V~~~~~~~~~~~vAlK~~~~------~~~~~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~~~ 207 (478)
.||.|....||++.+...++-|+||.-.. +.+ +-..++..-|..+|+... .| .+++++.+- .....
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~w-pl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~ 76 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESW-PLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAV 76 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCC-CCCccHHHHHHHHHHHhhccCccccCeEEEEc----cccce
Confidence 46889999999999754446799997431 111 222344556888887763 34 455564432 33456
Q ss_pred EEEeeccC
Q 011763 208 LVFEYMEH 215 (478)
Q Consensus 208 lv~e~~~~ 215 (478)
+|||+++.
T Consensus 77 ~vMEdL~~ 84 (370)
T TIGR01767 77 TVMEDLSH 84 (370)
T ss_pred ehHhhCcc
Confidence 89999864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.027 Score=57.25 Aligned_cols=76 Identities=14% Similarity=0.141 Sum_probs=50.0
Q ss_pred eeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC--C---hHHHHHHHHHHHHHHhcC---CCCeeeecceeeecCCce
Q 011763 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--E---PESVRFMAREILILRRLD---HPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 134 ~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~--~---~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~ 205 (478)
..+.||.|....||+..+. +..|+||.-..... . +....+...|+..|+.+. -.++++++.++.+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence 4678899999999999863 45688997542111 0 012344445677777663 2477788776653 3
Q ss_pred EEEEEeeccC
Q 011763 206 IYLVFEYMEH 215 (478)
Q Consensus 206 ~~lv~e~~~~ 215 (478)
.+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5789999976
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0079 Score=55.78 Aligned_cols=29 Identities=38% Similarity=0.647 Sum_probs=21.0
Q ss_pred CceeccCCCCcEEE-ecCCcEEEeeccccc
Q 011763 251 GVLHRDIKGSNLLV-NNEGVLKLADFGLAN 279 (478)
Q Consensus 251 givHrDlkp~NILl-~~~~~vkl~DFG~a~ 279 (478)
-++|+||.+.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 888999999999884
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.012 Score=59.55 Aligned_cols=77 Identities=22% Similarity=0.154 Sum_probs=49.4
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeec----CCCChHHHHHHHHHHHHHHhcC--CC-CeeeecceeeecCCceEE
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRF----DNFEPESVRFMAREILILRRLD--HP-NIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~----~~~~~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~~~ 207 (478)
++.||.|.-.-||++.+...++-|+||.-.. ...=+-..++..-|..+|+.+. .| ++++++.+- .....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D----~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD----SVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC----cHHhh
Confidence 6788999999999999743356789997421 1100233455566888888773 34 456664432 23456
Q ss_pred EEEeeccC
Q 011763 208 LVFEYMEH 215 (478)
Q Consensus 208 lv~e~~~~ 215 (478)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 88988864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.022 Score=57.85 Aligned_cols=86 Identities=20% Similarity=0.231 Sum_probs=47.5
Q ss_pred CcccccccceeeeeeeeecCceEEEEEEECCC-CcE-----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCC-Ceeeec
Q 011763 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDT-GKI-----VALKKVRFDNFEPESVRFMAREILILRRLDHP-NIIKLE 195 (478)
Q Consensus 123 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~-~~~-----vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~ 195 (478)
.|.....+.+++. .|..|-...+|++..... +.. |.+++.. ..... .-.-.+|+.+++.|... .-.+++
T Consensus 44 ~w~~~~~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g--~~~~l-~IdR~~E~~i~~~Ls~~glgP~l~ 119 (383)
T PTZ00384 44 FWNNVNPEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS--TYNSL-VIDNDLQYNIAKLLGDNNFGPKII 119 (383)
T ss_pred ccccCCcccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEecc--CCCce-EeccHHHHHHHHHHHhCCCCCeEE
Confidence 4443334445554 454588889999975432 122 4444321 11111 11124689999999544 445566
Q ss_pred ceeeecCCceEEEEEeeccCCch
Q 011763 196 GLITSRLSCSIYLVFEYMEHDIT 218 (478)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~ll 218 (478)
+.+.. ++|.||++|..+
T Consensus 120 ~~f~~------g~l~efIeGr~l 136 (383)
T PTZ00384 120 GRFGD------FTIQEWVEGNTM 136 (383)
T ss_pred EecCC------EEEEEEeccccC
Confidence 65532 489999998543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.032 Score=54.35 Aligned_cols=76 Identities=16% Similarity=0.196 Sum_probs=45.3
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCeeeecceeeecCCceEEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD---HPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+..+.|+.|....+|+.. .+++.+.||+-.. .....+..|..-|+.|. --.+++++.+... ....||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fL 89 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFL 89 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceE
Confidence 5556788999999999987 5778899998762 22345667888888883 3456677766554 334589
Q ss_pred EEeeccCC
Q 011763 209 VFEYMEHD 216 (478)
Q Consensus 209 v~e~~~~~ 216 (478)
||||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99998754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.042 Score=56.96 Aligned_cols=90 Identities=14% Similarity=0.193 Sum_probs=54.0
Q ss_pred ccccccCcccccccceeeeeeeeecCceEEEEEEECC--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC
Q 011763 117 AGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLD--------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188 (478)
Q Consensus 117 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~--------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h 188 (478)
..+.+.+|..+..++. -++.|..|-.-.+|++.... .++.|.+|+.-... +..-.-.+|..+++.+..
T Consensus 93 ~~~~vp~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lIdR~~E~~v~~~ls~ 168 (442)
T PTZ00296 93 CLEKVPEWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYNPISEFEVYKTMSK 168 (442)
T ss_pred HHHHCCccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeCHHHHHHHHHHHHH
Confidence 3333455665555666 66677678888899997542 14678899874322 111123458888888754
Q ss_pred CCe-eeecceeeecCCceEEEEEeeccCC
Q 011763 189 PNI-IKLEGLITSRLSCSIYLVFEYMEHD 216 (478)
Q Consensus 189 ~nI-v~l~~~~~~~~~~~~~lv~e~~~~~ 216 (478)
.+| .++++.+.. +.|.||+++.
T Consensus 169 ~gi~P~l~~~f~g------g~I~efi~g~ 191 (442)
T PTZ00296 169 YRIAPQLLNTFSG------GRIEEWLYGD 191 (442)
T ss_pred CCCCCceEEEeCC------CEEEEeeCCc
Confidence 333 345554422 3578999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.032 Score=55.04 Aligned_cols=31 Identities=19% Similarity=0.256 Sum_probs=28.1
Q ss_pred CceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 251 givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
++||+|+.+.|||+++++.+-|+||..+...
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 6999999999999999999999999988543
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.056 Score=61.97 Aligned_cols=31 Identities=35% Similarity=0.549 Sum_probs=26.4
Q ss_pred CCceeccCCCCcEEEecCC--cEE-Eeecccccc
Q 011763 250 RGVLHRDIKGSNLLVNNEG--VLK-LADFGLANF 280 (478)
Q Consensus 250 ~givHrDlkp~NILl~~~~--~vk-l~DFG~a~~ 280 (478)
.++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998854
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.16 Score=50.43 Aligned_cols=137 Identities=21% Similarity=0.290 Sum_probs=79.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC------eeeecceeeecCC--ceEE
Q 011763 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN------IIKLEGLITSRLS--CSIY 207 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~--~~~~ 207 (478)
..|.+ .-..||+.... +|. ++||+.+.. .. ...+..|+..|+.|.-.. |..+-|-...... .+.+
T Consensus 32 ~~l~s-~eN~~f~~~~~-~g~-~iLki~~~~-~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 32 RGLNS-EENSNFRVQTE-DGR-YILKIYRPG-WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccccc-ccCceEEEEec-CCC-eEEEEecCC-CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 34444 44568988753 344 499998754 22 344566888888883211 2333232222223 3788
Q ss_pred EEEeeccCCchhh-ccC-----------------CCC---------CCCHH----HH---------HHHHHHHHHHHHHH
Q 011763 208 LVFEYMEHDITGL-LSC-----------------PDI---------KFSEA----QI---------KCYMNQLLHGLEHC 247 (478)
Q Consensus 208 lv~e~~~~~ll~~-~~~-----------------~~~---------~l~~~----~~---------~~i~~qil~aL~~L 247 (478)
-+++|++|..+.. ... .+. ...+. .. .....++...++.+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999999865552 100 000 01111 00 11223444455555
Q ss_pred HhC--------C--ceeccCCCCcEEEecCCc-EEEeeccccc
Q 011763 248 HSR--------G--VLHRDIKGSNLLVNNEGV-LKLADFGLAN 279 (478)
Q Consensus 248 H~~--------g--ivHrDlkp~NILl~~~~~-vkl~DFG~a~ 279 (478)
.+. + +||+|+.|.||+++.+.. +.++||+-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 532 3 999999999999999885 8999999874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.044 Score=54.25 Aligned_cols=111 Identities=20% Similarity=0.285 Sum_probs=70.9
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
..+.|++|++-...+... . .-...++..++.+.+..++-+..+ ..-|||+...||||+ +|+|.|+||-+++..
T Consensus 298 ~~y~yl~~kdhgt~is~i-k----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDHGTPISII-K----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecCCceeeee-e----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 556778888765543322 1 124677788888877766666654 689999999999999 999999999999843
Q ss_pred CCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCC
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 330 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~ 330 (478)
.... .... ...--|-.+.| .-+.+-|||-+ |--|+.|.
T Consensus 372 ~~q~-~isy-----~rldhp~lF~G--~dd~QFeIYrl---Mr~l~~g~ 409 (488)
T COG5072 372 YSQG-IISY-----NRLDHPDLFNG--VDDYQFEIYRL---MRRLLKGR 409 (488)
T ss_pred cCCc-eeec-----cccCchhhhcC--ccceeeeHHHH---HHHHhcCc
Confidence 3221 1111 11223443444 23667788874 33444444
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.62 Score=46.32 Aligned_cols=72 Identities=15% Similarity=0.144 Sum_probs=41.6
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC--Ceeee---cceeeecCCceEEEEEeeccC
Q 011763 141 GTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP--NIIKL---EGLITSRLSCSIYLVFEYMEH 215 (478)
Q Consensus 141 G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l---~~~~~~~~~~~~~lv~e~~~~ 215 (478)
+.-..||+... .++..+++|+.+.... ....+..|+.++..|... .++.. -+-.....++..+.++++++|
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~---~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW---SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC---CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 34457899874 4567799998764432 234566788888777321 12221 121111114567889999887
Q ss_pred C
Q 011763 216 D 216 (478)
Q Consensus 216 ~ 216 (478)
.
T Consensus 112 ~ 112 (325)
T PRK11768 112 R 112 (325)
T ss_pred C
Confidence 4
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.073 Score=51.89 Aligned_cols=136 Identities=18% Similarity=0.205 Sum_probs=89.7
Q ss_pred eeeeeeecCceEEEEEEE-------CC---CCcEEEEEEeecC----------------------CCChHHHHHHH--HH
Q 011763 134 KLEKIGQGTYSSVFRARD-------LD---TGKIVALKKVRFD----------------------NFEPESVRFMA--RE 179 (478)
Q Consensus 134 ~~~~LG~G~~g~V~~~~~-------~~---~~~~vAlK~~~~~----------------------~~~~~~~~~~~--~E 179 (478)
|..+|..|.-+.|+.+.- .. .-+.+|||+++.. ..++..+-.++ +|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 345677888888988832 11 2346788887421 11222222333 34
Q ss_pred HHHHHhc-----CCCCeeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCce
Q 011763 180 ILILRRL-----DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH-SRGVL 253 (478)
Q Consensus 180 ~~~l~~l-----~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~giv 253 (478)
+.-|.++ .+|-+|.+- ...|||-|++..-+..-.-.+..|+..+.+..-.|+...+.-|. ++-+|
T Consensus 336 mhNL~RMq~~GlpcP~vV~lk---------khvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LV 406 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLK---------KHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLV 406 (531)
T ss_pred HHHHHHHHhcCCCCCceeeee---------cceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhhee
Confidence 4445554 356666652 24699999987443333333446888899888899988887664 66899
Q ss_pred eccCCCCcEEEecCCcEEEeeccccc
Q 011763 254 HRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 254 HrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
|-||.--|+|...+ .+-++|...+.
T Consensus 407 HADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 407 HADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred ecchhhhhheecCC-ceEEEechhcc
Confidence 99999999999875 88899987764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.26 Score=45.97 Aligned_cols=76 Identities=21% Similarity=0.264 Sum_probs=48.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC---CeeeecceeeecCCceEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP---NIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~~~ 207 (478)
+.+..+.+.-|..-..|...+ ....|.+|.- ..+....+..|+.-|..|.-. .+.+++.+- ....+.|
T Consensus 17 ~i~er~~v~gG~inea~~v~d--g~~~~FvK~n-----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G--~~~~~sy 87 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRD--GTDPFFVKCN-----QREQLSMFTAEADGLELLARSNTITVPKVIAVG--ASRDHSY 87 (286)
T ss_pred hhhcccccCCccccceeEeec--CCcceEEEec-----chhhHHHHHHHHHHHHHHHhcCCccccceEEec--CCCCeeE
Confidence 344445565566666666653 3456888873 244456677788777777443 455554333 3367899
Q ss_pred EEEeeccC
Q 011763 208 LVFEYMEH 215 (478)
Q Consensus 208 lv~e~~~~ 215 (478)
|||||++-
T Consensus 88 lVle~L~~ 95 (286)
T COG3001 88 LVLEYLPT 95 (286)
T ss_pred EEEeeccC
Confidence 99999985
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.078 Score=52.15 Aligned_cols=29 Identities=28% Similarity=0.509 Sum_probs=25.6
Q ss_pred CCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 250 ~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 478 | ||||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-61 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-61 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-61 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-61 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-56 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-56 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-56 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-56 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-56 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-56 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-56 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-56 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-56 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-56 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-56 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-56 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-56 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-56 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-56 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-56 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-56 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-56 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-56 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-56 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-56 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-56 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-56 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-56 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-56 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-56 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-56 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-56 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-56 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-56 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-56 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-56 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-56 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-56 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-56 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-55 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-55 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-55 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-55 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-54 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-54 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-54 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-54 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-50 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-49 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-49 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-49 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-49 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-48 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-48 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-48 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-48 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-46 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-46 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-43 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-42 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-42 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-42 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-41 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-41 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-41 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-41 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-41 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-41 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-41 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-41 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-41 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-41 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-41 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-41 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-41 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-41 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-41 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-41 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-41 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-41 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-41 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-41 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-41 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-40 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-40 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-40 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-40 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-40 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-40 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-40 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-40 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-40 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-40 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-40 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-40 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-40 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-40 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-40 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-40 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-40 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-40 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-40 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-40 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-40 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-40 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-40 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-40 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-40 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-40 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-40 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-40 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-40 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-40 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-40 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-40 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-40 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-40 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-40 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-40 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-40 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-40 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-40 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-40 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-40 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-40 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-40 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-40 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-40 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-40 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-40 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-40 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-40 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-40 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-40 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-40 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-39 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-39 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-39 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-39 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-39 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-39 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-39 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-39 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-39 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-39 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-39 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-39 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-39 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-39 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-39 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-39 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-39 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-39 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-39 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-39 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-39 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-39 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-39 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-39 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-39 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-39 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-39 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-39 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-39 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-39 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-39 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-39 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-39 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-39 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-38 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-38 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-38 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-36 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-36 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-35 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-35 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-34 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-34 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-33 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-33 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-33 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-33 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-32 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-32 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-32 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-32 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-32 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-32 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-32 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-32 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-32 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-32 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-32 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-32 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-32 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-32 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-32 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-32 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-32 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-32 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-32 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-32 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-32 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-32 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-32 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-32 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-32 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-32 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-32 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-31 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-31 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-31 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-30 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-27 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-27 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-27 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-27 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-27 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-27 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-27 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-27 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-27 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-27 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-27 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-27 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-27 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-27 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-27 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-27 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-27 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-27 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-27 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-27 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-27 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-27 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-27 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-27 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-27 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-27 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-27 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-27 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-27 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-27 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-27 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-27 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-27 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-27 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-27 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-27 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-27 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-27 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-27 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-26 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-26 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-26 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-26 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-26 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-26 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-26 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-26 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-26 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-26 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-26 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-26 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-26 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-26 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-26 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-26 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-25 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-25 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-25 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-25 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-25 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-25 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-24 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-24 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-24 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-24 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-24 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-24 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-24 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-24 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-24 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-23 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-23 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-23 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-23 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-23 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-23 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-23 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-22 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-22 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-22 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-22 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-22 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-22 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-22 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-22 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-22 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-22 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-22 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-22 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-21 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-21 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-21 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-21 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-21 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-21 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-21 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-21 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-21 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-21 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-21 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-21 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-21 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-21 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-21 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-21 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-21 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-21 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-21 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-21 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-21 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-20 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-20 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-20 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-19 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-19 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-18 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-17 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-17 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-16 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-16 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-16 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-16 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-16 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-12 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-08 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-08 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 6e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-07 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 8e-07 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 8e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 |
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 525 bits (1354), Expect = 0.0
Identities = 134/344 (38%), Positives = 190/344 (55%), Gaps = 16/344 (4%)
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA- 177
++++ +EKL KIGQGT+ VF+AR TG+ VALKKV +N E E A
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITAL 64
Query: 178 REILILRRLDHPNIIKLEGLITSRLS------CSIYLVFEYMEHDITGLLSCPDIKFSEA 231
REI IL+ L H N++ L + ++ S SIYLVF++ EHD+ GLLS +KF+ +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 232 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQP 288
+IK M LL+GL + H +LHRD+K +N+L+ +GVLKLADFGLA +
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
T+RVVTLWYRPPELLLG DYGP +DLW GC+ AE+ PI+QG TE QL I +L
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 349 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRA 405
CGS + W + + +++ K A++LI+ LL ++P +R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 406 TASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 449
+ AL ++F + P DL + + + RRK
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAP--PRRKH 346
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 477 bits (1229), Expect = e-168
Identities = 127/344 (36%), Positives = 189/344 (54%), Gaps = 12/344 (3%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--PESVRFMA-REIL 181
V RA +EKL+ +G+G +++V++ARD +T +IVA+KK++ + + + A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 182 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLL 241
+L+ L HPNII L + +I LVF++ME D+ ++ + + + IK YM L
Sbjct: 65 LLQELSHPNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
GLE+ H +LHRD+K +NLL++ GVLKLADFGLA + +R T +VVT WYR P
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAP 181
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-S 360
ELL GA YG VD+W+VGC+ AELL+ P L G ++++QL +IF+ G+P ++ W
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
LP FK L F ++LI+ L P R TA+ AL +YFS +P
Sbjct: 242 SLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299
Query: 421 YACDLSSLPIYPPSKEIDAKHRE---DARRKKVGGRVRGAETRK 461
LP E + +RK+ +G +K
Sbjct: 300 GPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKK 343
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 410 bits (1055), Expect = e-142
Identities = 112/324 (34%), Positives = 173/324 (53%), Gaps = 12/324 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + KL+K+G+GTY++V++ + T +VALK++R ++ E + RE+ +L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
NI+ L +I + S+ LVFEY++ D+ L + +K ++ QLL GL +CH
Sbjct: 61 NIVTLHDIIHTE--KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+ VLHRD+K NLL+N G LKLADFGLA S + + VVTLWYRPP++LLG+T
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYDNEVVTLWYRPPDILLGST 176
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATL 367
DY +D+W VGC+F E+ G+P+ G T EQLH IF++ G+P ++ W
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSS 427
+ + +L L + +L+ LL E R +A A+ +F +
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH--K 294
Query: 428 LPIYP---PSKEIDAKHREDARRK 448
LP KEI + R
Sbjct: 295 LPDTTSIFALKEIQLQKEASLRSA 318
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 406 bits (1047), Expect = e-141
Identities = 112/311 (36%), Positives = 165/311 (53%), Gaps = 20/311 (6%)
Query: 123 GWVPLRA-DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF---MAR 178
G + A +E + +IG G Y +V++ARD +G VALK VR N R
Sbjct: 1 GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 179 EILILRRL---DHPNIIKLEGLITSR---LSCSIYLVFEYMEHDITGLL-SCPDIKFSEA 231
E+ +LRRL +HPN+++L + + + LVFE+++ D+ L P
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 232 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLT 290
IK M Q L GL+ H+ ++HRD+K N+LV + G +KLADFGLA + ++ LT
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
VVTLWYR PE+LL +T Y VD+WSVGC+FAE+ KP+ G +E +QL KIF L G
Sbjct: 178 PVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 351 SPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409
PP+D W + LP P + ++ ++ + L+ +L+ P+KR +A
Sbjct: 237 LPPEDDWPRDVSLPRGAF--PPRGP-RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293
Query: 410 ALASEYFSTKP 420
AL Y
Sbjct: 294 ALQHSYLHKDE 304
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 403 bits (1039), Expect = e-140
Identities = 110/322 (34%), Positives = 170/322 (52%), Gaps = 20/322 (6%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRL 186
+ F++LEK+G GTY++V++ + TG VALK+V+ D+ E E A REI +++ L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-E-EGTPSTAIREISLMKEL 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK-----FSEAQIKCYMNQLL 241
H NI++L +I + + LVFE+M++D+ + + +K + QLL
Sbjct: 61 KHENIVRLYDVIHTE--NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRP 300
GL CH +LHRD+K NLL+N G LKL DFGLA F +S VVTLWYR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI--PVNTFSSEVVTLWYRA 176
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK- 359
P++L+G+ Y S+D+WS GC+ AE++ GKP+ G + EQL IF + G+P + W
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 360 SKLPHATLFKPQQPYDSSLRETFKD-----LPTTAVNLIETLLSVEPYKRATASAALASE 414
+KLP Q+P LR+ + L ++ + LL + P R +A AL
Sbjct: 237 TKLPKYNPNIQQRPP-RDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 415 YFSTKPYACDLSSLPIYPPSKE 436
+F+ + + +
Sbjct: 296 WFAEYYHHASMGGSRSHHHHHH 317
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 401 bits (1034), Expect = e-139
Identities = 124/295 (42%), Positives = 176/295 (59%), Gaps = 10/295 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+EKLEKIG+GTY +VF+A++ +T +IVALK+VR D+ + E V A REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI++L ++ S + LVFE+ + D+ + +K ++ QLL GL CH
Sbjct: 61 KNIVRLHDVLHSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
SR VLHRD+K NLL+N G LKLA+FGLA F + ++ VVTLWYRPP++L GA
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGA 176
Query: 308 TDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHA 365
Y S+D+WS GC+FAEL G+P+ G +QL +IF+L G+P ++ W +KLP
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
+ P P +SL L T +L++ LL P +R +A AL YFS
Sbjct: 237 KPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 401 bits (1034), Expect = e-139
Identities = 120/300 (40%), Positives = 174/300 (58%), Gaps = 9/300 (3%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
+ + ++KLEK+G+GTY V++A+D G+IVALK++R D E E + A REI +
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISL 72
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH 242
L+ L HPNI+ L +I S + LVFE+ME D+ +L ++QIK Y+ QLL
Sbjct: 73 LKELHHPNIVSLIDVIHSE--RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPP 301
G+ HCH +LHRD+K NLL+N++G LKLADFGLA F + T VVTLWYR P
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVTLWYRAP 188
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-S 360
++L+G+ Y SVD+WS+GC+FAE++ GKP+ G T+ +QL KIF + G+P W +
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
+LP Q ++L+ +L +P KR +A A+ YF
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-139
Identities = 111/397 (27%), Positives = 184/397 (46%), Gaps = 46/397 (11%)
Query: 122 QGWVPLRADAFEKL-EKIGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMAR 178
D FE K+G+GTY V++A+ D K ALK++ + R
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR---- 67
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL--------SCPDIKFSE 230
EI +LR L HPN+I L+ + S ++L+F+Y EHD+ ++ + ++
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR 286
+K + Q+L G+ + H+ VLHRD+K +N+LV G +K+AD G A N+ +
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 287 Q--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV----- 339
L VVT WYR PELLLGA Y ++D+W++GC+FAELL +PI R E
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 340 ----EQLHKIFKLCGSPPDDYWKK-SKLPHATLFKP---QQPYDSS-----LRETFKDLP 386
+QL +IF + G P D W+ K+P + + Y + + +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 387 TTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP---IYPPSKEIDAKHRE 443
+ A +L++ LL+++P KR T+ A+ YF P YP + + + +
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPD 367
Query: 444 DA----RRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
D +++ G T + ++ P++
Sbjct: 368 DKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLK 404
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 398 bits (1025), Expect = e-138
Identities = 111/291 (38%), Positives = 171/291 (58%), Gaps = 10/291 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+ + LEKIG+GTY V++A++ + G+ ALKK+R + E E + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKH 59
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+KL +I ++ + LVFE+++ D+ LL + K ++ QLL+G+ +CH
Sbjct: 60 SNIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
R VLHRD+K NLL+N EG LK+ADFGLA F + T +VTLWYR P++L+G+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGS 175
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
Y ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G+P W ++LP
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
K L + ++L+ +L ++P +R TA AL YF
Sbjct: 236 PNFTVYEP-LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-138
Identities = 118/323 (36%), Positives = 176/323 (54%), Gaps = 21/323 (6%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMA-REILILRRL- 186
+E + +IG+G Y VF+ARDL + G+ VALK+VR E + RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLE 69
Query: 187 --DHPNIIKLEGLITSRLS---CSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQL 240
+HPN+++L + T + + LVFE+++ D+T L P+ IK M QL
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYR 299
L GL+ HS V+HRD+K N+LV + G +KLADFGLA + + LTS VVTLWYR
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYR 186
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE+LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P ++ W +
Sbjct: 187 APEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 360 -SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
LP + + D+ +L+ L+ P KR +A +AL+ YF
Sbjct: 246 DVALPRQAFHSKSA---QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 419 KPYACD--LSSLPIYPPSKEIDA 439
+ S LP + E++
Sbjct: 303 LERCKENLDSHLPPSQNTSELNT 325
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-137
Identities = 106/311 (34%), Positives = 161/311 (51%), Gaps = 9/311 (2%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+ +EK+ KIG+G+Y VF+ R+ DTG+IVA+KK + ++ +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKH 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
PN++ L + + ++LVFEY +H + L E +K Q L + CH
Sbjct: 62 PNLVNLLEVFRRK--RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
+HRD+K N+L+ V+KL DFG A + G V T WYR PELL+G
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT--GPSDYYDDEVATRWYRSPELLVGD 177
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
T YGP VD+W++GCVFAELL G P+ G+++V+QL+ I K G + + S + +
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 367 LFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 425
K P L F ++ A+ L++ L ++P +R T L YF DL
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
Query: 426 SSLPIYPPSKE 436
+ P
Sbjct: 298 AKEHDKPAENL 308
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 395 bits (1018), Expect = e-136
Identities = 99/320 (30%), Positives = 172/320 (53%), Gaps = 17/320 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+ +E L +G+G+Y V + R+ DTG+IVA+KK + + + V+ +A REI +L++L H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRH 83
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
N++ L + + YLVFE+++H I L ++ Y+ Q+++G+ CH
Sbjct: 84 ENLVNLLEVCKKK--KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
S ++HRDIK N+LV+ GV+KL DFG A + G + V T WYR PELL+G
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGD 199
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
YG +VD+W++GC+ E+ +G+P+ G ++++QL+ I G+ + + +K P
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259
Query: 367 LFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 425
+ P+ L + L ++L + L ++P KR + L ++F +A
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAER- 318
Query: 426 SSLPIYPPSKEIDAKHREDA 445
S+E+ K ++DA
Sbjct: 319 -------FSQELQLKVQKDA 331
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-136
Identities = 113/301 (37%), Positives = 175/301 (58%), Gaps = 16/301 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
D + ++ K+G+GTY V++A D T + VA+K++R ++ E E V A RE+ +L+ L H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQH 92
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHC 247
NII+L+ +I ++L+FEY E+D+ + PD S IK ++ QL++G+ C
Sbjct: 93 RNIIELKSVIHHN--HRLHLIFEYAENDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFC 148
Query: 248 HSRGVLHRDIKGSNLLVN-----NEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPP 301
HSR LHRD+K NLL++ VLK+ DFGLA F + T ++TLWYRPP
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI--PIRQFTHEIITLWYRPP 206
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-S 360
E+LLG+ Y SVD+WS+ C++AE+L+ P+ G +E++QL KIF++ G P D W +
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
LP P+ + R L ++L+ +L ++P KR +A AL YFS
Sbjct: 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326
Query: 421 Y 421
+
Sbjct: 327 F 327
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 336 bits (863), Expect = e-112
Identities = 116/349 (33%), Positives = 173/349 (49%), Gaps = 19/349 (5%)
Query: 79 SGRASSNSESLSFRLGNLHKYIEGEQVAAGWPA-WLSAVAGEAIQGWVPLRADAFEKLEK 137
SGR + S + S + +V+ ++ V QG + ++ +
Sbjct: 2 SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL 197
IG G++ V++A+ D+G++VA+KKV D RF RE+ I+R+LDH NI++L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYF 115
Query: 198 ITSRLS----CSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
S + LV +Y+ + + S +K YM QL L + HS
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 251 GVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
G+ HRDIK NLL++ + VLKL DFG A G +P S + + +YR PEL+ GATD
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATD 233
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
Y S+D+WS GCV AELL+G+PI G + V+QL +I K+ G+P + ++ P+ T FK
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN-PNYTEFK 292
Query: 370 -PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
PQ + P A+ L LL P R T A A +F
Sbjct: 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-105
Identities = 103/295 (34%), Positives = 153/295 (51%), Gaps = 19/295 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + IG G++ VF+A+ +++ + VA+KKV D RF RE+ I+R + HPN+
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIVKHPNV 94
Query: 192 IKLEGLITSRLSCS----IYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGL 244
+ L+ S + LV EY+ + + IK YM QLL L
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 245 EHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
+ HS G+ HRDIK NLL++ GVLKL DFG A G +P S + + +YR PEL
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICSRYYRAPEL 212
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
+ GAT+Y ++D+WS GCV AEL+ G+P+ G + ++QL +I K+ G+P + K+ P
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI-KTMNP 271
Query: 364 HATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
+ K Q + F P A++LI LL P R TA AL +F
Sbjct: 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 2e-98
Identities = 100/337 (29%), Positives = 150/337 (44%), Gaps = 27/337 (8%)
Query: 114 SAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESV 173
S A A D F+ GQGT+ +V ++ TG VA+KKV D
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------P 60
Query: 174 RFMAREILILRRL---DHPNIIKLEGLITSRLSCS-----IYLVFEYME---HDITGLLS 222
RF RE+ I++ L HPNI++L+ + + +V EY+ H
Sbjct: 61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY 120
Query: 223 CPDIKFSEAQIKCYMNQLLHGLE--HCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLAN 279
+ IK ++ QL+ + H S V HRDIK N+LVN G LKL DFG A
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 339
+ +P + + + +YR PEL+ G Y +VD+WSVGC+FAE+++G+PI +G
Sbjct: 181 KLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ---QPYDSSLRETFKDLPTTAVNLIETL 396
QLH+I ++ G P + +K H + P+ + + A +L+ L
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298
Query: 397 LSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 433
L P +R AL YF + LP
Sbjct: 299 LQYLPEERMKPYEALCHPYFD--ELHDPATKLPNNKD 333
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 2e-96
Identities = 100/334 (29%), Positives = 153/334 (45%), Gaps = 52/334 (15%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+ + + +G G++ V D+++GK ALKKV D R+ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKV 56
Query: 186 LDHPNIIKLEGLITSRLSCS------------------------------------IYLV 209
LDH NIIKL + + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 210 FEYME---HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN- 265
EY+ H + I Y+ QL + HS G+ HRDIK NLLVN
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 266 NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 325
+ LKL DFG A +P + + + +YR PEL+LGAT+Y PS+DLWS+GCVF E
Sbjct: 177 KDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 326 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK-PQQPYDSSLRETF-K 383
L++GKP+ G T ++QL +I ++ G+P + + PH T + P R+ +
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN-PHYTEVRFPTLK-AKDWRKILPE 292
Query: 384 DLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
P+ A++L+E +L EP R A+A +F
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 2e-95
Identities = 93/301 (30%), Positives = 152/301 (50%), Gaps = 23/301 (7%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
D ++ + K+G+G YS VF A ++ + V +K ++ P + + REI IL L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 90
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
PNII L ++ +S + LVFE+ D L ++ I+ YM ++L L++C
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 146
Query: 248 HSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
HS G++HRD+K N+++++E L+L D+GLA F + G Q RV + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVD 204
Query: 307 ATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP-DDYWKKSKLPH 364
Y S+D+WS+GC+ A ++ K P G +QL +I K+ G+ DY K +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 365 ATLFKPQQPYDSSLR-------ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
F S R E + A++ ++ LL + R TA A+ YF
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
Query: 418 T 418
T
Sbjct: 325 T 325
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 7e-91
Identities = 107/315 (33%), Positives = 158/315 (50%), Gaps = 15/315 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
+ L IG+G Y V A D VA+KK+ F++ + REI IL R H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHEN 86
Query: 191 IIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
II + +I + +Y+V + ME D+ LL + S I ++ Q+L GL++
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL--SNDHICYFLYQILRGLKYI 144
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--NFSNTGHRQPLTSRVVTLWYRPPELLL 305
HS VLHRD+K SNLL+N LK+ DFGLA + H LT V T WYR PE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
+ Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I + GSP + A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 366 TLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ P+ + F + + A++L++ +L+ P+KR ALA Y Y
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE--QYY- 321
Query: 424 DLSSLPIYPPSKEID 438
D S PI + D
Sbjct: 322 DPSDEPIAEAPFKFD 336
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 1e-90
Identities = 107/303 (35%), Positives = 161/303 (53%), Gaps = 22/303 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ L+ +G G VF A D D K VA+KK+ + P+SV+ REI I+RRLDH NI
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNI 70
Query: 192 IKLEGLITSRLSCS------------IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
+K+ ++ S +Y+V EYME D+ +L + E + +M Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL--LEEHARLFMYQ 128
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA--NFSNTGHRQPLTSRVVTL 296
LL GL++ HS VLHRD+K +NL +N E VLK+ DFGLA + H+ L+ +VT
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
WYR P LLL +Y ++D+W+ GC+FAE+L GK + G E+EQ+ I + ++
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 357 WKK--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
++ S +P +P L + + AV+ +E +L+ P R TA AL+
Sbjct: 249 RQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307
Query: 415 YFS 417
Y S
Sbjct: 308 YMS 310
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-90
Identities = 103/377 (27%), Positives = 162/377 (42%), Gaps = 78/377 (20%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESV--RFMAREILILRRLDHP 189
+E IG G+Y V A D ++VA+KK+ FE R + REI IL RL+H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKR-ILREIAILNRLNHD 112
Query: 190 NIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
+++K+ ++ + +Y+V E + D L P + +E IK + LL G+++
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKY 171
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--------------------------NF 280
HS G+LHRD+K +N LVN + +K+ DFGLA
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-----------IG 329
++ LT VVT WYR PEL+L +Y ++D+WS+GC+FAELL
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
Query: 330 KPILQG--------------------RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
P+ G R +QL+ IF + G+P ++ + + A +
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI 351
Query: 370 PQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSS 427
P L E F A++L++ +L P KR T + LA +F
Sbjct: 352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK---------- 401
Query: 428 LPIYPPSKEIDAKHRED 444
+ E +A +
Sbjct: 402 -EVRIAEVETNATEKVR 417
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 2e-89
Identities = 105/321 (32%), Positives = 165/321 (51%), Gaps = 28/321 (8%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
+ +G G Y SV A D +G+ VA+KK+ F + + RE+L+L+ + H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHE 83
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T S YLV +M+ D+ ++ FSE +I+ + Q+L GL+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLK 140
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HS GV+HRD+K NL VN + LK+ DFGLA ++ +T VVT WYR PE++L
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVIL 196
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD+WSVGC+ AE+L GK + +G+ ++QL +I K+ G P ++ +K A
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256
Query: 366 TLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ P + F A +L+E +L ++ KR TA+ AL +F
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE------ 310
Query: 424 DLSSLPIYPPSKEIDAKHRED 444
P P +E +A+ D
Sbjct: 311 -----PFRDPEEETEAQQPFD 326
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 2e-89
Identities = 98/302 (32%), Positives = 151/302 (50%), Gaps = 20/302 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
F+ +G+G Y V A TG+IVA+KK+ FD P REI IL+ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHEN 70
Query: 191 IIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
II + + + +Y++ E M+ D+ ++S + S+ I+ ++ Q L ++
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML--SDDHIQYFIYQTLRAVKVL 128
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------NFSNTGHRQPLTSRVVTLWY 298
H V+HRD+K SNLL+N+ LK+ DFGLA N TG + + V T WY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
R PE++L + Y ++D+WS GC+ AEL + +PI GR QL IF + G+P D
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 359 KS-KLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
+ + P A + P L + F + ++L++ +L +P KR TA AL Y
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 416 FS 417
Sbjct: 309 LQ 310
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 7e-89
Identities = 100/310 (32%), Positives = 159/310 (51%), Gaps = 19/310 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
+ L+ +G G Y +V A D TG VA+KK+ F + + RE+ +L+ + H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHE 84
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T + YLV +M D+ L+ K E +I+ + Q+L GL
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 142
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ H+ G++HRD+K NL VN + LK+ DFGLA +++ +T VVT WYR PE++L
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVIL 198
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD+WSVGC+ AE++ GK + +G ++QL +I K+ G+PP ++ ++ + A
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 366 TLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ P + AVNL+E +L ++ +R TA ALA YF
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE--SLH- 315
Query: 424 DLSSLPIYPP 433
D P
Sbjct: 316 DTEDEPQVQK 325
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 2e-88
Identities = 84/302 (27%), Positives = 128/302 (42%), Gaps = 20/302 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR-FMA--------REILI 182
+ I G+Y +V D G VA+K+V + +V REI +
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 183 LRRLDHPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
L HPNI+ L + + +YLV E M D+ ++ I S I+ +M
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
+L GL H GV+HRD+ N+L+ + + + DF LA T V WYR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYR 200
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PEL++ + VD+WS GCV AE+ K + +G T QL+KI ++ G+P +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 360 SKLPHATLF----KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
P A + P + A++LI +L P +R + AL Y
Sbjct: 261 FSSPSARDYLRNSLSNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319
Query: 416 FS 417
F
Sbjct: 320 FE 321
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 5e-88
Identities = 103/310 (33%), Positives = 158/310 (50%), Gaps = 19/310 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
++ L +G G Y SV A D TG VA+KK+ F + + RE+ +L+ + H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHE 88
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T S +YLV M D+ ++ C + ++ ++ + Q+L GL+
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLK 146
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HS ++HRD+K SNL VN + LK+ DFGLA + +T V T WYR PE++L
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVATRWYRAPEIML 202
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P + KK A
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262
Query: 366 TLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ + F AV+L+E +L ++ KR TA+ ALA YF+ Y
Sbjct: 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA--QYH- 319
Query: 424 DLSSLPIYPP 433
D P+ P
Sbjct: 320 DPDDEPVADP 329
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 8e-85
Identities = 99/342 (28%), Positives = 169/342 (49%), Gaps = 46/342 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRL-DHP 189
+E ++K+G+G Y V+++ D TG++VA+KK+ FD F+ + REI+IL L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
NI+ L ++ + +YLVF+YME D+ ++ + + + QL+ +++ HS
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL--EPVHKQYVVYQLIKVIKYLHS 127
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA--------------------NFSNTGHRQPL 289
G+LHRD+K SN+L+N E +K+ADFGL+ + + L
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349
T V T WYR PE+LLG+T Y +D+WS+GC+ E+L GKPI G + + QL +I +
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247
Query: 350 GSPPDDYW----------------KKSKLPHATLFKPQQPYDSSLRETFKDLPTT--AVN 391
P ++ +K ++ + + + L + A++
Sbjct: 248 DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307
Query: 392 LIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 433
L++ LL P KR +A+ AL + S + + + P
Sbjct: 308 LLDKLLQFNPNKRISANDALKHPFVS--IFH-NPNEEPNCDH 346
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 6e-84
Identities = 90/330 (27%), Positives = 158/330 (47%), Gaps = 38/330 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
++ L+ IG G V A D + VA+KK+ F N + RE+++++ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHK 84
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
NII L + T + S +Y+V E M+ ++ ++ ++ + Q+L G++
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIK 141
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++L
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL 199
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK------ 359
G Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P ++ KK
Sbjct: 200 G-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258
Query: 360 ---SKLPHATLFKPQQPYDS--------SLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
P ++ + E K + A +L+ +L ++ KR +
Sbjct: 259 TYVENRPK----YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 409 AALASEYFSTKPYACDLSSLPIYPPSKEID 438
AL Y + + D S PP
Sbjct: 315 EALQHPYIN--VWY-DPSEAEAPPPKIPDK 341
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 7e-83
Identities = 107/368 (29%), Positives = 159/368 (43%), Gaps = 68/368 (18%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPN 190
+ IG+G+Y V+ A D +T K VA+KKV FE + + REI IL RL
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLIDCKRILREITILNRLKSDY 86
Query: 191 IIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
II+L LI +Y+V E + D+ L P I +E IK + LL G
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFI 145
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------------------NFSNTGHR 286
H G++HRD+K +N L+N + +K+ DFGLA N +
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-----------KPILQG 335
+ LTS VVT WYR PEL+L +Y S+D+WS GC+FAELL P+ G
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265
Query: 336 -----------------RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS-- 376
++ +QL+ IF + G+P +D K P + P+
Sbjct: 266 SSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPI 325
Query: 377 SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKE 436
+L++ + + +NL+E++L P KR T AL Y + E
Sbjct: 326 NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK-----------DVRKKKLE 374
Query: 437 IDAKHRED 444
+ +
Sbjct: 375 NFSTKKII 382
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 260 bits (665), Expect = 7e-82
Identities = 91/327 (27%), Positives = 160/327 (48%), Gaps = 38/327 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
++ L+ IG G V A D + VA+KK+ F N + RE+++++ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHK 121
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
NII L + T + + +YLV E M+ ++ ++ ++ + Q+L G++
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIK 178
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++L
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL 236
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK------ 359
G Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P ++ KK
Sbjct: 237 G-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295
Query: 360 ---SKLPHATLFKPQQPYDS--------SLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
P + + E K + A +L+ +L ++P KR +
Sbjct: 296 NYVENRPK----YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 409 AALASEYFSTKPYACDLSSLPIYPPSK 435
AL Y + + D + + PP
Sbjct: 352 DALQHPYIN--VWY-DPAEVEAPPPQI 375
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-66
Identities = 68/303 (22%), Positives = 119/303 (39%), Gaps = 46/303 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN- 190
+ L++IG G S VF+ + + +I A+K V + + +++ EI L +L +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 191 -IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
II+L + IY+V E D+ L + K Y +L + H
Sbjct: 89 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLGA- 307
G++H D+K +N L+ + G+LKL DFG+AN S+V T+ Y PPE +
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 308 ---------TDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYW 357
+ P D+WS+GC+ + GK Q + +LH I + ++
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PNHEIEFP 262
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
++++ L +P +R + LA Y
Sbjct: 263 -------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
Query: 418 TKP 420
+
Sbjct: 298 IQT 300
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 6e-66
Identities = 68/313 (21%), Positives = 129/313 (41%), Gaps = 55/313 (17%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
FE++ +GQG + V +AR+ + A+KK+R + ++ E+++L L+H +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASLNHQYV 64
Query: 192 IKL-----------EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQ 239
++ + + + ++++ EY E + L+ ++ + Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFSNTGHR 286
+L L + HS+G++HRD+K N+ ++ +K+ DFGLA + + G
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 346
LTS + T Y E+L G Y +D++S+G +F E++ P G V L K+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLR 242
Query: 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
+ P D+ + +I L+ +P KR
Sbjct: 243 SVSIEFPPDFD-------------------------DNKMKVEKKIIRLLIDHDPNKRPG 277
Query: 407 ASAALASEYFSTK 419
A L S + K
Sbjct: 278 ARTLLNSGWLPVK 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-65
Identities = 72/354 (20%), Positives = 132/354 (37%), Gaps = 46/354 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN- 190
+ L++IG G S VF+ + + +I A+K V + + +++ EI L +L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 191 -IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
II+L + IY+V E D+ L + K Y +L + H
Sbjct: 70 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLG-- 306
G++H D+K +N L+ + G+LKL DFG+AN S+V T+ Y PPE +
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 307 --------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYW 357
+ P D+WS+GC+ + GK Q + +LH I + ++
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PNHEIEFP 243
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
++++ L +P +R + LA Y
Sbjct: 244 DI-------------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
Query: 418 TKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSK 471
+ + + + K + + + + + +SH S
Sbjct: 279 IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 332
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 1e-64
Identities = 72/354 (20%), Positives = 129/354 (36%), Gaps = 46/354 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN- 190
+ L++IG G S VF+ + + +I A+K V + + +++ EI L +L +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 191 -IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
II+L + IY+V E D+ L + K Y +L + H
Sbjct: 117 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
G++H D+K +N L+ + G+LKL DFG+AN S+V + Y PPE + +
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 309 D----------YGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYW 357
P D+WS+GC+ + GK Q + +LH I
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE---- 288
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
P ++++ L +P +R + LA Y
Sbjct: 289 ----FP-------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
Query: 418 TKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSK 471
+ + + + K + + + + + +SH S
Sbjct: 326 IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 379
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-62
Identities = 79/300 (26%), Positives = 129/300 (43%), Gaps = 39/300 (13%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
P RA+ +E L IG G+Y + R GKI+ K++ + + + + E+ +LR
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL---SCPDIKFSEAQIKCYMNQLL 241
L HPNI++ I R + ++Y+V EY E D+ ++ + E + M QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 242 HGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
L+ CH R VLHRD+K +N+ ++ + +KL DFGLA N + V T
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTP 180
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
+Y PE + Y D+WS+GC+ EL P ++ E KI + G
Sbjct: 181 YYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFR--- 234
Query: 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
++P Y L +I +L+++ Y R + L +
Sbjct: 235 ----RIP--------YRYSDELN-----------EIITRMLNLKDYHRPSVEEILENPLI 271
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-62
Identities = 70/301 (23%), Positives = 118/301 (39%), Gaps = 25/301 (8%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + +GQG ++VFR R TG + A+K +F M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCP--DIKFSEAQIKCYMNQLLHGLEH 246
NI+KL + + L+ E+ + +L P E++ + ++ G+ H
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 247 CHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
G++HR+IK N++ + + V KL DFG A + S T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPD 185
Query: 303 LLLGATD-------YGPSVDLWSVGCVFAELLIGKP----ILQGRTEVEQLHKIFKLCGS 351
+ A YG +VDLWS+G F G R E ++KI S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+K++ + P SL + L ++ +L + K
Sbjct: 246 GAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQEKCWGFDQFF 301
Query: 412 A 412
A
Sbjct: 302 A 302
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 9e-61
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 40/293 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
+F++L ++G G+Y VF+ R + G++ A+K+ P+ E+ ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
P ++LE +YL E + EAQ+ Y+ L L H H
Sbjct: 117 PCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
S+G++H D+K +N+ + G KL DFGL G + + Y PELL G
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE---VQEGDPRYMAPELLQG- 230
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
YG + D++S+G E+ + E ++ + G P ++
Sbjct: 231 -SYGTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQ--GYLPPEFTAG-------- 276
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
S LR +++ +L +P RATA A LA +P
Sbjct: 277 ------LSSELR-----------SVLVMMLEPDPKLRATAEALLALPVL-RQP 311
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-60
Identities = 67/298 (22%), Positives = 115/298 (38%), Gaps = 29/298 (9%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + +GQG ++VFR R TG + A+K +F M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
NI+KL + + L+ E+ + + E++ + ++ G+
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY--GLPESEFLIVLRDVVGGM 125
Query: 245 EHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
H G++HR+IK N++ + + V KL DFG A + S T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLH 183
Query: 301 PELLLGATD-------YGPSVDLWSVGCVFAELLIGKP----ILQGRTEVEQLHKIFKLC 349
P++ A YG +VDLWS+G F G R E ++KI
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
S +K++ + P SL + L ++ +L + K
Sbjct: 244 PSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQEKCWGF 297
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-60
Identities = 75/348 (21%), Positives = 139/348 (39%), Gaps = 39/348 (11%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + +L+KIG+G++ + + G+ +K++ + RE+ +L + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHC 247
NI++ S+Y+V +Y E D+ ++ + F E QI + Q+ L+H
Sbjct: 84 NIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLG 306
H R +LHRDIK N+ + +G ++L DFG+A ++T + + T +Y PE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL--ARACIGTPYYLSPEICEN 199
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
Y D+W++GCV EL K + + + KI GS P +
Sbjct: 200 -KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFP-------PVS--- 246
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS 426
Y LR +L+ L P R + ++ L + + +
Sbjct: 247 -----LHYSYDLR-----------SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSP 290
Query: 427 SLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAP 474
L + +K K R + + + ++K A
Sbjct: 291 QLIAEEFCLKTFSKFGSQPIPAK---RPASGQNSISVMPAQKITKPAA 335
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-60
Identities = 71/305 (23%), Positives = 123/305 (40%), Gaps = 60/305 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F+++E IG G + VF+A+ GK +K+V+++N E RE+ L +LDH NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAE---REVKALAKLDHVNI 66
Query: 192 IKL--------------EGLITSRLSCSIYLVFEYMEH-DITGLLS-CPDIKFSEAQIKC 235
+ + + +++ E+ + + + K +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVV 294
Q+ G+++ HS+ +++RD+K SN+ + + +K+ DFGL + N G R T
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKG 183
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
TL Y PE + DYG VDL+++G + AELL T E L
Sbjct: 184 TLRYMSPEQISS-QDYGKEVDLYALGLILAELLHV-----CDTAFETSKFFTDL------ 231
Query: 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
+ + +D + L++ LLS +P R S L +
Sbjct: 232 ---RDGIIS--------DIFDKKEK-----------TLLQKLLSKKPEDRPNTSEILRTL 269
Query: 415 YFSTK 419
K
Sbjct: 270 TVWKK 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 7e-58
Identities = 81/290 (27%), Positives = 118/290 (40%), Gaps = 40/290 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
F +KIG+G +S V+RA L G VALKKV+ + R +EI +L++L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
PN+IK + +V E + + E + Y QL L
Sbjct: 92 PNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPEL 303
EH HSR V+HRDIK +N+ + GV+KL D GL FS+ S V T +Y PE
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPER 207
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQL-HKIFKLCGSPPDDYWKKSK 361
+ Y D+WS+GC+ E+ + G + L KI + P
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--CDYPP------- 257
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
P Y LR L+ ++ +P KR +
Sbjct: 258 -------LPSDHYSEELR-----------QLVNMCINPDPEKRPDVTYVY 289
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 9e-57
Identities = 72/311 (23%), Positives = 119/311 (38%), Gaps = 19/311 (6%)
Query: 118 GEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA 177
G +E E++G G + V R DTG+ VA+K+ R + P++
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWC 60
Query: 178 REILILRRLDHPNIIKL----EGLITSRLSCSIYLVFEYMEH-DITGLLSCPD--IKFSE 230
EI I+++L+HPN++ +GL + L EY E D+ L+ + E
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQ 287
I+ ++ + L + H ++HRD+K N+++ + K+ D G A + G +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--E 178
Query: 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
T V TL Y PELL Y +VD WS G + E + G + Q H +
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 348 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
+ L A F P + L ++ +L +R T
Sbjct: 238 --EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK---LERWLQCMLMWHQRQRGTD 292
Query: 408 SAALASEYFST 418
F
Sbjct: 293 PQNPNVGCFQA 303
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-56
Identities = 79/291 (27%), Positives = 131/291 (45%), Gaps = 46/291 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +++++K+G G Y V RD T A+K +R + S + E+ +L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLHG 243
NI+KL + + YLV E G L +I KF+E + Q+L G
Sbjct: 97 NIMKLYDFFEDKR--NYYLVMECY----KGGELFD--EIIHRMKFNEVDAAVIIKQVLSG 148
Query: 244 LEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ + H ++HRD+K NLL+ + + ++K+ DFGL+ + + R+ T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIA 206
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PE+L Y D+WS+G + LL G P G+T+ E L K+ K + WK
Sbjct: 207 PEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN- 263
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+ A +LI+ +L + +R +A AL
Sbjct: 264 ------------------------VSEGAKDLIKQMLQFDSQRRISAQQAL 290
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 7e-56
Identities = 68/312 (21%), Positives = 125/312 (40%), Gaps = 58/312 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
FE ++ +G+G + VF A++ A+K++R N E + M RE+ L +L+HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKLEHP 63
Query: 190 NIIK----------LEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQIKCY 236
I++ E L S +Y+ + ++ ++ C + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----------NFSNTGH 285
Q+ +E HS+G++HRD+K SN+ + V+K+ DFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
T +V T Y PE + G Y VD++S+G + ELL P T++E++ +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PF---STQMERVRTL 237
Query: 346 FKLC-GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ P + +K +++ +LS P +R
Sbjct: 238 TDVRNLKFPPLFTQKYP--------------------------CEYVMVQDMLSPSPMER 271
Query: 405 ATASAALASEYF 416
A + + F
Sbjct: 272 PEAINIIENAVF 283
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 9e-56
Identities = 83/340 (24%), Positives = 138/340 (40%), Gaps = 59/340 (17%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-MAREILILR 184
P + + +G+G ++ F D DT ++ A K V R M+ EI I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----DI-----KFSEAQIK 234
L H +++ G +++V E C ++ +E + +
Sbjct: 97 SLAHQHVVGFHGFFEDNDF--VFVVLEL----------CRRRSLLELHKRRKALTEPEAR 144
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQPLTSRV 293
Y+ Q++ G ++ H V+HRD+K NL +N + +K+ DFGLA G R
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLC 202
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
T Y PE+L + VD+WS+GC+ LL+GKP + E +I K
Sbjct: 203 GTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 256
Query: 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
+Y +P K + A +LI+ +L +P R T + L
Sbjct: 257 -EY----SIP-------------------KHINPVAASLIQKMLQTDPTARPTINELLND 292
Query: 414 EYFST--KPYACDLSSLPIYPPSKEIDAKHREDARRKKVG 451
E+F++ P ++ L I PP I + + RK +
Sbjct: 293 EFFTSGYIPARLPITCLTI-PPRFSIAPSSLDPSNRKPLT 331
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-55
Identities = 72/291 (24%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + + +G+G++ V + +D T + A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLHG 243
NI+KL ++ S Y+V E TG L +I +FSE + Q+ G
Sbjct: 82 NIMKLFEILEDSS--SFYIVGELY----TGGELFD--EIIKRKRFSEHDAARIIKQVFSG 133
Query: 244 LEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ + H ++HRD+K N+L+ + + +K+ DFGL+ + R+ T +Y
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIA 191
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PE+L G Y D+WS G + LL G P G+ E + L ++ + W+
Sbjct: 192 PEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT- 248
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+ A +LI +L+ P R TA+ L
Sbjct: 249 ------------------------ISDDAKDLIRKMLTFHPSLRITATQCL 275
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-55
Identities = 70/287 (24%), Positives = 111/287 (38%), Gaps = 51/287 (17%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++G+G++ V R +D TG A+KKVR + F E E++ L P I
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRI 112
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLLHGLEH 246
+ L G + +I++ E +E G S + E + Y+ Q L GLE+
Sbjct: 113 VPLYGAVREGPWVNIFM--ELLE---GG--SLGQLIKQMGCLPEDRALYYLGQALEGLEY 165
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVL-KLADFG----LANFSNTGHRQPLTSRVVTLWYRPP 301
H+R +LH D+K N+L++++G L DFG L T + P
Sbjct: 166 LHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
E+++G VD+WS C+ +L G T+ + K+ PP
Sbjct: 226 EVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW---TQYFRGPLCLKIASEPP-------- 273
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
P + S I+ L EP RA+A
Sbjct: 274 --------PIREIPPSCAPLTAQ-------AIQEGLRKEPVHRASAM 305
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 6e-55
Identities = 80/311 (25%), Positives = 133/311 (42%), Gaps = 47/311 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDH 188
D ++ +G+G++ V +D TG+ A+K + + + RE+ +L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLH 242
PNI+KL + YLV E G L +I +FSE + Q+L
Sbjct: 86 PNIMKLYEFFEDKGY--FYLVGEVYT----GGELFD--EIISRKRFSEVDAARIIRQVLS 137
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
G+ + H ++HRD+K NLL+ + + +++ DFGL+ + + ++ T +Y
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYI 195
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE+L G Y D+WS G + LL G P G E + L K+ K + WKK
Sbjct: 196 APEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419
+ +A +LI +L+ P R +A AL E+ T
Sbjct: 254 -------------------------VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288
Query: 420 PYACDLSSLPI 430
+P
Sbjct: 289 TKEQISVDVPS 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 7e-55
Identities = 62/293 (21%), Positives = 114/293 (38%), Gaps = 44/293 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ ++K+G+G +S V L G ALK++ + RE + R +HPNI
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNI 88
Query: 192 IKLEG--LITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
++L L +L+ + + + L +E QI + + GLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--------QPLTSRVVTLW 297
H++G HRD+K +N+L+ +EG L D G N + Q ++ T+
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 298 YRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
YR PEL D+WS+GCV ++ G+ + + +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-AVQN----- 262
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
+ +P + S+L L+ ++++V+P++R
Sbjct: 263 ---QLSIP------QSPRHSSALW-----------QLLNSMMTVDPHQRPHIP 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-54
Identities = 79/322 (24%), Positives = 131/322 (40%), Gaps = 58/322 (18%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-MAREILILR 184
P + + +G+G ++ F D DT ++ A K V R M+ EI I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----DI-----KFSEAQIK 234
L H +++ G +++V E C ++ +E + +
Sbjct: 71 SLAHQHVVGFHGFFEDNDF--VFVVLEL----------CRRRSLLELHKRRKALTEPEAR 118
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQPLTSRV 293
Y+ Q++ G ++ H V+HRD+K NL +N + +K+ DFGLA G R
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLC 176
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
T Y PE+L + VD+WS+GC+ LL+GKP + E +I K
Sbjct: 177 GTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 230
Query: 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
+Y +P K + A +LI+ +L +P R T + L
Sbjct: 231 -EY----SIP-------------------KHINPVAASLIQKMLQTDPTARPTINELLND 266
Query: 414 EYFST--KPYACDLSSLPIYPP 433
E+F++ P ++ L I P
Sbjct: 267 EFFTSGYIPARLPITCLTIPPR 288
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-54
Identities = 82/323 (25%), Positives = 131/323 (40%), Gaps = 57/323 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-----------FDNFEPESVRFMAR 178
+++ K+ K+G G Y V ++ + A+K ++ + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQ 232
EI +L+ LDHPNIIKL + + YLV E+ G L I KF E
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKY--FYLVTEFY----EGGELFE--QIINRHKFDECD 147
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPL 289
M Q+L G+ + H ++HRDIK N+L+ N +K+ DFGL++F + L
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKL 205
Query: 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349
R+ T +Y PE+L Y D+WS G + LL G P G+ + + + K+ K
Sbjct: 206 RDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263
Query: 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409
+ WK + A LI+ +L+ + KR TA
Sbjct: 264 YYFDFNDWKN-------------------------ISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 410 ALASEYFSTKPYACDLSSLPIYP 432
AL S + + S
Sbjct: 299 ALNSRWIKKYANNINKSDQKTLC 321
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-54
Identities = 71/296 (23%), Positives = 126/296 (42%), Gaps = 54/296 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + + +G+G++ V + +D T + A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKCYMNQLLH 242
NI+KL ++ S Y+V E +I +FSE + Q+
Sbjct: 82 NIMKLFEILEDSS--SFYIVGELYTGGELFDEIIKRK-------RFSEHDAARIIKQVFS 132
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
G+ + H ++HRD+K N+L+ ++ +K+ DFGL+ + R+ T +Y
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYI 190
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYW 357
PE+L G Y D+WS G + LL G P G+ E + L ++ G W
Sbjct: 191 APEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQW 246
Query: 358 KK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ S A +LI +L+ P R TA+ L
Sbjct: 247 RTISD--------------------------DAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 7e-54
Identities = 82/296 (27%), Positives = 124/296 (41%), Gaps = 53/296 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ E++G+G +S V R TG A K + + + RE I R+L HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKCYMNQLLH 242
NI++L I YLVF+ + DI +SEA + Q+L
Sbjct: 66 NIVRLHDSIQEE--SFHYLVFDLVTGGELFEDIVARE-------FYSEADASHCIQQILE 116
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
+ +CHS G++HR++K NLL+ ++ +KLADFGLA N + T Y
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYL 174
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYW 357
PE+L Y VD+W+ G + LL+G P + +I G+ P W
Sbjct: 175 SPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEW 231
Query: 358 KK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ A +LI+++L+V P KR TA AL
Sbjct: 232 DTVTP--------------------------EAKSLIDSMLTVNPKKRITADQALK 261
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-53
Identities = 62/296 (20%), Positives = 108/296 (36%), Gaps = 45/296 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPN 190
F + +G G ++ R + + VA+K++ PE F RE+ +LR D HPN
Sbjct: 26 FCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHPN 79
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+I+ R Y+ E + + D + + Q GL H HS
Sbjct: 80 VIRYFCTEKDRQF--QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 251 GVLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPEL 303
++HRD+K N+L++ ++DFGL G + T + PE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 304 LLGATD--YGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
L +VD++S GCVF ++ G + + + +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ A LIE +++++P KR +A L +F
Sbjct: 258 VI--------------------------ARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-53
Identities = 55/348 (15%), Positives = 92/348 (26%), Gaps = 66/348 (18%)
Query: 110 PAWLSAVAGEAIQGWVPLRADA--------FEKLEKIGQGTYSSVFRARDLDTGKIVALK 161
A + AV D+ + +E + G S VF RD++ + ALK
Sbjct: 34 AAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALK 93
Query: 162 KVRFDNFEPES-VRFMAREILILRRLDHPN------------------------IIKLEG 196
S + + RL + +L
Sbjct: 94 VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSP 153
Query: 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDI------KFSEAQIKCYMNQLLHGLEHCHSR 250
+ L+ D+ L S D + QL+ + S+
Sbjct: 154 GQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK 213
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATD 309
G++H NL + +G L L D T + V + Y P E L
Sbjct: 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTAT 269
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-DDYWKKSKLPHATLF 368
+ +++ W +G + C P K
Sbjct: 270 FTHALNAWQLGLSIYRV---------------------WCLFLPFGLVTPGIKGSWKRPS 308
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
DS + LP LI L+ + +R A+ + F
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-53
Identities = 64/338 (18%), Positives = 123/338 (36%), Gaps = 49/338 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMA----------- 177
+ + + QG ++ + K ALK K + +
Sbjct: 33 YRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 178 -REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME--------HDITGLLSCPDIKF 228
E+ I+ + + + EG+IT+ +Y+++EYME L
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 229 SEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
IKC + +L+ + H+ + + HRD+K SN+L++ G +KL+DFG + + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 288 PLTSRVVTLWYRPPELLLGATDY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH-KI 345
S T + PPE + Y G VD+WS+G + + + +L I
Sbjct: 209 --GS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 405
+ + P + + L ++ ++ L P +R
Sbjct: 266 RT------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 406 TASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRE 443
T+ AL E+ + + SKE+ K ++
Sbjct: 316 TSEDALKHEWLADTNIE------DLREFSKELYKKRKK 347
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 82/299 (27%), Positives = 137/299 (45%), Gaps = 35/299 (11%)
Query: 120 AIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-MAR 178
++ + + + F+ +G+G+++ V+RA + TG VA+K + + +
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYM 237
E+ I +L HP+I++L S +YLV E + ++ L FSE + + +M
Sbjct: 61 EVKIHCQLKHPSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
+Q++ G+ + HS G+LHRD+ SNLL+ +K+ADFGLA H + T T
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPN 177
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357
Y PE+ + +G D+WS+GC+F LLIG+P T L+K+ DY
Sbjct: 178 YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------DY- 229
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
++P L A +LI LL P R + S+ L +
Sbjct: 230 ---EMP-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 7e-53
Identities = 57/308 (18%), Positives = 109/308 (35%), Gaps = 62/308 (20%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPN 190
F +LEKIG G + SVF+ G I A+K+ + + RE+ L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK---FSEAQIKCYMNQLLHGLEH 246
+++ + + EY + +S F EA++K + Q+ GL +
Sbjct: 73 VVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVL-------------------KLADFGLANFSNTGHRQ 287
HS ++H DIK SN+ ++ + K+ D G
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV-----TRIS 185
Query: 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
+ E+L + P D++++ +P+ + +Q H+I +
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR---NGDQWHEIRQ 242
Query: 348 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
G P +P L + F + L++ ++ +P +R +A
Sbjct: 243 --GRLPR-------IP------------QVLSQEFTE-------LLKVMIHPDPERRPSA 274
Query: 408 SAALASEY 415
A +
Sbjct: 275 MALVKHSV 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-53
Identities = 85/293 (29%), Positives = 132/293 (45%), Gaps = 50/293 (17%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK-----KVRFDNFEPESVRFMAREILILRRL 186
FE +G+G + +V+ AR+ + I+ALK ++ E +R RE+ I L
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLR---REVEIQSHL 66
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHG 243
HPNI++L G + +YL+ EY G + KF E + Y+ +L +
Sbjct: 67 RHPNILRLYGYFHD--ATRVYLILEYAPL---GTVYRELQKLSKFDEQRTATYITELANA 121
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
L +CHS+ V+HRDIK NLL+ + G LK+ADFG + + + R L TL Y PPE+
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEM 178
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
+ G + VDLWS+G + E L+GKP + T E +I ++ ++ P
Sbjct: 179 IEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF----TFP 227
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ A +LI LL P +R L +
Sbjct: 228 -------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 9e-53
Identities = 82/296 (27%), Positives = 124/296 (41%), Gaps = 53/296 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ E++G+G +S V R TG A K + + + RE I R+L HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKCYMNQLLH 242
NI++L I YLVF+ + DI +SEA + Q+L
Sbjct: 89 NIVRLHDSIQEE--SFHYLVFDLVTGGELFEDIVARE-------FYSEADASHCIQQILE 139
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
+ +CHS G++HR++K NLL+ ++ +KLADFGLA N + T Y
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYL 197
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYW 357
PE+L Y VD+W+ G + LL+G P + +I G+ P W
Sbjct: 198 SPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEW 254
Query: 358 KK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ A +LI+++L+V P KR TA AL
Sbjct: 255 DTVTP--------------------------EAKSLIDSMLTVNPKKRITADQALK 284
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-52
Identities = 76/333 (22%), Positives = 117/333 (35%), Gaps = 80/333 (24%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRL 186
+ IGQG+Y V A + T I A+K K + P+ V + E+ ++++L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYME-------------------------------- 214
HPNI +L + I LV E
Sbjct: 86 HHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 215 --------HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-- 264
I G D E I M Q+ L + H++G+ HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 265 NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELLLGATD-YGPSVDLWSVG 320
N +KL DFGL+ N G +T++ T ++ PE+L + YGP D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 321 CVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYWKKSKLPHATLFKPQQPYDSSL 378
+ LL+G G + + + ++ + +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNY--------------------- 300
Query: 379 RETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
L A +L+ LL+ +R A AL
Sbjct: 301 ----NVLSPLARDLLSNLLNRNVDERFDAMRAL 329
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 4e-52
Identities = 74/319 (23%), Positives = 128/319 (40%), Gaps = 56/319 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV------RFDNFEPESVRFMAREILIL 183
D + + +G G V A + T K VA+K + E + + EI IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKCY 236
++L+HP IIK++ + Y+V E ME + + EA K Y
Sbjct: 70 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-------RLKEATCKLY 119
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 293
Q+L +++ H G++HRD+K N+L++++ ++K+ DFG + + +
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC 177
Query: 294 VTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCG 350
T Y PE+L+ Y +VD WS+G + L G P + RT+V +I
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 410
+ + W ++ A++L++ LL V+P R T A
Sbjct: 238 NFIPEVW-------------------------AEVSEKALDLVKKLLVVDPKARFTTEEA 272
Query: 411 LASEYFSTKPYACDLSSLP 429
L + + L
Sbjct: 273 LRHPWLQDEDMKRKFQDLL 291
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 5e-52
Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 54/297 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRL 186
+ ++ E++G+G +S V R + G+ A + + + + RE I R L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLL 67
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLL 241
HPNI++L I+ YL+F+ + DI +SEA + Q+L
Sbjct: 68 KHPNIVRLHDSISEEG--HHYLIFDLVTGGELFEDI-----VAREYYSEADASHCIQQIL 120
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+ HCH GV+HR++K NLL+ ++ +KLADFGLA G +Q T Y
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGY 179
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDY 356
PE+L YG VDLW+ G + LL+G P + +I G+ P
Sbjct: 180 LSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPE 236
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
W + A +LI +L++ P KR TA+ AL
Sbjct: 237 WDTVTP--------------------------EAKDLINKMLTINPSKRITAAEALK 267
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 9e-52
Identities = 78/287 (27%), Positives = 123/287 (42%), Gaps = 50/287 (17%)
Query: 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIK 193
+G+GTY V+ RDL +A+K++ + + + EI + + L H NI++
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 194 LEGLITSRLSCSIYLVFEYMEHD-ITGLL--SCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
G + I++ E + ++ LL +K +E I Y Q+L GL++ H
Sbjct: 84 YLGSFSENGFIKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 251 GVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
++HRDIKG N+L+N GVLK++DFG + G + TL Y PE++
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 310 -YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
YG + D+WS+GC E+ GKP P + + P A +F
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKP--------------------P----FYELGEPQAAMF 236
Query: 369 K-------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
K P+ P S K I +P KRA A+
Sbjct: 237 KVGMFKVHPEIPESMS--AEAKA-------FILKCFEPDPDKRACAN 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-51
Identities = 70/293 (23%), Positives = 116/293 (39%), Gaps = 46/293 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV--RFDNFEPESVRFMAREILILRRLD 187
D F K+G G + V + +G +K + E + EI +L+ LD
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE---AEIEVLKSLD 78
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLH 242
HPNIIK+ + + +Y+V E E I + SE + M Q+++
Sbjct: 79 HPNIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMN 135
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
L + HS+ V+H+D+K N+L + +K+ DFGLA + + T+ T Y
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYM 193
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE+ D D+WS G V LL G G + E K
Sbjct: 194 APEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------------TY 239
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ + + L AV+L++ +L+ +P +R +A+ L
Sbjct: 240 KEP--------------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 2e-51
Identities = 78/373 (20%), Positives = 134/373 (35%), Gaps = 59/373 (15%)
Query: 129 ADAFEKLEKIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
+E L IG+G +V AR TG+ V ++++ + E V F+ E+ + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 187 DHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI-------KFSEAQIKCYM 237
+HPNI+ + + L ++V +M + G S D+ +E I +
Sbjct: 84 NHPNIVPYRATFIADNEL----WVVTSFMAY---G--SAKDLICTHFMDGMNELAIAYIL 134
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQ-----PLTS 291
+L L++ H G +HR +K S++L++ +G + L+ + + G RQ
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 292 RVVTLWYRPPELLL-GATDYGPSVDLWSVGCVFAELLIGKP-------------ILQGRT 337
V L + PE+L Y D++SVG EL G L G
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 338 -----------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 386
E + + S D S + P PY + F
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH-- 312
Query: 387 TTAVNLIETLLSVEPYKRATASAALASEYF-STKPYACDLSSLPIYPPSKEIDAKHREDA 445
+E L P R +AS L +F K A + + P + + + +
Sbjct: 313 -----FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQ 367
Query: 446 RRKKVGGRVRGAE 458
+ G V E
Sbjct: 368 DHSGIFGLVTNLE 380
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-51
Identities = 74/301 (24%), Positives = 127/301 (42%), Gaps = 56/301 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV------RFDNFEPESVRFMAREILIL 183
D + + +G G V A + T K VA++ + E + + EI IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYM 237
++L+HP IIK++ + Y+V E M G L + + EA K Y
Sbjct: 195 KKLNHPCIIKIKNFFDAE---DYYIVLELM----EGGELFD--KVVGNKRLKEATCKLYF 245
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVV 294
Q+L +++ H G++HRD+K N+L++++ ++K+ DFG + + +
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCG 303
Query: 295 TLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGS 351
T Y PE+L+ Y +VD WS+G + L G P + RT+V +I +
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363
Query: 352 PPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 410
+ W + S+ A++L++ LL V+P R T A
Sbjct: 364 FIPEVWAEVSE--------------------------KALDLVKKLLVVDPKARFTTEEA 397
Query: 411 L 411
L
Sbjct: 398 L 398
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-51
Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 60/305 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVR----FMAREILI 182
+ +E E +G+G S V R T K A+K +F E V+ +E+ I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 183 LRRLD-HPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIK 234
LR++ HPNII+L+ + +LVF+ M+ +T SE + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKV-------TLSEKETR 127
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294
M LL + H ++HRD+K N+L++++ +KL DFG + + G + L
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCG 185
Query: 295 TLWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349
T Y PE++ + + YG VD+WS G + LL G P R ++ L I +
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MS 243
Query: 350 GSP--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
G+ W +T KD L+ L V+P KR TA
Sbjct: 244 GNYQFGSPEWD------------------DYSDTVKD-------LVSRFLVVQPQKRYTA 278
Query: 408 SAALA 412
ALA
Sbjct: 279 EEALA 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-51
Identities = 55/283 (19%), Positives = 106/283 (37%), Gaps = 46/283 (16%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
+IG+G++ +V++ D +T VA +++ + E +L+ L HPNI++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 196 G--LITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLLHGLEHCH 248
T + I LV E M +G + ++ + Q+L GL+ H
Sbjct: 92 DSWESTVKGKKCIVLVTELMT---SG--TLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 249 SRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+R ++HRD+K N+ + G +K+ D GLA + + + T + PE +
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPE--M 201
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y SVD+++ G E+ + Q+++
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------------------V 242
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
T +D K+ +IE + +R +
Sbjct: 243 TSGVKPASFDKVAIPEVKE-------IIEGCIRQNKDERYSIK 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-51
Identities = 76/297 (25%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDH 188
F +E +G G +S VF + TGK+ ALK ++ S+ EI +L+++ H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKH 65
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKCYMNQLL 241
NI+ LE + S YLV + + I G ++E + Q+L
Sbjct: 66 ENIVTLEDIYESTTH--YYLVMQLVSGGELFDRILERG-------VYTEKDASLVIQQVL 116
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+++ H G++HRD+K NLL + + DFGL+ G +++ T Y
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGY 173
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDY 356
PE+L Y +VD WS+G + LL G P TE + KI + G +
Sbjct: 174 VAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYEFESPF 230
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
W S+ +A + I LL +P +R T AL+
Sbjct: 231 WDDISE--------------------------SAKDFICHLLEKDPNERYTCEKALS 261
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-51
Identities = 86/307 (28%), Positives = 123/307 (40%), Gaps = 58/307 (18%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKL 194
IG+G++ V A T A KK+ E + + +EI I++ LDHPNII+L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRL 71
Query: 195 EGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
IYLV E + F E+ M +L + +C
Sbjct: 72 YETFEDNTD--IYLVMELCTGGELFERVVHKR-------VFRESDAARIMKDVLSAVAYC 122
Query: 248 HSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
H V HRD+K N L + LKL DFGLA G + + ++V T +Y P++L
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQVL 180
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYWKK-SK 361
G YGP D WS G + LL G P T+ E + KI G+ P+ W S
Sbjct: 181 EG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLNVSP 236
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
A +LI LL+ P +R T+ AL E+F +
Sbjct: 237 --------------------------QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270
Query: 422 ACDLSSL 428
+ + L
Sbjct: 271 SSPRNLL 277
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 5e-51
Identities = 84/319 (26%), Positives = 134/319 (42%), Gaps = 54/319 (16%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALK-----KVRFDNFEPESVRFMAREI 180
D F+ +G+G + +V+ AR+ I+ALK ++ + E +R REI
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQLR---REI 65
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQ 239
I L HPNI+++ R IYL+ E+ ++ L +F E + +M +
Sbjct: 66 EIQSHLRHPNILRMYNYFHDR--KRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEE 122
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
L L +CH R V+HRDIK NLL+ +G LK+ADFG + + + R+ + TL Y
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TLDYL 179
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PPE++ G + VDLW G + E L+G P + E +I + D
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DL--- 229
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF--S 417
K P L + +LI LL P +R + + +
Sbjct: 230 -KFP-------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269
Query: 418 TKPYACDLSSLPIYPPSKE 436
++ LP S +
Sbjct: 270 SRRV------LPPVYQSTQ 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-50
Identities = 73/320 (22%), Positives = 121/320 (37%), Gaps = 62/320 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-H 188
+ + +G G+ +V + G+ VA+K++ D + EI +L D H
Sbjct: 15 NLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDH 68
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYME---HDI---TGLLSCPDIKFSEAQIKCYMNQLLH 242
PN+I+ T+ +Y+ E D+ + E + Q+
Sbjct: 69 PNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGV-------------LKLADFGLANFSNTGH---R 286
G+ H HS ++HRD+K N+LV+ + ++DFGL ++G R
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 287 QPLTSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELL-IGKPILQGRTEV 339
L + T +R PELL + + S+D++S+GCVF +L GK +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 399
E I + L + +D SL D LI ++
Sbjct: 247 ES--NIIR----------GIFSLDE-----MKCLHDRSLIAEATD-------LISQMIDH 282
Query: 400 EPYKRATASAALASEYFSTK 419
+P KR TA L F K
Sbjct: 283 DPLKRPTAMKVLRHPLFWPK 302
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 6e-50
Identities = 82/337 (24%), Positives = 142/337 (42%), Gaps = 67/337 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR----EILILRRL- 186
+E L+ IG+G++ V +A D + VALK VR + + R EI IL L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLR 151
Query: 187 -----DHPNIIKLEGLITSRLSCSIY-----LVFEYMEHDITGLLSCPDIK-FSEAQIKC 235
+ N+I + L + + FE + ++ L+ + FS ++
Sbjct: 152 KQDKDNTMNVIHM-------LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK 204
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHRQPLTSRV 293
+ + +L L+ H ++H D+K N+L+ +G +K+ DFG + + + Q + + +
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----QRVYTYI 260
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
+ +YR PE++LGA YG +D+WS+GC+ AELL G P+L G E +QL + +L G P
Sbjct: 261 QSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319
Query: 354 DDYWKKSK----------LPHATLFKPQQ------PYDSSLRETFKDLPTTA-------- 389
SK P S R + P +
Sbjct: 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 390 ------VNLIETLLSVEPYKRATASAALASEYFSTKP 420
++ ++ L +P R T AL + +
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-49
Identities = 84/304 (27%), Positives = 121/304 (39%), Gaps = 59/304 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK-----KVRFDNFEPESVRFM-AREILIL 183
++ + IG+G S V R TG A+K R + E VR RE IL
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 184 RRL-DHPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKC 235
R++ HP+II L S ++LVF+ M +T SE + +
Sbjct: 154 RQVAGHPHIITLIDSYESSSF--MFLVFDLMRKGELFDYLTEKV-------ALSEKETRS 204
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 295
M LL + H+ ++HRD+K N+L+++ ++L+DFG + G + L T
Sbjct: 205 IMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGT 262
Query: 296 LWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
Y PE+L + D YG VDLW+ G + LL G P R ++ L I + G
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEG 320
Query: 351 SP--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
W T KD LI LL V+P R TA
Sbjct: 321 QYQFSSPEW------------------DDRSSTVKD-------LISRLLQVDPEARLTAE 355
Query: 409 AALA 412
AL
Sbjct: 356 QALQ 359
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-49
Identities = 73/319 (22%), Positives = 128/319 (40%), Gaps = 45/319 (14%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+ D +E E IG G + V A + VA+K++ + + + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 186 LDHPNIIKLEG--LITSRLSCSIYLVFEYME----HDI----TGLLSCPDIKFSEAQIKC 235
HPNI+ ++ L +LV + + DI E+ I
Sbjct: 70 CHHPNIVSYYTSFVVKDEL----WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-SNTGHRQPLTSR-- 292
+ ++L GLE+ H G +HRD+K N+L+ +G +++ADFG++ F + G R
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 293 -VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 351
V T + PE++ Y D+WS G EL G ++ L +
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--ND 243
Query: 352 PPDDYWKKSKLPHATLFKPQQPYDSSLR--ETFKDLPTTAVNLIETLLSVEPYKRATASA 409
PP +L Q + + ++F+ +I L +P KR TA+
Sbjct: 244 PP------------SLETGVQDKEMLKKYGKSFRK-------MISLCLQKDPEKRPTAAE 284
Query: 410 ALASEYFSTKPYACDLSSL 428
L ++F A + L
Sbjct: 285 LLRHKFFQK---AKNKEFL 300
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-49
Identities = 67/296 (22%), Positives = 123/296 (41%), Gaps = 50/296 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRR 185
D ++ E++G G ++ V + R+ TG A K ++ + S + RE+ IL+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQL 240
+ HPN+I L + ++ + L+ E + + +E + ++ Q+
Sbjct: 71 IQHPNVITLHEVYENKTD--VILILELVAGGELFDFLA-----EKESLTEEEATEFLKQI 123
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQPLTSRVVTL 296
L+G+ + HS + H D+K N+++ + +K+ DFGLA+ + G + T
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTP 181
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
+ PE++ G D+WS+G + LL G G T+ E L + + D+Y
Sbjct: 182 EFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+ S L A + I LL +P KR T +L
Sbjct: 241 FSNTSAL--------------------------AKDFIRRLLVKDPKKRMTIQDSL 270
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-49
Identities = 80/299 (26%), Positives = 127/299 (42%), Gaps = 54/299 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRL 186
D +E E IG+G +S V R + +TG+ A+K +F + S + RE I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLL 241
HP+I++L +S +Y+VFE+M+ +I +SEA YM Q+L
Sbjct: 84 KHPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQIL 140
Query: 242 HGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 297
L +CH ++HRD+K +L+ N +KL FG+A +G RV T
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPH 198
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGSP--P 353
+ PE++ YG VD+W G + LL G G E ++F+ + G
Sbjct: 199 FMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMN 252
Query: 354 DDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
W S+ +A +L+ +L ++P +R T AL
Sbjct: 253 PRQWSHISE--------------------------SAKDLVRRMLMLDPAERITVYEAL 285
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 73/297 (24%), Positives = 126/297 (42%), Gaps = 50/297 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFE-PESVRFMAREILILRR 185
D +E E++G G ++ V + R TGK A K K R + S + RE+ ILR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQL 240
+ HPNII L + ++ + L+ E + + +E + ++ Q+
Sbjct: 65 IRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLA-----EKESLTEDEATQFLKQI 117
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHRQPLTSRVVTL 296
L G+ + HS+ + H D+K N+++ ++ V +KL DFG+A+ G + T
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTP 175
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
+ PE++ G D+WS+G + LL G G T+ E L I + ++Y
Sbjct: 176 EFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ S+L A + I LL +P +R T + +L
Sbjct: 235 FSNTSEL--------------------------AKDFIRRLLVKDPKRRMTIAQSLE 265
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-49
Identities = 69/360 (19%), Positives = 124/360 (34%), Gaps = 57/360 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + E +G+G + V R + + K K V+ + V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
NI+ L S + ++FE++ I + +E +I Y++Q+ L
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEAL 115
Query: 245 EHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
+ HS + H DI+ N++ +K+ +FG A G Y PE
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPE 173
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
+ + D+WS+G + LL G T + + I + ++ +
Sbjct: 174 VHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF----- 227
Query: 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422
K++ A++ ++ LL E R TAS AL + K
Sbjct: 228 --------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
Query: 423 CDLSSLPIYPPSKEIDAKHREDARRKKVGGRVR-------GAETRKTTRKSHGMSKLAPV 475
+ + + + KK V G R S K+A +
Sbjct: 268 VSTKVI------RTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVASI 321
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-49
Identities = 71/310 (22%), Positives = 120/310 (38%), Gaps = 60/310 (19%)
Query: 123 GWVPLRADAFEKL----EKIGQGTYSSVFRARDLDTGKIVALK-------KVRFDNFEPE 171
G P + E E++G G ++ V + R+ TG A K + E
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 172 SVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDI 226
+ RE+ ILR++ H N+I L + +R + L+ E + +
Sbjct: 61 EIE---REVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFLA-----QKE 110
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSN 282
SE + ++ Q+L G+ + H++ + H D+K N+++ +KL DFGLA+
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 342
G + T + PE++ G D+WS+G + LL G G T+ E L
Sbjct: 171 DG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227
Query: 343 HKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 401
I + ++++ S+L A + I LL E
Sbjct: 228 ANITSVSYDFDEEFFSHTSEL--------------------------AKDFIRKLLVKET 261
Query: 402 YKRATASAAL 411
KR T AL
Sbjct: 262 RKRLTIQEAL 271
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-49
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 47/292 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDH 188
D ++ LE++G G + V R + TG++ K + +V+ EI I+ +L H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHH 107
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHG 243
P +I L + + L+ E+ ++G ++ D K SEA++ YM Q G
Sbjct: 108 PKLINLHDAFEDKYE--MVLILEF----LSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 244 LEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
L+H H ++H DIK N++ +K+ DFGLA N + + T + P
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAP 219
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-S 360
E++ G D+W++G + LL G G ++E L + + +D + S
Sbjct: 220 EIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
A + I+ LL EP KR T AL
Sbjct: 279 PE--------------------------AKDFIKNLLQKEPRKRLTVHDALE 304
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 50/342 (14%), Positives = 99/342 (28%), Gaps = 81/342 (23%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRL---- 186
+ +GQ + A D +TG+ + F P +++ M E+L LR L
Sbjct: 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134
Query: 187 ---------------------DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL---- 221
+I++ S + ++ M+ ++
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194
Query: 222 --SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279
S Q++ L H G++H ++ +++++ G + L F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELL----------LGATDYGPSVDLWSVGCVFAELLIG 329
V+ + PPEL T S D W++G V +
Sbjct: 255 RDGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 330 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 389
+ + IF+ C K++P
Sbjct: 310 DLPITKDAALGGSEWIFRSC---------------------------------KNIPQPV 336
Query: 390 VNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIY 431
L+E L R A+ + + + ++LP+Y
Sbjct: 337 RALLEGFLRYPKEDRLLPLQAMETPEY-EQLRTELSAALPLY 377
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 76/330 (23%), Positives = 137/330 (41%), Gaps = 51/330 (15%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLD 187
F L +IG G++ +V+ ARD+ ++VA+KK+ + + E + + +E+ L++L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 188 HPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
HPN I+ G L +LV EY + LL E +I + L GL
Sbjct: 113 HPNTIQYRGCYLREHTA----WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR---VVTLWYRPPE 302
+ HS ++HRD+K N+L++ G++KL DFG ++ + V T ++ PE
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFG---SASI-----MAPANSFVGTPYWMAPE 220
Query: 303 LLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
++L + Y VD+WS+G EL KP L + + ++ + +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL---FNMNAMSALYHIAQNES------- 270
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
P L E F++ +++ L P R T+ L +
Sbjct: 271 --P--ALQSGH------WSEYFRN-------FVDSCLQKIPQDRPTSEVLLKHRFVLR-- 311
Query: 421 YACDLSSL-PIYPPSKEIDAKHREDARRKK 449
+ + + +K+ + RK
Sbjct: 312 -ERPPTVIMDLIQRTKDAVRELDNLQYRKM 340
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-48
Identities = 67/293 (22%), Positives = 107/293 (36%), Gaps = 56/293 (19%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKL 194
+ +G G V TG+ ALK + + R +E+ + P+I+ +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKAR---QEVDHHWQASGGPHIVCI 87
Query: 195 EGLI--TSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+ + ++ E ME I D F+E + M + ++
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRI---QERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 248 HSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
HS + HRD+K NLL ++ VLKL DFG A + L + T +Y PE +
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPE-V 200
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGSP--PDDYWKK- 359
LG Y S D+WS+G + LL G P T + + G P+ W +
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
S+ A LI LL +P +R T + +
Sbjct: 261 SE--------------------------DAKQLIRLLLKTDPTERLTITQFMN 287
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-48
Identities = 74/304 (24%), Positives = 115/304 (37%), Gaps = 45/304 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
K E +G G + V + + TG +A K ++ + + EI ++ +LDH N+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANL 148
Query: 192 IKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
I+L S+ I LV EY++ I +E +M Q+ G+ H
Sbjct: 149 IQLYDAFESKND--IVLVMEYVDGGELFDRII----DESYNLTELDTILFMKQICEGIRH 202
Query: 247 CHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
H +LH D+K N+L N +K+ DFGLA + L T + PE++
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVV 260
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLP 363
D+WSVG + LL G G + E L+ I D+ ++ S+
Sbjct: 261 NY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE- 318
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
A I LL E R +AS AL + S
Sbjct: 319 -------------------------AKEFISKLLIKEKSWRISASEALKHPWLSDHKLHS 353
Query: 424 DLSS 427
LS+
Sbjct: 354 RLSA 357
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-48
Identities = 70/296 (23%), Positives = 122/296 (41%), Gaps = 50/296 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRR 185
D ++ E++G G ++ V + R+ TG A K ++ + + RE+ ILR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQL 240
+ HPNII L + +R + L+ E + + SE + ++ Q+
Sbjct: 72 VLHPNIITLHDVYENRTD--VVLILELVSGGELFDFLA-----QKESLSEEEATSFIKQI 124
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
L G+ + H++ + H D+K N+++ +KL DFGLA+ G + T
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTP 182
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
+ PE++ G D+WS+G + LL G G T+ E L I + +++
Sbjct: 183 EFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+ + S+L A + I LL E KR T AL
Sbjct: 242 FSQTSEL--------------------------AKDFIRKLLVKETRKRLTIQEAL 271
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 4e-48
Identities = 70/328 (21%), Positives = 112/328 (34%), Gaps = 50/328 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ E++G G + V R + TG A K V + + +EI + L HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHP 214
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
++ L + +++E+M + K SE + YM Q+ GL
Sbjct: 215 TLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGL 268
Query: 245 EHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
H H +H D+K N++ LKL DFGL + Q + T + PE
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPE 326
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SK 361
+ G G D+WSVG + LL G G + E L + + D + S+
Sbjct: 327 VAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+ I LL +P R T AL + +
Sbjct: 386 D--------------------------GKDFIRKLLLADPNTRMTIHQALEHPWLTP--- 416
Query: 422 ACDLSSLPIYPPSKEIDAKHREDARRKK 449
+ K R+ + K
Sbjct: 417 --GNAPGRDSQIPSSRYTKIRDSIKTKY 442
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 83/357 (23%), Positives = 145/357 (40%), Gaps = 50/357 (14%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-------- 186
+ K+G G +S+V+ A+D+ VA+K VR D E+ EI +L+R+
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKE 80
Query: 187 ---DHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQL 240
+I+KL + +VFE + ++ L+ +K QL
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 241 LHGLEHCHSR-GVLHRDIKGSNLLVNNE------GVLKLADFGLANFSNTGHRQPLTSRV 293
L GL++ H R G++H DIK N+L+ +K+AD G A + + + T+ +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD----EHYTNSI 196
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFK 347
T YR PE+LLGA +G D+WS C+ EL+ G + + + + + +I +
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 348 LCGSPP----------DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA---VNLIE 394
L G P ++ L P + L E +K A + +
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315
Query: 395 TLLSVEPYKRATASAALASEYFSTKPYACDLS--SLPIYPPSKEIDAKHREDARRKK 449
+L ++P KRA A + + ++ +Y +I E K+
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVRDHKR 372
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-47
Identities = 83/304 (27%), Positives = 138/304 (45%), Gaps = 50/304 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +V+ A D+ TG+ VA++++ + + EIL++R +PNI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNI 79
Query: 192 IKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLHGLE 245
+ L+ L ++V EY+ G S D+ E QI + L LE
Sbjct: 80 VNYLDSYLVGDEL----WVVMEYLA---GG--SLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELL 304
HS V+HRDIK N+L+ +G +KL DFG A + ++ ++ V T ++ PE++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVV 188
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
YGP VD+WS+G + E++ G+P L ++ + + P
Sbjct: 189 TR-KAYGPKVDIWSLGIMAIEMIEGEPPY---LNENPLRALYLIATNGT---------P- 234
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424
L P++ L F+D + L ++ KR +A L ++ A
Sbjct: 235 -ELQNPEK-----LSAIFRD-------FLNRCLEMDVEKRGSAKELLQHQFLKI---AKP 278
Query: 425 LSSL 428
LSSL
Sbjct: 279 LSSL 282
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-47
Identities = 79/295 (26%), Positives = 120/295 (40%), Gaps = 59/295 (20%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKL 194
+ +G+G++S + + + A+K + + + +EI L+ + HPNI+KL
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQ---KEITALKLCEGHPNIVKL 71
Query: 195 EGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLHGLEHCH 248
+ +L +LV E + G L I FSE + M +L+ + H H
Sbjct: 72 HEVFHDQLH--TFLVMELL----NGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 249 SRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
GV+HRD+K NLL +E +K+ DFG A QPL + TL Y PE LL
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCFTLHYAAPE-LL 181
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFK--LCGSP--PDDYWK 358
Y S DLWS+G + +L G+ Q +I K G + WK
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241
Query: 359 K-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
S+ A +LI+ LL+V+P KR S
Sbjct: 242 NVSQ--------------------------EAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-47
Identities = 79/312 (25%), Positives = 130/312 (41%), Gaps = 37/312 (11%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+G+G+Y V D +T A+K K + P + +EI +LRRL H N+I+L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-IPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
++ + +Y+V EY + +L S P+ +F Q Y QL+ GLE+ HS+G++
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDY-G 311
H+DIK NLL+ G LK++ G+A + + + ++PPE+ G + G
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSG 191
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
VD+WS G + G +G + I K Y +P
Sbjct: 192 FKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------GSY----AIP-------- 233
Query: 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIY 431
D +L++ +L EP KR + +F K + + +PI
Sbjct: 234 -----------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF-RKKHPPAEAPVPIP 281
Query: 432 PPSKEIDAKHRE 443
P D
Sbjct: 282 PSPDTKDRWRSM 293
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 8e-47
Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 46/288 (15%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH-PNIIKL 194
+++G+G ++ V + TG+ A K ++ + + EI +L P +I L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 195 EGLITSRLSCSIYLVFEYMEHDITG------LLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
+ + I L+ EY G L SE + + Q+L G+ + H
Sbjct: 95 HEVYENTSE--IILILEYA----AGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 249 SRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
++H D+K N+L+++ G +K+ DFG++ L + T Y PE+L
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILN 206
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPH 364
+ D+W++G + LL G E I ++ ++ + S+L
Sbjct: 207 Y-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL-- 263
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
A + I++LL P KR TA L+
Sbjct: 264 ------------------------ATDFIQSLLVKNPEKRPTAEICLS 287
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 66/292 (22%), Positives = 112/292 (38%), Gaps = 55/292 (18%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKL 194
+ +G G V + + T + ALK ++ + R RE+ + R P+I+++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRASQCPHIVRI 120
Query: 195 EGLI--TSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+ + +V E ++ I D F+E + M + +++
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 248 HSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
HS + HRD+K NLL ++ +LKL DFG A + + LT+ T +Y PE +
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPE-V 234
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGSP--PDDYWKK- 359
LG Y S D+WS+G + LL G P + + G P+ W +
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
S+ LI LL EP +R T + +
Sbjct: 295 SE--------------------------EVKMLIRNLLKTEPTQRMTITEFM 320
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 89/324 (27%), Positives = 152/324 (46%), Gaps = 51/324 (15%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+ F KLEKIG+G++ VF+ D T K+VA+K + + E E + + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 189 PNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLH 242
P + K G L ++L +++ EY+ G S D+ E QI + ++L
Sbjct: 80 PYVTKYYGSYLKDTKL----WIIMEYLG---GG--SALDLLEPGPLDETQIATILREILK 130
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPP 301
GL++ HS +HRDIK +N+L++ G +KLADFG+ ++T ++ + V T ++ P
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAP 188
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
E++ + Y D+WS+G EL G+P +E+ + +F + + P
Sbjct: 189 EVIKQS-AYDSKADIWSLGITAIELARGEPPH---SELHPMKVLFLIPKNNP-------- 236
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
P TL + + + K+ +E L+ EP R TA L ++
Sbjct: 237 -P--TL-------EGNYSKPLKE-------FVEACLNKEPSFRPTAKELLKHKFI--LRN 277
Query: 422 ACDLSSL-PIYPPSKEIDAKHRED 444
A S L + K A+ D
Sbjct: 278 AKKTSYLTELIDRYKRWKAEQSHD 301
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-46
Identities = 75/304 (24%), Positives = 138/304 (45%), Gaps = 50/304 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ KIG+G+ V AR+ +G+ VA+K + D + + + E++I+R H N+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNV 104
Query: 192 IKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLHGLE 245
+++ L+ L +++ E+++ G + DI + +E QI +L L
Sbjct: 105 VEMYKSYLVGEEL----WVLMEFLQ---GG--ALTDIVSQVRLNEEQIATVCEAVLQALA 155
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELL 304
+ H++GV+HRDIK ++L+ +G +KL+DFG A S ++ S V T ++ PE++
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVI 213
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
+ Y VD+WS+G + E++ G+P + + +L SPP P
Sbjct: 214 SR-SLYATEVDIWSLGIMVIEMVDGEPPY---FSDSPVQAMKRLRDSPP---------P- 259
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424
L + + +D +E +L +P +RATA L +
Sbjct: 260 -KLKNSHK-----VSPVLRDF-------LERMLVRDPQERATAQELLDHPFLLQ---TGL 303
Query: 425 LSSL 428
L
Sbjct: 304 PECL 307
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 77/307 (25%), Positives = 136/307 (44%), Gaps = 43/307 (14%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+ +E + ++G G + V++A++ +TG + A K + + E + EI IL DH
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDH 75
Query: 189 PNIIKLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
P I+KL G +L +++ E+ + ++ D +E QI+ Q+L L
Sbjct: 76 PYIVKLLGAYYHDGKL----WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
HS+ ++HRD+K N+L+ EG ++LADFG++ N Q S + T ++ PE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 306 GAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
T Y D+WS+G E+ +P E+ + + K+ S P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSDP-------- 239
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
P TL P S F+D ++ L P R +A+ L + S+
Sbjct: 240 -P--TLLTP-----SKWSVEFRD-------FLKIALDKNPETRPSAAQLLEHPFVSS--- 281
Query: 422 ACDLSSL 428
+L
Sbjct: 282 ITSNKAL 288
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-46
Identities = 75/346 (21%), Positives = 132/346 (38%), Gaps = 84/346 (24%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR----EILILRRL- 186
F + K+G GT+ V + +D K A+K VR +++ R E IL+++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQ 89
Query: 187 ----DHPNIIKLEG---------LITSRLSCSIYLVFEYM-EHDITGLLSCPDIKFSEAQ 232
++ NI+K G LI L S+Y E + ++ G F
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY---EIITRNNYNG--------FHIED 138
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV---------------------- 269
IK Y ++L L + + H D+K N LL +
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 270 --LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+KL DFG A F + S + T YR PE++L + S D+WS GCV AEL
Sbjct: 199 TGIKLIDFGCATFKS----DYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELY 253
Query: 328 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF------KPQQPYDSSLRET 381
G + + +E L + + P + ++ + + + K P ++S +
Sbjct: 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS 313
Query: 382 FKDLPTTA-----------VNLIETLLSVEPYKRATASAALASEYF 416
K + + + ++L ++P R + + L ++
Sbjct: 314 IKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 69/301 (22%), Positives = 117/301 (38%), Gaps = 63/301 (20%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALK--------KVRFDNFEPESVRFMA---------- 177
++IG+G+Y V A + + A+K + P
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 178 ------REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH----DITGLLSCPDIK 227
+EI IL++LDHPN++KL ++ +Y+VFE + ++
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKP 133
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
SE Q + Y L+ G+E+ H + ++HRDIK SNLLV +G +K+ADFG++N
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 288 PLTSRVVTLWYRPPELLLGAT-DY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
L++ V T + PE L + G ++D+W++G + G+ + KI
Sbjct: 194 -LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252
Query: 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 405
+ P D+ +LI +L P R
Sbjct: 253 KS------QAL----EFPD-----------------QPDIAEDLKDLITRMLDKNPESRI 285
Query: 406 T 406
Sbjct: 286 V 286
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-46
Identities = 70/322 (21%), Positives = 117/322 (36%), Gaps = 69/322 (21%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK-----KVRFDNFEPESVRFMAREILILRRL 186
+ +G+G + +VF L VA+K +V + +SV E+ +L ++
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKV 91
Query: 187 D----HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--------KFSEAQIK 234
HP +I+L ++ LV E D+ E +
Sbjct: 92 GAGGGHPGVIRLLDWFETQEG--FMLVLERPL-------PAQDLFDYITEKGPLGEGPSR 142
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRV 293
C+ Q++ ++HCHSRGV+HRDIK N+L++ G KL DFG H +P T
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFD 199
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
T Y PPE + + +WS+G + L+ + +CG P
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGIL-------------------LYDM--VCGDIP 238
Query: 354 -DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ ++ A L P + LI L+ +P R + L
Sbjct: 239 FERD---QEILEAELHFPAH------------VSPDCCALIRRCLAPKPSSRPSLEEILL 283
Query: 413 SEYFSTKPYACDLSSLPIYPPS 434
+ P + P+
Sbjct: 284 DPWM-QTPAEDVPLNPSKGGPA 304
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-46
Identities = 92/363 (25%), Positives = 134/363 (36%), Gaps = 74/363 (20%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
D +E E IG G+YS R T A+K + + EI IL R H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPT---EEIEILLRYGQH 75
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLH 242
PNII L+ + +Y+V E M G LL I FSE + + +
Sbjct: 76 PNIITLKDVYDDGKY--VYVVTELM----KGGELLD--KILRQKFFSEREASAVLFTITK 127
Query: 243 GLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+E+ H++GV+HRD+K SN+L N +++ DFG A L + T +
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCYTANF 186
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKP---ILQGRTEVEQLHKIFKLCGSPPDD 355
PE+L Y + D+WS+G + +L G T E L +I S
Sbjct: 187 VAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245
Query: 356 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
YW S TA +L+ +L V+P++R TA+ L
Sbjct: 246 YWNSVSD--------------------------TAKDLVSKMLHVDPHQRLTAALVLRH- 278
Query: 415 YFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH----GMS 470
P+ LP Y +R+DA G + G S
Sbjct: 279 -----PWIVHWDQLPQYQL-------NRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRS 326
Query: 471 KLA 473
LA
Sbjct: 327 TLA 329
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-45
Identities = 88/324 (27%), Positives = 158/324 (48%), Gaps = 43/324 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ F+ LEK+G+G+Y SV++A +TG+IVA+K+V ++ + + + +EI I+++ D P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEII---KEISIMQQCDSP 84
Query: 190 NIIKLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
+++K G + L ++V EY ++ ++ + +E +I + L GLE+
Sbjct: 85 HVVKYYGSYFKNTDL----WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
H +HRDIK N+L+N EG KLADFG+A T + + T ++ PE++
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG-QLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
Y D+WS+G E+ GKP ++ + IF + +PP P T
Sbjct: 200 I-GYNCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMIPTNPP---------P--T 244
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS 426
KP+ + F D ++ L P +RATA+ L + + A +S
Sbjct: 245 FRKPEL-----WSDNFTD-------FVKQCLVKSPEQRATATQLLQHPFVRS---AKGVS 289
Query: 427 SL-PIYPPSKEIDAKHREDARRKK 449
L + + ++ K +E +R++
Sbjct: 290 ILRDLINEAMDVKLKRQESQQREE 313
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 72/344 (20%), Positives = 135/344 (39%), Gaps = 74/344 (21%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR----EILILR 184
D +E IG+G++ V +A D + VA+K ++ + + E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLE 105
Query: 185 RL------DHPNIIKLEGLITSRLSCSIY-----LVFEYMEHDITGLLSCPDIK-FSEAQ 232
+ I+ L ++ LVFE + +++ LL + + S
Sbjct: 106 LMNKHDTEMKYYIVHL-------KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNL 158
Query: 233 IKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHRQP 288
+ + Q+ L + ++H D+K N+L+ N +K+ DFG + Q
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----QR 214
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
+ + + +YR PE+LLG Y ++D+WS+GC+ E+ G+P+ G EV+Q++KI ++
Sbjct: 215 IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273
Query: 349 CGSPPDDYWKKS---------------------------------KLPHATLFKPQQPYD 375
G PP ++ KL + + P
Sbjct: 274 LGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333
Query: 376 SSLRETFKDLPTTA--VNLIETLLSVEPYKRATASAALASEYFS 417
E+ + +LI +L +P R AL +F
Sbjct: 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-45
Identities = 86/297 (28%), Positives = 124/297 (41%), Gaps = 58/297 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D FE ++G+G S V+R + T K ALK ++ + + VR EI +L RL HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVR---TEIGVLLRLSHP 108
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLHG 243
NIIKL+ + + I LV E + TG L I +SE + Q+L
Sbjct: 109 NIIKLKEIFETPTE--ISLVLELV----TGGELFD--RIVEKGYYSERDAADAVKQILEA 160
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ + H G++HRD+K NLL LK+ADFGL+ + + T Y
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCA 218
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGSP--PDDY 356
PE+L G YGP VD+WSVG + LL G +F+ L +
Sbjct: 219 PEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMFRRILNCEYYFISPW 274
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
W + S A +L+ L+ ++P KR T AL
Sbjct: 275 WDEVSL--------------------------NAKDLVRKLIVLDPKKRLTTFQALQ 305
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 67/309 (21%), Positives = 114/309 (36%), Gaps = 64/309 (20%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKL 194
+ +G+G ++ V +L T + A+K + S + RE+ +L + H N+++L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLEL 76
Query: 195 EGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLHGLEHCH 248
YLVFE M G +LS I F+E + + + L+ H
Sbjct: 77 IEFFEEEDR--FYLVFEKM----RGGSILS--HIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 249 SRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHR------QPLTSRVVTLWYR 299
++G+ HRD+K N+L + +K+ DF L + L + + Y
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 300 PPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-- 353
PE++ A+ Y DLWS+G + IL L G PP
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILY-------IL--------------LSGYPPFV 227
Query: 354 --DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT--------TAVNLIETLLSVEPYK 403
A ++S + + P A +LI LL + +
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQ 286
Query: 404 RATASAALA 412
R +A+ L
Sbjct: 287 RLSAAQVLQ 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 61/301 (20%), Positives = 117/301 (38%), Gaps = 57/301 (18%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPN 190
+ +G ++ V+ A+D+ +G+ ALK++ + E R + +E+ +++L HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPN 87
Query: 191 IIKLEGLITSRLSCSIYLVFEY---MEHDITGLLSC-----PDIKFSEAQIKCYMNQLLH 242
I++ + S E+ E L+ S + Q
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 243 GLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--------- 291
++H H + ++HRD+K NLL++N+G +KL DFG A + ++
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 292 --RVVTLWYRPPEL--LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
R T YR PE+ L G D+W++GC+ L + + ++ ++ +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS 267
Query: 348 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
+ PP D + +LI +L V P +R +
Sbjct: 268 I---PPHD-----------------TQYTVFH-----------SLIRAMLQVNPEERLSI 296
Query: 408 S 408
+
Sbjct: 297 A 297
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 69/324 (21%), Positives = 120/324 (37%), Gaps = 68/324 (20%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNF-EPESVRFMAREILILRRLD 187
++ +G G + SV+ + VA+K K R ++ E + + E+++L+++
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 188 H--PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--------KFSEAQIKCYM 237
+I+L S L+ E E D+ E + +
Sbjct: 105 SGFSGVIRLLDWFERPDS--FVLILERPE-------PVQDLFDFITERGALQEELARSFF 155
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
Q+L + HCH+ GVLHRDIK N+L++ N G LKL DFG T T
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTR 212
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-DD 355
Y PPE + +G S +WS+G + ++ +CG P +
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM---------------------VCGDIPFEH 251
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
++ +F Q+ + + +LI L++ P R T +
Sbjct: 252 ---DEEIIRGQVFFRQR------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296
Query: 416 F---STKPYACDLSSLPIYP-PSK 435
++ + P PSK
Sbjct: 297 MQDVLLPQETAEIHLHSLSPGPSK 320
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 69/346 (19%), Positives = 123/346 (35%), Gaps = 82/346 (23%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTG-KIVALKKVRFDNFEPESVRFMAR----EILILRRL 186
+E ++ +G+G + V D G + VA+K V+ +V EI +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHL 68
Query: 187 ------DHPNIIKLEG---------LITSRLSCSIYLVFEYM-EHDITGLLSCPDIKFSE 230
+++ ++ L S Y +++ E+ F
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY---DFIKENGFLP--------FRL 117
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------------LK 271
I+ Q+ + HS + H D+K N L V ++ +K
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 272 LADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
+ DFG A + + + ++ V T YR PE++L + D+WS+GC+ E +G
Sbjct: 178 VVDFGSATYDD----EHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFT 232
Query: 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF---KPQQPYDSSLRETF----KD 384
+ E L + ++ G P +K++ F + SS K
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRK--YFHHDRLDWDEHSSAGRYVSRACKP 290
Query: 385 LPT----------TAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
L +LI+ +L +P KR T AL +F
Sbjct: 291 LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-44
Identities = 80/322 (24%), Positives = 140/322 (43%), Gaps = 57/322 (17%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+L K IG+G ++ V AR + TG+ VA+K + P S++ + RE+ I++ L+HPNI+
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 193 KL-EGLITSRLSCSIYLVFEY----------MEHDITGLLSCPDIKFSEAQIKCYMNQLL 241
KL E + T + ++YL+ EY + H + E + + Q++
Sbjct: 78 KLFEVIETEK---TLYLIMEYASGGEVFDYLVAHG----------RMKEKEARSKFRQIV 124
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
+++CH + ++HRD+K NLL++ + +K+ADFG +N G L + Y P
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAP 182
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
EL G GP VD+WS+G + L+ G G+ E ++ + G ++
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFY---- 236
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+ T NL++ L + P KR T + + +
Sbjct: 237 -----------------------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI-NAGH 272
Query: 422 ACDLSSLPIYPPSKEIDAKHRE 443
D + P D K +
Sbjct: 273 EEDELKPFVEPELDISDQKRID 294
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-44
Identities = 68/323 (21%), Positives = 124/323 (38%), Gaps = 63/323 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK-----KVRFDNF-EPESVRFMAREILILRR 185
+ + +G G + V+ A D + K V +K KV D + E + + EI IL R
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--------KFSEAQIKCYM 237
++H NIIK+ + ++ LV ME +GL D+ + E
Sbjct: 86 VEHANIIKVLDIFENQGF--FQLV---MEKHGSGL----DLFAFIDRHPRLDEPLASYIF 136
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
QL+ + + + ++HRDIK N+++ + +KL DFG A + G + T+
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCGTIE 194
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-DDY 356
Y PE+L+G GP +++WS+G L + P +
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTL---------------------VFEENPFCEL 233
Query: 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ + A + P + ++L+ LL P +R T + +
Sbjct: 234 EETVE---AAIHPP------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278
Query: 417 STKPYACDLSSLPIYPPSKEIDA 439
T+P + + ++
Sbjct: 279 -TQPVNLADYTWEEVFRVNKPES 300
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-44
Identities = 71/345 (20%), Positives = 130/345 (37%), Gaps = 80/345 (23%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGK-IVALKKVRFDNFEPESVRFMAR----EILILRRL 186
+E + +G+GT+ V D GK VALK +R +V EI +L+++
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVLKKI 73
Query: 187 ------DHPNIIKLEG---------LITSRLSCSIYLVFEYM-EHDITGLLSCPDIKFSE 230
+ + + + L + + E++ E++ +
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF---EFLKENNFQP--------YPL 122
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------------LK 271
++ QL H L H + H D+K N L VN+E ++
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 272 LADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
+ADFG A F + + T+ V T YRPPE++L + D+WS+GC+ E G
Sbjct: 183 VADFGSATFDH----EHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFT 237
Query: 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH----------------ATLFKPQQPYD 375
+ Q E L + K+ G P +++ + + +P
Sbjct: 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK 297
Query: 376 SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
S + + + +L+ +L +P +R T + AL +F+
Sbjct: 298 SYMLQDSLEHVQL-FDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-44
Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 44/277 (15%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+G+G Y V A + T + VA+K R + PE+++ +EI I + L+H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
G YL EY G L PDI E + + +QL+ G+ + H G
Sbjct: 71 YGHRREG--NIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGATDY 310
+ HRDIK NLL++ LK++DFGLA +R+ L +++ TL Y PELL +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 311 GPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
VD+WS G V +L G+ P Q ++ + +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-----------------KKTYL 228
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
+K + + + L+ +L P R T
Sbjct: 229 NP----------WKKIDSAPLALLHKILVENPSARIT 255
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-44
Identities = 78/314 (24%), Positives = 123/314 (39%), Gaps = 46/314 (14%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRLDHP 189
L + +G+G Y V A + T + VA+K R + PE+++ +EI I + L+H
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHE 65
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEH 246
N++K G YL EY G L PDI E + + +QL+ G+ +
Sbjct: 66 NVVKFYGHRREG--NIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLL 305
H G+ HRDIK NLL++ LK++DFGLA +R + L TL Y PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 306 GATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
+ VD+WS G V +L G+ P Q ++ +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----------------- 223
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424
+ +K + + + L+ +L P R T ++ KP
Sbjct: 224 KKTYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPLKKG 272
Query: 425 LSSLPIYPPSKEID 438
+
Sbjct: 273 AKRPRVTSGGVSES 286
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-43
Identities = 59/292 (20%), Positives = 100/292 (34%), Gaps = 76/292 (26%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKL 194
+ +G G V + + T + ALK ++ + R RE+ + R P+I+++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRASQCPHIVRI 76
Query: 195 EGLI--TSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+ + +V E ++ I D F+E + M + +++
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 248 HSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
HS + HRD+K NLL ++ +LKL DFG A E
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------KETT 171
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGSP--PDDYWKK- 359
Y S D+WS+G + LL G P + + G P+ W +
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
S+ LI LL EP +R T + +
Sbjct: 230 SE--------------------------EVKMLIRNLLKTEPTQRMTITEFM 255
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 5e-43
Identities = 41/321 (12%), Positives = 86/321 (26%), Gaps = 69/321 (21%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-VRFMAREILILRRL---- 186
+ +GQ + A D +TG+ + F P + ++ M E+L LR L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 187 ---------------------DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--- 222
+I++ S + ++ M+ ++
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 223 ---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279
Q++ L H G++H ++ +++++ G + L F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQG 335
P+ +L T + D W++G +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 336 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 395
+ IF+ C K++P L+E
Sbjct: 320 DAALGGSEWIFRSC---------------------------------KNIPQPVRALLEG 346
Query: 396 LLSVEPYKRATASAALASEYF 416
L R A+ + +
Sbjct: 347 FLRYPKEDRLLPLQAMETPEY 367
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-42
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-D 187
A FE +E +G GTY V++ R + TG++ A+K + + + + +EI +L++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 188 HPNIIKLEG----LITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQ 239
H NI G + ++LV E+ D+ + + E I +
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 137
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWY 298
+L GL H H V+HRDIKG N+L+ +KL DFG+ A T R+ + + T ++
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYW 195
Query: 299 RPPELLLGATD----YGPSVDLWSVGCVFAELLIGKP 331
PE++ + Y DLWS+G E+ G P
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-41
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 22/272 (8%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
L+ D FEK+ ++G G VF+ +G ++A K + + +P + RE+ +L
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHEC 88
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLL 241
+ P I+ G S I + E+M+ G S + + E + ++
Sbjct: 89 NSPYIVGFYGAFYS--DGEISICMEHMD---GG--SLDQVLKKAGRIPEQILGKVSIAVI 141
Query: 242 HGLEHCHSRG-VLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYR 299
GL + + ++HRD+K SN+LVN+ G +KL DFG++ ++ S V T Y
Sbjct: 142 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYM 197
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE L G T Y D+WS+G E+ +G+ + E + +
Sbjct: 198 SPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 391
+ P L + DS +L VN
Sbjct: 257 PRTPGRPL--NKFGMDSRPPMAIFELLDYIVN 286
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 79/323 (24%), Positives = 127/323 (39%), Gaps = 49/323 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ ++ IG G + RD T ++VA+K + E+V+ REI+ R L HPNI
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNI 78
Query: 192 IKL-EGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHC 247
++ E ++T + ++ EY G L C +FSE + + + QLL G+ +C
Sbjct: 79 VRFKEVILTPT---HLAIIMEYASG---GELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 248 HSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
HS + HRD+K N L+ + LK+ DFG + S + S V T Y PE+LL
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLL 190
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCG--SPPDDYWKKSK 361
G D+WS G +L+G + E K + L S PDD
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR---- 246
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+ +LI + +P R + +F K
Sbjct: 247 -----------------------ISPECCHLISRIFVADPATRISIPEIKTHSWF-LKNL 282
Query: 422 ACDLSSLPIYPPSKEIDAKHRED 444
DL + + + +
Sbjct: 283 PADLMNESNTGSQFQEPEQPMQS 305
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 2e-40
Identities = 49/288 (17%), Positives = 95/288 (32%), Gaps = 35/288 (12%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMARE 179
L + +G+G ++ V+ A D + LK + N P +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQL 117
Query: 180 ILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-----ITGLLSCPDIKFSEAQIK 234
+ L+ +K + LV E + I + P+ + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----------EGVLKLADFGLANFSNT 283
+ ++L+ +E H ++H DIK N ++ N L L D G +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 284 -GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQ 341
T++ T ++ E+L + +D + V +L G + ++ +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQ---QPYDSSLRETFKDLP 386
+F+ P D W + H L P P LR+ K +
Sbjct: 295 PEGLFR--RLPHLDMWN--EFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-40
Identities = 66/297 (22%), Positives = 112/297 (37%), Gaps = 41/297 (13%)
Query: 121 IQGWV-PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMARE 179
I G + E L ++G GT V++ R TG ++A+K++R E + + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMD 73
Query: 180 ILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
+ ++ + D P I++ G + I E M L E +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFI--AMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 239 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTL 296
++ L + GV+HRD+K SN+L++ G +KL DFG+ + +
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCA 188
Query: 297 WYRPPE----LLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGS 351
Y PE DY D+WS+G EL G+ P +T+ E L K+ +
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EE 246
Query: 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
PP LP F F+ ++ L+ + KR +
Sbjct: 247 PP-------LLPGHMGFSGD----------FQS-------FVKDCLTKDHRKRPKYN 279
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 66/294 (22%), Positives = 121/294 (41%), Gaps = 41/294 (13%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
A+ + L +IG+G Y SV + +G+I+A+K++R + + + + ++ ++ R
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMR 76
Query: 186 L-DHPNIIKLEGLITSRLSCSIYLVFEYM----EHDITGLLSCPDIKFSEAQIKCYMNQL 240
D P I++ G + C I E M + + S D E +
Sbjct: 77 SSDCPYIVQFYGALFREGDCWI--CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 241 LHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWY 298
+ L H ++HRDIK SN+L++ G +KL DFG+ ++ + T Y
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPY 191
Query: 299 RPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPD 354
PE + + Y D+WS+G EL G+ P + + +QL ++ K G PP
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPP- 248
Query: 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
+L + ++ + S F + + L+ + KR
Sbjct: 249 ------QLSN----SEEREFSPS----FIN-------FVNLCLTKDESKRPKYK 281
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 73/287 (25%), Positives = 122/287 (42%), Gaps = 60/287 (20%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFE-PESVRFMAREILILRRLDH 188
+ + +G+G++ V A T + VALK + + V REI L+ L H
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRH 68
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY---------MEHDITGLLSCPDIKFSEAQIKCYMNQ 239
P+IIKL +IT+ I +V EY +E + +E + + + Q
Sbjct: 69 PHIIKLYDVITTP--TDIVMVIEYAGGELFDYIVEKK----------RMTEDEGRRFFQQ 116
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
++ +E+CH ++HRD+K NLL+++ +K+ADFGL+N G+ L + + Y
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYA 174
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE++ G GP VD+WS G V +L+G+ K+ Y
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS------CVY--- 225
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
+P L A +LI ++ +P +R T
Sbjct: 226 -VMP-------------------DFLSPGAQSLIRRMIVADPMQRIT 252
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 75/278 (26%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-MAREILILRRLDHPNI 191
L +G GT+ V TG VA+K + V + REI L+ HP+I
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCH 248
IKL +I++ ++V EY+ G L C + E + + Q+L +++CH
Sbjct: 74 IKLYQVISTP--TDFFMVMEYVSG---GELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
V+HRD+K N+L++ K+ADFGL+N + G L + + Y PE++ G
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRL 186
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
GP VD+WS G + LL G KI + +P
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------GVF----YIP----- 231
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
+ L + L+ +L V+P KRAT
Sbjct: 232 --------------EYLNRSVATLLMHMLQVDPLKRAT 255
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 36/281 (12%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-VRFMAREILILRR 185
R + F+ + +G+G++S+V AR+L T + A+K + + E+ V ++ RE ++ R
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
LDHP +KL T + +Y Y ++ ++ + F E + Y +++ L
Sbjct: 87 LDHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 143
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPEL 303
E+ H +G++HRD+K N+L+N + +++ DFG A + +Q + V T Y PEL
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
L S DLW++GC+ +L+ G P + E KI K + P
Sbjct: 204 LTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----------LEYDFP 252
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ A +L+E LL ++ KR
Sbjct: 253 -------------------EKFFPKARDLVEKLLVLDATKR 274
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 81/317 (25%), Positives = 128/317 (40%), Gaps = 56/317 (17%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-MAREILILRRLDHPNI 191
L +G GT+ V + TG VA+K + V + REI L+ HP+I
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 192 IKLEGLITSRLSCSIYLVFEY----------MEHDITGLLSCPDIKFSEAQIKCYMNQLL 241
IKL +I++ I++V EY ++ + E + + Q+L
Sbjct: 79 IKLYQVISTP--SDIFMVMEYVSGGELFDYICKNG----------RLDEKESRRLFQQIL 126
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
G+++CH V+HRD+K N+L++ K+ADFGL+N + G L + + Y P
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAP 184
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
E++ G GP VD+WS G + LL G KI G +
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--G----IF----Y 234
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
P + L + ++L++ +L V+P KRAT E+F +
Sbjct: 235 TP-------------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF-KQDL 274
Query: 422 ACDLSSLPIYPPSKEID 438
L S ID
Sbjct: 275 PKYLFPEDPSYSSTMID 291
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-38
Identities = 58/248 (23%), Positives = 105/248 (42%), Gaps = 21/248 (8%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILI-LR 184
++AD E + ++G+G Y V + R + +G+I+A+K++R + + + ++ I +R
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMR 61
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYME---HDITGLLSCPDIKFSEAQIKCYMNQLL 241
+D P + G + I E M+ + E + ++
Sbjct: 62 TVDCPFTVTFYGALFREGDVWI--CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 242 HGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYR 299
LEH HS V+HRD+K SN+L+N G +K+ DFG+ + + Y
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPYM 176
Query: 300 PPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP-- 353
PE + + Y D+WS+G EL I + P T +QL ++ + P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQL 234
Query: 354 -DDYWKKS 360
D +
Sbjct: 235 PADKFSAE 242
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 60/353 (16%), Positives = 111/353 (31%), Gaps = 99/353 (28%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVA----------------------LKKVRFDNFE 169
FE ++ +G+G + VF A++ A L K+
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 170 PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS------------------------ 205
++ + +K E S S
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 206 --------IYLVFEYMEH-DITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
+Y+ + ++ ++ C Q+ +E HS+G++H
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187
Query: 255 RDIKGSNLLVNNEGVLKLADFGLA-----------NFSNTGHRQPLTSRVVTLWYRPPEL 303
RD+K SN+ + V+K+ DFGL + T +V T Y PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
+ G +Y VD++S+G + ELL T++E++ I + + K P
Sbjct: 248 IHG-NNYSHKVDIFSLGLILFELLYSFS-----TQMERVRIITDV---------RNLKFP 292
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
F +++ +LS P +R A+ + + F
Sbjct: 293 ----------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 50/215 (23%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
R E +G+G + + +TG+++ +K+ F+ E+ R +E+ ++R L
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCL 64
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+HPN++K G++ + + EY++ + G++ D ++ +Q + + G+
Sbjct: 65 EHPNVLKFIGVLYK--DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFSNTGHRQPLTSR 292
+ HS ++HRD+ N LV + +ADFGLA R+ +
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
V ++ PE++ G Y VD++S G V E++
Sbjct: 183 VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEII 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 76/369 (20%), Positives = 139/369 (37%), Gaps = 98/369 (26%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-----DHP 189
+ K+G G +S+V+ + D+ K VA+K V+ E+ EI +L+ + + P
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDP 98
Query: 190 N---IIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHG 243
N +++L I+ I +VFE + H + + +K + Q+L G
Sbjct: 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 244 LEHCHSR-GVLHRDIKGSNLLVNNE----------------------------------- 267
L++ H++ ++H DIK N+L++
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 268 --------------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 313
+K+AD G A + + + + +R YR E+L+G+ Y
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRSLEVLIGS-GYNTP 273
Query: 314 VDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSK------ 361
D+WS C+ EL G + + + + + + I +L G P K
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333
Query: 362 -----LPHATLFKPQ-------QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409
L H T KP + Y+ S E + + +L + P KRATA+
Sbjct: 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT-----DFLLPMLELIPEKRATAAE 388
Query: 410 ALASEYFST 418
L + ++
Sbjct: 389 CLRHPWLNS 397
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 72/293 (24%), Positives = 112/293 (38%), Gaps = 47/293 (16%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILR 184
L+ D FE L+ IG+G +S V + TG++ A+K + + + V E +L
Sbjct: 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 185 RLDHPNIIKLEGLITSRLSCS------IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYM 237
D I +L + +YLV EY D+ LLS + + Y+
Sbjct: 117 NGDRRWITQLH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
+++ ++ H G +HRDIK N+L++ G ++LADFG V T
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 298 YRPPELLLG------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 351
Y PE+L YGP D W++G E+ G+ + E KI
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH---- 284
Query: 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
K L P + +P A + I+ LL P R
Sbjct: 285 ------YKEHLSL-----PLVD---------EGVPEEARDFIQRLLC-PPETR 316
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 48/213 (22%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-----VRFMAREILILRRL 186
E ++IG+G + V + R + +VA+K + + E E+ + RE+ I+ L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+HPNI+KL GL+ + +V E++ D+ L + M + G+E
Sbjct: 81 NHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 246 HCHSRG--VLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+ ++ ++HRD++ N+ + + K+ADFGL+ S ++ + +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQW 192
Query: 299 RPPELLLGATD-YGPSVDLWSVGCVFAELLIGK 330
PE + + Y D +S + +L G+
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 44/206 (21%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
++IG G++ +V++ + VA+K + P+ ++ E+ +LR+ H NI+
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 195 EGLITSRLSCS---IYLVFEYMEHDITG----LLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
G + + +V ++ E L + KF ++ Q G+++
Sbjct: 86 MG------YSTAPQLAIVTQWCEG---SSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-SNTGHRQPLTSRVVTLWYRPPELLLG 306
H++ ++HRD+K +N+ ++ + +K+ DFGLA S ++ + PE++
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 307 ATD--YGPSVDLWSVGCVFAELLIGK 330
Y D+++ G V EL+ G+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 14/245 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRR 185
L + FE L+ IG+G + V + + K+ A+K + ++ + E +L
Sbjct: 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 186 LDHPNIIKLEGLI--TSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLH 242
D I L + L YLV +Y D+ LLS + + E + Y+ +++
Sbjct: 131 GDSKWITTLHYAFQDDNNL----YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
++ H +HRDIK N+L++ G ++LADFG + V T Y PE
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 303 LLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI--FKLCGSPPDDY 356
+L YGP D WS+G E+L G+ + VE KI K P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306
Query: 357 WKKSK 361
S+
Sbjct: 307 TDVSE 311
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
E E +G+G + V +A+ K VA+K++ ++ F+ E+ L R++HPNI
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKA---FI-VELRQLSRVNHPNI 63
Query: 192 IKLEGLITSRLSCSIYLVFEYME----HDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEH 246
+KL G + + LV EY E +++ L P ++ A + Q G+ +
Sbjct: 64 VKLYGACLNPV----CLVMEYAEGGSLYNV--LHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 247 CHSR---GVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
HS ++HRD+K NLL+ G VLK+ DFG A T +T+ + + PE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPE 173
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGK 330
+ G ++Y D++S G + E++ +
Sbjct: 174 VFEG-SNYSEKCDVFSWGIILWEVITRR 200
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 30/204 (14%), Positives = 76/204 (37%), Gaps = 18/204 (8%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
L K+ + +++ R G + +K ++ ++ R E LR HPN++ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 195 EGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
G S + L+ +M +++ L + ++Q + + G+ H+
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 251 G--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-- 306
+ + +++++ + +++ + + R+ + PE L
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKP 184
Query: 307 ATDYGPSVDLWSVGCVFAELLIGK 330
S D+WS + EL+ +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 77/285 (27%), Positives = 118/285 (41%), Gaps = 39/285 (13%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRR 185
++A+ +E ++ IG+G + V R T K+ A+K + F+ + F E I+
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 186 LDHPNIIKLEGLI--TSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLH 242
+ P +++L L Y+V EYM D+ L+S + E + Y +++
Sbjct: 126 ANSPWVVQLFYAFQDDRYL----YMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVL 179
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
L+ HS G +HRD+K N+L++ G LKLADFG N + V T Y PE
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 303 LLL---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
+L G YG D WSVG E+L+G + V KI K
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN----------HK 289
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ L P D+ A NLI L+ + R
Sbjct: 290 NSLTF-----PDDN----------DISKEAKNLICAFLT-DREVR 318
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 60/291 (20%), Positives = 115/291 (39%), Gaps = 51/291 (17%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILR 184
P+ + F + +G+G + V + TGK+ A KK+ + + E IL
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 185 RLDHPNIIKLEGLITSRLSC-----SIYLVFEYME------HDITGLLSCPDIKFSEAQI 233
+++ ++ L ++ LV M H + F EA+
Sbjct: 240 KVNSRFVVSLA-------YAYETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPEARA 288
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293
Y ++ GLE H +++RD+K N+L+++ G ++++D GLA + Q + RV
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV 346
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
T+ Y PE++ Y S D W++GC+ E++ G+ Q R + + ++
Sbjct: 347 GTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------- 398
Query: 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ + + A +L LL +P +R
Sbjct: 399 -----RLVKEVPEEYSER-------------FSPQARSLCSQLLCKDPAER 431
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-33
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 132 FEKL---EKIGQGTYSSVFRA--RDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
+ L EKIG G++ +V RA G VA+K + +F E V RE+ I++RL
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAEWH----GSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK--FSEAQIKCYMNQLLHG 243
HPNI+ G +T + SI V EY+ + LL + E + + G
Sbjct: 92 RHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 244 LEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
+ + H+R ++HR++K NLLV+ + +K+ DFGL+ + S T + P
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAP 208
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGK 330
E+L D++S G + EL +
Sbjct: 209 EVLRD-EPSNEKSDVYSFGVILWELATLQ 236
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 55/289 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDH 188
D FE L IG+G++ V + DT K+ A+K + E VR + +E+ I++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 189 PNIIKLEGLI--TSRLSCSIYLVFEYME------HDITGLLSCPDIKFSEAQIKCYMNQL 240
P ++ L + ++V + + H L ++ F E +K ++ +L
Sbjct: 75 PFLVNLWYSFQDEEDM----FMVVDLLLGGDLRYH-----LQ-QNVHFKEETVKLFICEL 124
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ L++ ++ ++HRD+K N+L++ G + + DF +A + +T+ T Y
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA--AMLPRETQITTMAGTKPYMA 182
Query: 301 PELLL--GATDYGPSVDLWSVGCVFAELLIGKP---ILQGRTEVEQLHKIFKLCGSPPDD 355
PE+ Y +VD WS+G ELL G+ I + E +H
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-------- 234
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
P V+L++ LL P +R
Sbjct: 235 --TVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQR 262
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 67/292 (22%), Positives = 117/292 (40%), Gaps = 50/292 (17%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILR 184
P+ D F +G+G + VF + TGK+ A KK+ + + + E IL
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 185 RLDHPNIIKLEGLITSRLSC-----SIYLVFEYME------HDITGLLSCPDIKFSEAQI 233
++ I+ L + LV M H I + F E +
Sbjct: 241 KVHSRFIVSLA-------YAFETKTDLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRA 291
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293
Y Q++ GLEH H R +++RD+K N+L++++G ++++D GLA G +
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YA 350
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
T + PELLLG +Y SVD +++G E++ + + R E + ++ +
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------ 403
Query: 354 DDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKR 404
L + T+ + + E LL +P KR
Sbjct: 404 -----------RVLEQA---------VTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 42/215 (19%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 132 FEKL---EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
FE+L E IG+G + V+ R VA++ + + + ++ RE++ R+ H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
N++ G S +I + + + ++ I + + +++ G+ +
Sbjct: 89 ENVVLFMGACMSPPHLAI--ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVVTLWYRPPEL 303
H++G+LH+D+K N+ +N G + + DFGL L + L + PE+
Sbjct: 147 HAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 304 LLGATD--------YGPSVDLWSVGCVFAELLIGK 330
+ + + D++++G ++ EL +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 75/294 (25%), Positives = 124/294 (42%), Gaps = 62/294 (21%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR---DLDTGKIVALKKVRFDN-FEPESVRFMAREILI 182
FE L+ +GQG++ VF + D ++ A+K ++ + VR E I
Sbjct: 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDI 79
Query: 183 LRRLDHPNIIKLEGLITSRLSCS------IYLVFEY------MEHDITGLLSCPDIKFSE 230
L ++HP I+KL + +YL+ ++ LS ++ F+E
Sbjct: 80 LVEVNHPFIVKLH--------YAFQTEGKLYLILDFLRGGDLFTR-----LS-KEVMFTE 125
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290
+K Y+ +L L+H HS G+++RD+K N+L++ EG +KL DFGL+ + H +
Sbjct: 126 EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAY 184
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
S T+ Y PE++ + S D WS G + E+L G QG+ E + I K
Sbjct: 185 SFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--- 240
Query: 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
K +P + L A +L+ L P R
Sbjct: 241 -------AKLGMP-------------------QFLSPEAQSLLRMLFKRNPANR 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 136 EKIGQGTYSSVFRA--RDLDTGKIVALKKVRFDNFEPESVRFM--AREILILRRLDHPNI 191
E IG G + V+RA G VA+K R D E S +E + L HPNI
Sbjct: 13 EIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I L G+ ++ LV E+ + +LS I + + Q+ G+ + H
Sbjct: 69 IALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPD--ILVNWAVQIARGMNYLHDE 124
Query: 251 G---VLHRDIKGSNLLVNNEG--------VLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
++HRD+K SN+L+ + +LK+ DFGLA HR S +
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAWM 181
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGK 330
PE++ + + D+WS G + ELL G+
Sbjct: 182 APEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (290), Expect = 4e-29
Identities = 51/340 (15%), Positives = 99/340 (29%), Gaps = 78/340 (22%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE------PESVRFMAREILIL 183
+ ++ EKIG+G + VF+ VA+K + + + ++ + EI+I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 184 RRL---------DHPNIIKLEGLITSRLSCS----------------------------I 206
+ L I L + + S +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVN 265
++V E+ L S A K ++QL L + HRD+ N+L+
Sbjct: 138 FIVLEFEFGG-IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 266 NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 325
+ KL S P V++ DY S VF +
Sbjct: 197 KTSLKKLHYTLNGKSSTI----PSCGLQVSII-----------DYTLSRLERDGIVVFCD 241
Query: 326 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH---------ATLFKPQQPYDS 376
+ + + + G + + I++L ++ W + + K
Sbjct: 242 VSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK 299
Query: 377 SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
K + T+L+ +A+ L
Sbjct: 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 66/292 (22%), Positives = 121/292 (41%), Gaps = 57/292 (19%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILR 184
+ + FE L+ +G+GT+ V ++ TG+ A+K ++ + + V E +L+
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 185 RLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSEAQI 233
HP + L+ + V EY H LS + FSE +
Sbjct: 204 NSRHPFLTALK-------YSFQTHDRLCFVMEYANGGELFFH-----LS-RERVFSEDRA 250
Query: 234 KCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292
+ Y +++ L++ HS + V++RD+K NL+++ +G +K+ DFGL + +
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTF 309
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 352
T Y PE+L DYG +VD W +G V E++ G+ + + I
Sbjct: 310 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----- 363
Query: 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
++ + P + L A +L+ LL +P +R
Sbjct: 364 -----EEIRFP-------------------RTLGPEAKSLLSGLLKKDPKQR 391
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 71/299 (23%), Positives = 120/299 (40%), Gaps = 74/299 (24%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRR 185
+ + F+ L+ +G+GT+ V R+ TG+ A+K +R + + V E +L+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 186 LDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSEAQIK 234
HP + L+ + V EY H LS + F+E + +
Sbjct: 62 TRHPFLTALK-------YAFQTHDRLCFVMEYANGGELFFH-----LS-RERVFTEERAR 108
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GH 285
Y +++ LE+ HSR V++RDIK NL+++ +G +K+ DFGL T G
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG- 167
Query: 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
T Y PE+L DYG +VD W +G V E++ G+ + I
Sbjct: 168 ---------TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
Query: 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
++ + P + L A +L+ LL +P +R
Sbjct: 218 LM----------EEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQR 247
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 6e-29
Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 55/288 (19%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRR 185
F+ L +G G++ V R G+ A+K ++ + + V E L+L
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQL 240
+ HP II++ G T + + I+++ +Y+E G LL +F K Y ++
Sbjct: 63 VTHPFIIRMWG--TFQDAQQIFMIMDYIE----GGELFSLLRK-SQRFPNPVAKFYAAEV 115
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW--- 297
LE+ HS+ +++RD+K N+L++ G +K+ DFG A + TL
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--------VTYTLCGTP 167
Query: 298 -YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
Y PE++ Y S+D WS G + E+L G ++ KI
Sbjct: 168 DYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------- 217
Query: 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ + P +L+ L++ + +R
Sbjct: 218 -AELRFP-------------------PFFNEDVKDLLSRLITRDLSQR 245
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 63/285 (22%), Positives = 124/285 (43%), Gaps = 47/285 (16%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILR 184
+ D F++++ +G G++ V + ++G A+K + + + + E IL+
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
++ P ++KLE + + + ++Y+V EY+ ++ L +FSE + Y Q++
Sbjct: 97 AVNFPFLVKLEF--SFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLT 153
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL----WYR 299
E+ HS +++RD+K NLL++ +G +++ DFG A + + R TL
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA--------KRVKGRTWTLCGTPEAL 205
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE++L Y +VD W++G + E+ G P ++ KI K
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----------GK 254
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ P + +L+ LL V+ KR
Sbjct: 255 VRFP-------------------SHFSSDLKDLLRNLLQVDLTKR 280
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-29
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA---REIL- 181
L + F IG+G + V+ R DTGK+ A+K + + + +A R +L
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 182 ILRRLDHPNIIKLEGLI--TSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMN 238
++ D P I+ + +L + + M D+ LS FSEA ++ Y
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAA 299
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+++ GLEH H+R V++RD+K +N+L++ G ++++D GLA + + V T Y
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGY 356
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
PE+L Y S D +S+GC+ +LL G + ++ H+I +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR----------- 404
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ P +L+E LL + +R
Sbjct: 405 --MTLTMAVELPDS------------FSPELRSLLEGLLQRDVNRR 436
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 26/214 (12%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+ +++IG+G Y V+ + G+ VA+K E+ F EI + H NI+
Sbjct: 40 QMVKQIGKGRYGEVWMGK-WR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENIL 94
Query: 193 KLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ + +YL+ +Y E+ + L + Y + GL H H+
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAY--SSVSGLCHLHT 152
Query: 250 R--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWY 298
+ HRD+K N+LV G +AD GLA + + P +RV T Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 299 RPPELLLGAT-----DYGPSVDLWSVGCVFAELL 327
PPE+L + D++S G + E+
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 78/303 (25%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREIL 181
+R + FE L +G+G Y VF+ R + +TGKI A+K ++ + E
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 182 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 230
IL + HP I+ L +YL+ EY L + F E
Sbjct: 74 ILEEVKHPFIVDLI-------YAFQTGGKLYLILEYLSGGELFMQ-----LE-REGIFME 120
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT 283
Y+ ++ L H H +G+++RD+K N+++N++G +KL DFGL ++T
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
Query: 284 --GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341
G T+ Y PE+L+ + + +VD WS+G + ++L G P G +
Sbjct: 181 FCG----------TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 401
+ KI K K LP L A +L++ LL
Sbjct: 230 IDKILK----------CKLNLP-------------------PYLTQEARDLLKKLLKRNA 260
Query: 402 YKR 404
R
Sbjct: 261 ASR 263
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 47/218 (21%), Positives = 85/218 (38%), Gaps = 25/218 (11%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
A +E I G ++ A D + G+ V LK + M E L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAM-AERQFLAEVV 137
Query: 188 HPNIIKL------EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQL 240
HP+I+++ + Y+V EY+ + A+ Y+ ++
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVG---YIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEI 191
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYR 299
L L + HS G+++ D+K N+++ E + KL D G R + T ++
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAV------SRINSFGYLYGTPGFQ 244
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 337
PE++ + D+++VG A L + P GR
Sbjct: 245 APEIVRTGPT--VATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 53/214 (24%), Positives = 79/214 (36%), Gaps = 26/214 (12%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
LE +G+G Y V+R G+ VA+K + + F E+ L H NI+
Sbjct: 11 TLLECVGKGRYGEVWRGS-WQ-GENVAVKIFSSRDEKSW---FRETELYNTVMLRHENIL 65
Query: 193 KLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ + S ++L+ Y E + L + + GL H H
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVL--SIASGLAHLHI 123
Query: 250 R--------GVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSNTGHRQPLTSRVVTLWY 298
+ HRD+K N+LV G +AD GLA + S RV T Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 299 RPPELLLGATDYGPS-----VDLWSVGCVFAELL 327
PE+L VD+W+ G V E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 27/235 (11%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
++ + LE +G + V++A+ + VA+K F + +S + E+ L +
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKI--FPIQDKQSWQN-EYEVYSLPGM 75
Query: 187 DHPNIIKLEG--LITSRLSCSIYLVFEYMEH------------DITGLLSCPDIKFSEAQ 232
H NI++ G + + ++L+ + E L I + A+
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCH---IAETMAR 132
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292
Y+++ + GL+ H + HRDIK N+L+ N +ADFGLA G T
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 293 VV-TLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 342
V T Y PE+L GA D +D++++G V EL G + L
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 49/293 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESV-RFMAREILILRRLDHP 189
++ ++K+G G S+V+ A D VA+K + + E++ RF RE+ +L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRF-EREVHNSSQLSHQ 71
Query: 190 NIIKL------EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLH 242
NI+ + + YLV EY+E ++ + S + NQ+L
Sbjct: 72 NIVSMIDVDEEDDCY--------YLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILD 122
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV-TLWYRP 300
G++H H ++HRDIK N+L+++ LK+ DFG+A S T Q T+ V+ T+ Y
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLGTVQYFS 180
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PE G D++S+G V E+L+G+P G T V K
Sbjct: 181 PEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK---------------- 223
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-ATASAALA 412
H Q + + KD+P + N+I + R T
Sbjct: 224 ---HI-----QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKD 268
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-28
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 14/203 (6%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESVRFMAREILILRRLDHPNIIK 193
+G+G V+ A D +IVALK + + +P M RE RL P+++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 194 L--EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+ G I +L Y+ + D+ +L + + + Q+ L+ H+
Sbjct: 99 IHDFGEIDGQL----YVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV-TLWYRPPELLLGAT 308
G HRD+K N+LV+ + L DFG+A+ ++ Q V TL+Y PE +
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ--LGNTVGTLYYMAPERFSESH 211
Query: 309 DYGPSVDLWSVGCVFAELLIGKP 331
D++++ CV E L G P
Sbjct: 212 -ATYRADIYALTCVLYECLTGSP 233
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-28
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESV-RFMAREILILRRLDHP 189
+E E +G G S V ARDL + VA+K +R D +P RF RE L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF-RREAQNAAALNHP 72
Query: 190 NIIKL--EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
I+ + G + Y+V EY++ + ++ + + + + L
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNF 131
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV-TLWYRPPELL 304
H G++HRD+K +N++++ +K+ DFG+A +++G+ T+ V+ T Y PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKP 331
G + D++S+GCV E+L G+P
Sbjct: 192 RGDS-VDARSDVYSLGCVLYEVLTGEP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 69/302 (22%), Positives = 114/302 (37%), Gaps = 79/302 (26%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALK----KVRFDNFEPESVRFMAREILI 182
+ F L+ IG+G++ V AR A+K K E + + R +L
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM-SERNVL- 92
Query: 183 LRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSEA 231
L+ + HP ++ L +Y V +Y H L + F E
Sbjct: 93 LKNVKHPFLVGLH-------FSFQTADKLYFVLDYINGGELFYH-----LQ-RERCFLEP 139
Query: 232 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT- 283
+ + Y ++ L + HS +++RD+K N+L++++G + L DFGL + ++T
Sbjct: 140 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF 199
Query: 284 -GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 342
G T Y PE+L Y +VD W +G V E+L G P R E
Sbjct: 200 CG----------TPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
Query: 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 402
I K +L ++ +A +L+E LL +
Sbjct: 249 DNILN----------KPLQLK-------------------PNITNSARHLLEGLLQKDRT 279
Query: 403 KR 404
KR
Sbjct: 280 KR 281
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 6/154 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+++ +G+G + V R +TG+ VA+K ++ ++ +EI ILR
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRN 79
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
L H NI+K +G+ T I L+ E++ + L K + Q Y Q+ G+
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
++ SR +HRD+ N+LV +E +K+ DFGL
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 55/214 (25%), Positives = 84/214 (39%), Gaps = 26/214 (12%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
E IG+G + V+R + G+ VA+K F + E S F EI L H NI+
Sbjct: 45 VLQESIGKGRFGEVWRGK-WR-GEEVAVKI--FSSREERSW-FREAEIYQTVMLRHENIL 99
Query: 193 KLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ ++LV +Y EH + L+ + GL H H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL--STASGLAHLHM 157
Query: 250 R--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWY 298
+ HRD+K N+LV G +AD GLA ++ RV T Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 299 RPPELLLGAT-----DYGPSVDLWSVGCVFAELL 327
PE+L + + D++++G VF E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMARE--ILILRRLDHP 189
+ LE IG+G Y +V++ LD + VA+K F + + E I + ++H
Sbjct: 15 LKLLELIGRGRYGAVYKGS-LD-ERPVAVKV-----FSFANRQNFINEKNIYRVPLMEHD 67
Query: 190 NIIKLEG---LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
NI + +T+ LV EY + + LS + + + + GL
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH--SVTRGLA 125
Query: 246 HCHS---------RGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHRQPL 289
+ H+ + HRD+ N+LV N+G ++DFGL+
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 290 TSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELLIGK 330
S V T+ Y PE+L GA + VD++++G ++ E+ +
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 79/303 (26%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
L D FE + +G+G++ V AR +TG + A+K ++ + + E + IL
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM-TEKRIL 77
Query: 182 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 230
L R +HP + +L C ++ V E+ M H + +F E
Sbjct: 78 SLAR-NHPFLTQL-------FCCFQTPDRLFFVMEFVNGGDLMFH-----IQ-KSRRFDE 123
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT 283
A+ + Y +++ L H +G+++RD+K N+L+++EG KLADFG+ + T
Sbjct: 124 ARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183
Query: 284 --GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341
G T Y PE+L YGP+VD W++G + E+L G + E +
Sbjct: 184 FCG----------TPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 401
I + P L A ++++ ++ P
Sbjct: 233 FEAILN----------DEVVYP-------------------TWLHEDATGILKSFMTKNP 263
Query: 402 YKR 404
R
Sbjct: 264 TMR 266
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 8e-27
Identities = 66/288 (22%), Positives = 118/288 (40%), Gaps = 51/288 (17%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF----EPESVRFMAREILI 182
++ F L +G+G++ V + T ++ A+K ++ D + E + + +L
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLA 396
Query: 183 LRRLDHPNIIKLEGLITSRLSC-----SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 236
L P + +L SC +Y V EY+ D+ + +F E Y
Sbjct: 397 LPG-KPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFY 447
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
++ GL S+G+++RD+K N+++++EG +K+ADFG+ N + T
Sbjct: 448 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTP 506
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
Y PE++ YG SVD W+ G + E+L G+ +G E E I +
Sbjct: 507 DYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--------- 556
Query: 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
P K + AV + + L++ P KR
Sbjct: 557 -HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 584
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 71/294 (24%), Positives = 121/294 (41%), Gaps = 61/294 (20%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
L+ + F + +G+G++ VF A T + A+K ++ + + E + + +L
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM-VEKRVL 71
Query: 182 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 230
+HP + + +++ V EY M H + KF
Sbjct: 72 -SLAWEHPFLTHM-------FCTFQTKENLFFVMEYLNGGDLMYH-----IQSCH-KFDL 117
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290
++ Y +++ GL+ HS+G+++RD+K N+L++ +G +K+ADFG+ N
Sbjct: 118 SRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTN 176
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
+ T Y PE+LLG Y SVD WS G + E+LIG+ G+ E E H I
Sbjct: 177 TFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--- 232
Query: 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
P + L A +L+ L EP KR
Sbjct: 233 -------DNPFYP-------------------RWLEKEAKDLLVKLFVREPEKR 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 67/303 (22%), Positives = 118/303 (38%), Gaps = 79/303 (26%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
++ F L +G+G++ V + T ++ A+K ++ + + E + + +L
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVL 74
Query: 182 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 230
L P + +L SC +Y V EY M H + +F E
Sbjct: 75 ALPG-KPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYH-----IQQVG-RFKE 120
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT 283
Y ++ GL S+G+++RD+K N+++++EG +K+ADFG+ + T
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
Query: 284 --GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341
G T Y PE++ YG SVD W+ G + E+L G+ +G E E
Sbjct: 181 FCG----------TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 401
I + P K + AV + + L++ P
Sbjct: 230 FQSIME----------HNVAYP-------------------KSMSKEAVAICKGLMTKHP 260
Query: 402 YKR 404
KR
Sbjct: 261 GKR 263
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 47/154 (30%), Positives = 84/154 (54%), Gaps = 7/154 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+ L+++G+G + SV R +TG++VA+KK++ E +R REI IL+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKS 98
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
L H NI+K +G+ S ++ L+ EY+ + + L + ++ Y +Q+ G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
E+ ++ +HRD+ N+LV NE +K+ DFGL
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 47/154 (30%), Positives = 84/154 (54%), Gaps = 7/154 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+ L+++G+G + SV R +TG++VA+KK++ E +R REI IL+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKS 67
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
L H NI+K +G+ S ++ L+ EY+ + + L + ++ Y +Q+ G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
E+ ++ +HRD+ N+LV NE +K+ DFGL
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 72/311 (23%), Positives = 127/311 (40%), Gaps = 86/311 (27%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
PL F+ L IG+G+Y+ V R T +I A+K V+ D+ + + V+ + +
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ-TEKHVF 63
Query: 182 ILRRLDHPNIIKLEGLI--TSRLSCSIYLVFEY------MEHDITGLLSCPDIKFSEAQI 233
+HP ++ L SRL + V EY M H + K E
Sbjct: 64 EQAS-NHPFLVGLHSCFQTESRL----FFVIEYVNGGDLMFH-----MQ-RQRKLPEEHA 112
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--G 284
+ Y ++ L + H RG+++RD+K N+L+++EG +KL D+G+ + ++T G
Sbjct: 113 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344
T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 173 ----------TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS------------- 208
Query: 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-----------KDLPTTAVNLI 393
P + P ++ F + L A +++
Sbjct: 209 ------------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 250
Query: 394 ETLLSVEPYKR 404
++ L+ +P +R
Sbjct: 251 KSFLNKDPKER 261
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 10/155 (6%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+K+ +G+G + V + TG++VA+K ++ D + +EI ILR
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEIDILRT 89
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC-PDIKFSEAQIKCYMNQLLHG 243
L H +IIK +G + S+ LV EY+ G L P AQ+ + Q+ G
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPL---GSLRDYLPRHSIGLAQLLLFAQQICEG 146
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + H++ +HRD+ N+L++N+ ++K+ DFGLA
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 71/294 (24%), Positives = 128/294 (43%), Gaps = 52/294 (17%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREIL 181
+ + FE L+ +G G Y VF R + DTGK+ A+K ++ + ++ E
Sbjct: 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 182 ILRRLDH-PNIIKLEGLI--TSRLSCSIYLVFEY------MEHDITGLLSCPDIKFSEAQ 232
+L + P ++ L ++L +L+ +Y H LS +F+E +
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKL----HLILDYINGGELFTH-----LSQ-RERFTEHE 160
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292
++ Y+ +++ LEH H G+++RDIK N+L+++ G + L DFGL+ +
Sbjct: 161 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220
Query: 293 VVTLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF-KLCG 350
T+ Y P+++ G + +VD WS+G + ELL G E +I ++
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280
Query: 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
S P P +++ A +LI+ LL +P KR
Sbjct: 281 SEP-------PYP-------------------QEMSALAKDLIQRLLMKDPKKR 308
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 69/314 (21%), Positives = 126/314 (40%), Gaps = 92/314 (29%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
L F+ L IG+G+Y+ V R T +I A++ V+ D+ + + V+ + +
Sbjct: 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ-TEKHVF 106
Query: 182 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 230
+HP ++ L SC ++ V EY M H + K E
Sbjct: 107 EQAS-NHPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFH-----MQ-RQRKLPE 152
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT 283
+ Y ++ L + H RG+++RD+K N+L+++EG +KL D+G+ + ++T
Sbjct: 153 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
Query: 284 --GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341
G T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 213 FCG----------TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS---------- 251
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-----------KDLPTTAV 390
P + P ++ F + L A
Sbjct: 252 ---------------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290
Query: 391 NLIETLLSVEPYKR 404
+++++ L+ +P +R
Sbjct: 291 SVLKSFLNKDPKER 304
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 7/154 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+ + ++G+G + SV R +TG +VA+K+++ P+ R REI IL+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKA 80
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
L I+K G+ S+ LV EY+ + L + +++ Y +Q+ G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
E+ SR +HRD+ N+LV +E +K+ADFGLA
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 37/222 (16%), Positives = 65/222 (29%), Gaps = 38/222 (17%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESV--RFMAREILILRRLDHPNII 192
L G ++A D + VAL V P+ V + L L R+D P +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKPGVA 94
Query: 193 KLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
++ ++ +R +V E++ + + + M L + H G
Sbjct: 95 RVLDVVHTRAGG--LVVAEWIRGGSLQEVADTSPSPVGAIRA---MQSLAAAADAAHRAG 149
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
V S + V+ +G + LA P
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA--------N 180
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
P D+ +G LL+ + L L + P
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ IG G V R G+ VA+K ++ E + F+ E I+ + DHPNI
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQFDHPNI 112
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+LEG++T +V EYME+ + L D +F+ Q+ + + G+ +
Sbjct: 113 IRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G +HRD+ N+LV++ V K++DFGL+
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 5/158 (3%)
Query: 122 QGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREIL 181
WV L + E+IG+G + VF R +VA+K R +F+ +E
Sbjct: 107 DKWV-LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEAR 164
Query: 182 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQL 240
IL++ HPNI++L G+ T + IY+V E ++ D L + + +
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+E+ S+ +HRD+ N LV + VLK++DFG++
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 6/159 (3%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKI---VALKKVRFDNFEPESVRFMAREI 180
+ + E IG+G + V+ LD A+K + E +F+ E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 77
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQ 239
+I++ HPN++ L G+ R S +V YM+H D+ + + + + Q
Sbjct: 78 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ G+++ S+ +HRD+ N +++ + +K+ADFGLA
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 37/160 (23%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR---DLDTGKI-VALKKVRFDNFEPESVRFMAREILI 182
L+ F+K++ +G G + +V++ + + KI VA+K++R + + E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYV 70
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC---PDIKFSEAQIKCYMN 238
+ +D+P++ +L G+ + ++ L+ + M G LL + +
Sbjct: 71 MASVDNPHVCRLLGICLTS---TVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV 124
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
Q+ G+ + R ++HRD+ N+LV +K+ DFGLA
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 52/232 (22%), Positives = 99/232 (42%), Gaps = 7/232 (3%)
Query: 52 RGSSNRKKGSKGEFGVAVSCGGSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPA 111
+ ++ + G+ V G L S SL + G+ + Y +G +
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69
Query: 112 WLSAVAGEAIQGWVPLRADAFEKLEK-IGQGTYSSVFRARDLDTGKI---VALKKVRFDN 167
L+ +A+Q V + + IG+G + V+ LD A+K +
Sbjct: 70 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 129
Query: 168 FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDI 226
E +F+ E +I++ HPN++ L G+ R S +V YM+H D+ +
Sbjct: 130 DIGEVSQFL-TEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETH 187
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + + Q+ G++ S+ +HRD+ N +++ + +K+ADFGLA
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 46/148 (31%), Positives = 78/148 (52%), Gaps = 7/148 (4%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ +G G + V R K VA+K ++ E + F+ E I+ + DHPNI
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNI 108
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+LEG++T S + +V EYME+ + L D +F+ Q+ + + G+++
Sbjct: 109 IRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G +HRD+ N+L+N+ V K++DFGL
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 115 AVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKI---VALKKVRFDNFEPE 171
G + + + ++ + E IG+G + V + + VA+K + +
Sbjct: 1 GAMGSSTRDYE-IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV 59
Query: 172 SVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSE 230
+F+ +E L +R+ DHP+I+KL G+IT ++++ E ++ L
Sbjct: 60 REKFL-QEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDL 115
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
A + Y QL L + S+ +HRDI N+LV++ +KL DFGL+
Sbjct: 116 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
K+G G Y V+ VA+K ++ D E E F+ +E +++ + HPN+++L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVMKEIKHPNLVQL 74
Query: 195 EGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
G+ T Y++ E+M + G L C + S + Q+ +E+
Sbjct: 75 LGVCT--REPPFYIITEFMTY---GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ +HRD+ N LV ++K+ADFGL+
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 35/145 (24%), Positives = 74/145 (51%), Gaps = 7/145 (4%)
Query: 137 KIGQGTYSSVFRAR-DLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
++G G + SV + + +I VA+K ++ + ++ M RE I+ +LD+P I++L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 75
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+ + ++ LV E + L + + + ++Q+ G+++ + +
Sbjct: 76 IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLA 278
HRD+ N+L+ N K++DFGL+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLS 157
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
K+G G Y V+ VA+K ++ D E E F+ E +++ + HPN+++L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK-EAAVMKEIKHPNLVQL 281
Query: 195 EGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
G+ T Y++ E+M + G L C + S + Q+ +E+
Sbjct: 282 LGVCTR--EPPFYIITEFMTY---GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGAT 308
+ +HR++ N LV ++K+ADFGL+ + ++ W P L
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK- 395
Query: 309 DYGPSVDLWSVGCVFAELL 327
+ D+W+ G + E+
Sbjct: 396 -FSIKSDVWAFGVLLWEIA 413
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR-DLDTGKI---VALKKVRFDNFEPESVRFMAREILI 182
+ + + IG G + V++ +GK VA+K ++ E + V F+ E I
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGI 99
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLL 241
+ + H NII+LEG+I+ + ++ EYME+ + L D +FS Q+ + +
Sbjct: 100 MGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+++ + +HRD+ N+LVN+ V K++DFGL+
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 126 PLRADAFE-------KLEKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVR- 174
PL++ LEK+G G++ V R + VA+K ++ D
Sbjct: 7 PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66
Query: 175 -FMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC---PDIKFS 229
F+ RE+ + LDH N+I+L G++ + + +V E G LL F
Sbjct: 67 DFI-REVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPL---GSLLDRLRKHQGHFL 119
Query: 230 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ Y Q+ G+ + S+ +HRD+ NLL+ ++K+ DFGL
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 8/148 (5%)
Query: 135 LEKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+G+G + V+ + KI VA+K + D +FM E +I++ LDHP+I
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAVIMKNLDHPHI 75
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+KL G+I +++ E + ++ L + Y Q+ + + S
Sbjct: 76 VKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+HRDI N+LV + +KL DFGL+
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 34/157 (21%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR---DLDTGKI-VALKKVRFDNFEPESVRFMAREILI 182
L+ F+K++ +G G + +V++ + + KI VA+K++R + + E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYV 70
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLL 241
+ +D+P++ +L G+ + ++ L+ + M + + + + Q+
Sbjct: 71 MASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+ + R ++HRD+ N+LV +K+ DFGLA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-22
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKI---VALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
IG+G + V + + VA+K + + +F+ +E L +R+ DHP+I
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHI 453
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+KL G+IT ++++ E ++ L A + Y QL L + S+
Sbjct: 454 VKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVTLWYRPPEL 303
+HRDI N+LV++ +KL DFGL+ + + + P+ W P +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI------KWMAPESI 564
Query: 304 LLGATDYGPSVDLWSVGCVFAELL 327
+ + D+W G E+L
Sbjct: 565 NFRR--FTSASDVWMFGVCMWEIL 586
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 33/164 (20%), Positives = 74/164 (45%), Gaps = 15/164 (9%)
Query: 126 PLRADAFE--------KLEKIGQGTYSSVFRAR-DLDTGKI-VALKKVRFDNFEPESVRF 175
+R + +++G G + +V + + VA+K ++ + +P
Sbjct: 5 EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 176 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 234
+ E ++++LD+P I+++ G+ + S LV E E + L + I
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNR-HVKDKNII 120
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
++Q+ G+++ +HRD+ N+L+ + K++DFGL+
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-22
Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 7/145 (4%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+++IG G + V L+ K VA+K +R E F+ E ++ +L HP +++L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--FI-EEAEVMMKLSHPKLVQL 68
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+ I LV E+MEH ++ L F+ + + G+ + V+
Sbjct: 69 YGVCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLA 278
HRD+ N LV V+K++DFG+
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMT 151
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 4e-22
Identities = 37/185 (20%), Positives = 82/185 (44%), Gaps = 7/185 (3%)
Query: 97 HKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRAR-DLDTG 155
K + + + S + R + ++G G + SV + +
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK 362
Query: 156 KI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214
+I VA+K ++ + ++ M RE I+ +LD+P I++L G+ + ++ LV E
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEMAG 418
Query: 215 H-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 273
+ L + + + ++Q+ G+++ + +HR++ N+L+ N K++
Sbjct: 419 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKIS 478
Query: 274 DFGLA 278
DFGL+
Sbjct: 479 DFGLS 483
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ K+GQG + V+ T + VA+K ++ PE F+ +E ++++L H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHE 239
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGL 244
+++L +++ IY+V EYM G L Q+ Q+ G+
Sbjct: 240 KLVQLYAVVSEE---PIYIVTEYMSK---GSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-WYRPPEL 303
+ +HRD++ +N+LV V K+ADFGLA + W P
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 304 LLGATDYGPSVDLWSVGCVFAELL 327
L G + D+WS G + EL
Sbjct: 354 LYGR--FTIKSDVWSFGILLTELT 375
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 6/159 (3%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREI 180
+P IG+G + V+ +D + A+K + + F+ RE
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REG 73
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQ 239
L++R L+HPN++ L G++ +++ YM H D+ + P + + + Q
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ G+E+ + +HRD+ N +++ +K+ADFGLA
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 33/157 (21%), Positives = 71/157 (45%), Gaps = 9/157 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR---DLDTGKI-VALKKVRFDNFEPESVRFMAREILI 182
+ KL+ +G G + +V + + ++ KI V +K + + +L
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLA 68
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLL 241
+ LDH +I++L GL S+ LV +Y+ + + + + Q+
Sbjct: 69 IGSLDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+ + G++HR++ N+L+ + +++ADFG+A
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 42/154 (27%), Positives = 82/154 (53%), Gaps = 15/154 (9%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + +E++G G + V+ K VA+K ++ + P++ F+A E ++++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA--FLA-EANLMKQLQHQ 68
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGL 244
+++L ++T IY++ EYME+ G L + IK + ++ Q+ G+
Sbjct: 69 RLVRLYAVVTQE---PIYIITEYMEN---GSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
R +HRD++ +N+LV++ K+ADFGLA
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 35/156 (22%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 135 LEKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ +G+G + SV + D + VA+K ++ DN + E ++ HPN+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 192 IKLEGLIT---SRLSCSIYLVFEYMEH-DITGLL-----SCPDIKFSEAQIKCYMNQLLH 242
I+L G+ S+ ++ +M++ D+ L + +M +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+E+ +R LHRD+ N ++ ++ + +ADFGL+
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 37/160 (23%), Positives = 69/160 (43%), Gaps = 19/160 (11%)
Query: 135 LEKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+G+G + SV A + D + VA+K ++ D + RE ++ DHP++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 192 IKLEGLIT----SRLSCSIYLVFEYMEHDITG-----LLSC----PDIKFSEAQIKCYMN 238
KL G+ ++ +M+H G LL+ + +M
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKH---GDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ G+E+ SR +HRD+ N ++ + + +ADFGL+
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ K+GQG + V+ T + VA+K ++ PE F+ +E ++++L H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHE 322
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGL 244
+++L +++ IY+V EYM G L Q+ Q+ G+
Sbjct: 323 KLVQLYAVVSEE---PIYIVTEYMSK---GSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-WYRPPEL 303
+ +HRD++ +N+LV V K+ADFGLA + W P
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 304 LLGATDYGPSVDLWSVGCVFAELL 327
L G + D+WS G + EL
Sbjct: 437 LYGR--FTIKSDVWSFGILLTELT 458
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 38/145 (26%), Positives = 73/145 (50%), Gaps = 7/145 (4%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
L+++G G + V + VA+K ++ + + F+ E ++ L H +++L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDE--FI-EEAKVMMNLSHEKLVQL 84
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+ T I+++ EYM + + L +F Q+ + +E+ S+ L
Sbjct: 85 YGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLA 278
HRD+ N LVN++GV+K++DFGL+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 33/145 (22%), Positives = 66/145 (45%), Gaps = 7/145 (4%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
L+++G G + V + VA+K ++ + + F +E + +L HP ++K
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSED--EFF-QEAQTMMKLSHPKLVKF 68
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+ + IY+V EY+ + + L +Q+ + G+ S +
Sbjct: 69 YGVCS--KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLA 278
HRD+ N LV+ + +K++DFG+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 16/171 (9%)
Query: 113 LSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES 172
++A GW L + L+ IG+G + V G VA+K ++ D
Sbjct: 5 VAAQDEFYRSGWA-LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQA- 60
Query: 173 VRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIK 227
F+ E ++ +L H N+++L G+I +Y+V EYM G L S
Sbjct: 61 --FL-AEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVTEYMAK---GSLVDYLRSRGRSV 113
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + + +E+ +HRD+ N+LV+ + V K++DFGL
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 29/159 (18%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++GQG++ V+ A+ + + VA+K V E + F+ E +++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCH 88
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL--SCPDIKFSEAQIKCYMNQLLH---- 242
++++L G+++ ++ E M D+ L P + + +++++
Sbjct: 89 HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 243 ---GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+ + ++ +HRD+ N +V + +K+ DFG+
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 16/170 (9%)
Query: 114 SAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESV 173
+A GW L + L+ IG+G + V G VA+K ++ D
Sbjct: 178 AAQDEFYRSGWA-LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQA-- 232
Query: 174 RFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKF 228
F+ E ++ +L H N+++L G+I +Y+V EYM G L S
Sbjct: 233 -FL-AEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAK---GSLVDYLRSRGRSVL 286
Query: 229 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + + +E+ +HRD+ N+LV+ + V K++DFGL
Sbjct: 287 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 36/165 (21%), Positives = 69/165 (41%), Gaps = 24/165 (14%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+E++G+ + V++ G+ VA+K ++ P F E ++ RL HP
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRARLQHP 72
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSEAQI 233
N++ L G++T + ++F Y H T
Sbjct: 73 NVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ Q+ G+E+ S V+H+D+ N+LV ++ +K++D GL
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 15/154 (9%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ + +K+G G + V+ A K VA+K ++ + E+ F+ E +++ L H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEA--FL-AEANVMKTLQHD 243
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGL 244
++KL ++T IY++ E+M G L S K ++ + Q+ G+
Sbjct: 244 KLVKLHAVVTKE---PIYIITEFMAK---GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
R +HRD++ +N+LV+ V K+ADFGLA
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-20
Identities = 41/238 (17%), Positives = 82/238 (34%), Gaps = 30/238 (12%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI-------VALKKVRFDNFEPESVRFMARE 179
+R + E +GQGT++ +F+ + G V LK + + F
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF-EA 62
Query: 180 ILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMN 238
++ +L H +++ G+ LV E+++ + L +
Sbjct: 63 ASMMSKLSHKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--------VLKLADFGLANF--SNTGHRQP 288
QL + ++H ++ N+L+ E +KL+D G++ ++
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKI 345
+ W PPE + + + D WS G E+ G L +L
Sbjct: 181 IP------WV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 43/227 (18%), Positives = 83/227 (36%), Gaps = 44/227 (19%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
+KIG G + ++ A + + A V+ E + + E+ +R+ + IK
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKV---EYQENGPLFSELKFYQRVAKKDCIKKW 99
Query: 196 GLITSRLSCSI-----------------YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
I ++V E + D+ + + F ++ +
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ-NGTFKKSTVLQLGI 158
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 295
++L LE+ H +H DIK +NLL+ N + LAD+GL+ + G+ +
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ----- 213
Query: 296 LWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK 330
P + G ++ S+ D+ +G L GK
Sbjct: 214 --ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 61/269 (22%), Positives = 97/269 (36%), Gaps = 64/269 (23%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF--MAREILILRRLDH- 188
F +KIG G + + ++L T + VA+K EP R + E ++L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 189 PNIIKL-----EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
I ++ G +V E + + L D FS + QL+
Sbjct: 65 DGIPQVYYFGPCGKYN-------AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISR 117
Query: 244 LEHCHSRGVLHRDIKGSNLLV-----NNEGVLKLADFGLANF---SNTGHRQPLTSRVVT 295
+E+ HS+ +++RD+K N L+ + V+ + DF LA T P
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP------- 170
Query: 296 LWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK-P--ILQGRTEVE 340
YR + L G Y S+ DL ++G +F L G P L+ T E
Sbjct: 171 --YREHKSLTGTARYM-SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE 227
Query: 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
+ KI K P L +
Sbjct: 228 RYQKIGD----------TKRATPIEVLCE 246
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 40/162 (24%), Positives = 68/162 (41%), Gaps = 22/162 (13%)
Query: 136 EKIGQGTYSSVFRAR--DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNII 192
+ IG+G + V +AR A+K+++ + + F E+ +L +L HPNII
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNII 89
Query: 193 KLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSEAQIKCY 236
L G +YL EY H + + S Q+ +
Sbjct: 90 NLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ G+++ + +HRD+ N+LV V K+ADFGL+
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 28/166 (16%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++G+G + VF +L + +VA+K ++ + E F RE +L L H
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REAELLTMLQHQ 103
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH----------DITGLLSCPDIKFSEAQIKCYMNQ 239
+I++ G+ T + +VFEYM H L + + + Q
Sbjct: 104 HIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG--LGQ 159
Query: 240 LLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
LL G+ + +HRD+ N LV V+K+ DFG++
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 58/263 (22%), Positives = 98/263 (37%), Gaps = 62/263 (23%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF--MAREILILRRLDH-PNII 192
KIG G++ ++ D+ G+ VA+K E + + E I + + I
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIK------LECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 193 KL-----EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+ EG +V E + + L + KFS + +Q++ +E+
Sbjct: 69 TIRWCGAEGDYN-------VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 248 HSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPP 301
HS+ +HRD+K N L+ ++ + DFGLA + T P YR
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP---------YREN 172
Query: 302 ELLLGATDYGPSV------------DLWSVGCVFAELLIGK---PILQGRTEVEQLHKIF 346
+ L G Y S+ DL S+G V +G L+ T+ ++ +I
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231
Query: 347 KLCGSPPDDYWKKSKLPHATLFK 369
+ KK P L K
Sbjct: 232 E----------KKMSTPIEVLCK 244
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 38/164 (23%), Positives = 65/164 (39%), Gaps = 28/164 (17%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +G G + V+ + VA+K + E + + F+ E LI+ + +H
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQ 93
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLH-- 242
NI++ G+ S +++ E M G L + + M LLH
Sbjct: 94 NIVRCIGVSL--QSLPRFILMELMAG---GDLKSFLRETRPRPSQPSSLA--MLDLLHVA 146
Query: 243 -----GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLA 278
G ++ +HRDI N L+ G V K+ DFG+A
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 32/173 (18%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ IG+G + VF+ A L + +VA+K ++ + F RE ++ D+P
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDNP 110
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-----------------DITGLLSCPDIKFSEAQ 232
NI+KL G+ + + L+FEYM + LS S
Sbjct: 111 NIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 233 IKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ L G+ + R +HRD+ N LV V+K+ADFGL+
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 25/165 (15%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++G+G + VF +L K +VA+K ++ D F RE +L L H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-REAELLTNLQHE 77
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL--------SCPDIKFSEAQIKCYMNQL 240
+I+K G+ + +VFEYM+H D+ L D + +A+ + ++Q+
Sbjct: 78 HIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 241 LH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
LH G+ + S+ +HRD+ N LV ++K+ DFG++
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 58/235 (24%), Positives = 106/235 (45%), Gaps = 43/235 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D F +G+G + V++ R L G +VA+K+++ + + ++F E+ ++ H
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHR 87
Query: 190 NIIKLEGL-ITS--RLSCSIYLVFEYME--------HDITGLLSCPD------IKFSEAQ 232
N+++L G +T RL LV+ YM + D I A+
Sbjct: 88 NLLRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 142
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG--HRQPLT 290
Y LH +HC + ++HRD+K +N+L++ E + DFGLA + H +T
Sbjct: 143 GLAY----LH--DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---VT 192
Query: 291 SRVV-TLWYRPPE-LLLG-ATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQ 341
+ V T+ + PE L G +++ D++ G + EL+ G + R +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 38/164 (23%), Positives = 65/164 (39%), Gaps = 28/164 (17%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +G G + V+ + VA+K + E + + F+ E LI+ + +H
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQ 134
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLH-- 242
NI++ G+ S +++ E M G L + + M LLH
Sbjct: 135 NIVRCIGVSL--QSLPRFILLELMAG---GDLKSFLRETRPRPSQPSSLA--MLDLLHVA 187
Query: 243 -----GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLA 278
G ++ +HRDI N L+ G V K+ DFG+A
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 63/284 (22%), Positives = 102/284 (35%), Gaps = 63/284 (22%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF--MAREILILRRLDH-PNII 192
+IG+G++ +F +L + VA+K FEP + E + L I
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIK------FEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
+ L LV + + + LL KFS + Q+L ++ H + +
Sbjct: 70 NVYYFGQEGLHN--VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127
Query: 253 LHRDIKGSNLLV-----NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELL 304
++RDIK N L+ N ++ + DFG+ F T P YR + L
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP---------YREKKNL 178
Query: 305 LGATDYGPSV------------DLWSVGCVFAELLIGK---PILQGRTEVEQLHKIFKLC 349
G Y S+ DL ++G VF L G L+ T ++ +I +
Sbjct: 179 SGTARYM-SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE-- 235
Query: 350 GSPPDDYWKKSKLPHATLFK--PQQ-----PYDSSLRETFKDLP 386
KK P L P++ Y +L F P
Sbjct: 236 --------KKQSTPLRELCAGFPEEFYKYMHYARNLA--FDATP 269
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 38/166 (22%), Positives = 68/166 (40%), Gaps = 24/166 (14%)
Query: 135 LEKIGQGTYSSVFRA--RDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLD-H 188
+ +G+G + V A +D VA+K ++ E M E+ IL + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SELKILIHIGHH 90
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSEAQ 232
N++ L G T + + ++ E+ + +
Sbjct: 91 LNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ CY Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 48/219 (21%)
Query: 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR----FMAREILILRRLDHPNII 192
K+G+G + V++ ++ VA+KK+ + + F EI ++ + H N++
Sbjct: 38 KMGEGGFGVVYKGY-VN-NTTVAVKKLA-AMVDITTEELKQQFDQ-EIKVMAKCQHENLV 93
Query: 193 KL-----EGLITSRLSCSIYLVFEYME--------HDITGLLSCP-----DIKFSEAQIK 234
+L +G LV+ YM + G I A
Sbjct: 94 ELLGFSSDG--DDLC-----LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN-- 144
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294
G+ H +HRDIK +N+L++ K++DFGLA S + +TSR+V
Sbjct: 145 --------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV 196
Query: 295 -TLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKP 331
T Y PE L G T D++S G V E++ G P
Sbjct: 197 GTTAYMAPEALRGEITP---KSDIYSFGVVLLEIITGLP 232
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 33/173 (19%), Positives = 73/173 (42%), Gaps = 32/173 (18%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +G+G + V +A VA+K ++ + E + E +L++++HP
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEFNVLKQVNHP 86
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH------------------------DITGLLSCPD 225
++IKL G + + L+ EY ++ + + L +
Sbjct: 87 HVIKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 226 IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + + Q+ G+++ ++HRD+ N+LV +K++DFGL+
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 57/240 (23%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR----FMAREILILRRLD 187
F+ IG G + V++ L G VALK+ PES + F EI L
Sbjct: 41 FDHKFLIGHGVFGKVYKGV-LRDGAKVALKR-----RTPESSQGIEEFET-EIETLSFCR 93
Query: 188 HPNIIKLEGLITSRLSCSIY--------LVFEYMEHDITGLLSCPDIKFSEAQIKCYM-- 237
HP+++ L G + L+++YME+ G L + M
Sbjct: 94 HPHLVSLIG----------FCDERNEMILIYKYMEN---GNLK--RHLYGSDLPTMSMSW 138
Query: 238 NQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290
Q L GL + H+R ++HRD+K N+L++ V K+ DFG++ + L+
Sbjct: 139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198
Query: 291 SRVV-TLWYRPPELLLGATDYGPS------VDLWSVGCVFAELLIGKPILQGRTEVEQLH 343
+ V TL Y PE Y D++S G V E+L + + E ++
Sbjct: 199 TVVKGTLGYIDPE-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 27/168 (16%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK-------IVALKKVRFDNFEPESVRFMAREILILRRL- 186
+ +G+G + V A + K VA+K ++ D E + + E+ +++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIG 98
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSE 230
H NII L G T +Y++ EY + P+ + +
Sbjct: 99 KHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ QL G+E+ S+ +HRD+ N+LV V+K+ADFGLA
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 59/258 (22%), Positives = 94/258 (36%), Gaps = 52/258 (20%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF--MAREILILRRL-DHPNII 192
KIG G++ ++ ++ T + VA+K E + + E I R L I
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
+ LV + + + L + K S + +Q+++ +E HS+
Sbjct: 67 NVRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
Query: 253 LHRDIKGSNLLV---NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELLLG 306
LHRDIK N L+ + + DFGLA ++T P YR + L G
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP---------YRENKNLTG 175
Query: 307 ATDYGPSV------------DLWSVGCVFAELLIGK---PILQGRTEVEQLHKIFKLCGS 351
Y SV DL S+G V L G L+ T+ ++ KI +
Sbjct: 176 TARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---- 230
Query: 352 PPDDYWKKSKLPHATLFK 369
KK L +
Sbjct: 231 ------KKVATSIEALCR 242
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 135 LEKIGQGTYSSVFRAR--DLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRL- 186
+ +G+G + V A +D K VA+K ++ D E + + E+ +++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIG 144
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSE 230
H NII L G T +Y++ EY + P+ + +
Sbjct: 145 KHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ QL G+E+ S+ +HRD+ N+LV V+K+ADFGLA
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 31/168 (18%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRLD-H 188
+ +G G + V A GK VA+K ++ E M E+ I+ L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-SELKIMSHLGQH 109
Query: 189 PNIIKLEGLITSRLSCS----IYLVFEYMEH--------------DITGLLSCPDIKFSE 230
NI+ L G C+ + ++ EY + + + + S
Sbjct: 110 ENIVNLLGA------CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + +Q+ G+ S+ +HRD+ N+L+ N V K+ DFGLA
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 46/245 (18%), Positives = 81/245 (33%), Gaps = 44/245 (17%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
IGQG + ++ A ++ + V EP + E+ +R P I+
Sbjct: 41 LPIGQGGFGCIYLADM-NSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 196 GLITSRLSCSI-----------------YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
+ +++ + D+ + +FS +
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 295
++L LE+ H +H DIK SNLL+N N + L D+GLA + G +
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA----- 214
Query: 296 LWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK-P--ILQGRTEVE 340
P G ++ S+ DL +G + L G P +
Sbjct: 215 --ADPKRCHDGTIEFT-SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271
Query: 341 QLHKI 345
+ KI
Sbjct: 272 RDSKI 276
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 27/168 (16%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKI-------VALKKVRFDNFEPESVRFMAREILILRRL- 186
+ +G+G + V A + K VA+K ++ D E + + E+ +++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIG 132
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSE 230
H NII L G T +Y++ EY P+ + S
Sbjct: 133 KHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 37/168 (22%), Positives = 63/168 (37%), Gaps = 27/168 (16%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
+ +G G + V A K VA+K ++ E M E+ +L L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLSYLGNH 86
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-----------DITGLLSCPDIKFSEAQIKCYM 237
NI+ L G T ++ EY + D + ++ +
Sbjct: 87 MNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 238 NQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
LL G+ S+ +HRD+ N+L+ + + K+ DFGLA
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 42/253 (16%), Positives = 73/253 (28%), Gaps = 60/253 (23%)
Query: 136 EKIGQGTYSSVFRARDLDTGKI--------VALKKVRFDNFEPESVRFMAREILILRRLD 187
+ ++ A T +LK + + R + E +R
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGR-LFNEQNFFQRAA 100
Query: 188 HPNIIKLEGLITSRLSCSI--------------YLVFEYMEHDITGLL-SCPDIKFSEAQ 232
P + + S +I +LV + + L P SE
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS 160
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLA-NFSNTGHRQPL 289
+ +LL LE H +H ++ N+ V ++ + LA +G A + +G
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA- 219
Query: 290 TSRVVTLWYR--PPELLLGATDYGPSV------------DLWSVGCVFAELLIGK-P--I 332
Y G ++ S+ DL S+G + L G P
Sbjct: 220 --------YVEGSRSPHEGDLEFI-SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270
Query: 333 LQGRTEVEQLHKI 345
TE K
Sbjct: 271 CLPNTEDIMKQKQ 283
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 32/173 (18%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
+ +G G + V A K VA+K ++ E M E+ ++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMTQLGSH 108
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSEAQ 232
NI+ L G T IYL+FEY + D + ++ E
Sbjct: 109 ENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 233 IKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
LL G+E + +HRD+ N+LV + V+K+ DFGLA
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 5e-08
Identities = 67/458 (14%), Positives = 133/458 (29%), Gaps = 143/458 (31%)
Query: 102 GEQVAAGWPAWLSAVAGEAIQG-------WVPL-RADAFEKLEKIGQGTYSSV---FRAR 150
G+ A L +Q W+ L ++ E + ++ Q + + +R
Sbjct: 162 GKTWVA-----LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 151 DLDTGKIVALKKVRFDNFEPESVRFMARE-----ILILRRLDHPNIIK-LEG----LITS 200
+ I K+R + + E R + + +L+L + + L+T+
Sbjct: 217 SDHSSNI----KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT 272
Query: 201 R-------LSCSIYLVFEYMEHDITG---------LLSCPDIKFSE--AQIKCYMNQLLH 242
R LS + ++H LL D + + ++ N
Sbjct: 273 RFKQVTDFLSAATTTHIS-LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV-LTTNPRRL 330
Query: 243 GL-------EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-------- 287
+ H VN + + + + L +R+
Sbjct: 331 SIIAESIRDGLATWDNWKH---------VNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF 381
Query: 288 ----PLTSRV-VTLW----YRPPELLLGATDYGPS-VDLWSVGCVFAELLIGKPILQGRT 337
+ + + +W +++ + S V+ E I P +
Sbjct: 382 PPSAHIPTILLSLIWFDVIKSDVMVVV-NKLHKYSLVEKQP-----KESTISIPSIYLEL 435
Query: 338 EVE-----QLHKIF--------KLCG---SPP--DDYWKKSKLP-HATLFKPQQP-YDSS 377
+V+ LH+ PP D Y+ S + H L + P +
Sbjct: 436 KVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF-YSHIGHH--LKNIEHPERMTL 492
Query: 378 LRETFKDL---------PTTAVN----LIETLLSVEPYKR-----ATASAALASEY--FS 417
R F D +TA N ++ TL ++ YK L + F
Sbjct: 493 FRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFL 552
Query: 418 TK--------PYACDLSSLPIYPPSKEI-DAKHREDAR 446
K Y DL + + + I + H++ R
Sbjct: 553 PKIEENLICSKY-TDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 19/44 (43%), Positives = 29/44 (65%)
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
CY Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 34/197 (17%), Positives = 67/197 (34%), Gaps = 19/197 (9%)
Query: 126 PLRADAFE------KLEK-IGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESV 173
P A +E KL K +G+G + V A K VA+K ++ E
Sbjct: 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 70
Query: 174 RFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQ 232
M E+ IL + H N++ L G T + + ++ E+ + G LS ++ +
Sbjct: 71 ALM-SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKF---GNLSTY-LRSKRNE 124
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292
Y + + G + D+K + + + F + +
Sbjct: 125 FVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184
Query: 293 VVTLWYRPPELLLGATD 309
+ + L+ +
Sbjct: 185 LYKDFLTLEHLICYSFQ 201
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 478 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.87 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.69 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.13 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.68 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.65 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.64 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.62 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.59 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.55 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.54 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.28 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.22 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.17 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.55 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.38 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.9 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 86.56 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.46 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-63 Score=500.90 Aligned_cols=293 Identities=32% Similarity=0.522 Sum_probs=246.2
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec----CCce
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSCS 205 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----~~~~ 205 (478)
++|++++.||+|+||+||+|++..+|+.||||+++.........+.+.+|+.+|+.|+|||||++++++... ....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999987666666677888999999999999999999987642 2467
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC-
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG- 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~- 284 (478)
+|||||||++++...+. ....+++..++.|++||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 134 ~~ivmE~~~g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCSEEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 99999999987666554 4568999999999999999999999999999999999999999999999999999865332
Q ss_pred --CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 285 --HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 285 --~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
......+.+||++|||||++.+...|+.++||||||||+|||++|++||.+.+..+++..|+...+.|+...|.....
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 223445679999999999998867789999999999999999999999999999999999999999999887755332
Q ss_pred CCccc--cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 363 PHATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 363 ~~~~~--~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
..... ..........+...++.+++++++||.+||.+||.+|||+.|+|+||||++...+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~ 355 (398)
T 4b99_A 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD 355 (398)
T ss_dssp -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence 21111 01111122345666788999999999999999999999999999999999865543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-63 Score=486.23 Aligned_cols=263 Identities=28% Similarity=0.434 Sum_probs=229.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++.||+|+||+||+|++..+++.||||++.+... .....+.+.+|+++|++|+|||||+++++|.+ ...+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEE
Confidence 4689999999999999999999999999999999976432 22345678899999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC-CC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HR 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~ 286 (478)
||||||+++.+..+......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+..... ..
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999998777666666678999999999999999999999999999999999999999999999999999876533 22
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
....+.+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|...-...|
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p------------- 254 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP------------- 254 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------------
T ss_pred ccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence 34566799999999999986 7799999999999999999999999999999998888876321111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHH------HHhCcccCCCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA------ALASEYFSTKPYAC 423 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e------~L~hp~f~~~~~~~ 423 (478)
..+++++++||.+||+.||.+|||+.| +++||||++..|..
T Consensus 255 ----------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 255 ----------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp ----------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred ----------------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 357889999999999999999999987 58999999877654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-62 Score=487.96 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=225.0
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+.|+++++||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.+|+.|+|||||+++++|.+ ...+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 4799999999999999999999999999999999865432 23457789999999999999999999988 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
||||+++.+..+... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ...
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 999998777666543 469999999999999999999999999999999999999999999999999998765432 334
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
.+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..|....... .
T Consensus 228 ~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~--------------- 290 (346)
T 4fih_A 228 KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-L--------------- 290 (346)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-C---------------
T ss_pred cccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-C---------------
Confidence 56799999999999876 779999999999999999999999999999988888876532111 1
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
..+..+++++++||.+||+.||++|||+.|+|+||||++..
T Consensus 291 ----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 291 ----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp ----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 11246899999999999999999999999999999998743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-63 Score=489.36 Aligned_cols=259 Identities=24% Similarity=0.453 Sum_probs=222.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+|+.||||+++.........+.+.+|+.+|++|+|||||+++++|.+ ...+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~yi 100 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYI 100 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999999887777778889999999999999999999999988 678999
Q ss_pred EEeeccCCchhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|||||+++.|..+. .....+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999986655443 344568999999999999999999999999999999999999999999999999998664321
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.+|......+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-------------- 244 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-------------- 244 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------------
T ss_pred ccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence 12345689999999999987 779999999999999999999999999999999888887632111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
....+++++++||.+||+.||.+|||+.|+|+||||++.
T Consensus 245 --------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 245 --------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred --------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 013678999999999999999999999999999999763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-62 Score=471.89 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=208.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++.||+|+||+||+|++..+++.||||++++.... ......+.+|+.+|++++|||||++++++.+ ...+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEE
Confidence 46899999999999999999999999999999999876543 3345678899999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
|||||++|+++..+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+..... .
T Consensus 90 ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 90 MVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp EEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 9999998777766654 457999999999999999999999999999999999999999999999999999866543 2
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
...+.+||+.|||||++.+...++.++|||||||++|+|++|++||.+.+..+.+.++.......
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~--------------- 231 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL--------------- 231 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 33567899999999999875556789999999999999999999999988888877776532111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...+++++++||.+||+.||++|||+.|+|+||||+.
T Consensus 232 --------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 232 --------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1357899999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-61 Score=488.81 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=224.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+.|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+ ...+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEE
Confidence 5799999999999999999999999999999999865432 23567899999999999999999999988 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
||||+++.|..+... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ...
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 999999777666543 369999999999999999999999999999999999999999999999999998765432 334
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
.+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..|....... .
T Consensus 305 ~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~--------------- 367 (423)
T 4fie_A 305 KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-L--------------- 367 (423)
T ss_dssp CCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-C---------------
T ss_pred cccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-C---------------
Confidence 66789999999999876 779999999999999999999999999999988888876532111 0
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..+..+++++++||.+||..||.+|||+.|+|+||||++.
T Consensus 368 ----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 368 ----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ----------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 1124689999999999999999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-60 Score=464.47 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=218.4
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec--CCceEEEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCSIYLV 209 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~~~lv 209 (478)
|++.++||+|+||+||+|++..++..||+|++..........+.+.+|+.+|++|+|||||+++++|... ....+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4777889999999999999999999999999987777777778899999999999999999999998652 24568999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEec-CCcEEEeecccccccCCCCC
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||+++.+..+......+++..++.|+.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 999999877777666678999999999999999999999998 999999999999984 79999999999986543
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
....+.+||+.|||||++.+ .|+.++|||||||+||||++|++||.+.+....+.+.+.. +..|..+
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~~~---------- 251 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASF---------- 251 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGGG----------
T ss_pred CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCCCC----------
Confidence 33456789999999998864 5899999999999999999999999877666555444321 1111111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...+++++++||.+||+.||.+|||+.|+|+||||++
T Consensus 252 ---------------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 252 ---------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ---------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ---------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1356788999999999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-62 Score=475.34 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=218.7
Q ss_pred ccceeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.++|++++.||+|+||+||+|++. .+++.||||+++...........+.+|+.+|++|+|||||+++++|.+ ...
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCE
Confidence 468999999999999999999874 468899999997654433334457789999999999999999999988 678
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+|||||||+++.+..+......+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 99999999987776666666689999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
....+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.+|.......
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------- 245 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM------------- 245 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred -ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC-------------
Confidence 33456789999999999987 789999999999999999999999999999999888887632111
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
...+++++++||.+||+.||++||| ++|+|+||||++..|
T Consensus 246 ----------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 246 ----------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp ----------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ----------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 1357899999999999999999998 589999999997654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-60 Score=466.53 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=217.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.+... .+|+.+|+.|+|||||+++++|.+ ...+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~--~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVRE--GPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 45799999999999999999999999999999999865432 369999999999999999999988 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-cEEEeecccccccCCCCC-
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHR- 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~~- 286 (478)
|||||+++.+..+......+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999877777666667899999999999999999999999999999999999999987 699999999987653221
Q ss_pred ---CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 287 ---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 287 ---~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
......+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.+|... .++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~---------- 274 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP---------- 274 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG----------
T ss_pred cceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC----------
Confidence 11234579999999999987 77999999999999999999999999988877777776552 111
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHH-------------HhCcccCCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA-------------LASEYFSTKP 420 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~-------------L~hp~f~~~~ 420 (478)
+.+..+.+++++.+||.+||+.||.+|||+.|+ |+|||+.+..
T Consensus 275 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 275 --------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp --------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred --------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 112235789999999999999999999999997 5789987643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-58 Score=461.94 Aligned_cols=283 Identities=27% Similarity=0.431 Sum_probs=221.1
Q ss_pred ccceeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 204 (478)
.++|++.++||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|+.+ +|||||+++++|.+ ..
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~ 93 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK--ND 93 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TT
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CC
Confidence 568999999999999999999874 467899999986543 234577899999998 79999999999988 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC-CcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~ 283 (478)
++||||||++++.+..+.. .+++.+++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+....
T Consensus 94 ~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 8999999999766555543 58999999999999999999999999999999999999987 8999999999975433
Q ss_pred CC---------------------------CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCC-CC
Q 011763 284 GH---------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-QG 335 (478)
Q Consensus 284 ~~---------------------------~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf-~~ 335 (478)
.. .....+.+||++|+|||++.+...|+.++||||+||++|||++|++|| .+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 21 122345689999999999987667999999999999999999999887 56
Q ss_pred CChHHHHHHHHHHcCCCCchhhccC---------CCCCcc------------ccCC----CCCCCccchhcccCCchhHH
Q 011763 336 RTEVEQLHKIFKLCGSPPDDYWKKS---------KLPHAT------------LFKP----QQPYDSSLRETFKDLPTTAV 390 (478)
Q Consensus 336 ~~~~~~~~~i~~~~g~~~~~~~~~~---------~~~~~~------------~~~~----~~~~~~~l~~~~~~~~~~l~ 390 (478)
.++.+++.+|...+|.++...+... ..+... ...+ .........+.+..++++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 6788999999998887653322210 000000 0000 00001112234567899999
Q ss_pred HHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 391 NLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 391 ~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
|||.+||++||.+|+|++|+|+||||++.+
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999998743
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-58 Score=448.10 Aligned_cols=262 Identities=23% Similarity=0.370 Sum_probs=199.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC-----
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----- 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 203 (478)
.++|++++.||+|+||+||+|+++.+++.||||+++... .....+.+.+|+.+|++|+|||||+++++|.+...
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 357999999999999999999999999999999998654 34556778899999999999999999999875432
Q ss_pred -----ceEEEEEeeccCCchhhccCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeec
Q 011763 204 -----CSIYLVFEYMEHDITGLLSCPDIK---FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (478)
Q Consensus 204 -----~~~~lv~e~~~~~ll~~~~~~~~~---l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF 275 (478)
.++|||||||+++.+..+...... .++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 257999999998766655544333 456678999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC-----------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011763 276 GLANFSNTGHR-----------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344 (478)
Q Consensus 276 G~a~~~~~~~~-----------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~ 344 (478)
|+|+....... ...++.+||+.|||||++.+ ..|+.++|||||||+||||++ ||.... +....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~ 236 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT 236 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence 99987643221 12244689999999999987 789999999999999999996 776432 33332
Q ss_pred HHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 345 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
+........+ ..+...++.+.+||.+||+.||.+|||+.|+|+||||++..++
T Consensus 237 ~~~~~~~~~p-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 237 LTDVRNLKFP-------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHTTCCC-------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred HHHHhcCCCC-------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 2222111111 1122446678899999999999999999999999999875543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=473.98 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=231.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.+ ...+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999997653 4445678899999999999999999999987 678999
Q ss_pred EEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC--CcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~--~~vkl~DFG~a~~~~~~~ 285 (478)
|||||+++.| ..+......|++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+.....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999998654 4455566689999999999999999999999999999999999999865 89999999999877543
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
......+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.+|......++...
T Consensus 311 -~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 379 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA--------- 379 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG---------
T ss_pred -CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc---------
Confidence 33456789999999999987 7799999999999999999999999999999999888876544333322
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 425 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~~ 425 (478)
+..+++++++||.+||+.||.+|||+.|+|+||||+...++...
T Consensus 380 ----------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 380 ----------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp ----------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTT
T ss_pred ----------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCch
Confidence 35789999999999999999999999999999999987665543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-56 Score=434.91 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=209.9
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|++.++||+|+||+||+|++.. .||||+++......+..+.+.+|+.+|++|+|||||++++++.+ ..+|
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~ 107 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLA 107 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEE
Confidence 35689999999999999999998643 59999998776677778889999999999999999999998754 3579
Q ss_pred EEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC-
Q 011763 208 LVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH- 285 (478)
Q Consensus 208 lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~- 285 (478)
||||||+++.|.. +......+++..+..|+.||+.||+|||+++||||||||+||||++++.+||+|||+|+......
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999866654 44556689999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.......+||+.|||||++.+ ...|+.++|||||||+||||+||+.||.+.+..+.+..++.....+|
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p---------- 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP---------- 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC----------
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC----------
Confidence 233456689999999999864 24689999999999999999999999998887776666554322111
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.+......+++++.+||.+||+.||++|||+.|++++
T Consensus 258 -------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 258 -------------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp -------------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred -------------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1112235688999999999999999999999987654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=472.75 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=217.8
Q ss_pred cccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC----ChHHHHHHHHHHHHHHhcCCCCeeeecceeeec
Q 011763 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF----EPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (478)
Q Consensus 126 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 201 (478)
++..++|++++.||+|+||+||+|+++.+|+.||||++++... ..........++.+++.++|||||+++++|.+
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~- 263 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT- 263 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-
Confidence 5568899999999999999999999999999999999975432 11222222334666677799999999999988
Q ss_pred CCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
...+|||||||+|+.|..++.....|++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+..
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 6789999999999877776666678999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCCCCchhhc
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~~~~g~~~~~~~~ 358 (478)
... ...+.+||+.|||||++.+...|+.++|||||||+||||++|++||.+.+. .+....+...- +
T Consensus 343 ~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~------ 411 (689)
T 3v5w_A 343 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--V------ 411 (689)
T ss_dssp SSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--C------
T ss_pred CCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--C------
Confidence 543 235679999999999997656799999999999999999999999986432 22333332211 0
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
.....+++++++||.+||+.||.+|++ +.|+++||||+...|
T Consensus 412 ---------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 412 ---------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred ---------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 011368999999999999999999998 799999999997654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=431.65 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=205.8
Q ss_pred ccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|.+.++||+|+||+||+|++. .+++.||||+++.. .....+.+.+|+.+|++|+|||||+++++|.+ .
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE--G 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 568999999999999999999864 36889999999743 45666789999999999999999999999987 5
Q ss_pred ceEEEEEeeccCCchhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC
Q 011763 204 CSIYLVFEYMEHDITGLLSCP---------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~---------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~ 268 (478)
..+|||||||+++.+..+... ..++++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 679999999998766654322 24699999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011763 269 VLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 346 (478)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~ 346 (478)
.+||+|||+|+....... ......++|+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.+..+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999986543322 22345678999999999986 779999999999999999999 999999999888887776
Q ss_pred HHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 347 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.....+ ....+++++.+||.+||+.||++|||+.|++++
T Consensus 275 ~g~~~~----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRELE----------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCCC----------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCC----------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 531110 013578999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=428.53 Aligned_cols=257 Identities=21% Similarity=0.332 Sum_probs=213.2
Q ss_pred ccccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 201 (478)
+..++|.+.+.||+|+||+||+|++. .+++.||||+++.. .....+.+.+|+.+|++|+|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~- 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE- 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-
Confidence 44678999999999999999999864 35789999999743 45666788999999999999999999999987
Q ss_pred CCceEEEEEeeccCCchhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC
Q 011763 202 LSCSIYLVFEYMEHDITGLLSC-------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~-------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~ 268 (478)
...+|||||||+++.+..++. ....+++..+..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 87 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 87 -GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 567999999999876655442 234699999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011763 269 VLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 346 (478)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~ 346 (478)
.+||+|||+|+........ ......+|+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999865432221 2233467999999999986 679999999999999999998 999999999888887776
Q ss_pred HHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 347 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...-.+ ....+|+++.+||.+||+.||++|||+.+++ +|+++
T Consensus 245 ~~~~~~----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 245 QGRVLQ----------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp HTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred cCCCCC----------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence 531110 0135789999999999999999999999994 56653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-54 Score=419.14 Aligned_cols=287 Identities=40% Similarity=0.685 Sum_probs=245.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|++++||||+++++++.+ ...+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 58999999999999999999999999999999998776666666778899999999999999999999987 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 158 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-ccc
Confidence 9999999888887777789999999999999999999999999999999999999999999999999998664322 233
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
....+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+...++.++...|...........
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 4567899999999998756689999999999999999987654 788888899999999999999888765332111112
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.+..+....+....+.+++++++||.+||+.||.+|||+.|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 222223334455557789999999999999999999999999999999863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=425.85 Aligned_cols=255 Identities=20% Similarity=0.324 Sum_probs=211.5
Q ss_pred ccccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 201 (478)
+..++++++++||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.+|++|+|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK- 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-
Confidence 44668999999999999999999853 467899999997543 33445778899999999999999999999987
Q ss_pred CCceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 265 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~ 265 (478)
...+|||||||+++.+..++.. ...+++..+..|+.||+.||.|||+++||||||||+||||+
T Consensus 101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 5678999999998766544321 23589999999999999999999999999999999999999
Q ss_pred cCCcEEEeecccccccCCCC-CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011763 266 NEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLH 343 (478)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~-~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~ 343 (478)
+++.+||+|||+|+...... .......++|+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999998654322 223345678999999999986 679999999999999999998 899999999888777
Q ss_pred HHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 344 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.+......+ ....+|+++.+||.+||+.||.+|||+.|++++
T Consensus 259 ~i~~~~~~~----------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLP----------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCC----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 765321110 113678999999999999999999999999865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=419.77 Aligned_cols=287 Identities=40% Similarity=0.714 Sum_probs=238.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++. +++.||+|++............+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCEEEE
Confidence 568999999999999999999985 58999999998665555556778899999999999999999999987 677999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 97 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 175 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS 175 (311)
T ss_dssp EEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence 99999998888887777789999999999999999999999999999999999999999999999999998665322 23
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...|...........
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 34457799999999988766789999999999999999999999999999999999999999998877765322110000
Q ss_pred -CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 369 -KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 369 -~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.........+....+.+++++++||.+||++||.+|||+.|+|+||||++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 011111223344556789999999999999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=412.21 Aligned_cols=284 Identities=38% Similarity=0.696 Sum_probs=233.9
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++++.||+|+||+||+|++ .+++.||+|++............+.+|+.+|+.++||||+++++++.. ...+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEE
Confidence 5899999999999999999998 678999999997654433344667789999999999999999999987 5679999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence 9999998777777666789999999999999999999999999999999999999999999999999997654321 223
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC-CCcccc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLF 368 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~ 368 (478)
....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+.++...++.++...|..... +....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP- 236 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc-
Confidence 4457799999999997756789999999999999999999999999999999999999999888777654221 11000
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.........+......+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00000111233445678999999999999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=438.83 Aligned_cols=294 Identities=33% Similarity=0.553 Sum_probs=229.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC---Cce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~ 205 (478)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.++|||||++++++.... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 35899999999999999999999999999999999766556667788899999999999999999999985422 357
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||||+++++...+.. ...+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 899999998876666654 4579999999999999999999999999999999999999999999999999998654221
Q ss_pred C--------------------------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-----------
Q 011763 286 R--------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI----------- 328 (478)
Q Consensus 286 ~--------------------------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt----------- 328 (478)
. ......++|++|+|||++.....|+.++||||||||||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1 123456789999999987655779999999999999999998
Q ss_pred CCCCCCCCC--------------------hHHHHHHHHHHcCCCCchhhccCCCCCccccC--CCCCCCccchhcccCCc
Q 011763 329 GKPILQGRT--------------------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--PQQPYDSSLRETFKDLP 386 (478)
Q Consensus 329 G~~pf~~~~--------------------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~~ 386 (478)
|+++|.+.+ ..+++..|+..+|.++.+.|..........+. ........+.+.++.++
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 788887765 36888999999999998877654332211111 11112234566678889
Q ss_pred hhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 387 TTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 387 ~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
+++++||.+||.+||.+|||+.|+|+||||+...++.
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 9999999999999999999999999999999876544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=439.33 Aligned_cols=285 Identities=30% Similarity=0.536 Sum_probs=231.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 56899999999999999999999999999999999876556666778889999999999999999999986532 24
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+||||||++++++..+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 6899999999987776643 4899999999999999999999999999999999999999999999999999866542
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
......++|++|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.+|++.+|.|+.++|.......
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 218 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred --cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 23456788999999999987 679999999999999999999999999999999999999999999988876542111
Q ss_pred ccccCCCCCC-Cccchhccc------------CCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 365 ATLFKPQQPY-DSSLRETFK------------DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 365 ~~~~~~~~~~-~~~l~~~~~------------~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.........+ ...+...++ ..++++++||.+||.+||.+|||+.|+|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 0111100000 011111111 125679999999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=413.62 Aligned_cols=259 Identities=28% Similarity=0.485 Sum_probs=226.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEE
Confidence 568999999999999999999999999999999998877677777888999999999999999999999977 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~ 169 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GK 169 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CG
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Cc
Confidence 9999988666555544557999999999999999999999999999999999999999999999999999766543 23
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
....++|+.|+|||++.+....+.++|||||||++|+|++|++||.+.+..+....+.......|
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p--------------- 234 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--------------- 234 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 45668899999999998754456899999999999999999999999988888777765321111
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
..+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 235 --------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 235 --------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp --------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred --------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 24688999999999999999999999999999998654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=423.87 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=209.6
Q ss_pred cccceeeeeeeeecCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CCeeeecceeeec
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPESVRFMAREILILRRLDH-PNIIKLEGLITSR 201 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~ 201 (478)
..++|++.+.||+|+||+||+|++..+ ++.||||++.... .....+.+.+|+.+|.++.| ||||+++++|...
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 357899999999999999999987543 4689999997543 44556778899999999954 9999999998653
Q ss_pred CCceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 265 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~ 265 (478)
+..+|||||||+++.+..++.. ...+++..+..|+.||+.||.|||+++||||||||+||||+
T Consensus 141 -~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 141 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp -TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 4568999999998766554321 24589999999999999999999999999999999999999
Q ss_pred cCCcEEEeecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011763 266 NEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLH 343 (478)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~ 343 (478)
+++.+||+|||+|+........ ......+|+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+.
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999866543222 2334578999999999986 779999999999999999998 999999876555544
Q ss_pred HHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 344 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
+++..-..++ ....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 299 ~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4443211111 013578899999999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=426.13 Aligned_cols=289 Identities=34% Similarity=0.583 Sum_probs=228.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|..+. ||||+++++++.......+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46899999999999999999999999999999999766556667777889999999996 99999999999875566899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC---
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG--- 284 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~--- 284 (478)
|||||+++++...+.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 88 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999999876666554 36899999999999999999999999999999999999999999999999999765321
Q ss_pred -----------------CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 011763 285 -----------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347 (478)
Q Consensus 285 -----------------~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~ 347 (478)
........++|++|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++..|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 112234568899999999998767899999999999999999999999999999999999999
Q ss_pred HcCCCCchhhccCCCCCccccCC-----CCCCCccchhcc-------------cCCchhHHHHHHHhcCCCCCCccCHHH
Q 011763 348 LCGSPPDDYWKKSKLPHATLFKP-----QQPYDSSLRETF-------------KDLPTTAVNLIETLLSVEPYKRATASA 409 (478)
Q Consensus 348 ~~g~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~~-------------~~~~~~l~~Li~~mL~~dP~~R~ta~e 409 (478)
.++.|+...+.....+....... .......+...+ ..+++++++||.+||.+||.+|||+.|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 99999887765433221100000 000000011111 267889999999999999999999999
Q ss_pred HHhCcccCCC
Q 011763 410 ALASEYFSTK 419 (478)
Q Consensus 410 ~L~hp~f~~~ 419 (478)
+|+||||+..
T Consensus 326 ~l~Hp~~~~~ 335 (388)
T 3oz6_A 326 ALKHPFVSIF 335 (388)
T ss_dssp HTTSTTTTTT
T ss_pred HhCCHHHHHh
Confidence 9999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=425.45 Aligned_cols=294 Identities=35% Similarity=0.560 Sum_probs=239.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC---ce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS---CS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~ 205 (478)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++..... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999999999999999998665566667888999999999999999999999876321 56
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||||+++++...+. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 89999999986666554 44579999999999999999999999999999999999999999999999999998664322
Q ss_pred C---------------------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-----------CCCCC
Q 011763 286 R---------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-----------GKPIL 333 (478)
Q Consensus 286 ~---------------------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-----------G~~pf 333 (478)
. ......++|++|+|||++.....|+.++|||||||++|||++ |.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1 123567889999999987666789999999999999999997 56667
Q ss_pred CCCC-----------------hHHHHHHHHHHcCCCCchhhccCCCCCcccc--CCCCCCCccchhcccCCchhHHHHHH
Q 011763 334 QGRT-----------------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLF--KPQQPYDSSLRETFKDLPTTAVNLIE 394 (478)
Q Consensus 334 ~~~~-----------------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~l~~Li~ 394 (478)
.+.+ ..+++..|++.+|.|+.+.+........... .........+...++.+++++++||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 6654 4788999999999999887765433211110 11111223455666789999999999
Q ss_pred HhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 395 TLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 395 ~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
+||.+||.+|||+.|+|+||||+...++.
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 99999999999999999999999865543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=413.12 Aligned_cols=288 Identities=36% Similarity=0.664 Sum_probs=223.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+++.||+|+++.... ......+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEE
Confidence 4589999999999999999999999999999999986542 2334567789999999999999999999987 678999
Q ss_pred EEeeccCCchhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 209 VFEYMEHDITGLLSC-----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 209 v~e~~~~~ll~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
||||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999999876655532 224589999999999999999999999999999999999999999999999999986643
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC-
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL- 362 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~- 362 (478)
.. .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++..++.++...|.....
T Consensus 161 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 161 PV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred Cc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 22 2234557899999999998756789999999999999999999999999999999999999999999888765321
Q ss_pred CCccccCCCCCCCccchh-----cccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 363 PHATLFKPQQPYDSSLRE-----TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~-----~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
+...... .......+.. ....++.++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 240 PKYNPNI-QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp TTCCTTC-CCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhccccc-ccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 1111000 0111111111 12367889999999999999999999999999999987443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=416.05 Aligned_cols=289 Identities=36% Similarity=0.656 Sum_probs=234.0
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++++.||+|+||+||+|++..+++.||||++..... ......+.+|+.+|+.++||||+++++++.. ....|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEE
Confidence 589999999999999999999999999999999975432 1111234479999999999999999999987 6779999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence 9999998888777767779999999999999999999999999999999999999999999999999997654322 233
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC-cccc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATLF 368 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~~~~ 368 (478)
....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...|....... ....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 445779999999998876778999999999999999999999999999999999999999999988775432111 0001
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
.........+....+.+++++.+||.+||++||.+|||+.|+|+||||.+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 111112223444556789999999999999999999999999999999875443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=412.99 Aligned_cols=288 Identities=37% Similarity=0.699 Sum_probs=228.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+++.||||+++...........+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 110 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLHL 110 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEEE
Confidence 568999999999999999999999999999999998765555555667789999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe-----cCCcEEEeecccccccCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-----NEGVLKLADFGLANFSNT 283 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-----~~~~vkl~DFG~a~~~~~ 283 (478)
||||+++++...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.....
T Consensus 111 v~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999999866665543 34699999999999999999999999999999999999995 445699999999976543
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC-
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL- 362 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~- 362 (478)
.. .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+.+++..++.++...|.....
T Consensus 190 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 190 PI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 22 2234457799999999998766789999999999999999999999999999999999999999998877754321
Q ss_pred CCccccCCCCCCCccchhcc-cCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 363 PHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~-~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
+......+ ......+...+ ..+++++.+||.+||++||.+|||+.|+|+||||+...|
T Consensus 269 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 269 PDWKQSFP-KFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TTCCTTCC-CCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhh-hhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 11111111 11112222222 347899999999999999999999999999999998665
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=417.99 Aligned_cols=289 Identities=33% Similarity=0.576 Sum_probs=234.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC----c
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----C 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~ 204 (478)
.++|++++.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+|+.++||||+++++++..... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 458999999999999999999999999999999997665556667788899999999999999999999876321 3
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-
Confidence 5699999996555554443 3689999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.....++|++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..|+..+|.++.+++.......
T Consensus 181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 181 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 23456789999999998876779999999999999999999999999999999999999999999988876543211
Q ss_pred ccccC--CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 365 ATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 365 ~~~~~--~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
...+. ........+...++.+++.+.+||.+||..||.+|||+.|+|+||||+....+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence 10000 001112234455678899999999999999999999999999999998765443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=413.95 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=227.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.+.|++.+.||+|+||+||+|++..+++.||+|++....... ...+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 457999999999999999999999999999999998654321 134678899999999999999999999987 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC----cEEEeecccccc
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANF 280 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~DFG~a~~ 280 (478)
.+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 8999999999877776666677899999999999999999999999999999999999998877 799999999987
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... ......++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+..+
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~---- 241 (361)
T 2yab_A 169 IEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF---- 241 (361)
T ss_dssp CCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH----
T ss_pred cCCC--CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh----
Confidence 6543 23355678999999999876 6789999999999999999999999999998888888766444333333
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
+..+++.+++||.+||..||.+|||+.|+|+||||+..
T Consensus 242 ---------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 242 ---------------------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp ---------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred ---------------------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 35788999999999999999999999999999999853
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=411.12 Aligned_cols=295 Identities=40% Similarity=0.690 Sum_probs=240.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP---ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.++|++++.||+|+||+||+|++..+++.||||++....... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 86 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSN 86 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CCc
Confidence 568999999999999999999999999999999997543221 112456789999999999999999999977 567
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
.|+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 89999999998777777766789999999999999999999999999999999999999999999999999998664332
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC-CCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~ 364 (478)
.......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.++...|.... .+.
T Consensus 167 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 167 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred -ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 233456789999999998775678999999999999999999999999999999999999999999888776532 221
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCCCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL 428 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~~~~~ 428 (478)
...+.. .....+...+..+++++++||.+||..||.+|||+.|+|+||||++.+.+.....+
T Consensus 246 ~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~~~ 307 (346)
T 1ua2_A 246 YVTFKS--FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 307 (346)
T ss_dssp CCCCCC--CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSS
T ss_pred cccccc--cCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcccC
Confidence 111111 11122445567889999999999999999999999999999999987776554433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=413.38 Aligned_cols=295 Identities=42% Similarity=0.703 Sum_probs=242.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL------ 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 202 (478)
.++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 56899999999999999999999999999999999766554444556778999999999999999999987643
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...+||||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 34689999999998888887777789999999999999999999999999999999999999999999999999997654
Q ss_pred CC---CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 283 TG---HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 283 ~~---~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
.. .........+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++...|..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 22 122334567799999999998766789999999999999999999999999999999999999999998887755
Q ss_pred CCCCCc-cccCCCCCCCccchhccc--CCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 360 SKLPHA-TLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 360 ~~~~~~-~~~~~~~~~~~~l~~~~~--~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
...... ............+...+. ..++.+.+||.+||+.||.+|||+.|+|+||||+..+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 321110 000000011111111111 2477899999999999999999999999999999876654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=401.38 Aligned_cols=291 Identities=34% Similarity=0.585 Sum_probs=236.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEE
Confidence 358999999999999999999999999999999998766566667778899999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DY 158 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cc
Confidence 99999998888777766789999999999999999999999999999999999999999999999999997655322 22
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc--c
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA--T 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~--~ 366 (478)
.....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++...+..+........ .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 34557899999999998767789999999999999999999999999999999999988888776544322111100 0
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
...+.......+...++.++..+.+||.+||+.||.+|||+.|+|+||||++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 00111112223444567899999999999999999999999999999999875543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=402.84 Aligned_cols=286 Identities=37% Similarity=0.662 Sum_probs=233.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhc---CCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---PESVRFMAREILILRRL---DHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~---~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~ 202 (478)
.++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56899999999999999999999999999999999754321 11123455677777666 5999999999987643
Q ss_pred C---ceEEEEEeeccCCchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccc
Q 011763 203 S---CSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (478)
Q Consensus 203 ~---~~~~lv~e~~~~~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a 278 (478)
. ..+++||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 2 2589999999987776665543 34999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhc
Q 011763 279 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 279 ~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.+++..++.++...|.
T Consensus 168 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSYQ--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTTC--CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCCC--cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 766432 23355678999999999886 678999999999999999999999999999999999999999999988886
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.........+.+. ....+....+.+++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPPR--GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCCC--CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccCCC--CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 5432222222211 2233455567899999999999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=407.88 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=223.7
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
..++|++++.||+|+||+||+|++..+++.||||+++.... .......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEE
Confidence 36789999999999999999999999999999999975421 12334567889999999999999999999987 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 9999999987776665555679999999999999999999999999999999999999999999999999997543222
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......++|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....+.......
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 224 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-------------- 224 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 23455688999999999876 678999999999999999999999999988877777765421110
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
...+++++.+||.+||+.||.+|| ++.|+++||||+...|
T Consensus 225 ---------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 225 ---------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 125788999999999999999999 9999999999987654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=412.86 Aligned_cols=289 Identities=34% Similarity=0.570 Sum_probs=226.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec----CCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----~~~ 204 (478)
.++|++++.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+|+.++||||+++++++... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4589999999999999999999999999999999976655566677888999999999999999999998653 125
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 6899999997665555433 4799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.....++|++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..|+..+|.|+...+.......
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 23456789999999998876778999999999999999999999999999999999999999999988776543221
Q ss_pred cccc--CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 365 ATLF--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 365 ~~~~--~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
...+ .........+...+...++.+.+||.+||..||.+|||+.|+|+||||+....+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence 1100 0001112234555678899999999999999999999999999999999765544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=409.86 Aligned_cols=260 Identities=30% Similarity=0.455 Sum_probs=227.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+|+.++||||+++++++.+ ....|+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 357999999999999999999999999999999998877677777888999999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC---cEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~DFG~a~~~~~~~ 285 (478)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 999999876665555566899999999999999999999999999999999999998654 5999999999866533
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......+...
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 253 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE--------- 253 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG---------
T ss_pred -cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc---------
Confidence 23345678999999999876 6789999999999999999999999999988888887766433333222
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
+..+++++.+||.+||..||.+|||+.++|+||||..
T Consensus 254 ----------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 254 ----------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp ----------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ----------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 2468899999999999999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=414.53 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=220.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 206 (478)
.++|++++.||+|+||+||+|++..+++.||||+++.... .....+.+.+|+.+|..+ +||||+++++++.. ...+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEE
Confidence 6789999999999999999999999999999999975422 223455677899999988 79999999999987 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 9999999987776666555689999999999999999999999999999999999999999999999999997543222
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......++|+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.+|.......|
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p------------- 244 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP------------- 244 (353)
T ss_dssp -------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence 23355689999999999876 6789999999999999999999999999999988888876321111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH------HHHHhCcccCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 421 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta------~e~L~hp~f~~~~~ 421 (478)
..+++++.+||.+||+.||.+||++ .++++||||+...|
T Consensus 245 ----------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 245 ----------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred ----------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 2478899999999999999999998 99999999998655
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=419.91 Aligned_cols=261 Identities=30% Similarity=0.447 Sum_probs=226.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|.+..+++.||+|++..........+.+.+|+.+|+.++||||+++++++.+ ....||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEE
Confidence 458999999999999999999999999999999998777666667788899999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe---cCCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~vkl~DFG~a~~~~~~~ 285 (478)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999876655555556799999999999999999999999999999999999998 45789999999997665432
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+...
T Consensus 168 -~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 236 (444)
T 3soa_A 168 -QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE--------- 236 (444)
T ss_dssp -CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT---------
T ss_pred -ceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc---------
Confidence 23345688999999999876 6789999999999999999999999999998888888876544333322
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
++.+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 237 ----------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 237 ----------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ----------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ----------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 2468899999999999999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=415.98 Aligned_cols=287 Identities=30% Similarity=0.530 Sum_probs=225.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999999999999999999876556666778889999999999999999999987532 23
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+||||+++++...+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 789999999998777664 25899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++..++.+.+.+|.......
T Consensus 181 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 181 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred --cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 22345678999999999987 678999999999999999999999999999999999999999998887765432100
Q ss_pred ccccCCCCCC-Cccchhcc------------cCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 365 ATLFKPQQPY-DSSLRETF------------KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~~~~~-~~~l~~~~------------~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
.........+ ...+...+ ...+.++++||.+||..||.+|||+.|+|+||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 0000000000 00111111 112568999999999999999999999999999987544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=401.47 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=225.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||+||+|++..+++.||+|++... ......+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEE
Confidence 46899999999999999999999999999999999743 3445667899999999999999999999987 678999
Q ss_pred EEeeccCCchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec--CCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~--~~~vkl~DFG~a~~~~~~~ 285 (478)
||||++++.+. .+......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 99999985554 44444457999999999999999999999999999999999999997 789999999999876543
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 226 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA--------- 226 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH---------
T ss_pred -CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh---------
Confidence 22345678999999999876 5689999999999999999999999999999888888877544333322
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
++.+++++.+||.+||..||.+|||+.|+|+||||++...
T Consensus 227 ----------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 227 ----------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp ----------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred ----------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 3578999999999999999999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=406.82 Aligned_cols=289 Identities=34% Similarity=0.545 Sum_probs=239.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC---Cce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~ 205 (478)
.++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|.+++||||+++++++.... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 458999999999999999999999999999999997533 4455577889999999999999999999986532 246
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
.|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 899999999877666543 368999999999999999999999999999999999999999999999999997664322
Q ss_pred C--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 286 R--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 286 ~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. ......++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.++.+.|......
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 12345678999999999876667899999999999999999999999999999999999999999998776543211
Q ss_pred Cccc--cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 364 HATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 364 ~~~~--~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
.... ..........+...++.+++++.+||.+||++||.+|||+.|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 1000 00111112234455678899999999999999999999999999999998753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=413.39 Aligned_cols=284 Identities=36% Similarity=0.585 Sum_probs=231.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec----CCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----~~~ 204 (478)
..+|++++.||+|+||+||+|++..+++.||||++..+.. ...+|+++|+.++|||||+++++|... ...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 4479999999999999999999999999999999975431 123699999999999999999988542 123
Q ss_pred eEEEEEeeccCCchhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC-CcEEEeecccccc
Q 011763 205 SIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANF 280 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~~ 280 (478)
+++|||||+++++...+. .....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 578999999987655443 345679999999999999999999999999999999999999965 5789999999986
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... .....++|+.|+|||++.+...|+.++|||||||+||||++|++||.+.+..+++.+++..++.+..+.|...
T Consensus 207 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 54332 2345678999999999987567999999999999999999999999999999999999999999988777553
Q ss_pred CCCCccccCCCCCCCccchhcc-cCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~-~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
.........+ ......+...+ +.+++++++||.+||.+||.+|||+.|+|+||||+....
T Consensus 285 ~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 285 NPNYTEFKFP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CSCCCCCCCC-CCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred ChhhhhhccC-ccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 2211111111 11112233333 467899999999999999999999999999999986433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=398.72 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=225.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.+.|++.+.||+|+||.||+|++..+++.||+|++....... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CC
Confidence 357999999999999999999999999999999998654321 235678899999999999999999999987 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC----cEEEeecccccc
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANF 280 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~DFG~a~~ 280 (478)
.+|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 8999999999877766666667899999999999999999999999999999999999999887 899999999987
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+..
T Consensus 168 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 239 (326)
T 2y0a_A 168 IDFG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE----- 239 (326)
T ss_dssp CCTT--SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHH-----
T ss_pred CCCC--CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcc-----
Confidence 6533 22345678999999999876 678999999999999999999999999998888887776643333322
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.+..++..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 240 --------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 240 --------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp --------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred --------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 235688999999999999999999999999999999763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=400.95 Aligned_cols=258 Identities=23% Similarity=0.374 Sum_probs=223.7
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
..++|++++.||+|+||+||+|++..+++.||+|+++.... .....+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEE
Confidence 36789999999999999999999999999999999975421 11234567789999999999999999999987 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999998776666655668999999999999999999999999999999999999999999999999999865432
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
....++|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+...++.......
T Consensus 160 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------- 222 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF-------------- 222 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--------------
T ss_pred --cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 245678999999999876 678999999999999999999999999998888888876532111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
...+++++.+||.+||..||.+|| +++++++||||+...|
T Consensus 223 ---------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 223 ---------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred ---------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 125788999999999999999999 9999999999997655
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=393.78 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=214.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh------------------------HHHHHHHHHHHHHH
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP------------------------ESVRFMAREILILR 184 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 184 (478)
.++|++.+.||+|+||+||+|++..+++.||||++....... ...+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 568999999999999999999999999999999997654211 12356788999999
Q ss_pred hcCCCCeeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 011763 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (478)
Q Consensus 185 ~l~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl 264 (478)
.++||||+++++++.+.....+||||||++++.+..+.. ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 999999999999998766778999999999877666543 3479999999999999999999999999999999999999
Q ss_pred ecCCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 011763 265 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 342 (478)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~--~~~~~DiwslG~il~elltG~~pf~~~~~~~~~ 342 (478)
+.++.+||+|||++....... .......+|+.|+|||++.+... ++.++|||||||++|+|++|+.||.........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999998665332 22344678999999999876332 477899999999999999999999988776666
Q ss_pred HHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 343 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
..+.......+ ....+++++.+||.+||+.||.+|||+.|+|+||||+
T Consensus 250 ~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEFP---------------------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCCC---------------------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCCC---------------------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 55544211111 0136789999999999999999999999999999996
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=408.37 Aligned_cols=281 Identities=34% Similarity=0.587 Sum_probs=230.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec-------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR------- 201 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------- 201 (478)
.++|++.+.||+|+||+||+|++..+++.||||++..+... ..+|+.+|+.++||||++++++|...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 56899999999999999999999999999999999754321 23699999999999999999988542
Q ss_pred -----------------------------CCceEEEEEeeccCCchhhc---cCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 011763 202 -----------------------------LSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHS 249 (478)
Q Consensus 202 -----------------------------~~~~~~lv~e~~~~~ll~~~---~~~~~~l~~~~~~~i~~qil~aL~~LH~ 249 (478)
...++++||||+++++...+ ......+++..++.++.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 23458999999998754443 3455689999999999999999999999
Q ss_pred CCceeccCCCCcEEEe-cCCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh
Q 011763 250 RGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 328 (478)
Q Consensus 250 ~givHrDlkp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt 328 (478)
+||+||||||+||||+ .++.+||+|||+++..... .......+|+.|+|||++.+...++.++|||||||++|+|++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 9999999999999998 6889999999999866443 233456779999999998876679999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcc-cCCchhHHHHHHHhcCCCCCCccCH
Q 011763 329 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATA 407 (478)
Q Consensus 329 G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~l~~Li~~mL~~dP~~R~ta 407 (478)
|++||.+.+..+++.+++..++.|+.+.|............+.. ....+...+ ..+++++.+||.+||.+||.+|||+
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL-KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCC-CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCcc-CcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99999999999999999999999988776553322111111111 122233333 3588999999999999999999999
Q ss_pred HHHHhCcccCC
Q 011763 408 SAALASEYFST 418 (478)
Q Consensus 408 ~e~L~hp~f~~ 418 (478)
.|+|+||||+.
T Consensus 317 ~e~l~hp~f~~ 327 (383)
T 3eb0_A 317 YEAMAHPFFDH 327 (383)
T ss_dssp HHHHTSGGGHH
T ss_pred HHHhcCHHHHH
Confidence 99999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=419.44 Aligned_cols=271 Identities=24% Similarity=0.337 Sum_probs=225.4
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
+..++|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+|..++||||++++++|.+ ...
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~ 148 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNN 148 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCE
Confidence 346799999999999999999999999999999999975321 11112336789999999999999999999987 678
Q ss_pred EEEEEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
+||||||++++.+..+. .....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 99999999876555444 43568999999999999999999999999999999999999999999999999999766544
Q ss_pred CCCCccccccCCcccCccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 285 HRQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
........+||+.|+|||++. +...|+.++|||||||+||||++|++||.+.+..+.+.+|+.......
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------- 301 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ------- 301 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-------
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc-------
Confidence 333344568999999999986 235689999999999999999999999999999888888864321110
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCC--ccCHHHHHhCcccCCCCCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPYAC 423 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~--R~ta~e~L~hp~f~~~~~~~ 423 (478)
+...+..+++++++||++||..+|++ |++++|+++||||+...|..
T Consensus 302 -----------------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 302 -----------------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp -----------------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred -----------------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 00112358899999999999999988 99999999999999876654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=404.83 Aligned_cols=287 Identities=34% Similarity=0.583 Sum_probs=236.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc----
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC---- 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~---- 204 (478)
.++|.+.+.||+|+||+||+|++..+++.||||++............+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4589999999999999999999999999999999987665666677888999999999999999999999763221
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+||||+.+++...+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 121 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 249999999987665552 34899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+.++....+.++.+++.......
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3446779999999998876778999999999999999999999999999999999999999999888765533211
Q ss_pred ccc--cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 365 ATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 365 ~~~--~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
... ..........+...++.+++.+.+||.+||++||.+|||+.|+|+||||+....+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 000 0001112223445556789999999999999999999999999999999865443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=410.37 Aligned_cols=260 Identities=23% Similarity=0.419 Sum_probs=216.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 206 (478)
.++|++++.||+|+||+||+|++..+++.||||+++..... ......+.+|+.+|.++ +||||++++++|.. ...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEE
Confidence 56899999999999999999999999999999999865432 33345577899999887 89999999999987 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 207 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 207 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-C
Confidence 999999998777666655668999999999999999999999999999999999999999999999999999753322 2
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHcCCCCchhh
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---------~~~~~~i~~~~g~~~~~~~ 357 (478)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||..... ......+......
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 280 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------ 280 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC------
T ss_pred CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC------
Confidence 33456789999999999987 6789999999999999999999999964321 1222333221100
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH------HHHHhCcccCCCCC
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 421 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta------~e~L~hp~f~~~~~ 421 (478)
....++.++++||.+||+.||.+||++ .|+++||||+...|
T Consensus 281 -----------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 281 -----------------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred -----------------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 013578899999999999999999985 89999999998665
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=400.80 Aligned_cols=262 Identities=24% Similarity=0.426 Sum_probs=218.9
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCc
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 204 (478)
+..++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|..+ +||||+++++++.. ..
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~ 83 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ES 83 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CC
Confidence 346789999999999999999999999999999999987654 345567788999999988 89999999999987 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 89999999998766665555567999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHHcCCCCch
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------EVEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~---------~~~~~~~i~~~~g~~~~~ 355 (478)
. ......++|+.|+|||++.+ ..++.++|||||||++|||++|++||.... .......+......
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---- 237 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---- 237 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC----
T ss_pred C-CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC----
Confidence 1 23455688999999999886 678999999999999999999999997521 22222333221000
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH------HHHHhCcccCCCCC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 421 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta------~e~L~hp~f~~~~~ 421 (478)
....++.++.+||.+||+.||.+||++ .++++||||+...|
T Consensus 238 -------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 238 -------------------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp -------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred -------------------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 013578899999999999999999995 89999999987655
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=393.26 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=220.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEE
Confidence 56899999999999999999999999999999999765432 24567889999999999999999999987 677999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+..+.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cc
Confidence 99999887666555433 68999999999999999999999999999999999999999999999999997665432 23
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+........
T Consensus 173 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 236 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------------- 236 (297)
T ss_dssp BCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------------
T ss_pred cCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 345678999999999886 6789999999999999999999999999888777766654321110
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 237 -----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 237 -----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp -----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred -----------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 011357889999999999999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=401.51 Aligned_cols=287 Identities=31% Similarity=0.587 Sum_probs=237.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEEE
Confidence 568999999999999999999999999999999998776666667778899999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 180 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 180 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cc
Confidence 99999998888776666689999999999999999999999999999999999999999999999999997654322 22
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC--Ccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP--HAT 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~--~~~ 366 (478)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+..++..+...... ...
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 344578999999999987567899999999999999999999999999999999999988888775543221100 000
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...+.......+...++.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 1111112223344556788999999999999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=406.53 Aligned_cols=284 Identities=36% Similarity=0.571 Sum_probs=229.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
..+|++++.||+|+||+||+|++..+++ ||+|++..+... ..+|+.+|+.++||||++++++|.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4579999999999999999999887766 888887643311 236999999999999999999986532 23
Q ss_pred eEEEEEeeccCCchhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe-cCCcEEEeecccccc
Q 011763 205 SIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANF 280 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-~~~~vkl~DFG~a~~ 280 (478)
++||||||++++++..+. .....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 488999999987665443 2355799999999999999999999999999999999999999 789999999999987
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... ......+|+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+++..++..++.|+...+...
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 64432 2345678999999999987667999999999999999999999999999999999999999999987766543
Q ss_pred CCCCccccCCCCCCCccchhcc-cCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~-~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
.........+. .....+...+ ..+++++.+||.+||++||.+|||+.|+|+||||++....
T Consensus 270 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 270 NPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp CGGGSSSCCCC-CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred Chhhhhhcccc-ccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 21111111111 1112233333 3589999999999999999999999999999999875443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=416.42 Aligned_cols=268 Identities=27% Similarity=0.370 Sum_probs=223.5
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
+..++|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+|..++|||||+++++|.+ ...
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 143 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRY 143 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCE
Confidence 447799999999999999999999999999999999975221 11112346789999999999999999999987 678
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||||++++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 144 ~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999988666555443 368999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCccccccCCcccCcccccCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGAT---DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~---~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
.......+||+.|+|||++.+.. .|+.++|||||||+||||++|++||.+.+..+...+|.........
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 294 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF-------- 294 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC--------
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC--------
Confidence 33344678999999999987632 2789999999999999999999999999998888888653211100
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCC--ccCHHHHHhCcccCCCCCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPYA 422 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~--R~ta~e~L~hp~f~~~~~~ 422 (478)
.....+++++++||.+||..+|.+ |+++.|+++||||+...|.
T Consensus 295 -----------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 295 -----------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp -----------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred -----------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 001357899999999999999988 9999999999999986654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=405.40 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=222.7
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCc
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 204 (478)
+..++|++++.||+|+||+||+|++..+++.||||+++.... .......+..|..+|..+ +||||+++++++.+ ..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KE 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CC
Confidence 447799999999999999999999999999999999975421 122345567899999887 99999999999987 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 89999999998776666555567999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
. ......++|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+.++.......
T Consensus 172 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 237 (345)
T 1xjd_A 172 D-AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY------------ 237 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred C-CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC------------
Confidence 2 23456788999999999986 678999999999999999999999999998888887775421110
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHH-HHHhCcccCCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~-e~L~hp~f~~~~~ 421 (478)
...+++++.+||.+||..||.+||++. ++++||||+...|
T Consensus 238 -----------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 238 -----------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp -----------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred -----------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 024788999999999999999999998 9999999998665
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=395.19 Aligned_cols=262 Identities=27% Similarity=0.382 Sum_probs=215.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+ ....||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEE
Confidence 5689999999999999999999999999999999975542 2334567889999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC-CC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 287 (478)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999987777777777789999999999999999999999999999999999999999999999999997653221 12
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+|+.|+|||++.+...++.++|||||||++|+|++|+.||...................
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 227 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 227 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT---------------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc---------------
Confidence 23456789999999999875555789999999999999999999998766543322222211100
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
...+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 228 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 228 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 01124678999999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=413.50 Aligned_cols=280 Identities=26% Similarity=0.360 Sum_probs=227.7
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
+..++|++++.||+|+||+||+++++.+++.||||++++... .......+.+|+.+|..++||||++++++|.+ ...
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~ 135 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENY 135 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCE
Confidence 446899999999999999999999999999999999975321 12223446789999999999999999999987 678
Q ss_pred EEEEEeeccCCchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
+||||||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999998765554443 3447999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCccccccCCcccCcccccC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhc
Q 011763 285 HRQPLTSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~------~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
........+||+.|+|||++.. ...|+.++|||||||++|||++|++||.+.+..+.+.+|........
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~----- 290 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS----- 290 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-----
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC-----
Confidence 3323345688999999999862 25689999999999999999999999999998888888764210000
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCc---cCHHHHHhCcccCCCCCCCCCCCCCCCCC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR---ATASAALASEYFSTKPYACDLSSLPIYPP 433 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R---~ta~e~L~hp~f~~~~~~~~~~~~p~~~~ 433 (478)
+ ......+++++++||.+||. +|.+| ++++|+++||||+...|.......|.+.|
T Consensus 291 ---~----------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p 348 (412)
T 2vd5_A 291 ---L----------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTP 348 (412)
T ss_dssp ---C----------------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCC
T ss_pred ---C----------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence 0 00113688999999999999 99998 59999999999998877665444444433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=405.30 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=220.2
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
+..++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+|+.++|||||+++++|.+ ...
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 89 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EED 89 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 346799999999999999999999999999999999975431 22334667889999999999999999999987 678
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 9999999998877777766778999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCCCCchhhccC
Q 011763 286 RQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
......++|+.|+|||++.. ...|+.++|||||||++|+|++|++||..... .+....+.......
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------- 239 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY-------- 239 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC--------
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC--------
Confidence 33456789999999999864 24589999999999999999999999985432 23333332211110
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-HHHHHhCcccCCCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAALASEYFSTKPY 421 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-a~e~L~hp~f~~~~~ 421 (478)
...+++.+.+||.+||+.||.+||+ +.++++||||+...|
T Consensus 240 ---------------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 240 ---------------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp ---------------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred ---------------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 1357889999999999999999998 999999999987654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=402.96 Aligned_cols=259 Identities=23% Similarity=0.379 Sum_probs=223.9
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
...++|++++.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 115 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSN 115 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCE
Confidence 447899999999999999999999999999999999975432 12334667889999999999999999999987 678
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999988666655555557999999999999999999999999999999999999999999999999999866432
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+...++.......
T Consensus 195 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------- 257 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF------------- 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred ---cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 245678999999999886 678999999999999999999999999998888888776531111
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
...++.++.+||.+||+.||.+||+ +.++++||||+...|
T Consensus 258 ----------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 258 ----------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp ----------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred ----------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 1257889999999999999999998 999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=403.28 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=222.8
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCc
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 204 (478)
+..++|++++.||+|+||+||+|++..+++.||||+++.... .....+.+..|..+|..+ +||||+++++++.. ..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~ 94 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MD 94 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CC
Confidence 346799999999999999999999999999999999975422 123345677899999988 89999999999987 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 89999999998766666555567999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
. ......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+.+|.......
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------ 240 (353)
T 2i0e_A 175 G-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY------------ 240 (353)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred C-cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC------------
Confidence 1 23455688999999999876 678999999999999999999999999999888888876531111
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
...+++++.+||.+||..||.+|| ++.++++||||+...|
T Consensus 241 -----------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 241 -----------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp -----------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred -----------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 125789999999999999999999 4799999999987655
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=391.14 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=209.4
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|+++++||+|+||+||+|++..+++.||||++...............|+..+..+ +||||+++++++.+ ...+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 479999999999999999999999999999999876655555555556677666665 99999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+++++...+......+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++...... ..
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--~~ 212 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--GA 212 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--CC
Confidence 9999988888777766667999999999999999999999999999999999999999999999999999766543 22
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+|+.|+|||++.+ .++.++|||||||++|||++|..||....... .+.. +..+.
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~~~~-------------- 271 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GYLPP-------------- 271 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TCCCH--------------
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cCCCc--------------
Confidence 344568999999998875 68999999999999999999987776543222 2211 11111
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
+....+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 272 -----------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 -----------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -----------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 122468899999999999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=409.53 Aligned_cols=281 Identities=28% Similarity=0.487 Sum_probs=230.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc------CCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL------DHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~ 202 (478)
..+|++++.||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--
Confidence 45799999999999999999999999999999999743 34456677899888887 57799999999987
Q ss_pred CceEEEEEeeccCCchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc--EEEeeccccc
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLAN 279 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--vkl~DFG~a~ 279 (478)
...+||||||+.+++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++
T Consensus 171 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 67899999999988777665443 45999999999999999999999999999999999999999987 9999999997
Q ss_pred ccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
..... ....++|+.|+|||++.+ ..++.++|||||||+||||++|++||.+.+..+++..+++.++.++..++..
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ecCCc----ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 65432 345678999999999987 6789999999999999999999999999999999999999999999887654
Q ss_pred CCCCCccccCC-----------------------------CCCCCccchhcc-cCCchhHHHHHHHhcCCCCCCccCHHH
Q 011763 360 SKLPHATLFKP-----------------------------QQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASA 409 (478)
Q Consensus 360 ~~~~~~~~~~~-----------------------------~~~~~~~l~~~~-~~~~~~l~~Li~~mL~~dP~~R~ta~e 409 (478)
.......+... ..+....+...+ ...++.+.+||.+||++||.+|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 32110000000 001111112222 245788999999999999999999999
Q ss_pred HHhCcccCCC
Q 011763 410 ALASEYFSTK 419 (478)
Q Consensus 410 ~L~hp~f~~~ 419 (478)
+|+||||+..
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 9999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=383.60 Aligned_cols=263 Identities=30% Similarity=0.451 Sum_probs=227.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||+||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.. ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEE
Confidence 468999999999999999999999999999999998877777777888899999999999999999999977 677899
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc---EEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkl~DFG~a~~~~~~~ 285 (478)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~- 161 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence 9999998666544444557999999999999999999999999999999999999987665 999999999766543
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......+..
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 229 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---------- 229 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----------
T ss_pred -ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch----------
Confidence 22344678999999999876 678999999999999999999999999998888887776643333221
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
.+..+++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 230 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 230 ---------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp ---------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred ---------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 12467899999999999999999999999999999987543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=407.90 Aligned_cols=292 Identities=36% Similarity=0.664 Sum_probs=219.1
Q ss_pred ccceeee-eeeeecCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKL-EKIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~-~~LG~G~~g~V~~~~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.+.|++. ++||+|+||+||+|++. .+++.||||++...... ..+.+|+.+|+.|+||||+++++++.......
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 3468774 57999999999999965 56889999999755433 34678999999999999999999997766788
Q ss_pred EEEEEeeccCCchhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----ecCCcEEEe
Q 011763 206 IYLVFEYMEHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLA 273 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~--------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~vkl~ 273 (478)
+||||||++++++..+.. ....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999999999987765532 22358999999999999999999999999999999999999 677899999
Q ss_pred ecccccccCCCCC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHH
Q 011763 274 DFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQL 342 (478)
Q Consensus 274 DFG~a~~~~~~~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---------~~~~ 342 (478)
|||+++....... ......++|+.|+|||++.+...++.++|||||||+||+|++|++||.+... .+++
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999986643211 2234567899999999998766799999999999999999999999987654 5889
Q ss_pred HHHHHHcCCCCchhhccCC-CCCccc----cC----CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 343 HKIFKLCGSPPDDYWKKSK-LPHATL----FK----PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 343 ~~i~~~~g~~~~~~~~~~~-~~~~~~----~~----~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
..++..++.|+...|.... ++.... +. ........+.......++.+.+||.+||++||.+|||+.|+|+|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 9999999999988886532 111000 00 00000011111122347889999999999999999999999999
Q ss_pred cccCCCCCCCC
Q 011763 414 EYFSTKPYACD 424 (478)
Q Consensus 414 p~f~~~~~~~~ 424 (478)
|||++.+.+..
T Consensus 335 p~f~~~~~~~~ 345 (405)
T 3rgf_A 335 PYFLEDPLPTS 345 (405)
T ss_dssp GGGTSSSCCCS
T ss_pred hhhccCCCCcc
Confidence 99998776653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=398.67 Aligned_cols=261 Identities=29% Similarity=0.438 Sum_probs=215.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.++|++.+.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGM 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 3479999999999999999999999999999999964321 11235678899999999999999999999987 678
Q ss_pred EEEEEeeccCCchh-hccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc---EEEeecccc
Q 011763 206 IYLVFEYMEHDITG-LLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLA 278 (478)
Q Consensus 206 ~~lv~e~~~~~ll~-~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkl~DFG~a 278 (478)
+||||||++++.+. .+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999976553 3322 3345899999999999999999999999999999999999987655 999999999
Q ss_pred cccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhc
Q 011763 279 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 279 ~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
....... ......++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.. .+....+.......+..
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~--- 254 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR--- 254 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH---
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc---
Confidence 8765432 22345678999999999876 678999999999999999999999998753 34455554432222222
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.+..+++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 255 ----------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 255 ----------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ----------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ----------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 235688999999999999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=393.56 Aligned_cols=260 Identities=28% Similarity=0.464 Sum_probs=212.1
Q ss_pred ccceeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vAlK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|++++.||+|+||.||++++. .+++.||+|+++.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--G 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--C
Confidence 568999999999999999999985 6899999999976543 12334556789999999999999999999987 6
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 78999999999876665555556799999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.. ......++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.++.......|
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p---------- 241 (327)
T 3a62_A 174 DG-TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP---------- 241 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----------
T ss_pred CC-ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence 21 22345678999999999876 6789999999999999999999999999988888877765321111
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
..+++++.+||.+||..||.+|| ++.|+|+||||+...|
T Consensus 242 -------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 242 -------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp -------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred -------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 25788999999999999999999 8999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=398.08 Aligned_cols=279 Identities=25% Similarity=0.408 Sum_probs=226.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----CCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-----HPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l~~~~~~~~~ 203 (478)
.++|+++++||+|+||+||+|++..+++.||||++.. .......+..|+.+++.+. ||||+++++++.. .
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~ 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--Y 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--T
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--C
Confidence 4589999999999999999999999999999999963 2344566778999999996 9999999999987 6
Q ss_pred ceEEEEEeeccCCchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec----------------
Q 011763 204 CSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---------------- 266 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---------------- 266 (478)
...||||||+.+++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 7899999999666666654433 35899999999999999999999999999999999999975
Q ss_pred ---------CCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 011763 267 ---------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 337 (478)
Q Consensus 267 ---------~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~ 337 (478)
++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 789999999999865432 245678999999999987 678999999999999999999999999999
Q ss_pred hHHHHHHHHHHcCCCCchhhccCCCCCccccC---------CCCCCC-c-------cchhcccCCchhHHHHHHHhcCCC
Q 011763 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK---------PQQPYD-S-------SLRETFKDLPTTAVNLIETLLSVE 400 (478)
Q Consensus 338 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~-~-------~l~~~~~~~~~~l~~Li~~mL~~d 400 (478)
..+.+..+....+.+|...+..........+. +..... . .+.......++.+.+||.+||++|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 99999999999988887665442221110000 000000 0 000011123577889999999999
Q ss_pred CCCccCHHHHHhCcccC
Q 011763 401 PYKRATASAALASEYFS 417 (478)
Q Consensus 401 P~~R~ta~e~L~hp~f~ 417 (478)
|.+|||+.|+|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999995
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=393.72 Aligned_cols=254 Identities=23% Similarity=0.269 Sum_probs=189.4
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC--ceEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS--CSIY 207 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~~~ 207 (478)
.+|.+.++||+|+||+||+|++ +|+.||||+++... ........|+.++.+++|||||++++++..... ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 3699999999999999999987 58999999996432 222223346666778899999999999976432 3689
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
||||||+++.|..+... ..+++..+..++.|++.||+|||++ +||||||||+||||+.++++||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999998766665543 3689999999999999999999987 99999999999999999999999999998
Q ss_pred ccCCCCCC---CccccccCCcccCcccccCCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCh-------------
Q 011763 280 FSNTGHRQ---PLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELLIGKPILQGRTE------------- 338 (478)
Q Consensus 280 ~~~~~~~~---~~~~~~~t~~y~APE~l~~~~-----~~~~~~DiwslG~il~elltG~~pf~~~~~------------- 338 (478)
........ .....+||+.|||||++.+.. .|+.++|||||||+||||+||.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 66543221 223467999999999987532 367799999999999999999887753321
Q ss_pred -HHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcc--cCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 339 -VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 339 -~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.+.+.+.+..-+ ....+...+ ...+..+.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~-----------------------~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 237 SVEEMRKVVCEQK-----------------------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CHHHHHHHHTTSC-----------------------CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhccc-----------------------CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 111211111000 000011111 123457889999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=404.87 Aligned_cols=302 Identities=24% Similarity=0.410 Sum_probs=235.6
Q ss_pred CCccccccCCcccccchhhhhcCcchhhhhcccccccCcccccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeec
Q 011763 86 SESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRF 165 (478)
Q Consensus 86 ~~s~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~ 165 (478)
.....|..++++++..|+.+. ++|+++++||+|+||+||+|++..+++.||||++..
T Consensus 16 e~~~~~~~~~~~~~~~g~~~~-----------------------~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~ 72 (397)
T 1wak_A 16 EDPNDYCKGGYHLVKIGDLFN-----------------------GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS 72 (397)
T ss_dssp ------CC--CCSSCTTCEET-----------------------TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS
T ss_pred cccccCCCCCceEEehhhhcC-----------------------CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec
Confidence 445566677777777766553 389999999999999999999999999999999974
Q ss_pred CCCChHHHHHHHHHHHHHHhcC--------CCCeeeecceeeec--CCceEEEEEeeccCCchhhccCCC-CCCCHHHHH
Q 011763 166 DNFEPESVRFMAREILILRRLD--------HPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIK 234 (478)
Q Consensus 166 ~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~~~--~~~~~~lv~e~~~~~ll~~~~~~~-~~l~~~~~~ 234 (478)
. ....+.+.+|+.+|+.+. |+||+++++++... ....+||||||++++++..+.... ..+++..++
T Consensus 73 ~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~ 149 (397)
T 1wak_A 73 A---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149 (397)
T ss_dssp C---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHH
T ss_pred C---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHH
Confidence 3 455667889999999985 78899999988732 356799999999988888776543 569999999
Q ss_pred HHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCC---------------------------------------------
Q 011763 235 CYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEG--------------------------------------------- 268 (478)
Q Consensus 235 ~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~--------------------------------------------- 268 (478)
.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 150 ~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (397)
T 1wak_A 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN 229 (397)
T ss_dssp HHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGG
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccc
Confidence 9999999999999998 999999999999999775
Q ss_pred ----cEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------h
Q 011763 269 ----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------E 338 (478)
Q Consensus 269 ----~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~------~ 338 (478)
.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||+||+|++|++||...+ .
T Consensus 230 ~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 304 (397)
T 1wak_A 230 AEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304 (397)
T ss_dssp GGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHH
T ss_pred ccccceEecccccccccccc----CccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCch
Confidence 7999999999866532 344578999999999987 668999999999999999999999998765 5
Q ss_pred HHHHHHHHHHcCCCCchhhccCCCCCccccCC--------CCCCC--ccchhc---ccCCchhHHHHHHHhcCCCCCCcc
Q 011763 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP--------QQPYD--SSLRET---FKDLPTTAVNLIETLLSVEPYKRA 405 (478)
Q Consensus 339 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~l~~~---~~~~~~~l~~Li~~mL~~dP~~R~ 405 (478)
.+.+..+...++.+|...+...+.....+... ..++. ..+.+. ....+..+.+||.+||+.||.+||
T Consensus 305 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 384 (397)
T 1wak_A 305 EDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384 (397)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC
T ss_pred HHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC
Confidence 67888899999999887664433321111000 00000 000111 123456789999999999999999
Q ss_pred CHHHHHhCcccCC
Q 011763 406 TASAALASEYFST 418 (478)
Q Consensus 406 ta~e~L~hp~f~~ 418 (478)
|+.|+|+||||+.
T Consensus 385 t~~e~l~hp~~~~ 397 (397)
T 1wak_A 385 TAAECLRHPWLNS 397 (397)
T ss_dssp CHHHHHTSGGGGC
T ss_pred CHHHHhhCccccC
Confidence 9999999999963
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=398.96 Aligned_cols=290 Identities=31% Similarity=0.500 Sum_probs=225.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC-----C
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL-----S 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~ 203 (478)
.++|++.+.||+|+||+||+|++..+++.||||++..+... .....+|+..+..++||||+++++++.... .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 67899999999999999999999999999999998654322 234556888889999999999999986532 2
Q ss_pred ceEEEEEeeccCCchhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcEEEec-CCcEEEeeccc
Q 011763 204 CSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCH--SRGVLHRDIKGSNLLVNN-EGVLKLADFGL 277 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~---~~~~~l~~~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~~-~~~vkl~DFG~ 277 (478)
.++++||||+++++...+. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 2488999999998665443 45667899999999999999999999 999999999999999997 89999999999
Q ss_pred ccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhh
Q 011763 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 278 a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 357 (478)
+....... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...|
T Consensus 179 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 98665432 2345577999999999877666899999999999999999999999999999999999999999998877
Q ss_pred ccCCCCCcccc---CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 358 KKSKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 358 ~~~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
........... ....++...+.......++++.+||.+||++||.+|||+.|+|+||||++...+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 65432211111 1111111112222234678999999999999999999999999999999865544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=393.24 Aligned_cols=286 Identities=35% Similarity=0.598 Sum_probs=233.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC----c
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----C 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~ 204 (478)
.++|.+.+.||+|+||+||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 358999999999999999999999999999999998765556667788899999999999999999999876322 2
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+||||+.+++...+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 359999999976555442 25899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++..++.......
T Consensus 180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 2345779999999998875678999999999999999999999999999999999999999999887765432210
Q ss_pred cccc--CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 365 ATLF--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~--~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
...+ .........+...++.+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 0000 00001111223344678999999999999999999999999999999987544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=402.88 Aligned_cols=292 Identities=21% Similarity=0.311 Sum_probs=219.0
Q ss_pred cccceeeeeeeeec--CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 128 RADAFEKLEKIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 128 ~~~~y~~~~~LG~G--~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
..++|++++.||+| +||+||+|++..+++.||||++..........+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCE
Confidence 36789999999999 99999999999999999999998877667777888899999999999999999999987 678
Q ss_pred EEEEEeeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 206 IYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
+||||||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999998666555432 35699999999999999999999999999999999999999999999999999854321
Q ss_pred C------CCCCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC-----
Q 011763 284 G------HRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS----- 351 (478)
Q Consensus 284 ~------~~~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~----- 351 (478)
. ........++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 1 01112334779999999998763 56899999999999999999999999987766655444321110
Q ss_pred ---CCchhhccC-------CCCCccccCC--CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 352 ---PPDDYWKKS-------KLPHATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 352 ---~~~~~~~~~-------~~~~~~~~~~--~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
+........ .+........ ..............+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 000000000 0000000000 0000011112335688999999999999999999999999999999875
Q ss_pred CC
Q 011763 420 PY 421 (478)
Q Consensus 420 ~~ 421 (478)
..
T Consensus 341 ~~ 342 (389)
T 3gni_B 341 KR 342 (389)
T ss_dssp --
T ss_pred hh
Confidence 54
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=397.99 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=221.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+|+.++||||+++++++.+ ...+||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEE
Confidence 468999999999999999999999999999999997543 3445578899999999999999999999987 678999
Q ss_pred EEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec--CCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~--~~~vkl~DFG~a~~~~~~~ 285 (478)
||||+.++.+.. +......+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 999998865544 4444457999999999999999999999999999999999999974 477999999999876543
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+.
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 271 (387)
T 1kob_A 205 -EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----------- 271 (387)
T ss_dssp -SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred -cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 22344578999999999876 67899999999999999999999999999888888777653222111
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
..+..+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 272 --------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 272 --------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp --------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred --------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 12346889999999999999999999999999999998643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=396.51 Aligned_cols=256 Identities=29% Similarity=0.382 Sum_probs=212.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+|+++|.++ +||||+++++++.+ ...+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEE
Confidence 46899999999999999999999999999999999765432 24688888888 79999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC----CcEEEeecccccccCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNT 283 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~----~~vkl~DFG~a~~~~~ 283 (478)
|||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||+.++ +.+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999986665555555679999999999999999999999999999999999998544 3599999999986654
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHcCCCCchhhccC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR---TEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~---~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.. ......++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+. +..+.+..+.......+..
T Consensus 173 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~----- 245 (342)
T 2qr7_A 173 EN-GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG----- 245 (342)
T ss_dssp TT-CCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST-----
T ss_pred CC-CceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc-----
Confidence 32 23345678999999999875 56889999999999999999999999863 4445555554422221111
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.+..+++++++||.+||..||.+|||+.++|+||||..+
T Consensus 246 --------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 246 --------------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp --------------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred --------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 234689999999999999999999999999999999764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=401.91 Aligned_cols=260 Identities=24% Similarity=0.374 Sum_probs=214.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHH-HHhcCCCCeeeecceeeecCCceE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILI-LRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
.++|++++.||+|+||+||+|++..+++.||||+++.... .......+.+|..+ ++.++||||++++++|.. ...+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~~ 114 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKL 114 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCEE
Confidence 5689999999999999999999999999999999986543 23334556667776 467899999999999987 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++......
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~- 193 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 193 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence 9999999987776665555679999999999999999999999999999999999999999999999999997643222
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......++|+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+...+|....-.
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 257 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--------------- 257 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC---------------
T ss_pred CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC---------------
Confidence 23456788999999999886 67899999999999999999999999999888888887652111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH----HHHHhCcccCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKPY 421 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta----~e~L~hp~f~~~~~ 421 (478)
..+.++.++.+||.+||+.||.+||++ .++++||||+...|
T Consensus 258 --------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 258 --------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp --------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred --------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 013678999999999999999999986 69999999987655
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=394.51 Aligned_cols=290 Identities=28% Similarity=0.461 Sum_probs=230.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC---------ChHHHHHHHHHHHHHHhcCCCCeeeecceee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---------EPESVRFMAREILILRRLDHPNIIKLEGLIT 199 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 199 (478)
.++|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 5689999999999999999999855 89999999865432 1233467889999999999999999999985
Q ss_pred e---cCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecc
Q 011763 200 S---RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 276 (478)
Q Consensus 200 ~---~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG 276 (478)
. .....+|+||||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 4 2245789999999998888888777789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchh
Q 011763 277 LANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~ 356 (478)
++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...
T Consensus 180 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 180 LAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 99754432 2234457799999999988756789999999999999999999999999999999999999999888665
Q ss_pred hccCCCCCcccc---CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 357 WKKSKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 357 ~~~~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
+.....+....+ .........+....+.+++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 432221110000 00111112334445678899999999999999999999999999999987533
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=399.97 Aligned_cols=256 Identities=28% Similarity=0.393 Sum_probs=213.8
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEe
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e 211 (478)
|...+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+|++++||||+++++++.. ...+|||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E 166 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVME 166 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEe
Confidence 444678999999999999999999999999998643 3455678899999999999999999999987 677999999
Q ss_pred eccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe--cCCcEEEeecccccccCCCCCCC
Q 011763 212 YMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 212 ~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~--~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|++++.+ ..+......+++..++.++.||+.||.|||++||+||||||+||||. .++.+||+|||++....... .
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 9987544 55545555799999999999999999999999999999999999994 56789999999998765432 2
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++......++.
T Consensus 245 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-------------- 309 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED-------------- 309 (373)
T ss_dssp CCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS--------------
T ss_pred cccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh--------------
Confidence 344578999999999876 67899999999999999999999999999998888888764332221
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..+..+++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 310 -----------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 310 -----------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp -----------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred -----------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 2235689999999999999999999999999999999763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=401.83 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=212.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|.+.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTDIV 85 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEE
Confidence 56899999999999999999999999999999999753211 1223467889999999999999999999987 66799
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
|||||++++++..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 86 lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~ 162 (336)
T 3h4j_B 86 MVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--N 162 (336)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--B
T ss_pred EEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--c
Confidence 99999987777666443 47999999999999999999999999999999999999999999999999999866543 2
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
.....++|+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+....+
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------------- 220 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------------- 220 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------------------
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------------------
Confidence 3355678999999999987444578999999999999999999999764322111000
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..........+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 221 -------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 -------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000001113578999999999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=387.22 Aligned_cols=261 Identities=26% Similarity=0.373 Sum_probs=224.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.++|++.+.||+|+||.||+|++..+++.||+|++....... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 457999999999999999999999999999999998654321 135678899999999999999999999987 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC----cEEEeecccccc
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANF 280 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~DFG~a~~ 280 (478)
.+|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 8999999998866666655666899999999999999999999999999999999999999888 799999999986
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 239 (321)
T 2a2a_A 169 IEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE------ 239 (321)
T ss_dssp CCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH------
T ss_pred cCcc--ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh------
Confidence 6543 22345578999999999876 67899999999999999999999999999888887777653322222
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 240 -------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 240 -------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp -------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred -------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 2235688999999999999999999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=393.16 Aligned_cols=258 Identities=30% Similarity=0.425 Sum_probs=202.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.+|++++||||+++++++.. ...+||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEE
Confidence 457999999999999999999999999999999997542 23557789999999999999999999987 677999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec---CCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~~~~~~~ 285 (478)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++.....
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 9999998766666666668999999999999999999999999999999999999975 789999999999765432
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+ .+..+.......+.
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~---------- 272 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS---------- 272 (349)
T ss_dssp ---------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT----------
T ss_pred -cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC----------
Confidence 22345678999999999886 678999999999999999999999998776555 44444332111111
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
..+..++.++.+||.+||..||++|||+.|+|+||||+...
T Consensus 273 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 273 ---------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ---------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ---------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 12346889999999999999999999999999999998643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=411.11 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=214.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEE
Confidence 5789999999999999999999999999999999975422 23344566789999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|||||++++.+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++......
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 303 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 303 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence 999999987776666556689999999999999999999998 999999999999999999999999999997543322
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......++|+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+.+..+....+.......
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 368 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF-------------- 368 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred cccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 23455788999999999876 678999999999999999999999999988888777775522111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
...+++++.+||.+||+.||.+|| |+.|+|+||||+...|
T Consensus 369 ---------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 369 ---------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 125788999999999999999999 9999999999997654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=409.56 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=223.4
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
..++|.+.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEE
Confidence 367899999999999999999999999999999999754321 1234568899999999999999999999987 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-- 169 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 169 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--
Confidence 999999988777666666778999999999999999999999999999999999999999999999999999876543
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......++|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+......++.......|
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------------- 236 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP------------- 236 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC-------------
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC-------------
Confidence 2334568899999999998744457899999999999999999999999888877777754321111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 237 ----------------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 237 ----------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ----------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ----------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 2468899999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=387.72 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=221.9
Q ss_pred cceeee-eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 130 DAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 130 ~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
+.|.+. +.||+|+||+||+|++..+++.||+|++............+.+|+.++..+ +||||+++++++.. ...+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~~ 105 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEII 105 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeEE
Confidence 468887 899999999999999999999999999987655555567788999999999 57999999999977 67799
Q ss_pred EEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec---CCcEEEeecccccccC
Q 011763 208 LVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSN 282 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~~~~ 282 (478)
+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999866555543 2357999999999999999999999999999999999999998 7899999999998765
Q ss_pred CCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......+..
T Consensus 186 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------- 255 (327)
T 3lm5_A 186 HA--CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE------- 255 (327)
T ss_dssp ----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-------
T ss_pred Cc--cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch-------
Confidence 33 22344678999999999876 678999999999999999999999999999888887776654333222
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
.+..+++.+.+||.+||+.||.+|||+.++|+||||+...+..
T Consensus 256 ------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 256 ------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp ------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred ------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 2246789999999999999999999999999999999876653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=389.89 Aligned_cols=293 Identities=32% Similarity=0.531 Sum_probs=233.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec---CCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR---LSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---~~~~ 205 (478)
.++|++.+.||+|+||+||+|++..+++.||||++.... .......+.+|+.+|+.++||||+++++++... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 468999999999999999999999999999999996433 345566778999999999999999999987642 1357
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
.|+||||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 89 ~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 899999999876665543 368999999999999999999999999999999999999999999999999997654321
Q ss_pred CC---------CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchh
Q 011763 286 RQ---------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 286 ~~---------~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~ 356 (478)
.. ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 11 123356799999999887657789999999999999999999999999999999999999888876332
Q ss_pred h-ccCCCCCcc-c-cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCC
Q 011763 357 W-KKSKLPHAT-L-FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424 (478)
Q Consensus 357 ~-~~~~~~~~~-~-~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~ 424 (478)
. ......... . ..........+...++.+++++.+||.+||..||.+|||+.|+|+||||+....+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 317 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND 317 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccc
Confidence 1 111000000 0 000001122344556788999999999999999999999999999999998665543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=384.86 Aligned_cols=288 Identities=39% Similarity=0.654 Sum_probs=233.8
Q ss_pred ccceeeeeeeeecCceEEEEEEEC-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCeeeecceeee---c
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMAREILILRRL---DHPNIIKLEGLITS---R 201 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~-~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~---~ 201 (478)
.++|++++.||+|+||+||+|++. .+++.||+|++............+.+|+.+++.+ .||||+++++++.. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 468999999999999999999985 6789999999976543322223455677777666 89999999999862 1
Q ss_pred CCceEEEEEeeccCCchhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
....+++||||+++++...+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 25678999999998776665443 34589999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...|...
T Consensus 170 ~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 170 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccCC--CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 5432 22344577999999999876 67899999999999999999999999999999999999999999888777543
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
.......+.. .....+......++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 247 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 247 VALPRQAFHS--KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CSSCGGGSCC--CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccchhhhcc--cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 2211111111 1112344555788999999999999999999999999999999987543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=412.45 Aligned_cols=259 Identities=29% Similarity=0.480 Sum_probs=218.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..++..||+|++............+.+|+.+|+.++||||+++++++.+ ...+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 347999999999999999999999999999999998765444445678899999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC---CcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a~~~~~~~ 285 (478)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.. +.+||+|||++......
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 99999987665544445579999999999999999999999999999999999999764 45999999999876543
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
......++|+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+...
T Consensus 193 -~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 260 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE--------- 260 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG---------
T ss_pred -ccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh---------
Confidence 2335567899999999886 4689999999999999999999999999999888888876544433322
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
+..+++.+++||.+||+.||.+|||+.|+|+||||+.
T Consensus 261 ----------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 ----------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp ----------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred ----------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 3468899999999999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=412.54 Aligned_cols=261 Identities=26% Similarity=0.444 Sum_probs=221.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|++++||||+++++++.. ...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEE
Confidence 458999999999999999999999999999999997543333345678899999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe---cCCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~vkl~DFG~a~~~~~~~ 285 (478)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999999866655444445799999999999999999999999999999999999995 4567999999999766543
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
......++|+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+...
T Consensus 178 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 245 (486)
T 3mwu_A 178 -TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ--------- 245 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG---------
T ss_pred -CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc---------
Confidence 23345678999999999875 589999999999999999999999999999888888766433332222
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
+..+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus 246 ----------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 246 ----------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp ----------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred ----------------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 346889999999999999999999999999999998643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=410.86 Aligned_cols=261 Identities=30% Similarity=0.464 Sum_probs=220.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh-----------HHHHHHHHHHHHHHhcCCCCeeeecce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-----------ESVRFMAREILILRRLDHPNIIKLEGL 197 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 197 (478)
.++|+++++||+|+||+||+|++..+++.||||++....... ...+.+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 458999999999999999999999999999999998654321 235678899999999999999999999
Q ss_pred eeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC---cEEEee
Q 011763 198 ITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLAD 274 (478)
Q Consensus 198 ~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~D 274 (478)
+.+ ...+||||||++++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|
T Consensus 115 ~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 987 678999999999866655444455799999999999999999999999999999999999999876 699999
Q ss_pred cccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCc
Q 011763 275 FGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354 (478)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~ 354 (478)
||++...... ......++|+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+.
T Consensus 193 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 193 FGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CTTCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred CCCCEEcCCC--CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 9999876543 23355678999999998864 5899999999999999999999999999998888888764333332
Q ss_pred hhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
.. +..+++++++||.+||.+||.+|||+.|+|+||||+...
T Consensus 269 ~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 269 ND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred cc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 22 357899999999999999999999999999999998643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=397.22 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=201.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||++++..+++.||||++...... .+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEEE
Confidence 56899999999999999999999999999999999765432 2456789999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc--EEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--vkl~DFG~a~~~~~~~~ 286 (478)
||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.....
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 9999988766655555557999999999999999999999999999999999999987765 999999999744322
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
.......+|+.|+|||++.+....+.++|||||||++|+|++|++||.+.........++.........
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----------- 240 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS----------- 240 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC-----------
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC-----------
Confidence 223445789999999999874444455999999999999999999998765433222222211110000
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
. .....+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus 241 -------~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 241 -------I-----PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -------C-----CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -------C-----CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 0 0012578899999999999999999999999999999653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=377.50 Aligned_cols=257 Identities=33% Similarity=0.462 Sum_probs=222.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||+||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEE
Confidence 3579999999999999999999999999999999976543 234667899999999999999999999987 677999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---ecCCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~~~ 285 (478)
||||++++.+.........+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 99999986665554445579999999999999999999999999999999999999 77899999999999766543
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+......++...|
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 231 (277)
T 3f3z_A 163 -KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW-------- 231 (277)
T ss_dssp -SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH--------
T ss_pred -cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh--------
Confidence 23345678999999998865 4899999999999999999999999999988888887765444443332
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..+++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus 232 -----------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 -----------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred -----------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 467899999999999999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=389.62 Aligned_cols=256 Identities=30% Similarity=0.464 Sum_probs=194.0
Q ss_pred cceeee---eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCce
Q 011763 130 DAFEKL---EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 130 ~~y~~~---~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 205 (478)
++|++. +.||+|+||+||+|++..+++.||||++... ....+.+|+.+|+.+. ||||+++++++.+ ...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCE
Confidence 457765 7899999999999999999999999999643 3456678999999996 9999999999987 678
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC---cEEEeecccccccC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSN 282 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~DFG~a~~~~ 282 (478)
.||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999876666555566899999999999999999999999999999999999998776 89999999998655
Q ss_pred CCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHHcCCCCch
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-------VEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~-------~~~~~~i~~~~g~~~~~ 355 (478)
... ......++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+. .+.+..+.......+.
T Consensus 161 ~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~- 237 (325)
T 3kn6_A 161 PDN-QPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG- 237 (325)
T ss_dssp C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS-
T ss_pred CCC-CcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc-
Confidence 432 33345677999999999876 6789999999999999999999999987543 2333333322111111
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..+..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 238 ------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 238 ------------------------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp ------------------------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ------------------------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 2235689999999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=411.95 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=225.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++.+.||+|+||+||+|++..+++.||||++...... ....+.+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 46899999999999999999999999999999999765432 3445678899999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---ecCCcEEEeecccccccCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~~ 284 (478)
+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++......
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999987665555555689999999999999999999999999999999999999 56789999999999866543
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
......++|+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------- 250 (484)
T 3nyv_A 183 --KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ-------- 250 (484)
T ss_dssp --CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG--------
T ss_pred --cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc--------
Confidence 23345678999999999875 589999999999999999999999999999888888876433332222
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
+..+++++++||.+||++||.+|||+.|+|+||||+...
T Consensus 251 -----------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 251 -----------------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp -----------------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred -----------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 246889999999999999999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=390.80 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=220.0
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
+.|++++.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.. ....||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEEE
Confidence 469999999999999999999999999999999986543 33445678899999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 9999998877777655668999999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 289 LTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
....+|+.|+|||++.+ ...++.++|||||||++|||++|++||...+..+.+..+........
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 273 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL------------- 273 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------------
Confidence 34578999999999852 35789999999999999999999999999888777766654211000
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
....+++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 274 --------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 274 --------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 01356888999999999999999999999999999976
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=390.26 Aligned_cols=266 Identities=27% Similarity=0.377 Sum_probs=217.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN---FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCe
Confidence 458999999999999999999999999999999997542 234556778899999999999999999999977 678
Q ss_pred EEEEEeeccCCchhhccC----------------------------------------CCCCCCHHHHHHHHHHHHHHHH
Q 011763 206 IYLVFEYMEHDITGLLSC----------------------------------------PDIKFSEAQIKCYMNQLLHGLE 245 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~----------------------------------------~~~~l~~~~~~~i~~qil~aL~ 245 (478)
.||||||++++.+..+.. ....+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 999999998865554432 0223467889999999999999
Q ss_pred HHHhCCceeccCCCCcEEEecCC--cEEEeecccccccCCC---CCCCccccccCCcccCcccccCC-CCCCChhhHHHH
Q 011763 246 HCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTG---HRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSV 319 (478)
Q Consensus 246 ~LH~~givHrDlkp~NILl~~~~--~vkl~DFG~a~~~~~~---~~~~~~~~~~t~~y~APE~l~~~-~~~~~~~Diwsl 319 (478)
|||++||+||||||+||||+.++ .+||+|||++...... .........+|+.|+|||++.+. ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 8999999999764321 11223456789999999998642 578999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCC
Q 011763 320 GCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 399 (478)
Q Consensus 320 G~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~ 399 (478)
||++|+|++|+.||.+.+..+.+.++.......+.. .+..+++.+.+||.+||+.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-------------------------NYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-------------------------GGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-------------------------ccccCCHHHHHHHHHHcCC
Confidence 999999999999999999988888877643222211 1245789999999999999
Q ss_pred CCCCccCHHHHHhCcccCCCCC
Q 011763 400 EPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 400 dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
||.+|||+.++|+||||+...+
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTTSS
T ss_pred ChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999987544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=379.34 Aligned_cols=258 Identities=32% Similarity=0.492 Sum_probs=217.2
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
..++|++.+.||+|+||+||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+ ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEE
Confidence 367999999999999999999999999999999999653321 1224567889999999999999999999987 6779
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|+||||++++.+.........+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 999999998766555555557999999999999999999999999999999999999999999999999998654432
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.......+
T Consensus 163 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 227 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------- 227 (279)
T ss_dssp ------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-------------
T ss_pred -cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC-------------
Confidence 2244577999999999876 6789999999999999999999999999888887777655322111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
..+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 228 ----------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 228 ----------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp ----------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ----------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 24688899999999999999999999999999998643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=381.41 Aligned_cols=257 Identities=23% Similarity=0.419 Sum_probs=218.7
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~ 210 (478)
.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.. ....|+||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLV--GEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 58888999999999999999998999999999976542 334667899999999999999999999987 67799999
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCcc
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 290 (478)
||++++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ....
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 199 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 199 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccc
Confidence 99998777666554 369999999999999999999999999999999999999999999999999997655432 2234
Q ss_pred ccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCC
Q 011763 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (478)
Q Consensus 291 ~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 370 (478)
...+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+........
T Consensus 200 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------- 261 (321)
T 2c30_A 200 SLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL----------------- 261 (321)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-----------------
T ss_pred cccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-----------------
Confidence 5678999999999876 6789999999999999999999999999888777766654211000
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
.....+++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus 262 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 262 ---------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 01135788999999999999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=393.08 Aligned_cols=281 Identities=25% Similarity=0.434 Sum_probs=224.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CC-----CeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HP-----NIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~ 202 (478)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.+. |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 46899999999999999999999999999999999743 344566778999998884 55 49999999887
Q ss_pred CceEEEEEeeccCCchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcEEEe--cCCcEEEeeccc
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCH--SRGVLHRDIKGSNLLVN--NEGVLKLADFGL 277 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~--~~~~vkl~DFG~ 277 (478)
...+||||||+++++...+.... ..+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+||+|||+
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 67899999999987777665543 46899999999999999999999 56999999999999995 467899999999
Q ss_pred ccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhh
Q 011763 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 278 a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 357 (478)
++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.++...++.++...+
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceecccc----cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9876532 245678999999999987 67899999999999999999999999999999999999999999987766
Q ss_pred ccCCC--------CCccc---------cCCCCCCCccchhcccC------------------CchhHHHHHHHhcCCCCC
Q 011763 358 KKSKL--------PHATL---------FKPQQPYDSSLRETFKD------------------LPTTAVNLIETLLSVEPY 402 (478)
Q Consensus 358 ~~~~~--------~~~~~---------~~~~~~~~~~l~~~~~~------------------~~~~l~~Li~~mL~~dP~ 402 (478)
..... +.... .....+....+...+.. ..+++++||.+||++||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 43211 00000 00000001111111100 113789999999999999
Q ss_pred CccCHHHHHhCcccCCC
Q 011763 403 KRATASAALASEYFSTK 419 (478)
Q Consensus 403 ~R~ta~e~L~hp~f~~~ 419 (478)
+|||+.|+|+||||++.
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=383.90 Aligned_cols=291 Identities=35% Similarity=0.589 Sum_probs=225.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec-------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR------- 201 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------- 201 (478)
.++|++++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 45899999999999999999999999999999999754 356667788999999999999999999887432
Q ss_pred -----CCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe-cCCcEEEeec
Q 011763 202 -----LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADF 275 (478)
Q Consensus 202 -----~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-~~~~vkl~DF 275 (478)
.....|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ +++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 2467899999999866655533 4689999999999999999999999999999999999998 5679999999
Q ss_pred ccccccCCCC--CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 011763 276 GLANFSNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353 (478)
Q Consensus 276 G~a~~~~~~~--~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~ 353 (478)
|++....... ........+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9998654321 12223456699999999987657789999999999999999999999999999999998888776665
Q ss_pred chhhccCCCCCcc-ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 354 DDYWKKSKLPHAT-LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 354 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
...+......... ...........+....+.++.++.+||.+||+.||.+|||+.|+|+||||+...++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 5444321100000 000000011223444567899999999999999999999999999999999866653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=416.21 Aligned_cols=262 Identities=24% Similarity=0.423 Sum_probs=217.2
Q ss_pred cccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 126 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
++..++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++|||||++++++.+ ..
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~ 257 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KD 257 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CC
Confidence 3557889999999999999999999999999999999975432 12234557789999999999999999999987 67
Q ss_pred eEEEEEeeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 205 SIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
.+||||||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 89999999988666544433 2349999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHcCCCCchhhc
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~----~~~~~~i~~~~g~~~~~~~~ 358 (478)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+... .+....+... +..
T Consensus 338 ~~--~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----~~~--- 407 (576)
T 2acx_A 338 EG--QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----PEE--- 407 (576)
T ss_dssp TT--CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----CCC---
T ss_pred cC--ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----ccc---
Confidence 43 23345689999999999986 6789999999999999999999999987643 2222222221 100
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
....+++++++||.+||+.||.+|| ++.|+++||||+...|
T Consensus 408 ----------------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 408 ----------------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred ----------------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 0135789999999999999999999 8999999999997544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=383.71 Aligned_cols=281 Identities=30% Similarity=0.537 Sum_probs=221.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++.||+|+||+||+|++..+++.||||++... ..+.+.+|+.+|+.+. ||||+++++++........+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 56899999999999999999999999999999998633 2356788999999996 99999999999876677899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-cEEEeecccccccCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHR 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~~ 286 (478)
+||||+.++.+..+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++.......
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 9999999876665553 489999999999999999999999999999999999999777 89999999998665432
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHcCCCCch-hhccCCCCC
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-QGRTEVEQLHKIFKLCGSPPDD-YWKKSKLPH 364 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf-~~~~~~~~~~~i~~~~g~~~~~-~~~~~~~~~ 364 (478)
......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+....+.+..+...++.+... ++.......
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 2345678999999999887677899999999999999999999888 4556667777777766543321 111111100
Q ss_pred ccc------cCCCCCCCccch-hcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 365 ATL------FKPQQPYDSSLR-ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 365 ~~~------~~~~~~~~~~l~-~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
... ......+...+. .....+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 000 000000000000 1113478999999999999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=376.23 Aligned_cols=257 Identities=28% Similarity=0.406 Sum_probs=209.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|.+.+.||+|+||+||++++..++..||+|++..... ....+.+.+|+.+|+.++||||+++++++.. ....|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEE
Confidence 4689999999999999999999999999999999986543 2335678899999999999999999999977 677999
Q ss_pred EEeeccCCchh-hccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---ecCCcEEEeeccccccc
Q 011763 209 VFEYMEHDITG-LLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFS 281 (478)
Q Consensus 209 v~e~~~~~ll~-~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~~ 281 (478)
||||++++.+. .+.. ....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999985443 3322 23579999999999999999999999999999999999999 44578999999999765
Q ss_pred CCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
... .......+|+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+.......+
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 245 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-------- 245 (285)
T ss_dssp -----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred CCc--ccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc--------
Confidence 432 2234557899999999875 4688999999999999999999999999887776655543211110
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....+++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 246 ------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 ------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 111347889999999999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=387.04 Aligned_cols=261 Identities=30% Similarity=0.451 Sum_probs=221.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC--Ch----HHHHHHHHHHHHHHhc-CCCCeeeecceeeec
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EP----ESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~--~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 201 (478)
.++|++.+.||.|+||.||+|++..+|+.||||+++.... .. ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES- 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence 4579999999999999999999998999999999976542 11 2245677899999999 89999999999877
Q ss_pred CCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
....||||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...
T Consensus 172 -~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 172 -SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 6789999999998766655555567999999999999999999999999999999999999999999999999999766
Q ss_pred CCCCCCCccccccCCcccCcccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchh
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~-----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~ 356 (478)
... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||...+....+..+......++...
T Consensus 251 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 251 EPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 543 22345678999999998853 23588899999999999999999999999888877777765433322222
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
+..++..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 329 -------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 -------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp -------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred -------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 2467889999999999999999999999999999963
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=373.04 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=217.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec--CCceE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCSI 206 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~~ 206 (478)
...|++.+.||+|+||+||+|.+..++..||+|++..........+.+.+|+.+|+.++||||+++++++... ....+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 4569999999999999999999999999999999987777777788889999999999999999999988653 24568
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEe-cCCcEEEeecccccccCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNT 283 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~vkl~DFG~a~~~~~ 283 (478)
|+||||++++.+..+......+++..++.++.||+.||.|||+++ |+|+||||+||||+ .++.+||+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999998776666655567999999999999999999999999 99999999999998 789999999999975543
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||................ ..+.
T Consensus 185 ~---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~--------- 249 (290)
T 1t4h_A 185 S---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPA--------- 249 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCG---------
T ss_pred c---ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc-CCcc---------
Confidence 2 2345678999999998864 58999999999999999999999998866655544433211 1110
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
......++++.+||.+||..||.+|||+.++|+||||++.
T Consensus 250 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 250 ----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ----------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 1113567889999999999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=396.40 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=206.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC------hHHHHHHHHHHHHHHhcCCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE------PESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 202 (478)
.++|.+.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 46899999999999999999999999999999999764321 1222346789999999999999999999854
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC---cEEEeeccccc
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLAN 279 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~DFG~a~ 279 (478)
...||||||++++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 45799999999877766666667899999999999999999999999999999999999997654 59999999998
Q ss_pred ccCCCCCCCccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HcCCCCchh
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK-LCGSPPDDY 356 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~-~~g~~~~~~ 356 (478)
..... ......++|+.|+|||++.+ ...++.++|||||||++|+|++|++||........+...+. .....
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~---- 364 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF---- 364 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC----
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC----
Confidence 76532 23345678999999999853 35678899999999999999999999987654333332222 11111
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..+.+..+++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 365 ---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 365 ---------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 12334578999999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=377.99 Aligned_cols=261 Identities=23% Similarity=0.402 Sum_probs=202.1
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++++.||+|+||+||+|++..+++.||+|++..........+.+.++..+++.++||||+++++++.. ....
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~ 81 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDV 81 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCE
Confidence 34679999999999999999999999999999999997664444444455556666788899999999999987 6679
Q ss_pred EEEEeeccCCchhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 207 YLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
|+||||+++++...+. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 82 WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999999986654443 3556799999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCCCccccccCCcccCcccc---cCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCchhhc
Q 011763 283 TGHRQPLTSRVVTLWYRPPELL---LGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l---~~~~~~~~~~DiwslG~il~elltG~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
... ......+|+.|+|||++ .....++.++|||||||++|+|++|+.||... .....+..+........
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 234 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL----- 234 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC-----
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc-----
Confidence 432 22334689999999997 23467899999999999999999999999873 44444444433211000
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
....+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 235 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 235 ----------------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ----------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ----------------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 01357889999999999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=422.83 Aligned_cols=263 Identities=24% Similarity=0.376 Sum_probs=225.0
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCc
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 204 (478)
+..++|++++.||+|+||+||+|++..+++.||||+++.... .....+.+..|..+|..+ +||||++++++|.+ ..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~ 415 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MD 415 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SS
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CC
Confidence 456789999999999999999999999999999999975421 123345667899999988 79999999999877 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+||||||++++.+..+......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 89999999998777666665568999999999999999999999999999999999999999999999999999854322
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
. ......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.+|.......|
T Consensus 496 ~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----------- 562 (674)
T 3pfq_A 496 G-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----------- 562 (674)
T ss_dssp T-CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC-----------
T ss_pred C-cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence 2 23456789999999999976 6789999999999999999999999999999888888865221111
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH-----HHHHhCcccCCCCCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPYA 422 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta-----~e~L~hp~f~~~~~~ 422 (478)
..+++++.+||.+||+.||.+|+++ .|+++||||+...|.
T Consensus 563 ------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 563 ------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp ------------------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred ------------------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 3578999999999999999999997 999999999987653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=389.96 Aligned_cols=300 Identities=27% Similarity=0.457 Sum_probs=230.0
Q ss_pred cccCCcccccchhhhhcCcchhhhhcccccccCcccccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh
Q 011763 91 FRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP 170 (478)
Q Consensus 91 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~ 170 (478)
|+.+++++...++.+. .++|++++.||+|+||+||+|++..+++.||||++..+ .
T Consensus 2 y~~~~~~p~~~~~~~~----------------------~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~ 56 (373)
T 1q8y_A 2 YRPGGYHPAFKGEPYK----------------------DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---K 56 (373)
T ss_dssp -----CCCCCTTCEET----------------------TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---H
T ss_pred CCCCCceeeecCCccc----------------------CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---c
Confidence 5667777777766553 35899999999999999999999999999999999743 3
Q ss_pred HHHHHHHHHHHHHHhcC-----------CCCeeeecceeeecC--CceEEEEEeeccCCchhhccC-CCCCCCHHHHHHH
Q 011763 171 ESVRFMAREILILRRLD-----------HPNIIKLEGLITSRL--SCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCY 236 (478)
Q Consensus 171 ~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~~~--~~~~~lv~e~~~~~ll~~~~~-~~~~l~~~~~~~i 236 (478)
...+.+.+|+.+++++. ||||+++++++.... ...+++||||+.+++...+.. ....+++..++.+
T Consensus 57 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i 136 (373)
T 1q8y_A 57 VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHH
T ss_pred cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHH
Confidence 44566788999999886 899999999987532 337899999996666666544 3346999999999
Q ss_pred HHHHHHHHHHHHhC-CceeccCCCCcEEEecC------CcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCC
Q 011763 237 MNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNE------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309 (478)
Q Consensus 237 ~~qil~aL~~LH~~-givHrDlkp~NILl~~~------~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~ 309 (478)
+.||+.||.|||++ ||+||||||+||||+.+ +.+||+|||++...... .....+|+.|+|||++.+ ..
T Consensus 137 ~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~-~~ 211 (373)
T 1q8y_A 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG-AP 211 (373)
T ss_dssp HHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-CC
T ss_pred HHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhC-CC
Confidence 99999999999998 99999999999999643 37999999999766532 244578999999999987 67
Q ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHcCCCCchhhccCCCCCc-----cccCCCCCC----
Q 011763 310 YGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSKLPHA-----TLFKPQQPY---- 374 (478)
Q Consensus 310 ~~~~~DiwslG~il~elltG~~pf~~~~------~~~~~~~i~~~~g~~~~~~~~~~~~~~~-----~~~~~~~~~---- 374 (478)
++.++|||||||++|+|++|+.||.+.+ ..+.+.++...++.+|...+...+.... .........
T Consensus 212 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (373)
T 1q8y_A 212 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 291 (373)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc
Confidence 8999999999999999999999998754 5678888999999999877654432110 000000000
Q ss_pred -Cccchhc---ccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 375 -DSSLRET---FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 375 -~~~l~~~---~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
...+... ...++.++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 292 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 0001111 123467899999999999999999999999999998743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=370.29 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=216.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEE
Confidence 4589999999999999999999999999999999976543 2445678899999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC-CC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 287 (478)
||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999987666666666789999999999999999999999999999999999999999999999999997653221 12
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHcCCCCchhhccCCCCCcc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......+|+.|+|||++.+...++.++|||||||++|+|++|+.||........ +..+.....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 226 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------- 226 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT----------------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc----------------
Confidence 234457799999999988744457899999999999999999999987654322 222211000
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
....+..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 227 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 227 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 001124678999999999999999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=382.23 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=206.5
Q ss_pred ccceeee-eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceE
Q 011763 129 ADAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 129 ~~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 206 (478)
.+.|++. +.||+|+||+||+|++..+++.||||++.... ......+.+|+.+|.++ +||||+++++++.+ ...+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEE
Confidence 4579986 78999999999999999999999999997653 23346678899999985 79999999999987 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc---EEEeecccccccCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNT 283 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkl~DFG~a~~~~~ 283 (478)
|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999997666555544557999999999999999999999999999999999999998776 99999999875432
Q ss_pred CC------CCCccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------------
Q 011763 284 GH------RQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--------------- 338 (478)
Q Consensus 284 ~~------~~~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~--------------- 338 (478)
.. .......++|+.|+|||++.+ ...++.++|||||||++|+|++|++||.+...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 11 112234568999999999863 13478899999999999999999999987642
Q ss_pred HHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 339 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
......+.......+. ..+..+++++++||.+||..||.+|||+.|+|+||||+.
T Consensus 247 ~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPD-------------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHCCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHHHHHHhccCcccCc-------------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 2223333322111111 123468899999999999999999999999999999986
Q ss_pred C
Q 011763 419 K 419 (478)
Q Consensus 419 ~ 419 (478)
.
T Consensus 302 ~ 302 (316)
T 2ac3_A 302 C 302 (316)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=377.68 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=217.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|.+.+.||+|+||+||++++..+++.||+|++..... .....+.+|+.+|+.++||||+++++++.. ....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEE
Confidence 3589999999999999999999999999999999985432 233567789999999999999999999977 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---ecCCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~~~ 285 (478)
||||++++.+.........+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 99999876555444444579999999999999999999999999999999999999 7788999999999875443
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.......+..
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 229 (304)
T 2jam_A 162 -GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESP---------- 229 (304)
T ss_dssp -BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTT----------
T ss_pred -CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcc----------
Confidence 22344568999999999876 678999999999999999999999999988888777776533222111
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.+..+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 230 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 230 ---------------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---------------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 124678999999999999999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=375.81 Aligned_cols=258 Identities=29% Similarity=0.439 Sum_probs=218.4
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
..++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+ ....
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 89 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRI 89 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEE
Confidence 367999999999999999999999999999999999753221 1223567889999999999999999999987 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|+||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-- 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence 999999988655555444457999999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......
T Consensus 168 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------- 230 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--------------- 230 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---------------
T ss_pred -ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC---------------
Confidence 2234578999999999886 67899999999999999999999999988877776665432110
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
....++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 231 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 231 --------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp --------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred --------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 0135788999999999999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=382.29 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=223.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|.+.+.||+|+||.||++++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEE
Confidence 5689999999999999999999999999999999976543 44566778899999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~ 196 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 196 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-c
Confidence 999999987666665555679999999999999999999999999999999999999999999999999997654322 2
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.......
T Consensus 197 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 260 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI--------------- 260 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------------
T ss_pred cccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC---------------
Confidence 2344578999999999876 678999999999999999999999999888777766665421111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
...+++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 261 --------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 261 --------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred --------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 1256788999999999999999999999999999987544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=374.42 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=223.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|.+.+.||+|+||+||++++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEEE
Confidence 5689999999999999999999999999999999976543 44566778899999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-c
Confidence 999999987666665555679999999999999999999999999999999999999999999999999997654322 2
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+......
T Consensus 171 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 233 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS---------------- 233 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----------------
T ss_pred ccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC----------------
Confidence 2344568999999999876 67899999999999999999999999988877766655431110
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
....+++.+.+||.+||+.||.+|||+.|+|+||||+....+.
T Consensus 234 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 234 -------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred -------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 0125678899999999999999999999999999998765543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=373.54 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=218.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.++|++.+.||+|+||+||+|++..+++.||+|++....... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 81 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KT 81 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CC
Confidence 357999999999999999999999999999999998654321 235678899999999999999999999987 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC----cEEEeecccccc
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANF 280 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~DFG~a~~ 280 (478)
..|+||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 7999999998766665555556799999999999999999999999999999999999999887 899999999976
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 162 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 231 (283)
T 3bhy_A 162 IEAGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD------- 231 (283)
T ss_dssp CC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-------
T ss_pred ccCCC--cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc-------
Confidence 64332 2344568999999999876 6789999999999999999999999999888777776654322221
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 232 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 232 ------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 1223568899999999999999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=405.81 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=218.6
Q ss_pred cccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 126 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
++..++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|+.++||||++++++|.. ..
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~ 258 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KT 258 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CC
Confidence 45578999999999999999999999999999999999754321 1234567789999999999999999999887 67
Q ss_pred eEEEEEeeccCCchhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 205 SIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
.+||||||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 89999999998666544322 34699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHcCCCCchh
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT----EVEQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~----~~~~~~~i~~~~g~~~~~~ 356 (478)
..... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+ ..+....+.......
T Consensus 339 ~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~---- 412 (543)
T 3c4z_A 339 LKAGQ-TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY---- 412 (543)
T ss_dssp CCTTC-CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC----
T ss_pred ccCCC-cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC----
Confidence 65432 22344589999999999987 678999999999999999999999998764 234444443311100
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
...+++.+.+||.+||+.||.+||+ +.++++||||+...|
T Consensus 413 -------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 413 -------------------------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp -------------------------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred -------------------------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 1357899999999999999999996 589999999998655
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=383.10 Aligned_cols=264 Identities=24% Similarity=0.353 Sum_probs=216.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC--ce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLS--CS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~ 205 (478)
.++|++.+.||+|+||+||+|++..+++.||||++..... .......+.+|+.++..++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4689999999999999999999999999999999986543 34556678899999999999999999999875332 24
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
.||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 69999999987666665555679999999999999999999999999999999999999999999999999997654322
Q ss_pred C--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 286 R--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 286 ~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++......++.
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 240 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------- 240 (311)
T ss_dssp -----------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH---------
T ss_pred cccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc---------
Confidence 1 12234567999999999986 67899999999999999999999999999888777766553222211
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....+++++.+||.+||+.||.+||++.++|.|+|++.
T Consensus 241 ----------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ----------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 122468899999999999999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=391.82 Aligned_cols=256 Identities=24% Similarity=0.345 Sum_probs=200.1
Q ss_pred ccceeee-eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh-cCCCCeeeecceeee--cCCc
Q 011763 129 ADAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR-LDHPNIIKLEGLITS--RLSC 204 (478)
Q Consensus 129 ~~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~--~~~~ 204 (478)
.++|.+. +.||+|+||+||+|++..+++.||||++... ..+.+|+.++.+ ++||||++++++|.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4578887 7899999999999999999999999999632 345678888755 489999999998864 2245
Q ss_pred eEEEEEeeccCCchhhcc-CC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec---CCcEEEeeccccc
Q 011763 205 SIYLVFEYMEHDITGLLS-CP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLAN 279 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~-~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~ 279 (478)
.+||||||++++.+..+. .. ...+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 789999999985554443 32 246999999999999999999999999999999999999998 7899999999998
Q ss_pred ccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHcCCCCch
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE----QLHKIFKLCGSPPDD 355 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~----~~~~i~~~~g~~~~~ 355 (478)
..... ......++|+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+... ....+.......+.
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~- 288 (400)
T 1nxk_A 213 ETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN- 288 (400)
T ss_dssp ECC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT-
T ss_pred ccCCC--CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC-
Confidence 65432 22345678999999999876 678999999999999999999999998765322 22233221111111
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..+..+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 289 ------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 289 ------------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp ------------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1134688999999999999999999999999999999763
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=370.65 Aligned_cols=263 Identities=29% Similarity=0.417 Sum_probs=221.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC---C----hHHHHHHHHHHHHHHhcC-CCCeeeecceeee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---E----PESVRFMAREILILRRLD-HPNIIKLEGLITS 200 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 200 (478)
.++|++.+.||+|+||.||+|++..+++.||||++..... . ....+.+.+|+.+|+++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 5689999999999999999999999999999999976531 1 223456778999999995 9999999999977
Q ss_pred cCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 201 RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 201 ~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
....|+||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 678999999999866655555556799999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCccccccCCcccCccccc-----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCch
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLL-----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~-----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 355 (478)
..... ......+|+.|+|||++. ....++.++|||||||++|+|++|..||...+..+....+.......+.
T Consensus 174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 250 (298)
T 1phk_A 174 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS- 250 (298)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred cCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc-
Confidence 65432 234457899999999875 2356889999999999999999999999998887777776653322211
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
..+..++..+.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 251 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 251 ------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp ------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 11246788999999999999999999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=379.89 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=204.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC-----
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----- 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 203 (478)
.++|++++.||+|+||.||+|++..+++.||||+++... .....+.+.+|+.+|++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 458999999999999999999999999999999998654 34456778899999999999999999998865321
Q ss_pred --------------------------------------------------ceEEEEEeeccCCchhhccCCC---CCCCH
Q 011763 204 --------------------------------------------------CSIYLVFEYMEHDITGLLSCPD---IKFSE 230 (478)
Q Consensus 204 --------------------------------------------------~~~~lv~e~~~~~ll~~~~~~~---~~l~~ 230 (478)
.++|+||||++++.+..+.... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 2489999999986665554433 23566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-----------CCccccccCCccc
Q 011763 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-----------QPLTSRVVTLWYR 299 (478)
Q Consensus 231 ~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-----------~~~~~~~~t~~y~ 299 (478)
..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .......+|+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 77899999999999999999999999999999999999999999999987654321 1224457899999
Q ss_pred CcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccch
Q 011763 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLR 379 (478)
Q Consensus 300 APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 379 (478)
|||++.+ ..++.++|||||||++|+|++|..|+. +....+........ .
T Consensus 244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~-------------------------~ 292 (332)
T 3qd2_B 244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKF-------------------------P 292 (332)
T ss_dssp CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCC-------------------------C
T ss_pred ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCC-------------------------C
Confidence 9999886 678999999999999999999876643 11111111111110 0
Q ss_pred hcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 380 ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 380 ~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..+...++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 112345678899999999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=381.57 Aligned_cols=264 Identities=26% Similarity=0.436 Sum_probs=208.7
Q ss_pred cccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCeeeecceeeecCC
Q 011763 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--PNIIKLEGLITSRLS 203 (478)
Q Consensus 126 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~ 203 (478)
.+..++|++++.||+|+||+||++.+ .+++.||||++..........+.+.+|+.+|..+.| +||+++++++.. .
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~ 81 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--D 81 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--S
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--C
Confidence 34467899999999999999999997 468999999998777677777888999999999976 999999999987 6
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..+|||||+..+++...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++....
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 78999999766666555543 45799999999999999999999999999999999999997 68899999999986654
Q ss_pred CCCC-CccccccCCcccCcccccC----------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCC
Q 011763 284 GHRQ-PLTSRVVTLWYRPPELLLG----------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGS 351 (478)
Q Consensus 284 ~~~~-~~~~~~~t~~y~APE~l~~----------~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~~~g~ 351 (478)
.... .....++|+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..+..+.. .
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~ 236 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---P 236 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---T
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc---C
Confidence 3221 2335678999999999853 256889999999999999999999999875433 33333321 1
Q ss_pred CCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
.... ......+.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 237 ~~~~------------------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 237 NHEI------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp TSCC------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred Cccc------------------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 1000 001234678999999999999999999999999999986443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=388.30 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=207.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--CCCeeeecceeeecCCceE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD--HPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~~ 206 (478)
.++|++++.||+|+||+||++.+.. ++.||||++..........+.+.+|+.+|..|. ||||+++++++.. ...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEE
Confidence 4579999999999999999999765 899999999877767777788999999999996 5999999999887 6679
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|||||+..+++...+. ....+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.......
T Consensus 132 ~lv~E~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEECCSEEHHHHHH-HCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9999965555555544 344789999999999999999999999999999999999995 68999999999986653322
Q ss_pred -CCccccccCCcccCcccccC----------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCCCCc
Q 011763 287 -QPLTSRVVTLWYRPPELLLG----------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPD 354 (478)
Q Consensus 287 -~~~~~~~~t~~y~APE~l~~----------~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~~~g~~~~ 354 (478)
......++|+.|+|||++.+ ...++.++|||||||+||+|++|++||...... ..+..+.......
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~-- 287 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-- 287 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC--
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC--
Confidence 12345678999999999864 136889999999999999999999999876433 3343332210000
Q ss_pred hhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
......+.++.+||.+||..||.+|||+.|+|+||||+....
T Consensus 288 -------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 288 -------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp -------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred -------------------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 001234678999999999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=372.39 Aligned_cols=262 Identities=26% Similarity=0.387 Sum_probs=214.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++.||+|+||+||+|++..+++.||+|++..... .....+.+.+|+.++..++||||+++++++.. ...+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEE
Confidence 4589999999999999999999999999999999876543 45556778899999999999999999999877 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||++++.+..+.....++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999998777666555567999999999999999999999999999999999999999999999999999876544333
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...+.... ..+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~-------------- 230 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVP-------------- 230 (294)
T ss_dssp -------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--CCC--------------
T ss_pred ccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--cCC--------------
Confidence 3445678999999999887 67899999999999999999999999998877665554331 111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
.......+.+++.+.++|.+||+.||.+||+..+.|.+.|..
T Consensus 231 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 231 --------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp --------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred --------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 111222357899999999999999999999777777777764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=370.53 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=209.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEE
Confidence 5689999999999999999999999999999999975421 12234567889999999999999999999977 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 999999886665555444578999999999999999999999999999999999999999999999999997665432
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+|+.|+|||++.+....+.++|||||||++|+|++|+.||...+..+....+.......
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 230 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI--------------- 230 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------------
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC---------------
Confidence 22345679999999998874444689999999999999999999999887777666654421111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
...++..+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 231 --------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 231 --------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 12467889999999999999999999999999999763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=392.47 Aligned_cols=262 Identities=26% Similarity=0.452 Sum_probs=210.8
Q ss_pred ccceeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vAlK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 202 (478)
.++|++++.||+|+||+||++++. .+++.||||+++.... .....+.+.+|+.+|..+ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 568999999999999999999984 5899999999865321 112233456799999999 79999999999987
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 67899999999987666555555579999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHcCCCCchhh
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~----~~~~~~i~~~~g~~~~~~~ 357 (478)
..........++|+.|+|||++.+. ..++.++|||||||+||+|++|+.||..... ......+.... +
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~----- 283 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--P----- 283 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--C-----
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--C-----
Confidence 3322333456789999999998752 4578999999999999999999999976432 22222222210 0
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
.....++..+.+||.+||..||.+|| |+.|+|+||||+...|
T Consensus 284 ----------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 284 ----------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ----------------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 01135788899999999999999999 9999999999987543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=374.37 Aligned_cols=265 Identities=27% Similarity=0.407 Sum_probs=217.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
.++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++........
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4689999999999999999999999999999999975432 12345678899999999999999999999865546789
Q ss_pred EEEEeeccCCchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 207 YLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
|+||||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99999999886555543 34579999999999999999999999999999999999999999999999999997654321
Q ss_pred -CCCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 286 -RQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 286 -~~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
........+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~------------ 231 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA------------ 231 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC------------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC------------
Confidence 1222345679999999998752 23477999999999999999999999998877776666542110
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
....+++.+.+||.+||..||.+|||+.|+|+||||+....+
T Consensus 232 -----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 232 -----------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp -----------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred -----------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 013578899999999999999999999999999999875443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=372.88 Aligned_cols=258 Identities=31% Similarity=0.478 Sum_probs=190.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++.+ ....|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeEE
Confidence 56899999999999999999999999999999999743211 1224567889999999999999999999987 67899
Q ss_pred EEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 208 LVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 208 lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
+||||++++.+.. +......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 166 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH- 166 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-
Confidence 9999998755544 44444679999999999999999999999999999999999999999999999999997654322
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+.. .
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------~--- 227 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---------------A--- 227 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS---------------S---
T ss_pred CcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh---------------c---
Confidence 12234567999999999876 6788999999999999999999999987654333322110 0
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
. ......++.++.+||.+||+.||.+|||+.++|+||||...
T Consensus 228 ----~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 228 ----D-------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ----C-------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ----c-------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 0 00113578899999999999999999999999999999763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=369.99 Aligned_cols=252 Identities=20% Similarity=0.254 Sum_probs=207.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++.||+|+||+||+|++..+++.||||++............+.+|+.++..+ +||||+++++++.+ ....|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 4589999999999999999999999999999999987665556667788999999999 99999999999987 67899
Q ss_pred EEEeeccCCchhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC----------------
Q 011763 208 LVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---------------- 267 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---------------- 267 (478)
+||||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999988555544332 2568999999999999999999999999999999999999844
Q ss_pred ---CcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011763 268 ---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344 (478)
Q Consensus 268 ---~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~ 344 (478)
..+||+|||++...... ....+|+.|+|||++.+...++.++|||||||++|+|++|.+++...... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~ 239 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HE 239 (289)
T ss_dssp --CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HH
T ss_pred CCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HH
Confidence 47999999999866542 23457999999999987556778999999999999999999887654322 22
Q ss_pred HHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 345 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
+... .. ......+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 240 ~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 240 IRQG--RL--------------------------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHTT--CC--------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHcC--CC--------------------------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 2211 00 0111357899999999999999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=386.21 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=210.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE------SVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 202 (478)
.++|++++.||+|+||+||+|++..+++.||||++........ ....+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 4589999999999999999999999999999999986543211 23345679999999999999999999987
Q ss_pred CceEEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 203 SCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 203 ~~~~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
...+++||||+..+ .+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 67899999999764 55555556667999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||...... ....
T Consensus 181 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~------------ 240 (335)
T 3dls_A 181 ERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VEAA------------ 240 (335)
T ss_dssp CTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TTTC------------
T ss_pred CCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hhhc------------
Confidence 543 22345678999999999987444588999999999999999999999752210 0000
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
......+++++.+||.+||..||.+|||+.++|+||||+.
T Consensus 241 -----------------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 241 -----------------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp -----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred -----------------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 0001247889999999999999999999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=376.81 Aligned_cols=279 Identities=23% Similarity=0.421 Sum_probs=225.3
Q ss_pred ccceeeeeeeeecCceEEEEEEE-CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC------Ceeeecceeeec
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARD-LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP------NIIKLEGLITSR 201 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~-~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~l~~~~~~~ 201 (478)
.++|++++.||+|+||+||+|.+ ..+++.||||+++.. ....+.+.+|+.+++.++|+ +|+++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-
Confidence 45899999999999999999998 567899999999643 34556778899999998665 49999999987
Q ss_pred CCceEEEEEeeccCCchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec--------------
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------------- 266 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-------------- 266 (478)
...+||||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 89 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 -HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 67899999999777777665433 36899999999999999999999999999999999999987
Q ss_pred -----CCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 011763 267 -----EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341 (478)
Q Consensus 267 -----~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~ 341 (478)
++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999765432 234578999999999886 6789999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCchhhccCCCCCccccCCCCCCCc-------------cchh---cccCCchhHHHHHHHhcCCCCCCcc
Q 011763 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS-------------SLRE---TFKDLPTTAVNLIETLLSVEPYKRA 405 (478)
Q Consensus 342 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~l~~---~~~~~~~~l~~Li~~mL~~dP~~R~ 405 (478)
+..+....+.+|...+........ .......+.. .+.. .....++++.+||.+||+.||.+||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKY-FHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGG-EETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHhCCCCHHHHhhccchhH-HhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 999999999888877654332110 0000000000 0000 0122357799999999999999999
Q ss_pred CHHHHHhCcccCC
Q 011763 406 TASAALASEYFST 418 (478)
Q Consensus 406 ta~e~L~hp~f~~ 418 (478)
|+.|+|+||||+.
T Consensus 322 t~~ell~hp~f~~ 334 (339)
T 1z57_A 322 TLREALKHPFFDL 334 (339)
T ss_dssp CHHHHTTSGGGGG
T ss_pred CHHHHhcCHHHHH
Confidence 9999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=370.36 Aligned_cols=262 Identities=28% Similarity=0.445 Sum_probs=220.1
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
...++|++++.||+|+||.||++++..+++.||+|++..........+.+.+|+.++++++||||+++++++.......+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34679999999999999999999999999999999998877677777888999999999999999999998876557789
Q ss_pred EEEEeeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcEEEecCCcEEEeeccc
Q 011763 207 YLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGL 277 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDlkp~NILl~~~~~vkl~DFG~ 277 (478)
|+||||++++.+..+.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999998755444332 2345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhh
Q 011763 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 278 a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 357 (478)
+....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~------ 234 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR------ 234 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred heeecccc-ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc------
Confidence 97654321 11233467999999999886 67899999999999999999999999998877766666542110
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.....+++++.+||.+||+.||.+|||+.|+|+|+|+..
T Consensus 235 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 235 ----------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ----------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 001257889999999999999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=378.54 Aligned_cols=280 Identities=24% Similarity=0.417 Sum_probs=226.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCC-cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC------eeeecceeeec
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTG-KIVALKKVRFDNFEPESVRFMAREILILRRLDHPN------IIKLEGLITSR 201 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~-~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~ 201 (478)
.++|++++.||+|+||+||+|++..++ +.||+|+++.. ....+.+.+|+.+++.+.|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-
Confidence 458999999999999999999998776 68999999642 345567778999999997655 8888888877
Q ss_pred CCceEEEEEeeccCCchhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----------------
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---------------- 264 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---------------- 264 (478)
...+||||||++++++..+.... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 94 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 -HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred -CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 67899999999888887776543 469999999999999999999999999999999999999
Q ss_pred ---ecCCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 011763 265 ---NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341 (478)
Q Consensus 265 ---~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~ 341 (478)
+.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 66789999999999865432 244578999999999886 6789999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCchhhccCCCCCccccCCCCCCCcc-------------chh---cccCCchhHHHHHHHhcCCCCCCcc
Q 011763 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSS-------------LRE---TFKDLPTTAVNLIETLLSVEPYKRA 405 (478)
Q Consensus 342 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------l~~---~~~~~~~~l~~Li~~mL~~dP~~R~ 405 (478)
+..+...++.+|..++......... +.....+... +.. .....+.++.+||.+||+.||.+||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYF-YKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGE-ETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhh-cccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 9999999999988776543321110 0000000000 000 0012245789999999999999999
Q ss_pred CHHHHHhCcccCCC
Q 011763 406 TASAALASEYFSTK 419 (478)
Q Consensus 406 ta~e~L~hp~f~~~ 419 (478)
|+.|+|+||||+..
T Consensus 327 t~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 327 TLAEALLHPFFAGL 340 (355)
T ss_dssp CHHHHTTSGGGGGC
T ss_pred CHHHHhcChhhcCC
Confidence 99999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=375.92 Aligned_cols=260 Identities=28% Similarity=0.434 Sum_probs=208.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC------hHHHHHHHHHHHHHHhcCCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE------PESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 202 (478)
.++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 45899999999999999999999999999999999754321 1223457789999999999999999999865
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc---EEEeeccccc
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLAN 279 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkl~DFG~a~ 279 (478)
. ..|+||||++++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 87 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 E-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp S-SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred C-ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 2 38999999998666555556668999999999999999999999999999999999999987664 9999999997
Q ss_pred ccCCCCCCCccccccCCcccCccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHcCCCCchh
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL-HKIFKLCGSPPDDY 356 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~--~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~-~~i~~~~g~~~~~~ 356 (478)
..... .......+|+.|+|||++. +...++.++|||||||++|+|++|..||........+ ..+.......
T Consensus 166 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 239 (322)
T 2ycf_A 166 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF---- 239 (322)
T ss_dssp ECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC----
T ss_pred ecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc----
Confidence 66432 1223456799999999873 3467899999999999999999999999875543222 2222211111
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
+.+.+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 240 ---------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 240 ---------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ---------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 12233568899999999999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=370.36 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=219.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+++.||||++............+.+|+.++++++||||+++++++.. ....|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEE
Confidence 458999999999999999999999999999999998665444556778899999999999999999999977 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC---CcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a~~~~~~~ 285 (478)
||||+.++.+.........+++..++.++.||+.||.|||++||+|+||||+||||+.+ +.+||+|||++.......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999876554444344579999999999999999999999999999999999999764 469999999997654332
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 179 --~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 243 (287)
T 2wei_A 179 --KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----------- 243 (287)
T ss_dssp --SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred --ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----------
Confidence 2234467899999998875 4899999999999999999999999998888777776553221111
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..+..+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 244 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 244 --------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp --------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred --------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 1124678999999999999999999999999999999763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=371.53 Aligned_cols=258 Identities=25% Similarity=0.361 Sum_probs=208.3
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|++.+.||+|+||+||+|++ +++.||||++..........+.+.+|+.+|++++||||+++++++.. ...+|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PPNLS 110 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TTCCE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCceE
Confidence 367899999999999999999986 58899999998777677777888999999999999999999999977 56789
Q ss_pred EEEeeccCCchhhccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 208 LVFEYMEHDITGLLSCPDI---KFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
+||||++++.+..+..... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999866655544333 3899999999999999999999999 9999999999999999999999999997544
Q ss_pred CCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......+
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------- 258 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL---------- 258 (309)
T ss_dssp ------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred ccc-cccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Confidence 321 22345678999999999886 678999999999999999999999999988877666654321111
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh--CcccCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFST 418 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~--hp~f~~ 418 (478)
.....+++.+.+||.+||+.||.+|||+.++++ .++++.
T Consensus 259 -----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 -----------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 011367889999999999999999999999997 577654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=378.66 Aligned_cols=278 Identities=23% Similarity=0.330 Sum_probs=212.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+|+.++||||+++++++........||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 5689999999999999999999999999999999975432 223456778999999999999999999998765668999
Q ss_pred EEeeccCCchhhccCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----ecCCcEEEeeccccccc
Q 011763 209 VFEYMEHDITGLLSCPD---IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFS 281 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~vkl~DFG~a~~~ 281 (478)
||||++++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999876555444332 238999999999999999999999999999999999999 67778999999999876
Q ss_pred CCCCCCCccccccCCcccCcccccC-------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHcC
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLG-------ATDYGPSVDLWSVGCVFAELLIGKPILQGRT----EVEQLHKIFKLCG 350 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~-------~~~~~~~~DiwslG~il~elltG~~pf~~~~----~~~~~~~i~~~~g 350 (478)
.... ......+|+.|+|||++.. ...++.++|||||||++|+|++|+.||.... ..+.+.++..
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--- 241 (319)
T 4euu_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--- 241 (319)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH---
T ss_pred CCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc---
Confidence 5432 2345678999999998752 2678999999999999999999999997543 2344444433
Q ss_pred CCCchhhccCCCCCcccc--CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcc
Q 011763 351 SPPDDYWKKSKLPHATLF--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (478)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~ 415 (478)
..|...|........... ....+.. ......++..+.+||.+||++||++|||+.|+|+||-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTT---CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcc---cccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 233333322111000000 0000000 0111345678999999999999999999999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=382.48 Aligned_cols=286 Identities=23% Similarity=0.319 Sum_probs=216.7
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++++.||+|+||+||++++..+++.||+|++.... .....+.+.+|+.+|+.++||||+++++++.. ...+
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 106 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEI 106 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEE
Confidence 44678999999999999999999999999999999998653 45666778899999999999999999999987 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
|+||||++++.+..+......+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++......
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999866666655555799999999999999999999996 9999999999999999999999999998654321
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-chhhccCCC--
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-DDYWKKSKL-- 362 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~-~~~~~~~~~-- 362 (478)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+........ ...+.....
T Consensus 186 --~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp --C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred --cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2234578999999999886 6789999999999999999999999998776654433321111111 100000000
Q ss_pred CCccccCCCCCCCc---cc---------hhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 363 PHATLFKPQQPYDS---SL---------RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 363 ~~~~~~~~~~~~~~---~l---------~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
..........+... .+ ......++.++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 00000000000000 00 00012468899999999999999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=383.67 Aligned_cols=266 Identities=19% Similarity=0.225 Sum_probs=194.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc--CCCCeeeec-------cee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL--DHPNIIKLE-------GLI 198 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~nIv~l~-------~~~ 198 (478)
..+|++.+.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4469999999999999999999999999999999987654 334556677786555555 699988755 344
Q ss_pred eecCC---------------ceEEEEEeeccCCchhhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCceeccC
Q 011763 199 TSRLS---------------CSIYLVFEYMEHDITGLLSCPDIKFSEAQI------KCYMNQLLHGLEHCHSRGVLHRDI 257 (478)
Q Consensus 199 ~~~~~---------------~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~------~~i~~qil~aL~~LH~~givHrDl 257 (478)
..... ..+||||||++++|...+......+++..+ ..++.||+.||+|||++||+||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33211 458999999997766666543334455555 677799999999999999999999
Q ss_pred CCCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccCcccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 011763 258 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGR 336 (478)
Q Consensus 258 kp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~-~~~~~~~~DiwslG~il~elltG~~pf~~~ 336 (478)
||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ...++.++|||||||+||+|++|+.||.+.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999866432 124566799999999864 246899999999999999999999999876
Q ss_pred ChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 337 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 337 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.... ...|....... ..........+..+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 297 ~~~~-------------~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 297 TPGI-------------KGSWKRPSLRV-------PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp CTTC-------------TTCCCBCCTTS-------CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred Cccc-------------ccchhhhhhhh-------ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 4221 00111100000 000001111234789999999999999999999999999999999
Q ss_pred CC
Q 011763 417 ST 418 (478)
Q Consensus 417 ~~ 418 (478)
++
T Consensus 357 ~~ 358 (371)
T 3q60_A 357 LQ 358 (371)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=362.95 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=218.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+.|++++.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEE
Confidence 4579999999999999999999999999999999986543 3445678899999999999999999999987 677999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+..+... ..+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... ..
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 9999998666665544 479999999999999999999999999999999999999999999999999997655432 22
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||......+....+.... ++
T Consensus 176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~--------------- 237 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--PP--------------- 237 (303)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC---------------
T ss_pred cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--CC---------------
Confidence 244578999999999876 678999999999999999999999999887776665543311 10
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.....++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 238 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 238 -----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -----------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -----------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0113678899999999999999999999999999999763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=374.74 Aligned_cols=275 Identities=23% Similarity=0.388 Sum_probs=215.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh---------------HHHHHHHHHHHHHHhcCCCCeee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP---------------ESVRFMAREILILRRLDHPNIIK 193 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~ 193 (478)
.++|++.+.||+|+||.||+|++ +++.||||++....... ...+.+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 57899999999999999999998 89999999997542211 11267889999999999999999
Q ss_pred ecceeeecCCceEEEEEeeccCCchhhc------cCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEE
Q 011763 194 LEGLITSRLSCSIYLVFEYMEHDITGLL------SCP--DIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLV 264 (478)
Q Consensus 194 l~~~~~~~~~~~~~lv~e~~~~~ll~~~------~~~--~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl 264 (478)
+++++.+ ...+|+||||++++.+..+ ... ...+++..++.++.||+.||.|||+ +||+|+||||+|||+
T Consensus 108 ~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999987 6789999999998655554 333 5679999999999999999999999 999999999999999
Q ss_pred ecCCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCC-hhhHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 011763 265 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP-SVDLWSVGCVFAELLIGKPILQGRTE-VEQL 342 (478)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~-~~DiwslG~il~elltG~~pf~~~~~-~~~~ 342 (478)
+.++.+||+|||++...... ......+|+.|+|||++.+...++. ++|||||||++|+|++|+.||...+. .+..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999865432 2345678999999999987435666 99999999999999999999998776 5555
Q ss_pred HHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 343 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
..+.......+... . ....+ ............++.++.+||.+||+.||.+|||+.|+|+||||+..+
T Consensus 263 ~~i~~~~~~~~~~~-~-------~~~~~--~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 263 NNIRTKNIEYPLDR-N-------HFLYP--LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHTSCCCCCCCSS-S-------SSTTT--TCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhccCcCCccch-h-------hhhcc--ccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 55533211111100 0 00000 000011122256889999999999999999999999999999998643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=369.45 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=208.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC----C
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL----S 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~----~ 203 (478)
.++|++++.||+|+||.||+|++..+++.||||++..... ....+.+|+.+++++ +||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 5689999999999999999999999999999999975532 235677899999999 8999999999997643 4
Q ss_pred ceEEEEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 204 CSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
..+|+||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 67899999999855544433 2356899999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCCCccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhh
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 357 (478)
.... .......+|+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+..+..... +.
T Consensus 180 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~--- 253 (326)
T 2x7f_A 180 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--PR--- 253 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CC---
T ss_pred CcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--cc---
Confidence 4321 12234568999999999862 25688999999999999999999999998887766655543210 00
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
.....++..+.+||.+||..||.+|||+.++|+||||+..+
T Consensus 254 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 254 ----------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp ----------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred ----------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 00135788999999999999999999999999999998743
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=368.53 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=197.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.++..+++.++||||+++++++.. ...+|+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEE
Confidence 678999999999999999999999999999999998765444444455556667888899999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||+++.+..........+++..++.++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (318)
T 2dyl_A 102 AMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-- 179 (318)
T ss_dssp EECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--
Confidence 999995444444433356799999999999999999999995 99999999999999999999999999997654322
Q ss_pred CccccccCCcccCccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 288 PLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~----~~~~~~~~~DiwslG~il~elltG~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
......+|+.|+|||++. ....++.++|||||||++|+|++|+.||... ...+.+..+.... ++.
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~-------- 249 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PPL-------- 249 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CCC--------
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CCC--------
Confidence 223456799999999985 2356889999999999999999999999874 4445555554421 100
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
......+++++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 250 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 250 ----------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp ----------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred ----------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 0001257889999999999999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=367.78 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=211.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++..++||||+++++++.. ...+|+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEE
Confidence 468999999999999999999999999999999987543 3345677889999999999999999999987 567999
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||++++.+..+. .....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 99999987665543 334579999999999999999999999999999999999999999999999999975322110 1
Q ss_pred CccccccCCcccCccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 288 PLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
......+|+.|+|||++. ....++.++|||||||++|+|++|..||...+..+.+..+........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 242 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL---------- 242 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc----------
Confidence 113346799999999884 336789999999999999999999999999888777666554211000
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 243 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 243 ----------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp ----------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred ----------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 0013568889999999999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=372.82 Aligned_cols=271 Identities=25% Similarity=0.382 Sum_probs=194.5
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|++.+.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES--SSCEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcE
Confidence 36789999999999999999999988999999999875432 2345667789999999999999999999987 56799
Q ss_pred EEEeeccCCchhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 208 LVFEYMEHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~--------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
+||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 9999998765544432 34569999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCC----CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCch
Q 011763 280 FSNTGHR----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 280 ~~~~~~~----~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 355 (478)
....... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||........+...... .++ .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~-~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN--DPP-S 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--SCC-C
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--CCC-c
Confidence 6543211 11234567999999999865456899999999999999999999999987766555443321 111 0
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
.. ...........++.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 247 ~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 247 LE----------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp TT----------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred cc----------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 00 00001122356789999999999999999999999999999998643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=366.51 Aligned_cols=258 Identities=28% Similarity=0.463 Sum_probs=211.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWI 101 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 568999999999999999999999999999999997643 23457789999999999999999999987 677999
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||++++.+..+. .....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-A 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-S
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-c
Confidence 99999986555443 345579999999999999999999999999999999999999999999999999997654322 2
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.... ++.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~------------- 244 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--PPT------------- 244 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCC-------------
T ss_pred ccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--Ccc-------------
Confidence 2344577999999999876 678999999999999999999999999887766655443311 100
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
......++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 245 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 245 -----------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -----------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 001134688999999999999999999999999999998744
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=391.82 Aligned_cols=252 Identities=17% Similarity=0.244 Sum_probs=197.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHH---HHHhcCCCCeeeec-------ce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREIL---ILRRLDHPNIIKLE-------GL 197 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~---~l~~l~h~nIv~l~-------~~ 197 (478)
.++|++.+.||+|+||+||+|++..+++.||||++..... .....+.+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 5689999999999999999999989999999999986532 3455677889994 55555899999998 55
Q ss_pred eeecCC----------c-----eEEEEEeeccCCchhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 011763 198 ITSRLS----------C-----SIYLVFEYMEHDITGLLSCP------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 256 (478)
Q Consensus 198 ~~~~~~----------~-----~~~lv~e~~~~~ll~~~~~~------~~~l~~~~~~~i~~qil~aL~~LH~~givHrD 256 (478)
+..... . ..||||||+++++...+... ...+++..++.++.||+.||.|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 443211 1 37899999977665555432 12234588889999999999999999999999
Q ss_pred CCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccCcccccCC----------CCCCChhhHHHHHHHHHHH
Q 011763 257 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA----------TDYGPSVDLWSVGCVFAEL 326 (478)
Q Consensus 257 lkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~----------~~~~~~~DiwslG~il~el 326 (478)
|||+||||+.++.+||+|||+++.... ......+ +.|+|||++.+. ..++.++|||||||+||||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999999986432 2344566 999999998763 2689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC
Q 011763 327 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406 (478)
Q Consensus 327 ltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t 406 (478)
++|+.||.+.+..+.... +...+..+++++.+||.+||+.||.+|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 307 WCADLPITKDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHSSCCC------CCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHCCCCCcccccccchhh---------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 999999976543221111 11122468899999999999999999999
Q ss_pred HHHHHhCcccCC
Q 011763 407 ASAALASEYFST 418 (478)
Q Consensus 407 a~e~L~hp~f~~ 418 (478)
+.|+|+||||+.
T Consensus 354 ~~e~l~hp~f~~ 365 (377)
T 3byv_A 354 PLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHTSHHHHH
T ss_pred HHHHhhChHHHH
Confidence 999999999964
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=363.29 Aligned_cols=259 Identities=25% Similarity=0.450 Sum_probs=202.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec-------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR------- 201 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------- 201 (478)
.++|++++.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 35799999999999999999999999999999999643 35567788999999999999999999987652
Q ss_pred ----CCceEEEEEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecc
Q 011763 202 ----LSCSIYLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 276 (478)
Q Consensus 202 ----~~~~~~lv~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG 276 (478)
....+|+||||++++.+ ..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 24578999999987544 4444455578899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-------------CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChHHHH
Q 011763 277 LANFSNTGH-------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQL 342 (478)
Q Consensus 277 ~a~~~~~~~-------------~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~-~~~~~~ 342 (478)
++....... ........+|+.|+|||++.+...++.++|||||||++|+|++ ||... +..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 997654211 1222345679999999998865678999999999999999998 55432 222333
Q ss_pred HHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 343 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..+.......+. ......+..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 239 ~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 KKLRSVSIEFPP-------------------------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHSTTCCCCT-------------------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HhccccccccCc-------------------------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 333221111110 111356778999999999999999999999999999975
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=357.35 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=211.1
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++++.||+|+||+||+|++. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+ ....
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPI 80 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEec--CCce
Confidence 34678999999999999999999986 4778999999865433 3557889999999999999999999977 5679
Q ss_pred EEEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 207 YLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 207 ~lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
|+||||++++.+.. +......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 99999999865554 44555679999999999999999999999999999999999999999999999999998664432
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+........
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 228 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----------- 228 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-----------
T ss_pred cccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC-----------
Confidence 223334456788999999875 678999999999999999999 9999999888877777654211110
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...+++.+.+||.+||+.||.+|||+.++|+|
T Consensus 229 -----------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 229 -----------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 12468889999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=374.34 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=208.3
Q ss_pred cccceeeeeeeeecCceEEEEEEEC-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceee
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDL-------DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLIT 199 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 199 (478)
..++|++.+.||+|+||+||+|++. .++..||||+++... .....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 3578999999999999999999864 345689999997553 455667788999999999 8999999999997
Q ss_pred ecCCceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 011763 200 SRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263 (478)
Q Consensus 200 ~~~~~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NIL 263 (478)
. ...+||||||++++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 158 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 158 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred c--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 7 5678999999998655444321 235899999999999999999999999999999999999
Q ss_pred EecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 011763 264 VNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQ 341 (478)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~ 341 (478)
|+.++.+||+|||+++....... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999999986543221 22233456889999999886 678999999999999999999 9999998877666
Q ss_pred HHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 342 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...+...... .....++.++.+||.+||+.||.+|||+.|++++
T Consensus 315 ~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 315 FKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5554331100 0113578899999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=365.92 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=209.2
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
..++|++.+.||+|+||+||+|++..+++ .||||++.... .....+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GR 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CC
Confidence 35689999999999999999999976554 59999997543 45566778899999999999999999999977 56
Q ss_pred eEEEEEeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..||||||++++.+..+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 78999999988555444 45556899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCC--ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 284 GHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 284 ~~~~~--~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+......+.
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 275 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA------- 275 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-------
T ss_pred CccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC-------
Confidence 32211 122344778999999876 678999999999999999999 9999999888887777654321110
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
...+++.+.+||.+||..||.+|||+.++++
T Consensus 276 ---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 ---------------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1357889999999999999999999999984
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=368.08 Aligned_cols=263 Identities=19% Similarity=0.276 Sum_probs=194.4
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
..++|++.+.||+|+||+||+|++..++. .||||++..........+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 36689999999999999999999877665 899999987665566678889999999999999999999998763221
Q ss_pred ----eEEEEEeeccCCchhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEee
Q 011763 205 ----SIYLVFEYMEHDITGLLSC------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (478)
Q Consensus 205 ----~~~lv~e~~~~~ll~~~~~------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D 274 (478)
..++||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 2389999999865554432 222589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCC
Q 011763 275 FGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSP 352 (478)
Q Consensus 275 FG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~ 352 (478)
||+++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 259 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC
Confidence 999976543221 11223445788999999876 678999999999999999999 999999988877766654321100
Q ss_pred CchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-------HHHHHhCcccCCC
Q 011763 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-------ASAALASEYFSTK 419 (478)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-------a~e~L~hp~f~~~ 419 (478)
....+++++.+||.+||+.||.+||| +.+++.|||+...
T Consensus 260 ----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 260 ----------------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ----------------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 11357889999999999999999999 7888999999763
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=371.58 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=208.2
Q ss_pred cccceeeeeeeeecCceEEEEEE-----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeec
Q 011763 128 RADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~-----~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 201 (478)
..++|++.+.||+|+||.||+|+ +..+++.||||+++... .....+.+.+|+.+|.++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 36789999999999999999998 56677999999997543 445567788999999999 899999999998764
Q ss_pred CCceEEEEEeeccCCchhhccCCC--------------------------------------------------------
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCPD-------------------------------------------------------- 225 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~~-------------------------------------------------------- 225 (478)
...+++||||+.++.+..+....
T Consensus 99 -~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 99 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp -TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred -CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 34589999999986554443222
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-CCcccccc
Q 011763 226 ----------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVV 294 (478)
Q Consensus 226 ----------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~ 294 (478)
..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .......+
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 1289999999999999999999999999999999999999999999999999976543221 22334567
Q ss_pred CCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCC
Q 011763 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (478)
Q Consensus 295 t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 373 (478)
|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+...+.....++
T Consensus 258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 316 (359)
T 3vhe_A 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-------------------- 316 (359)
T ss_dssp CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--------------------
T ss_pred CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--------------------
Confidence 889999999876 678999999999999999998 9999998776555544444221111
Q ss_pred CCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 374 ~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 317 -------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 -------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 013578899999999999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=354.39 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=210.0
Q ss_pred cccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 126 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.+..++|++++.||+|+||+||++.+. ++..||+|++...... .+.+.+|+.++..++||||+++++++.. ...
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 77 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSK--EYP 77 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSS
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCc
Confidence 345779999999999999999999875 5678999999765433 3457889999999999999999999976 667
Q ss_pred EEEEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.|+||||++++.+.. +......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999998765444 4444446999999999999999999999999999999999999999999999999999866544
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 226 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR---------- 226 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----------
T ss_pred hhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC----------
Confidence 3333334455778999999876 568999999999999999999 9999999888777766543211110
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....++.+.+||.+||+.||.+|||+.++|++
T Consensus 227 ------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 227 ------------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ------------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12467889999999999999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=359.13 Aligned_cols=252 Identities=22% Similarity=0.395 Sum_probs=206.7
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|++.+.||+|+||+||+|++..+++.||+|++.. ......+.+.+|+.+|+.++||||+++++++.+ ....|
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 83 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLN 83 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeE
Confidence 36789999999999999999999999999999999853 346667788999999999999999999999987 67799
Q ss_pred EEEeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 208 LVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
+||||++++.+..+ ......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999998655544 44466799999999999999999999999999999999999999999999999999976543222
Q ss_pred CC-------------ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHH
Q 011763 287 QP-------------LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-----QLHKIFKL 348 (478)
Q Consensus 287 ~~-------------~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~-----~~~~i~~~ 348 (478)
.. .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence 11 114578999999999886 778999999999999999999999886532110 0000000
Q ss_pred cCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 349 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 349 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
......+++.+.+||.+||+.||++|||+.++++ |+.
T Consensus 242 ------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~ 278 (310)
T 3s95_A 242 ------------------------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE 278 (310)
T ss_dssp ------------------------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred ------------------------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence 0012467889999999999999999999999986 544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=356.86 Aligned_cols=260 Identities=28% Similarity=0.431 Sum_probs=205.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|.....||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 96 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKI 96 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEE
Confidence 345666779999999999999999999999999997653 3445678899999999999999999999987 678999
Q ss_pred EEeeccCCchhhccC-C--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-CCcEEEeecccccccCCC
Q 011763 209 VFEYMEHDITGLLSC-P--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTG 284 (478)
Q Consensus 209 v~e~~~~~ll~~~~~-~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~ 284 (478)
||||++++.+..+.. . ...+++..++.++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999998765554432 2 235679999999999999999999999999999999999998 899999999999765432
Q ss_pred CCCCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. .......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||...................+
T Consensus 177 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 245 (295)
T 2clq_A 177 N-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP---------- 245 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC----------
T ss_pred C-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc----------
Confidence 2 122345679999999998652 2378899999999999999999999976544332211111111110
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.....+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 246 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 246 ----------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp ----------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred ----------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 0113578899999999999999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=357.04 Aligned_cols=250 Identities=21% Similarity=0.315 Sum_probs=206.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||++.+. ++..||+|++...... .+.+.+|+.++..++||||+++++++.. ...+|+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEec--CCCeEE
Confidence 568999999999999999999875 5778999999865433 3457889999999999999999999976 667999
Q ss_pred EEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||++++.+.. +......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999998755544 4443567999999999999999999999999999999999999999999999999999765443222
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+........
T Consensus 177 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 242 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------------- 242 (283)
T ss_dssp STTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------------
T ss_pred cccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC-------------
Confidence 2233455788999999876 568999999999999999998 9999999888877777654321111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....++.+.+||.+||+.||.+|||+.++|+|
T Consensus 243 ---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 ---------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ---------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 12467889999999999999999999999976
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=377.50 Aligned_cols=258 Identities=18% Similarity=0.262 Sum_probs=210.0
Q ss_pred ccceeeeeeeeecCceEEEEEE-----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~-----~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|++++.||+|+||+||+|+ +..+++.||||+++... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--S 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--C
Confidence 5689999999999999999999 44577899999997443 45555678889999999999999999999977 5
Q ss_pred ceEEEEEeeccCCchhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC---cEEEe
Q 011763 204 CSIYLVFEYMEHDITGLLSC-------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLA 273 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~ 273 (478)
...||||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 66899999998755544432 123589999999999999999999999999999999999999655 59999
Q ss_pred ecccccccCCC-CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 011763 274 DFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (478)
Q Consensus 274 DFG~a~~~~~~-~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 351 (478)
|||+++..... .........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+.+..+......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999754211 1122234567899999999876 678999999999999999998 99999998888777666542211
Q ss_pred CCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
. ....++..+.+||.+||+.||.+|||+.++|+|.++..
T Consensus 306 ~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 306 D----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp C----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1 01357889999999999999999999999999988753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=358.54 Aligned_cols=264 Identities=26% Similarity=0.419 Sum_probs=206.0
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--CCCeeeecceeeecCCc
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD--HPNIIKLEGLITSRLSC 204 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~ 204 (478)
+..++|++++.||+|+||.||++.+. +++.||||++............+.+|+.++.++. |+||+++++++.. ..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~ 101 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQ 101 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SS
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CC
Confidence 34668999999999999999999985 5889999999877767777788899999999996 5999999999877 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+|+|||+..+++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 102 ~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred EEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 7999999666665555543 45789999999999999999999999999999999999996 589999999999765432
Q ss_pred CC-CCccccccCCcccCcccccC----------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCCC
Q 011763 285 HR-QPLTSRVVTLWYRPPELLLG----------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSP 352 (478)
Q Consensus 285 ~~-~~~~~~~~t~~y~APE~l~~----------~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~~~g~~ 352 (478)
.. .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..+..+.......
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 21 12234567999999999864 136888999999999999999999999876433 3333322110000
Q ss_pred CchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
......+.++.+||.+||..||.+|||+.|+|+||||+....+
T Consensus 260 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 260 ---------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp ---------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred ---------------------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 0012457789999999999999999999999999999875543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=363.59 Aligned_cols=252 Identities=21% Similarity=0.236 Sum_probs=205.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.| +||||+++++++.. ....|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccE
Confidence 45899999999999999999999999999999999755322 3467899999999 99999999999887 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc-----EEEeecccccccC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-----LKLADFGLANFSN 282 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-----vkl~DFG~a~~~~ 282 (478)
|||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++...
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999955666655554568999999999999999999999999999999999999999887 9999999998654
Q ss_pred CCCCC------CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHcCCCC
Q 011763 283 TGHRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPP 353 (478)
Q Consensus 283 ~~~~~------~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~---~~~~~~~i~~~~g~~~ 353 (478)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+ ..+.+..+.......+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 32211 1245678999999999887 678999999999999999999999998843 3344444433211111
Q ss_pred chhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
. ......+| ++.+||..||..||.+||++.++++
T Consensus 241 ~------------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 I------------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp H------------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred H------------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 11123455 8999999999999999999988875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=354.66 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=197.6
Q ss_pred cccceeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
..++|++.+.||+|+||+||+|++..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---S
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---C
Confidence 356899999999999999999998653 4579999987543 44556778899999999999999999998853 4
Q ss_pred eEEEEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..|+||||++++.+.. +......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 5789999999855444 444455799999999999999999999999999999999999999999999999999986654
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
..........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~----------- 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----------- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----------
T ss_pred ccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC-----------
Confidence 33222333455788999999875 678999999999999999996 99999988877766665432100
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 237 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 237 -----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0113678999999999999999999999999853
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=349.20 Aligned_cols=251 Identities=14% Similarity=0.204 Sum_probs=210.3
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||+||+|++. ++.||+|++..........+.+.+|+.+++.++||||+++++++........
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 44679999999999999999999984 8899999998877677777889999999999999999999999987555788
Q ss_pred EEEEeeccCCchhhccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 207 YLVFEYMEHDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
++||||++++.+..+..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999755554443332 5899999999999999999999999 9999999999999999999999999875433
Q ss_pred CCCCCCccccccCCcccCcccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~--~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
. ....+|+.|+|||++.+.. .++.++|||||||++|+|++|+.||...+..+....+......+.
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 231 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT------- 231 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC-------
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC-------
Confidence 2 3356799999999987632 223389999999999999999999999888777666654221111
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++++.+||.+||+.||.+|||+.++++
T Consensus 232 --------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 232 --------------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11357889999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=365.89 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=179.5
Q ss_pred ccceeeee-eeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec--CCce
Q 011763 129 ADAFEKLE-KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCS 205 (478)
Q Consensus 129 ~~~y~~~~-~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 205 (478)
.++|.+++ .||+|+||+||+|++..+++.||||++... .. ...+....++.+.||||+++++++... ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 45899966 599999999999999999999999999643 11 122233345677999999999998652 2445
Q ss_pred EEEEEeeccCCchhhcc-CC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC---CcEEEeecccccc
Q 011763 206 IYLVFEYMEHDITGLLS-CP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANF 280 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~-~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a~~ 280 (478)
+||||||++++.+..+. .. ...+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 89999999985554443 33 2469999999999999999999999999999999999999864 5599999999976
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+........
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 249 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ------- 249 (336)
T ss_dssp C--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred cccc---ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc-------
Confidence 5432 2244577999999999865 6788999999999999999999999987655433222111100000
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
. ......+..+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 250 ------~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 250 ------Y--------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ------c--------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0 00011224688999999999999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=357.16 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=199.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.. ...+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEE
Confidence 5689999999999999999999999999999999976533 34445778899999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999998666655555557999999999999999999999999999999999999999999999999999766544333
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... +...+......
T Consensus 191 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~--------------- 253 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAIPR--------------- 253 (309)
T ss_dssp ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSCCCC---------------
T ss_pred cccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccCCCC---------------
Confidence 3445678999999999876 678999999999999999999999999876543 33322211111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-CHHHHHh
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-TASAALA 412 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-ta~e~L~ 412 (478)
.....+.+++.+.+||.+||+.||.+|| ++.++++
T Consensus 254 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 ----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1112246889999999999999999999 7777763
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.31 Aligned_cols=253 Identities=20% Similarity=0.237 Sum_probs=208.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.+ +|+||+++++++.. ....|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeE
Confidence 4689999999999999999999999999999999875432 23467899999999 89999999998876 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc-----EEEeecccccccC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-----LKLADFGLANFSN 282 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-----vkl~DFG~a~~~~ 282 (478)
+||||+.+++...+......+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+|||++....
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999965666666555557999999999999999999999999999999999999988776 9999999998665
Q ss_pred CCCC------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHcCCCC
Q 011763 283 TGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPP 353 (478)
Q Consensus 283 ~~~~------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~---~~~~~~~i~~~~g~~~ 353 (478)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+ ..+.+..+......++
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 4322 12345578999999999876 678999999999999999999999998743 3444444443221111
Q ss_pred chhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+......+++++.+||.+||+.||.+|||+.++++
T Consensus 242 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 242 ------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 12233478999999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=356.24 Aligned_cols=270 Identities=23% Similarity=0.361 Sum_probs=201.3
Q ss_pred cccceeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..++|++++.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 35789999999999999999998 5678999999999744 45566778899999999999999999999876545
Q ss_pred ceEEEEEeeccCCchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
..+++||||++++.+. .+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 6789999999875554 444444569999999999999999999999999999999999999999999999999998664
Q ss_pred CCCC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 283 TGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 283 ~~~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+..+...+...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQMIVF 239 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccchhHH
Confidence 3221 11223445778999999876 67899999999999999999999998753221 1111111111000000
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.... ..... ........+++++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~--~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLIE--LLKNN-----GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHH--HHHTT-----CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHH--HHhcc-----CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 00000 000011367899999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=369.51 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=207.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcC--CCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLD--HPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~ 202 (478)
.++|++.+.||+|+||+||+|++..+++.||||++....... .....+.+|+.+++.+. |+||+++++++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-- 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--
Confidence 458999999999999999999999999999999997654321 12234567999999995 5999999999987
Q ss_pred CceEEEEEeeccC-CchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe-cCCcEEEeecccccc
Q 011763 203 SCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANF 280 (478)
Q Consensus 203 ~~~~~lv~e~~~~-~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-~~~~vkl~DFG~a~~ 280 (478)
....++|||++.+ +.+..+......+++..++.++.||+.||.|||++||+||||||+||||+ +++.+||+|||++..
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 6779999999975 44444444455799999999999999999999999999999999999999 779999999999986
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||..... +... ..
T Consensus 200 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~~-------- 260 (320)
T 3a99_A 200 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--QV-------- 260 (320)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--CC--------
T ss_pred cccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--cc--------
Confidence 6532 234457899999999987644457889999999999999999999975321 1110 00
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
.....+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 261 -------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 261 -------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp -------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 00135788999999999999999999999999999998743
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=362.79 Aligned_cols=262 Identities=23% Similarity=0.371 Sum_probs=189.1
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHH-HHHhcCCCCeeeecceeeecCCceE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREIL-ILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
..++|++++.||+|+||.||+|.+..+++.||||++.... .......+..|+. +++.++||||+++++++.. ....
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~ 96 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDC 96 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCce
Confidence 3578999999999999999999999999999999998654 3334445555665 6677799999999999987 5789
Q ss_pred EEEEeeccCCchhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 207 YLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
|+||||+++++...+. .....+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++...
T Consensus 97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9999999987655443 2355789999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCCCccccccCCcccCccccc---CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCCCCchhh
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLL---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~---~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~~~g~~~~~~~ 357 (478)
.... ......+|+.|+|||++. ....++.++|||||||++|+|++|+.||...... +.+..+ ....+
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~---- 247 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV---VKGDP---- 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC---CCSCC----
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH---hcCCC----
Confidence 4322 223346899999999983 2356899999999999999999999999864422 111110 00000
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..........+++.+.+||.+||..||.+|||+.++|+||||..
T Consensus 248 -----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 248 -----------------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp -----------------CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -----------------CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 00001112467899999999999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=366.05 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=210.1
Q ss_pred cccceeeeeeeeecCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceee
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLD-------TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLIT 199 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 199 (478)
..++|.+.+.||+|+||+||+|++.. .+..||||++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 35689999999999999999999753 34579999997653 455667788999999999 9999999999997
Q ss_pred ecCCceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 011763 200 SRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263 (478)
Q Consensus 200 ~~~~~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NIL 263 (478)
. ....||||||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 146 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 146 Q--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred c--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 7 5678999999988655544322 235999999999999999999999999999999999999
Q ss_pred EecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 011763 264 VNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQ 341 (478)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~ 341 (478)
|+.++.+||+|||+++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999986653321 22334456889999999886 678999999999999999999 9999998887776
Q ss_pred HHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 342 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...+....... ....+++++.+||.+||+.||.+|||+.|++++
T Consensus 303 ~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 303 FKLLKEGHRMD----------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHTTCCCC----------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66554321100 013578899999999999999999999999976
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=363.10 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=208.7
Q ss_pred cccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 202 (478)
..++|++++.||+|+||.||+|++. .+++.||||+++... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence 3678999999999999999999986 455899999997543 45556778899999999999999999999977
Q ss_pred CceEEEEEeeccCCchhhccCC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 011763 203 SCSIYLVFEYMEHDITGLLSCP------------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~------------------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlk 258 (478)
....||||||++++.+..+... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 5678999999998555444321 1578999999999999999999999999999999
Q ss_pred CCcEEEecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 011763 259 GSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGR 336 (478)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~ 336 (478)
|+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 9999999999999999999975532211 12234466889999999876 668999999999999999999 99999998
Q ss_pred ChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 337 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 337 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
+..+....+...... .....++..+.+||.+||+.||.+|||+.+++++
T Consensus 281 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 281 AHEEVIYYVRDGNIL----------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHhCCCcC----------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 887776665432100 0113578899999999999999999999999853
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=361.44 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=199.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhc----CCCCeeeecceeee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRL----DHPNIIKLEGLITS 200 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~nIv~l~~~~~~ 200 (478)
.++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.++.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 458999999999999999999999999999999997654322 1223345799999999 89999999999877
Q ss_pred cCCceEEEEEee-ccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe-cCCcEEEeecccc
Q 011763 201 RLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLA 278 (478)
Q Consensus 201 ~~~~~~~lv~e~-~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-~~~~vkl~DFG~a 278 (478)
....++|||+ +.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 110 --~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 --QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred --CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 5668999999 66655555544455799999999999999999999999999999999999999 8899999999999
Q ss_pred cccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhc
Q 011763 279 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 279 ~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
...... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||..... +.....
T Consensus 188 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~-------- 250 (312)
T 2iwi_A 188 ALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAEL-------- 250 (312)
T ss_dssp EECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCC--------
T ss_pred hhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhcc--------
Confidence 876542 234556899999999987644445689999999999999999999975321 111100
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
.....++..+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 251 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 251 ---------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred ---------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 011357889999999999999999999999999999987443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=354.36 Aligned_cols=248 Identities=19% Similarity=0.233 Sum_probs=201.5
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceee
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG-------KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLIT 199 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~-------~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 199 (478)
+..++|++.+.||+|+||+||+|++..++ ..||+|++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 44679999999999999999999988776 469999986543 344567889999999999999999999998
Q ss_pred ecCCceEEEEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc--------E
Q 011763 200 SRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--------L 270 (478)
Q Consensus 200 ~~~~~~~~lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--------v 270 (478)
. ....|+||||++++.+.. +......+++..++.++.||+.||.|||++||+||||||+||||+.++. +
T Consensus 83 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 83 C--GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp C--TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred e--CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 7 566899999999755544 4444445999999999999999999999999999999999999999887 9
Q ss_pred EEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHc
Q 011763 271 KLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLC 349 (478)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~-~pf~~~~~~~~~~~i~~~~ 349 (478)
||+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++|. +||......... .+....
T Consensus 161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~ 234 (289)
T 4fvq_A 161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDR 234 (289)
T ss_dssp EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTT
T ss_pred eeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhcc
Confidence 9999999865432 133456889999999986567899999999999999999955 555555544333 332211
Q ss_pred CCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 350 g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
... ....++++.+||.+||+.||.+|||+.++++|
T Consensus 235 ~~~-----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQL-----------------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCC-----------------------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCC-----------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111 12457789999999999999999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=348.21 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=197.7
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--PESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
+..++|++.+.||+|+||+||+|.+. ++.||||++...... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 79 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EP 79 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C-
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CC
Confidence 34678999999999999999999974 789999998754322 2334678899999999999999999999977 56
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCcEEEec--------CCcEEEe
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG---VLHRDIKGSNLLVNN--------EGVLKLA 273 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~--------~~~vkl~ 273 (478)
..|+||||++++.+..+.. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+
T Consensus 80 ~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred ceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 7899999999877766654 347999999999999999999999999 999999999999986 6789999
Q ss_pred ecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 011763 274 DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353 (478)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~ 353 (478)
|||++....... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......++
T Consensus 159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3dtc_A 159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC
T ss_pred cCCccccccccc---ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC
Confidence 999997654322 234578999999999876 6789999999999999999999999998887766655433111100
Q ss_pred chhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 235 ---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 235 ---------------------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 113578899999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=357.37 Aligned_cols=254 Identities=19% Similarity=0.290 Sum_probs=208.2
Q ss_pred cccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 202 (478)
..++|.+.+.||+|+||.||+|++. .+++.||+|++.... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--
Confidence 3678999999999999999999873 456899999997543 45666788899999999999999999999877
Q ss_pred CceEEEEEeeccCCchhhccCCC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPD------------------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~------------------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlk 258 (478)
....|+||||++++.+..+.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 56789999999976554443221 248999999999999999999999999999999
Q ss_pred CCcEEEecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 011763 259 GSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGR 336 (478)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~ 336 (478)
|+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999976543221 12233455788999999876 668999999999999999999 99999988
Q ss_pred ChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 337 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 337 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
+..+....+.... .+ .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 257 PPERLFNLLKTGH--RM--------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CGGGHHHHHHTTC--CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHhhcCC--cC--------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7766555443211 00 0113678999999999999999999999999865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=350.24 Aligned_cols=257 Identities=21% Similarity=0.353 Sum_probs=200.2
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.++||+|+||+||++++.. .||+|+++.........+.+.+|+.+|+.++||||++++++.. ....
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~ 94 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQL 94 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSC
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCcc
Confidence 335689999999999999999998643 5999999877767777788999999999999999999998654 3457
Q ss_pred EEEEeeccCCchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC-
Q 011763 207 YLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG- 284 (478)
Q Consensus 207 ~lv~e~~~~~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~- 284 (478)
++||||++++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 8999999975554 44455667999999999999999999999999999999999999999999999999999755421
Q ss_pred CCCCccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
.........+|+.|+|||++.. ...++.++|||||||++|+|++|+.||......+.+..+.......+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 245 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP--------- 245 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC---------
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc---------
Confidence 1222344568999999999862 35678899999999999999999999998777776666554322111
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.+......+++.+.+||.+||+.||.+|||+.++|+
T Consensus 246 --------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 --------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp --------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111222467899999999999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=370.36 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=208.4
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||.||+|++..+++.||||+++.. ........+.+|+.+|+.++||||+++++++.. ...+
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 187 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPI 187 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSC
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCc
Confidence 4467899999999999999999999989999999998754 344555677889999999999999999999976 5678
Q ss_pred EEEEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 207 YLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 207 ~lv~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
||||||++++.+ ..+......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999987544 4444444568999999999999999999999999999999999999999999999999997644321
Q ss_pred CCCc-cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 286 RQPL-TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 286 ~~~~-~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.... ....+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+.... .++
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~---------- 335 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLP---------- 335 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CCC----------
T ss_pred eeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC----------
Confidence 1111 12234678999999875 568999999999999999998 999999888776655543211 110
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++.+.+||.+||+.||.+|||+.++++
T Consensus 336 -----------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 336 -----------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01247889999999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=348.78 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=204.0
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHH-----HHHHHHHHHHHhcCCCCeeeecceeeecC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESV-----RFMAREILILRRLDHPNIIKLEGLITSRL 202 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 202 (478)
..++|++.+.||+|+||+||+|++..+++.||+|++.......... +.+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP- 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence 3568999999999999999999999999999999997654322221 5678999999999999999999998653
Q ss_pred CceEEEEEeeccC-CchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEecCCc-----EEEee
Q 011763 203 SCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGV-----LKLAD 274 (478)
Q Consensus 203 ~~~~~lv~e~~~~-~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~-----vkl~D 274 (478)
. ++||||+++ ++...+......+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|
T Consensus 96 -~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 -P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 2 699999986 455666666678999999999999999999999999 999999999999988876 99999
Q ss_pred cccccccCCCCCCCccccccCCcccCcccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHcCC
Q 011763 275 FGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ--LHKIFKLCGS 351 (478)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~-~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~--~~~i~~~~g~ 351 (478)
||+++.... ......+|+.|+|||++.. ...++.++|||||||++|+|++|+.||...+..+. ...+.. .+.
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGL 247 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SCC
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cCC
Confidence 999975432 2345678999999999843 34578899999999999999999999987654332 333222 111
Q ss_pred CCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.+ .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 248 ~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 RP--------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC--------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11 011367889999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=353.71 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=210.3
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|++.+.||+|+||+||+|.+..++..||+|++..+. ...+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCEE
Confidence 4678999999999999999999999999999999997543 345678899999999999999999999977 56799
Q ss_pred EEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 208 LVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999755444432 34569999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+.......+......
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------------- 231 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------------- 231 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-------------
T ss_pred cccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC-------------
Confidence 333344456788999999876 678999999999999999999 99999988766655554332110
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 232 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 232 ---------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 011357889999999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=354.11 Aligned_cols=256 Identities=20% Similarity=0.287 Sum_probs=209.0
Q ss_pred ccccceeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeee
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 200 (478)
+..++|++.+.||+|+||+||+|++ ..+++.||||++.... .....+.+.+|+.+|+++ +||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 3357899999999999999999984 4678899999997553 345567788999999999 99999999999977
Q ss_pred cCCceEEEEEeeccCCchhhcc-CCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 011763 201 RLSCSIYLVFEYMEHDITGLLS-CPD-----------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (478)
Q Consensus 201 ~~~~~~~lv~e~~~~~ll~~~~-~~~-----------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NI 262 (478)
....++||||++++.+..+. ... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 56789999999885444433 222 2489999999999999999999999999999999999
Q ss_pred EEecCCcEEEeecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 011763 263 LVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340 (478)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~ 340 (478)
|++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999866543221 1223455788999999876 678999999999999999998 999999877655
Q ss_pred HHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 341 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.+..+......+. ....+++.+.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCC---------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5555544321110 013578899999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=360.74 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=204.8
Q ss_pred ccceeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 202 (478)
.++|++.+.||+|+||+||+|++ ..++..||||++.... .....+.+.+|+.+|.++ +||||+++++++..
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 57899999999999999999997 3466789999997543 334456788999999999 89999999999987
Q ss_pred CceEEEEEeeccCCchhh-ccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 011763 203 SCSIYLVFEYMEHDITGL-LSCPD----------------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKG 259 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~-~~~~~----------------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp 259 (478)
...+||||||++++.+.. +.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 567899999998755444 33322 2379999999999999999999999999999999
Q ss_pred CcEEEecCCcEEEeecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 011763 260 SNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRT 337 (478)
Q Consensus 260 ~NILl~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~ 337 (478)
+||||+.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999765433221 1223455788999999876 678999999999999999998 999999877
Q ss_pred hHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcc
Q 011763 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (478)
Q Consensus 338 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~ 415 (478)
....+..++.....++ ....+++++.+||.+||..||.+|||+.++++|-.
T Consensus 280 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cHHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 6655555544211110 01256889999999999999999999999998653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=349.26 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=204.7
Q ss_pred ccccceeeeeeeeecCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
+..++|++.+.||+|+||+||+|++.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 84 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--- 84 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---
Confidence 346789999999999999999998643 34569999997653 45566788899999999999999999998865
Q ss_pred ceEEEEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...|+||||++++.+.. +......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 34689999999755544 43444569999999999999999999999999999999999999999999999999998665
Q ss_pred CCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
...........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||......+....+......+.
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 235 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-------- 235 (281)
T ss_dssp --------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC--------
T ss_pred cccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC--------
Confidence 433223334456889999999875 678999999999999999998 9999988777666655543211110
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...+++.+.+||.+||..||.+|||+.+++++
T Consensus 236 --------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 236 --------------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp --------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 12578899999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=345.93 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=208.8
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||.||++.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.. ....
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 78 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPI 78 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSC
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCe
Confidence 34678999999999999999999986 5788999999865433 3567889999999999999999999977 5678
Q ss_pred EEEEeeccCCchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 207 YLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 207 ~lv~e~~~~~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
|+||||++++.+. .+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999875544 444445578999999999999999999999999999999999999999999999999997654322
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
........+++.|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+.......
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~------------ 225 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY------------ 225 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------------
T ss_pred ccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC------------
Confidence 222233456788999999875 678999999999999999999 899999988877776664321100
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....++..+.+||.+||+.||.+|||+.+++++
T Consensus 226 ----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 226 ----------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012467889999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=352.81 Aligned_cols=258 Identities=19% Similarity=0.268 Sum_probs=202.5
Q ss_pred ccccceeeeeeeeecCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
+..++|.+.+.||+|+||+||+|.+.. ++..||+|++..........+.+.+|+.++++++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 346789999999999999999998754 55689999998776667777888999999999999999999999876432
Q ss_pred c---eEEEEEeeccCCchhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEee
Q 011763 204 C---SIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (478)
Q Consensus 204 ~---~~~lv~e~~~~~ll~~~~------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D 274 (478)
. ..|+||||++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 2 469999999986555443 3445799999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCC
Q 011763 275 FGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSP 352 (478)
Q Consensus 275 FG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~ 352 (478)
||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 268 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL- 268 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-
T ss_pred cCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC-
Confidence 999976543221 11223455789999999876 678999999999999999999 99999988877666655432110
Q ss_pred CchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 269 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 ---------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ---------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113678899999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=365.09 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=198.8
Q ss_pred ccccceeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
+..++|++.+.||+|+||+||+|++. .++..||||+++... .....+.+.+|+.+|++++||||+++++++.. .
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 118 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--S 118 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--C
Confidence 34568999999999999999999876 467789999997543 45566778899999999999999999999977 5
Q ss_pred ceEEEEEeeccCCchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
..+||||||++++.+. .+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 6789999999875554 444455579999999999999999999999999999999999999999999999999998665
Q ss_pred CCCCCCc--cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 283 TGHRQPL--TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 283 ~~~~~~~--~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
....... ....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||...+..+....+......+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~------ 271 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------ 271 (373)
T ss_dssp ---------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC------
T ss_pred cCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 4322111 12234678999999876 678999999999999999998 9999998888777666543211110
Q ss_pred CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
...++..+.+||.+||+.||.+||++.++++
T Consensus 272 ----------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 272 ----------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ----------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 1257889999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=373.87 Aligned_cols=276 Identities=23% Similarity=0.350 Sum_probs=209.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+|+.++||||+++++++........||
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 5689999999999999999999999999999999975432 223456678999999999999999999998765668899
Q ss_pred EEeeccCCchhhccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----ecCCcEEEeeccccccc
Q 011763 209 VFEYMEHDITGLLSCPDI---KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFS 281 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~vkl~DFG~a~~~ 281 (478)
||||++++.+..+..... .+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999866655544322 39999999999999999999999999999999999999 66778999999999866
Q ss_pred CCCCCCCccccccCCcccCcccccCC-------CCCCChhhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHcC
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLGA-------TDYGPSVDLWSVGCVFAELLIGKPILQGR----TEVEQLHKIFKLCG 350 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~~-------~~~~~~~DiwslG~il~elltG~~pf~~~----~~~~~~~~i~~~~g 350 (478)
... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||... ...+.+.++..
T Consensus 167 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--- 241 (396)
T 4eut_A 167 EDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--- 241 (396)
T ss_dssp CCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH---
T ss_pred cCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc---
Confidence 543 223456789999999987531 35678999999999999999999999753 23344444433
Q ss_pred CCCchhhccCCC-CCccc-cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 351 SPPDDYWKKSKL-PHATL-FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 351 ~~~~~~~~~~~~-~~~~~-~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
..|...|..... ..... +....+.. ......++..+.+||.+||++||++|||+.+++++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTT---CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcc---cccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 333333322111 00000 00000000 01113456788999999999999999999998543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=363.94 Aligned_cols=272 Identities=22% Similarity=0.261 Sum_probs=200.3
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC--Cc
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL--SC 204 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~ 204 (478)
+..++|++++.||+|+||+||+|++. ++.||||++.... .......+|+.+|.+++||||+++++++.... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 34678999999999999999999874 7899999997542 33344556999999999999999999997643 34
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCcEEEecCCcEEEee
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR----------GVLHRDIKGSNLLVNNEGVLKLAD 274 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~----------givHrDlkp~NILl~~~~~vkl~D 274 (478)
.+|+||||++++.+..+.... .+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred eEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 579999999986665554333 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC-CCccccccCCcccCcccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 011763 275 FGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349 (478)
Q Consensus 275 FG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~----~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~ 349 (478)
||+++....... .......+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.+..............
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999976543322 223346789999999998762 245668899999999999999999998754322111111111
Q ss_pred CCCCchhhccCCCCCccccCCCCCCCccchhccc--CCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 350 g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
..+....+...... ......+...+. ..++++.+||.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 255 QHPSLEDMQEVVVH--------KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SSCCHHHHHHHHTT--------SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCchhhhhhhhhc--------ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111111000000 000001111111 23456999999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=360.23 Aligned_cols=253 Identities=19% Similarity=0.279 Sum_probs=202.8
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKI----VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~----vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..++|++++.||+|+||+||+|++..+++. ||+|++.... .......+.+|+.++..++||||+++++++..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--- 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---
Confidence 357899999999999999999999888776 7777765332 12223445679999999999999999998854
Q ss_pred ceEEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...++||||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 4589999999875 445555555679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 283 TGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 283 ~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 237 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA-------- 237 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC--------
T ss_pred cccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC--------
Confidence 43322 2334556789999999876 678999999999999999999 999999887666655543311000
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....++.++.+||.+||..||.+|||+.++++|
T Consensus 238 --------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 238 --------------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp --------------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred --------------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012357788999999999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=354.45 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=206.5
Q ss_pred ccceeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 202 (478)
.++|++.+.||+|+||+||+|++ ..+++.||||++.... .....+.+.+|+.+|.++ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 57899999999999999999984 4577899999997553 445566788999999999 799999999998764
Q ss_pred CceEEEEEeeccCCchhhccCCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDI----------------KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN 266 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~ 266 (478)
...+|+||||++++.+..+..... .+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 456899999999855554433222 2899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011763 267 EGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHK 344 (478)
Q Consensus 267 ~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~ 344 (478)
++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+..
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 99999999999976543322 11233456889999999876 678999999999999999998 9999988765444444
Q ss_pred HHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 345 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.+.....++ ....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 263 ~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 263 RLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCccCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333211110 012468899999999999999999999999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=348.13 Aligned_cols=253 Identities=19% Similarity=0.249 Sum_probs=205.6
Q ss_pred cccceeeee-eeeecCceEEEEEE--ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 128 RADAFEKLE-KIGQGTYSSVFRAR--DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 128 ~~~~y~~~~-~LG~G~~g~V~~~~--~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
..++|++.+ .||+|+||+||+|. +..+++.||||+++.........+.+.+|+.+++.++||||+++++++. ..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CC
Confidence 356899998 99999999999994 4567889999999866555556778889999999999999999999983 45
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
..|+||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 68999999998766666555567999999999999999999999999999999999999999999999999999766443
Q ss_pred CCC--CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 285 HRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 285 ~~~--~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.... .+
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~-------- 239 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--RM-------- 239 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--CC--------
T ss_pred CCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CC--------
Confidence 221 1122345688999999875 568899999999999999999 999999888776655543311 00
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 240 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 ------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011367889999999999999999999999984
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=350.36 Aligned_cols=269 Identities=23% Similarity=0.331 Sum_probs=201.2
Q ss_pred ccceeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.+.|++++.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+|+.++||||+++++++......
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 4579999999999999999998 56789999999997554 233456788999999999999999999999876557
Q ss_pred eEEEEEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
.+++||||++++.+..+. .....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 799999999885554443 4555799999999999999999999999999999999999999999999999999987654
Q ss_pred CCC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 284 GHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 284 ~~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..|+.... ..+....+......... .
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~-~ 251 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQMTVT-R 251 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGGGHHH-H
T ss_pred CCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccccCHH-H
Confidence 322 22234566888999999876 668899999999999999999998864321 11111111111100000 0
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....... . ........+++.+.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~--~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKE--G-----KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHT--T-----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhc--c-----CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0000000 0 000112367899999999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=356.43 Aligned_cols=254 Identities=20% Similarity=0.333 Sum_probs=199.0
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI----VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~----vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 202 (478)
+..++|++++.||+|+||+||+|++..+++. ||+|.+.... .....+.+.+|+.+|++++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 88 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--
Confidence 3467899999999999999999998877765 4777775432 33445678899999999999999999999976
Q ss_pred CceEEEEEeeccCCc-hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 203 SCSIYLVFEYMEHDI-TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 203 ~~~~~lv~e~~~~~l-l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
. ..++|+||+.++. ...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 89 ~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 3 3778999998754 4455555667999999999999999999999999999999999999999999999999999866
Q ss_pred CCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 282 NTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 282 ~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------- 239 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------- 239 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------
T ss_pred cCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC-------
Confidence 433221 2233455789999999886 678999999999999999999 999999887766554443211100
Q ss_pred CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....++.++.+||.+||+.||.+|||+.++|++
T Consensus 240 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 ---------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 013467889999999999999999999999976
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=354.18 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=207.6
Q ss_pred cccceeeeeeeeecCceEEEEEEEC-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceee
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDL-------DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLIT 199 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 199 (478)
..++|++.+.||+|+||+||+|++. .++..||||++.... .......+.+|+.+|+.+ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3678999999999999999999975 456789999997543 455667788999999999 8999999999997
Q ss_pred ecCCceEEEEEeeccCCchhhccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 011763 200 SRLSCSIYLVFEYMEHDITGLLSCPD----------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263 (478)
Q Consensus 200 ~~~~~~~~lv~e~~~~~ll~~~~~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NIL 263 (478)
. ...+|+||||++++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 112 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 112 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp S--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred c--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 7 56789999999885554443322 24899999999999999999999999999999999999
Q ss_pred EecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 011763 264 VNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQ 341 (478)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~ 341 (478)
|+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 99999999999999976553221 11223455788999999876 668999999999999999999 9999999887776
Q ss_pred HHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 342 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...+....... ....++..+.+||.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 269 FKLLKEGHRMD----------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCC----------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66654421100 013578899999999999999999999999865
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.37 Aligned_cols=256 Identities=20% Similarity=0.247 Sum_probs=210.2
Q ss_pred ccccceeeee-eeeecCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 127 LRADAFEKLE-KIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 127 ~~~~~y~~~~-~LG~G~~g~V~~~~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
+..++|.+++ .||+|+||+||+|.+. .++..||||+++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 81 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--- 81 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---
Confidence 3456888887 9999999999999854 467889999997653 45667788899999999999999999999843
Q ss_pred ceEEEEEeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...++||||++++.+..+ ......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 458999999998655544 4455679999999999999999999999999999999999999999999999999998664
Q ss_pred CCCC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 283 TGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 283 ~~~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.... .+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--~~------ 232 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--RM------ 232 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--CC------
T ss_pred cCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC--cC------
Confidence 3322 11223345889999999875 568999999999999999998 999999888777665554311 00
Q ss_pred CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcc
Q 011763 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~ 415 (478)
.....+++.+.+||.+||..||.+||++.++++|.+
T Consensus 233 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 233 --------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp --------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred --------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 011367899999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=345.59 Aligned_cols=254 Identities=20% Similarity=0.246 Sum_probs=204.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+.++... ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC-CCceEE
Confidence 46899999999999999999999999999999998765432 3467899999999988877776665443 667899
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---ecCCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~~~ 285 (478)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999666666665456679999999999999999999999999999999999999 488999999999998665432
Q ss_pred CC------CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCCCCchh
Q 011763 286 RQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 286 ~~------~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~~~~g~~~~~~ 356 (478)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+.+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 21 1245578999999999886 6789999999999999999999999987432 233333332211111
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.......+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11122467899999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=355.38 Aligned_cols=268 Identities=24% Similarity=0.309 Sum_probs=206.1
Q ss_pred cccceeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|++++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 36799999999999999999998 5678999999999754 35556778899999999999999999999876657
Q ss_pred ceEEEEEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
..+|+||||++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 7899999999876555443 334569999999999999999999999999999999999999999999999999998665
Q ss_pred CCCC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--chhhc
Q 011763 283 TGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP--DDYWK 358 (478)
Q Consensus 283 ~~~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~--~~~~~ 358 (478)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||............ .....+ .....
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG--CERDVPALSRLLE 255 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc--cccccccHHHHHH
Confidence 3321 12233456888999999876 66899999999999999999999998754322110000 000000 00000
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
... .. ........+++.+.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~--------~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLE--------EG-----QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHH--------TT-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hhh--------cc-----cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 00 0000123678999999999999999999999999643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.85 Aligned_cols=262 Identities=16% Similarity=0.242 Sum_probs=212.9
Q ss_pred ccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|++.+.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--C
Confidence 568999999999999999999876 357889999997543 34555678899999999999999999999976 5
Q ss_pred ceEEEEEeeccCCchhhccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEe
Q 011763 204 CSIYLVFEYMEHDITGLLSCP----------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 273 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~----------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~ 273 (478)
...|+||||++++.+..+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 678999999987555444321 1357899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 011763 274 DFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (478)
Q Consensus 274 DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 351 (478)
|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC
Confidence 9999975543211 11223455889999999876 678999999999999999999 89999988877766655431100
Q ss_pred CCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC------cccCCCCCC
Q 011763 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS------EYFSTKPYA 422 (478)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h------p~f~~~~~~ 422 (478)
.....++..+.+||.+||..||.+|||+.++++| ++|++..+.
T Consensus 260 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 260 ----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308 (322)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccc
Confidence 0113678899999999999999999999999987 777654443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=371.68 Aligned_cols=256 Identities=24% Similarity=0.345 Sum_probs=196.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..+|.+.+.||+|+||+||.. ...+++.||||++..+.. ..+.+|+.+|+.+ +|||||++++++.+ ....|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~ 94 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKD--RQFQY 94 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEE
T ss_pred cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEE
Confidence 457999999999999997643 346789999999965432 2245799999999 89999999999877 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC-----CcEEEeecccccccC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-----GVLKLADFGLANFSN 282 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-----~~vkl~DFG~a~~~~ 282 (478)
|||||+++++...+......+.+..+..++.||+.||.|||++||+||||||+||||+.+ ..+||+|||+++...
T Consensus 95 lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 95 IAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 999999998887777666667777788999999999999999999999999999999532 357899999998665
Q ss_pred CCCC--CCccccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhh
Q 011763 283 TGHR--QPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 283 ~~~~--~~~~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 357 (478)
.... .......+|+.|+|||++.+ ...++.++|||||||++|+|++ |.+||......... .+ .+......+
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~---~~~~~~~~~ 250 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-IL---LGACSLDCL 250 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HH---TTCCCCTTS
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HH---hccCCcccc
Confidence 3221 22345678999999999874 3567889999999999999999 89999765443322 11 111110000
Q ss_pred ccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
......+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 251 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 251 ----------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ----------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ----------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 000123556899999999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=347.57 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=201.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+..+... ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEE
Confidence 46899999999999999999999999999999997654322 3467899999999988877777666443 677899
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---ecCCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~~~ 285 (478)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999666666665556679999999999999999999999999999999999999 788999999999998665432
Q ss_pred C------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHcCCCCchh
Q 011763 286 R------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV---EQLHKIFKLCGSPPDDY 356 (478)
Q Consensus 286 ~------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~---~~~~~i~~~~g~~~~~~ 356 (478)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch---
Confidence 2 12234578999999999886 67899999999999999999999999875432 22222222111111
Q ss_pred hccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.......+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11222467899999999999999999999999885
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=355.81 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=203.6
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEE--EEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCC
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIV--ALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~v--AlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 203 (478)
+..++|++.+.||+|+||.||+|++..++..+ |+|.+.... .....+.+.+|+.+|+++ +||||+++++++.. .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~ 98 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 98 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--T
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee--C
Confidence 44679999999999999999999998888765 999987432 334456688999999999 99999999999987 6
Q ss_pred ceEEEEEeeccCCchhhccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC
Q 011763 204 CSIYLVFEYMEHDITGLLSCPD----------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~ 267 (478)
..+|+||||++++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 7899999999875554443322 369999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011763 268 GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 346 (478)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~ 346 (478)
+.+||+|||++...... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.
T Consensus 179 ~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CeEEEcccCcCcccccc--ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 99999999999744321 11223455788999999875 668999999999999999998 999999888776655543
Q ss_pred HHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 347 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
..... .....+++.+.+||.+||..||.+|||+.++|++
T Consensus 256 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRL----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 21100 0112578899999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=354.36 Aligned_cols=254 Identities=23% Similarity=0.370 Sum_probs=188.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeee------c
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITS------R 201 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~------~ 201 (478)
..+|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 45899999999999999999999999999999998654 3455677889999999995 9999999998842 2
Q ss_pred CCceEEEEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEecCCcEEEeeccc
Q 011763 202 LSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGL 277 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFG~ 277 (478)
....+++||||+++++...+.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 2456899999999877766543 4457999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCC-----------CccccccCCcccCccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011763 278 ANFSNTGHRQ-----------PLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344 (478)
Q Consensus 278 a~~~~~~~~~-----------~~~~~~~t~~y~APE~l~--~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~ 344 (478)
+......... ......+|+.|+|||++. ....++.++|||||||++|+|++|+.||........+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9866532211 112345799999999983 236688999999999999999999999976544322211
Q ss_pred HHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcc
Q 011763 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (478)
Q Consensus 345 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~ 415 (478)
. . .. ......+..+.+||.+||+.||.+|||+.|+|+|-+
T Consensus 265 ~---~-~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 K---Y-SI---------------------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----C-CC---------------------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred c---c-cC---------------------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1 0 00 001245677999999999999999999999998854
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=358.89 Aligned_cols=264 Identities=22% Similarity=0.292 Sum_probs=204.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||+||+|++ .+++.||||++.... ....+.+.+|+.+|+.++||||+++++++.. ....|+
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 112 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEMIL 112 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTCCEE
T ss_pred HhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 57899999999999999999996 468999999987543 3445678899999999999999999999877 567899
Q ss_pred EEeeccCCchhhccCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 209 VFEYMEHDITGLLSCPD----IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
||||++++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999986665554322 35899999999999999999999999999999999999999999999999999765432
Q ss_pred CC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHcCCCCchhhccC
Q 011763 285 HR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI---FKLCGSPPDDYWKKS 360 (478)
Q Consensus 285 ~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i---~~~~g~~~~~~~~~~ 360 (478)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+ ...... .
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~ 263 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN--------G 263 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT--------T
T ss_pred cccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc--------c
Confidence 21 22234567999999999876 57899999999999999999999999765432211100 000000 0
Q ss_pred CCCCccccCCCCCCCccchh-cccCCchhHHHHHHHhcCCCCCCccCHHHHHhCc
Q 011763 361 KLPHATLFKPQQPYDSSLRE-TFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp 414 (478)
.+. ...+..+.. .....+..+.+||.+||+.||++|||+.|+|++-
T Consensus 264 ~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 264 QLE--------QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CCC--------SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHH--------HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 000 000111111 1124567899999999999999999999999764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=355.47 Aligned_cols=258 Identities=18% Similarity=0.256 Sum_probs=204.9
Q ss_pred ccceeeeeeeeecCceEEEEEE-----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~-----~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.++++++||||+++++++.. .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--S 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--C
Confidence 5689999999999999999998 55678899999997443 44556678899999999999999999999987 5
Q ss_pred ceEEEEEeeccCCchhhccC-CC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC---CcEEEe
Q 011763 204 CSIYLVFEYMEHDITGLLSC-PD------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLA 273 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~-~~------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~ 273 (478)
...|+||||++++.+..+.. .. ..+++..++.++.||+.||.|||++||+||||||+||||+.+ ..+||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 66899999998755544432 21 358999999999999999999999999999999999999944 469999
Q ss_pred ecccccccCCCC-CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 011763 274 DFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (478)
Q Consensus 274 DFG~a~~~~~~~-~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~ 351 (478)
|||++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 999997543221 122234466889999999876 678999999999999999998 99999988877766655432110
Q ss_pred CCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
. ....++..+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 265 ~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 265 D----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp C----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 0 01357889999999999999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=375.83 Aligned_cols=252 Identities=19% Similarity=0.304 Sum_probs=209.4
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||.||+|++..++..||||+++.+.. ..+.+.+|+.+|++++||||+++++++.. ...+
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 291 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPF 291 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSC
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcE
Confidence 446789999999999999999999998899999999976543 34668899999999999999999999977 5678
Q ss_pred EEEEeeccCCchhhcc-C-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 207 YLVFEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~-~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
||||||+.++.+..+. . ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999975554443 2 3456899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.........+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+....+......
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------ 438 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------------ 438 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC------------
T ss_pred ceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 3222333455788999999875 668999999999999999999 99999988776655544321100
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 439 ----------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 439 ----------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 011357889999999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=353.96 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=206.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~-----~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 202 (478)
.++|++.+.||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+|+.+ +||||+++++++..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 5689999999999999999999876654 79999997543 445567788999999999 89999999999977
Q ss_pred CceEEEEEeeccCCchhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC
Q 011763 203 SCSIYLVFEYMEHDITGLLSC--------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~--------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~ 268 (478)
...+|+||||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 567899999998855444332 134689999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011763 269 VLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 346 (478)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~ 346 (478)
.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 9999999999765432211 1223455788999999876 678999999999999999998 999999877666555554
Q ss_pred HHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 347 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....++. ....++.+.+||.+||+.||.+|||+.++++
T Consensus 281 ~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 281 KDGYQMAQ---------------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHTCCCCC---------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCCC---------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 43211110 1246788999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.33 Aligned_cols=248 Identities=21% Similarity=0.344 Sum_probs=205.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+|+.++||||+++++++.. ...|+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEE
Confidence 578999999999999999999975 5678999999765432 4567889999999999999999998864 34789
Q ss_pred EEeeccCCchhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 209 VFEYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||++++.+..+.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999876666555433 2689999999999999999999999999999999999999999999999999987654332
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+.......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 230 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV------------- 230 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred ccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC-------------
Confidence 23334456788999999875 568899999999999999999 999999988877666654321000
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 231 ---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 231 ---------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01357889999999999999999999999885
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=351.23 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=202.9
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~----~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 202 (478)
+..++|++.+.||+|+||+||+|.+..++ ..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 117 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-- 117 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--
Confidence 34668999999999999999999876543 459999997543 45556678899999999999999999999976
Q ss_pred CceEEEEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 203 SCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
....||||||++++.+.. +......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 667999999999855544 4444567999999999999999999999999999999999999999999999999999766
Q ss_pred CCCCCCC--ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhc
Q 011763 282 NTGHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 282 ~~~~~~~--~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
....... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+......+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~------ 270 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------ 270 (333)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------
T ss_pred ccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC------
Confidence 4322111 122345778999999876 678999999999999999999 999999888777766654321110
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....++..+.+||.+||+.||.+||++.+++++
T Consensus 271 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 ----------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ----------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012578899999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=361.00 Aligned_cols=262 Identities=19% Similarity=0.171 Sum_probs=197.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCC-----CcEEEEEEeecCCCChHH---------HHHHHHHHHHHHhcCCCCeeee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPES---------VRFMAREILILRRLDHPNIIKL 194 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vAlK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~nIv~l 194 (478)
.++|++.+.||+|+||+||+|.+..+ ++.||||++......... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 55899999999999999999998764 588999998754311000 0122345566777789999999
Q ss_pred cceeeecC--CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe--cCCcE
Q 011763 195 EGLITSRL--SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVL 270 (478)
Q Consensus 195 ~~~~~~~~--~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~--~~~~v 270 (478)
++++.... ..+.||||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+ .++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 99987632 256899999995555555555556899999999999999999999999999999999999999 88999
Q ss_pred EEeecccccccCCCCC------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011763 271 KLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344 (478)
Q Consensus 271 kl~DFG~a~~~~~~~~------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~ 344 (478)
||+|||+++....... .......+|+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.........
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999976543211 11234558999999999886 6689999999999999999999999986433222222
Q ss_pred HHH-HcCCCCchhhccCCCCCccccCCCCCCCccchhcc--cCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 345 IFK-LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 345 i~~-~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
... ........ .+...+ ..+++++.+||..||..||.+||++.++++
T Consensus 273 ~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIAS---------------------LMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHH---------------------HHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHH---------------------HHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 211 11000000 011111 467899999999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=345.71 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=194.0
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|++.+.||+|+||+||++++. ++.||||++... ...+.+.+|+.+|++++||||+++++++.+ ..|
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~ 75 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN----PVC 75 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcE
Confidence 3568999999999999999999874 788999998632 345678899999999999999999998764 368
Q ss_pred EEEeeccCCchhhccCCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCcEEEecCCc-EEEeecccccc
Q 011763 208 LVFEYMEHDITGLLSCPDI---KFSEAQIKCYMNQLLHGLEHCHS---RGVLHRDIKGSNLLVNNEGV-LKLADFGLANF 280 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~-vkl~DFG~a~~ 280 (478)
+||||++++.+..+..... .+++..+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999998866555543332 47899999999999999999999 89999999999999999887 79999999975
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHcCCCCchhhc
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE--QLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~--~~~~i~~~~g~~~~~~~~ 358 (478)
.... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+.. +..+
T Consensus 156 ~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~----- 223 (307)
T 2eva_A 156 IQTH----MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTRP----- 223 (307)
T ss_dssp -------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCCC-----
T ss_pred cccc----cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCCC-----
Confidence 5432 234468999999999876 678999999999999999999999998643322 2222111 1111
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh-----CcccCC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA-----SEYFST 418 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~-----hp~f~~ 418 (478)
.....++..+.+||.+||+.||.+|||+.++++ .++|..
T Consensus 224 ---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 ---------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ---------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ---------------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 112467889999999999999999999999987 355544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=345.79 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=195.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++.. ....+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 108 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELN 108 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEE
Confidence 568999999999999999999999999999999997643 345666778899999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 208 LVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
+||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999865554432 355789999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHcCCCCchhhccCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
.. .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......+ .....++.
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~------- 258 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPPL------- 258 (310)
T ss_dssp -----------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH-HTTCSCCC-------
T ss_pred CC-ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh-hcccCCCC-------
Confidence 22 22234567999999999876 6789999999999999999999999976432 2222222 21111100
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....+++++.+||.+||..||.+|||+.+++++
T Consensus 259 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 259 -------------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp -------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 013578899999999999999999999999853
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=369.63 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=206.9
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|+.+|+.++||||+++++++.. ..+
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~ 257 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPI 257 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC---Ccc
Confidence 45678999999999999999999985 46789999998654 235678899999999999999999998863 458
Q ss_pred EEEEeeccCCchhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 207 YLVFEYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
||||||+.++.+..+.... ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999876555444322 36889999999999999999999999999999999999999999999999999866432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.........+|+.|+|||++.. ..++.++|||||||+||||++ |+.||.+.+..+.+..+......+.
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---------- 406 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---------- 406 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC----------
T ss_pred ceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 2122233345788999999875 678999999999999999999 9999999988887777654321110
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
...+++++.+||.+||..||.+|||+.++++
T Consensus 407 ------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 407 ------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1357889999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=355.66 Aligned_cols=260 Identities=17% Similarity=0.126 Sum_probs=197.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECC---CCcEEEEEEeecCCCChH---------HHHHHHHHHHHHHhcCCCCeeeecc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPE---------SVRFMAREILILRRLDHPNIIKLEG 196 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vAlK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~nIv~l~~ 196 (478)
.++|++.+.||+|+||+||+|++.. ++..||||++........ ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 5689999999999999999999987 788999999976532111 1123557888999999999999999
Q ss_pred eeeec--CCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC--cEEE
Q 011763 197 LITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKL 272 (478)
Q Consensus 197 ~~~~~--~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~vkl 272 (478)
++... .....||||||+ ++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 98763 256789999999 555555555445899999999999999999999999999999999999999887 9999
Q ss_pred eecccccccCCCC------CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHH
Q 011763 273 ADFGLANFSNTGH------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR--TEVEQLHK 344 (478)
Q Consensus 273 ~DFG~a~~~~~~~------~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~--~~~~~~~~ 344 (478)
+|||+++...... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||... +.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 9999997653221 112244578999999999886 67899999999999999999999999653 22222222
Q ss_pred HHHHcCCCCchhhccCCCCCccccCCCCCCCccchhccc--CCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 345 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
........+... ....+ .+++++.+||.+||..||.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 274 KTNLLDELPQSV----------------------LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHTTTHHH----------------------HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhcccccHHH----------------------HhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 222222222211 11122 68899999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=355.66 Aligned_cols=268 Identities=20% Similarity=0.263 Sum_probs=201.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||+||+|++ .+++.||||++...... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 104 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLL 104 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC--SSCCEE
T ss_pred hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEec--CCceEE
Confidence 67899999999999999999985 46899999999754322 222357789999999999999999999987 566899
Q ss_pred EEeeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 209 VFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSR---GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 209 v~e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
||||+.++.+..+.. ....+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 999999865554433 223499999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHcCCCCchhh
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR----TEVEQLHKIFKLCGSPPDDYW 357 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~----~~~~~~~~i~~~~g~~~~~~~ 357 (478)
............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||... .............
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 255 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL-------- 255 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT--------
T ss_pred CcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH--------
Confidence 5444344445568999999999876 56899999999999999999999999621 0000011111000
Q ss_pred ccCCCCCccccCCCCCCCccch-hcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 358 KKSKLPHATLFKPQQPYDSSLR-ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
....... ...+..+. ......+..+.+||.+||+.||.+|||+.++|+|-.-
T Consensus 256 ----~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 ----LKEKKLE---ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp ----TSSCCST---TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ----hhchhhh---hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000000 00000011 1112345789999999999999999999999988653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=351.59 Aligned_cols=252 Identities=20% Similarity=0.333 Sum_probs=199.1
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEE----EEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIV----ALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~v----AlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..++|++++.||+|+||+||+|++..+++.| |+|.+.... .....+.+.+|+.+|+.++||||+++++++.. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT--S 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--S
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--C
Confidence 4678999999999999999999998888765 666665332 33445678899999999999999999999876 2
Q ss_pred ceEEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
..++|+||+.++ +...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 378899999875 444555556679999999999999999999999999999999999999999999999999997654
Q ss_pred CCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 283 TGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 283 ~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 239 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-------- 239 (327)
T ss_dssp -----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC--------
T ss_pred CccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 3221 12233445788999999886 678999999999999999999 999999887766655543321111
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++.++.+||.+||..||.+|||+.|+|+
T Consensus 240 --------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 240 --------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp --------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01356788999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=343.30 Aligned_cols=253 Identities=20% Similarity=0.261 Sum_probs=202.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
..+|++.+.||+|+||+||+|++..+ ...||+|++.... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CCc
Confidence 45799999999999999999986543 3468999987533 455667788999999999999999999986543 456
Q ss_pred EEEEEeeccCCchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.|+||||++++.+. .+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 88999999985554 44455567899999999999999999999999999999999999999999999999999765432
Q ss_pred CC---CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 285 HR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 285 ~~---~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+........
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 253 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ------- 253 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC-------
T ss_pred chhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC-------
Confidence 11 12233456789999999876 678999999999999999999 6788887776666555543211110
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
...+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 254 ---------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1246888999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=365.26 Aligned_cols=246 Identities=20% Similarity=0.325 Sum_probs=202.1
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||.||++.+. ++.||||+++.+. ..+.+.+|+.+|++++||||+++++++... ...+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCce
Confidence 45778999999999999999999874 7799999997543 345678999999999999999999998763 3468
Q ss_pred EEEEeeccCCchhhccC-CC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 207 YLVFEYMEHDITGLLSC-PD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~-~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
||||||++++.+..+.. .. ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999855544433 22 24799999999999999999999999999999999999999999999999999754432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.....+++.|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+....+......+
T Consensus 343 ----~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------- 406 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD----------- 406 (450)
T ss_dssp --------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC-----------
T ss_pred ----ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 122356889999999876 678999999999999999998 999999887766666554321000
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++.+.+||.+||+.||.+|||+.++++
T Consensus 407 -----------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 407 -----------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11357899999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=340.66 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=202.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.-.|.+.+.||+|+||+||+|++..++. .||+|++.... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 97 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-EGL 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-CCC
Confidence 3468888999999999999998755444 79999987533 445667788999999999999999999998763 344
Q ss_pred EEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.++||||+.++ +...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 58999999765 44555555667899999999999999999999999999999999999999999999999999754332
Q ss_pred C---CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 285 H---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 285 ~---~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ +.+||...+..+....+......+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-------- 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP-------- 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC--------
T ss_pred cccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC--------
Confidence 1 122234456889999999876 678999999999999999999 556666666655555443321111
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++.+.+||.+||+.||.+|||+.++++
T Consensus 249 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 249 --------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01357889999999999999999999999885
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=363.04 Aligned_cols=258 Identities=27% Similarity=0.389 Sum_probs=192.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+ ..+.+.+|+.+|+.+ +|||||++++++.+ ...+|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~ 85 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLY 85 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEE
Confidence 3457778999999999998764 457999999998743 234567899999886 89999999998876 67899
Q ss_pred EEEeeccCCchhhccCCCCC------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC-------------C
Q 011763 208 LVFEYMEHDITGLLSCPDIK------FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-------------G 268 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~------l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-------------~ 268 (478)
|||||+++++...+...... .++..++.++.||+.||.|||++||+||||||+||||+.+ +
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 99999988666555433211 1233457899999999999999999999999999999764 4
Q ss_pred cEEEeecccccccCCCCCC---CccccccCCcccCcccccC------CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 011763 269 VLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTE 338 (478)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~---~~~~~~~t~~y~APE~l~~------~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~ 338 (478)
.+||+|||+++........ ......+|+.|+|||++.+ ...++.++|||||||++|||++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999876543211 2234578999999999864 2568999999999999999999 9999987654
Q ss_pred HHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 339 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.+ ..+.......+.. ..+ ....+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus 246 ~~--~~i~~~~~~~~~~--------------------~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 246 RE--SNIIRGIFSLDEM--------------------KCL--HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HH--HHHHHTCCCCCCC--------------------TTC--CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hH--HHHhcCCCCcccc--------------------ccc--ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 43 2333221111000 000 01235678999999999999999999999999999964
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=365.09 Aligned_cols=256 Identities=23% Similarity=0.340 Sum_probs=204.7
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||+||+|.+.. +..||||+++..... .+.+.+|+.+|++++||||+++++++.. ..+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---Cce
Confidence 446789999999999999999999865 467999999865433 3567899999999999999999998865 458
Q ss_pred EEEEeeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 207 YLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
||||||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999998655555432 245899999999999999999999999999999999999999999999999999866543
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.........+|..|+|||++.+ ..++.++|||||||+||||++ |+.||.+....+.+..+......+
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------- 401 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------- 401 (452)
T ss_dssp ---------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred ceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2222233455788999999876 678999999999999999999 999999988887776664321110
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC--cccCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS--EYFST 418 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h--p~f~~ 418 (478)
....+++.+.+||.+||+.||.+|||+.++++. .+|..
T Consensus 402 -----------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 -----------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 013578899999999999999999999999863 55543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=341.07 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=202.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeee--------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITS-------- 200 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 200 (478)
..+|++++.||+|+||.||+|++..+++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 357999999999999999999999899999999997543 235689999999999999999998754
Q ss_pred ------cCCceEEEEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEE
Q 011763 201 ------RLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKL 272 (478)
Q Consensus 201 ------~~~~~~~lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl 272 (478)
.....+|+||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 12445899999999855554432 2357899999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 011763 273 ADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 352 (478)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~ 352 (478)
+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .....+.. +.
T Consensus 164 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~--~~- 235 (284)
T 2a19_B 164 GDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD--GI- 235 (284)
T ss_dssp CCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT--TC-
T ss_pred Ccchhheeccccc--cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc--cc-
Confidence 9999997665432 2344568999999999876 678999999999999999999998875211 11111110 00
Q ss_pred CchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
....++..+.+||.+||..||.+|||+.|+++|.+.-.
T Consensus 236 ----------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 ----------------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ----------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 01246788999999999999999999999999988644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=346.84 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=201.0
Q ss_pred ceeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 131 AFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~----~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
.|++++.||+|+||+||++. +..+++.||||++.... .....+.+.+|+.+|+.++||||+++++++.+.....+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 35999999999999998875 34578999999998653 45666778899999999999999999999988666789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|+||||++++.+..+.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999986665555433 489999999999999999999999999999999999999999999999999987654321
Q ss_pred --CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-----------HHHHHHHHcCCCC
Q 011763 287 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-----------QLHKIFKLCGSPP 353 (478)
Q Consensus 287 --~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~-----------~~~~i~~~~g~~~ 353 (478)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+...+...
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 267 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG- 267 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT-
T ss_pred ccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc-
Confidence 11233456888999999876 568899999999999999999999997543211 011111110000
Q ss_pred chhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
. .......++.++.+||.+||+.||.+|||+.++++
T Consensus 268 -------~----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 268 -------E----------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -------C----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------c----------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 00111367889999999999999999999999984
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=377.00 Aligned_cols=250 Identities=19% Similarity=0.255 Sum_probs=204.5
Q ss_pred ceeee-eeeeecCceEEEEEEE--CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 131 AFEKL-EKIGQGTYSSVFRARD--LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 131 ~y~~~-~~LG~G~~g~V~~~~~--~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.+.+. +.||+|+||+||+|.+ ..+++.||||+++.........+.+.+|+.+|++++|||||++++++.. ..++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~ 445 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWM 445 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEE
Confidence 34443 4899999999999954 4567899999998765555667788999999999999999999998864 3488
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC-
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~- 286 (478)
|||||+.++.+..+......+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999877766666666899999999999999999999999999999999999999999999999999986643321
Q ss_pred -CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 287 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 287 -~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.......+|+.|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+....+......+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~------------ 592 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------ 592 (635)
T ss_dssp ---------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------
T ss_pred cccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 12233345788999999876 678999999999999999998 999999998887776664321100
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++++.+||..||+.||++|||+.++++
T Consensus 593 ----------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 593 ----------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11357899999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=353.84 Aligned_cols=256 Identities=15% Similarity=0.152 Sum_probs=197.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECC--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeee-------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD--------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIK------- 193 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~--------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~------- 193 (478)
.++|++.+.||+|+||+||+|++.. .++.||||++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 4689999999999999999999987 4889999999744 24678999999999999998
Q ss_pred --------ecceeeecCCceEEEEEeeccCCchhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 011763 194 --------LEGLITSRLSCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (478)
Q Consensus 194 --------l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl 264 (478)
+++++.. .....||||||+.++|...+... ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 114 ~~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 3444443 25678999999944554444432 3679999999999999999999999999999999999999
Q ss_pred ecCC--cEEEeecccccccCCCCC------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 011763 265 NNEG--VLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 336 (478)
Q Consensus 265 ~~~~--~vkl~DFG~a~~~~~~~~------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~ 336 (478)
+.++ .+||+|||+++....... .......+|+.|+|||++.+ ..++.++|||||||+||+|++|+.||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 999999999976543211 12234578999999999876 67899999999999999999999999876
Q ss_pred C-hHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 337 T-EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 337 ~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
. ..+.+..........+..+. .....+..+++++.+||.+||..||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFV-------------------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEE-------------------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhh-------------------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 33333333222111111100 000112467899999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=349.12 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=199.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec--CCceE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCSI 206 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~~ 206 (478)
.++|++++.||+|+||.||++++..+++.||||++... .....+.+.+|+.+++.++||||+++++++... .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 56899999999999999999999999999999998754 345667788999999999999999999998632 24578
Q ss_pred EEEEeeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 207 YLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999855543322 45679999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCC--------CccccccCCcccCcccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCC
Q 011763 283 TGHRQ--------PLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGS 351 (478)
Q Consensus 283 ~~~~~--------~~~~~~~t~~y~APE~l~~~~--~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~~~g~ 351 (478)
..... ......+|+.|+|||++.+.. .++.++|||||||++|+|++|+.||...... +.+.........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC
Confidence 21100 011234589999999987532 3688999999999999999999999531100 001111110000
Q ss_pred CCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCc
Q 011763 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414 (478)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp 414 (478)
. .....++..+.+||.+||+.||.+|||+.+++++=
T Consensus 266 ~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 266 I---------------------------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp C---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C---------------------------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 0 00135788999999999999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=341.01 Aligned_cols=255 Identities=26% Similarity=0.304 Sum_probs=194.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCCeeeecceeeec--CCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR--LDHPNIIKLEGLITSR--LSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~--~~~ 204 (478)
.++|++++.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 56899999999999999999987 6899999998643 23445567777776 7999999999987542 235
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCcEEEecCCcEEEeecc
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH--------SRGVLHRDIKGSNLLVNNEGVLKLADFG 276 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~givHrDlkp~NILl~~~~~vkl~DFG 276 (478)
.+|+||||++++.+..+... ..+++..+..++.||+.||.||| +++|+||||||+||||+.++.+||+|||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 68999999998666655543 37999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCC---CccccccCCcccCcccccCCC-----CCCChhhHHHHHHHHHHHHhC----------CCCCCCCC-
Q 011763 277 LANFSNTGHRQ---PLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELLIG----------KPILQGRT- 337 (478)
Q Consensus 277 ~a~~~~~~~~~---~~~~~~~t~~y~APE~l~~~~-----~~~~~~DiwslG~il~elltG----------~~pf~~~~- 337 (478)
+++........ ......+|+.|+|||++.+.. .++.++|||||||++|||++| .+||....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99765432211 123347899999999987632 344689999999999999999 88886532
Q ss_pred ---hHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 338 ---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 338 ---~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+..+.......+. .. ........++.+.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~-------------------~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPN-------------------IP--NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCC-------------------CC--GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcchhhhhHHHhccCCCCC-------------------CC--hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22333332221111100 00 00011235678999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=343.15 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=196.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-CCc--EEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-TGK--IVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-~~~--~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.++|++++.||+|+||+||+|++.. +++ .||||+++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 5689999999999999999998643 333 689999876543 345567788999999999999999999998763
Q ss_pred eEEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..++||||+.++ +...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 378999999875 4444444445799999999999999999999999999999999999999999999999999976654
Q ss_pred CCCC--CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 284 GHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 284 ~~~~--~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+......++
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 245 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP------- 245 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-------
T ss_pred cccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC-------
Confidence 3221 1223456788999999876 568899999999999999999 9999999888777766643211111
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++++.+||.+||..||.+|||+.++++
T Consensus 246 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 246 --------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11367899999999999999999999999996
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=340.75 Aligned_cols=246 Identities=20% Similarity=0.328 Sum_probs=194.2
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||+||++++ +++.||||+++.+. ..+.+.+|+.+++.++||||+++++++... ...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 90 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGL 90 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCce
Confidence 3367899999999999999999987 48899999987442 346678899999999999999999987553 3468
Q ss_pred EEEEeeccCCchhhccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
|+||||++++.+..+..... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999855544433222 3789999999999999999999999999999999999999999999999998755432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. ....+++.|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+.....
T Consensus 171 ~----~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------- 232 (278)
T 1byg_A 171 Q----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------- 232 (278)
T ss_dssp ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-------------
T ss_pred c----cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-------------
Confidence 1 23356889999999875 678999999999999999998 9999998776665554422100
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 233 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 233 ---------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0011357889999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=354.97 Aligned_cols=254 Identities=20% Similarity=0.263 Sum_probs=195.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
...|++.+.||+|+||+||+|++..+ +..||+|.++... .....+.+.+|+.+|++++||||+++++++... ...
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~ 165 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGS 165 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCC
Confidence 45689999999999999999987533 3468999987533 445667888999999999999999999987543 456
Q ss_pred EEEEEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.|+||||++++.+ ..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 7899999998544 444455567899999999999999999999999999999999999999999999999999765432
Q ss_pred CC---CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 285 HR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 285 ~~---~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.. .......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+......+
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~-------- 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-------- 316 (373)
T ss_dssp ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC--------
T ss_pred ccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 11 11233456788999999876 678999999999999999999 788998776655554443211000
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 317 --------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 --------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012578899999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=359.63 Aligned_cols=253 Identities=22% Similarity=0.251 Sum_probs=203.1
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC-CeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP-NIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~~~ 207 (478)
.++|+++++||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.|.|+ +|+.+..++.. ....|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEE
Confidence 56899999999999999999999999999999998765432 2366899999999775 44444444444 67789
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---ecCCcEEEeecccccccCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~~ 284 (478)
|||||+.+.|...+......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.....
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999666666666556689999999999999999999999999999999999999 68899999999999866543
Q ss_pred CCC------CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCCCCch
Q 011763 285 HRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 285 ~~~------~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~~~~g~~~~~ 355 (478)
... ......+|+.|+|||++.+ ..++.++|||||||+||||++|+.||.+... .+.+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-----
T ss_pred ccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-----
Confidence 221 1235678999999999887 6789999999999999999999999987543 333444333211
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
...+......+++++.+||..||..||.+||++.++++
T Consensus 234 -------------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 234 -------------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -------------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -------------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01122333578999999999999999999999988763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=380.61 Aligned_cols=281 Identities=23% Similarity=0.302 Sum_probs=207.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeee----cCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITS----RLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~ 204 (478)
.++|++.+.||+|+||+||+|.+..+++.||||++... ......+.+.+|+.+|++++||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 35899999999999999999999999999999998754 355667778899999999999999999988754 2255
Q ss_pred eEEEEEeeccCCchhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCc---EEEeecccc
Q 011763 205 SIYLVFEYMEHDITGLLSCP---DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLA 278 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkl~DFG~a 278 (478)
..|+||||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 67999999987655544432 226899999999999999999999999999999999999997765 999999999
Q ss_pred cccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhc
Q 011763 279 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 279 ~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.................. .....
T Consensus 172 ~~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~--~~~~~ 246 (676)
T 3qa8_A 172 KELDQGE--LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN--EHIVV 246 (676)
T ss_dssp CBTTSCC--CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--------CCS
T ss_pred ccccccc--ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc--hhhhh
Confidence 8765432 2345678999999999876 67899999999999999999999999876544322111000000 00000
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.........+.... .........+++.+.+||.+||.+||.+|||+.++|+||||+.
T Consensus 247 ~~~l~g~~~~~~~l---p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 247 YDDLTGAVKFSSVL---PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCCSSSCCCCSSS---CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhcccccccccc---CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00000000000000 0111223457789999999999999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=365.58 Aligned_cols=252 Identities=16% Similarity=0.199 Sum_probs=195.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCC-CCeeeec-----------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDH-PNIIKLE----------- 195 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~nIv~l~----------- 195 (478)
...|.+.+.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.+++.+.| +|+..+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4569999999999999999999999999999999874332 22335678899999999977 3221111
Q ss_pred ----------ceeeecC---CceEEEEEeeccCCchhhc------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 011763 196 ----------GLITSRL---SCSIYLVFEYMEHDITGLL------SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 256 (478)
Q Consensus 196 ----------~~~~~~~---~~~~~lv~e~~~~~ll~~~------~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrD 256 (478)
.++.... ...++++|+++.+++...+ ......+++..+..++.||+.||.|||++||+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 2346888998887776655 23345688889999999999999999999999999
Q ss_pred CCCCcEEEecCCcEEEeecccccccCCCCCCCccccccCCcccCccccc---------CCCCCCChhhHHHHHHHHHHHH
Q 011763 257 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL---------GATDYGPSVDLWSVGCVFAELL 327 (478)
Q Consensus 257 lkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~---------~~~~~~~~~DiwslG~il~ell 327 (478)
|||+||||+.++.+||+|||+++..... ....++ +.|+|||++. ....++.++|||||||++|+|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999765432 344566 9999999983 3356888999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCH
Q 011763 328 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407 (478)
Q Consensus 328 tG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta 407 (478)
+|+.||...+..+.... +......+++.+.+||.+||+.||.+|||+
T Consensus 312 tg~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HSSCCCCTTGGGSCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCcchhhhHHH---------------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCH
Confidence 99999986543221111 111123678999999999999999999999
Q ss_pred HHHHhCcccCC
Q 011763 408 SAALASEYFST 418 (478)
Q Consensus 408 ~e~L~hp~f~~ 418 (478)
.++|+||||+.
T Consensus 359 ~~~l~~~~~~~ 369 (413)
T 3dzo_A 359 LQAMETPEYEQ 369 (413)
T ss_dssp HHHTTSHHHHH
T ss_pred HHHHhCHHHHH
Confidence 99999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=369.28 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=208.7
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.++||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|+.|+||||+++++++.+ ..+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~ 336 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 336 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccc
Confidence 446789999999999999999999865 467999999865433 3567899999999999999999998865 458
Q ss_pred EEEEeeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 207 YLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
||||||+.++.+..+... ...+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999998655544432 245899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.........++..|+|||++.+ ..++.++|||||||+||||++ |+.||.+....+.+..+......+
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------- 484 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------- 484 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred ceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 1112223345788999999876 678999999999999999999 999999988887776664321100
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC--cccC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS--EYFS 417 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h--p~f~ 417 (478)
....+++.+.+||.+||+.||++|||+.++++. .+|.
T Consensus 485 -----------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 -----------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 013578899999999999999999999999864 5554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=346.34 Aligned_cols=251 Identities=17% Similarity=0.272 Sum_probs=201.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++.+.||+|+||.||+|++.. .||+|++..........+.+.+|+.+++.++||||+++++++.. ...+++
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~i 106 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHLAI 106 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCceEE
Confidence 5789999999999999999999754 49999998655444444556789999999999999999999987 567999
Q ss_pred EEeeccCCchhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC---
Q 011763 209 VFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG--- 284 (478)
Q Consensus 209 v~e~~~~~ll~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~--- 284 (478)
||||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999765555444 444799999999999999999999999999999999999998 689999999998654321
Q ss_pred -CCCCccccccCCcccCcccccC--------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCch
Q 011763 285 -HRQPLTSRVVTLWYRPPELLLG--------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 285 -~~~~~~~~~~t~~y~APE~l~~--------~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 355 (478)
.........+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+.......+........
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 263 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL-- 263 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC--
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC--
Confidence 1122334467899999999864 24578899999999999999999999998887776666543211000
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++.++.+||.+||..||.+|||+.++++
T Consensus 264 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 264 -------------------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -------------------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -------------------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01257889999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=342.40 Aligned_cols=262 Identities=22% Similarity=0.266 Sum_probs=200.2
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCC--CChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN--FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
|...+.||+|+||+||+|.+ +++.||+|++.... ......+.+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceEEE
Confidence 45559999999999999986 68899999987542 234456778899999999999999999999977 5678999
Q ss_pred EeeccCCchhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 210 FEYMEHDITGLLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 210 ~e~~~~~ll~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 99998755544332 234689999999999999999999999999999999999999999999999999976543221
Q ss_pred C-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 287 Q-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 287 ~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
. ......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||........+..+..............
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 260 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY------ 260 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH------
T ss_pred cccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh------
Confidence 1 1233567999999998865 478999999999999999999999987654433333322211111000000
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.+..+.......+..+.+||.+||+.||.+|||+.+++++
T Consensus 261 --------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 261 --------IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp --------SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000111112346779999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=342.90 Aligned_cols=270 Identities=23% Similarity=0.361 Sum_probs=201.8
Q ss_pred cccceeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 35689999999999999999998 4668999999999754 34556778899999999999999999999876545
Q ss_pred ceEEEEEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 204 CSIYLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
..+++||||++++.+ ..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 578999999987544 4444444579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC--CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 283 TGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 283 ~~~~~--~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||..... .+....+......+...
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCTHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccchhhhHH
Confidence 43211 1223455778999999876 5688999999999999999999998864311 11111111111000000
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.+. ........ ......+++++.+||.+||..||.+|||+.++++
T Consensus 271 ~~~--~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 271 HLI--ELLKNNGR-----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHH--HHHHTTCC-----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHH--HHhhcCCC-----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 00000000 0011357889999999999999999999999984
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=369.26 Aligned_cols=257 Identities=21% Similarity=0.264 Sum_probs=205.4
Q ss_pred cccceeeee-eeeecCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 128 RADAFEKLE-KIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 128 ~~~~y~~~~-~LG~G~~g~V~~~~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
..++|.+.+ .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+|+.++|||||++++++.. .
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~ 408 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---E 408 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---S
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---C
Confidence 345677776 8999999999999765 356679999997653 33456778899999999999999999999865 3
Q ss_pred eEEEEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
.+||||||+.++.+.. +......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 5899999999866554 444556799999999999999999999999999999999999999999999999999986643
Q ss_pred CCCCC--ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 284 GHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 284 ~~~~~--~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... .....+|+.|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+....+......
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--------- 558 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--------- 558 (613)
T ss_dssp -------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---------
T ss_pred CCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 22111 122234688999999875 678999999999999999998 99999998888777666432100
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHH---HhCcccC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA---LASEYFS 417 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~---L~hp~f~ 417 (478)
.....+++++.+||.+||..||.+|||+.++ |++.|+.
T Consensus 559 -------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 559 -------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0113578999999999999999999999987 4555554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=339.06 Aligned_cols=240 Identities=22% Similarity=0.319 Sum_probs=186.2
Q ss_pred ccceeee-eeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHH-HhcCCCCeeeecceeee--cCCc
Q 011763 129 ADAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILIL-RRLDHPNIIKLEGLITS--RLSC 204 (478)
Q Consensus 129 ~~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~--~~~~ 204 (478)
.++|.++ +.||+|+||.||++++..+++.||||++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4578888 7899999999999999999999999999632 3456788888 55699999999998864 2345
Q ss_pred eEEEEEeeccCCchhh-ccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec---CCcEEEeeccccc
Q 011763 205 SIYLVFEYMEHDITGL-LSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLAN 279 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~-~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~ 279 (478)
.+||||||++++.+.. +... ...+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 7899999998855444 4332 346999999999999999999999999999999999999998 7889999999985
Q ss_pred ccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
... ...++.++|||||||++|+|++|++||...........+...
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~----------- 213 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----------- 213 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS-----------
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH-----------
Confidence 432 134678999999999999999999999876543321110000
Q ss_pred CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCC
Q 011763 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~ 420 (478)
. ...........+..+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 214 ~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 214 I----------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp S----------CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred H----------hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0 00000011122356899999999999999999999999999999998643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.38 Aligned_cols=248 Identities=17% Similarity=0.175 Sum_probs=194.7
Q ss_pred ccccceeeeeeeeecCceEEEEE-----EECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCeeeeccee
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRA-----RDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD---HPNIIKLEGLI 198 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~-----~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~ 198 (478)
+..++|.+.+.||+|+||+||+| .+..+++.||||++.... ...+.+|+.++..++ |+||+++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 44678999999999999999999 467789999999997432 345667888888886 99999999999
Q ss_pred eecCCceEEEEEeeccCCchhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-------
Q 011763 199 TSRLSCSIYLVFEYMEHDITGLLSC-----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN------- 266 (478)
Q Consensus 199 ~~~~~~~~~lv~e~~~~~ll~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~------- 266 (478)
.. ....||||||++++.+..+.. ....+++..++.++.||+.||.|||++|||||||||+||||+.
T Consensus 137 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 137 LF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred ec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 87 567899999999766555443 4557999999999999999999999999999999999999998
Q ss_pred ----CCcEEEeecccccccCC-CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 011763 267 ----EGVLKLADFGLANFSNT-GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341 (478)
Q Consensus 267 ----~~~vkl~DFG~a~~~~~-~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~ 341 (478)
++.+||+|||+|+.... .........++|+.|+|||++.+ ..|+.++|||||||++|||++|+.||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~-- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCC--
Confidence 89999999999975431 12233455678999999999987 66899999999999999999999998643220
Q ss_pred HHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcc
Q 011763 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (478)
Q Consensus 342 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~ 415 (478)
.|... ..+.. ...++.+.+++..||+.+|.+|++..+.|.+.+
T Consensus 292 --------------~~~~~---------------~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 292 --------------ECKPE---------------GLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp --------------EEEEC---------------SCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred --------------ceeec---------------hhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 00000 00000 023667899999999999999977666555443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=349.02 Aligned_cols=250 Identities=18% Similarity=0.208 Sum_probs=192.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcC---------CCCeee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF------EPESVRFMAREILILRRLD---------HPNIIK 193 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~nIv~ 193 (478)
.++|++++.||+|+||+||+|++ +++.||||++..... .....+.+.+|+.+|+.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999998 689999999987542 2233467788999999886 555555
Q ss_pred ecce-----------------eeec-----------CCceEEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHH
Q 011763 194 LEGL-----------------ITSR-----------LSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGL 244 (478)
Q Consensus 194 l~~~-----------------~~~~-----------~~~~~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL 244 (478)
++++ |... ....+||||||+.++ ++..+.. ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 5444 4321 156799999999876 5666543 4689999999999999999
Q ss_pred HHHH-hCCceeccCCCCcEEEecCC--------------------cEEEeecccccccCCCCCCCccccccCCcccCccc
Q 011763 245 EHCH-SRGVLHRDIKGSNLLVNNEG--------------------VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303 (478)
Q Consensus 245 ~~LH-~~givHrDlkp~NILl~~~~--------------------~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~ 303 (478)
.||| ++||+||||||+||||+.++ .+||+|||+|+.... ...++|+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhh
Confidence 9999 99999999999999999987 899999999987653 23478999999999
Q ss_pred ccCCCCCCChhhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhc
Q 011763 304 LLGATDYGPSVDLWSVGCV-FAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRET 381 (478)
Q Consensus 304 l~~~~~~~~~~DiwslG~i-l~elltG~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 381 (478)
+.+. . +.++|||||+++ .++++.|..||..... ......+........ ......
T Consensus 249 ~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~ 304 (336)
T 2vuw_A 249 FTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT----------------------KCNTPA 304 (336)
T ss_dssp GCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS----------------------CCCSHH
T ss_pred hcCC-C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc----------------------ccchhh
Confidence 9863 3 889999998777 7788899999854221 112222222111000 001122
Q ss_pred ccCCchhHHHHHHHhcCCCCCCccCHHHHH-hCcccC
Q 011763 382 FKDLPTTAVNLIETLLSVEPYKRATASAAL-ASEYFS 417 (478)
Q Consensus 382 ~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L-~hp~f~ 417 (478)
++.+++++++||.+||++| |+.|+| +||||+
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 3467889999999999987 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.76 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=205.7
Q ss_pred cccceeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
..++|++.+.||+|+||+||+|.+..+ +..||||++.... .....+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---C
Confidence 357899999999999999999998643 4679999987543 44556778899999999999999999998854 4
Q ss_pred eEEEEEeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..|+||||++++.+..+ ......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 58999999997655444 43455799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
..........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+......+
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 612 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---------- 612 (656)
T ss_dssp ----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC----------
T ss_pred CcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 33333334456789999999876 678999999999999999997 999999998888777765421111
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 613 ------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 613 ------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01357889999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=346.42 Aligned_cols=280 Identities=23% Similarity=0.281 Sum_probs=191.5
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHH--HHhcCCCCeeeecceeee---c
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILI--LRRLDHPNIIKLEGLITS---R 201 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~---~ 201 (478)
+..++|++++.||+|+||+||+|++ +++.||||++.... ...+..|.++ +..++||||+++++.+.. .
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 4578999999999999999999976 68999999997432 2233334444 455899999999875532 2
Q ss_pred CCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCcEEEecCCcEEE
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR---------GVLHRDIKGSNLLVNNEGVLKL 272 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---------givHrDlkp~NILl~~~~~vkl 272 (478)
....+||||||++++.+..+.... .+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 244679999999886655554333 458999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCC-------CCCccccccCCcccCcccccCC------CCCCChhhHHHHHHHHHHHHhCCCCC-CCCCh
Q 011763 273 ADFGLANFSNTGH-------RQPLTSRVVTLWYRPPELLLGA------TDYGPSVDLWSVGCVFAELLIGKPIL-QGRTE 338 (478)
Q Consensus 273 ~DFG~a~~~~~~~-------~~~~~~~~~t~~y~APE~l~~~------~~~~~~~DiwslG~il~elltG~~pf-~~~~~ 338 (478)
+|||+++...... ........+|+.|+|||++.+. ..++.++|||||||++|||++|..|| .+...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999997654321 1222345789999999998752 34567899999999999999996554 43322
Q ss_pred HHHHHHHHHHcCCCCc-hhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHH------H
Q 011763 339 VEQLHKIFKLCGSPPD-DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA------L 411 (478)
Q Consensus 339 ~~~~~~i~~~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~------L 411 (478)
.+....+....+..+. ..+....... ...+. +...+ .....+++.+.+||.+||+.||.+|||+.|+ |
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSRE--KQRPK--FPEAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTS--CCCCC--CCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhccc--ccCCC--CCccc-ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 1111111111111111 1000000000 00000 00000 0011245679999999999999999999999 5
Q ss_pred hCcccCCC
Q 011763 412 ASEYFSTK 419 (478)
Q Consensus 412 ~hp~f~~~ 419 (478)
.++|-++.
T Consensus 317 l~~~~~~~ 324 (336)
T 3g2f_A 317 MMIWERNK 324 (336)
T ss_dssp HHCCCC--
T ss_pred HHHHHhcc
Confidence 67887664
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=339.15 Aligned_cols=255 Identities=23% Similarity=0.293 Sum_probs=189.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc--CCCCeeeecceeeecCC--c
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL--DHPNIIKLEGLITSRLS--C 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~~~--~ 204 (478)
.++|++++.||+|+||.||+|++. ++.||||++.... .....+|.+++..+ +||||+++++++..... .
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 358999999999999999999874 8999999986432 23344556666554 99999999999876432 6
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcEEEecCCcEEEeecc
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFG 276 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------givHrDlkp~NILl~~~~~vkl~DFG 276 (478)
.+|+||||++++.+..+... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 79999999998655555433 2689999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCC---CccccccCCcccCcccccCCCCCCC------hhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 011763 277 LANFSNTGHRQ---PLTSRVVTLWYRPPELLLGATDYGP------SVDLWSVGCVFAELLIG----------KPILQGRT 337 (478)
Q Consensus 277 ~a~~~~~~~~~---~~~~~~~t~~y~APE~l~~~~~~~~------~~DiwslG~il~elltG----------~~pf~~~~ 337 (478)
++......... ......+|+.|+|||++.+ ..+.. ++|||||||++|||++| ..||....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 99765432211 1234578999999999876 33444 39999999999999999 66665421
Q ss_pred ----hHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 338 ----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 338 ----~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.......+.......+ . ... ......+++++.+||.+||+.||.+|||+.++++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~-----------------~--~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRP-----------------S--FPN--RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCC-----------------C--CCG--GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCc-----------------c--ccc--cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222222221110000 0 000 00012456789999999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=330.88 Aligned_cols=253 Identities=23% Similarity=0.266 Sum_probs=195.0
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCCeeeecceeeecCC--ce
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR--LDHPNIIKLEGLITSRLS--CS 205 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~~--~~ 205 (478)
++|++.+.||+|+||+||++++ +++.||||++... ....+.+|++++.. ++||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 4899999999999999999997 5899999998632 34556789999988 699999999999876432 27
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCcEEEecCCcEEEeeccc
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH--------SRGVLHRDIKGSNLLVNNEGVLKLADFGL 277 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~givHrDlkp~NILl~~~~~vkl~DFG~ 277 (478)
+|+||||++++.+..+... ..+++..++.++.||+.||.||| +++|+||||||+||||+.++.+||+|||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 8999999998655554433 36899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCC---CccccccCCcccCcccccCCCC-----CCChhhHHHHHHHHHHHHhC----------CCCCCCCC--
Q 011763 278 ANFSNTGHRQ---PLTSRVVTLWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIG----------KPILQGRT-- 337 (478)
Q Consensus 278 a~~~~~~~~~---~~~~~~~t~~y~APE~l~~~~~-----~~~~~DiwslG~il~elltG----------~~pf~~~~-- 337 (478)
+......... ......+|+.|+|||++.+... ++.++|||||||++|+|++| ..||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 9765543211 2244578999999999876322 23689999999999999999 77886542
Q ss_pred --hHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcc--cCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 338 --EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 338 --~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
..+.+...+...... ..+...+ ...++.+.+||.+||+.||.+|||+.++++|
T Consensus 274 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLR-----------------------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTTSCCC-----------------------CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHHHhC-----------------------CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 222222222110000 0000111 2345679999999999999999999999965
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=324.27 Aligned_cols=228 Identities=18% Similarity=0.143 Sum_probs=184.7
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.++..++||||+++++++.. ....||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEEE
Confidence 489999999999999999999999999999999986654 34556778899999999999999999999987 677999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++++.+..+.... ..+.++..++.||+.||.|||++||+||||||+||||+.++.+||++++
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 99999986666665443 4666788999999999999999999999999999999999999998543
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
|++ .++.++|||||||++|+|++|+.||.+.+..+.+....
T Consensus 175 ---------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---------------------- 215 (286)
T 3uqc_A 175 ---------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---------------------- 215 (286)
T ss_dssp ---------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----------------------
T ss_pred ---------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----------------------
Confidence 333 36789999999999999999999998765322110000
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
................+++++.+||.+||+.||.+| |+.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 000000111223346789999999999999999999 99999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=367.05 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=198.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC---c
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS---C 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~ 204 (478)
.++|++.+.||+|+||+||++++.. +++.||||++.... .......+.+|+.+|..++||||+++++++..... .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3589999999999999999999976 78999999987543 45556678899999999999999999999976422 1
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
..||||||++++.+..+... .+++..++.++.||+.||.|||++|||||||||+||||+.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 26999999998777665544 79999999999999999999999999999999999999875 9999999999866532
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
....+|+.|+|||++.+ .++.++|||||||+||+|++|.+||.+.... ..+
T Consensus 235 -----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~----------- 285 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLP----------- 285 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCC-----------
T ss_pred -----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-----------ccc-----------
Confidence 44578999999999865 3488999999999999999999888742110 000
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
.. ......++.+.+||.+||+.||.+||+..++|.|+|+.
T Consensus 286 ---------~~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ---------ED----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---------TT----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---------cc----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 00012457899999999999999999999999999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-34 Score=302.35 Aligned_cols=185 Identities=17% Similarity=0.066 Sum_probs=132.2
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCC--------ChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEEE
Q 011763 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF--------EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 138 LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~l 208 (478)
++.|+++.+..++....|+.||+|++..+.. .....+.+.+|+++|+++ .|+||+++++++++ ...+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~yL 319 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGWL 319 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEEE
Confidence 3456666666666556789999999976532 123456688999999999 79999999999988 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
||||++|+.|..++....++++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ..
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~ 395 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SW 395 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----CC
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-cc
Confidence 99999998888877777788765 478899999999999999999999999999999999999999998765432 33
Q ss_pred ccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCC
Q 011763 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 330 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~ 330 (478)
..+.+||+.|+|||++.+ .+..++|+|++|+++++|.++.
T Consensus 396 ~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred ccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence 456789999999999876 4667899999999988876654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=252.89 Aligned_cols=188 Identities=16% Similarity=0.132 Sum_probs=139.7
Q ss_pred eeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE------SVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 133 ~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
...+.||+|+||+||++. ..++.+++|++........ ..+.+.+|+++|++++||||+++..++.. ....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNK 414 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCcc
Confidence 345789999999999995 4578899998765433211 23457899999999999999955545544 4456
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||||++++.+..+... +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999997666555443 5689999999999999999999999999999998 999999999987654211
Q ss_pred CC------ccccccCCcccCcccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 011763 287 QP------LTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQ 334 (478)
Q Consensus 287 ~~------~~~~~~t~~y~APE~l~~-~~~~~~~~DiwslG~il~elltG~~pf~ 334 (478)
.. .....+|+.|+|||++.. ...|+..+|+|+..+-..+.+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 11 135678999999999864 1346778899999988888887776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=209.19 Aligned_cols=146 Identities=16% Similarity=0.140 Sum_probs=115.8
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh----------------HHHHHHHHHHHHHHhcCCCCeeee
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----------------ESVRFMAREILILRRLDHPNIIKL 194 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~l 194 (478)
.|.+.+.||+|+||.||+|.+ .+++.||||+++...... .....+.+|+.+|++++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 345559999999999999999 889999999996532211 23566789999999999 5 777
Q ss_pred cceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEee
Q 011763 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (478)
Q Consensus 195 ~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D 274 (478)
.+++.. ...|+||||++++.+..+.. .....++.||+.||.|||++||+||||||+||||+ ++.+||+|
T Consensus 167 ~~~~~~---~~~~lvmE~~~g~~L~~l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 167 PKVYAW---EGNAVLMELIDAKELYRVRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CCEEEE---ETTEEEEECCCCEEGGGCCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CeEEec---cceEEEEEecCCCcHHHcch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 776644 34689999999866655321 23457999999999999999999999999999999 99999999
Q ss_pred cccccccCCCCCCCccccccCCcccCccccc
Q 011763 275 FGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305 (478)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~t~~y~APE~l~ 305 (478)
||+|+.. ..|+|||++.
T Consensus 236 FG~a~~~--------------~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVEV--------------GEEGWREILE 252 (282)
T ss_dssp CTTCEET--------------TSTTHHHHHH
T ss_pred CCCCeEC--------------CCCCHHHHHH
Confidence 9998633 3378899764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8.3e-22 Score=188.38 Aligned_cols=140 Identities=18% Similarity=0.213 Sum_probs=106.2
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcE--EEEEEeecCCCCh----------------------HHHHHHHHHHHHHHhc
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEP----------------------ESVRFMAREILILRRL 186 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~--vAlK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l 186 (478)
-|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778888 9999976532110 1123567899999999
Q ss_pred CCCCe--eeecceeeecCCceEEEEEeeccC-C----chhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCC
Q 011763 187 DHPNI--IKLEGLITSRLSCSIYLVFEYMEH-D----ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH-SRGVLHRDIK 258 (478)
Q Consensus 187 ~h~nI--v~l~~~~~~~~~~~~~lv~e~~~~-~----ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givHrDlk 258 (478)
.|++| +.+++ . ...+|||||+++ + .+..... .+++..+..++.||+.+|.||| ++||+|||||
T Consensus 128 ~~~~i~~p~~~~---~---~~~~lVmE~~g~~g~~~~~L~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYT---Y---MKNVLLMEFIGEDELPAPTLVELGR---ELKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEE---E---ETTEEEEECCEETTEECCBHHHHGG---GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HhCCCCCCeEEE---c---CCCEEEEEecCCCCCccccHHHHhh---ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 88764 33322 1 235899999953 2 2322211 1235577899999999999999 9999999999
Q ss_pred CCcEEEecCCcEEEeeccccccc
Q 011763 259 GSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~ 281 (478)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.5e-18 Score=170.62 Aligned_cols=140 Identities=17% Similarity=0.187 Sum_probs=100.2
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC---------------ChHHH-----HHHHHHHHHHHhcCCCC
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---------------EPESV-----RFMAREILILRRLDHPN 190 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~---------------~~~~~-----~~~~~E~~~l~~l~h~n 190 (478)
-|++.++||.|+||.||+|.+. +|+.||||+++.... ..... ....+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999974 699999999864211 00000 11234677777775444
Q ss_pred eeeecceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC--
Q 011763 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-- 268 (478)
Q Consensus 191 Iv~l~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-- 268 (478)
+. +...+.. ...+|||||+++..+..+... .....++.||+.+|.+||++|||||||||.||||++++
T Consensus 175 v~-vp~p~~~---~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FP-VPEPIAQ---SRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CS-CCCEEEE---ETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CC-CCeeeec---cCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 32 2112211 113799999998766554322 23467889999999999999999999999999999887
Q ss_pred --------cEEEeeccccccc
Q 011763 269 --------VLKLADFGLANFS 281 (478)
Q Consensus 269 --------~vkl~DFG~a~~~ 281 (478)
.+.|+||+.+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999988543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=124.61 Aligned_cols=140 Identities=14% Similarity=0.089 Sum_probs=107.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 207 (478)
.+.|++...++.|+++.||++.. .+..+++|+...... .....+.+|+.+|+.|. +..++++++++.. ....|
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~ 86 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSN 86 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceE
Confidence 45799999999999999999974 367899999874321 11234778999999994 6778888888766 56789
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-------------------------------------- 249 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-------------------------------------- 249 (478)
+||||++|..+..... +......++.+++.+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999976654321 122334778899999999998
Q ss_pred ---------------------CCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 250 ---------------------RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 250 ---------------------~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876566799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.8e-11 Score=115.71 Aligned_cols=134 Identities=14% Similarity=0.109 Sum_probs=96.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--eeeecceeeecCCceEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN--IIKLEGLITSRLSCSIY 207 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~~~ 207 (478)
..|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+|+.+.+.+ +++++++... .+..+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~ 91 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDW 91 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCE
Confidence 3566554444666799999964 457789999976431 134668999999985434 5567776655 45689
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG------------------------------------ 251 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g------------------------------------ 251 (478)
+||||++|..+. .. ... ...++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~-~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL-SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT-TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC-cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999996664 21 112 2356678888888888753
Q ss_pred ----------------------ceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 252 ----------------------VLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 252 ----------------------ivHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
++|+|++|.|||+++++.+.|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=1e-10 Score=116.57 Aligned_cols=145 Identities=15% Similarity=0.220 Sum_probs=105.0
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEee--cCCCChHHHHHHHHHHHHHHhcC--CCCeeeecceeeecCC-ceE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLD--HPNIIKLEGLITSRLS-CSI 206 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~-~~~ 206 (478)
...++.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+|+.|. +..+++++.++.+... +..
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 345778899999999999853 4678889875 3221 122345778999999996 4557788777655311 447
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS------------------------------------- 249 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~------------------------------------- 249 (478)
|+||||++|..+.... -..+++.....++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 8999999986553211 1246788889999999999999997
Q ss_pred ---------------------CCceeccCCCCcEEEecCCc--EEEeeccccccc
Q 011763 250 ---------------------RGVLHRDIKGSNLLVNNEGV--LKLADFGLANFS 281 (478)
Q Consensus 250 ---------------------~givHrDlkp~NILl~~~~~--vkl~DFG~a~~~ 281 (478)
..++|+|+++.|||++.++. +.|+||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999998753 689999998654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.05 E-value=7.6e-11 Score=114.73 Aligned_cols=184 Identities=15% Similarity=0.127 Sum_probs=118.4
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCC--eeeecceeeecC-CceEEEEE
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPN--IIKLEGLITSRL-SCSIYLVF 210 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~-~~~~~lv~ 210 (478)
++.++.|.+..||++. ..+++|+... ......+.+|+.+|+.+. +.. +.+++....... ....|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4568999999999873 4588998642 244567889999999883 332 333333322211 12348899
Q ss_pred eeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 011763 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS----------------------------------------- 249 (478)
Q Consensus 211 e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~----------------------------------------- 249 (478)
++++|..+..... ..++..+...++.|++..|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999965542211 246777888888888888888885
Q ss_pred -----------------CCceeccCCCCcEEEec--CCcEEEeecccccccCCCCCCCccccccCCcc---cCcccc---
Q 011763 250 -----------------RGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWY---RPPELL--- 304 (478)
Q Consensus 250 -----------------~givHrDlkp~NILl~~--~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y---~APE~l--- 304 (478)
..++|+|++|.|||+++ ...+.|+||+.+........ ......+ ..|+.+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHHH
Confidence 13799999999999998 45678999999865432110 0000001 122211
Q ss_pred -cCCCC---------CCChhhHHHHHHHHHHHHhCCCCCC
Q 011763 305 -LGATD---------YGPSVDLWSVGCVFAELLIGKPILQ 334 (478)
Q Consensus 305 -~~~~~---------~~~~~DiwslG~il~elltG~~pf~ 334 (478)
..... ...-.+.|+++.++|.+.+|.++|.
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00000 1122689999999999999987653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=2e-07 Score=90.58 Aligned_cols=136 Identities=16% Similarity=0.167 Sum_probs=93.1
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC---CeeeecceeeecCCceEEEEEe
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP---NIIKLEGLITSRLSCSIYLVFE 211 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~~~lv~e 211 (478)
++.++.|....||+. +..+++|+-. .......+.+|+.+|+.|.+. .+.+++.+... ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEe
Confidence 456788999999998 4668889853 234556788999999999642 24455544432 2455789999
Q ss_pred eccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 011763 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR----------------------------------------- 250 (478)
Q Consensus 212 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~----------------------------------------- 250 (478)
+++|..+....-. .++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9999655432111 234555555666666666655532
Q ss_pred -------------------CceeccCCCCcEEEec---CCc-EEEeecccccccC
Q 011763 251 -------------------GVLHRDIKGSNLLVNN---EGV-LKLADFGLANFSN 282 (478)
Q Consensus 251 -------------------givHrDlkp~NILl~~---~~~-vkl~DFG~a~~~~ 282 (478)
.++|+|++|.|||++. ++. +.|+||+.+....
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999997 455 4899999886543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=2e-07 Score=88.58 Aligned_cols=132 Identities=15% Similarity=0.125 Sum_probs=90.3
Q ss_pred eeeecCce-EEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEEEEEeecc
Q 011763 137 KIGQGTYS-SVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYME 214 (478)
Q Consensus 137 ~LG~G~~g-~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~lv~e~~~ 214 (478)
.+..|..+ .||+......+..+++|+-.. .....+.+|..+|+.|. +--+.+++.++.+ .+..|+|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeC
Confidence 34445544 699988777778899998652 33456788999999884 3346677777766 567899999999
Q ss_pred CCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 011763 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS--------------------------------------------- 249 (478)
Q Consensus 215 ~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~--------------------------------------------- 249 (478)
|..+...... .......+..++...|.-||.
T Consensus 104 G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 104 GKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp SEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred CccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8654332111 112223344555555555553
Q ss_pred ------C-------CceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 250 ------R-------GVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 250 ------~-------givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
. .++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1 27999999999999987777799999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=2.5e-06 Score=85.78 Aligned_cols=78 Identities=19% Similarity=0.197 Sum_probs=48.4
Q ss_pred eeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC--C---hHHHHHHHHHHHHHHhcCC--C-CeeeecceeeecCCce
Q 011763 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--E---PESVRFMAREILILRRLDH--P-NIIKLEGLITSRLSCS 205 (478)
Q Consensus 134 ~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~--~---~~~~~~~~~E~~~l~~l~h--~-nIv~l~~~~~~~~~~~ 205 (478)
.++.||.|.++.||++....+++.|+||....... . ......+..|..+|+.+.. + .+++++.+ + ...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d--~~~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D--TEM 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E--TTT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c--CCc
Confidence 46789999999999997655678899998653211 0 0112345678899888732 3 34455433 2 223
Q ss_pred EEEEEeeccC
Q 011763 206 IYLVFEYMEH 215 (478)
Q Consensus 206 ~~lv~e~~~~ 215 (478)
.++|||++++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 5799999986
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=2.7e-06 Score=84.15 Aligned_cols=87 Identities=8% Similarity=0.059 Sum_probs=53.9
Q ss_pred eeeeeee-eecCceEEEEEEEC---C---CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-C--CCeeeecceeee
Q 011763 132 FEKLEKI-GQGTYSSVFRARDL---D---TGKIVALKKVRFDNF-EPESVRFMAREILILRRLD-H--PNIIKLEGLITS 200 (478)
Q Consensus 132 y~~~~~L-G~G~~g~V~~~~~~---~---~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~ 200 (478)
...++.| +.|....+|+.... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3456778 88889999998643 0 156789998653220 0000134567888888883 2 346667666544
Q ss_pred cC-CceEEEEEeeccCCch
Q 011763 201 RL-SCSIYLVFEYMEHDIT 218 (478)
Q Consensus 201 ~~-~~~~~lv~e~~~~~ll 218 (478)
.. ....|+||||++|..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 21 1346899999998543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.8e-05 Score=77.35 Aligned_cols=30 Identities=17% Similarity=0.274 Sum_probs=27.3
Q ss_pred CCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 250 ~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00017 Score=69.95 Aligned_cols=76 Identities=18% Similarity=0.180 Sum_probs=57.2
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCeeeecceeeecCCceEEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD---HPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~l 208 (478)
..-++.|+.|.+..+|+... ++..+++|+.... ....+..|+..|+.|. ...+++++.+... ....++
T Consensus 38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~l 108 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFL 108 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEE
T ss_pred eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEE
Confidence 34467889999999999974 4678889987632 2456778999998883 3567777776654 467899
Q ss_pred EEeeccCC
Q 011763 209 VFEYMEHD 216 (478)
Q Consensus 209 v~e~~~~~ 216 (478)
||||+++.
T Consensus 109 vme~l~G~ 116 (312)
T 3jr1_A 109 LLEALNKS 116 (312)
T ss_dssp EEECCCCC
T ss_pred EEEeccCC
Confidence 99999975
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.68 E-value=8.1e-05 Score=75.35 Aligned_cols=79 Identities=9% Similarity=0.098 Sum_probs=47.5
Q ss_pred HhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccc--cCCcccCcccccCCC--CCCChhhHHHHHHHH
Q 011763 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV--VTLWYRPPELLLGAT--DYGPSVDLWSVGCVF 323 (478)
Q Consensus 248 H~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~--~t~~y~APE~l~~~~--~~~~~~DiwslG~il 323 (478)
+...++|+|++|.|||++.++ +.|+||+.+........ ..... ....|++|+...... ......++..+...+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 356799999999999998876 99999999865432110 00000 023466665443110 111234555777777
Q ss_pred HHHHhC
Q 011763 324 AELLIG 329 (478)
Q Consensus 324 ~elltG 329 (478)
|+.+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00025 Score=68.77 Aligned_cols=142 Identities=15% Similarity=0.111 Sum_probs=77.3
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--eeeeccee----eecCCce
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN--IIKLEGLI----TSRLSCS 205 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~----~~~~~~~ 205 (478)
..-++.|+.|....+|++... ++ .+++|+..... ....+..|+.+++.|.... +.+++... .....+.
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 344677888888999999753 33 68899886421 1223456788877773212 33333211 0011345
Q ss_pred EEEEEeeccCCchhh---------------ccC--CC--CC----CCHHHHHHH---------------HHHHHHHHHHH
Q 011763 206 IYLVFEYMEHDITGL---------------LSC--PD--IK----FSEAQIKCY---------------MNQLLHGLEHC 247 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~---------------~~~--~~--~~----l~~~~~~~i---------------~~qil~aL~~L 247 (478)
.+++|+|++|..+.. +.. .. .+ ......... ...+...+++|
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 789999999843211 000 00 00 111100000 01133445555
Q ss_pred Hh-------CCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 248 HS-------RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 248 H~-------~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
+. .+++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 42 369999999999999987666899999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00031 Score=67.57 Aligned_cols=133 Identities=17% Similarity=0.133 Sum_probs=72.9
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCe-eeecceeeecCCceEEEEEeec
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~lv~e~~ 213 (478)
++.|+.|....+|++ ..+++|+..... .......+|+.+++.+....+ .+++.++.+ .-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~----~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVDPA----TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTT----TCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEECC----CCEEEEeec
Confidence 788989999999999 458899875421 111112458888877732222 455443322 236899999
Q ss_pred -cCCchhh-------------------ccCCCCCC----C-HHHHHHHHHH--------------HHHHHH----HHHh-
Q 011763 214 -EHDITGL-------------------LSCPDIKF----S-EAQIKCYMNQ--------------LLHGLE----HCHS- 249 (478)
Q Consensus 214 -~~~ll~~-------------------~~~~~~~l----~-~~~~~~i~~q--------------il~aL~----~LH~- 249 (478)
++..+.. +......+ . ...+..+..+ +...+. .|..
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 6633221 00011000 0 1111111111 111111 1111
Q ss_pred ---CCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 250 ---RGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 250 ---~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
..++|+|+.+.||| ..++.+.|+||..+...
T Consensus 170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 13899999999999 66778899999988643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00025 Score=70.62 Aligned_cols=147 Identities=18% Similarity=0.228 Sum_probs=86.1
Q ss_pred cccccccceeeeeeeeecCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeec
Q 011763 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLD-------TGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLE 195 (478)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~ 195 (478)
|..+..+.+++ +.|..|-...+|++.... +++.|++|+.... ......+.+|..+++.|. +.-..+++
T Consensus 45 W~~~~~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll 120 (379)
T 3feg_A 45 WRRVQPEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLY 120 (379)
T ss_dssp GGGCCGGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEE
T ss_pred CCCCCcCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEE
Confidence 44443445554 566668888899998642 3578999985321 112344568999998883 33345666
Q ss_pred ceeeecCCceEEEEEeeccCCchhh--c----------------cCCC----CCC--CHHHHHHHHHHHHH---------
Q 011763 196 GLITSRLSCSIYLVFEYMEHDITGL--L----------------SCPD----IKF--SEAQIKCYMNQLLH--------- 242 (478)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~ll~~--~----------------~~~~----~~l--~~~~~~~i~~qil~--------- 242 (478)
+++.+ .+||||++|..+.. + .... ... -+.++..+..++..
T Consensus 121 ~~~~~------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~ 194 (379)
T 3feg_A 121 GVFPE------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEM 194 (379)
T ss_dssp EEETT------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSC
T ss_pred EEcCC------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchh
Confidence 55432 28999999843321 0 0111 111 24566666655422
Q ss_pred ----------HHHHHH----hC----CceeccCCCCcEEEecC----CcEEEeecccccc
Q 011763 243 ----------GLEHCH----SR----GVLHRDIKGSNLLVNNE----GVLKLADFGLANF 280 (478)
Q Consensus 243 ----------aL~~LH----~~----givHrDlkp~NILl~~~----~~vkl~DFG~a~~ 280 (478)
.+..|. .. .++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 195 ~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 195 NLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233332 22 49999999999999887 7899999998853
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00054 Score=62.01 Aligned_cols=96 Identities=17% Similarity=0.076 Sum_probs=63.5
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCccccccC
Q 011763 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 295 (478)
Q Consensus 217 ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t 295 (478)
|...+...+.+++++++|.++.|.+..|.-+-. ..-..+=+.|..|+|..+|.|-+.+ ..+. ...
T Consensus 35 L~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~ 100 (229)
T 2yle_A 35 LEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AGE 100 (229)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------------
T ss_pred HHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------ccc
Confidence 455666677899999999999999998876621 1222344567999999999998764 1110 012
Q ss_pred CcccCcccccCCCCCCChhhHHHHHHHHHHHHh
Q 011763 296 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 328 (478)
Q Consensus 296 ~~y~APE~l~~~~~~~~~~DiwslG~il~ellt 328 (478)
..+.|||.+. ...+.+.=|||||++||.-+-
T Consensus 101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred cCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 2367888763 345678899999999998874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00038 Score=66.43 Aligned_cols=78 Identities=15% Similarity=0.193 Sum_probs=53.8
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC---CeeeecceeeecCCceE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP---NIIKLEGLITSRLSCSI 206 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~~ 206 (478)
....-++.+|.|..+.||+.+. .+|+.|++|+...... .....+..|+..|+.|... .+++++.+ + . .
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~--~ 85 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--D--R 85 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--T--T
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec--c--C--c
Confidence 3567789999999999999985 5688999998654322 2223567899999988422 23444332 2 1 3
Q ss_pred EEEEeeccCC
Q 011763 207 YLVFEYMEHD 216 (478)
Q Consensus 207 ~lv~e~~~~~ 216 (478)
++||||+.+.
T Consensus 86 ~lv~e~l~~~ 95 (288)
T 3f7w_A 86 TLAMEWVDER 95 (288)
T ss_dssp EEEEECCCCC
T ss_pred eEEEEeeccc
Confidence 6899998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00051 Score=69.67 Aligned_cols=72 Identities=19% Similarity=0.216 Sum_probs=48.0
Q ss_pred eeeeeeecCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-eeeecceeeecCCce
Q 011763 134 KLEKIGQGTYSSVFRARDLD-------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN-IIKLEGLITSRLSCS 205 (478)
Q Consensus 134 ~~~~LG~G~~g~V~~~~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~ 205 (478)
.++.|+.|....||++.... .+..|++|+..... . ...+.+|+.+++.|...+ .+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----
Confidence 35678888889999998643 25789999874321 1 133457999998884333 3566655432
Q ss_pred EEEEEeeccC
Q 011763 206 IYLVFEYMEH 215 (478)
Q Consensus 206 ~~lv~e~~~~ 215 (478)
.+|+||++|
T Consensus 148 -g~v~e~l~G 156 (429)
T 1nw1_A 148 -GRLEEYIPS 156 (429)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEeCC
Confidence 289999987
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00061 Score=67.47 Aligned_cols=73 Identities=11% Similarity=0.080 Sum_probs=42.3
Q ss_pred eeeeeecCceEEEEEEECC--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-eeeecceeeecCCce
Q 011763 135 LEKIGQGTYSSVFRARDLD--------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN-IIKLEGLITSRLSCS 205 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~--------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~ 205 (478)
+..|+.|....+|++.... .+..+++|+..... ........|..+++.|...+ ++++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF----NG- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TT-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec----CC-
Confidence 4567788888999998643 12678999865321 11112356888888884323 34555433 11
Q ss_pred EEEEEeeccCC
Q 011763 206 IYLVFEYMEHD 216 (478)
Q Consensus 206 ~~lv~e~~~~~ 216 (478)
++||||++|.
T Consensus 110 -~~v~e~i~G~ 119 (369)
T 3c5i_A 110 -GRIEEWLYGD 119 (369)
T ss_dssp -EEEEECCCSE
T ss_pred -cEEEEEecCC
Confidence 5899999874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0031 Score=64.38 Aligned_cols=74 Identities=19% Similarity=0.152 Sum_probs=46.9
Q ss_pred eeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCe-eeecceeeecCCceEEEEEee
Q 011763 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLITSRLSCSIYLVFEY 212 (478)
Q Consensus 134 ~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~lv~e~ 212 (478)
.++.|+.|-...+|++.....+..|++|+...... . .-...+|+.+|..|...++ +++++++. . .+||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~-~idR~~E~~vl~~L~~~gl~P~ll~~~~---~---G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--E-IINREREKKISCILYNKNIAKKIYVFFT---N---GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--S-CSCHHHHHHHHHHHTTSSSBCCEEEEET---T---EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--h-hcCHHHHHHHHHHHHhcCCCCCEEEEeC---C---eEEEEe
Confidence 45678888889999998754457889998743211 1 0011479999999964444 56666552 2 259999
Q ss_pred ccCC
Q 011763 213 MEHD 216 (478)
Q Consensus 213 ~~~~ 216 (478)
++|.
T Consensus 183 I~G~ 186 (458)
T 2qg7_A 183 MDGY 186 (458)
T ss_dssp CCSE
T ss_pred eCCc
Confidence 9873
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0032 Score=61.56 Aligned_cols=32 Identities=28% Similarity=0.424 Sum_probs=28.2
Q ss_pred CceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 251 givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
.++|+|+.+.|||+++++.+.|+||+.+....
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 59999999999999988899999999876543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0049 Score=59.61 Aligned_cols=140 Identities=12% Similarity=0.083 Sum_probs=78.9
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCeeeecce---eeecCCceEEEE
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--PNIIKLEGL---ITSRLSCSIYLV 209 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~---~~~~~~~~~~lv 209 (478)
+..|+ |....||++.. .+|+.+++|+.+..... ...+..|+.+++.|.. -.+++++.. ......+..+++
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 34566 88889998864 34667999998643222 2445668888887732 124444432 000113456889
Q ss_pred EeeccCCchhh---------------c---cCC-----CCCCCHHHH----------------------HHHHHHHHHHH
Q 011763 210 FEYMEHDITGL---------------L---SCP-----DIKFSEAQI----------------------KCYMNQLLHGL 244 (478)
Q Consensus 210 ~e~~~~~ll~~---------------~---~~~-----~~~l~~~~~----------------------~~i~~qil~aL 244 (478)
|++++|..+.. + ... ...+..... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 99998743210 0 000 001111110 11112222222
Q ss_pred HHH----HhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 245 EHC----HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 245 ~~L----H~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
.-+ ....++|+|+++.|||++ + .+.|+||+.+...
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 222 223589999999999999 4 8999999987543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00079 Score=65.60 Aligned_cols=33 Identities=30% Similarity=0.377 Sum_probs=28.3
Q ss_pred CCceeccCCCCcEEEecC----CcEEEeecccccccC
Q 011763 250 RGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSN 282 (478)
Q Consensus 250 ~givHrDlkp~NILl~~~----~~vkl~DFG~a~~~~ 282 (478)
..++|+|+.+.|||++.+ +.+.|+||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 469999999999999875 689999999986544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0059 Score=61.60 Aligned_cols=75 Identities=9% Similarity=0.024 Sum_probs=46.5
Q ss_pred eeeeeeecCceEEEEEEECCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCce
Q 011763 134 KLEKIGQGTYSSVFRARDLDT-------GKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 134 ~~~~LG~G~~g~V~~~~~~~~-------~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 205 (478)
.++.|..|-...+|++..... +..|++|+..... +..-...+|..+++.|. +.-..++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----E- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C-
Confidence 345666788889999986421 5789999864321 11112346888888884 333455554331 1
Q ss_pred EEEEEeeccCCc
Q 011763 206 IYLVFEYMEHDI 217 (478)
Q Consensus 206 ~~lv~e~~~~~l 217 (478)
++||||++|..
T Consensus 146 -~~I~efI~G~~ 156 (424)
T 3mes_A 146 -GRIEEFIDGEP 156 (424)
T ss_dssp -EEEEECCCSEE
T ss_pred -CEEEEEeCCcc
Confidence 68999999843
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.034 Score=55.58 Aligned_cols=29 Identities=28% Similarity=0.486 Sum_probs=24.8
Q ss_pred ceeccCCCCcEEEe------cCCcEEEeecccccc
Q 011763 252 VLHRDIKGSNLLVN------NEGVLKLADFGLANF 280 (478)
Q Consensus 252 ivHrDlkp~NILl~------~~~~vkl~DFG~a~~ 280 (478)
++|+|+.+.|||+. ++..+.|+||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 68999999999994 456799999999853
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.90 E-value=0.03 Score=57.13 Aligned_cols=64 Identities=14% Similarity=0.190 Sum_probs=18.5
Q ss_pred eeeeeeeecCceEEEEEEECCCCcEEEE------EEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceee
Q 011763 133 EKLEKIGQGTYSSVFRARDLDTGKIVAL------KKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLIT 199 (478)
Q Consensus 133 ~~~~~LG~G~~g~V~~~~~~~~~~~vAl------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 199 (478)
.+.+.|| ||.||++........||+ |.++......+....+.+|..+++.++|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4456676 999999987665568888 776654444555566778999999999999999988654
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=86.56 E-value=7.4 Score=37.27 Aligned_cols=141 Identities=13% Similarity=0.168 Sum_probs=78.5
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecce-------------
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL------------- 197 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------------- 197 (478)
+++.++.+-.|..| ||.+.- ++..|+||-. .....+.+..++...-.+.-|+..-+.-.
T Consensus 70 ~v~~I~~s~~Gstg-vff~~t--d~~~~VVK~s-----~~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~ 141 (342)
T 1cja_A 70 QFKGIERSEKGTEG-LFFVET--ESGVFIVKRS-----TNIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAA 141 (342)
T ss_dssp GEEEEEECCSTTSC-EEEEEE--SSCEEEEECC-----TTHHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHH
T ss_pred CeeEEEeccCCCCC-eEEEEe--CCCEEEEeCc-----HHHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHH
Confidence 47788888777755 555543 4778899943 12344455555555555666663322110
Q ss_pred -------eeecCCceEEEEEeeccCCchhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcEE
Q 011763 198 -------ITSRLSCSIYLVFEYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRG-----VLHRDIKGSNLL 263 (478)
Q Consensus 198 -------~~~~~~~~~~lv~e~~~~~ll~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDlkp~NIL 263 (478)
..........++|+|.+|-.+..+.... ..+.++....+. + +.+++.+..+. +-+.--.+.|||
T Consensus 142 ~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG-~-Ii~FDi~InN~DR~Pl~W~n~GN~~NIL 219 (342)
T 1cja_A 142 IDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG-S-LMALDVIVNNSDRLPIAWTNEGNLDNIM 219 (342)
T ss_dssp HCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH-H-HHHHHHHHTCCSSSCSSSCSCCCGGGEE
T ss_pred hhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhc-h-hheehhhhcCCccCcccccCCCChhheE
Confidence 0011122467999999975443332210 113333322211 1 34677777653 222235789999
Q ss_pred EecCCc-EEEeeccccccc
Q 011763 264 VNNEGV-LKLADFGLANFS 281 (478)
Q Consensus 264 l~~~~~-vkl~DFG~a~~~ 281 (478)
+++++. +.++|-+.+...
T Consensus 220 ~~~~n~~~~~IDhn~af~~ 238 (342)
T 1cja_A 220 LSERGATVVPIDSKIIPLD 238 (342)
T ss_dssp EESBTTCEEECSCCCCCCC
T ss_pred EeCCCCeEEEEcCCccccC
Confidence 988655 889999888543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.46 E-value=5.7 Score=35.55 Aligned_cols=115 Identities=14% Similarity=0.108 Sum_probs=74.1
Q ss_pred CCCCeeeecceeeecCCceEEEEEeeccCC-chhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 011763 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 265 (478)
Q Consensus 187 ~h~nIv~l~~~~~~~~~~~~~lv~e~~~~~-ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~ 265 (478)
.||+++.. .+-.. .+.+.+.++.-... ....+. .++....+.++.+|+....++ ..-+|--|.|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~--eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTEL--RDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEEC--SSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEc--ccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEc
Confidence 68888866 23333 45566666655432 222222 467888888888888766444 3457888999999999
Q ss_pred cCCcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 011763 266 NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 334 (478)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~ 334 (478)
.++.++|.--|+-... +|. .++...=+-.+=|++..++.++..|.
T Consensus 114 ~~~~p~i~~RGik~~l------------------~P~------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 114 RDGLPIAKTRGLQNVV------------------DPL------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TTSCEEESCCEETTTB------------------SCC------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCCEEEEEccCccCC------------------CCC------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999987764222 222 11222223346688888888877763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 478 | ||||
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-86 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-86 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-80 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-80 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-79 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-78 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-77 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-77 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-77 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-73 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-73 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-73 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-72 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-71 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-71 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-70 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-70 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-70 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-70 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-69 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-69 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-66 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-66 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-65 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-63 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-60 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-59 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-59 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-58 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-57 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-56 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-54 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-53 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-51 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-28 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (680), Expect = 1e-86
Identities = 119/302 (39%), Positives = 174/302 (57%), Gaps = 9/302 (2%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---EPESVRFMAREILILRRLDHP 189
EKL+ +G+G +++V++ARD +T +IVA+KK++ + + R REI +L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
NII L + +I LVF++ME D+ ++ + + + IK YM L GLE+ H
Sbjct: 61 NIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+LHRD+K +NLL++ GVLKLADFGLA + +R T +VVT WYR PELL GA
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARM 177
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLF 368
YG VD+W+VGC+ AELL+ P L G ++++QL +IF+ G+P ++ W LP F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL 428
K L F ++LI+ L P R TA+ AL +YFS +P L
Sbjct: 238 KSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295
Query: 429 PI 430
P
Sbjct: 296 PR 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (677), Expect = 4e-86
Identities = 130/306 (42%), Positives = 176/306 (57%), Gaps = 12/306 (3%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+EKL KIGQGT+ VF+AR TG+ VALKKV +N + REI IL+ L H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 192 IKLEGLITSRLS------CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+ L + ++ S SIYLVF++ EHD+ GLLS +KF+ ++IK M LL+GL
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPE 302
+ H +LHRD+K +N+L+ +GVLKLADFGLA + T+RVVTLWYRPPE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW---KK 359
LLLG DYGP +DLW GC+ AE+ PI+QG TE QL I +LCGS + W
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419
+L Q R A++LI+ LL ++P +R + AL ++F +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311
Query: 420 PYACDL 425
P DL
Sbjct: 312 PMPSDL 317
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 2e-80
Identities = 108/327 (33%), Positives = 157/327 (48%), Gaps = 13/327 (3%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+ L IG+G Y V A D VA+KK+ + R + REI IL R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 189 PNIIKLEGLI---TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
NII + +I T +YLV M D+ LL S I ++ Q+L GL+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLK 123
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPEL 303
+ HS VLHRD+K SNLL+N LK+ DFGLA + H LT V T WYR PE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
+L + Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I + GSP +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 364 HATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
A + P+ + F + + A++L++ +L+ P+KR ALA Y
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY- 302
Query: 422 ACDLSSLPIYPPSKEIDAKHREDARRK 448
D S PI + D + + + K
Sbjct: 303 --DPSDEPIAEAPFKFDMELDDLPKEK 327
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (639), Expect = 4e-80
Identities = 101/325 (31%), Positives = 164/325 (50%), Gaps = 12/325 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ L+ +G G Y +V A D TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 190 NIIKLEGLITSR----LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T YLV +M D+ L+ K E +I+ + Q+L GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 135
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ H+ G++HRD+K NL VN + LK+ DFGLA ++ +T VVT WYR PE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVIL 191
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD+WSVGC+ AE++ GK + +G ++QL +I K+ G+PP ++ ++ + A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 366 TLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ P + AVNL+E +L ++ +R TA ALA YF +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 424 DLSSLPIYPPSKEIDAKHREDARRK 448
D + Y S + + ++ +R
Sbjct: 312 DEPQVQKYDDSFDDVDRTLDEWKRV 336
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 9e-79
Identities = 105/314 (33%), Positives = 156/314 (49%), Gaps = 18/314 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + IG G++ V++A+ D+G++VA+KKV D RF RE+ I+R+LDH NI
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNI 75
Query: 192 IKLEGLITS----RLSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGL 244
++L S + + LV +Y+ + + S +K YM QL L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
+ HS G+ HRDIK NLL++ + VLKL DFG A G +P S + + +YR PEL
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPEL 193
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
+ GATDY S+D+WS GCV AELL+G+PI G + V+QL +I K+ G+P + ++
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ PQ + P A+ L LL P R T A A +F
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELRD 311
Query: 424 DLSSLPIYPPSKEI 437
LP + +
Sbjct: 312 PNVKLPNGRDTPAL 325
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 3e-78
Identities = 104/324 (32%), Positives = 161/324 (49%), Gaps = 12/324 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ ++ L +G G Y SV A D TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 190 NIIKLEGLITSRLSC----SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T S +YLV M D+ ++ C K ++ ++ + Q+L GL+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 135
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HS ++HRD+K SNL VN + LK+ DFGLA ++ T V T WYR PE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIML 191
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK--SKLP 363
Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P + KK S+
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ Q + F AV+L+E +L ++ KR TA+ ALA YF+
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 424 DLSSLPIYPPSKEIDAKHREDARR 447
D Y S E ++ +
Sbjct: 312 DEPVADPYDQSFESRDLLIDEWKS 335
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 3e-77
Identities = 118/294 (40%), Positives = 168/294 (57%), Gaps = 6/294 (2%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ F+K+EKIG+GTY V++AR+ TG++VALKK+R D REI +L+ L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+KL +I + +YLVFE++ D+ + + IK Y+ QLL GL CH
Sbjct: 62 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S VLHRD+K NLL+N EG +KLADFGLA R T VVTLWYR PE+LLG
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCK 178
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
Y +VD+WS+GC+FAE++ + + G +E++QL +IF+ G+P + W
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS--TKP 420
+ + L +L+ +L +P KR +A AALA +F TKP
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 240 bits (613), Expect = 5e-77
Identities = 106/287 (36%), Positives = 164/287 (57%), Gaps = 4/287 (1%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + LEKIG+GTY V++A++ + G+ ALKK+R + + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
NI+KL +I ++ + LVFE+++ D+ LL + K ++ QLL+G+ +CH
Sbjct: 61 NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
R VLHRD+K NLL+N EG LK+ADFGLA R+ +VTLWYR P++L+G+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKK 177
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
Y ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G+P W
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
K L + ++L+ +L ++P +R TA AL YF
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 7e-77
Identities = 117/287 (40%), Positives = 165/287 (57%), Gaps = 4/287 (1%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+EKLEKIG+GTY +VF+A++ +T +IVALK+VR D+ + REI +L+ L H NI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
++L ++ S + LVFE+ + D+ + +K ++ QLL GL CHSR
Sbjct: 64 VRLHDVLHSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
VLHRD+K NLL+N G LKLA+FGLA R ++ VVTLWYRPP++L GA Y
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 312 PSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370
S+D+WS GC+FAEL P+ G +QL +IF+L G+P ++ W P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
P +SL L T +L++ LL P +R +A AL YFS
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 4e-74
Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 31/293 (10%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ ++ ++ +G+G Y V A + T + VA+K V + + +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHE 63
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
N++K G R YL EY PDI E + + +QL+ G+ + H
Sbjct: 64 NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGAT 308
G+ HRDIK NLL++ LK++DFGLA +R+ L +++ TL Y PELL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
+ VD+WS G V +L G+ ++ Q + +K + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------------- 228
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+K + + + L+ +L P R T ++ KP
Sbjct: 229 -------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPL 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 2e-73
Identities = 66/306 (21%), Positives = 120/306 (39%), Gaps = 23/306 (7%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
L+ D FEK+ ++G G VF+ +G ++A K + + + + RE+ +L
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-RELQVLHEC 61
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
+ P I+ G S I + E+M+ + + E + ++ GL +
Sbjct: 62 NSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 247 CHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ ++HRD+K SN+LVN+ G +KL DFG++ S V T Y PE L
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQ 176
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWK-----K 359
G T Y D+WS+G E+ +G+ + E +L ++ G + + +
Sbjct: 177 G-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTT---------AVNLIETLLSVEPYKRATASAA 410
+ +P L + P + + L P +RA
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 411 LASEYF 416
+ +
Sbjct: 296 MVHAFI 301
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 232 bits (592), Expect = 6e-73
Identities = 75/323 (23%), Positives = 129/323 (39%), Gaps = 40/323 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ LE++G G + V R + TG++ K + P + EI I+ +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHP 86
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
+I L + + L+ E++ ++ ++ D K SEA++ YM Q GL+H H
Sbjct: 87 KLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 249 SRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
++H DIK N++ +K+ DFGLA N + T + PE++
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDR 202
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
G D+W++G + LL G G ++E L + + +D +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS------- 254
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS 426
+ A + I+ LL EP KR T AL + D S
Sbjct: 255 ------------------VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG-----DHS 291
Query: 427 SLPIYPPSKEIDAKHREDARRKK 449
+L PS + ++ +
Sbjct: 292 NLTSRIPSSRYNKIRQKIKEKYA 314
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 232 bits (592), Expect = 6e-73
Identities = 71/340 (20%), Positives = 121/340 (35%), Gaps = 35/340 (10%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ E++G G + V R + TG A K V + + +EI + L HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHP 83
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
++ L + +++E+M ++ ++ K SE + YM Q+ GL H H
Sbjct: 84 TLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 249 SRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
+H D+K N++ + LKL DFGL + + T + PE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEG 199
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
G D+WSVG + LL G G + E L + + D +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS 426
+ + I LL +P R T AL + + S
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 427 SLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKS 466
+P +K D+ + + + + RK
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 333
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 227 bits (581), Expect = 7e-72
Identities = 78/321 (24%), Positives = 133/321 (41%), Gaps = 39/321 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPN 190
F L +IG G++ +V+ ARD+ ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+ G + +LV EY + LL E +I + L GL + HS
Sbjct: 77 TIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD- 309
++HRD+K N+L++ G++KL DFG A+ P S V T ++ PE++L +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSFVGTPYWMAPEVILAMDEG 189
Query: 310 -YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
Y VD+WS+G EL KP L + L+ I + P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPALQS----------- 236
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL 428
N +++ L P R T+ L + + + L
Sbjct: 237 --------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282
Query: 429 P--IYPPSKEIDAKHREDARR 447
+E+D ++
Sbjct: 283 IQRTKDAVRELDNLQYRKMKK 303
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 4e-71
Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 41/308 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +V+ A D+ TG+ VA++++ + EIL++R +PNI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNI 79
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ +++V EY+ G L+ + E QI + L LE HS
Sbjct: 80 VNYLDSYLV--GDELWVVMEYLAG---GSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
V+HRDIK N+L+ +G +KL DFG + ++ V T ++ PE++
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTR-KA 192
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
YGP VD+WS+G + E++ G+P + L+ I G+P +K
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEK---------- 241
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL- 428
L + + L ++ KR +A L ++ A LSSL
Sbjct: 242 ---------------LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI---AKPLSSLT 283
Query: 429 PIYPPSKE 436
P+ +KE
Sbjct: 284 PLIAAAKE 291
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 8e-71
Identities = 84/289 (29%), Positives = 131/289 (45%), Gaps = 36/289 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR-FMAREILILRRLDH 188
+ FE +G+G + +V+ AR+ + I+ALK + E V + RE+ I L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
PNI++L G + +YL+ EY KF E + Y+ +L + L +CH
Sbjct: 66 PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S+ V+HRDIK NLL+ + G LK+ADFG + + + R + TL Y PPE++ G
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRM 180
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
+ VDLWS+G + E L+GKP + T E +I ++ + PD
Sbjct: 181 -HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-------------- 225
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
+ A +LI LL P +R L + +
Sbjct: 226 ---------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (573), Expect = 3e-70
Identities = 91/337 (27%), Positives = 167/337 (49%), Gaps = 24/337 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ L+ IG G V A D + VA+KK+ + RE+++++ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 192 IKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L + T + + +YLV E M+ L ++ ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 192
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P ++ KK +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 368 FKPQQPYDS-------------SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
+ + Y + E K + A +L+ +L ++P KR + AL
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 415 YFSTKPYACDLSSLPIYPPSKEID-AKHREDARRKKV 450
Y + ++ + P K++D +H + ++ +
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELI 349
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 223 bits (570), Expect = 6e-70
Identities = 90/300 (30%), Positives = 151/300 (50%), Gaps = 21/300 (7%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
D ++ + K+G+G YS VF A ++ + V +K ++ P + + REI IL L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 89
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
PNII L ++ +S + LVFE++ + ++ I+ YM ++L L++CH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCH 146
Query: 249 SRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
S G++HRD+K N+++++E L+L D+GLA F + G RV + +++ PELL+
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDY 204
Query: 308 TDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSP-PDDYWKKSKLPHA 365
Y S+D+WS+GC+ A ++ K P G +QL +I K+ G+ DY K +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 366 TLFKPQQPYDSSLR-------ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
F S R E + A++ ++ LL + R TA A+ YF T
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 6e-70
Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D +E + ++G G + V++A++ +T + A K + + E + EI IL DHP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHP 69
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+KL +++++ E+ + ++ + +E+QI+ Q L L + H
Sbjct: 70 NIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
++HRD+K N+L +G +KLADFG++ NT Q S + T ++ PE+++ T
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 309 D----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
Y D+WS+G E+ +P + L KI K P +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSR----- 240
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
+ + ++ L R T S L + +
Sbjct: 241 --------------------WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 7e-70
Identities = 74/296 (25%), Positives = 129/296 (43%), Gaps = 34/296 (11%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL 186
R + F+ + +G+G++S+V AR+L T + A+K + + + V ++ RE ++ RL
Sbjct: 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
DHP +KL +Y Y ++ F E + Y +++ LE+
Sbjct: 66 DHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLL 305
H +G++HRD+K N+L+N + +++ DFG A + +Q + V T Y PELL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
+ S DLW++GC+ +L+ G P + E KI KL P+ ++ K
Sbjct: 184 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK------ 236
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
A +L+E LL ++ KR P+
Sbjct: 237 -----------------------ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 8e-70
Identities = 112/293 (38%), Positives = 165/293 (56%), Gaps = 13/293 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMAREILILRRL---D 187
+E + +IG+G Y VF+ARDL + G+ VALK+VR E RE+ +LR L +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 188 HPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHG 243
HPN+++L + T + + LVFE+++ D+T L P+ IK M QLL G
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
L+ HS V+HRD+K N+LV + G +KLADFGLA + TS VVTLWYR PE+
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEV 186
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P ++ W +
Sbjct: 187 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
F + + + D+ +L+ L+ P KR +A +AL+ YF
Sbjct: 246 PRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 5e-69
Identities = 75/297 (25%), Positives = 124/297 (41%), Gaps = 39/297 (13%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
RA+ +E L IG G+Y + R GKI+ K++ + + + + E+ +LR L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
HPNI++ I R + ++Y+V EY E + + E + M QL
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 244 LEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
L+ CH R VLHRD+K +N+ ++ + +KL DFGLA N + V T +Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYY 180
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
PE + Y D+WS+GC+ EL P ++ E KI + K
Sbjct: 181 MSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---------GK 230
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
++P+ +I +L+++ Y R + L +
Sbjct: 231 FRRIPY-------------------RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 7e-69
Identities = 70/351 (19%), Positives = 129/351 (36%), Gaps = 40/351 (11%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + E +G+G + V R + + K K V+ + V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+ L S + ++FE++ DI ++ + +E +I Y++Q+ L+ H
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 249 SRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
S + H DI+ N++ +K+ +FG A G Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH 177
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
+ D+WS+G + LL G T + + I + ++ +
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS 426
K++ A++ ++ LL E R TAS AL + K
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
Query: 427 SLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEV 477
+ + ++D R+ R G+S +A V+V
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAARISCG---GAIRSQKGVS-VAKVKV 318
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (546), Expect = 1e-66
Identities = 74/317 (23%), Positives = 132/317 (41%), Gaps = 36/317 (11%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ + +G G +S V A D T K+VA+K + E + EI +L ++ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+ L+ + S +YL+ + + ++ + ++E + Q+L +++ H
Sbjct: 68 NIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 249 SRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
G++HRD+K NLL + + + ++DFGL+ + G L++ T Y PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLA 182
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD WS+G + LL G P + + +I K YW
Sbjct: 183 Q-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-------- 233
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 425
D+ +A + I L+ +P KR T AL + +
Sbjct: 234 -----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
Query: 426 SSLPIYPPSKEIDAKHR 442
+ K+ AK +
Sbjct: 277 IHQSVSEQIKKNFAKSK 293
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 211 bits (539), Expect = 5e-66
Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-------VRFMAREILI 182
+ +E E +G+G S V R T K A+K + S +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 183 LRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQL 240
LR++ HPNII+L+ + +LVF+ M+ ++ L+ + SE + + M L
Sbjct: 63 LRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRAL 119
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L + H ++HRD+K N+L++++ +KL DFG + + G + L T Y
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 301 PELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
PE++ + + YG VD+WS G + LL G P R ++ L I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
W D T +L+ L V+P KR TA ALA +
Sbjct: 238 EW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
Query: 416 F 416
F
Sbjct: 273 F 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-65
Identities = 71/312 (22%), Positives = 130/312 (41%), Gaps = 38/312 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRR 185
D ++ E++G G ++ V + R+ TG A K ++ + S + RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+ HPN+I L + ++ + L+ E + +E + ++ Q+L+G+
Sbjct: 70 IQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
+ HS + H D+K N+++ + V +K+ DFGLA+ + G+ + T + P
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAP 185
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
E++ G D+WS+G + LL G G T+ E L + + D+Y+
Sbjct: 186 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---- 240
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+ A + I LL +P KR T +L + K
Sbjct: 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279
Query: 422 ACDLSSLPIYPP 433
LSS +P
Sbjct: 280 QQALSSAWSHPQ 291
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-63
Identities = 55/288 (19%), Positives = 117/288 (40%), Gaps = 33/288 (11%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++IG G++ +V++ + VA+K + P+ ++ E+ +LR+ H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+ G T+ + +V ++ E + L + KF ++ Q G+++ H
Sbjct: 65 NILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGA 307
++ ++HRD+K +N+ ++ + +K+ DFGLA + ++ ++ + PE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 308 TD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y D+++ G V EL+ G+ +Q+ + PD
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD----------- 230
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
L + + P L+ L + +R LAS
Sbjct: 231 ------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 197 bits (502), Expect = 1e-60
Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 31/291 (10%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLD 187
+D +E E +G G S V ARDL + VA+K +R D +P RE L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 188 HPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
HP I+ + + Y+V EY++ + + + + + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPEL 303
H G++HRD+K +N++++ +K+ DFG+A + + + T Y PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
G + D++S+GCV E+L G+P G + V ++ + PP
Sbjct: 186 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------ 238
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
+ L ++ L+ P R +A + ++
Sbjct: 239 -------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 199 bits (506), Expect = 4e-60
Identities = 70/330 (21%), Positives = 133/330 (40%), Gaps = 45/330 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA----REILILRR 185
+ F IG+G + V+ R DTGK+ A+K + + + +A + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
D P I+ + + + + + M FSEA ++ Y +++ GLE
Sbjct: 64 GDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
H H+R V++RD+K +N+L++ G ++++D GLA + ++ + V T Y PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVLQ 178
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y S D +S+GC+ +LL G + ++ H+I ++ + +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP-------- 229
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE-----YFST-- 418
+L+E LL + +R A E +F +
Sbjct: 230 -----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
Query: 419 --KPYACDLSSLPIYPPSKEIDAKHREDAR 446
+ P+ PP E++A D
Sbjct: 273 WQMVFLQKYPP-PLIPPRGEVNAADAFDIG 301
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-59
Identities = 58/291 (19%), Positives = 107/291 (36%), Gaps = 37/291 (12%)
Query: 132 FEKLE-KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN 190
F K + +IG+G++ +V++ D +T VA +++ + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 191 IIKLEGLI--TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
I++ T + I LV E M ++ + Q+L GL+ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 249 SRG--VLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+R ++HRD+K N+ + G +K+ D GLA + + T + PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE 186
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y SVD+++ G E+ + Q+++ G P +
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-SGVKPASFD-------- 235
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
K +IE + +R + L +F
Sbjct: 236 -----------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 194 bits (494), Expect = 7e-59
Identities = 65/321 (20%), Positives = 120/321 (37%), Gaps = 43/321 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPN 190
F+ L +G G++ V R G+ A+K ++ + + V E L+L + HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
II++ G I+++ +Y+E L +F K Y ++ LE+ HS+
Sbjct: 66 IIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
+++RD+K N+L++ G +K+ DFG A + + T Y PE++ Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKP-Y 178
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370
S+D WS G + E+L G ++ KI P + +
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED----------- 227
Query: 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAALASEYFSTKPYACDL 425
+L+ L++ + +R +F + L
Sbjct: 228 ------------------VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE-KL 268
Query: 426 SSLPIYPPSKEIDAKHREDAR 446
S I P + + + D
Sbjct: 269 LSRNIETPYEPPIQQGQGDTS 289
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 9e-58
Identities = 68/284 (23%), Positives = 121/284 (42%), Gaps = 35/284 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLD 187
+ F + +G+G++ VF A T + A+K ++ D + + M + ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
HP + + ++ +++ V EY+ KF ++ Y +++ GL+
Sbjct: 62 HPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS+G+++RD+K N+L++ +G +K+ADFG+ + G + + T Y PE+LLG
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEILLGQ 178
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y SVD WS G + E+LIG+ G+ E E H I P
Sbjct: 179 K-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR------------- 224
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
L A +L+ L EP KR +
Sbjct: 225 ----------------WLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-57
Identities = 69/356 (19%), Positives = 134/356 (37%), Gaps = 49/356 (13%)
Query: 130 DAFEKLEK-IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-D 187
D ++ + +G G V + + T + ALK ++ RE+ + R
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 63
Query: 188 HPNIIKLEGLITSRLSC--SIYLVFEYMEH-DITGLL-SCPDIKFSEAQIKCYMNQLLHG 243
P+I+++ + + + + +V E ++ ++ + D F+E + M +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 244 LEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+++ HS + HRD+K NLL +LKL DFG A + + + + T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYVA 181
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PE+L Y S D+WS+G + LL G P + +
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------- 233
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
++ P S + E K LI LL EP +R T + + +
Sbjct: 234 -------YEFPNPEWSEVSEEVKM-------LIRNLLKTEPTQRMTITEFMNHPWIMQ-- 277
Query: 421 YACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
+ + P++ + K R + ++++ T R + K+ +E
Sbjct: 278 -STKVPQTPLHTSRVLKEDKERWEDVKEEM------TSALATMRVDYEQIKIKKIE 326
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-56
Identities = 64/299 (21%), Positives = 109/299 (36%), Gaps = 49/299 (16%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
PL ++ +G G + SV+ + VA+K V D E + + E++
Sbjct: 1 PL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 59
Query: 182 ILRRLD--HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMN 238
+L+++ +I+L S L+ E E E + +
Sbjct: 60 LLKKVSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
Q+L + HCH+ GVLHRDIK N+L++ N G LKL DFG T T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRV 174
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357
Y PPE + +G S +WS+G + +++ G + E+ + F+
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------- 224
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ + + +LI L++ P R T +
Sbjct: 225 -------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 7e-56
Identities = 75/326 (23%), Positives = 137/326 (42%), Gaps = 45/326 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDH 188
+ F+ L+ +G+GT+ V R+ TG+ A+K +R + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
P + L+ + + V EY + F+E + + Y +++ LE+ H
Sbjct: 65 PFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
SR V++RDIK NL+++ +G +K+ DFGL + + + T Y PE+L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPEVLED-N 180
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
DYG +VD W +G V E++ G+ + I
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------E 220
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAALASEYFSTKPYAC 423
+ + P + L A +L+ LL +P +R + A + +F + +
Sbjct: 221 EIRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ- 270
Query: 424 DLSSLPIYPPSK-----EIDAKHRED 444
D+ + PP K E+D ++ +D
Sbjct: 271 DVVQKKLLPPFKPQVTSEVDTRYFDD 296
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (472), Expect = 2e-55
Identities = 62/316 (19%), Positives = 124/316 (39%), Gaps = 43/316 (13%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILI 182
+ D F++++ +G G++ V + ++G A+K + + + + E I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH 242
L+ ++ P ++KLE ++Y+V EY+ +FSE + Y Q++
Sbjct: 95 LQAVNFPFLVKLEFSFKDN--SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
E+ HS +++RD+K NLL++ +G +++ DFG A + + T PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPE 208
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
++L Y +VD W++G + E+ G P ++ KI P +
Sbjct: 209 IILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD--- 264
Query: 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAALASEYFS 417
+L+ LL V+ KR + ++F+
Sbjct: 265 --------------------------LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 418 TKPYACDLSSLPIYPP 433
T + + + P
Sbjct: 299 TTDWI-AIYQRKVEAP 313
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-55
Identities = 57/293 (19%), Positives = 119/293 (40%), Gaps = 41/293 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + +E++G G + V+ + VA+K ++ + P++ E ++++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFL---AEANLMKQLQHQ 68
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+++L ++T IY++ EYME+ + L + IK + ++ Q+ G+
Sbjct: 69 RLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
R +HRD++ +N+LV++ K+ADFGLA + + PE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 308 TDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
T + D+WS G + E++ G+ G T E + + +
Sbjct: 186 T-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------- 225
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFS 417
++ +P + P L+ P R T + ++F+
Sbjct: 226 GYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-54
Identities = 65/313 (20%), Positives = 116/313 (37%), Gaps = 49/313 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ K+GQG + V+ T + VA+K ++ PE+ +E ++++L H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKLRHE 72
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLL--SCPDIKFSEAQIKCYMNQLLHGLEHC 247
+++L +++ IY+V EYM Q+ Q+ G+ +
Sbjct: 73 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
+HRD++ +N+LV V K+ADFGLA + + PE L
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 308 TDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
+ D+WS G + EL G+ G E L ++ + P
Sbjct: 190 R-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP----------- 237
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFSTKPYACD 424
+ P + +L+ EP +R T A +YF+
Sbjct: 238 -----------------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT------- 273
Query: 425 LSSLPIYPPSKEI 437
S+ P Y P + +
Sbjct: 274 -STEPQYQPGENL 285
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-53
Identities = 71/318 (22%), Positives = 133/318 (41%), Gaps = 40/318 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILR 184
+ FE L+ +G G Y VF R + DTGK+ A+K ++ + ++ E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 185 RLDH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
+ P ++ L + ++L+ +Y+ +F+E +++ Y+ +++
Sbjct: 84 HIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
LEH H G+++RDIK N+L+++ G + L DFGL+ + T+ Y P++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 304 LLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
+ G + + +VD WS+G + ELL G E +I + Y
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----- 256
Query: 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAALASEYFS 417
+++ A +LI+ LL +P KR A +F
Sbjct: 257 --------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
Query: 418 TKPYACDLSSLPIYPPSK 435
+ DL++ + P K
Sbjct: 297 KINWD-DLAAKKVPAPFK 313
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 3e-53
Identities = 51/289 (17%), Positives = 98/289 (33%), Gaps = 36/289 (12%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+ + KIG G++ ++ D+ G+ VA+K P+ + E I + +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
I + +V E + + L + KFS + +Q++ +E+ H
Sbjct: 62 GVGIPTIRWCGAE-GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 249 SRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTG------HRQPLTSRVVTLWYR 299
S+ +HRD+K N L+ ++ + DFGLA + + T Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
LG + DL S+G V +G QG + K ++
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---------- 229
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
++ + + K P+ + S+ + S
Sbjct: 230 -----------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 6e-53
Identities = 68/288 (23%), Positives = 109/288 (37%), Gaps = 39/288 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNF-EPESVRFMAREILILRRLD 187
LEK+G G++ V R VA+K ++ D +PE++ RE+ + LD
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
H N+I+L G++ + + +V E + L F + Y Q+ G+ +
Sbjct: 70 HRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPELL 304
S+ +HRD+ NLL+ ++K+ DFGL N H R V + PE L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 305 LGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
T + + D W G E+ G+ G + LHKI K P
Sbjct: 187 KTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP-------- 237
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+D P N++ + +P R T A
Sbjct: 238 -------------------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 176 bits (447), Expect = 3e-52
Identities = 50/284 (17%), Positives = 93/284 (32%), Gaps = 38/284 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ +IG+G++ +F +L + VA+K + P+ + E + L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTG 62
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
I LV + + + LL KFS + Q+L ++ H +
Sbjct: 63 IPNVYYFGQE-GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 252 VLHRDIKGSNLLVNN-----EGVLKLADFGLANF------SNTGHRQPLTSRVVTLWYRP 300
+++RDIK N L+ ++ + DFG+ F + + T Y
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
LG + DL ++G VF L G QG K ++
Sbjct: 182 INTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----------- 229
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
++ + LRE P + ++
Sbjct: 230 ----------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-52
Identities = 53/292 (18%), Positives = 107/292 (36%), Gaps = 44/292 (15%)
Query: 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILI 182
GW L + L+ IG+G + V G VA+K ++ + + E +
Sbjct: 1 GW-ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIK----NDATAQAFLAEASV 53
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQL 240
+ +L H N+++L G+I +Y+V EYM + L S + + +
Sbjct: 54 MTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+E+ +HRD+ N+LV+ + V K++DFGL +++ + + + +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTA 168
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE L + D+WS G + E+ G+ + + ++ K
Sbjct: 169 PEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 215
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+K P P +++ ++ R +
Sbjct: 216 -------GYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-51
Identities = 62/284 (21%), Positives = 106/284 (37%), Gaps = 37/284 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+++IG G + V L+ VA+K +R E E ++ +L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
+++L G+ I LVFE+MEH ++ L F+ + + G+ +
Sbjct: 61 KLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
V+HRD+ N LV V+K++DFG+ F T + + PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-S 177
Query: 309 DYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y D+WS G + E+ GK + R+ E + I +T
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------------STG 218
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
F+ +P + T ++ P R S L
Sbjct: 219 FRLYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-51
Identities = 55/283 (19%), Positives = 110/283 (38%), Gaps = 37/283 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
L+++G G + V + VA+K ++ + + E ++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKL 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
++L G+ T I+++ EYM + + L +F Q+ + +E+ S+
Sbjct: 62 VQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
LHRD+ N LVN++GV+K++DFGL+ + + + PPE+L+ + +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 311 GPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
D+W+ G + E+ +GK + T E I A +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------------AQGLR 219
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+P ++ + + +R T L+
Sbjct: 220 LYRP---------HLASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 175 bits (444), Expect = 4e-51
Identities = 77/352 (21%), Positives = 139/352 (39%), Gaps = 53/352 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + K+G G +S+V+ A+D+ VA+K VR D E+ EI +L+R++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 192 IKLEGLITSRL-----------SCSIYLVFEYMEHDITGL---LSCPDIKFSEAQIKCYM 237
K + + + + +++V + L +K
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 238 NQLLHGLEHC-HSRGVLHRDIKGSNLLVNNEGV------LKLADFGLANFSNTGHRQPLT 290
QLL GL++ G++H DIK N+L+ +K+AD G A + + + +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHK 344
+R YR PE+LLGA +G D+WS C+ EL+ G + + + + + +
Sbjct: 192 TR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 345 IFKLCGSPPDDYWKKSK----------LPHATLFKPQQPYDSSLRETFK---DLPTTAVN 391
I +L G P + K L P + L E +K D +
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 392 LIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRE 443
+ +L ++P KRA A + + L I P +E+ +
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKD-----TLGMEEIRVPDRELYGSGSD 353
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 6e-51
Identities = 49/282 (17%), Positives = 95/282 (33%), Gaps = 31/282 (10%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
K+G G Y V+ VA+K ++ D E E +E +++ + HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHP 73
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
N+++L G+ T I F + + L C + S + Q+ +E+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+ +HRD+ N LV ++K+ADFGL+ + + PE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
+ D+W+ G + E+ ++ Q++++ +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------------- 238
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+ P L+ P R + +
Sbjct: 239 -------------EGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-50
Identities = 60/288 (20%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRL 186
+ E IG+G + V + + VA+K + + +F+ +E L +R+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQF 65
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
DHP+I+KL G+IT ++++ E ++ L A + Y QL L
Sbjct: 66 DHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ S+ +HRDI N+LV++ +KL DFGL+ + + + + + PE +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 306 GATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
+ + D+W G E+L+ G QG + + +I ++ +P
Sbjct: 183 F-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------GERLPMP- 231
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ P T +L+ + +P +R + A
Sbjct: 232 ------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-50
Identities = 50/290 (17%), Positives = 110/290 (37%), Gaps = 40/290 (13%)
Query: 137 KIGQGTYSSVFRA--RDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
++G G + +V + + K VA+K ++ + +P + E ++++LD+P I+++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
G+ + S LV E E + + I ++Q+ G+++ +H
Sbjct: 74 IGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 255 RDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
RD+ N+L+ + K++DFGL+ ++ + + T + + PE + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSS 189
Query: 313 SVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
D+WS G + E G+ +G E + K ++ P
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------GERMGCP-------- 232
Query: 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AALASEYFST 418
P +L+ + + R + L + Y+
Sbjct: 233 -----------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (432), Expect = 5e-50
Identities = 63/294 (21%), Positives = 117/294 (39%), Gaps = 41/294 (13%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILIL 183
+ + + IG G + V GK VA+K ++ E + F+ E I+
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIM 81
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLH 242
+ DHPN+I LEG++T S + ++ E+ME+ + L D +F+ Q+ + +
Sbjct: 82 GQFDHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV----TLWY 298
G+++ +HRD+ N+LVN+ V K++DFGL+ F P + + + +
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357
PE + + + D+WS G V E++ G+ T + ++ I + PP
Sbjct: 200 TAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM-- 256
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
D P+ L+ + R +
Sbjct: 257 --------------------------DCPSALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-49
Identities = 54/290 (18%), Positives = 112/290 (38%), Gaps = 42/290 (14%)
Query: 137 KIGQGTYSSVFRA--RDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
++G G + SV + R VA+K ++ + ++ M RE I+ +LD+P I++L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 74
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+ + ++ LV E + L + + + ++Q+ G+++ + +
Sbjct: 75 IGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
HRD+ N+L+ N K++DFGL+ ++ + ++ L + PE + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS 190
Query: 312 PSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370
D+WS G E L G+ + E + I + K+ + P
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------GKRMECP------- 234
Query: 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AALASEYFS 417
+ P L+ + R + + Y+S
Sbjct: 235 ------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-48
Identities = 67/310 (21%), Positives = 113/310 (36%), Gaps = 62/310 (20%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKI-----VALKKVRFDNFEPESVRFMAREILILR 184
+ E + +G G + V A K VA+K ++ E M E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMT 95
Query: 185 RL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSE------------ 230
+L H NI+ L G T S IYL+FEY + D+ L KFSE
Sbjct: 96 QLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 231 ----------AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280
+ C+ Q+ G+E + +HRD+ N+LV + V+K+ DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 281 SNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTE 338
+ + + + + + PE L Y D+WS G + E+ +G G
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 398
+K+ + FK QP ++++ +
Sbjct: 273 DANFYKLIQ------------------NGFKMDQP---------FYATEEIYIIMQSCWA 305
Query: 399 VEPYKRATAS 408
+ KR +
Sbjct: 306 FDSRKRPSFP 315
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 4e-48
Identities = 66/310 (21%), Positives = 115/310 (37%), Gaps = 63/310 (20%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILR 184
+ E + IG+G + VF+AR + +VA+K ++ + F RE ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMA 71
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEH------------------------DITGL 220
D+PNI+KL G+ + L+FEYM + +
Sbjct: 72 EFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 221 LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-N 279
S S A+ C Q+ G+ + R +HRD+ N LV V+K+ADFGL+ N
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTE 338
+ + + + + + + PPE + Y D+W+ G V E+ G G
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 398
E ++ + D ++ ++ P NL+ S
Sbjct: 249 EEVIYYVR----------------------------DGNILACPENCPLELYNLMRLCWS 280
Query: 399 VEPYKRATAS 408
P R +
Sbjct: 281 KLPADRPSFC 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-47
Identities = 50/294 (17%), Positives = 105/294 (35%), Gaps = 42/294 (14%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILIL 183
L+ F+K++ +G G + +V++ + G+ V + K + P++ + + E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK---FSEAQIKCYMNQL 240
+D+P++ +L G+ + ++ L+ + M LL + + Q+
Sbjct: 66 ASVDNPHVCRLLGICLTS---TVQLITQLMPFG--CLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYR 299
G+ + R ++HRD+ N+LV +K+ DFGLA ++ + +
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
E +L Y D+WS G EL+ G G E + K
Sbjct: 181 ALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----------- 228
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ QP ++ ++ R +
Sbjct: 229 --------GERLPQP---------PICTIDVYMIMVKCWMIDADSRPKFRELII 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-46
Identities = 66/293 (22%), Positives = 102/293 (34%), Gaps = 33/293 (11%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
E IG+G + V+R + G+ VA+K E F EI L H NI+
Sbjct: 8 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 62
Query: 195 EGLITSRLSC--SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-- 249
++LV +Y EH + L+ + + GL H H
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 250 ------RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRP 300
+ HRD+K N+LV G +AD GLA ++ RV T Y
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 301 PELLLGA-----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
PE+L + + D++++G VF E+ I G E QL + P +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSDPSVE 239
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
+K +P P E + + ++ R TA
Sbjct: 240 EMRKVVCEQ--KLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTAL 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-45
Identities = 54/308 (17%), Positives = 100/308 (32%), Gaps = 57/308 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILR 184
+ + +G G + V A D VA+K ++ E M E+ +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81
Query: 185 RL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH------------------DITGLLSCPD 225
L +H NI+ L G T ++ EY + ++ +
Sbjct: 82 YLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 226 IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285
+ + + Q+ G+ S+ +HRD+ N+L+ + + K+ DFGLA
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 286 RQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLH 343
+ + + PE + Y D+WS G EL +G G + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 403
K+ K + P ++++T +P K
Sbjct: 259 KMIKEGFRMLSP---------------------------EHAPAEMYDIMKTCWDADPLK 291
Query: 404 RATASAAL 411
R T +
Sbjct: 292 RPTFKQIV 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-44
Identities = 57/293 (19%), Positives = 111/293 (37%), Gaps = 38/293 (12%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKKVRFDNFEPESVRFMAREILI 182
+ + + IG G + V++ + VA+K ++ E + V F+ E I
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGI 62
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLL 241
+ + H NII+LEG+I+ + ++ EYME+ D +FS Q+ + +
Sbjct: 63 MGQFSHHNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYR 299
G+++ + +HRD+ N+LVN+ V K++DFGL+ + + + + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE + + D+WS G V E++ ++ K P
Sbjct: 181 APEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP---- 235
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
D P+ L+ E +R + ++
Sbjct: 236 -----------------------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-44
Identities = 55/285 (19%), Positives = 105/285 (36%), Gaps = 39/285 (13%)
Query: 136 EKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
E IG+G + V+ LD A+K + E +F+ E +I++ HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVL 91
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
L G I R S +V YM+H D+ + + + + Q+ G++ S+
Sbjct: 92 SLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+HRD+ N +++ + +K+ADFGLA T + + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-Q 209
Query: 309 DYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
+ D+WS G + EL+ G P + + + ++ P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------GRRLLQP---- 256
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ P ++ + R + S ++
Sbjct: 257 ---------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-43
Identities = 63/304 (20%), Positives = 118/304 (38%), Gaps = 54/304 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRL- 186
+ + + IG+G + V +AR G A+K+++ + + F E+ +L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLG 68
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSE 230
HPNII L G R +YL EY H + + S
Sbjct: 69 HHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290
Q+ + + G+++ + +HRD+ N+LV V K+ADFGL+ ++ T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLC 349
+ + + E L + Y + D+WS G + E++ +G G T E K+ +
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241
Query: 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409
++ ++P + +L+ +PY+R + +
Sbjct: 242 -----------------GYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 410 ALAS 413
L S
Sbjct: 276 ILVS 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-43
Identities = 51/321 (15%), Positives = 113/321 (35%), Gaps = 50/321 (15%)
Query: 110 PAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVR 164
P + SA W + + ++GQG++ V+ + VA+K V
Sbjct: 1 PEYFSAADVYVPDEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 59
Query: 165 FDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC 223
E + F+ E +++ + ++++L G+++ ++ E M D+ L
Sbjct: 60 EAASMRERIEFL-NEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRS 116
Query: 224 PD---------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274
S +++ ++ G+ + ++ +HRD+ N +V + +K+ D
Sbjct: 117 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176
Query: 275 FGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPI 332
FG+ T + + ++ + + PE L + D+WS G V E+ +
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP 235
Query: 333 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 392
QG + + L + + L + + P L
Sbjct: 236 YQGLSNEQVLRFVM----------------------------EGGLLDKPDNCPDMLFEL 267
Query: 393 IETLLSVEPYKRATASAALAS 413
+ P R + ++S
Sbjct: 268 MRMCWQYNPKMRPSFLEIISS 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-42
Identities = 59/306 (19%), Positives = 103/306 (33%), Gaps = 54/306 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGK-------IVALKKVRFDNFEPESVRFMAREILI 182
D + +G+G + V A + K VA+K ++ D E + ++ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDI 226
H NII L G T +Y++ EY P+
Sbjct: 73 KMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286
+ S + Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 287 QPLT-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
T + + + + PE L Y D+WS G + E+ VE+L K+
Sbjct: 191 YKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 405
K + ++ P +R
Sbjct: 250 LKEGHRMDKP---------------------------SNCTNELYMMMRDCWHAVPSQRP 282
Query: 406 TASAAL 411
T +
Sbjct: 283 TFKQLV 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-41
Identities = 53/305 (17%), Positives = 95/305 (31%), Gaps = 52/305 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILR 184
D + + +G+G + V A T + VA+K ++ E M+ +++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD----------------ITGLLSCPDIKF 228
H N++ L G T + ++ E+ +
Sbjct: 73 IGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 229 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288
+ + CY Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 289 LTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIF 346
L + PE + Y D+WS G + E+ G E+ +
Sbjct: 192 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
K + EP +R T
Sbjct: 251 KEGTRMRAP---------------------------DYTTPEMYQTMLDCWHGEPSQRPT 283
Query: 407 ASAAL 411
S +
Sbjct: 284 FSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 107 bits (269), Expect = 5e-28
Identities = 29/204 (14%), Positives = 67/204 (32%), Gaps = 42/204 (20%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDN----------------FEPESVRFMARE 179
+ +G+G S+VF +K + + F ++R E
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 180 ILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
L++L + K+ + ++ E ++ + ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN------AVLMELIDAKELY-------RVRVENPDEVLDM 111
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR---VVTL 296
+L + + RG++H D+ N+LV+ EG+ + DF + + + R +
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 297 WYRPPELLLGATDYGPSVDLWSVG 320
++ Y D+ S
Sbjct: 171 YFS--------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 478 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.01 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.62 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.53 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.83 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-61 Score=471.49 Aligned_cols=293 Identities=40% Similarity=0.674 Sum_probs=246.3
Q ss_pred eeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP---ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 133 ~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+.+++||+|+||+||+|++..+|+.||||+++...... ...+.+.+|+.+|+.++|||||++++++.. .+++|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~iv 78 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLV 78 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeeh
Confidence 35789999999999999999999999999997654321 123467899999999999999999999987 6779999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||+.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-ccc
Confidence 9999998888888878889999999999999999999999999999999999999999999999999998665433 233
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC-Ccccc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP-HATLF 368 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~~~~~ 368 (478)
...++|+.|+|||++.+...|+.++|||||||++|||++|.+||.+.++.+++.+|.+.++.++...|...... ....+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 45678999999999887677899999999999999999999999999999999999999999998877553221 11111
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCCCCCCCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPI 430 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~~~~~p~ 430 (478)
. ......+...++.+++++++||.+||++||++|||+.|+|+||||++.|.+++...+|.
T Consensus 238 ~--~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 238 K--SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp C--CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred c--cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence 1 11123355666788999999999999999999999999999999999998887776653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-61 Score=461.20 Aligned_cols=261 Identities=27% Similarity=0.384 Sum_probs=218.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|+++.+++.||||+++.... .+..+.+.+|+.+|++++|||||++++++.+ ...+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEE
Confidence 5789999999999999999999999999999999986543 2334567899999999999999999999988 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC-CC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 287 (478)
||||++++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...... ..
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999987776666677789999999999999999999999999999999999999999999999999998764332 22
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
.....+||+.|+|||++.+...++.++|||||||+||||++|++||....+..............
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------------- 225 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 225 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence 34567899999999999874455788999999999999999999998766544433333211111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...+..+++++++||.+||+.||++|||++|+|+||||++
T Consensus 226 -----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -----------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0112468899999999999999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=457.41 Aligned_cols=255 Identities=32% Similarity=0.483 Sum_probs=222.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++.||+|+||+||+|+++.+++.||+|++...... ....+.+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEE
Confidence 57899999999999999999999999999999999754321 2334567889999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
|||||++++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 99999998777666666668999999999999999999999999999999999999999999999999999765542
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.++...-...
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------- 223 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--------------- 223 (263)
T ss_dssp CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC---------------
T ss_pred cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 2345688999999999987 678999999999999999999999999998888877765421111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.+.+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 224 --------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 224 --------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred --------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 1257899999999999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-59 Score=456.37 Aligned_cols=291 Identities=39% Similarity=0.680 Sum_probs=241.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.|+|++++.||+|+||+||+|++..+++.||||+++.+.......+.+.+|+++|++++|||||+++++|.+ ...+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~i 78 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYL 78 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeE
Confidence 368999999999999999999999999999999997665444455778899999999999999999999988 678999
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||+.++++..+. .....+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...... .
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 99999987766553 445679999999999999999999999999999999999999999999999999998765432 3
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......+|+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+++.++....+.+.+..|..........
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 34556889999999998876677899999999999999999999999999999999999999998877776532211111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
..........+...+..+++++++||.+||..||++|||+.|+|+||||++.+.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1111112223444556889999999999999999999999999999999876554
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-59 Score=454.19 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=222.8
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|+++++||+|+||+||+|++..+|+.||||+++..... ..+.+.+|+.+|+.++|||||+++++|.+ ...+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEE
Confidence 4799999999999999999999999999999999865432 24668899999999999999999999988 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||++++.+..+... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+...... ...
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 999998777666543 369999999999999999999999999999999999999999999999999998765432 334
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+..... ++..
T Consensus 174 ~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~-------------- 237 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQ-------------- 237 (293)
T ss_dssp CCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCS--------------
T ss_pred cccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCC--------------
Confidence 56689999999999987 6789999999999999999999999999988888777665321 1110
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
....+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 238 -----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 238 -----------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -----------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -----------CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 11367899999999999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-58 Score=460.97 Aligned_cols=268 Identities=25% Similarity=0.384 Sum_probs=231.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+|++|+|||||+++++|.+ ...+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 568999999999999999999999999999999997543 4455778899999999999999999999988 678999
Q ss_pred EEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec--CCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~--~~~vkl~DFG~a~~~~~~~ 285 (478)
|||||+++.+ ..+......+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+.....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999998655 445456668999999999999999999999999999999999999964 578999999999876543
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+|+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.+|......++..
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 247 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS---------- 247 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG----------
T ss_pred -cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc----------
Confidence 33455788999999999987 678999999999999999999999999999999988887654333322
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCCCCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL 428 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~~~~~ 428 (478)
.+..+++++++||.+||+.||.+|||+.|+|+||||+....+.....+
T Consensus 248 ---------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~ 295 (350)
T d1koaa2 248 ---------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295 (350)
T ss_dssp ---------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCB
T ss_pred ---------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhC
Confidence 224689999999999999999999999999999999987665544433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-60 Score=456.80 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=223.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++.||+|+||+||+|+++.+++.||||++..... .....+.+.+|+++|++++|||||+++++|.+ ...+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEE
Confidence 4689999999999999999999999999999999975432 22345678899999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC-C
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-R 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 286 (478)
|||||++++.+..+......+++..++.++.||+.||+|||++|||||||||+||||++++.+||+|||+|+...... .
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999987776666666689999999999999999999999999999999999999999999999999998765332 2
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|...-...
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 229 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-------------- 229 (288)
T ss_dssp -----CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC--------------
T ss_pred cccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence 33445689999999999987 678999999999999999999999999999888888775421111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHH------HHhCcccCCCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA------ALASEYFSTKPYAC 423 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e------~L~hp~f~~~~~~~ 423 (478)
...+++++++||.+||+.||.+|||++| +++||||++..|..
T Consensus 230 ---------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 230 ---------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp ---------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred ---------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 1257899999999999999999999987 58899998876643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-59 Score=450.39 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=212.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+++|++++|||||++++++.+.....+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 57899999999999999999999999999999999887777777788899999999999999999999997765677999
Q ss_pred EEeeccCCchhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 209 VFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 209 v~e~~~~~ll~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
|||||+++.+..+.. ....+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999876655432 3457999999999999999999999876 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
...... ......++|+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+...++...- .+
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~--~~------ 232 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR------ 232 (269)
T ss_dssp HC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CC------
T ss_pred ecccCC-CccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC------
Confidence 765432 23345788999999999876 678999999999999999999999999998888877775521 10
Q ss_pred CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCccc
Q 011763 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f 416 (478)
.....+++++.+||.+||+.||.+|||+.|+|+|||+
T Consensus 233 --------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 --------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0113578899999999999999999999999999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=450.41 Aligned_cols=265 Identities=25% Similarity=0.375 Sum_probs=226.5
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE----PESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+.+|+.+|++|+|||||+++++|.+ ..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CC
Confidence 35799999999999999999999999999999999765432 2235678899999999999999999999987 67
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC----cEEEeecccccc
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANF 280 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~DFG~a~~ 280 (478)
.+|||||||+++.+..+......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 8999999999877766665566899999999999999999999999999999999999998876 599999999987
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
..... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+.++......++..
T Consensus 167 ~~~~~--~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----- 238 (293)
T d1jksa_ 167 IDFGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE----- 238 (293)
T ss_dssp CTTSC--BCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH-----
T ss_pred cCCCc--cccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch-----
Confidence 65432 3345678999999999986 678999999999999999999999999999998888876543332222
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
.++.+++++++||.+||+.||.+|||++|+|+||||+...+..
T Consensus 239 --------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 281 (293)
T d1jksa_ 239 --------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281 (293)
T ss_dssp --------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred --------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence 2357899999999999999999999999999999998755433
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=457.25 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=228.3
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
..++|++++.||+|+||+||+|+++.+++.||||++++... .....+.+.+|+.+|+.++|||||+++++|.+ ...+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 80 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--cccc
Confidence 36799999999999999999999999999999999976432 22345667899999999999999999999988 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
||||||++++.+..+......+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 9999999998887777777789999999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+.......
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~-------------- 224 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-------------- 224 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC--------------
Confidence 33456789999999999987 678999999999999999999999999999888887776532111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
...+++++++||.+||++||.+|+ ++.|+|+||||++..|
T Consensus 225 ---------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 225 ---------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 135789999999999999999999 4999999999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-58 Score=441.49 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=216.8
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec--CCceEEEE
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCSIYLV 209 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~~~lv 209 (478)
|++.++||+|+||+||+|++..+++.||+|++..........+.+.+|+++|++++|||||++++++... ....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4677899999999999999999999999999987776777778889999999999999999999998653 24568999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEe-cCCcEEEeecccccccCCCCC
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|||++++.+..+......+++..++.++.||+.||+|||+++ |+||||||+||||+ +++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---
Confidence 999999877776666668999999999999999999999998 99999999999997 478999999999986543
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+......+.+.+.. +..+..+
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~~~---------- 234 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASF---------- 234 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGGG----------
T ss_pred CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCccc----------
Confidence 23356789999999998865 5899999999999999999999999877665554443321 1111111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
....++++.+||.+||+.||++|||+.|+|+||||+
T Consensus 235 ---------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 235 ---------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 135788899999999999999999999999999995
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-58 Score=447.32 Aligned_cols=285 Identities=37% Similarity=0.668 Sum_probs=239.2
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|+++++||+|+||+||+|+++ +++.||||+++.........+.+.+|+.+|++++|||||+++++|.. ....|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeEE
Confidence 68999999999999999999985 78999999998765444446778899999999999999999999987 6779999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
|||+.++++..+......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-ccc
Confidence 9999999998888888899999999999999999999999999999999999999999999999999997665332 223
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccC
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 369 (478)
....+++.|+|||++.+...++.++|||||||++|||++|++||.+.++.+++.++...++.++...|............
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 44567999999999987677899999999999999999999999999999999999999999988777543211111111
Q ss_pred CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 370 ~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...............+++++.+||++||++||++|||+.|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1111112233445678999999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-59 Score=454.21 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=207.4
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.+.|++++.||+|+||+||+|+++.+++.||||++...... .....+.+|+.+|+.++|||||++++++.+ ...+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 35799999999999999999999999999999999866543 223557789999999999999999999987 678999
Q ss_pred EEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe---cCCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~vkl~DFG~a~~~~~~~ 285 (478)
|||||+++.+..+......+++..++.++.||+.||.|||++||+||||||+|||+. +++.+||+|||+|+.....
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 999999876666555667899999999999999999999999999999999999995 4789999999999866543
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+....+......++..
T Consensus 164 -~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 231 (307)
T d1a06a_ 164 -SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP---------- 231 (307)
T ss_dssp ----------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT----------
T ss_pred -CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc----------
Confidence 23345689999999999987 679999999999999999999999999998888887776532222211
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.++.+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 232 ---------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 232 ---------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ---------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ---------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 12468999999999999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-58 Score=453.10 Aligned_cols=254 Identities=29% Similarity=0.472 Sum_probs=223.1
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.|++++.||+|+||+||+|++..+++.||||+++..... ....+.+.+|+.+|++|+|||||++++++.+ ...+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEEE
Confidence 599999999999999999999999999999999876543 4455678899999999999999999999987 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
||||.++++..+.....++++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|..... .
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----B
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----C
Confidence 99999988877666667899999999999999999999999999999999999999999999999999976543 2
Q ss_pred cccccCCcccCcccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 290 TSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
...+||+.|+|||++.+ ...|+.++|||||||++|||++|++||.+.+..+.+.++......+..
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------- 235 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ------------- 235 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-------------
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC-------------
Confidence 45679999999999864 246899999999999999999999999999888888777653211100
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
...+++++++||.+||+.||.+|||+.|+|+||||..
T Consensus 236 --------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 236 --------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 1357889999999999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-59 Score=450.40 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=220.2
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
+.|++++.||+|+||+||+|++..+++.||||+++... ....+.+.+|+++|++++|||||++++++.+ ...+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEE
Confidence 46999999999999999999999999999999997653 3445677899999999999999999999988 6789999
Q ss_pred EeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCC
Q 011763 210 FEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (478)
Q Consensus 210 ~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 288 (478)
|||++++.+..+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999998776655 4445679999999999999999999999999999999999999999999999999997543211 12
Q ss_pred ccccccCCcccCcccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 289 LTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 289 ~~~~~~t~~y~APE~l~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.....||+.|+|||++.. ...|+.++|||||||+||||++|++||.+.+..+.+.++.... ++.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~~---------- 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PPT---------- 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CCC----------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCC----------
Confidence 235678999999999842 3568999999999999999999999999998888887776521 110
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
......+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 235 --------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 235 --------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0111367899999999999999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-59 Score=461.76 Aligned_cols=285 Identities=24% Similarity=0.331 Sum_probs=216.6
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|+++++||+|+||+||+|++..+|+.||+|+++.+. .......+.+|+.+|+.++|||||+++++|.+ ...+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 79 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEI 79 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEE
Confidence 45789999999999999999999999999999999998654 34555778899999999999999999999987 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
||||||++++.+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+|+.....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999987777666666689999999999999999999997 59999999999999999999999999999865432
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHcCCCCchhhcc----C
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWKK----S 360 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~----~ 360 (478)
...+.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+. ...+....+.+....... .
T Consensus 159 --~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2345689999999999987 7799999999999999999999999987664432 222222222221110000 0
Q ss_pred CCCCc-cccCCCCCCCccchh---------cccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 361 KLPHA-TLFKPQQPYDSSLRE---------TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 361 ~~~~~-~~~~~~~~~~~~l~~---------~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..... ....+.......+.. ....++.++++||.+||.+||.+|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00000 000000000000000 00235788999999999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.6e-58 Score=456.29 Aligned_cols=259 Identities=27% Similarity=0.458 Sum_probs=227.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++..+|+.||||+++... ......+.+|+.+|++|+|||||+++++|.+ ...+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 467999999999999999999999999999999997653 3445677899999999999999999999987 678999
Q ss_pred EEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe--cCCcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~--~~~~vkl~DFG~a~~~~~~~ 285 (478)
|||||+++.+ ..+.....++++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|......
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999998665 44555566799999999999999999999999999999999999998 5689999999999877643
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+|+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.++......++...
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 251 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA--------- 251 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST---------
T ss_pred -CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc---------
Confidence 33455678999999999886 7799999999999999999999999999999999888877544333222
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
+..+++++++||.+||++||.+|||+.|+|+||||+..
T Consensus 252 ----------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 252 ----------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ----------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 24689999999999999999999999999999999863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-58 Score=450.68 Aligned_cols=258 Identities=23% Similarity=0.389 Sum_probs=227.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
+++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeee
Confidence 5689999999999999999999999999999999975432 12335678899999999999999999999987 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
+||||+.++.+..+......+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999999888877777778999999999999999999999999999999999999999999999999999876532
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
....+||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+.+.++...-...|
T Consensus 158 -~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p-------------- 221 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP-------------- 221 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred -cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC--------------
Confidence 345789999999999876 6789999999999999999999999999999888888866321111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~~ 422 (478)
+.+++++++||.+||..||.+|+ |++++|+||||++..|.
T Consensus 222 ---------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 222 ---------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ---------------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 35788999999999999999996 99999999999986543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-57 Score=447.05 Aligned_cols=295 Identities=42% Similarity=0.701 Sum_probs=239.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC------
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL------ 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 202 (478)
.++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 57999999999999999999999999999999999876655555667889999999999999999999885422
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...+|+||||+.++++.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999999888888878889999999999999999999999999999999999999999999999999997654
Q ss_pred CCC---CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 283 TGH---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 283 ~~~---~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
... .......++|+.|+|||++.+...|+.++|||||||++|||++|++||.+.++.+.+..+...++.++...+..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 322 12334457899999999998767899999999999999999999999999999999999999999998877655
Q ss_pred CCCCC-ccccCCCCCCCccchhccc--CCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCC
Q 011763 360 SKLPH-ATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (478)
Q Consensus 360 ~~~~~-~~~~~~~~~~~~~l~~~~~--~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~ 423 (478)
..... .............+...+. ..+++++|||.+||++||++|||+.|+|+||||++.|.|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 33211 1111111111122222221 3467889999999999999999999999999999876654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-57 Score=442.44 Aligned_cols=286 Identities=40% Similarity=0.677 Sum_probs=236.3
Q ss_pred ccceeeeeeeeecCceEEEEEEECCC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCeeeecceeeec---
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDT-GKIVALKKVRFDNFEPESVRFMAREILILRRL---DHPNIIKLEGLITSR--- 201 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~-~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~--- 201 (478)
.++|++++.||+|+||+||+|++..+ ++.||||+++.+.........+.+|+.+|+.| +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999765 67899999976554433334455788777766 799999999998532
Q ss_pred CCceEEEEEeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 202 LSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
....+|++|||+.++++... ......+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 24578999999998766543 44556799999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... .......||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++.+++..++.++...|...
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hccc--ccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 5432 33456788999999999987 78999999999999999999999999999999999999999999988887654
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.......+... ....+......+++.+++||.+||++||++|||+.|+|+||||++.
T Consensus 243 ~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 243 VALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhccc--cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 33222222111 1223344556889999999999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-57 Score=453.69 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=226.2
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
..++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.+|+.++|||||++++++.+ ...+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 116 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--cccc
Confidence 36899999999999999999999999999999999975432 22334667899999999999999999999987 6789
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (478)
|+||||+.++.+.........+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999998777666666668999999999999999999999999999999999999999999999999999876532
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
.....||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+....+.++......+|
T Consensus 195 --~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p------------- 258 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP------------- 258 (350)
T ss_dssp --BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred --cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC-------------
Confidence 245688999999999987 7789999999999999999999999999998888888866322111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
..+++++.+||.+||..||.+|+ |++++|+||||+...|
T Consensus 259 ----------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 259 ----------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp ----------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred ----------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 35789999999999999999995 9999999999987654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-57 Score=448.72 Aligned_cols=296 Identities=33% Similarity=0.562 Sum_probs=237.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC----Cc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 204 (478)
.++|+++++||+|+||+||+|++..+|+.||||+++.........+.+.+|+.+|+.++|||||+++++|.... ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999999999999999999877666677788899999999999999999999997532 23
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
.+||||||++..+..... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 97 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~- 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC-
Confidence 579999999655444433 23699999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
..+...+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++..+|.......
T Consensus 174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 174 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 23557889999999999876778999999999999999999999999999999999999999999988876544321
Q ss_pred ccccC--CCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCCCCCCCCCC
Q 011763 365 ATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPI 430 (478)
Q Consensus 365 ~~~~~--~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~~~~~~~p~ 430 (478)
..... ........+...+..+++++++||.+||.+||.+|||+.|+|+||||++...+.+....+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~ 318 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK 318 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCC
Confidence 11000 0111122344455678999999999999999999999999999999987654444333333
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.5e-57 Score=433.12 Aligned_cols=261 Identities=30% Similarity=0.421 Sum_probs=224.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC-------hHHHHHHHHHHHHHHhcC-CCCeeeecceeee
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-------PESVRFMAREILILRRLD-HPNIIKLEGLITS 200 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 200 (478)
.++|++++.||+|+||+||+|++..+++.||||+++..... ....+.+.+|+.+|++|+ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999999999999999999875432 122345778999999996 9999999999987
Q ss_pred cCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccc
Q 011763 201 RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (478)
Q Consensus 201 ~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~ 280 (478)
...+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 788999999999866665555566899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCccccccCCcccCcccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCch
Q 011763 281 SNTGHRQPLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (478)
Q Consensus 281 ~~~~~~~~~~~~~~t~~y~APE~l~~-----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~ 355 (478)
..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+......++.
T Consensus 160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~- 236 (277)
T d1phka_ 160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS- 236 (277)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC-
Confidence 66532 3355688999999999852 345789999999999999999999999999988888887764322221
Q ss_pred hhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
..+..+++++++||.+||+.||++|||+.|+|+||||++
T Consensus 237 ------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 237 ------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 112468999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-57 Score=442.81 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=224.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|+++.+++.||||+++... .....+.+|+.+|+.++|||||+++++|.+ ...+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 468999999999999999999999999999999997653 334567799999999999999999999988 678999
Q ss_pred EEeeccCCchhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC--CcEEEeecccccccCCCC
Q 011763 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGH 285 (478)
Q Consensus 209 v~e~~~~~ll~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~--~~vkl~DFG~a~~~~~~~ 285 (478)
|||||+++.+..+. .....+++.+++.|+.||+.||.|||++||+||||||+||||+.+ ..+||+|||+++.....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 99999986555444 444579999999999999999999999999999999999999854 48999999999876543
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
.......+|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.+|......++...
T Consensus 158 -~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 226 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA--------- 226 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH---------
T ss_pred -CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh---------
Confidence 22345678999999998876 6789999999999999999999999999999999999887554444333
Q ss_pred cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
++.+++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 227 ----------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 227 ----------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 35789999999999999999999999999999999764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=445.68 Aligned_cols=281 Identities=36% Similarity=0.567 Sum_probs=234.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec----CCceE
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSCSI 206 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----~~~~~ 206 (478)
+|+.+++||+|+||+||+|++..+++.||||++..+... ..+|+.+|++++||||++++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999999999999999999765422 23699999999999999999998542 24568
Q ss_pred EEEEeeccCCchhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-cEEEeecccccccC
Q 011763 207 YLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSN 282 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~ 282 (478)
||||||+++++...+. .....+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999999987655443 3556799999999999999999999999999999999999999775 89999999998765
Q ss_pred CCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
.. ......++|+.|+|||++.+...|+.++|||||||++|||++|++||...+..+++.+++..+|.++.+.|.....
T Consensus 175 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 43 3345568899999999988767899999999999999999999999999999999999999999999888765432
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.......+............+.+++++.+||.+||.+||++|||+.|+|+||||++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 222222222111222223345789999999999999999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-56 Score=430.80 Aligned_cols=286 Identities=40% Similarity=0.691 Sum_probs=243.6
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++++.||+|+||+||+|++..+++.||||+++.+.........+.+|+.+|+.++||||+++++++.+ ....++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEE
Confidence 58999999999999999999999999999999998777666677888999999999999999999999988 6789999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCCCc
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (478)
++++.++++..+......+++..++.++.|++.||+|||++|||||||||+||||+.++.+||+|||.++...... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~ 158 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-ccc
Confidence 9999998888887778889999999999999999999999999999999999999999999999999998765432 233
Q ss_pred cccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHcCCCCchhhccCCCCCcccc
Q 011763 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (478)
Q Consensus 290 ~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 368 (478)
....+++.|+|||++.+...++.++|||||||++|||++|+.| |.+.+..+++.++....+.++...|...........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 4456688999999988766789999999999999999998866 677788888999999999888777654321111111
Q ss_pred CCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCC
Q 011763 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (478)
Q Consensus 369 ~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~ 418 (478)
.+.......+......+++.+.+||++||++||.+||||+|+|+||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 11222233344455678999999999999999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.8e-57 Score=449.50 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=216.1
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHH---HHHHHHHhcCCCCeeeecceeeecCC
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMA---REILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~-~~~~~~~---~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
..++|++++.||+|+||+||+|++..+|+.||||++....... .....+. +|+.+++.++|||||+++++|.+ .
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--P 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--S
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--C
Confidence 3679999999999999999999999999999999997543211 1112233 35677777789999999999987 6
Q ss_pred ceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..+||||||++++.+..+......+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 78999999999877776666667899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 284 ~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
. .....+||+.|+|||++.....|+.++|||||||+||||++|++||.+.+..+.... .......+.
T Consensus 160 ~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-~~~~~~~~~--------- 226 (364)
T d1omwa3 160 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMAV--------- 226 (364)
T ss_dssp S---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-HHHSSSCCC---------
T ss_pred C---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcccCCC---------
Confidence 3 234568999999999997656799999999999999999999999987654433322 221111111
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccC-----HHHHHhCcccCCCCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~t-----a~e~L~hp~f~~~~~ 421 (478)
.....+++++++||.+||..||.+||| |+|+|+||||+...|
T Consensus 227 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 227 ----------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp ----------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred ----------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 111368899999999999999999999 899999999987654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=438.92 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=222.2
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHH-hcCCCCeeeecceeeecCCceEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILR-RLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
++|++++.||+|+||+||+|+++.+++.||||+++++.. .....+.+..|+.++. .++|||||++++++.+ ...+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence 689999999999999999999999999999999975432 1223445566777665 6899999999999988 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
|||||++++.+..+......+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 999999998777777677789999999999999999999999999999999999999999999999999998654332 3
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 367 (478)
......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+.++... .+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~-------------- 221 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPF-------------- 221 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC--------------
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC--------------
Confidence 3455688999999999987 67999999999999999999999999999988888777542 111
Q ss_pred cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHH-HHHhCcccCCCCC
Q 011763 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASEYFSTKPY 421 (478)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~-e~L~hp~f~~~~~ 421 (478)
..+.+++++++||.+||+.||.+|||+. ++++||||++..|
T Consensus 222 -------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 222 -------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp -------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred -------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 0135789999999999999999999995 8999999987543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=444.30 Aligned_cols=287 Identities=30% Similarity=0.516 Sum_probs=229.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec----CCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----~~~ 204 (478)
.++|+++++||+|+||+||+|++..+|+.||||+++...........+.+|+.+|++++|||||+++++|... ...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3589999999999999999999999999999999988776777777889999999999999999999999643 246
Q ss_pred eEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
++|+||||+.++++..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 899999999998887664 35899999999999999999999999999999999999999999999999998766543
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
......++|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+...+..+++..++.++.++|.......
T Consensus 173 --~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 173 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp ----------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred --cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 23355678999999999987 688999999999999999999999999999999999999999999888876532110
Q ss_pred ccccCCCCCC-------------CccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 365 ATLFKPQQPY-------------DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~~~~~-------------~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
.......... ..........+++++++||++||.+||++||||+|+|+||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 0000000000 00001111235678999999999999999999999999999997544
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=432.63 Aligned_cols=289 Identities=32% Similarity=0.502 Sum_probs=233.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC---Cce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~ 205 (478)
.++|+++++||+|+||+||+|++..+|+.||||+++....+....+.+.+|+.+|+.|+|||||++++++.... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999999999999999999877666677778889999999999999999999886421 222
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
.+++|+|+.++.+..+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 3444555666555555443 3699999999999999999999999999999999999999999999999999975542
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCc
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 365 (478)
......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.++.+.+........
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 334567899999999988767789999999999999999999999999999999999999999988776644322111
Q ss_pred cc--cCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 366 TL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 366 ~~--~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
.. ..........+...+..+++++++||.+||+.||.+|||+.|+|+||||++...+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 10 0111112233445567889999999999999999999999999999999875443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=423.29 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=208.4
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcC--CCCeeeecceeeecCC
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLD--HPNIIKLEGLITSRLS 203 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~ 203 (478)
++|++.+.||+|+||+||+|++..+++.||||+++...... .....+.+|+.+|++++ |||||++++++.+ .
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--P 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--S
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--C
Confidence 47999999999999999999999999999999998654321 11233567999999996 8999999999987 6
Q ss_pred ceEEEEEeeccC-CchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC-CcEEEeeccccccc
Q 011763 204 CSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFS 281 (478)
Q Consensus 204 ~~~~lv~e~~~~-~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~~~ 281 (478)
..+|+||||+.+ +++..+......+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 789999999976 4555555555689999999999999999999999999999999999999955 79999999999865
Q ss_pred CCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 282 ~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|+.||...+ .+.... .
T Consensus 162 ~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~--~--------- 221 (273)
T d1xwsa_ 162 KD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ--V--------- 221 (273)
T ss_dssp CS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC--C---------
T ss_pred cc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc--c---------
Confidence 43 234567899999999999865556788999999999999999999998632 222210 0
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
.....+|+++++||.+||..||++|||++|+|+||||++.
T Consensus 222 ------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 222 ------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0013578999999999999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.2e-54 Score=422.93 Aligned_cols=283 Identities=30% Similarity=0.512 Sum_probs=225.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|+++++||+|+||+||+|++..+++.||||+++... .+.+.+|+.+|+.+ .||||++++++|.......+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 568999999999999999999999999999999996432 35678899999999 499999999999876667899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCC-cEEEeecccccccCCCCC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHR 286 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~~ 286 (478)
+||||+.++.+..+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+......
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 999999987766553 3699999999999999999999999999999999999999765 69999999998765432
Q ss_pred CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCchhhc-cCCCCC
Q 011763 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWK-KSKLPH 364 (478)
Q Consensus 287 ~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~-~~~~~~ 364 (478)
.....++|+.|+|||++.+...++.++|||||||++|+|++|+.||... +..++...+...++.+....|. ......
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 3355678999999999887677899999999999999999999998654 5566777777777765433221 111111
Q ss_pred ccccCC------CCCCCcc-chhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCC
Q 011763 365 ATLFKP------QQPYDSS-LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (478)
Q Consensus 365 ~~~~~~------~~~~~~~-l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~ 421 (478)
...+.. ....... .......+++++++||++||++||.+|||++|+|+||||++..+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 111100 0000011 11122457889999999999999999999999999999987543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-54 Score=426.75 Aligned_cols=290 Identities=34% Similarity=0.540 Sum_probs=231.4
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC---CceE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSI 206 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~~ 206 (478)
++|+++++||+|+||+||+|++..+|+.||||+++... .....+.+.+|+.+|+.|+||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 57999999999999999999999999999999997544 3455667889999999999999999999986532 2346
Q ss_pred EEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC-
Q 011763 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH- 285 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~- 285 (478)
||++++++++|...+.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 77766665555555433 369999999999999999999999999999999999999999999999999997654322
Q ss_pred -CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 -RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 -~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.......++|+.|+|||++.....++.++||||+||++|+|++|++||.+.+..++...+...+..+............
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 1233556789999999998776778999999999999999999999999999999999998888888765443221110
Q ss_pred c--cccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCCCCC
Q 011763 365 A--TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (478)
Q Consensus 365 ~--~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~~~~ 422 (478)
. ............+...++.+++++++||.+||++||.+|||+.|+|+||||+....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 0 001111122223445567889999999999999999999999999999999876443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=432.28 Aligned_cols=260 Identities=23% Similarity=0.328 Sum_probs=207.4
Q ss_pred ccceeeee-eeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeee--cCCc
Q 011763 129 ADAFEKLE-KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS--RLSC 204 (478)
Q Consensus 129 ~~~y~~~~-~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~--~~~~ 204 (478)
.++|+++. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 56899986 599999999999999999999999999632 3466899987655 89999999999865 2346
Q ss_pred eEEEEEeeccCCchhh-ccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec---CCcEEEeeccccc
Q 011763 205 SIYLVFEYMEHDITGL-LSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLAN 279 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~-~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~ 279 (478)
++|||||||+++.+.. +... ...|++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 7899999999765544 4333 357999999999999999999999999999999999999986 4679999999998
Q ss_pred ccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhcc
Q 011763 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (478)
Q Consensus 280 ~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 359 (478)
...... .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+....+.........
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~----- 234 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY----- 234 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-----
T ss_pred eccCCC--ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-----
Confidence 765432 3355689999999999876 67999999999999999999999999887765555444332111000
Q ss_pred CCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccCCC
Q 011763 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (478)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~~~ 419 (478)
......+..+++++++||.+||+.||++|||+.|+|+||||.+.
T Consensus 235 ----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 235 ----------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ----------------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ----------------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 00011234688999999999999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=415.98 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=210.9
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.+ ..+
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~ 78 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQL 78 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEE
Confidence 34578999999999999999999853 359999998777677778889999999999999999999998754 357
Q ss_pred EEEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 207 YLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 207 ~lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
||||||++++.+.. +......+++..+..++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999765544 44556679999999999999999999999999999999999999999999999999997664322
Q ss_pred -CCCccccccCCcccCcccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCC
Q 011763 286 -RQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (478)
Q Consensus 286 -~~~~~~~~~t~~y~APE~l~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 362 (478)
........+|+.|+|||++.+. ..|+.++|||||||+||||++|+.||.+.+....+..+......+|
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p--------- 229 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP--------- 229 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---------
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---------
Confidence 2233456789999999998642 3589999999999999999999999999887776666554322222
Q ss_pred CCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.+......+++++.+||.+||+.||.+|||+.|++++
T Consensus 230 --------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 --------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1122234688999999999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-54 Score=416.58 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=215.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC--Cce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRL--SCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~ 205 (478)
.++|++.+.||+|+||+||+|++..+++.||||+++.+.. +......+.+|+.+|+.++|||||++++++.... ...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4579999999999999999999999999999999987654 3555677889999999999999999999987643 245
Q ss_pred EEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
+||||||++++.+.........+++..++.++.||+.||+|||++|||||||||+||||+.++.++|+|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999988777666666689999999999999999999999999999999999999999999999999987543221
Q ss_pred --CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 286 --RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 286 --~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.++......++.
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 235 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------- 235 (277)
T ss_dssp -------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG---------
T ss_pred ccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc---------
Confidence 223445678999999999876 67899999999999999999999999999988888877664322221
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhCcccC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~hp~f~ 417 (478)
...+.+|+++.+||.+||+.||.+||+..+.|.|+|++
T Consensus 236 ----------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 236 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 12257899999999999999999999655556677753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-54 Score=414.80 Aligned_cols=253 Identities=19% Similarity=0.311 Sum_probs=208.3
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||+||+|++..+++.||||+++.+.. ..+.+.+|+.+|++++|||||++++++.+ ...+
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 88 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPF 88 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSC
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEee--CCee
Confidence 346789999999999999999999999999999999976543 34568899999999999999999999987 5678
Q ss_pred EEEEeeccCCchhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 207 YLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
||||||++++.+..+. .....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999986554443 34567999999999999999999999999999999999999999999999999999876654
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.........+|+.|+|||++.+ ..|+.++|||||||++|||++|..||........+.+++..-..+
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~------------ 235 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------------ 235 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC------------
T ss_pred CceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC------------
Confidence 4333344557899999999886 678999999999999999999665554444444444433321111
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.....+++++.+||.+||+.||.+|||+.|+++
T Consensus 236 ---------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 ---------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 011367899999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-54 Score=411.59 Aligned_cols=255 Identities=21% Similarity=0.357 Sum_probs=212.2
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEE
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 207 (478)
..++|++.+.||+|+||+||+|++. +++.||||+++..... .+.+.+|+.+|++++|||||++++++.+ ..+|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~ 83 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 83 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeE
Confidence 3578999999999999999999975 5788999999765433 3568899999999999999999998754 3478
Q ss_pred EEEeeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCC
Q 011763 208 LVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (478)
|||||++++.+..+... ..++++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+......
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999998777654332 2358999999999999999999999999999999999999999999999999998776544
Q ss_pred CCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 286 ~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
........+|+.|+|||++.+ ..++.++|||||||++|||+| |.+||...+..+.+..+......+
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~------------ 230 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV------------ 230 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------
T ss_pred cccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC------------
Confidence 344455678999999999875 678999999999999999999 567777777776666654321100
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh--CcccCC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFST 418 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~--hp~f~~ 418 (478)
....+++++.+||.+||+.||++|||+.++++ |+||+.
T Consensus 231 ----------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 ----------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 01357889999999999999999999999998 888863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=405.59 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=200.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|++++.||+|+||+||+|++. +++.||||+++.+... .+.+.+|+++|++++|||||++++++.. ...+||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceecc--CCceEE
Confidence 468999999999999999999975 5678999999865433 3567899999999999999999999987 567899
Q ss_pred EEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||++++.+.. +......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++........
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999876554 4555567899999999999999999999999999999999999999999999999999876554434
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||...+..+.+..+......+.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~------------- 223 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------------- 223 (263)
T ss_dssp -------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC-------------
T ss_pred eecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Confidence 4445678999999999886 679999999999999999999 6788888777777776654211110
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....++++.+||.+||+.||++|||++|+|+|
T Consensus 224 ---------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 224 ---------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 12467899999999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=403.07 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=214.9
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~l 208 (478)
.++|+++++||+|+||+||+|+++ +++.||||+++...... +.+.+|+.++++++|||||++++++.+ ...+++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~i 76 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEee--CCceEE
Confidence 468999999999999999999984 67899999998765443 467899999999999999999999987 567999
Q ss_pred EEeeccCCchh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC
Q 011763 209 VFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (478)
Q Consensus 209 v~e~~~~~ll~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 287 (478)
||||++++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999976544 44555667999999999999999999999999999999999999999999999999999876654444
Q ss_pred CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCcc
Q 011763 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (478)
Q Consensus 288 ~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 366 (478)
......+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+...++......+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~------------- 222 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------------- 222 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-------------
T ss_pred eecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence 4455678999999999886 678999999999999999998 8999999998888777654221111
Q ss_pred ccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
....++++.+||.+||+.||++|||+.++|+|
T Consensus 223 ---------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 223 ---------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 12567899999999999999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-53 Score=411.33 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=201.9
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
..++|++.+.||+|+||+||+|++..+++ .||||++.... .....+.+.+|+.+|++|+|||||++++++.. ..
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~ 100 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--ST 100 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CC
Confidence 35689999999999999999999876654 58899886543 45566778999999999999999999999977 56
Q ss_pred eEEEEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
.+|||||||+++.+.. +......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 7899999999876665 444456799999999999999999999999999999999999999999999999999986653
Q ss_pred CCCC----CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhc
Q 011763 284 GHRQ----PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 284 ~~~~----~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
.... ......+|+.|+|||++.+ ..|+.++|||||||+||||++ |++||.+.+..+.+..+......+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----- 254 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP----- 254 (299)
T ss_dssp ---------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-----
T ss_pred CCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 3221 1122456899999999876 678999999999999999998 8999999988887777654221111
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...+++++.+||.+||+.||.+|||+.|++++
T Consensus 255 -----------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 -----------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -----------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -----------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 13578899999999999999999999998865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-53 Score=407.48 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=213.7
Q ss_pred cccceeeeee-eeecCceEEEEEEECC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 128 RADAFEKLEK-IGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 128 ~~~~y~~~~~-LG~G~~g~V~~~~~~~--~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
..++|.+.+. ||+|+||+||+|.++. ++..||||+++... .....+.+.+|+++|++++|||||++++++.. +
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~ 81 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---E 81 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---S
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---C
Confidence 3568999985 9999999999998754 45579999997553 45667788999999999999999999999865 3
Q ss_pred eEEEEEeeccCCchhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
.+||||||++++.+..+ ......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 48999999998766554 55566899999999999999999999999999999999999999999999999999987654
Q ss_pred CCC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 284 GHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 284 ~~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+.+..+.... .+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~--~~------- 231 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--RM------- 231 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--CC-------
T ss_pred cccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CC-------
Confidence 322 22234567899999999876 678999999999999999998 999999988877776664311 10
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHH---HhCcccC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA---LASEYFS 417 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~---L~hp~f~ 417 (478)
...+.+|+++.+||.+||+.||++|||+.++ |+|+|++
T Consensus 232 -------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 -------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0113678999999999999999999999887 6788874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=409.08 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=204.5
Q ss_pred eeeeecCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEEEeec
Q 011763 136 EKIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 136 ~~LG~G~~g~V~~~~~~--~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
++||+|+||+||+|.+. .+++.||||+++....+....+.+.+|+.+|++++|||||++++++.. +..||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 47999999999999754 456789999998665556667788999999999999999999999864 3478999999
Q ss_pred cCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCCC--Cccc
Q 011763 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTS 291 (478)
Q Consensus 214 ~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~--~~~~ 291 (478)
+++.+..+......+++..+..++.||+.||.|||+++||||||||+||||+.++.+||+|||+++........ ....
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 99877777666678999999999999999999999999999999999999999999999999999876543221 2233
Q ss_pred cccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCCCccccCC
Q 011763 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (478)
Q Consensus 292 ~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 370 (478)
..+|+.|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+... ..+
T Consensus 170 ~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~~~----------------- 229 (277)
T d1xbba_ 170 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ERM----------------- 229 (277)
T ss_dssp -CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CCC-----------------
T ss_pred cCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--CCC-----------------
Confidence 467899999999876 678999999999999999998 89999998887766665431 110
Q ss_pred CCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHH---HhCcccC
Q 011763 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA---LASEYFS 417 (478)
Q Consensus 371 ~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~---L~hp~f~ 417 (478)
.....+|+++.+||.+||+.||.+|||+.++ |+|+|++
T Consensus 230 ---------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 230 ---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 0013578999999999999999999999998 5676653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-53 Score=415.67 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=207.1
Q ss_pred cccceeeeeeeeecCceEEEEEEECCCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeec
Q 011763 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (478)
Q Consensus 128 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~-----~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 201 (478)
..++|++.+.||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|.++ +|||||++++++.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~- 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL- 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee-
Confidence 35789999999999999999999865543 69999986543 234445678899999998 89999999999987
Q ss_pred CCceEEEEEeeccCCchhhccCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 011763 202 LSCSIYLVFEYMEHDITGLLSCPD-----------------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~~~-----------------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlk 258 (478)
...+|||||||+++.+..+.... ..+++..++.|+.||+.||.|||+++|||||||
T Consensus 113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 113 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred -CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 56789999999986655443221 348999999999999999999999999999999
Q ss_pred CCcEEEecCCcEEEeecccccccCCCCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 011763 259 GSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGR 336 (478)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~ 336 (478)
|+|||++.++.+||+|||+|+........ ......+|+.|+|||++.+ ..|+.++|||||||+||||++ |++||.+.
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999866543322 2234567999999999876 678999999999999999997 89999988
Q ss_pred ChHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 337 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 337 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
+..+.+.+++..-..++ ....+++++.+||.+||+.||++|||++|+++|
T Consensus 271 ~~~~~~~~~~~~~~~~~---------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCC---------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77777766665321111 013578999999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=417.42 Aligned_cols=266 Identities=25% Similarity=0.413 Sum_probs=217.7
Q ss_pred ccceeeeeeeeecCceEEEEEEE---CCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCC-CCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARD---LDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLDH-PNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~---~~~~~~vAlK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~ 202 (478)
.++|++++.||+|+||+||+|++ ..+|+.||||+++.... +....+.+.+|+++|++++| |||+++++++.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence 67899999999999999999987 44789999999865432 11223456789999999965 899999999988
Q ss_pred CceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccC
Q 011763 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~ 282 (478)
...+|+||||+.++.+..+......+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 67899999999988777776666688999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCccccccCCcccCcccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 283 TGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 283 ~~~~~~~~~~~~t~~y~APE~l~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
...........+++.|+|||++.+. ..++.++|||||||+||+|++|+.||.+.+..+...++.........
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~------- 253 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------- 253 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC-------
Confidence 4444444567789999999998753 35788999999999999999999999887655555444432211110
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCcc-----CHHHHHhCcccCCCCC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~-----ta~e~L~hp~f~~~~~ 421 (478)
.....+++++.+||.+||.+||.+|| |++|+|+||||+...+
T Consensus 254 ------------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 254 ------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp ------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ------------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 01136789999999999999999999 5899999999987553
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=401.55 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=205.6
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||+||+|++..+ +.||||+++..... .+.+.+|+.+|++++|||||++++++.+ +.+
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~ 86 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 86 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec---CCe
Confidence 3467899999999999999999998655 56999999765433 3568899999999999999999998854 347
Q ss_pred EEEEeeccCCchhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 207 YLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
|+||||++++.+..+.. ....+++.++..++.||+.||+|||++||+||||||+||||+.++++||+|||+++.....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 89999999876554433 2346999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.........+|+.|+|||++.. ..++.++|||||||+||||++| .+||......+.+..+......+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~----------- 234 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------- 234 (285)
T ss_dssp ---------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred CceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 4444455678999999999976 6789999999999999999995 56677777776766664422111
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh--CcccCC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFST 418 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~--hp~f~~ 418 (478)
....+++++++||.+||+.||++|||++++++ ++||+.
T Consensus 235 -----------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 -----------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11367899999999999999999999999988 889976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=399.85 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=200.2
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCce
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTG---KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~---~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 205 (478)
.++|++.+.||+|+||+||+|++..++ ..||||+++... .....+.+.+|+.+|++++|||||++++++.+ +.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---Ce
Confidence 568999999999999999999986543 468888886433 45556778899999999999999999999854 45
Q ss_pred EEEEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 206 IYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 206 ~~lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
+||||||++++.+.. +......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 899999999865554 4455667999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.........+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+.++..... +
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~--~---------- 228 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--L---------- 228 (273)
T ss_dssp ---------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--C----------
T ss_pred cceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--C----------
Confidence 3334445667999999999876 678999999999999999998 8999999988887777654211 0
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
...+.+|+++.+||.+||+.||.+|||+.|+++|
T Consensus 229 ----------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 ----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0124688999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=393.98 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=200.2
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecC
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~----~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 202 (478)
+..+.|++.+.||+|+||+||+|.+..++ ..||||+++... .......+.+|+.+|++++|||||++++++.+
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-- 80 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-- 80 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--
Confidence 34568999999999999999999876544 479999997543 45556678899999999999999999999977
Q ss_pred CceEEEEEeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeeccccccc
Q 011763 203 SCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~ 281 (478)
...+++||||+.++++.. +......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 567899999999876554 4445567999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCC--CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCCchhhc
Q 011763 282 NTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (478)
Q Consensus 282 ~~~~~--~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 358 (478)
..... .......+|+.|+|||++.+ ..++.++|||||||+||||++| .+||...+..+.+..+.... .++
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~~----- 233 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RLP----- 233 (283)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCC-----
T ss_pred cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-CCC-----
Confidence 43322 12233467899999999876 6799999999999999999995 56666666666555543321 110
Q ss_pred cCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....++..+.+||.+||+.||++|||+.|+++
T Consensus 234 ----------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 234 ----------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ----------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 01357889999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=402.13 Aligned_cols=252 Identities=20% Similarity=0.326 Sum_probs=203.0
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.++|++++.||+|+||+||+|++..+|+ .||+|+++... .....+.+.+|+.+|++++|||||++++++.+ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~- 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT--S- 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--S-
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C-
Confidence 4579999999999999999999987776 58888876433 33446678899999999999999999999976 3
Q ss_pred eEEEEEeeccC-CchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~-~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
..++++||+.+ +++..+......+++..++.++.||+.||.|||+++||||||||+||||+.++.+||+|||+|+....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 35677777765 56666666677899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC-CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCC
Q 011763 284 GHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (478)
Q Consensus 284 ~~~~-~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 361 (478)
.... ......+|+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+....+..... ++
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~-------- 233 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LP-------- 233 (317)
T ss_dssp TCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-CC--------
T ss_pred ccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CC--------
Confidence 3322 2234467999999999886 679999999999999999998 8999998877766555544211 11
Q ss_pred CCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
..+.+++++.+||.+||..||.+|||+.|+|+|
T Consensus 234 -------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 234 -------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp -------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 013578899999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=393.75 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=197.8
Q ss_pred ccceeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 202 (478)
.++|++.++||+|+||+||+|++.. +++.||||+++... .....+.+.+|+.++.++ +|+|||.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~- 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence 5789999999999999999998643 45789999997544 344456677788888777 789999999887654
Q ss_pred CceEEEEEeeccCCchhhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec
Q 011763 203 SCSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN 266 (478)
Q Consensus 203 ~~~~~lv~e~~~~~ll~~~~~----------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~ 266 (478)
...+++|||||+++.+..+.. ....+++..+..++.||+.||.|||+++||||||||+||||+.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 456899999999876655432 1235899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHH
Q 011763 267 EGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHK 344 (478)
Q Consensus 267 ~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~ 344 (478)
++.+||+|||+|+....... .......||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+....+.+.+
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986543322 23345678999999999986 7789999999999999999986 578988766555555
Q ss_pred HHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 345 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
++.....++ ....+++++.+||.+||+.||++|||+.|+|+|
T Consensus 249 ~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCC---------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 544221111 113578899999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=389.00 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=199.1
Q ss_pred ccceeeeeeeeecCceEEEEEEEC-CCC--cEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCc
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL-DTG--KIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~-~~~--~~vAlK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 204 (478)
.++|++++.||+|+||+||+|+.. .++ ..||||+++.+.. ..+..+.+.+|+.+|++++|||||++++++.+ .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---P 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---c
Confidence 568999999999999999999854 333 4689999876544 34456778899999999999999999999965 3
Q ss_pred eEEEEEeeccCCch-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCC
Q 011763 205 SIYLVFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (478)
Q Consensus 205 ~~~lv~e~~~~~ll-~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~ 283 (478)
.+++||||++++.+ ..+......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 47899999997554 44444556799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 284 GHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 284 ~~~~--~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.... ......+|..|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+.+.++......++
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~------- 235 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP------- 235 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-------
T ss_pred CCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC-------
Confidence 3221 1223456889999999986 678999999999999999998 8999999999988887754211111
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+|+++.+||.+||+.||++|||+.|+++
T Consensus 236 --------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 --------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11367899999999999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-50 Score=389.65 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=208.4
Q ss_pred ccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 203 (478)
.++|++++.||+|+||+||+|+.+ .+++.||||+++... .....+.+.+|+.+|++++||||+++++++.. .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeecc--C
Confidence 568999999999999999999864 356789999997543 45566788999999999999999999999987 5
Q ss_pred ceEEEEEeeccCCchhhccC------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 011763 204 CSIYLVFEYMEHDITGLLSC------------------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKG 259 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~------------------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp 259 (478)
...++||||++++.+..+.. ....+++..+..++.||+.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 67899999999865554432 122489999999999999999999999999999999
Q ss_pred CcEEEecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCC
Q 011763 260 SNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRT 337 (478)
Q Consensus 260 ~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~-~pf~~~~ 337 (478)
+||||+.++.+||+|||+|+....... .......+|+.|+|||++.+ ..|+.++|||||||+||||++|. +||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999976543222 22345677899999999986 77999999999999999999985 7899998
Q ss_pred hHHHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 338 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
..+.+..+.+.. .+ .....+++++.+||.+||+.||++|||+.|+++
T Consensus 248 ~~e~~~~v~~~~--~~--------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGN--IL--------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTC--CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCC--CC--------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888877765421 11 011367889999999999999999999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=383.38 Aligned_cols=247 Identities=19% Similarity=0.327 Sum_probs=198.4
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceE
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 206 (478)
+..++|++.+.||+|+||.||+|++ +|+.||||+++.+. ..+.+.+|+++|++++||||+++++++.+. ...+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~ 76 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGL 76 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CC
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcE
Confidence 3467899999999999999999997 47789999997543 345678999999999999999999988653 3457
Q ss_pred EEEEeeccCCchhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCC
Q 011763 207 YLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (478)
Q Consensus 207 ~lv~e~~~~~ll~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (478)
||||||++++.+..+... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999998766655432 235899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCchhhccCCCC
Q 011763 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (478)
Q Consensus 285 ~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 363 (478)
.....+|+.|+|||++.+ ..++.++|||||||++|||++ |++||...+..+.+..+.... .+
T Consensus 157 ----~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~--~~---------- 219 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KM---------- 219 (262)
T ss_dssp ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--CC----------
T ss_pred ----CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--CC----------
Confidence 233456889999999986 678999999999999999998 799999888777766653211 00
Q ss_pred CccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
.....+++++.+||.+||..||.+|||+.+++++
T Consensus 220 ----------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 220 ----------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0113578899999999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.9e-49 Score=393.95 Aligned_cols=282 Identities=26% Similarity=0.422 Sum_probs=218.3
Q ss_pred ceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----------CCCeeeecceee
Q 011763 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-----------HPNIIKLEGLIT 199 (478)
Q Consensus 131 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~ 199 (478)
+|+++++||+|+||+||+|++..+|+.||||+++.+ ....+.+.+|+.+|+.++ |+||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 699999999999999999999999999999999754 234456778999998885 478999999987
Q ss_pred ecCCceEEEEEeeccCCc---hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEecCCc------
Q 011763 200 SRLSCSIYLVFEYMEHDI---TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGV------ 269 (478)
Q Consensus 200 ~~~~~~~~lv~e~~~~~l---l~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~------ 269 (478)
.......+++|+++.... ..........+++..++.++.||+.||+|||+ +||+||||||+||||+.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 765667777777765432 22334455678999999999999999999997 89999999999999987653
Q ss_pred EEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHH
Q 011763 270 LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLH 343 (478)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~------~~~~~~ 343 (478)
++|+|||.+..... .....++|+.|+|||++.+ ..|+.++|||||||++++|++|+.||.... ..+.+.
T Consensus 171 ~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeeccccccccc----ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 99999999976543 2345678999999999886 678999999999999999999999997543 456778
Q ss_pred HHHHHcCCCCchhhccCCCCCccc-----cCC--C---CCCCccchhc---ccCCchhHHHHHHHhcCCCCCCccCHHHH
Q 011763 344 KIFKLCGSPPDDYWKKSKLPHATL-----FKP--Q---QPYDSSLRET---FKDLPTTAVNLIETLLSVEPYKRATASAA 410 (478)
Q Consensus 344 ~i~~~~g~~~~~~~~~~~~~~~~~-----~~~--~---~~~~~~l~~~---~~~~~~~l~~Li~~mL~~dP~~R~ta~e~ 410 (478)
+++..+|.++...+.......... ... . .+....+... ....++++++||.+||.+||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 888899998877765433211100 000 0 0011111111 12456789999999999999999999999
Q ss_pred HhCcccCCCC
Q 011763 411 LASEYFSTKP 420 (478)
Q Consensus 411 L~hp~f~~~~ 420 (478)
|+||||++..
T Consensus 326 L~Hp~f~~~~ 335 (362)
T d1q8ya_ 326 VNHPWLKDTL 335 (362)
T ss_dssp HTCGGGTTCT
T ss_pred hcCcccCCCC
Confidence 9999998644
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=389.56 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=205.3
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCCcE--EEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeeecCC
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~--vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 203 (478)
+..++|++.+.||+|+||+||+|++..++.. ||||+++... ..+..+.+.+|+++|+++ +|||||++++++.+ .
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~ 83 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 83 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--T
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--C
Confidence 4467999999999999999999999888764 6777775432 334456788999999999 79999999999987 6
Q ss_pred ceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecC
Q 011763 204 CSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (478)
Q Consensus 204 ~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~ 267 (478)
..+||||||++++.+..+... ...+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 789999999998666555432 3579999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCCCCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHH
Q 011763 268 GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIF 346 (478)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~-~pf~~~~~~~~~~~i~ 346 (478)
+.+||+|||+++....... .....+|..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+....+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp GCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CceEEcccccccccccccc--ccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999976543221 234467999999999976 67899999999999999999965 6888888777766654
Q ss_pred HHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 347 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
... .+ .....+++++.+||.+||+.||++|||+.|+|+|
T Consensus 241 ~~~--~~--------------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGY--RL--------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTC--CC--------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcC--CC--------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 311 10 0113578899999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=389.28 Aligned_cols=260 Identities=16% Similarity=0.227 Sum_probs=214.4
Q ss_pred ccccceeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeec
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 201 (478)
+..++|++.+.||+|+||+||+|.+. .+++.||||+++... .......+.+|+.++++++|||||++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~- 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ- 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-
Confidence 34679999999999999999999874 245789999997543 44556678899999999999999999999976
Q ss_pred CCceEEEEEeeccCCchhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEE
Q 011763 202 LSCSIYLVFEYMEHDITGLLSC----------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLK 271 (478)
Q Consensus 202 ~~~~~~lv~e~~~~~ll~~~~~----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vk 271 (478)
....+|||||+.++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+||||+.++++|
T Consensus 95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 567899999999876654432 223578999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHc
Q 011763 272 LADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLC 349 (478)
Q Consensus 272 l~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~~ 349 (478)
|+|||+|+....... .......+|+.|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+.+..+....
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 999999986543322 22233467999999999886 6789999999999999999998 58899888888877765421
Q ss_pred CCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh------CcccCC
Q 011763 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA------SEYFST 418 (478)
Q Consensus 350 g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~------hp~f~~ 418 (478)
. ++ ..+.+++.+.+||.+||+.||++|||+.++|+ +|+|++
T Consensus 253 ~-~~---------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 253 L-LD---------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp C-CC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred C-CC---------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 1 00 11357889999999999999999999999997 677654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=383.45 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=204.5
Q ss_pred ccccceeeeeeeeecCceEEEEEEECCCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeeccee
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG-------KIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLI 198 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~-------~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 198 (478)
+..++|++.+.||+|+||.||+|++..++ ..||||+++.+. .......+.+|+.++.++ +|||||+++++|
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 34679999999999999999999875543 479999997654 445567788899999888 899999999999
Q ss_pred eecCCceEEEEEeeccCCchhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 011763 199 TSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (478)
Q Consensus 199 ~~~~~~~~~lv~e~~~~~ll~~~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NI 262 (478)
.+ ...+|+||||++++.+..+... ...+++..++.++.||+.||.|||+++||||||||+||
T Consensus 89 ~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 89 TQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp CS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred cc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 87 5679999999998766555432 23589999999999999999999999999999999999
Q ss_pred EEecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 011763 263 LVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340 (478)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~ 340 (478)
|++.++.+||+|||+++....... .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 999999999999999986644322 22344567999999999876 789999999999999999998 789999888766
Q ss_pred HHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 341 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
....+... ..++ ....+++++.+||.+||+.||.+|||+.|+|+
T Consensus 246 ~~~~i~~~--~~~~--------------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 246 LFKLLKEG--HRMD--------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHTT--CCCC--------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcC--CCCC--------------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 65554321 1110 01357899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=384.54 Aligned_cols=255 Identities=20% Similarity=0.293 Sum_probs=211.5
Q ss_pred ccccceeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCeeeecceeee
Q 011763 127 LRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (478)
Q Consensus 127 ~~~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 200 (478)
+..++|++.++||+|+||.||+|++ ..+++.||||+++... .......+.+|+.++..+ +|||||++++++.+
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 3457999999999999999999985 3567899999998654 455566788999999999 79999999999987
Q ss_pred cCCceEEEEEeeccCCchhhccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 011763 201 RLSCSIYLVFEYMEHDITGLLSC------------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (478)
Q Consensus 201 ~~~~~~~lv~e~~~~~ll~~~~~------------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NI 262 (478)
...+|||||||+++.+..+.. ....+++..+..++.||+.||.|||+++||||||||+||
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 567899999999876555432 223589999999999999999999999999999999999
Q ss_pred EEecCCcEEEeecccccccCCCCC-CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 011763 263 LVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340 (478)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~ 340 (478)
|++.++.+||+|||+++....... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987654332 22344577999999999876 678999999999999999998 778888887777
Q ss_pred HHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 341 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.+.+++..-..+.. ...+++++.+||.+||+.||.+|||+.|+|+
T Consensus 256 ~~~~~i~~~~~~~~---------------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 256 KFYKMIKEGFRMLS---------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHTCCCCC---------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCCC---------------------------cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77766653211110 1357889999999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-48 Score=380.21 Aligned_cols=262 Identities=19% Similarity=0.241 Sum_probs=205.5
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+++++.++|+|++.++..+... ....++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEE
Confidence 5799999999999999999999999999999998765432 2366899999999877766555444332 6778999
Q ss_pred EeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec---CCcEEEeecccccccCCCCC
Q 011763 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR 286 (478)
Q Consensus 210 ~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~~~~~~~~ 286 (478)
|||+++++...+......+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.......
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999999888877777778999999999999999999999999999999999999864 45799999999987654321
Q ss_pred ------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCchhhccC
Q 011763 287 ------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (478)
Q Consensus 287 ------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 360 (478)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-------- 232 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-------- 232 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH--------
T ss_pred ccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc--------
Confidence 12345678999999999887 678999999999999999999999998766554433332211000
Q ss_pred CCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHH---HHHhCcccCC
Q 011763 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AALASEYFST 418 (478)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~---e~L~hp~f~~ 418 (478)
.........+.+|+++.+||..||+.||++||++. ++|+|+|.+.
T Consensus 233 -------------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 233 -------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -------------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00011223357899999999999999999999986 5578887653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=374.11 Aligned_cols=250 Identities=19% Similarity=0.239 Sum_probs=198.0
Q ss_pred eeeeeeeecCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCCceEEEE
Q 011763 133 EKLEKIGQGTYSSVFRARDLDTG---KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (478)
Q Consensus 133 ~~~~~LG~G~~g~V~~~~~~~~~---~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~lv 209 (478)
.+.++||+|+||+||+|++..++ ..||||+++.. ......+.+.+|+++|++++|||||++++++... ....++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEE
Confidence 34678999999999999986543 36899998743 3566678899999999999999999999988653 4568999
Q ss_pred EeeccCCchhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeecccccccCCCCC--
Q 011763 210 FEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 286 (478)
Q Consensus 210 ~e~~~~~ll~~-~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 286 (478)
||||+++++.. +......+++..+..++.||+.||.|||+++|+||||||+||||++++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999876654 444555688899999999999999999999999999999999999999999999999986543321
Q ss_pred -CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHcCCCCchhhccCCCCC
Q 011763 287 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (478)
Q Consensus 287 -~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~ 364 (478)
.......+|+.|+|||++.. ..++.++|||||||+||||++|..||.... ..+....+... ..+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~~~----------- 253 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RRL----------- 253 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--CCC-----------
T ss_pred ceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--CCC-----------
Confidence 22233567999999999876 678999999999999999999776665443 33333333221 110
Q ss_pred ccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHhC
Q 011763 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (478)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~h 413 (478)
. ..+.+++++.+||.+||+.||++|||+.|+++|
T Consensus 254 ------~---------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 254 ------L---------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ------C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------C---------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 013578899999999999999999999999988
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-46 Score=365.03 Aligned_cols=253 Identities=20% Similarity=0.229 Sum_probs=206.7
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH-PNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~ 207 (478)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|++++..|.| +||+.+++++.. ....|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccE
Confidence 35899999999999999999999999999999998754322 235679999999964 899999998877 67899
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-----CCcEEEeecccccccC
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----EGVLKLADFGLANFSN 282 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-----~~~vkl~DFG~a~~~~ 282 (478)
+||||+++++...+......+++..+..++.|++.||.|||++||+||||||+||||+. ++.+||+|||+|+...
T Consensus 78 ~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999988888777777778999999999999999999999999999999999999974 5789999999998754
Q ss_pred CCCC------CCccccccCCcccCcccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCCCC
Q 011763 283 TGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPP 353 (478)
Q Consensus 283 ~~~~------~~~~~~~~t~~y~APE~l~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~~~~g~~~ 353 (478)
.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... .+...++....-.+
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~- 235 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST- 235 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-
T ss_pred cCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-
Confidence 3211 12345678999999999987 7799999999999999999999999986543 33333333221111
Q ss_pred chhhccCCCCCccccCCCCCCCccchhcccCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
.+.+..+.+|+++.+||..|+..+|++||+.+.+.+
T Consensus 236 -----------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 -----------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -----------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123344678999999999999999999999776643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=362.49 Aligned_cols=254 Identities=23% Similarity=0.257 Sum_probs=188.1
Q ss_pred cceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCeeeecceeeecCC--ceEE
Q 011763 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS--CSIY 207 (478)
Q Consensus 130 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~~~ 207 (478)
++|.+.+.||+|+||+||+|+. +|+.||||+++... ........|+..+..++|||||++++++..... ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 4799999999999999999986 68899999986432 211222235555567899999999999976433 3689
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS--------RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~--------~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
|||||++++.+..+.... .+++..+..++.|++.||.|||+ +|||||||||+||||+.++.+||+|||+++
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999987666665443 68999999999999999999996 599999999999999999999999999998
Q ss_pred ccCCCCC---CCccccccCCcccCcccccCCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCChH------------
Q 011763 280 FSNTGHR---QPLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELLIGKPILQGRTEV------------ 339 (478)
Q Consensus 280 ~~~~~~~---~~~~~~~~t~~y~APE~l~~~~-----~~~~~~DiwslG~il~elltG~~pf~~~~~~------------ 339 (478)
....... .......+|+.|+|||++.+.. .++.++|||||||+||||++|.+||......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 6644321 1234567899999999986532 2567899999999999999999887542211
Q ss_pred --HHHHHHHHHcCCCCchhhccCCCCCccccCCCCCCCccchhcc--cCCchhHHHHHHHhcCCCCCCccCHHHHHh
Q 011763 340 --EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALA 412 (478)
Q Consensus 340 --~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~l~~Li~~mL~~dP~~R~ta~e~L~ 412 (478)
+.+......-+ ..+.+...+ ......+.+||.+||..||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~-----------------------~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 237 SVEEMRKVVCEQK-----------------------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CHHHHHHHHTTSC-----------------------CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhccc-----------------------cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11111110000 000011111 123456899999999999999999999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=8.2e-26 Score=204.08 Aligned_cols=165 Identities=16% Similarity=0.108 Sum_probs=120.1
Q ss_pred eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCC----------------hHHHHHHHHHHHHHHhcCCCCeeeec
Q 011763 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE----------------PESVRFMAREILILRRLDHPNIIKLE 195 (478)
Q Consensus 132 y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~nIv~l~ 195 (478)
+.+.++||+|+||+||+|++. +|+.||||+++..... .........|..+|.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999985 6899999987642110 11123345688999999999998876
Q ss_pred ceeeecCCceEEEEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecCCcEEEeec
Q 011763 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (478)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF 275 (478)
++. . .+|+|||+++..... +++..+..++.||+.+|.|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~----~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWE----G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEE----T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred Eec----C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 542 1 269999999865443 3444567899999999999999999999999999999865 5899999
Q ss_pred ccccccCCCCCCCccccccCCcccC------cccccCCCCCCChhhHHHHHHH
Q 011763 276 GLANFSNTGHRQPLTSRVVTLWYRP------PELLLGATDYGPSVDLWSVGCV 322 (478)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~t~~y~A------PE~l~~~~~~~~~~DiwslG~i 322 (478)
|+|......... .|.. .+.+. +.|+.++|+||+.--
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHHH--HHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHHc--CCCCCcccHHHHHHH
Confidence 999765432110 1111 12221 457889999996533
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=1.8e-07 Score=86.04 Aligned_cols=140 Identities=13% Similarity=0.090 Sum_probs=89.6
Q ss_pred ccceeeeeeeeecCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeecceeeecCCceEE
Q 011763 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (478)
Q Consensus 129 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 207 (478)
...|+..+..+-++.+.||+.. .+++.++||+...... .....+.+|..+|..|. +--+.+++.+... .+..|
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~ 86 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSN 86 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceE
Confidence 3467777766555567899986 3566778888754321 11223567888888774 4345666666655 56789
Q ss_pred EEEeeccCCchhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 011763 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-------------------------------------- 249 (478)
Q Consensus 208 lv~e~~~~~ll~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-------------------------------------- 249 (478)
+||++++|..+....... .....++.++...|..||+
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 999999986553322111 1112233344444444442
Q ss_pred ---------------C------CceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 250 ---------------R------GVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 250 ---------------~------givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
. .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 27999999999999977666799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.17 E-value=8.8e-06 Score=73.92 Aligned_cols=74 Identities=14% Similarity=0.094 Sum_probs=48.6
Q ss_pred eeeecCc-eEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCeeeecceeeecCCceEEEEEeec
Q 011763 137 KIGQGTY-SSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--PNIIKLEGLITSRLSCSIYLVFEYM 213 (478)
Q Consensus 137 ~LG~G~~-g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~~~lv~e~~ 213 (478)
.+..|.. +.||+... ..+..+++|....... ..+..|+..|+.|.. -.+.+++.+..+ ....++||+++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEee
Confidence 3344443 67999975 4567789998654332 235678888887732 335666666555 55689999999
Q ss_pred cCCch
Q 011763 214 EHDIT 218 (478)
Q Consensus 214 ~~~ll 218 (478)
+|..+
T Consensus 89 ~G~~~ 93 (255)
T d1nd4a_ 89 PGQDL 93 (255)
T ss_dssp SSEET
T ss_pred ecccc
Confidence 88543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.01 E-value=5.5e-06 Score=80.90 Aligned_cols=76 Identities=20% Similarity=0.239 Sum_probs=47.0
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEeecC------CCChHHHHHHHHHHHHHHhc-CC--CCeeeecceeeecCCce
Q 011763 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFD------NFEPESVRFMAREILILRRL-DH--PNIIKLEGLITSRLSCS 205 (478)
Q Consensus 135 ~~~LG~G~~g~V~~~~~~~~~~~vAlK~~~~~------~~~~~~~~~~~~E~~~l~~l-~h--~nIv~l~~~~~~~~~~~ 205 (478)
.+.||.|....||++.+..+++.|+||.-... .. +....+...|+.+|+.+ .+ ..+++++.+ + ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~-~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d--~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESW-PLTIDRARIESSALIRQGEHVPHLVPRVFYS--D--TEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCC-CCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E--TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCC-CCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c--CCC
Confidence 55789999999999998777888999975421 11 11223445688888776 22 345556443 2 223
Q ss_pred EEEEEeeccC
Q 011763 206 IYLVFEYMEH 215 (478)
Q Consensus 206 ~~lv~e~~~~ 215 (478)
.++|||++++
T Consensus 106 ~~lvmE~L~~ 115 (392)
T d2pula1 106 AVTVMEDLSH 115 (392)
T ss_dssp TEEEECCCTT
T ss_pred CEEEEeccCC
Confidence 4689999976
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.62 E-value=0.00011 Score=69.34 Aligned_cols=71 Identities=13% Similarity=0.163 Sum_probs=44.5
Q ss_pred ceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCe-----eeecceeeecCCceEEEEEeeccCCc
Q 011763 143 YSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-----IKLEGLITSRLSCSIYLVFEYMEHDI 217 (478)
Q Consensus 143 ~g~V~~~~~~~~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~l~~~~~~~~~~~~~lv~e~~~~~l 217 (478)
--.||+++. .+|..|++|+.+....+ .+.+..|+..|..|....| +..-+-.........+.++++++|..
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 358999985 56888999998755433 3556778888888842222 12211111112556788999988743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.53 E-value=0.00019 Score=69.53 Aligned_cols=82 Identities=18% Similarity=0.209 Sum_probs=53.5
Q ss_pred cccccccceeeeeeeeecCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCeeeec
Q 011763 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLD-------TGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLE 195 (478)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vAlK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~ 195 (478)
|..+..+.+++ +.|+.|-.-.+|++.... ..+.|.+++.- .... .-...+|..+++.+. +.-..+++
T Consensus 37 W~~~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~---~idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 37 WKTVPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET---ESHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp HHHCCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC---HHHHHHHHHHHHHHHHTTSSSCEE
T ss_pred ccCCCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch---hhHHHHHHHHHHHHHhCCCCCeEE
Confidence 54445566665 567778888999998643 24567888765 2211 223457999999884 44445776
Q ss_pred ceeeecCCceEEEEEeeccCC
Q 011763 196 GLITSRLSCSIYLVFEYMEHD 216 (478)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~ 216 (478)
+++.+ .+|+||+++.
T Consensus 112 ~~~~~------g~I~efi~g~ 126 (395)
T d1nw1a_ 112 GIFSG------GRLEEYIPSR 126 (395)
T ss_dssp EEETT------EEEECCCCEE
T ss_pred EEcCC------ceEEEEeccc
Confidence 66532 4799999874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.83 E-value=0.0011 Score=61.66 Aligned_cols=30 Identities=30% Similarity=0.450 Sum_probs=26.8
Q ss_pred CCceeccCCCCcEEEecCCcEEEeeccccc
Q 011763 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (478)
Q Consensus 250 ~givHrDlkp~NILl~~~~~vkl~DFG~a~ 279 (478)
.|+||+|+.+.||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988777899999874
|